(lp1
(dp2
S'CDSRfilename'
p3
VCD002112 v. 6.0 Desmopressin for nocturnal enuresis in children.rm5
p4
sS'refs'
p5
(lp6
(dp7
S'PMfilename'
p8
V3539030.xml
p9
sS'CDSRrefcode'
p10
VSTD-Dimson-1986_x0023_
p11
sS'PMCid'
p12
S'PMC1778127'
p13
sa(dp14
g8
V7039520.xml
p15
sg10
VSTD-Aladjem-1982
p16
sg12
S'PMC1627511'
p17
sa(dp18
g8
V3307643.xml
p19
sg10
VSTD-Fjellestad-1987_x0023_
p20
sg12
S'PMC1779260'
p21
sa(dp22
g8
V3513716.xml
p23
sg10
VSTD-Wille-1986
p24
sg12
S'PMC1777552'
p25
sasa(dp26
g3
VCD003019 v. 7.0 Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in child.rm5
p27
sg5
(lp28
(dp29
g8
V6407644.xml
p30
sg10
VSTD-Dearlove-1983
p31
sg12
S'PMC1548276'
p32
sasa(dp33
g3
VCD003167 v. 5.0 Medical interventions for primary open angle glaucoma and ocular hypertension.rm5
p34
sg5
(lp35
(dp36
g8
V2562546.xml
p37
sg10
VSTD-Kass-1989
p38
sg12
S'PMC1298559'
p39
sa(dp40
g8
V3067745.xml
p41
sg10
VSTD-Geyer-1988
p42
sg12
S'PMC1041616'
p43
sa(dp44
g8
V11466256.xml
p45
sg10
VSTD-Watson-2001
p46
sg12
S'PMC1724066'
p47
sasa(dp48
g3
VCD000560 v. 11.0 Psychological debriefing for preventing post traumatic stress disorder (PTSD).rm5
p49
sg5
(lp50
(dp51
g8
V11053173.xml
p52
sg10
VSTD-Small-2000
p53
sg12
S'PMC27510'
p54
sa(dp55
g8
V8973231.xml
p56
sg10
VSTD-Hobbs-1996
p57
sg12
S'PMC2352974'
p58
sasa(dp59
g3
VCD000016 v. 10.0 Amodiaquine for treating malaria.rm5
p60
sg5
(lp61
(dp62
g8
V3293827.xml
p63
sg10
VSTD-Mozambique-1986
p64
sg12
S'PMC2491050'
p65
sa(dp66
g8
V3048759.xml
p67
sg10
VSTD-China-1986
p68
sg12
S'PMC2491139'
p69
sa(dp70
g8
V12163917.xml
p71
sg10
VSTD-Cameroon_x002d_H_x00e9_v_x00e9_cam2001
p72
sg12
S'PMC2567565'
p73
sasa(dp74
g3
VCD002992 v. 11.0 Cardioselective beta-blockers for reversible airway disease.rm5
p75
sg5
(lp76
(dp77
g8
V2878680.xml
p78
sg10
VSTD-Lammers-1986a
p79
sg12
S'PMC1401187'
p80
sa(dp81
g8
V26371.xml
p82
sg10
VSTD-Benson-1978
p83
sg12
S'PMC1429350'
p84
sa(dp85
g8
V786353.xml
p86
sg10
VSTD-Skinner-1975b
p87
sg12
S'PMC1402628'
p88
sasa(dp89
g3
VCD008987 v. 2.0 Surgical interventions for treating radial head fractures in adults.rm5
p90
sg5
(lp91
(dp92
g8
V20680272.xml
p93
sg10
VSTD-Chen-2011
p94
sg12
S'PMC3167410'
p95
sa(dp96
g8
V17938924.xml
p97
sg10
VSTD-Ruan-2009
p98
sg12
S'PMC2899229'
p99
sasa(dp100
g3
VCD007482 v. 3.0 Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.rm5
p101
sg5
(lp102
(dp103
g8
V6344970.xml
p104
sg10
VSTD-Fugere-1983
p105
sg12
S'PMC1875263'
p106
sasa(dp107
g3
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p108
sg5
(lp109
(dp110
g8
V23078768.xml
p111
sg10
VSTD-Hansudewechakul--2012
p112
sg12
S'PMC3494174'
p113
sa(dp114
g8
V20687955.xml
p115
sg10
VSTD-Humphreys-2010
p116
sg12
S'PMC2924332'
p117
sa(dp118
g8
V20877631.xml
p119
sg10
VSTD-Fatti-2010
p120
sg12
S'PMC2943483'
p121
sa(dp122
g8
V19939445.xml
p123
sg10
VSTD-Jaffar-2009
p124
sg12
S'PMC2806484'
p125
sa(dp126
g8
V23272094.xml
p127
sg10
VSTD-Odafe-2012
p128
sg12
S'PMC3521762'
p129
sasa(dp130
g3
VCD001218 v. 8.0 Acupuncture for migraine prophylaxis.rm5
p131
sg5
(lp132
(dp133
g8
V15023828.xml
p134
sg10
VSTD-Vickers-2004
p135
sg12
S'PMC381326'
p136
sasa(dp137
g3
VCD004149 v. 4.0 Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic c.rm5
p138
sg5
(lp139
(dp140
g8
V23426574.xml
p141
sg10
VSTD-DeLuca-2002
p142
sg12
S'PMC3580954'
p143
sasa(dp144
g3
VCD000284 v. 13.5 Chlorpromazine versus placebo for schizophrenia.rm5
p145
sg5
(lp146
(dp147
g8
V23776198.xml
p148
sg10
VSTD-Abrams-1958
p149
sg12
S'PMC3699438'
p150
sa(dp151
g8
V16699603.xml
p152
sg10
VSTD-Chouinard-1990
p153
sg12
S'PMC1449877'
p154
sa(dp155
g8
V23388243.xml
p156
sg10
VSTD-Payne-1960
p157
sg12
S'PMC3577661'
p158
sa(dp159
g8
V13357965.xml
p160
sg10
VSTD-Shepherd-1956
p161
sg12
S'PMC497211'
p162
sasa(dp163
g3
VCD006216 v. 5.0 Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.rm5
p164
sg5
(lp165
(dp166
g8
V10348762.xml
p167
sg10
VSTD-Harbarth-1999
p168
sg12
S'PMC89288'
p169
sasa(dp170
g3
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p171
sg5
(lp172
(dp173
g8
V12609940.xml
p174
sg10
VSTD-Trivedi-2003
p175
sg12
S'PMC150177'
p176
sa(dp177
g8
V17355644.xml
p178
sg10
VSTD-Lannin-2007
p179
sg12
S'PMC1832184'
p180
sa(dp181
g8
V9055716.xml
p182
sg10
VSTD-McMurdo-1997
p183
sg12
S'PMC2126045'
p184
sa(dp185
g8
V21680622.xml
p186
sg10
VSTD-Spink-2011
p187
sg12
S'PMC3116775'
p188
sa(dp189
g8
V11264206.xml
p190
sg10
VSTD-Robertson-2001a
p191
sg12
S'PMC30094'
p192
sa(dp193
g8
V2354297.xml
p194
sg10
VSTD-Carpenter-1990
p195
sg12
S'PMC1662856'
p196
sa(dp197
g8
V16183652.xml
p198
sg10
VSTD-Campbell-2005
p199
sg12
S'PMC1246082'
p200
sa(dp201
g8
V15615747.xml
p202
sg10
VSTD-Harwood-2005
p203
sg12
S'PMC1772474'
p204
sa(dp205
g8
V8343668.xml
p206
sg10
VSTD-Van-Rossum-1993
p207
sg12
S'PMC1678489'
p208
sa(dp209
g8
V11039967.xml
p210
sg10
VSTD-Van-Haastregt-2000
p211
sg12
S'PMC27508'
p212
sa(dp213
g8
V7977921.xml
p214
sg10
VSTD-Wagner-1994
p215
sg12
S'PMC1615188'
p216
sa(dp217
g8
V12403738.xml
p218
sg10
VSTD-Carter-2002
p219
sg12
S'PMC134175'
p220
sa(dp221
g8
V9366737.xml
p222
sg10
VSTD-Campbell-1997
p223
sg12
S'PMC2127698'
p224
sa(dp225
g8
V20501583.xml
p226
sg10
VSTD-Haran-2010
p227
sg12
S'PMC2876235'
p228
sa(dp229
g8
V20823124.xml
p230
sg10
VSTD-Conroy-2010
p231
sg12
S'PMC2956530'
p232
sa(dp233
g8
V21526229.xml
p234
sg10
VSTD-Dangour-2011
p235
sg12
S'PMC3079648'
p236
sa(dp237
g8
V1392755.xml
p238
sg10
VSTD-Vetter-1992
p239
sg12
S'PMC1882829'
p240
sa(dp241
g8
V20460331.xml
p242
sg10
VSTD-Logan-2010
p243
sg12
S'PMC2868162'
p244
sa(dp245
g8
V15860827.xml
p246
sg10
VSTD-Porthouse-2005
p247
sg12
S'PMC557150'
p248
sa(dp249
g8
V11563205.xml
p250
sg10
VSTD-Hogan-2001
p251
sg12
S'PMC81411'
p252
sa(dp253
g8
V10746118.xml
p254
sg10
VSTD-Steinberg-2000
p255
sg12
S'PMC1731645'
p256
sa(dp257
g8
V18373136.xml
p258
sg10
VSTD-Weber-2008
p259
sg12
S'PMC2359523'
p260
sa(dp261
g8
V15086643.xml
p262
sg10
VSTD-Liu_x002d_Ambrose-2004
p263
sg12
S'PMC3344816'
p264
sasa(dp265
g3
VCD001732 v. 7.0 Injection sclerotherapy for varicose veins.rm5
p266
sg5
(lp267
(dp268
g8
V7427301.xml
p269
sg10
VSTD-Batch-1980
p270
sg12
S'PMC1713320'
p271
sa(dp272
g8
V3883876.xml
p273
sg10
VSTD-Scurr-1985
p274
sg12
S'PMC2498276'
p275
sa(dp276
g8
V2690721.xml
p277
sg10
VSTD-Shouler-1989
p278
sg12
S'PMC2499037'
p279
sasa(dp280
g3
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p281
sg5
(lp282
(dp283
g8
V12856053.xml
p284
sg10
VSTD-Asilian-2003
p285
sg12
S'PMC2572463'
p286
sa(dp287
g8
V17466071.xml
p288
sg10
VSTD-Nilforoushzadeh-2007
p289
sg12
S'PMC1891315'
p290
sa(dp291
g8
V18830058.xml
p292
sg10
VSTD-Nilforoushzadeh-2004
p293
sg12
S'PMC2553342'
p294
sasa(dp295
g3
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p296
sg5
(lp297
(dp298
g8
V11734634.xml
p299
sg10
VSTD-Dybul-2001
p300
sg12
S'PMC65000'
p301
sa(dp302
g8
V15630469.xml
p303
sg10
VSTD-Papasavvas-2004
p304
sg12
S'PMC539050'
p305
sa(dp306
g8
V11413308.xml
p307
sg10
VSTD-Hance-2001
p308
sg12
S'PMC114364'
p309
sa(dp310
g8
V11687611.xml
p311
sg10
VSTD-Ortiz-2001
p312
sg12
S'PMC60863'
p313
sa(dp314
g8
V12370434.xml
p315
sg10
VSTD-Oxenius-2002a
p316
sg12
S'PMC129766'
p317
sa(dp318
g8
V12239291.xml
p319
sg10
VSTD-Oxenius-2002
p320
sg12
S'PMC136545'
p321
sasa(dp322
g3
VCD001537 v. 7.0 Interventions for minimal change disease in adults with nephrotic syndrome.rm5
p323
sg5
(lp324
(dp325
g8
V3933645.xml
p326
sg10
VSTD-Imbasciati-1985
p327
sg12
S'PMC1417455'
p328
sa(dp329
g8
V3915841.xml
p330
sg10
VSTD-Coggins-1985
p331
sg12
S'PMC2279687'
p332
sasa(dp333
g3
VCD002218 v. 8.0 Antibiotics versus control for toxoplasma retinochoroiditis.rm5
p334
sg5
(lp335
(dp336
g8
V13374225.xml
p337
sg10
VSTD-Perkins-1956
p338
sg12
S'PMC1324697'
p339
sasa(dp340
g3
VCD002114 v. 10.0 Weighted vaginal cones for urinary incontinence.rm5
p341
sg5
(lp342
(dp343
g8
V10024253.xml
p344
sg10
VSTD-B_x00f8_-1999
p345
sg12
S'PMC27740'
p346
sasa(dp347
g3
VCD006484 v. 4.0 Influenza vaccination in children being treated with chemotherapy for cancer.rm5
p348
sg5
(lp349
(dp350
g8
V11369567.xml
p351
sg10
VSTD-Chisholm-2001
p352
sg12
S'PMC1718812'
p353
sasa(dp354
g3
VCD004338 v. 7.0 Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.rm5
p355
sg5
(lp356
(dp357
g8
V9536833.xml
p358
sg10
VSTD-Lyon-1998
p359
sg12
S'PMC1720741'
p360
sasa(dp361
g3
VCD006517 v. 5.2 Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.rm5
p362
sg5
(lp363
(dp364
g8
V22692090.xml
p365
sg10
VSTD-Murphy-2008
p366
sg12
S'PMC3767995'
p367
sasa(dp368
g3
VCD003489 v. 5.2 Malaria chemoprophylaxis in sickle cell disease.rm5
p369
sg5
(lp370
(dp371
g8
V14305376.xml
p372
sg10
VSTD-Warley-1965
p373
sg12
S'PMC1845333'
p374
sasa(dp375
g3
VCD001275 v. 12.0 Therapeutic ultrasound for pressure ulcers.rm5
p376
sg5
(lp377
(dp378
g8
V7728058.xml
p379
sg10
VSTD-ter-Riet-1995
p380
sg12
S'PMC2549431'
p381
sasa(dp382
g3
VCD007058 v. 3.0 Ultrasound for fetal assessment in early pregnancy.rm5
p383
sg5
(lp384
(dp385
g8
V7688253.xml
p386
sg10
VSTD-Norway
p387
sg12
S'PMC1678377'
p388
sasa(dp389
g3
VCD002240 v. 6.0 Behavioural and cognitive interventions with or without other treatments for the management of faeca.rm5
p390
sg5
(lp391
(dp392
g8
V3717993.xml
p393
sg10
VSTD-Taitz-1986
p394
sg12
S'PMC1777784'
p395
sa(dp396
g8
V9797593.xml
p397
sg10
VSTD-Nolan-1998
p398
sg12
S'PMC1717674'
p399
sa(dp400
g8
V8957948.xml
p401
sg10
VSTD-van-der-Plas-1996a
p402
sg12
S'PMC1511777'
p403
sasa(dp404
g3
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p405
sg5
(lp406
(dp407
g8
V18476075.xml
p408
sg10
VSTD-Hager-1996
p409
sg12
S'PMC2364471'
p410
sasa(dp411
g3
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p412
sg5
(lp413
(dp414
g8
V20855048.xml
p415
sg10
VSTD-Gilboa_x002d_Schechtman-2010
p416
sg12
S'PMC2945239'
p417
sa(dp418
g8
V19439099.xml
p419
sg10
VSTD-Catani-2009
p420
sg12
S'PMC2685130'
p421
sasa(dp422
g3
VCD002215 v. 4.0 Capitation salary fee-for-service and mixed systems of payment effects on the behaviour of primar.rm5
p423
sg5
(lp424
(dp425
g8
V2390552.xml
p426
sg10
VSTD-Krasnik-1990
p427
sg12
S'PMC1663335'
p428
sa(dp429
g8
V8603321.xml
p430
sg10
VSTD-Hutchison-1996
p431
sg12
S'PMC1487544'
p432
sasa(dp433
g3
VCD004282 v. 7.0 Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.rm5
p434
sg5
(lp435
(dp436
g8
V10102851.xml
p437
sg10
VSTD-Bredin-1999
p438
sg12
S'PMC27809'
p439
sa(dp440
g8
V20164474.xml
p441
sg10
VSTD-Wilkie-2010
p442
sg12
S'PMC3644582'
p443
sa(dp444
g8
V12433764.xml
p445
sg10
VSTD-Moore-2002
p446
sg12
S'PMC133453'
p447
sasa(dp448
g3
VCD007617 v. 4.0 Interventions for supporting informal caregivers of patients in the terminal phase of a disease.rm5
p449
sg5
(lp450
(dp451
g8
V18788966.xml
p452
sg10
VSTD-Allen-2008
p453
sg12
S'PMC2664509'
p454
sa(dp455
g8
V1483075.xml
p456
sg10
VSTD-Addington_x002d_Hall-1992
p457
sg12
S'PMC1883850'
p458
sasa(dp459
g3
VCD003525 v. 7.0 Surgery for lateral elbow pain.rm5
p460
sg5
(lp461
(dp462
g8
V17551726.xml
p463
sg10
VSTD-Radwan-2008
p464
sg12
S'PMC2551723'
p465
sasa(dp466
g3
VCD000520 v. 7.0 Injectable gold for rheumatoid arthritis.rm5
p467
sg5
(lp468
(dp469
g8
V13856636.xml
p470
sg10
VSTD-ERC-1960
p471
sg12
S'PMC1007132'
p472
sasa(dp473
g3
VCD004981 v. 4.0 Treatment for femoral pseudoaneurysms.rm5
p474
sg5
(lp475
(dp476
g8
V16415194.xml
p477
sg10
VSTD-Paschalidis-2006
p478
sg12
S'PMC1860748'
p479
sasa(dp480
g3
VCD002178 v. 6.0 Early emergency department treatment of acute asthma with systemic corticosteroids.rm5
p481
sg5
(lp482
(dp483
g8
V8135557.xml
p484
sg10
VSTD-Connett-1994a
p485
sg12
S'PMC1029734'
p486
sa(dp487
g8
V8135557.xml
p488
sg10
VSTD-Connett-1994b
p489
sg12
S'PMC1029734'
p490
sasa(dp491
g3
VCD008567 v. 5.0 General physical health advice for people with serious mental illness.rm5
p492
sg5
(lp493
(dp494
g8
V20008945.xml
p495
sg10
VSTD-Druss-2010
p496
sg12
S'PMC3775666'
p497
sasa(dp498
g3
VCD006283 v. 4.0 Physical therapy for Bell's palsy (idiopathic facial paralysis).rm5
p499
sg5
(lp500
(dp501
g8
V13572865.xml
p502
sg10
VSTD-Mosforth-1958
p503
sg12
S'PMC2026410'
p504
sa(dp505
g8
V24027359.xml
p506
sg10
VSTD-Qu-2005
p507
sg12
S'PMC3770119'
p508
sasa(dp509
g3
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p510
sg5
(lp511
(dp512
g8
V15743283.xml
p513
sg10
VSTD-Marigold-2005
p514
sg12
S'PMC3226796'
p515
sa(dp516
g8
V20501583.xml
p517
sg10
VSTD-Haran-2010
p518
sg12
S'PMC2876235'
p519
sasa(dp520
g3
VCD003340 v. 7.0 Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.rm5
p521
sg5
(lp522
(dp523
g8
V8328783.xml
p524
sg10
VSTD-Walsh-1993
p525
sg12
S'PMC187962'
p526
sa(dp527
g8
V7695302.xml
p528
sg10
VSTD-Parras-1995
p529
sg12
S'PMC162505'
p530
sa(dp531
g8
V10348762.xml
p532
sg10
VSTD-Harbarth-1999
p533
sg12
S'PMC89288'
p534
sasa(dp535
g3
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p536
sg5
(lp537
(dp538
g8
V16371154.xml
p539
sg10
VSTD-Elliott-2005
p540
sg12
S'PMC1352364'
p541
sasa(dp542
g3
VCD003573 v. 8.6 Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.rm5
p543
sg5
(lp544
(dp545
g8
V11082090.xml
p546
sg10
VSTD-Davies-2000
p547
sg12
S'PMC27532'
p548
sa(dp549
g8
V11828049.xml
p550
sg10
VSTD-Ojoo-2002
p551
sg12
S'PMC1746235'
p552
sa(dp553
g8
V11050257.xml
p554
sg10
VSTD-Cotton-2000
p555
sg12
S'PMC1745631'
p556
sa(dp557
g8
V11050258.xml
p558
sg10
VSTD-Skwarska-2000
p559
sg12
S'PMC1745644'
p560
sasa(dp561
g3
VCD001751 v. 6.2 Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.rm5
p562
sg5
(lp563
(dp564
g8
V6351994.xml
p565
sg10
VSTD-Gleeson-1983
p566
sg12
S'PMC1875644'
p567
sasa(dp568
g3
VCD005959 v. 3.0 Dynamic compression plating versus locked intramedullary nailing for humeral shaft fractures in adul.rm5
p569
sg5
(lp570
(dp571
g8
V16900354.xml
p572
sg10
VSTD-Changulani-2007
p573
sg12
S'PMC2267584'
p574
sasa(dp575
g3
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p576
sg5
(lp577
(dp578
g8
V7767151.xml
p579
sg10
VSTD-Bergmann-1995
p580
sg12
S'PMC2549556'
p581
sa(dp582
g8
V2539180.xml
p583
sg10
VSTD-Selby-1989
p584
sg12
S'PMC2247066'
p585
sa(dp586
g8
V6378236.xml
p587
sg10
VSTD-Anderson-1984
p588
sg12
S'PMC1976928'
p589
sa(dp590
g8
V2669626.xml
p591
sg10
VSTD-Bubley-1989
p592
sg12
S'PMC284246'
p593
sasa(dp594
g3
VCD002265 v. 9.0 Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lup.rm5
p595
sg5
(lp596
(dp597
g8
V15769918.xml
p598
sg10
VSTD-Barile_x002d_Fabris-2005
p599
sg12
S'PMC1755456'
p600
sasa(dp601
g3
VCD004534 v. 5.2 Educational and skills-based interventions for preventing relationship and dating violence in adoles.rm5
p602
sg5
(lp603
(dp604
g8
V9584032.xml
p605
sg10
VSTD-Foshee-1998
p606
sg12
S'PMC1508378'
p607
sa(dp608
g8
V21734267.xml
p609
sg10
VSTD-Davis-1997
p610
sg12
S'PMC3184292'
p611
sasa(dp612
g3
VCD003518 v. 8.0 Expectant care versus surgical treatment for miscarriage.rm5
p613
sg5
(lp614
(dp615
g8
V16707509.xml
p616
sg10
VSTD-Trinder-2006
p617
sg12
S'PMC1471967'
p618
sasa(dp619
g3
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p620
sg5
(lp621
(dp622
g8
V9894177.xml
p623
sg10
VSTD-Noyes-1998
p624
sg12
S'PMC1784814'
p625
sasa(dp626
g3
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p627
sg5
(lp628
(dp629
g8
V18710487.xml
p630
sg10
VSTD-Jamtvedt-2008
p631
sg12
S'PMC2518288'
p632
sa(dp633
g8
V9764257.xml
p634
sg10
VSTD-Clarke-1998
p635
sg12
S'PMC1756722'
p636
sa(dp637
g8
V16646970.xml
p638
sg10
VSTD-Finsen-2006
p639
sg12
S'PMC1459867'
p640
sa(dp641
g8
V16250910.xml
p642
sg10
VSTD-Cockayne-2005
p643
sg12
S'PMC1280926'
p644
sa(dp645
g8
V6465406.xml
p646
sg10
VSTD-Sallis-1984
p647
sg12
S'PMC1651776'
p648
sa(dp649
g8
V2348155.xml
p650
sg10
VSTD-Campbell-1990
p651
sg12
S'PMC1060602'
p652
sa(dp653
g8
V977774.xml
p654
sg10
VSTD-Stafford-1966
p655
sg12
S'PMC476133'
p656
sa(dp657
g8
V16157604.xml
p658
sg10
VSTD-Junghans-2005
p659
sg12
S'PMC1261191'
p660
sa(dp661
g8
V9101691.xml
p662
sg10
VSTD-Deehan-1997
p663
sg12
S'PMC1312912'
p664
sa(dp665
g8
V18738566.xml
p666
sg10
VSTD-Jacobs-1986
p667
sg12
S'PMC1517029'
p668
sa(dp669
g8
V9578862.xml
p670
sg10
VSTD-Etter-1998b
p671
sg12
S'PMC1756667'
p672
sa(dp673
g8
V9284664.xml
p674
sg10
VSTD-Dorman-1997
p675
sg12
S'PMC2127345'
p676
sa(dp677
g8
V8228774.xml
p678
sg10
VSTD-Roberts-1993
p679
sg12
S'PMC1059805'
p680
sa(dp681
g8
V9328560.xml
p682
sg10
VSTD-Leigh-Brown-1997
p683
sg12
S'PMC1060522'
p684
sa(dp685
g8
V12821704.xml
p686
sg10
VSTD-Morrison-2003
p687
sg12
S'PMC1732498'
p688
sa(dp689
g8
V11449019.xml
p690
sg10
VSTD-Clark-2001
p691
sg12
S'PMC1731952'
p692
sa(dp693
g8
V11152085.xml
p694
sg10
VSTD-Ashing_x002d_Giwa-2000
p695
sg12
S'PMC2568330'
p696
sa(dp697
g8
V9374887.xml
p698
sg10
VSTD-Sloan-1997
p699
sg12
S'PMC2127714'
p700
sa(dp701
g8
V15631963.xml
p702
sg10
VSTD-Leece-2006a
p703
sg12
S'PMC1550620'
p704
sa(dp705
g8
V10692967.xml
p706
sg10
VSTD-Roberts-2000
p707
sg12
S'PMC1731530'
p708
sa(dp709
g8
V15533256.xml
p710
sg10
VSTD-Roberts-2004
p711
sg12
S'PMC534094'
p712
sa(dp713
g8
V16091137.xml
p714
sg10
VSTD-McKenzie_x002d_McHarg-2005
p715
sg12
S'PMC1190172'
p716
sa(dp717
g8
V11812810.xml
p718
sg10
VSTD-Salim-Silva-2002
p719
sg12
S'PMC1732073'
p720
sa(dp721
g8
V3933719.xml
p722
sg10
VSTD-Smith-1985
p723
sg12
S'PMC1418119'
p724
sa(dp725
g8
V4009104.xml
p726
sg10
VSTD-Mortagy-1985
p727
sg12
S'PMC1052430'
p728
sa(dp729
g8
V1573369.xml
p730
sg10
VSTD-Salvesen-1992
p731
sg12
S'PMC1059502'
p732
sa(dp733
g8
V9039392.xml
p734
sg10
VSTD-Barker-1996
p735
sg12
S'PMC1060390'
p736
sa(dp737
g8
V9578863.xml
p738
sg10
VSTD-Peters-1998
p739
sg12
S'PMC1756664'
p740
sa(dp741
g8
V7122824.xml
p742
sg10
VSTD-Mullner-1982
p743
sg12
S'PMC1424368'
p744
sa(dp745
g8
V5484686.xml
p746
sg10
VSTD-Mann-2005
p747
sg12
S'PMC1179175'
p748
sa(dp749
g8
V11221822.xml
p750
sg10
VSTD-Shaw-2001
p751
sg12
S'PMC1089193'
p752
sa(dp753
g8
V11255905.xml
p754
sg10
VSTD-Shah-2001
p755
sg12
S'PMC1313955'
p756
sa(dp757
g8
V5496532.xml
p758
sg10
VSTD-Kaplan-1970b
p759
sg12
S'PMC1059291'
p760
sa(dp761
g8
V5496532.xml
p762
sg10
VSTD-Kaplan-1970a
p763
sg12
S'PMC1059291'
p764
sa(dp765
g8
V23252713.xml
p766
sg10
VSTD-Martin-1994
p767
sg12
S'PMC3628293'
p768
sa(dp769
g8
V16109160.xml
p770
sg10
VSTD-Kenyon-2005
p771
sg12
S'PMC1201139'
p772
sa(dp773
g8
V8238685.xml
p774
sg10
VSTD-Tambor-1993
p775
sg12
S'PMC1694880'
p776
sa(dp777
g8
V10628925.xml
p778
sg10
VSTD-Marsh-1999
p779
sg12
S'PMC1730548'
p780
sa(dp781
g8
V23760252.xml
p782
sg10
VSTD-Miller-1994
p783
sg12
S'PMC3754053'
p784
sa(dp785
g8
V2705601.xml
p786
sg10
VSTD-Maheux-1989b
p787
sg12
S'PMC1349512'
p788
sa(dp789
g8
V2705601.xml
p790
sg10
VSTD-Maheux-1989a
p791
sg12
S'PMC1349512'
p792
sa(dp793
g8
V15631963.xml
p794
sg10
VSTD-Leece-2006b
p795
sg12
S'PMC1550620'
p796
sa(dp797
g8
V18174120.xml
p798
sg10
VSTD-Br_x00f8_gger-2007
p799
sg12
S'PMC2270416'
p800
sa(dp801
g8
V18507819.xml
p802
sg10
VSTD-Lavelle-2008
p803
sg12
S'PMC2427026'
p804
sa(dp805
g8
V15537429.xml
p806
sg10
VSTD-Harrison-2004
p807
sg12
S'PMC534787'
p808
sa(dp809
g8
V16286502.xml
p810
sg10
VSTD-Paul-2005
p811
sg12
S'PMC1732979'
p812
sa(dp813
g8
V15222889.xml
p814
sg10
VSTD-Moses-2004
p815
sg12
S'PMC449720'
p816
sa(dp817
g8
V1573368.xml
p818
sg10
VSTD-Windsor-1992
p819
sg12
S'PMC1059500'
p820
sa(dp821
g8
V11782286.xml
p822
sg10
VSTD-Clark-TJ-2001
p823
sg12
S'PMC64502'
p824
sasa(dp825
g3
VCD007501 v. 2.0 Interventions to modify sexual risk behaviours for preventing HIV in homeless youth.rm5
p826
sg5
(lp827
(dp828
g8
V15878048.xml
p829
sg10
VSTD-Slesnick-2005
p830
sg12
S'PMC1933523'
p831
sa(dp832
g8
V17940861.xml
p833
sg10
VSTD-Slesnick-2008
p834
sg12
S'PMC2430633'
p835
sasa(dp836
g3
VCD005049 v. 5.0 Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.rm5
p837
sg5
(lp838
(dp839
g8
V10956284.xml
p840
sg10
VSTD-Kochiadakis-2000
p841
sg12
S'PMC1760955'
p842
sa(dp843
g8
V1093559.xml
p844
sg10
VSTD-Sodermark-1975
p845
sg12
S'PMC482826'
p846
sa(dp847
g8
V4934041.xml
p848
sg10
VSTD-Hillestad-1971
p849
sg12
S'PMC487206'
p850
sa(dp851
g8
V4911757.xml
p852
sg10
VSTD-Byrne_x002d_Quinn-1970
p853
sg12
S'PMC487336'
p854
sasa(dp855
g3
VCD004322 v. 6.0 Phlebotonics for haemorrhoids.rm5
p856
sg5
(lp857
(dp858
g8
V21472103.xml
p859
sg10
VSTD-A-ba_x002d_bai_x002d_ke_x002d_re-2011
p860
sg12
S'PMC3070018'
p861
sasa(dp862
g3
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p863
sg5
(lp864
(dp865
g8
V15026791.xml
p866
sg10
VSTD-Body-2004
p867
sg12
S'PMC2409647'
p868
sa(dp869
g8
V18711172.xml
p870
sg10
VSTD-Hershman-2008
p871
sg12
S'PMC2653138'
p872
sasa(dp873
g3
VCD008351 v. 2.3 Airway clearance techniques for bronchiectasis.rm5
p874
sg5
(lp875
(dp876
g8
V3353875.xml
p877
sg10
VSTD-Sutton-1988
p878
sg12
S'PMC461097'
p879
sasa(dp880
g3
VCD002113 v. 5.0 Prompted voiding for the management of urinary incontinence in adults.rm5
p881
sg5
(lp882
(dp883
g8
V6885672.xml
p884
sg10
VSTD-Schnelle-1983
p885
sg12
S'PMC1307878'
p886
sasa(dp887
g3
VCD002047 v. 9.2 Leflunomide for the treatment of rheumatoid arthritis.rm5
p888
sg5
(lp889
(dp890
g8
V15271770.xml
p891
sg10
VSTD-Dougados-2005
p892
sg12
S'PMC1755199'
p893
sa(dp894
g8
V11557646.xml
p895
sg10
VSTD-Scott-2001
p896
sg12
S'PMC1753377'
p897
sasa(dp898
g3
VCD005175 v. 4.0 The medical use of cannabis for reducing morbidity and mortality in patients with HIVAIDS.rm5
p899
sg5
(lp900
(dp901
g8
V18688212.xml
p902
sg10
VSTD-Ellis-2009
p903
sg12
S'PMC3066045'
p904
sasa(dp905
g3
VCD001005 v. 3.0 Limited (information only) patient education programs for adults with asthma.rm5
p906
sg5
(lp907
(dp908
g8
V8093148.xml
p909
sg10
VSTD-Osman-1994
p910
sg12
S'PMC2539560'
p911
sa(dp912
g8
V3416147.xml
p913
sg10
VSTD-Jenkinson-1988
p914
sg12
S'PMC1833935'
p915
sa(dp916
g8
V436049.xml
p917
sg10
VSTD-Moldofsky-1979
p918
sg12
S'PMC1819150'
p919
sasa(dp920
g3
VCD005401 v. 8.0 Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries.rm5
p921
sg5
(lp922
(dp923
g8
V16887950.xml
p924
sg10
VSTD-Hagel-2006
p925
sg12
S'PMC2586783'
p926
sasa(dp927
g3
VCD009670 v. 3.0 Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.rm5
p928
sg5
(lp929
(dp930
g8
V20409497.xml
p931
sg10
VSTD-Swan-2010
p932
sg12
S'PMC2879135'
p933
sa(dp934
g8
V17483139.xml
p935
sg10
VSTD-Aveyard-2007
p936
sg12
S'PMC2094265'
p937
sa(dp938
g8
V20363089.xml
p939
sg10
VSTD-Williams-2010
p940
sg12
S'PMC2859987'
p941
sa(dp942
g8
V10373999.xml
p943
sg10
VSTD-Reid-1999
p944
sg12
S'PMC1230362'
p945
sa(dp946
g8
V19339135.xml
p947
sg10
VSTD-Gariti-2009
p948
sg12
S'PMC2778325'
p949
sa(dp950
g8
V19349629.xml
p951
sg10
VSTD-Ellerbeck-2009
p952
sg12
S'PMC2825176'
p953
sa(dp954
g8
V9357351.xml
p955
sg10
VSTD-Lando-1997
p956
sg12
S'PMC1381132'
p957
sa(dp958
g8
V18048633.xml
p959
sg10
VSTD-Hollis-2007
p960
sg12
S'PMC2598511'
p961
sa(dp962
g8
V19915080.xml
p963
sg10
VSTD-Wu-2009
p964
sg12
S'PMC2784492'
p965
sa(dp966
g8
V19719796.xml
p967
sg10
VSTD-Lloyd_x002d_Richardson-2009
p968
sg12
S'PMC2763031'
p969
sa(dp970
g8
V19392908.xml
p971
sg10
VSTD-Hall-2009
p972
sg12
S'PMC2718733'
p973
sasa(dp974
g3
VCD003974 v. 5.0 Placebo interventions for all clinical conditions.rm5
p975
sg5
(lp976
(dp977
g8
V14600055.xml
p978
sg10
VSTD-Hovell-2003
p979
sg12
S'PMC1448065'
p980
sa(dp981
g8
V18390493.xml
p982
sg10
VSTD-Kaptchuk-2008
p983
sg12
S'PMC2364862'
p984
sa(dp985
g8
V11423594.xml
p986
sg10
VSTD-Robinson-2001
p987
sg12
S'PMC1760991'
p988
sa(dp989
g8
V9685273.xml
p990
sg10
VSTD-Tarrier-1998
p991
sg12
S'PMC28621'
p992
sa(dp993
g8
V3109581.xml
p994
sg10
VSTD-Thomas-1987
p995
sg12
S'PMC1246362'
p996
sa(dp997
g8
V12364304.xml
p998
sg10
VSTD-Thomas-2002b
p999
sg12
S'PMC128377'
p1000
sa(dp1001
g8
V12364304.xml
p1002
sg10
VSTD-Thomas-2002a
p1003
sg12
S'PMC128377'
p1004
sa(dp1005
g8
V16055451.xml
p1006
sg10
VSTD-Melchart-2005
p1007
sg12
S'PMC1184247'
p1008
sa(dp1009
g8
V17699546.xml
p1010
sg10
VSTD-Foster-2007
p1011
sg12
S'PMC1962890'
p1012
sa(dp1013
g8
V3538985.xml
p1014
sg10
VSTD-Conn-1986
p1015
sg12
S'PMC2498376'
p1016
sa(dp1017
g8
V10574854.xml
p1018
sg10
VSTD-Carbajal-1999
p1019
sg12
S'PMC28282'
p1020
sa(dp1021
g8
V3092933.xml
p1022
sg10
VSTD-Dundee-1986
p1023
sg12
S'PMC1341376'
p1024
sasa(dp1025
g3
VCD006858 v. 2.9 Personal assistance for children and adolescents (0-18) with intellectual impairments.rm5
p1026
sg5
(lp1027
(dp1028
g8
V17244293.xml
p1029
sg10
VSTD-Carlson-2007
p1030
sg12
S'PMC1955332'
p1031
sasa(dp1032
g3
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p1033
sg5
(lp1034
(dp1035
g8
V15154607.xml
p1036
sg10
VSTD-Ziboh-2004
p1037
sg12
S'PMC2275406'
p1038
sa(dp1039
g8
V9014601.xml
p1040
sg10
VSTD-Hederos-1996
p1041
sg12
S'PMC1511801'
p1042
sasa(dp1043
g3
VCD004431 v. 5.0 Psychological interventions for multiple sclerosis.rm5
p1044
sg5
(lp1045
(dp1046
g8
V11784832.xml
p1047
sg10
VSTD-Lincoln-2002
p1048
sg12
S'PMC1737698'
p1049
sasa(dp1050
g3
VCD006886 v. 2.0 Psychosocial interventions for smoking cessation in patients with coronary heart disease.rm5
p1051
sg5
(lp1052
(dp1053
g8
V14644967.xml
p1054
sg10
VSTD-Quist_x002d_Paulsen-2003
p1055
sg12
S'PMC286243'
p1056
sa(dp1057
g8
V9093045.xml
p1058
sg10
VSTD-Carlsson-1997
p1059
sg12
S'PMC484693'
p1060
sa(dp1061
g8
V11786452.xml
p1062
sg10
VSTD-Hajek-2002
p1063
sg12
S'PMC64504'
p1064
sasa(dp1065
g3
VCD003080 v. 6.0 Vocational rehabilitation for people with severe mental illness.rm5
p1066
sg5
(lp1067
(dp1068
g8
V18953116.xml
p1069
sg10
VSTD-Becker_x002d_Fort-Worth
p1070
sg12
S'PMC3372084'
p1071
sasa(dp1072
g3
VCD000155 v. 9.0 Ovulation suppression for endometriosis for women with subfertility.rm5
p1073
sg5
(lp1074
(dp1075
g8
V3107721.xml
p1076
sg10
VSTD-Thomas-1987
p1077
sg12
S'PMC1246283'
p1078
sasa(dp1079
g3
VCD003738 v. 6.0 Interventions for preventing posterior capsule opacification.rm5
p1080
sg5
(lp1081
(dp1082
g8
V11190013.xml
p1083
sg10
VSTD-Flach-2000
p1084
sg12
S'PMC1298216'
p1085
sa(dp1086
g8
V14736768.xml
p1087
sg10
VSTD-Hayashi-2004
p1088
sg12
S'PMC1771981'
p1089
sa(dp1090
g8
V15148204.xml
p1091
sg10
VSTD-Nejima-2004
p1092
sg12
S'PMC1772204'
p1093
sa(dp1094
g8
V17202203.xml
p1095
sg10
VSTD-Rabsilber-2007
p1096
sg12
S'PMC1955631'
p1097
sa(dp1098
g8
V12446370.xml
p1099
sg10
VSTD-Laurell-2002
p1100
sg12
S'PMC1771439'
p1101
sa(dp1102
g8
V17124239.xml
p1103
sg10
VSTD-Zemaitiene-2007
p1104
sg12
S'PMC1954737'
p1105
sasa(dp1106
g3
VCD008635 v. 2.3 Umbilical cord antiseptics for preventing sepsis and death among newborns.rm5
p1107
sg5
(lp1108
(dp1109
g8
V16546539.xml
p1110
sg10
VSTD-Mullany-2006
p1111
sg12
S'PMC2367116'
p1112
sa(dp1113
g8
V21509239.xml
p1114
sg10
VSTD-Al_x002d_Binali-2006
p1115
sg12
S'PMC3074703'
p1116
sa(dp1117
g8
V7030227.xml
p1118
sg10
VSTD-Arad-1981
p1119
sg12
S'PMC1627396'
p1120
sasa(dp1121
g3
VCD006903 v. 3.0 Peer support telephone calls for improving health.rm5
p1122
sg5
(lp1123
(dp1124
g8
V10983211.xml
p1125
sg10
VSTD-Duan-2000
p1126
sg12
S'PMC1447636'
p1127
sa(dp1128
g8
V11800243.xml
p1129
sg10
VSTD-Dennis-2002a
p1130
sg12
S'PMC99222'
p1131
sasa(dp1132
g3
VCD002192 v. 10.0 Premedication for anxiety in adult day surgery.rm5
p1133
sg5
(lp1134
(dp1135
g8
V1744867.xml
p1136
sg10
VSTD-Mackenzie-1991
p1137
sg12
S'PMC1295464'
p1138
sasa(dp1139
g3
VCD001888 v. 10.0 Cell salvage for minimising perioperative allogeneic blood transfusion.rm5
p1140
sg5
(lp1141
(dp1142
g8
V1759769.xml
p1143
sg10
VSTD-Majowski-1991
p1144
sg12
S'PMC2499479'
p1145
sa(dp1146
g8
V16810542.xml
p1147
sg10
VSTD-Zacharopoulos-2007
p1148
sg12
S'PMC2267590'
p1149
sa(dp1150
g8
V12039820.xml
p1151
sg10
VSTD-McGill-2002
p1152
sg12
S'PMC113763'
p1153
sa(dp1154
g8
V17115155.xml
p1155
sg10
VSTD-Altinel-2007
p1156
sg12
S'PMC2266671'
p1157
sa(dp1158
g8
V16761149.xml
p1159
sg10
VSTD-Abuzakuk-2007
p1160
sg12
S'PMC2267563'
p1161
sasa(dp1162
g3
VCD004060 v. 8.0 Treatment for Barrett's oesophagus.rm5
p1163
sg5
(lp1164
(dp1165
g8
V10486353.xml
p1166
sg10
VSTD-Peters-1999
p1167
sg12
S'PMC1727665'
p1168
sa(dp1169
g8
V15138203.xml
p1170
sg10
VSTD-Hage-2004
p1171
sg12
S'PMC1774080'
p1172
sa(dp1173
g8
V11034574.xml
p1174
sg10
VSTD-Ackroyd-2000
p1175
sg12
S'PMC1728096'
p1176
sa(dp1177
g8
V17405999.xml
p1178
sg10
VSTD-Heath-2007
p1179
sg12
S'PMC3755596'
p1180
sa(dp1181
g8
V16905695.xml
p1182
sg10
VSTD-Sharma-2006
p1183
sg12
S'PMC1860010'
p1184
sa(dp1185
g8
V12616111.xml
p1186
sg10
VSTD-Parrilla-2003
p1187
sg12
S'PMC1514316'
p1188
sasa(dp1189
g3
VCD006605 v. 5.0 Long-term opioid management for chronic noncancer pain.rm5
p1190
sg5
(lp1191
(dp1192
g8
V18443671.xml
p1193
sg10
VSTD-Thorne-2008
p1194
sg12
S'PMC2671217'
p1195
sasa(dp1196
g3
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p1197
sg5
(lp1198
(dp1199
g8
V16928714.xml
p1200
sg10
VSTD-Barlow-2007
p1201
sg12
S'PMC2111288'
p1202
sa(dp1203
g8
V7929770.xml
p1204
sg10
VSTD-Doern-1994
p1205
sg12
S'PMC263786'
p1206
sa(dp1207
g8
V12095438.xml
p1208
sg10
VSTD-Fridkin-2002
p1209
sg12
S'PMC3369588'
p1210
sa(dp1211
g8
V2473995.xml
p1212
sg10
VSTD-Trenholme-1989
p1213
sg12
S'PMC267554'
p1214
sa(dp1215
g8
V22514426.xml
p1216
sg10
VSTD-Salama-1996
p1217
sg12
S'PMC3327382'
p1218
sa(dp1219
g8
V9774287.xml
p1220
sg10
VSTD-Wyatt-1998
p1221
sg12
S'PMC28686'
p1222
sa(dp1223
g8
V11678786.xml
p1224
sg10
VSTD-Kumana-2001
p1225
sg12
S'PMC2014574'
p1226
sa(dp1227
g8
V9824802.xml
p1228
sg10
VSTD-Shojania-1998
p1229
sg12
S'PMC61335'
p1230
sasa(dp1231
g3
VCD004848 v. 16.0 Common antiepileptic drugs in pregnancy in women with epilepsy.rm5
p1232
sg5
(lp1233
(dp1234
g8
V2025009.xml
p1235
sg10
VSTD-D_x0027_Souza-1991
p1236
sg12
S'PMC1792889'
p1237
sa(dp1238
g8
V9014606.xml
p1239
sg10
VSTD-Ornoy-1996
p1240
sg12
S'PMC1511819'
p1241
sasa(dp1242
g3
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p1243
sg5
(lp1244
(dp1245
g8
V17593956.xml
p1246
sg10
VSTD-Luabeya-2007
p1247
sg12
S'PMC1891438'
p1248
sa(dp1249
g8
V19117833.xml
p1250
sg10
VSTD-Arpadi-2009
p1251
sg12
S'PMC3110671'
p1252
sa(dp1253
g8
V18541571.xml
p1254
sg10
VSTD-Kupka-2008
p1255
sg12
S'PMC2474659'
p1256
sa(dp1257
g8
V7625499.xml
p1258
sg10
VSTD-Coutsoudis-1995
p1259
sg12
S'PMC1615817'
p1260
sa(dp1261
g8
V18471061.xml
p1262
sg10
VSTD-Villamor-2008
p1263
sg12
S'PMC2564793'
p1264
sasa(dp1265
g3
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p1266
sg5
(lp1267
(dp1268
g8
V20472675.xml
p1269
sg10
VSTD-Del-Romero-2010
p1270
sg12
S'PMC2871073'
p1271
sa(dp1272
g8
V20537376.xml
p1273
sg10
VSTD-Donnell-2010
p1274
sg12
S'PMC2922041'
p1275
sa(dp1276
g8
V21160416.xml
p1277
sg10
VSTD-Reynolds-2011
p1278
sg12
S'PMC3261071'
p1279
sasa(dp1280
g3
VCD004364 v. 4.0 Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.rm5
p1281
sg5
(lp1282
(dp1283
g8
V9167318.xml
p1284
sg10
VSTD-Sharp-1996
p1285
sg12
S'PMC1312921'
p1286
sa(dp1287
g8
V9167318.xml
p1288
sg10
VSTD-Sharp-1996i
p1289
sg12
S'PMC1312921'
p1290
sa(dp1291
g8
V9167318.xml
p1292
sg10
VSTD-Sharp-1996ii
p1293
sg12
S'PMC1312921'
p1294
sasa(dp1295
g3
VCD003902 v. 5.0 Oral theophylline for chronic obstructive pulmonary disease.rm5
p1296
sg5
(lp1297
(dp1298
g8
V3147048.xml
p1299
sg10
VSTD-Chrystyn-1988
p1300
sg12
S'PMC1835250'
p1301
sa(dp1302
g8
V8202902.xml
p1303
sg10
VSTD-Fink-1994
p1304
sg12
S'PMC475365'
p1305
sasa(dp1306
g3
VCD006504 v. 4.0 Cholinesterase inhibitors for dementia with Lewy bodies Parkinson's disease dementia and cognitive .rm5
p1307
sg5
(lp1308
(dp1309
g8
V23951200.xml
p1310
sg10
VSTD-McKeith-2000
p1311
sg12
S'PMC3739737'
p1312
sa(dp1313
g8
V12023410.xml
p1314
sg10
VSTD-Aarsland-2002a
p1315
sg12
S'PMC1737925'
p1316
sa(dp1317
g8
V15965198.xml
p1318
sg10
VSTD-Ravina-2005
p1319
sg12
S'PMC1739697'
p1320
sasa(dp1321
g3
VCD000305 v. 8.0 Heparin low molecular weight heparin and physical methods for preventing deep vein thrombosis and p.rm5
p1322
sg5
(lp1323
(dp1324
g8
V843794.xml
p1325
sg10
VSTD-Morris-1977
p1326
sg12
S'PMC1605162'
p1327
sa(dp1328
g8
V9349964.xml
p1329
sg10
VSTD-Eskander-1997
p1330
sg12
S'PMC3617695'
p1331
sasa(dp1332
g3
VCD006419 v. 4.0 Deworming helminth co-infected individuals for delaying HIV disease progression.rm5
p1333
sg5
(lp1334
(dp1335
g8
V18670219.xml
p1336
sg10
VSTD-Walson-2008
p1337
sg12
S'PMC2637615'
p1338
sasa(dp1339
g3
VCD004334 v. 5.0 Interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.rm5
p1340
sg5
(lp1341
(dp1342
g8
V11144634.xml
p1343
sg10
VSTD-Johnston-2000
p1344
sg12
S'PMC1730673'
p1345
sa(dp1346
g8
V23678285.xml
p1347
sg10
VSTD-Stevens-2000
p1348
sg12
S'PMC3584800'
p1349
sasa(dp1350
g3
VCD004181 v. 6.0 Immunoglobulins for preventing hepatitis A.rm5
p1351
sg5
(lp1352
(dp1353
g8
V6754845.xml
p1354
sg10
VSTD-Kark-1982a
p1355
sg12
S'PMC1052206'
p1356
sasa(dp1357
g3
VCD002258 v. 4.0 Bromocriptine versus levodopa in early Parkinson's disease.rm5
p1358
sg5
(lp1359
(dp1360
g8
V8057111.xml
p1361
sg10
VSTD-Hely-1994
p1362
sg12
S'PMC1073071'
p1363
sa(dp1364
g8
V8555803.xml
p1365
sg10
VSTD-UK_x002d_PDRG-1993
p1366
sg12
S'PMC2551499'
p1367
sasa(dp1368
g3
VCD005121 v. 3.0 Anakinra for rheumatoid arthritis.rm5
p1369
sg5
(lp1370
(dp1371
g8
V15082469.xml
p1372
sg10
VSTD-Cohen-2004
p1373
sg12
S'PMC1755108'
p1374
sasa(dp1375
g3
VCD003672 v. 7.0 Cholinesterase inhibitors for dementia with Lewy bodies.rm5
p1376
sg5
(lp1377
(dp1378
g8
V23951200.xml
p1379
sg10
VSTD-McKeith-2000
p1380
sg12
S'PMC3739737'
p1381
sasa(dp1382
g3
VCD008510 v. 3.7 Chinese herbal medicines for threatened miscarriage.rm5
p1383
sg5
(lp1384
(dp1385
g8
V22904831.xml
p1386
sg10
VSTD-Yang-2001
p1387
sg12
S'PMC3414298'
p1388
sa(dp1389
g8
V23634098.xml
p1390
sg10
VSTD-Liu-2008
p1391
sg12
S'PMC3629611'
p1392
sasa(dp1393
g3
VCD008145 v. 2.2 Interventions for improving coverage of child immunization in low- and middle-income countries.rm5
p1394
sg5
(lp1395
(dp1396
g8
V19828055.xml
p1397
sg10
VSTD-Djibuti-2009
p1398
sg12
S'PMC3226230'
p1399
sa(dp1400
g8
V9002332.xml
p1401
sg10
VSTD-Brugha-1996
p1402
sg12
S'PMC2486871'
p1403
sa(dp1404
g8
V19828066.xml
p1405
sg10
VSTD-Andersson-2009
p1406
sg12
S'PMC3226240'
p1407
sasa(dp1408
g3
VCD004305 v. 8.4 Healthcare financing systems for increasing the use of tobacco dependence treatment.rm5
p1409
sg5
(lp1410
(dp1411
g8
V10326267.xml
p1412
sg10
VSTD-Dey-1999
p1413
sg12
S'PMC1313349'
p1414
sa(dp1415
g8
V11387540.xml
p1416
sg10
VSTD-Schauffler-2001
p1417
sg12
S'PMC1747566'
p1418
sa(dp1419
g8
V18783459.xml
p1420
sg10
VSTD-Joyce-2008
p1421
sg12
S'PMC2614005'
p1422
sa(dp1423
g8
V17297068.xml
p1424
sg10
VSTD-Twardella-2007
p1425
sg12
S'PMC2598437'
p1426
sasa(dp1427
g3
VCD000561 v. 13.0 Antidepressants versus placebo for the depressed elderly.rm5
p1428
sg5
(lp1429
(dp1430
g8
V8018452.xml
p1431
sg10
VSTD-Tan-1994
p1432
sg12
S'PMC1364731'
p1433
sasa(dp1434
g3
VCD004168 v. 3.0 Alcohol ignition interlock programmes for reducing drink driving recidivism.rm5
p1435
sg5
(lp1436
(dp1437
g8
V10553391.xml
p1438
sg10
VSTD-Maryland
p1439
sg12
S'PMC1508998'
p1440
sasa(dp1441
g3
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p1442
sg5
(lp1443
(dp1444
g8
V17713983.xml
p1445
sg10
VSTD-Tonwe_x002d_Gold-2007
p1446
sg12
S'PMC1949842'
p1447
sa(dp1448
g8
V18614871.xml
p1449
sg10
VSTD-Lehman-2008
p1450
sg12
S'PMC2765916'
p1451
sa(dp1452
g8
V18670224.xml
p1453
sg10
VSTD-Bae-2008
p1454
sg12
S'PMC2664540'
p1455
sasa(dp1456
g3
VCD006775 v. 5.2 Punctal occlusion for dry eye syndrome.rm5
p1457
sg5
(lp1458
(dp1459
g8
V14644860.xml
p1460
sg10
VSTD-Tsifetaki-2003
p1461
sg12
S'PMC1754388'
p1462
sasa(dp1463
g3
VCD004795 v. 6.0 Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).rm5
p1464
sg5
(lp1465
(dp1466
g8
V19345831.xml
p1467
sg10
VSTD-Conde-2009
p1468
sg12
S'PMC2866651'
p1469
sasa(dp1470
g3
VCD005483 v. 3.0 Anabolic steroids for the treatment of weight loss in HIV-infected individuals.rm5
p1471
sg5
(lp1472
(dp1473
g8
V10683055.xml
p1474
sg10
VSTD-Bhasin-2000_x0028_i_x0029__x002d_no-e
p1475
sg12
S'PMC3173037'
p1476
sasa(dp1477
g3
VCD001350 v. 9.4 Surgical interventions for lumbar disc prolapse.rm5
p1478
sg5
(lp1479
(dp1480
g8
V17119141.xml
p1481
sg10
VSTD-Weinstein-2006
p1482
sg12
S'PMC2562254'
p1483
sa(dp1484
g8
V10990391.xml
p1485
sg10
VSTD-Krugluger-2000
p1486
sg12
S'PMC3619876'
p1487
sasa(dp1488
g3
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p1489
sg5
(lp1490
(dp1491
g8
V11189100.xml
p1492
sg10
VSTD-Domenge-2000
p1493
sg12
S'PMC2363468'
p1494
sa(dp1495
g8
V19357741.xml
p1496
sg10
VSTD-Chauhan-2008
p1497
sg12
S'PMC2583266'
p1498
sa(dp1499
g8
V19875337.xml
p1500
sg10
VSTD-UKHAN-2010
p1501
sg12
S'PMC2806549'
p1502
sasa(dp1503
g3
VCD007006 v. 2.1 Abstinence-plus programs for HIV infection prevention in high-income countries.rm5
p1504
sg5
(lp1505
(dp1506
g8
V11889277.xml
p1507
sg10
VSTD-Coyle-2001
p1508
sg12
S'PMC1913682'
p1509
sa(dp1510
g8
V15117710.xml
p1511
sg10
VSTD-Coyle-2004
p1512
sg12
S'PMC1448347'
p1513
sa(dp1514
g8
V16894074.xml
p1515
sg10
VSTD-Villarruel-2006
p1516
sg12
S'PMC3034476'
p1517
sasa(dp1518
g3
VCD007675 v. 2.0 Interactive computer-based interventions for weight loss or weight maintenance in overweight or obes.rm5
p1519
sg5
(lp1520
(dp1521
g8
V20478333.xml
p1522
sg10
VSTD-Harvey_x002d_Berino-2010
p1523
sg12
S'PMC3101104'
p1524
sa(dp1525
g8
V19696764.xml
p1526
sg10
VSTD-Bennett-2010
p1527
sg12
S'PMC3710670'
p1528
sasa(dp1529
g3
VCD007612 v. 2.0 Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica.rm5
p1530
sg5
(lp1531
(dp1532
g8
V7546872.xml
p1533
sg10
VSTD-Wilkinson-1995
p1534
sg12
S'PMC1239372'
p1535
sa(dp1536
g8
V2931153.xml
p1537
sg10
VSTD-Gilbert-1985
p1538
sg12
S'PMC1417150'
p1539
sasa(dp1540
g3
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p1541
sg5
(lp1542
(dp1543
g8
V18442423.xml
p1544
sg10
VSTD-Lenssen-2008
p1545
sg12
S'PMC2386789'
p1546
sa(dp1547
g8
V1471839.xml
p1548
sg10
VSTD-Johnson-1992
p1549
sg12
S'PMC2497687'
p1550
sasa(dp1551
g3
VCD003852 v. 7.0 Ginkgo biloba for tinnitus.rm5
p1552
sg5
(lp1553
(dp1554
g8
V11154618.xml
p1555
sg10
VSTD-Drew-2001
p1556
sg12
S'PMC26593'
p1557
sasa(dp1558
g3
VCD001402 v. 10.0 Newborn screening for cystic fibrosis.rm5
p1559
sg5
(lp1560
(dp1561
g8
V1996888.xml
p1562
sg10
VSTD-UK-Trial-1991
p1563
sg12
S'PMC1590363'
p1564
sasa(dp1565
g3
VCD005028 v. 6.0 Topical treatments for chronic plaque psoriasis.rm5
p1566
sg5
(lp1567
(dp1568
g8
V18787325.xml
p1569
sg10
VSTD-Luger-2008
p1570
sg12
S'PMC2790732'
p1571
sa(dp1572
g8
V10066222.xml
p1573
sg10
VSTD-Cheesbrough-1992
p1574
sg12
S'PMC1115105'
p1575
sa(dp1576
g8
V23328491.xml
p1577
sg10
VSTD-Maier-2004
p1578
sg12
S'PMC3627666'
p1579
sasa(dp1580
g3
VCD010243 v. 3.0 Behavioral interventions for improving contraceptive use among women living with HIV.rm5
p1581
sg5
(lp1582
(dp1583
g8
V21963940.xml
p1584
sg10
VSTD-Kosgei-2011
p1585
sg12
S'PMC3779789'
p1586
sa(dp1587
g8
V8484453.xml
p1588
sg10
VSTD-Allen-1993
p1589
sg12
S'PMC1694707'
p1590
sasa(dp1591
g3
VCD002124 v. 5.0 Herbal and dietary therapies for primary and secondary dysmenorrhoea.rm5
p1592
sg5
(lp1593
(dp1594
g8
V21961521.xml
p1595
sg10
VSTD-Davis-1988
p1596
sg12
S'PMC3195724'
p1597
sasa(dp1598
g3
VCD003440 v. 10.6 Workplace interventions for smoking cessation.rm5
p1599
sg5
(lp1600
(dp1601
g8
V8669517.xml
p1602
sg10
VSTD-Sorensen-1996
p1603
sg12
S'PMC1380434'
p1604
sa(dp1605
g8
V9807537.xml
p1606
sg10
VSTD-Sorensen-1998
p1607
sg12
S'PMC1508574'
p1608
sa(dp1609
g8
V10814655.xml
p1610
sg10
VSTD-Lang-2000
p1611
sg12
S'PMC1731676'
p1612
sa(dp1613
g8
V12709522.xml
p1614
sg10
VSTD-Rodriguez-2003
p1615
sg12
S'PMC1740534'
p1616
sa(dp1617
g8
V7299342.xml
p1618
sg10
VSTD-Cambien-1981
p1619
sg12
S'PMC1052130'
p1620
sa(dp1621
g8
V8362997.xml
p1622
sg10
VSTD-Gomel-1993a
p1623
sg12
S'PMC1694995'
p1624
sa(dp1625
g8
V3303976.xml
p1626
sg10
VSTD-Sutton-1987
p1627
sg12
S'PMC1647001'
p1628
sa(dp1629
g8
V11818305.xml
p1630
sg10
VSTD-Hennrikus-2002
p1631
sg12
S'PMC1447056'
p1632
sa(dp1633
g8
V7856780.xml
p1634
sg10
VSTD-Glasgow-1995
p1635
sg12
S'PMC1615302'
p1636
sa(dp1637
g8
V6441794.xml
p1638
sg10
VSTD-Malott-1984
p1639
sg12
S'PMC1307970'
p1640
sasa(dp1641
g3
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p1642
sg5
(lp1643
(dp1644
g8
V12521968.xml
p1645
sg10
VSTD-Shaw-2003
p1646
sg12
S'PMC139930'
p1647
sa(dp1648
g8
V18845605.xml
p1649
sg10
VSTD-Kerse-2008
p1650
sg12
S'PMC2565754'
p1651
sa(dp1652
g8
V21649623.xml
p1653
sg10
VSTD-Lapane-2011
p1654
sg12
S'PMC3157676'
p1655
sa(dp1656
g8
V15066200.xml
p1657
sg10
VSTD-Crotty-2004b
p1658
sg12
S'PMC415557'
p1659
sa(dp1660
g8
V18332052.xml
p1661
sg10
VSTD-Cumming-2008
p1662
sg12
S'PMC2287238'
p1663
sa(dp1664
g8
V15031238.xml
p1665
sg10
VSTD-Haines-2004
p1666
sg12
S'PMC381222'
p1667
sa(dp1668
g8
V21045097.xml
p1669
sg10
VSTD-Dykes-2010
p1670
sg12
S'PMC3107709'
p1671
sa(dp1672
g8
V17061151.xml
p1673
sg10
VSTD-Stenvall-2007
p1674
sg12
S'PMC1766476'
p1675
sasa(dp1676
g3
VCD006806 v. 4.2 Peri-operative glycaemic control regimens for preventing surgical site infections in adults.rm5
p1677
sg5
(lp1678
(dp1679
g8
V17215967.xml
p1680
sg10
VSTD-Li-2006
p1681
sg12
S'PMC1764949'
p1682
sasa(dp1683
g3
VCD006391 v. 5.4 Benzodiazepines for schizophrenia.rm5
p1684
sg5
(lp1685
(dp1686
g8
V14512476.xml
p1687
sg10
VSTD-TREC_x002d_Rio-2003
p1688
sg12
S'PMC200800'
p1689
sasa(dp1690
g3
VCD003686 v. 7.0 Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.rm5
p1691
sg5
(lp1692
(dp1693
g8
V10514160.xml
p1694
sg10
VSTD-Hay-1999
p1695
sg12
S'PMC28251'
p1696
sasa(dp1697
g3
VCD000386 v. 9.0 Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malari.rm5
p1698
sg5
(lp1699
(dp1700
g8
V3048759.xml
p1701
sg10
VSTD-Huang-1988
p1702
sg12
S'PMC2491139'
p1703
sa(dp1704
g8
V3293827.xml
p1705
sg10
VSTD-Schapira-1988
p1706
sg12
S'PMC2491050'
p1707
sa(dp1708
g8
V12163917.xml
p1709
sg10
VSTD-Basco-2002
p1710
sg12
S'PMC2567565'
p1711
sasa(dp1712
g3
VCD004606 v. 6.0 School-based secondary prevention programmes for preventing violence.rm5
p1713
sg5
(lp1714
(dp1715
g8
V10535230.xml
p1716
sg10
VSTD-CPPRG-1999
p1717
sg12
S'PMC2762610'
p1718
sa(dp1719
g8
V19283597.xml
p1720
sg10
VSTD-Cavell-2000
p1721
sg12
S'PMC2664521'
p1722
sa(dp1723
g8
V19890177.xml
p1724
sg10
VSTD-Quinn-1995
p1725
sg12
S'PMC2774204'
p1726
sa(dp1727
g8
V21215834.xml
p1728
sg10
VSTD-Hughes-1993
p1729
sg12
S'PMC3053018'
p1730
sasa(dp1731
g3
VCD000353 v. 9.0 Homeopathy for chronic asthma.rm5
p1732
sg5
(lp1733
(dp1734
g8
V12668794.xml
p1735
sg10
VSTD-White-2003
p1736
sg12
S'PMC1746635'
p1737
sa(dp1738
g8
V11777781.xml
p1739
sg10
VSTD-Lewith-2002
p1740
sg12
S'PMC1121932'
p1741
sasa(dp1742
g3
VCD003038 v. 9.2 Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeni.rm5
p1743
sg5
(lp1744
(dp1745
g8
V9257745.xml
p1746
sg10
VSTD-Yamamura-1997
p1747
sg12
S'PMC163989'
p1748
sa(dp1749
g8
V1503442.xml
p1750
sg10
VSTD-Cornelissen-1992
p1751
sg12
S'PMC189424'
p1752
sa(dp1753
g8
V6357076.xml
p1754
sg10
VSTD-Gribble-1983
p1755
sg12
S'PMC185330'
p1756
sa(dp1757
g8
V6524903.xml
p1758
sg10
VSTD-Piccart-1984
p1759
sg12
S'PMC180041'
p1760
sa(dp1761
g8
V8723449.xml
p1762
sg10
VSTD-Cometta-1996
p1763
sg12
S'PMC163274'
p1764
sasa(dp1765
g3
VCD003698 v. 6.2 Community pharmacy personnel interventions for smoking cessation.rm5
p1766
sg5
(lp1767
(dp1768
g8
V9825420.xml
p1769
sg10
VSTD-Sinclair-1998
p1770
sg12
S'PMC1763872'
p1771
sasa(dp1772
g3
VCD000514 v. 6.0 Thrombolysis (different doses routes of administration and agents) for acute ischaemic stroke.rm5
p1773
sg5
(lp1774
(dp1775
g8
V19097942.xml
p1776
sg10
VSTD-DIAS_x002d_2
p1777
sg12
S'PMC2730486'
p1778
sa(dp1779
g8
V20185783.xml
p1780
sg10
VSTD-TNK_x002d_S2B
p1781
sg12
S'PMC2860601'
p1782
sasa(dp1783
g3
VCD003109 v. 6.0 Advanced trauma life support training for ambulance crews.rm5
p1784
sg5
(lp1785
(dp1786
g8
V18427089.xml
p1787
sg10
VSTD-Stiell-2008
p1788
sg12
S'PMC2292763'
p1789
sasa(dp1790
g3
VCD005364 v. 9.0 Topical anaesthetics for repair of dermal laceration.rm5
p1791
sg5
(lp1792
(dp1793
g8
V9291744.xml
p1794
sg10
VSTD-Ernst-1997
p1795
sg12
S'PMC1304430'
p1796
sa(dp1797
g8
V8653235.xml
p1798
sg10
VSTD-Kendall-1996
p1799
sg12
S'PMC1342653'
p1800
sasa(dp1801
g3
VCD001087 v. 13.4 Crisis intervention for people with severe mental illnesses.rm5
p1802
sg5
(lp1803
(dp1804
g8
V16103032.xml
p1805
sg10
VSTD-Johnson-2005
p1806
sg12
S'PMC1215550'
p1807
sasa(dp1808
g3
VCD007854 v. 3.0 Acupuncture for dysmenorrhoea.rm5
p1809
sg5
(lp1810
(dp1811
g8
V21799683.xml
p1812
sg10
VSTD-Smith-2010
p1813
sg12
S'PMC3140031'
p1814
sasa(dp1815
g3
VCD009601 v. 2.0 Therapeutic ultrasound for carpal tunnel syndrome.rm5
p1816
sg5
(lp1817
(dp1818
g8
V9529407.xml
p1819
sg10
VSTD-Ebenbichler-1998
p1820
sg12
S'PMC28476'
p1821
sasa(dp1822
g3
VCD009586 v. 2.0 Effectiveness of systematic screening for the detection of atrial fibrillation.rm5
p1823
sg5
(lp1824
(dp1825
g8
V17673732.xml
p1826
sg10
VSTD-Hobbs-2005
p1827
sg12
S'PMC1952508'
p1828
sasa(dp1829
g3
VCD000994 v. 9.4 Home care by outreach nursing for chronic obstructive pulmonary disease.rm5
p1830
sg5
(lp1831
(dp1832
g8
V12399344.xml
p1833
sg10
VSTD-Hermiz-2002
p1834
sg12
S'PMC130059'
p1835
sa(dp1836
g8
V1926024.xml
p1837
sg10
VSTD-Littlejohns-1991
p1838
sg12
S'PMC463273'
p1839
sa(dp1840
g8
V3101821.xml
p1841
sg10
VSTD-Cockcroft-1987
p1842
sg12
S'PMC1245234'
p1843
sasa(dp1844
g3
VCD000273 v. 8.0 Caffeine versus theophylline for apnea in preterm infants.rm5
p1845
sg5
(lp1846
(dp1847
g8
V1586184.xml
p1848
sg10
VSTD-Scanlon-1992
p1849
sg12
S'PMC1590510'
p1850
sasa(dp1851
g3
VCD003540 v. 5.0 Effects of interventions aimed at changing the length of primary care physicians' consultation.rm5
p1852
sg5
(lp1853
(dp1854
g8
V3083919.xml
p1855
sg10
VSTD-Morrell-1986
p1856
sg12
S'PMC1339978'
p1857
sa(dp1858
g8
V2558202.xml
p1859
sg10
VSTD-Ridsdale-1989
p1860
sg12
S'PMC1712205'
p1861
sa(dp1862
g8
V1739798.xml
p1863
sg10
VSTD-Wilson-1992
p1864
sg12
S'PMC1881485'
p1865
sasa(dp1866
g3
VCD006893 v. 3.2 Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.rm5
p1867
sg5
(lp1868
(dp1869
g8
V17299059.xml
p1870
sg10
VSTD-Sandborn-2007b
p1871
sg12
S'PMC2701613'
p1872
sa(dp1873
g8
V15361500.xml
p1874
sg10
VSTD-Sandborn-2004
p1875
sg12
S'PMC1774244'
p1876
sasa(dp1877
g3
VCD003010 v. 8.0 Traction for low-back pain with or without sciatica.rm5
p1878
sg5
(lp1879
(dp1880
g8
V1535495.xml
p1881
sg10
VSTD-Konrad-1992
p1882
sg12
S'PMC1004758'
p1883
sasa(dp1884
g3
VCD006971 v. 2.0 Intracervical prostaglandins for induction of labour.rm5
p1885
sg5
(lp1886
(dp1887
g8
V23652486.xml
p1888
sg10
VSTD-Bernstein-1991
p1889
sg12
S'PMC3680006'
p1890
sa(dp1891
g8
V8212680.xml
p1892
sg10
VSTD-Gilson-1993
p1893
sg12
S'PMC1022221'
p1894
sasa(dp1895
g3
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p1896
sg5
(lp1897
(dp1898
g8
V17626056.xml
p1899
sg10
VSTD-WISDOM-2007
p1900
sg12
S'PMC1939792'
p1901
sa(dp1902
g8
V18366766.xml
p1903
sg10
VSTD-EPHT-2006
p1904
sg12
S'PMC2330032'
p1905
sasa(dp1906
g3
VCD009849 v. 2.3 Steroidal contraceptives and bone fractures in women evidence from observational studies.rm5
p1907
sg5
(lp1908
(dp1909
g8
V8935460.xml
p1910
sg10
VSTD-O_x0027_Neill-1996
p1911
sg12
S'PMC1060285'
p1912
sasa(dp1913
g3
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p1914
sg5
(lp1915
(dp1916
g8
V2645988.xml
p1917
sg10
VSTD-Arkinstall-1989
p1918
sg12
S'PMC1268755'
p1919
sa(dp1920
g8
V14647133.xml
p1921
sg10
VSTD-Lauretti-2003
p1922
sg12
S'PMC2376845'
p1923
sa(dp1924
g8
V376079.xml
p1925
sg10
VSTD-Melzack-1979
p1926
sg12
S'PMC1818901'
p1927
sasa(dp1928
g3
VCD000133 v. 7.0 Maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treatin.rm5
p1929
sg5
(lp1930
(dp1931
g8
V3089466.xml
p1932
sg10
VSTD-Cant-1986
p1933
sg12
S'PMC1341170'
p1934
sasa(dp1935
g3
VCD001507 v. 12.0 Tyrosine supplementation for phenylketonuria.rm5
p1936
sg5
(lp1937
(dp1938
g8
V9579151.xml
p1939
sg10
VSTD-Smith-1998
p1940
sg12
S'PMC1717450'
p1941
sasa(dp1942
g3
VCD007543 v. 2.2 Enhanced glucose control for preventing and treating diabetic neuropathy.rm5
p1943
sg5
(lp1944
(dp1945
g8
V3096429.xml
p1946
sg10
VSTD-Dahl_x002d_Jorgensen-1986
p1947
sg12
S'PMC1341978'
p1948
sasa(dp1949
g3
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p1950
sg5
(lp1951
(dp1952
g8
V17563840.xml
p1953
sg10
VSTD-Campos-2007
p1954
sg12
S'PMC3476141'
p1955
sa(dp1956
g8
V2351965.xml
p1957
sg10
VSTD-Eljamel-1990
p1958
sg12
S'PMC488052'
p1959
sasa(dp1960
g3
VCD007893 v. 2.0 Effect of cyclosporine on blood pressure.rm5
p1961
sg5
(lp1962
(dp1963
g8
V3281603.xml
p1964
sg10
VSTD-Dougados-1988_x0028_4.6mg_x002f_kg_x002f_d_x0029_
p1965
sg12
S'PMC1003464'
p1966
sasa(dp1967
g3
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p1968
sg5
(lp1969
(dp1970
g8
V20409497.xml
p1971
sg10
VSTD-Swan-2010
p1972
sg12
S'PMC2879135'
p1973
sa(dp1974
g8
V18263663.xml
p1975
sg10
VSTD-Aubin-2008
p1976
sg12
S'PMC2569194'
p1977
sa(dp1978
g8
V22080588.xml
p1979
sg10
VSTD-Rennard-2011
p1980
sg12
S'PMC3281242'
p1981
sasa(dp1982
g3
VCD001401 v. 10.0 Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.rm5
p1983
sg5
(lp1984
(dp1985
g8
V2038733.xml
p1986
sg10
VSTD-van-der-Schans-1991
p1987
sg12
S'PMC463090'
p1988
sasa(dp1989
g3
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p1990
sg5
(lp1991
(dp1992
g8
V21407865.xml
p1993
sg10
VSTD-Avasthi-2001
p1994
sg12
S'PMC2956152'
p1995
sasa(dp1996
g3
VCD001861 v. 7.5 Interventions for recurrent corneal erosions.rm5
p1997
sg5
(lp1998
(dp1999
g8
V3873960.xml
p2000
sg10
VSTD-Williams-1985
p2001
sg12
S'PMC1040623'
p2002
sasa(dp2003
g3
VCD006768 v. 4.0 Non-surgical interventions for convergence insufficiency.rm5
p2004
sg5
(lp2005
(dp2006
g8
V16170124.xml
p2007
sg10
VSTD-CITT-2005a
p2008
sg12
S'PMC1772876'
p2009
sa(dp2010
g8
V18852411.xml
p2011
sg10
VSTD-CITT-2008
p2012
sg12
S'PMC2779032'
p2013
sasa(dp2014
g3
VCD001027 v. 14.0 Cognitive behaviour therapy for chronic fatigue syndrome in adults.rm5
p2015
sg5
(lp2016
(dp2017
g8
V16693831.xml
p2018
sg10
VSTD-Strang-2002
p2019
sg12
S'PMC434753'
p2020
sa(dp2021
g8
V19594903.xml
p2022
sg10
VSTD-King-1999
p2023
sg12
S'PMC2722588'
p2024
sasa(dp2025
g3
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p2026
sg5
(lp2027
(dp2028
g8
V20370912.xml
p2029
sg10
VSTD-Becker-2010
p2030
sg12
S'PMC2888216'
p2031
sasa(dp2032
g3
VCD001915 v. 11.2 Inhaled corticosteroids for cystic fibrosis.rm5
p2033
sg5
(lp2034
(dp2035
g8
V9301350.xml
p2036
sg10
VSTD-UK-Trial-1997
p2037
sg12
S'PMC1717269'
p2038
sasa(dp2039
g3
VCD004487 v. 6.0 Paracetamol for pain relief after surgical removal of lower wisdom teeth.rm5
p2040
sg5
(lp2041
(dp2042
g8
V8799525.xml
p2043
sg10
VSTD-Seymour-1996
p2044
sg12
S'PMC2042618'
p2045
sasa(dp2046
g3
VCD005110 v. 4.0 Hypnotherapy for treatment of irritable bowel syndrome.rm5
p2047
sg5
(lp2048
(dp2049
g8
V16464325.xml
p2050
sg10
VSTD-Roberts-2006
p2051
sg12
S'PMC1828217'
p2052
sasa(dp2053
g3
VCD002744 v. 10.0 Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).rm5
p2054
sg5
(lp2055
(dp2056
g8
V20368393.xml
p2057
sg10
VSTD-Sugaya-2010
p2058
sg12
S'PMC2876358'
p2059
sasa(dp2060
g3
VCD002839 v. 6.0 Vasoactive drugs for acute stroke.rm5
p2061
sg5
(lp2062
(dp2063
g8
V3126956.xml
p2064
sg10
VSTD-Barer-1988-propanolol
p2065
sg12
S'PMC2545364'
p2066
sa(dp2067
g8
V3126956.xml
p2068
sg10
VSTD-Barer-1988_x002f_50-mg
p2069
sg12
S'PMC2545364'
p2070
sa(dp2071
g8
V3126956.xml
p2072
sg10
VSTD-Barer-1988_x002f_80-mg
p2073
sg12
S'PMC2545364'
p2074
sa(dp2075
g8
V3126956.xml
p2076
sg10
VSTD-Barer-1988-atenolol
p2077
sg12
S'PMC2545364'
p2078
sasa(dp2079
g3
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p2080
sg5
(lp2081
(dp2082
g8
V12511452.xml
p2083
sg10
VSTD-Carbajal-2003
p2084
sg12
S'PMC139493'
p2085
sa(dp2086
g8
V21632824.xml
p2087
sg10
VSTD-Whipple-2004
p2088
sg12
S'PMC3110955'
p2089
sa(dp2090
g8
V18513662.xml
p2091
sg10
VSTD-Kostandy-2008
p2092
sg12
S'PMC2647362'
p2093
sa(dp2094
g8
V17640375.xml
p2095
sg10
VSTD-Curtis-2007
p2096
sg12
S'PMC1950500'
p2097
sa(dp2098
g8
V10574854.xml
p2099
sg10
VSTD-Carbajal-1999
p2100
sg12
S'PMC28282'
p2101
sa(dp2102
g8
V19448377.xml
p2103
sg10
VSTD-Elserafy-2009
p2104
sg12
S'PMC2813645'
p2105
sasa(dp2106
g3
VCD002771 v. 6.0 Kangaroo mother care to reduce morbidity and mortality in low birthweight infants.rm5
p2107
sg5
(lp2108
(dp2109
g8
V3060024.xml
p2110
sg10
VSTD-Whitelaw-1988
p2111
sg12
S'PMC1779160'
p2112
sa(dp2113
g8
V20629927.xml
p2114
sg10
VSTD-Neu-2010
p2115
sg12
S'PMC2935695'
p2116
sasa(dp2117
g3
VCD003219 v. 9.0 Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome.rm5
p2118
sg5
(lp2119
(dp2120
g8
V8219859.xml
p2121
sg10
VSTD-Spooner-1993
p2122
sg12
S'PMC2379872'
p2123
sa(dp2124
g8
V9529407.xml
p2125
sg10
VSTD-Ebenbichler-1998
p2126
sg12
S'PMC28476'
p2127
sa(dp2128
g8
V11482310.xml
p2129
sg10
VSTD-Hui-2001
p2130
sg12
S'PMC1753810'
p2131
sasa(dp2132
g3
VCD001385 v. 8.0 Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contai.rm5
p2133
sg5
(lp2134
(dp2135
g8
V7974313.xml
p2136
sg10
VSTD-Jones-1994
p2137
sg12
S'PMC475231'
p2138
sa(dp2139
g8
V10319056.xml
p2140
sg10
VSTD-Taylor-1998
p2141
sg12
S'PMC1745306'
p2142
sa(dp2143
g8
V7597661.xml
p2144
sg10
VSTD-Newnham-1995
p2145
sg12
S'PMC1021218'
p2146
sa(dp2147
g8
V8296255.xml
p2148
sg10
VSTD-Booth-1993
p2149
sg12
S'PMC464894'
p2150
sasa(dp2151
g3
VCD000189 v. 12.0 Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid.rm5
p2152
sg5
(lp2153
(dp2154
g8
V4613287.xml
p2155
sg10
VSTD-Berry-1974
p2156
sg12
S'PMC1006318'
p2157
sa(dp2158
g8
V15140776.xml
p2159
sg10
VSTD-Kirwan-2004
p2160
sg12
S'PMC1755023'
p2161
sa(dp2162
g8
V4283768.xml
p2163
sg10
VSTD-Jasani-1968
p2164
sg12
S'PMC1031152'
p2165
sa(dp2166
g8
V4861386.xml
p2167
sg10
VSTD-Boardman-1967
p2168
sg12
S'PMC1748911'
p2169
sasa(dp2170
g3
VCD005430 v. 4.0 Topical corticosteroids as adjunctive therapy for bacterial keratitis.rm5
p2171
sg5
(lp2172
(dp2173
g8
V2203467.xml
p2174
sg10
VSTD-Carmichael-1990
p2175
sg12
S'PMC1042200'
p2176
sasa(dp2177
g3
VCD000443 v. 7.0 Services for reducing duration of hospital care for acute stroke patients.rm5
p2178
sg5
(lp2179
(dp2180
g8
V9366727.xml
p2181
sg10
VSTD-London-1999
p2182
sg12
S'PMC2127677'
p2183
sasa(dp2184
g3
VCD005108 v. 4.0 Self-management education programmes by lay leaders for people with chronic conditions.rm5
p2185
sg5
(lp2186
(dp2187
g8
V16281998.xml
p2188
sg10
VSTD-Griffiths-2005
p2189
sg12
S'PMC1570787'
p2190
sa(dp2191
g8
V12764513.xml
p2192
sg10
VSTD-Fu-2003
p2193
sg12
S'PMC2572423'
p2194
sa(dp2195
g8
V17040926.xml
p2196
sg10
VSTD-Buszewicz-2006
p2197
sg12
S'PMC1626290'
p2198
sa(dp2199
g8
V17325405.xml
p2200
sg10
VSTD-Kennedy-2007
p2201
sg12
S'PMC2652924'
p2202
sasa(dp2203
g3
VCD002817 v. 10.2 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
p2204
sg5
(lp2205
(dp2206
g8
V17229744.xml
p2207
sg10
VSTD-Nieuwboer-2007
p2208
sg12
S'PMC2077658'
p2209
sa(dp2210
g8
V20976096.xml
p2211
sg10
VSTD-Schilling-2008
p2212
sg12
S'PMC2957327'
p2213
sa(dp2214
g8
V20976086.xml
p2215
sg10
VSTD-de-Bruin-2010a
p2216
sg12
S'PMC2957229'
p2217
sa(dp2218
g8
V20976086.xml
p2219
sg10
VSTD-de-Bruin-2010b
p2220
sg12
S'PMC2957229'
p2221
sa(dp2222
g8
V19329350.xml
p2223
sg10
VSTD-Hackney-2009
p2224
sg12
S'PMC2783812'
p2225
sa(dp2226
g8
V17119004.xml
p2227
sg10
VSTD-Ashburn-2007
p2228
sg12
S'PMC2117667'
p2229
sa(dp2230
g8
V18534554.xml
p2231
sg10
VSTD-Fisher-2008
p2232
sg12
S'PMC2989816'
p2233
sasa(dp2234
g3
VCD005242 v. 4.4 Increased police patrols for preventing alcohol-impaired driving.rm5
p2235
sg5
(lp2236
(dp2237
g8
V21819824.xml
p2238
sg10
VSTD-Zador-1976
p2239
sg12
S'PMC3153731'
p2240
sa(dp2241
g8
V21768380.xml
p2242
sg10
VSTD-Campbell-1981
p2243
sg12
S'PMC3150899'
p2244
sa(dp2245
g8
V8659651.xml
p2246
sg10
VSTD-Hingson-1996
p2247
sg12
S'PMC1380396'
p2248
sasa(dp2249
g3
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p2250
sg5
(lp2251
(dp2252
g8
V12448802.xml
p2253
sg10
VSTD-Black-2002
p2254
sg12
S'PMC1743616'
p2255
sa(dp2256
g8
V19775439.xml
p2257
sg10
VSTD-Dobbins-2009
p2258
sg12
S'PMC2936828'
p2259
sa(dp2260
g8
V11701573.xml
p2261
sg10
VSTD-Mason-2001
p2262
sg12
S'PMC59683'
p2263
sa(dp2264
g8
V9774287.xml
p2265
sg10
VSTD-Wyatt-1998
p2266
sg12
S'PMC28686'
p2267
sasa(dp2268
g3
VCD006170 v. 4.2 Methods of milk expression for lactating women.rm5
p2269
sg5
(lp2270
(dp2271
g8
V23991112.xml
p2272
sg10
VSTD-Francis-2008
p2273
sg12
S'PMC3749169'
p2274
sa(dp2275
g8
V11517200.xml
p2276
sg10
VSTD-Jones-2001
p2277
sg12
S'PMC1721311'
p2278
sasa(dp2279
g3
VCD002768 v. 11.0 Physical training for cystic fibrosis.rm5
p2280
sg5
(lp2281
(dp2282
g8
V15563708.xml
p2283
sg10
VSTD-Moorcroft-2004
p2284
sg12
S'PMC1746905'
p2285
sasa(dp2286
g3
VCD004715 v. 6.0 Pharmacological interventions for pain in patients with temporomandibular disorders.rm5
p2287
sg5
(lp2288
(dp2289
g8
V20216107.xml
p2290
sg10
VSTD-Tchivileva-et-al-2010
p2291
sg12
S'PMC2876724'
p2292
sasa(dp2293
g3
VCD005046 v. 9.0 Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasi.rm5
p2294
sg5
(lp2295
(dp2296
g8
V9895383.xml
p2297
sg10
VSTD-Vaezi-1999
p2298
sg12
S'PMC1727388'
p2299
sasa(dp2300
g3
VCD003566 v. 5.0 Cardioselective beta-blockers for chronic obstructive pulmonary disease.rm5
p2301
sg5
(lp2302
(dp2303
g8
V369647.xml
p2304
sg10
VSTD-Sinclair-1979
p2305
sg12
S'PMC1597640'
p2306
sa(dp2307
g8
V4041341.xml
p2308
sg10
VSTD-Lammers-1985a
p2309
sg12
S'PMC1400701'
p2310
sa(dp2311
g8
V339932.xml
p2312
sg10
VSTD-Perks-1978
p2313
sg12
S'PMC1429247'
p2314
sa(dp2315
g8
V2902873.xml
p2316
sg10
VSTD-Macquin_x002d_Mavier-1988
p2317
sg12
S'PMC1386540'
p2318
sasa(dp2319
g3
VCD005279 v. 5.0 Ultrasound use for the placement of haemodialysis catheters.rm5
p2320
sg5
(lp2321
(dp2322
g8
V19965532.xml
p2323
sg10
VSTD-Prabhu-2010
p2324
sg12
S'PMC2827594'
p2325
sasa(dp2326
g3
VCD004118 v. 4.0 Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p2327
sg5
(lp2328
(dp2329
g8
V9536943.xml
p2330
sg10
VSTD-Marteau-1998
p2331
sg12
S'PMC1727004'
p2332
sasa(dp2333
g3
VCD007070 v. 3.5 Acupuncture for treating fibromyalgia.rm5
p2334
sg5
(lp2335
(dp2336
g8
V20331844.xml
p2337
sg10
VSTD-Itoh-2010
p2338
sg12
S'PMC2852376'
p2339
sa(dp2340
g8
V1477566.xml
p2341
sg10
VSTD-Deluze-1992
p2342
sg12
S'PMC1883744'
p2343
sa(dp2344
g8
V19501658.xml
p2345
sg10
VSTD-Harris-2009
p2346
sg12
S'PMC2757074'
p2347
sasa(dp2348
g3
VCD004493 v. 8.2 Family-based programmes for preventing smoking by children and adolescents.rm5
p2349
sg5
(lp2350
(dp2351
g8
V11291373.xml
p2352
sg10
VSTD-Bauman-2001
p2353
sg12
S'PMC1446646'
p2354
sa(dp2355
g8
V15376818.xml
p2356
sg10
VSTD-Schinke-2004
p2357
sg12
S'PMC2795165'
p2358
sa(dp2359
g8
V8435601.xml
p2360
sg10
VSTD-Nutbeam-1993
p2361
sg12
S'PMC1676653'
p2362
sa(dp2363
g8
V12612363.xml
p2364
sg10
VSTD-Jackson-2006
p2365
sg12
S'PMC1759106'
p2366
sasa(dp2367
g3
VCD006009 v. 4.0 Dopamine agonists for the treatment of restless legs syndrome.rm5
p2368
sg5
(lp2369
(dp2370
g8
V14707315.xml
p2371
sg10
VSTD-Trenkwalder-2004b
p2372
sg12
S'PMC1757460'
p2373
sasa(dp2374
g3
VCD000434 v. 11.2 Interventions for treating proximal humeral fractures in adults.rm5
p2375
sg5
(lp2376
(dp2377
g8
V21387176.xml
p2378
sg10
VSTD-Zhang-2011
p2379
sg12
S'PMC3193968'
p2380
sasa(dp2381
g3
VCD002814 v. 9.26 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.rm5
p2382
sg5
(lp2383
(dp2384
g8
V6842217.xml
p2385
sg10
VSTD-Scott-1983
p2386
sg12
S'PMC1027296'
p2387
sasa(dp2388
g3
VCD000436 v. 7.0 Dietary sodium manipulation and asthma.rm5
p2389
sg5
(lp2390
(dp2391
g8
V1609379.xml
p2392
sg10
VSTD-Lieberman-1992
p2393
sg12
S'PMC463751'
p2394
sa(dp2395
g8
V2928987.xml
p2396
sg10
VSTD-Burney-1989
p2397
sg12
S'PMC461661'
p2398
sa(dp2399
g8
V8153919.xml
p2400
sg10
VSTD-Carey-1993
p2401
sg12
S'PMC464652'
p2402
sasa(dp2403
g3
VCD005640 v. 6.5 T-tube drainage versus primary closure after open common bile duct exploration.rm5
p2404
sg5
(lp2405
(dp2406
g8
V3538986.xml
p2407
sg10
VSTD-Payne-1986
p2408
sg12
S'PMC2498399'
p2409
sasa(dp2410
g3
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p2411
sg5
(lp2412
(dp2413
g8
V21935312.xml
p2414
sg10
VSTD-Naik-2010
p2415
sg12
S'PMC3169962'
p2416
sa(dp2417
g8
V12728159.xml
p2418
sg10
VSTD-Brusasco-2003
p2419
sg12
S'PMC1746668'
p2420
sa(dp2421
g8
V17370096.xml
p2422
sg10
VSTD-Rutten_x002d_van-Molken-2007
p2423
sg12
S'PMC1913175'
p2424
sasa(dp2425
g3
VCD003823 v. 7.0 Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hyper.rm5
p2426
sg5
(lp2427
(dp2428
g8
V8198936.xml
p2429
sg10
VSTD-Vandenburg-1994
p2430
sg12
S'PMC1364758'
p2431
sa(dp2432
g8
V2556172.xml
p2433
sg10
VSTD-Gomez-1989
p2434
sg12
S'PMC1379991'
p2435
sa(dp2436
g8
V9643623.xml
p2437
sg10
VSTD-Scholze-1998
p2438
sg12
S'PMC1873536'
p2439
sa(dp2440
g8
V3555588.xml
p2441
sg10
VSTD-Kayanakis-1987
p2442
sg12
S'PMC1386051'
p2443
sasa(dp2444
g3
VCD002769 v. 11.0 Non-invasive ventilation for cystic fibrosis.rm5
p2445
sg5
(lp2446
(dp2447
g8
V14514944.xml
p2448
sg10
VSTD-Holland-2003
p2449
sg12
S'PMC1746478'
p2450
sasa(dp2451
g3
VCD003530 v. 4.0 Beclomethasone versus budesonide for chronic asthma.rm5
p2452
sg5
(lp2453
(dp2454
g8
V3662586.xml
p2455
sg10
VSTD-Springer-1987
p2456
sg12
S'PMC1778496'
p2457
sa(dp2458
g8
V6756319.xml
p2459
sg10
VSTD-Field-1982
p2460
sg12
S'PMC1628026'
p2461
sa(dp2462
g8
V3547757.xml
p2463
sg10
VSTD-Ebden-1986
p2464
sg12
S'PMC460512'
p2465
sasa(dp2466
g3
VCD001820 v. 8.0 Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.rm5
p2467
sg5
(lp2468
(dp2469
g8
V4879059.xml
p2470
sg10
VSTD-Gent_x002d_AMI-1968
p2471
sg12
S'PMC1912602'
p2472
sasa(dp2473
g3
VCD007933 v. 2.2 Genital ulcer disease treatment for reducing sexual acquisition of HIV.rm5
p2474
sg5
(lp2475
(dp2476
g8
V2502065.xml
p2477
sg10
VSTD-MacDonald-1989
p2478
sg12
S'PMC172499'
p2479
sasa(dp2480
g3
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p2481
sg5
(lp2482
(dp2483
g8
V17060756.xml
p2484
sg10
VSTD-Balasubramanian-2006
p2485
sg12
S'PMC1856614'
p2486
sa(dp2487
g8
V19358717.xml
p2488
sg10
VSTD-Ethgen-2009
p2489
sg12
S'PMC2679061'
p2490
sa(dp2491
g8
V20482769.xml
p2492
sg10
VSTD-Yu-2010
p2493
sg12
S'PMC2886040'
p2494
sa(dp2495
g8
V20332510.xml
p2496
sg10
VSTD-Hopewell-2010
p2497
sg12
S'PMC2844941'
p2498
sa(dp2499
g8
V19930576.xml
p2500
sg10
VSTD-Partsinevelou-2009
p2501
sg12
S'PMC2788535'
p2502
sa(dp2503
g8
V18270568.xml
p2504
sg10
VSTD-Prady-2008
p2505
sg12
S'PMC2216683'
p2506
sa(dp2507
g8
V15760970.xml
p2508
sg10
VSTD-Hewitt-2005
p2509
sg12
S'PMC557225'
p2510
sa(dp2511
g8
V19554136.xml
p2512
sg10
VSTD-Thoma-2006
p2513
sg12
S'PMC2686052'
p2514
sa(dp2515
g8
V19070681.xml
p2516
sg10
VSTD-Han-2008
p2517
sg12
S'PMC3489160'
p2518
sa(dp2519
g8
V20067642.xml
p2520
sg10
VSTD-Montan_x00e9_-2010
p2521
sg12
S'PMC2822812'
p2522
sasa(dp2523
g3
VCD002020 v. 11.2 Group-based parent training programmes for improving parental psychosocial health.rm5
p2524
sg5
(lp2525
(dp2526
g8
V16293780.xml
p2527
sg10
VSTD-Lipman-2005
p2528
sg12
S'PMC1316160'
p2529
sa(dp2530
g8
V19067166.xml
p2531
sg10
VSTD-Gross-2009
p2532
sg12
S'PMC2770507'
p2533
sa(dp2534
g8
V12456542.xml
p2535
sg10
VSTD-Patterson-2002
p2536
sg12
S'PMC1755810'
p2537
sa(dp2538
g8
V18747059.xml
p2539
sg10
VSTD-Fanning-2007
p2540
sg12
S'PMC1781028'
p2541
sa(dp2542
g8
V18244958.xml
p2543
sg10
VSTD-Hiscock-2008
p2544
sg12
S'PMC2234515'
p2545
sasa(dp2546
g3
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p2547
sg5
(lp2548
(dp2549
g8
V15770205.xml
p2550
sg10
VSTD-Senkus_x002d_Konefka-2005
p2551
sg12
S'PMC2361948'
p2552
sa(dp2553
g8
V1705140.xml
p2554
sg10
VSTD-MRC-1991
p2555
sg12
S'PMC1971762'
p2556
sa(dp2557
g8
V1377484.xml
p2558
sg10
VSTD-MRC-1992
p2559
sg12
S'PMC1977779'
p2560
sasa(dp2561
g3
VCD005306 v. 3.1 Written action plans for asthma in children.rm5
p2562
sg5
(lp2563
(dp2564
g8
V2148702.xml
p2565
sg10
VSTD-Charlton-1990
p2566
sg12
S'PMC1664498'
p2567
sasa(dp2568
g3
VCD003614 v. 5.2 Trimetazidine for stable angina.rm5
p2569
sg5
(lp2570
(dp2571
g8
V8198938.xml
p2572
sg10
VSTD-Detry-1994
p2573
sg12
S'PMC1364760'
p2574
sa(dp2575
g8
V9404250.xml
p2576
sg10
VSTD-Manchanda-1997
p2577
sg12
S'PMC1892273'
p2578
sasa(dp2579
g3
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p2580
sg5
(lp2581
(dp2582
g8
V20058059.xml
p2583
sg10
VSTD-Frankel-2010
p2584
sg12
S'PMC2890979'
p2585
sasa(dp2586
g3
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p2587
sg5
(lp2588
(dp2589
g8
V11720460.xml
p2590
sg10
VSTD-Brown-2001
p2591
sg12
S'PMC2375236'
p2592
sa(dp2593
g8
V18777429.xml
p2594
sg10
VSTD-Ho-2008
p2595
sg12
S'PMC3149814'
p2596
sa(dp2597
g8
V15479685.xml
p2598
sg10
VSTD-Kennedy-2004
p2599
sg12
S'PMC1774266'
p2600
sa(dp2601
g8
V15904552.xml
p2602
sg10
VSTD-Harmsen-2005
p2603
sg12
S'PMC1463156'
p2604
sa(dp2605
g8
V16438813.xml
p2606
sg10
VSTD-Longo-2006
p2607
sg12
S'PMC1821413'
p2608
sa(dp2609
g8
V18474884.xml
p2610
sg10
VSTD-Krones-2008
p2611
sg12
S'PMC2384995'
p2612
sa(dp2613
g8
V15610326.xml
p2614
sg10
VSTD-Glasgow-2004
p2615
sg12
S'PMC1492587'
p2616
sa(dp2617
g8
V15353051.xml
p2618
sg10
VSTD-McLean-2004
p2619
sg12
S'PMC1326066'
p2620
sa(dp2621
g8
V17893379.xml
p2622
sg10
VSTD-Stewart-2007
p2623
sg12
S'PMC2000315'
p2624
sa(dp2625
g8
V16882375.xml
p2626
sg10
VSTD-Hobma-2006
p2627
sg12
S'PMC1874521'
p2628
sa(dp2629
g8
V9794859.xml
p2630
sg10
VSTD-Kinmonth-1998
p2631
sg12
S'PMC28704'
p2632
sa(dp2633
g8
V16808764.xml
p2634
sg10
VSTD-Smith-2006
p2635
sg12
S'PMC1924714'
p2636
sa(dp2637
g8
V8776911.xml
p2638
sg10
VSTD-Howe-1996
p2639
sg12
S'PMC1239692'
p2640
sasa(dp2641
g3
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p2642
sg5
(lp2643
(dp2644
g8
V22054336.xml
p2645
sg10
VSTD-Woodfine-2011
p2646
sg12
S'PMC3207090'
p2647
sa(dp2648
g8
V23863613.xml
p2649
sg10
VSTD-Rosen-2006
p2650
sg12
S'PMC3734469'
p2651
sa(dp2652
g8
V14629776.xml
p2653
sg10
VSTD-Lumley-2006
p2654
sg12
S'PMC305350'
p2655
sa(dp2656
g8
V21680632.xml
p2657
sg10
VSTD-Florence-2011
p2658
sg12
S'PMC3116927'
p2659
sasa(dp2660
g3
VCD005415 v. 9.0 Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bl.rm5
p2661
sg5
(lp2662
(dp2663
g8
V11511559.xml
p2664
sg10
VSTD-Hawkey-2001
p2665
sg12
S'PMC1728427'
p2666
sa(dp2667
g8
V1737157.xml
p2668
sg10
VSTD-Daneshmend-1992
p2669
sg12
S'PMC1881159'
p2670
sasa(dp2671
g3
VCD006949 v. 5.0 Interventions for erythema nodosum leprosum.rm5
p2672
sg5
(lp2673
(dp2674
g8
V4904935.xml
p2675
sg10
VSTD-Karat-1970
p2676
sg12
S'PMC1699291'
p2677
sa(dp2678
g8
V4947831.xml
p2679
sg10
VSTD-Iyer-1971
p2680
sg12
S'PMC2427977'
p2681
sasa(dp2682
g3
VCD006499 v. 4.0 Botulinum toxin for the treatment of strabismus.rm5
p2683
sg5
(lp2684
(dp2685
g8
V9613374.xml
p2686
sg10
VSTD-Tejedor-1998
p2687
sg12
S'PMC1722471'
p2688
sa(dp2689
g8
V10381663.xml
p2690
sg10
VSTD-Tejedor-1999
p2691
sg12
S'PMC1723128'
p2692
sasa(dp2693
g3
VCD004464 v. 6.0 Sacral nerve stimulation for faecal incontinence and constipation in adults.rm5
p2694
sg5
(lp2695
(dp2696
g8
V16244539.xml
p2697
sg10
VSTD-Leroi-2005
p2698
sg12
S'PMC1409867'
p2699
sasa(dp2700
g3
VCD002819 v. 6.0 Cyclophosphamide for multiple sclerosis.rm5
p2701
sg5
(lp2702
(dp2703
g8
V1783915.xml
p2704
sg10
VSTD-Likosky-1991
p2705
sg12
S'PMC1014677'
p2706
sasa(dp2707
g3
VCD007705 v. 2.0 Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery.rm5
p2708
sg5
(lp2709
(dp2710
g8
V17394704.xml
p2711
sg10
VSTD-Padmanabhan-2007
p2712
sg12
S'PMC1964741'
p2713
sasa(dp2714
g3
VCD003938 v. 6.0 Provider training and experience for people living with HIVAIDS.rm5
p2715
sg5
(lp2716
(dp2717
g8
V11556937.xml
p2718
sg10
VSTD-Keitz-2001
p2719
sg12
S'PMC1495270'
p2720
sa(dp2721
g8
V12709089.xml
p2722
sg10
VSTD-Landon-2003
p2723
sg12
S'PMC1494839'
p2724
sasa(dp2725
g3
VCD002773 v. 4.0 Neuromuscular paralysis for newborn infants receiving mechanical ventilation.rm5
p2726
sg5
(lp2727
(dp2728
g8
V8285749.xml
p2729
sg10
VSTD-Shaw-1993
p2730
sg12
S'PMC1029588'
p2731
sasa(dp2732
g3
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p2733
sg5
(lp2734
(dp2735
g8
V19684043.xml
p2736
sg10
VSTD-ENGAGE-2009
p2737
sg12
S'PMC2777786'
p2738
sasa(dp2739
g3
VCD003993 v. 4.0 Thymic peptides for treatment of cancer patients.rm5
p2740
sg5
(lp2741
(dp2742
g8
V23618554.xml
p2743
sg10
VSTD-Pavesi-1993
p2744
sg12
S'PMC3640956'
p2745
sasa(dp2746
g3
VCD003909 v. 12.0 Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa.rm5
p2747
sg5
(lp2748
(dp2749
g8
V12082182.xml
p2750
sg10
VSTD-Bergh-2002
p2751
sg12
S'PMC123167'
p2752
sa(dp2753
g8
V10079459.xml
p2754
sg10
VSTD-Bachar-1999
p2755
sg12
S'PMC3330539'
p2756
sasa(dp2757
g3
VCD002126 v. 5.2 Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.rm5
p2758
sg5
(lp2759
(dp2760
g8
V9552948.xml
p2761
sg10
VSTD-Lahteenmaki-1998
p2762
sg12
S'PMC28513'
p2763
sasa(dp2764
g3
VCD006036 v. 5.0 Multidisciplinary rehabilitation for adults with multiple sclerosis.rm5
p2765
sg5
(lp2766
(dp2767
g8
V12185154.xml
p2768
sg10
VSTD-Pozzilli-2002
p2769
sg12
S'PMC1738043'
p2770
sa(dp2771
g8
V12933923.xml
p2772
sg10
VSTD-Craig-2003
p2773
sg12
S'PMC1738635'
p2774
sasa(dp2775
g3
VCD001096 v. 6.0 The effects of on-screen point of care computer reminders on processes and outcomes of care.rm5
p2776
sg5
(lp2777
(dp2778
g8
V12975221.xml
p2779
sg10
VSTD-Tamblyn-2003
p2780
sg12
S'PMC191278'
p2781
sa(dp2782
g8
V18373141.xml
p2783
sg10
VSTD-Hicks-2008
p2784
sg12
S'PMC2359515'
p2785
sa(dp2786
g8
V16191138.xml
p2787
sg10
VSTD-Kenealy-2005
p2788
sg12
S'PMC1490216'
p2789
sa(dp2790
g8
V14687254.xml
p2791
sg10
VSTD-Tierney-2003
p2792
sg12
S'PMC1494965'
p2793
sa(dp2794
g8
V12183309.xml
p2795
sg10
VSTD-Flottorp-2002
p2796
sg12
S'PMC117890'
p2797
sa(dp2798
g8
V15762903.xml
p2799
sg10
VSTD-Tierney-2005
p2800
sg12
S'PMC1361152'
p2801
sa(dp2802
g8
V12399345.xml
p2803
sg10
VSTD-Eccles-2002a
p2804
sg12
S'PMC130060'
p2805
sa(dp2806
g8
V15802479.xml
p2807
sg10
VSTD-Sequist-2005
p2808
sg12
S'PMC1174888'
p2809
sa(dp2810
g8
V9292842.xml
p2811
sg10
VSTD-Overhage-1997
p2812
sg12
S'PMC61254'
p2813
sa(dp2814
g8
V16622171.xml
p2815
sg10
VSTD-Judge-2006
p2816
sg12
S'PMC1513672'
p2817
sasa(dp2818
g3
VCD003719 v. 7.0 Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in I.rm5
p2819
sg5
(lp2820
(dp2821
g8
V16021858.xml
p2822
sg10
VSTD-Abdelmassih-2005
p2823
sg12
S'PMC3455286'
p2824
sa(dp2825
g8
V18925430.xml
p2826
sg10
VSTD-Farrag-2008
p2827
sg12
S'PMC2582096'
p2828
sasa(dp2829
g3
VCD002230 v. 5.0 Phosphodiesterase III inhibitors for heart failure.rm5
p2830
sg5
(lp2831
(dp2832
g8
V7946771.xml
p2833
sg10
VSTD-Cowley-1994
p2834
sg12
S'PMC1025506'
p2835
sa(dp2836
g8
V8868980.xml
p2837
sg10
VSTD-PICO-1996
p2838
sg12
S'PMC484511'
p2839
sasa(dp2840
g3
VCD009356 v. 2.7 Hypnosis for pain management during labour and childbirth.rm5
p2841
sg5
(lp2842
(dp2843
g8
V3081212.xml
p2844
sg10
VSTD-Freeman-1986
p2845
sg12
S'PMC1339642'
p2846
sasa(dp2847
g3
VCD000245 v. 16.0 Antibiotics for acute bronchitis.rm5
p2848
sg5
(lp2849
(dp2850
g8
V786428.xml
p2851
sg10
VSTD-Stott-1976
p2852
sg12
S'PMC1688091'
p2853
sa(dp2854
g8
V8790652.xml
p2855
sg10
VSTD-Verheij-1994
p2856
sg12
S'PMC1238988'
p2857
sasa(dp2858
g3
VCD001823 v. 10.0 Lumbar supports for prevention and treatment of low back pain.rm5
p2859
sg5
(lp2860
(dp2861
g8
V6458250.xml
p2862
sg10
VSTD-Million-1981
p2863
sg12
S'PMC1000779'
p2864
sa(dp2865
g8
V123815.xml
p2866
sg10
VSTD-Doran-1975
p2867
sg12
S'PMC1675960'
p2868
sasa(dp2869
g3
VCD008079 v. 2.0 Rituximab ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.rm5
p2870
sg5
(lp2871
(dp2872
g8
V21321292.xml
p2873
sg10
VSTD-CALBG-9712
p2874
sg12
S'PMC3084002'
p2875
sasa(dp2876
g3
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p2877
sg5
(lp2878
(dp2879
g8
V10327712.xml
p2880
sg10
VSTD-Rojas-de-Arias-1999
p2881
sg12
S'PMC2557652'
p2882
sa(dp2883
g8
V23751246.xml
p2884
sg10
VSTD-Barnes-2003
p2885
sg12
S'PMC3779532'
p2886
sa(dp2887
g8
V17324975.xml
p2888
sg10
VSTD-Howden_x002d_Chapman-2007
p2889
sg12
S'PMC1808149'
p2890
sa(dp2891
g8
V8762355.xml
p2892
sg10
VSTD-Hopton-1996
p2893
sg12
S'PMC1060205'
p2894
sa(dp2895
g8
V22155834.xml
p2896
sg10
VSTD-Ambrose-2000
p2897
sg12
S'PMC3294956'
p2898
sa(dp2899
g8
V13845013.xml
p2900
sg10
VSTD-Wilner-1960
p2901
sg12
S'PMC1373218'
p2902
sa(dp2903
g8
V22054336.xml
p2904
sg10
VSTD-CHARISMA-2011
p2905
sg12
S'PMC3207090'
p2906
sa(dp2907
g8
V21563714.xml
p2908
sg10
VSTD-Breysse-2011
p2909
sg12
S'PMC3072905'
p2910
sa(dp2911
g8
V18812366.xml
p2912
sg10
VSTD-Howden_x002d_Chapman-2008
p2913
sg12
S'PMC2658826'
p2914
sa(dp2915
g8
V17325397.xml
p2916
sg10
VSTD-Thomson-2007
p2917
sg12
S'PMC2652910'
p2918
sa(dp2919
g8
V17699530.xml
p2920
sg10
VSTD-Barton-2007
p2921
sg12
S'PMC2659999'
p2922
sasa(dp2923
g3
VCD009000 v. 2.2 Ready-to-use therapeutic food for home-based treatment of severe acute malnutrition in children from.rm5
p2924
sg5
(lp2925
(dp2926
g8
V15155403.xml
p2927
sg10
VSTD-Manary-2004
p2928
sg12
S'PMC1719944'
p2929
sa(dp2930
g8
V20980648.xml
p2931
sg10
VSTD-Oakley-2010
p2932
sg12
S'PMC2981006'
p2933
sasa(dp2934
g3
VCD000219 v. 16.0 Antibiotics for acute otitis media in children.rm5
p2935
sg5
(lp2936
(dp2937
g8
V17846935.xml
p2938
sg10
VSTD-Neumark-2007
p2939
sg12
S'PMC3379776'
p2940
sa(dp2941
g8
V1912887.xml
p2942
sg10
VSTD-Burke-1991
p2943
sg12
S'PMC1670875'
p2944
sa(dp2945
g8
V15684116.xml
p2946
sg10
VSTD-Le-Saux-2005
p2947
sg12
S'PMC545757'
p2948
sa(dp2949
g8
V4190002.xml
p2950
sg10
VSTD-Laxdal-1970
p2951
sg12
S'PMC1946394'
p2952
sa(dp2953
g8
V1773154.xml
p2954
sg10
VSTD-Appelman-1991
p2955
sg12
S'PMC1671677'
p2956
sa(dp2957
g8
V11159657.xml
p2958
sg10
VSTD-Little-2001
p2959
sg12
S'PMC26576'
p2960
sa(dp2961
g8
V10657332.xml
p2962
sg10
VSTD-Damoiseaux-2000
p2963
sg12
S'PMC27282'
p2964
sa(dp2965
g8
V21226576.xml
p2966
sg10
VSTD-Hoberman-2011
p2967
sg12
S'PMC3042231'
p2968
sasa(dp2969
g3
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p2970
sg5
(lp2971
(dp2972
g8
V17485422.xml
p2973
sg10
VSTD-Nishimoto-2007-_x0028_SAMURAI_x0029_
p2974
sg12
S'PMC1955155'
p2975
sa(dp2976
g8
V18979150.xml
p2977
sg10
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p2978
sg12
S'PMC2638601'
p2979
sasa(dp2980
g3
VCD005632 v. 3.0 Steroid avoidance or withdrawal for kidney transplant recipients.rm5
p2981
sg5
(lp2982
(dp2983
g8
V8462048.xml
p2984
sg10
VSTD-Sinclair-1992
p2985
sg12
S'PMC1491724'
p2986
sasa(dp2987
g3
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p2988
sg5
(lp2989
(dp2990
g8
V21252104.xml
p2991
sg10
VSTD-Driver-2011-age-matched
p2992
sg12
S'PMC3023971'
p2993
sa(dp2994
g8
V21368281.xml
p2995
sg10
VSTD-Gao-2011
p2996
sg12
S'PMC3059148'
p2997
sa(dp2998
g8
V21252104.xml
p2999
sg10
VSTD-Driver-2011-age_x002b_-matched
p3000
sg12
S'PMC3023971'
p3001
sasa(dp3002
g3
VCD005188 v. 6.0 Interventions to increase influenza vaccination rates of those 60 years and older in the community.rm5
p3003
sg5
(lp3004
(dp3005
g8
V12236277.xml
p3006
sg10
VSTD-Siriwardena-2002
p3007
sg12
S'PMC1314414'
p3008
sa(dp3009
g8
V9686713.xml
p3010
sg10
VSTD-Baker-1998
p3011
sg12
S'PMC1496989'
p3012
sa(dp3013
g8
V10701382.xml
p3014
sg10
VSTD-Dalby-2000
p3015
sg12
S'PMC1231166'
p3016
sa(dp3017
g8
V12236273.xml
p3018
sg10
VSTD-Hull-2002
p3019
sg12
S'PMC1314410'
p3020
sa(dp3021
g8
V12236274.xml
p3022
sg10
VSTD-Arthur-2002
p3023
sg12
S'PMC1314411'
p3024
sa(dp3025
g8
V21263970.xml
p3026
sg10
VSTD-Lukasik-1987
p3027
sg12
S'PMC2218648'
p3028
sa(dp3029
g8
V8259810.xml
p3030
sg10
VSTD-Black-1993
p3031
sg12
S'PMC1694928'
p3032
sa(dp3033
g8
V11276541.xml
p3034
sg10
VSTD-Lemelin-2001
p3035
sg12
S'PMC80870'
p3036
sa(dp3037
g8
V3093045.xml
p3038
sg10
VSTD-McDowell-1986
p3039
sg12
S'PMC1491283'
p3040
sa(dp3041
g8
V10432913.xml
p3042
sg10
VSTD-Clayton-1999
p3043
sg12
S'PMC1508682'
p3044
sa(dp3045
g8
V10480825.xml
p3046
sg10
VSTD-Kerse-1999
p3047
sg12
S'PMC28221'
p3048
sa(dp3049
g8
V3565663.xml
p3050
sg10
VSTD-Mullooly-1987
p3051
sg12
S'PMC1647052'
p3052
sa(dp3053
g8
V9481466.xml
p3054
sg10
VSTD-Hogg-1998
p3055
sg12
S'PMC2277568'
p3056
sasa(dp3057
g3
VCD002900 v. 6.0 Surgical methods for first trimester termination of pregnancy.rm5
p3058
sg5
(lp3059
(dp3060
g8
V23040108.xml
p3061
sg10
VSTD-Yin-2005
p3062
sg12
S'PMC3523975'
p3063
sasa(dp3064
g3
VCD001561 v. 10.0 Multiple risk factor interventions for primary prevention of coronary heart disease.rm5
p3065
sg5
(lp3066
(dp3067
g8
V10514155.xml
p3068
sg10
VSTD-Change-of-Heart--1999
p3069
sg12
S'PMC28246'
p3070
sa(dp3071
g8
V2115348.xml
p3072
sg10
VSTD-Abingdon-1990
p3073
sg12
S'PMC1371239'
p3074
sa(dp3075
g8
V6849473.xml
p3076
sg10
VSTD-Johns-Hopkins
p3077
sg12
S'PMC1650522'
p3078
sa(dp3079
g8
V7742677.xml
p3080
sg10
VSTD-CELL-Study-1995
p3081
sg12
S'PMC2549500'
p3082
sa(dp3083
g8
V8124120.xml
p3084
sg10
VSTD-OXCHECK-1994
p3085
sg12
S'PMC2539253'
p3086
sa(dp3087
g8
V21432327.xml
p3088
sg10
VSTD-Okayama-2004
p3089
sg12
S'PMC2723573'
p3090
sa(dp3091
g8
V8124121.xml
p3092
sg10
VSTD-Family-Heart-1994-F
p3093
sg12
S'PMC2539278'
p3094
sa(dp3095
g8
V15823786.xml
p3096
sg10
VSTD-Toobert-_x0028_MLP_x0029_-2005
p3097
sg12
S'PMC1557654'
p3098
sa(dp3099
g8
V8124121.xml
p3100
sg10
VSTD-Family-Heart--1994-M
p3101
sg12
S'PMC2539278'
p3102
sa(dp3103
g8
V7856780.xml
p3104
sg10
VSTD-Take-Heart-1995
p3105
sg12
S'PMC1615302'
p3106
sasa(dp3107
g3
VCD001547 v. 6.2 Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults.rm5
p3108
sg5
(lp3109
(dp3110
g8
V3461726.xml
p3111
sg10
VSTD-Desjardins-1986
p3112
sg12
S'PMC2175477'
p3113
sasa(dp3114
g3
VCD004450 v. 5.0 Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-depende.rm5
p3115
sg5
(lp3116
(dp3117
g8
V4821036.xml
p3118
sg10
VSTD-Barry-1974
p3119
sg12
S'PMC1610120'
p3120
sasa(dp3121
g3
VCD000175 v. 8.0 Prophylactic intravenous preloading for regional analgesia in labour.rm5
p3122
sg5
(lp3123
(dp3124
g8
V719463.xml
p3125
sg10
VSTD-Collins-1978
p3126
sg12
S'PMC1608676'
p3127
sasa(dp3128
g3
VCD006790 v. 3.0 Type I interferons for induction of remission in ulcerative colitis.rm5
p3129
sg5
(lp3130
(dp3131
g8
V12912859.xml
p3132
sg10
VSTD-Nikolaus-2003
p3133
sg12
S'PMC1773804'
p3134
sa(dp3135
g8
V14633951.xml
p3136
sg10
VSTD-Tilg-2003
p3137
sg12
S'PMC1773891'
p3138
sasa(dp3139
g3
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p3140
sg5
(lp3141
(dp3142
g8
V16508640.xml
p3143
sg10
VSTD-Burton-2006
p3144
sg12
S'PMC3216418'
p3145
sasa(dp3146
g3
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p3147
sg5
(lp3148
(dp3149
g8
V17626140.xml
p3150
sg10
VSTD-Thomson-2007
p3151
sg12
S'PMC2083581'
p3152
sa(dp3153
g8
V22615652.xml
p3154
sg10
VSTD-Rafati-2011
p3155
sg12
S'PMC3232099'
p3156
sa(dp3157
g8
V15479678.xml
p3158
sg10
VSTD-Voskujl-2004
p3159
sg12
S'PMC1774276'
p3160
sasa(dp3161
g3
VCD001001 v. 8.0 Lung volume reduction surgery for diffuse emphysema.rm5
p3162
sg5
(lp3163
(dp3164
g8
V12728160.xml
p3165
sg10
VSTD-Goldstein-2003
p3166
sg12
S'PMC1746667'
p3167
sasa(dp3168
g3
VCD008666 v. 3.0 Vitamin A supplementation during pregnancy for maternal and newborn outcomes.rm5
p3169
sg5
(lp3170
(dp3171
g8
V10037634.xml
p3172
sg10
VSTD-West-1999
p3173
sg12
S'PMC27760'
p3174
sasa(dp3175
g3
VCD000123 v. 8.0 Lipid-lowering for peripheral arterial disease of the lower limb.rm5
p3176
sg5
(lp3177
(dp3178
g8
V12433762.xml
p3179
sg10
VSTD-LEADER
p3180
sg12
S'PMC133451'
p3181
sasa(dp3182
g3
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p3183
sg5
(lp3184
(dp3185
g8
V21865419.xml
p3186
sg10
VSTD-Teo-2011
p3187
sg12
S'PMC3187313'
p3188
sa(dp3189
g8
V20825313.xml
p3190
sg10
VSTD-Boehme-2010d
p3191
sg12
S'PMC2947799'
p3192
sa(dp3193
g8
V20825313.xml
p3194
sg10
VSTD-Boehme-2010e
p3195
sg12
S'PMC2947799'
p3196
sa(dp3197
g8
V21849695.xml
p3198
sg10
VSTD-Miller-2011
p3199
sg12
S'PMC3187315'
p3200
sa(dp3201
g8
V20825313.xml
p3202
sg10
VSTD-Boehme-2010a
p3203
sg12
S'PMC2947799'
p3204
sa(dp3205
g8
V20825313.xml
p3206
sg10
VSTD-Boehme-2010b
p3207
sg12
S'PMC2947799'
p3208
sa(dp3209
g8
V20825313.xml
p3210
sg10
VSTD-Boehme-2010c
p3211
sg12
S'PMC2947799'
p3212
sa(dp3213
g8
V19864480.xml
p3214
sg10
VSTD-Helb-2010
p3215
sg12
S'PMC2812290'
p3216
sa(dp3217
g8
V21738575.xml
p3218
sg10
VSTD-Rachow-2011
p3219
sg12
S'PMC3126807'
p3220
sa(dp3221
g8
V21653771.xml
p3222
sg10
VSTD-Friedrich-2011
p3223
sg12
S'PMC3147741'
p3224
sa(dp3225
g8
V21289151.xml
p3226
sg10
VSTD-Marlowe-2011
p3227
sg12
S'PMC3122817'
p3228
sa(dp3229
g8
V21814495.xml
p3230
sg10
VSTD-Scott-2011
p3231
sg12
S'PMC3144192'
p3232
sa(dp3233
g8
V21507477.xml
p3234
sg10
VSTD-Boehme-2011f
p3235
sg12
S'PMC3085933'
p3236
sa(dp3237
g8
V21507477.xml
p3238
sg10
VSTD-Boehme-2011e
p3239
sg12
S'PMC3085933'
p3240
sa(dp3241
g8
V21507477.xml
p3242
sg10
VSTD-Boehme-2011d
p3243
sg12
S'PMC3085933'
p3244
sa(dp3245
g8
V21507477.xml
p3246
sg10
VSTD-Boehme-2011c
p3247
sg12
S'PMC3085933'
p3248
sa(dp3249
g8
V21507477.xml
p3250
sg10
VSTD-Boehme-2011b
p3251
sg12
S'PMC3085933'
p3252
sa(dp3253
g8
V21507477.xml
p3254
sg10
VSTD-Boehme-2011a
p3255
sg12
S'PMC3085933'
p3256
sa(dp3257
g8
V21677069.xml
p3258
sg10
VSTD-Ioannidis-2011
p3259
sg12
S'PMC3147726'
p3260
sa(dp3261
g8
V21191053.xml
p3262
sg10
VSTD-Moure-2011
p3263
sg12
S'PMC3067676'
p3264
sa(dp3265
g8
V21818180.xml
p3266
sg10
VSTD-Lawn-2011
p3267
sg12
S'PMC3144215'
p3268
sa(dp3269
g8
V21956978.xml
p3270
sg10
VSTD-Zeka-2011
p3271
sg12
S'PMC3232962'
p3272
sasa(dp3273
g3
VCD008320 v. 3.0 Pharmacological interventions for pruritus in adult palliative care patients.rm5
p3274
sg5
(lp3275
(dp3276
g8
V322794.xml
p3277
sg10
VSTD-Silverberg-1977
p3278
sg12
S'PMC1605638'
p3279
sa(dp3280
g8
V6145483.xml
p3281
sg10
VSTD-Duncan-1984
p3282
sg12
S'PMC1442057'
p3283
sasa(dp3284
g3
VCD002988 v. 6.5 Intravenous beta2-agonists for acute asthma in the emergency department.rm5
p3285
sg5
(lp3286
(dp3287
g8
V1106817.xml
p3288
sg10
VSTD-Williams-1981
p3289
sg12
S'PMC1675841'
p3290
sa(dp3291
g8
V7031975.xml
p3292
sg10
VSTD-Williams-1975
p3293
sg12
S'PMC471658'
p3294
sa(dp3295
g8
V383024.xml
p3296
sg10
VSTD-Hambleton-1979
p3297
sg12
S'PMC1545558'
p3298
sa(dp3299
g8
V319876.xml
p3300
sg10
VSTD-Femi_x002d_Pearse-2-1977
p3301
sg12
S'PMC1605098'
p3302
sa(dp3303
g8
V319876.xml
p3304
sg10
VSTD-Femi_x002d_Pearse-1-1977
p3305
sg12
S'PMC1605098'
p3306
sa(dp3307
g8
V373852.xml
p3308
sg10
VSTD-Bloomfield-1979
p3309
sg12
S'PMC1598545'
p3310
sa(dp3311
g8
V638577.xml
p3312
sg10
VSTD-Johnson-1978
p3313
sg12
S'PMC1603977'
p3314
sa(dp3315
g8
V339993.xml
p3316
sg10
VSTD-Lawford-1978
p3317
sg12
S'PMC1602586'
p3318
sa(dp3319
g8
V3139138.xml
p3320
sg10
VSTD-Cheong-1988
p3321
sg12
S'PMC1833883'
p3322
sasa(dp3323
g3
VCD008012 v. 3.0 Psychological and pharmacological interventions for depression in patients with coronary artery dise.rm5
p3324
sg5
(lp3325
(dp3326
g8
V19742062.xml
p3327
sg10
VSTD-Barth-2005
p3328
sg12
S'PMC2736492'
p3329
sa(dp3330
g8
V16423095.xml
p3331
sg10
VSTD-McLaughlin-2005
p3332
sg12
S'PMC1490273'
p3333
sasa(dp3334
g3
VCD001477 v. 11.0 Antibiotics for preventing complications in children with measles.rm5
p3335
sg5
(lp3336
(dp3337
g8
V17060336.xml
p3338
sg10
VSTD-Garly-2006
p3339
sg12
S'PMC1702442'
p3340
sasa(dp3341
g3
VCD005064 v. 9.0 Anticonvulsants for alcohol withdrawal.rm5
p3342
sg5
(lp3343
(dp3344
g8
V12047731.xml
p3345
sg10
VSTD-Malcolm-2002
p3346
sg12
S'PMC1495040'
p3347
sasa(dp3348
g3
VCD000032 v. 8.0 Antenatal dietary advice and supplementation to increase energy and protein intake.rm5
p3349
sg5
(lp3350
(dp3351
g8
V6819028.xml
p3352
sg10
VSTD-Viegas-1982a
p3353
sg12
S'PMC1499417'
p3354
sa(dp3355
g8
V6819029.xml
p3356
sg10
VSTD-Viegas-1982b
p3357
sg12
S'PMC1499470'
p3358
sa(dp3359
g8
V9345173.xml
p3360
sg10
VSTD-Ceesay-1997
p3361
sg12
S'PMC2127544'
p3362
sasa(dp3363
g3
VCD001115 v. 9.0 Continuous versus intermittent beta-agonists for acute asthma.rm5
p3364
sg5
(lp3365
(dp3366
g8
V12454298.xml
p3367
sg10
VSTD-Innes-2002
p3368
sg12
S'PMC1758800'
p3369
sasa(dp3370
g3
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p3371
sg5
(lp3372
(dp3373
g8
V20920186.xml
p3374
sg10
VSTD-Pakasi-2010
p3375
sg12
S'PMC2957385'
p3376
sa(dp3377
g8
V18471061.xml
p3378
sg10
VSTD-Villamor-2008
p3379
sg12
S'PMC2564793'
p3380
sa(dp3381
g8
V19858174.xml
p3382
sg10
VSTD-Martins-2009
p3383
sg12
S'PMC2767482'
p3384
sasa(dp3385
g3
VCD005365 v. 3.0 Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts.rm5
p3386
sg5
(lp3387
(dp3388
g8
V3552176.xml
p3389
sg10
VSTD-Rieder-1987
p3390
sg12
S'PMC1491956'
p3391
sasa(dp3392
g3
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p3393
sg5
(lp3394
(dp3395
g8
V19018255.xml
p3396
sg10
VSTD-Johansson-2008
p3397
sg12
S'PMC2607225'
p3398
sa(dp3399
g8
V9492666.xml
p3400
sg10
VSTD-Moynihan-1998
p3401
sg12
S'PMC2665582'
p3402
sa(dp3403
g8
V19349551.xml
p3404
sg10
VSTD-Parker-2009
p3405
sg12
S'PMC2716938'
p3406
sa(dp3407
g8
V8608288.xml
p3408
sg10
VSTD-McArdle-1996
p3409
sg12
S'PMC2350687'
p3410
sasa(dp3411
g3
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p3412
sg5
(lp3413
(dp3414
g8
V18235151.xml
p3415
sg10
VSTD-Ogawa-2008
p3416
sg12
S'PMC2390947'
p3417
sa(dp3418
g8
V20368925.xml
p3419
sg10
VSTD-Ghorbani-2009
p3420
sg12
S'PMC2847809'
p3421
sasa(dp3422
g3
VCD002059 v. 6.0 Opiate treatment for opiate withdrawal in newborn infants.rm5
p3423
sg5
(lp3424
(dp3425
g8
V18694901.xml
p3426
sg10
VSTD-Kraft-2009
p3427
sg12
S'PMC2574639'
p3428
sa(dp3429
g8
V15210660.xml
p3430
sg10
VSTD-Jackson-2004
p3431
sg12
S'PMC1721707'
p3432
sasa(dp3433
g3
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p3434
sg5
(lp3435
(dp3436
g8
V18476153.xml
p3437
sg10
VSTD-Eriksen-1997
p3438
sg12
S'PMC2364551'
p3439
sasa(dp3440
g3
VCD001323 v. 7.2 Surgical interventions for age-related cataract.rm5
p3441
sg5
(lp3442
(dp3443
g8
V12770957.xml
p3444
sg10
VSTD-PUNE
p3445
sg12
S'PMC1771720'
p3446
sa(dp3447
g8
V2872913.xml
p3448
sg10
VSTD-OCTET
p3449
sg12
S'PMC1041029'
p3450
sa(dp3451
g8
V15148202.xml
p3452
sg10
VSTD-Waddell-2004
p3453
sg12
S'PMC1772160'
p3454
sasa(dp3455
g3
VCD006853 v. 3.0 Dynamic exercise programs (aerobic capacity andor muscle strength training) in patients with rheuma.rm5
p3456
sg5
(lp3457
(dp3458
g8
V8976635.xml
p3459
sg10
VSTD-Van-den-Ende-1996
p3460
sg12
S'PMC1010314'
p3461
sasa(dp3462
g3
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p3463
sg5
(lp3464
(dp3465
g8
V23557411.xml
p3466
sg10
VSTD-Fernandez_x002d_Cruz-2012
p3467
sg12
S'PMC3633042'
p3468
sa(dp3469
g8
V10973392.xml
p3470
sg10
VSTD-Yeo-2000
p3471
sg12
S'PMC1421155'
p3472
sa(dp3473
g8
V21694864.xml
p3474
sg10
VSTD-Katsourakis-2010
p3475
sg12
S'PMC3108665'
p3476
sasa(dp3477
g3
VCD007294 v. 4.2 Chemotherapy wafers for high grade glioma.rm5
p3478
sg5
(lp3479
(dp3480
g8
V12672279.xml
p3481
sg10
VSTD-Westphal-2003
p3482
sg12
S'PMC1920672'
p3483
sasa(dp3484
g3
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p3485
sg5
(lp3486
(dp3487
g8
V18575629.xml
p3488
sg10
VSTD-Cornuz-2008
p3489
sg12
S'PMC2432028'
p3490
sasa(dp3491
g3
VCD001117 v. 7.0 Self-management education and regular practitioner review for adults with asthma.rm5
p3492
sg5
(lp3493
(dp3494
g8
V7570436.xml
p3495
sg10
VSTD-Jones-1995
p3496
sg12
S'PMC474903'
p3497
sa(dp3498
g8
V8605463.xml
p3499
sg10
VSTD-Lahdensuo-1996
p3500
sg12
S'PMC2350456'
p3501
sa(dp3502
g8
V8296253.xml
p3503
sg10
VSTD-Yoon-1993
p3504
sg12
S'PMC464888'
p3505
sa(dp3506
g8
V10679534.xml
p3507
sg10
VSTD-Moudgil-2000
p3508
sg12
S'PMC1745690'
p3509
sa(dp3510
g8
V7570406.xml
p3511
sg10
VSTD-Allen-1995
p3512
sg12
S'PMC474644'
p3513
sa(dp3514
g8
V10335002.xml
p3515
sg10
VSTD-Abdulwadud-1999
p3516
sg12
S'PMC1745497'
p3517
sa(dp3518
g8
V7974314.xml
p3519
sg10
VSTD-Garret-1994
p3520
sg12
S'PMC475232'
p3521
sasa(dp3522
g3
VCD000122 v. 8.0 Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.rm5
p3523
sg5
(lp3524
(dp3525
g8
V9175946.xml
p3526
sg10
VSTD-Kennedy-1997
p3527
sg12
S'PMC1720640'
p3528
sasa(dp3529
g3
VCD002770 v. 8.0 Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease.rm5
p3530
sg5
(lp3531
(dp3532
g8
V5506931.xml
p3533
sg10
VSTD-Llewellyn-1970
p3534
sg12
S'PMC1647632'
p3535
sa(dp3536
g8
V4920541.xml
p3537
sg10
VSTD-Murdock-1970
p3538
sg12
S'PMC1647512'
p3539
sasa(dp3540
g3
VCD001486 v. 9.0 Surgery for varicose veins use of tourniquet.rm5
p3541
sg5
(lp3542
(dp3543
g8
V2647025.xml
p3544
sg10
VSTD-Corbett-1989
p3545
sg12
S'PMC2498882'
p3546
sa(dp3547
g8
V10932665.xml
p3548
sg10
VSTD-Sykes-2000
p3549
sg12
S'PMC2503503'
p3550
sa(dp3551
g8
V2185680.xml
p3552
sg10
VSTD-Thompson-1990
p3553
sg12
S'PMC2499114'
p3554
sasa(dp3555
g3
VCD003183 v. 6.0 Medicinal herbs for hepatitis C virus infection.rm5
p3556
sg5
(lp3557
(dp3558
g8
V23573108.xml
p3559
sg10
VSTD-Yu-1995
p3560
sg12
S'PMC3616209'
p3561
sa(dp3562
g8
V23583105.xml
p3563
sg10
VSTD-Jiang-1999
p3564
sg12
S'PMC3659167'
p3565
sasa(dp3566
g3
VCD008960 v. 2.0 Phyllanthus species for chronic hepatitis B virus infection.rm5
p3567
sg5
(lp3568
(dp3569
g8
V21672207.xml
p3570
sg10
VSTD-He-2008
p3571
sg12
S'PMC3142497'
p3572
sasa(dp3573
g3
VCD000384 v. 7.0 Length of hospitalisation for people with severe mental illness.rm5
p3574
sg5
(lp3575
(dp3576
g8
V427401.xml
p3577
sg10
VSTD-Hirsch-1979
p3578
sg12
S'PMC1597797'
p3579
sasa(dp3580
g3
VCD006929 v. 4.0 Functional analysis-based interventions for challenging behaviour in dementia.rm5
p3581
sg5
(lp3582
(dp3583
g8
V20662955.xml
p3584
sg10
VSTD-Gitlin-2010
p3585
sg12
S'PMC2955191'
p3586
sa(dp3587
g8
V12937335.xml
p3588
sg10
VSTD-Burgio-2003
p3589
sg12
S'PMC2579272'
p3590
sa(dp3591
g8
V16543297.xml
p3592
sg10
VSTD-Fossey-2006
p3593
sg12
S'PMC1420717'
p3594
sasa(dp3595
g3
VCD003700 v. 11.3 Vitamin A for non-measles pneumonia in children.rm5
p3596
sg5
(lp3597
(dp3598
g8
V9329303.xml
p3599
sg10
VSTD-Nacul-1997
p3600
sg12
S'PMC2127384'
p3601
sasa(dp3602
g3
VCD007683 v. 3.2 Laparoscopy for the management of acute lower abdominal pain in women of childbearing age.rm5
p3603
sg5
(lp3604
(dp3605
g8
V17122613.xml
p3606
sg10
VSTD-Morino-2006
p3607
sg12
S'PMC1856631'
p3608
sasa(dp3609
g3
VCD003181 v. 6.0 Bile acids for viral hepatitis.rm5
p3610
sg5
(lp3611
(dp3612
g8
V22682344.xml
p3613
sg10
VSTD-Scotto-1997
p3614
sg12
S'PMC3496235'
p3615
sa(dp3616
g8
V11286466.xml
p3617
sg10
VSTD-Kawata-1994
p3618
sg12
S'PMC2363838'
p3619
sasa(dp3620
g3
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p3621
sg5
(lp3622
(dp3623
g8
V16135930.xml
p3624
sg10
VSTD-Katkhouda-2005
p3625
sg12
S'PMC1357752'
p3626
sa(dp3627
g8
V7677456.xml
p3628
sg10
VSTD-Martin-1995
p3629
sg12
S'PMC1234801'
p3630
sa(dp3631
g8
V8203983.xml
p3632
sg10
VSTD-Frazee-1994
p3633
sg12
S'PMC1243232'
p3634
sa(dp3635
g8
V17663093.xml
p3636
sg10
VSTD-Ricca-2007
p3637
sg12
S'PMC3015793'
p3638
sasa(dp3639
g3
VCD004788 v. 7.0 Small-incision versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p3640
sg5
(lp3641
(dp3642
g8
V1461854.xml
p3643
sg10
VSTD-O_x0027_Dwyer-1992
p3644
sg12
S'PMC2399524'
p3645
sasa(dp3646
g3
VCD003481 v. 9.0 Ibuprofen for the treatment of patent ductus arteriosus in preterm andor low birth weight infants.rm5
p3647
sg5
(lp3648
(dp3649
g8
V9175948.xml
p3650
sg10
VSTD-Van-Overmeire-1997
p3651
sg12
S'PMC1720646'
p3652
sasa(dp3653
g3
VCD008085 v. 1.6 Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p3654
sg5
(lp3655
(dp3656
g8
V16432349.xml
p3657
sg10
VSTD-Wu-2006
p3658
sg12
S'PMC1448924'
p3659
sasa(dp3660
g3
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p3661
sg5
(lp3662
(dp3663
g8
V12923337.xml
p3664
sg10
VSTD-Ataoglu-2003
p3665
sg12
S'PMC3055095'
p3666
sasa(dp3667
g3
VCD000562 v. 15.0 Psychological treatments for bulimia nervosa and binging.rm5
p3668
sg5
(lp3669
(dp3670
g8
V12830564.xml
p3671
sg10
VSTD-Durand-2003
p3672
sg12
S'PMC1314596'
p3673
sa(dp3674
g8
V16458252.xml
p3675
sg10
VSTD-Burton-2006
p3676
sg12
S'PMC1618764'
p3677
sa(dp3678
g8
V10079459.xml
p3679
sg10
VSTD-Bachar-1999
p3680
sg12
S'PMC3330539'
p3681
sasa(dp3682
g3
VCD007396 v. 4.0 Parenteral opioids for maternal pain management in labour.rm5
p3683
sg5
(lp3684
(dp3685
g8
V4913784.xml
p3686
sg10
VSTD-Mowat-1970
p3687
sg12
S'PMC1700846'
p3688
sasa(dp3689
g3
VCD004386 v. 7.2 Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemother.rm5
p3690
sg5
(lp3691
(dp3692
g8
V9145895.xml
p3693
sg10
VSTD-Hidalgo-1997
p3694
sg12
S'PMC163876'
p3695
sa(dp3696
g8
V2327768.xml
p3697
sg10
VSTD-Liang-1990
p3698
sg12
S'PMC171559'
p3699
sa(dp3700
g8
V8460916.xml
p3701
sg10
VSTD-Talbot-1993
p3702
sg12
S'PMC187695'
p3703
sa(dp3704
g8
V8203838.xml
p3705
sg10
VSTD-Kern-1994b
p3706
sg12
S'PMC284481'
p3707
sa(dp3708
g8
V8203857.xml
p3709
sg10
VSTD-Broun-1994
p3710
sg12
S'PMC284500'
p3711
sa(dp3712
g8
V464573.xml
p3713
sg10
VSTD-Bender-1979
p3714
sg12
S'PMC352683'
p3715
sa(dp3716
g8
V6275778.xml
p3717
sg10
VSTD-Hargadon-1981
p3718
sg12
S'PMC181762'
p3719
sa(dp3720
g8
V9624484.xml
p3721
sg10
VSTD-Ford-1998
p3722
sg12
S'PMC105612'
p3723
sasa(dp3724
g3
VCD001837 v. 12.4 Interventions for smoking cessation in hospitalised patients.rm5
p3725
sg5
(lp3726
(dp3727
g8
V14644967.xml
p3728
sg10
VSTD-Quist_x002d_Paulsen-2003
p3729
sg12
S'PMC286243'
p3730
sa(dp3731
g8
V11786452.xml
p3732
sg10
VSTD-Hajek-2002
p3733
sg12
S'PMC64504'
p3734
sa(dp3735
g8
V19546455.xml
p3736
sg10
VSTD-Smith-2009
p3737
sg12
S'PMC2696525'
p3738
sa(dp3739
g8
V12775857.xml
p3740
sg10
VSTD-Molyneux-2003
p3741
sg12
S'PMC1746718'
p3742
sasa(dp3743
g3
VCD000195 v. 8.0 Corticosteroids for preventing relapse following acute exacerbations of asthma.rm5
p3744
sg5
(lp3745
(dp3746
g8
V3089439.xml
p3747
sg10
VSTD-Deshpande-1986
p3748
sg12
S'PMC1340908'
p3749
sasa(dp3750
g3
VCD001176 v. 5.0 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative coli.rm5
p3751
sg5
(lp3752
(dp3753
g8
V14684584.xml
p3754
sg10
VSTD-Mimura-2004
p3755
sg12
S'PMC1773918'
p3756
sasa(dp3757
g3
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p3758
sg5
(lp3759
(dp3760
g8
V19165383.xml
p3761
sg10
VSTD-Ettinger-2009
p3762
sg12
S'PMC2627861'
p3763
sasa(dp3764
g3
VCD004200 v. 10.0 Palliative biliary stents for obstructing pancreatic carcinoma.rm5
p3765
sg5
(lp3766
(dp3767
g8
V10673303.xml
p3768
sg10
VSTD-England-2000
p3769
sg12
S'PMC1727856'
p3770
sa(dp3771
g8
V2475392.xml
p3772
sg10
VSTD-Andersen-1989
p3773
sg12
S'PMC1434171'
p3774
sa(dp3775
g8
V15082593.xml
p3776
sg10
VSTD-Isayama-2004
p3777
sg12
S'PMC1774024'
p3778
sasa(dp3779
g3
VCD002053 v. 5.0 Sedatives for opiate withdrawal in newborn infants.rm5
p3780
sg5
(lp3781
(dp3782
g8
V19398463.xml
p3783
sg10
VSTD-Agthe-2009
p3784
sg12
S'PMC2746902'
p3785
sasa(dp3786
g3
VCD001396 v. 7.3 Selective serotonin reuptake inhibitors for premenstrual syndrome.rm5
p3787
sg5
(lp3788
(dp3789
g8
V23675477.xml
p3790
sg10
VSTD-Freeman-2010
p3791
sg12
S'PMC3651198'
p3792
sa(dp3793
g8
V1392887.xml
p3794
sg10
VSTD-Menkes-1992
p3795
sg12
S'PMC1883028'
p3796
sasa(dp3797
g3
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p3798
sg5
(lp3799
(dp3800
g8
V20877714.xml
p3801
sg10
VSTD-Yeboah_x002d_Antwi-2010
p3802
sg12
S'PMC2943441'
p3803
sa(dp3804
g8
V18364043.xml
p3805
sg10
VSTD-Kouyate-2008
p3806
sg12
S'PMC2287184'
p3807
sa(dp3808
g8
V8823965.xml
p3809
sg10
VSTD-Delacollette-1996
p3810
sg12
S'PMC2486885'
p3811
sa(dp3812
g8
V21750697.xml
p3813
sg10
VSTD-Mubi-2011
p3814
sg12
S'PMC3130036'
p3815
sa(dp3816
g8
V21655317.xml
p3817
sg10
VSTD-Kangwana-2011
p3818
sg12
S'PMC3104978'
p3819
sa(dp3820
g8
V21416034.xml
p3821
sg10
VSTD-Eriksen-2010
p3822
sg12
S'PMC3052812'
p3823
sasa(dp3824
g3
VCD006362 v. 8.0 Non-steroidal anti-inflammatory drugs for the common cold.rm5
p3825
sg5
(lp3826
(dp3827
g8
V2557947.xml
p3828
sg10
VSTD-Sperber-1989
p3829
sg12
S'PMC1807791'
p3830
sasa(dp3831
g3
VCD007244 v. 4.0 Black cohosh (Cimicifuga spp.) for menopausal symptoms.rm5
p3832
sg5
(lp3833
(dp3834
g8
V19745648.xml
p3835
sg10
VSTD-Amsterdam-2009
p3836
sg12
S'PMC3600411'
p3837
sa(dp3838
g8
V19609225.xml
p3839
sg10
VSTD-Geller--2009
p3840
sg12
S'PMC2783540'
p3841
sasa(dp3842
g3
VCD004920 v. 7.0 Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.rm5
p3843
sg5
(lp3844
(dp3845
g8
V11303137.xml
p3846
sg10
VSTD-Pelz-2001
p3847
sg12
S'PMC1421284'
p3848
sasa(dp3849
g3
VCD003927 v. 7.3 Oral betamimetics for maintenance therapy after threatened preterm labour.rm5
p3850
sg5
(lp3851
(dp3852
g8
V16489694.xml
p3853
sg10
VSTD-Matijevic-2006
p3854
sg12
S'PMC2080361'
p3855
sasa(dp3856
g3
VCD001366 v. 5.2 Dietary advice given by a dietitian versus other health professional or self-help resources to reduc.rm5
p3857
sg5
(lp3858
(dp3859
g8
V8179048.xml
p3860
sg10
VSTD-Barratt-1994
p3861
sg12
S'PMC1615036'
p3862
sa(dp3863
g8
V7888933.xml
p3864
sg10
VSTD-Neil-1995
p3865
sg12
S'PMC2548942'
p3866
sa(dp3867
g8
V8974552.xml
p3868
sg10
VSTD-Gosselin-1996
p3869
sg12
S'PMC2146929'
p3870
sasa(dp3871
g3
VCD004651 v. 6.0 Oral water soluble contrast for the management of adhesive small bowel obstruction.rm5
p3872
sg5
(lp3873
(dp3874
g8
V1306666.xml
p3875
sg10
VSTD-Joyce-1992
p3876
sg12
S'PMC2497688'
p3877
sasa(dp3878
g3
VCD006748 v. 4.0 Social norms interventions to reduce alcohol misuse in University or College students.rm5
p3879
sg5
(lp3880
(dp3881
g8
V17014274.xml
p3882
sg10
VSTD-Neighbors-2006
p3883
sg12
S'PMC2474672'
p3884
sa(dp3885
g8
V17032098.xml
p3886
sg10
VSTD-Carey--2006
p3887
sg12
S'PMC2442891'
p3888
sa(dp3889
g8
V17658695.xml
p3890
sg10
VSTD-Lewis-2007b
p3891
sg12
S'PMC2969166'
p3892
sa(dp3893
g8
V17286341.xml
p3894
sg10
VSTD-Lewis-2007a
p3895
sg12
S'PMC2459320'
p3896
sa(dp3897
g8
V11499124.xml
p3898
sg10
VSTD-Baer-2001
p3899
sg12
S'PMC1446766'
p3900
sa(dp3901
g8
V17286341.xml
p3902
sg10
VSTD-Lewis-2007a_x002c_-Female
p3903
sg12
S'PMC2459320'
p3904
sa(dp3905
g8
V16187809.xml
p3906
sg10
VSTD-Borsari-2005
p3907
sg12
S'PMC2663045'
p3908
sa(dp3909
g8
V17286341.xml
p3910
sg10
VSTD-Lewis-2007a_x002c_-Male
p3911
sg12
S'PMC2459320'
p3912
sasa(dp3913
g3
VCD003344 v. 5.0 Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy .rm5
p3914
sg5
(lp3915
(dp3916
g8
V1433118.xml
p3917
sg10
VSTD-Finer-1992
p3918
sg12
S'PMC1293638'
p3919
sa(dp3920
g8
V3899005.xml
p3921
sg10
VSTD-Cone-1985
p3922
sg12
S'PMC176304'
p3923
sa(dp3924
g8
V3056255.xml
p3925
sg10
VSTD-Bergeron-1988
p3926
sg12
S'PMC172383'
p3927
sa(dp3928
g8
V6550482.xml
p3929
sg10
VSTD-Coppens-1983
p3930
sg12
S'PMC184612'
p3931
sa(dp3932
g8
V10898671.xml
p3933
sg10
VSTD-Dupont-2000
p3934
sg12
S'PMC90009'
p3935
sa(dp3936
g8
V8092830.xml
p3937
sg10
VSTD-Cometta-1994
p3938
sg12
S'PMC188203'
p3939
sa(dp3940
g8
V6524903.xml
p3941
sg10
VSTD-Piccart-1984
p3942
sg12
S'PMC180041'
p3943
sa(dp3944
g8
V9593156.xml
p3945
sg10
VSTD-Jaspers-1998
p3946
sg12
S'PMC105786'
p3947
sasa(dp3948
g3
VCD005045 v. 4.0 Treatment for periodic paralysis.rm5
p3949
sg5
(lp3950
(dp3951
g8
V3066848.xml
p3952
sg10
VSTD-Links-1988
p3953
sg12
S'PMC1033016'
p3954
sasa(dp3955
g3
VCD006537 v. 3.4 Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.rm5
p3956
sg5
(lp3957
(dp3958
g8
V9924306.xml
p3959
sg10
VSTD-Frennesson-1995
p3960
sg12
S'PMC1722362'
p3961
sasa(dp3962
g3
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p3963
sg5
(lp3964
(dp3965
g8
V19158208.xml
p3966
sg10
VSTD-Wang-2009
p3967
sg12
S'PMC2667658'
p3968
sa(dp3969
g8
V19417743.xml
p3970
sg10
VSTD-Akhter-2009
p3971
sg12
S'PMC2695684'
p3972
sa(dp3973
g8
V18559549.xml
p3974
sg10
VSTD-Bobe-2008
p3975
sg12
S'PMC2517243'
p3976
sa(dp3977
g8
V18491403.xml
p3978
sg10
VSTD-Cutler-2008
p3979
sg12
S'PMC2572165'
p3980
sasa(dp3981
g3
VCD004127 v. 7.0 Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respirator.rm5
p3982
sg5
(lp3983
(dp3984
g8
V18439326.xml
p3985
sg10
VSTD-Trevisan-2008
p3986
sg12
S'PMC2447590'
p3987
sasa(dp3988
g3
VCD006672 v. 4.2 Perineal techniques during the second stage of labour for reducing perineal trauma.rm5
p3989
sg5
(lp3990
(dp3991
g8
V16154062.xml
p3992
sg10
VSTD-Albers-2005
p3993
sg12
S'PMC1350988'
p3994
sa(dp3995
g8
V11375230.xml
p3996
sg10
VSTD-Stamp-2001
p3997
sg12
S'PMC31922'
p3998
sasa(dp3999
g3
VCD004503 v. 3.0 Long versus short inspiratory times in neonates receiving mechanical ventilation.rm5
p4000
sg5
(lp4001
(dp4002
g8
V2505689.xml
p4003
sg10
VSTD-Greenough-1989
p4004
sg12
S'PMC1792547'
p4005
sa(dp4006
g8
V1863121.xml
p4007
sg10
VSTD-OCTAVE-1991
p4008
sg12
S'PMC1590232'
p4009
sasa(dp4010
g3
VCD005393 v. 6.2 Stapled versus conventional surgery for hemorrhoids.rm5
p4011
sg5
(lp4012
(dp4013
g8
V15973098.xml
p4014
sg10
VSTD-Gravie--2005
p4015
sg12
S'PMC1357701'
p4016
sasa(dp4017
g3
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p4018
sg5
(lp4019
(dp4020
g8
V21927264.xml
p4021
sg10
VSTD-Channabasavanna-1987
p4022
sg12
S'PMC3172444'
p4023
sa(dp4024
g8
V4943034.xml
p4025
sg10
VSTD-Van-Praag-1971
p4026
sg12
S'PMC1799991'
p4027
sasa(dp4028
g3
VCD008241 v. 2.5 Intramedullary nailing for tibial shaft fractures in adults.rm5
p4029
sg5
(lp4030
(dp4031
g8
V19047701.xml
p4032
sg10
VSTD-SPRINT-2008
p4033
sg12
S'PMC2663330'
p4034
sasa(dp4035
g3
VCD002879 v. 5.0 Beclomethasone at different doses for chronic asthma.rm5
p4036
sg5
(lp4037
(dp4038
g8
V359091.xml
p4039
sg10
VSTD-Carmichael-1978
p4040
sg12
S'PMC1607388'
p4041
sa(dp4042
g8
V3296296.xml
p4043
sg10
VSTD-Smith-1986
p4044
sg12
S'PMC460555'
p4045
sa(dp4046
g8
V8323338.xml
p4047
sg10
VSTD-Wolthers-1993
p4048
sg12
S'PMC1029340'
p4049
sasa(dp4050
g3
VCD004923 v. 7.0 Non-hormonal interventions for hot flushes in women with a history of breast cancer.rm5
p4051
sg5
(lp4052
(dp4053
g8
V16139656.xml
p4054
sg10
VSTD-Pandya-2005
p4055
sg12
S'PMC1627210'
p4056
sasa(dp4057
g3
VCD001822 v. 11.1 Physical conditioning programs for improving work outcomes in workers with back pain.rm5
p4058
sg5
(lp4059
(dp4060
g8
V16847036.xml
p4061
sg10
VSTD-Steenstra-2006
p4062
sg12
S'PMC2077992'
p4063
sasa(dp4064
g3
VCD008137 v. 1.0 The impact of conditional cash transfers on health outcomes and use of health services in low and mi.rm5
p4065
sg5
(lp4066
(dp4067
g8
V23393551.xml
p4068
sg10
VSTD-Thornton-2006
p4069
sg12
S'PMC3564866'
p4070
sa(dp4071
g8
V19793851.xml
p4072
sg10
VSTD-Behrman-2005
p4073
sg12
S'PMC2762161'
p4074
sasa(dp4075
g3
VCD005544 v. 3.0 Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalis.rm5
p4076
sg5
(lp4077
(dp4078
g8
V11202662.xml
p4079
sg10
VSTD-Silva-2001
p4080
sg12
S'PMC80627'
p4081
sasa(dp4082
g3
VCD006894 v. 4.0 Interventions for preventing infectious complications in haemodialysis patients with central venous .rm5
p4083
sg5
(lp4084
(dp4085
g8
V23977660.xml
p4086
sg10
VSTD-Atapour-2006
p4087
sg12
S'PMC3748638'
p4088
sasa(dp4089
g3
VCD001458 v. 5.0 Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.rm5
p4090
sg5
(lp4091
(dp4092
g8
V11786451.xml
p4093
sg10
VSTD-Kretschmer-1990
p4094
sg12
S'PMC64503'
p4095
sasa(dp4096
g3
VCD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
p4097
sg5
(lp4098
(dp4099
g8
V17543129.xml
p4100
sg10
VSTD-Beck-2007
p4101
sg12
S'PMC1896161'
p4102
sa(dp4103
g8
V11919104.xml
p4104
sg10
VSTD-Abul_x002d_Ainine-2002
p4105
sg12
S'PMC1719150'
p4106
sasa(dp4107
g3
VCD002894 v. 6.0 Computerized advice on drug dosage to improve prescribing practice.rm5
p4108
sg5
(lp4109
(dp4110
g8
V2775618.xml
p4111
sg10
VSTD-Begg-1989
p4112
sg12
S'PMC1379894'
p4113
sa(dp4114
g8
V9154031.xml
p4115
sg10
VSTD-Vadher-1997
p4116
sg12
S'PMC2126598'
p4117
sasa(dp4118
g3
VCD005951 v. 4.0 Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.rm5
p4119
sg5
(lp4120
(dp4121
g8
V20736966.xml
p4122
sg10
VSTD-ATICH
p4123
sg12
S'PMC2972357'
p4124
sasa(dp4125
g3
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p4126
sg5
(lp4127
(dp4128
g8
V17196358.xml
p4129
sg10
VSTD-Champion-2007
p4130
sg12
S'PMC1858664'
p4131
sa(dp4132
g8
V21149743.xml
p4133
sg10
VSTD-Sequist-2011
p4134
sg12
S'PMC3169179'
p4135
sa(dp4136
g8
V19105686.xml
p4137
sg10
VSTD-Bodurtha-2009
p4138
sg12
S'PMC2945922'
p4139
sa(dp4140
g8
V20978060.xml
p4141
sg10
VSTD-Smith-2010
p4142
sg12
S'PMC2965151'
p4143
sa(dp4144
g8
V18308500.xml
p4145
sg10
VSTD-Rawl-2008
p4146
sg12
S'PMC2492833'
p4147
sa(dp4148
g8
V19418107.xml
p4149
sg10
VSTD-Manne-2009
p4150
sg12
S'PMC2707254'
p4151
sa(dp4152
g8
V9552998.xml
p4153
sg10
VSTD-Hutchison-1998
p4154
sg12
S'PMC28524'
p4155
sa(dp4156
g8
V10358689.xml
p4157
sg10
VSTD-Schwartz-1999
p4158
sg12
S'PMC1508646'
p4159
sa(dp4160
g8
V21636633.xml
p4161
sg10
VSTD-Steckelberg-2011
p4162
sg12
S'PMC3106362'
p4163
sa(dp4164
g8
V8279610.xml
p4165
sg10
VSTD-Skinner-1994
p4166
sg12
S'PMC1614921'
p4167
sa(dp4168
g8
V21090893.xml
p4169
sg10
VSTD-Manne-2010
p4170
sg12
S'PMC3058834'
p4171
sasa(dp4172
g3
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p4173
sg5
(lp4174
(dp4175
g8
V21596735.xml
p4176
sg10
VSTD-Vadillo_x002d_Ortega-2011
p4177
sg12
S'PMC3100912'
p4178
sa(dp4179
g8
V12637400.xml
p4180
sg10
VSTD-Christian-2003
p4181
sg12
S'PMC151518'
p4182
sa(dp4183
g8
V18996930.xml
p4184
sg10
VSTD-Zeng-2008
p4185
sg12
S'PMC2577799'
p4186
sasa(dp4187
g3
VCD000361 v. 10.0 Intravenous immunoglobulin for preventing infection in preterm andor low birth weight infants.rm5
p4188
sg5
(lp4189
(dp4190
g8
V3284483.xml
p4191
sg10
VSTD-Stabile-1988
p4192
sg12
S'PMC1778825'
p4193
sasa(dp4194
g3
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p4195
sg5
(lp4196
(dp4197
g8
V12915873.xml
p4198
sg10
VSTD-Fry-2003
p4199
sg12
S'PMC2376929'
p4200
sa(dp4201
g8
V17047645.xml
p4202
sg10
VSTD-Young-2006
p4203
sg12
S'PMC2360713'
p4204
sasa(dp4205
g3
VCD003558 v. 5.0 Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.rm5
p4206
sg5
(lp4207
(dp4208
g8
V821577.xml
p4209
sg10
VSTD-Mitchell-1976
p4210
sg12
S'PMC1687559'
p4211
sa(dp4212
g8
V407559.xml
p4213
sg10
VSTD-Ng-1977
p4214
sg12
S'PMC2496657'
p4215
sasa(dp4216
g3
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p4217
sg5
(lp4218
(dp4219
g8
V3296295.xml
p4220
sg10
VSTD-Hofmeyr-1986
p4221
sg12
S'PMC460551'
p4222
sa(dp4223
g8
V486968.xml
p4224
sg10
VSTD-Pryor-1979
p4225
sg12
S'PMC1595668'
p4226
sa(dp4227
g8
V7701456.xml
p4228
sg10
VSTD-Miller-1995
p4229
sg12
S'PMC473916'
p4230
sa(dp4231
g8
V14514944.xml
p4232
sg10
VSTD-Holland-2003
p4233
sg12
S'PMC1746478'
p4234
sa(dp4235
g8
V19703826.xml
p4236
sg10
VSTD-Osman-2008
p4237
sg12
S'PMC2922723'
p4238
sasa(dp4239
g3
VCD007380 v. 4.0 Efficacy of Psychostimulant Drugs for Cocaine Dependence.rm5
p4240
sg5
(lp4241
(dp4242
g8
V19058926.xml
p4243
sg10
VSTD-Mooney-2009
p4244
sg12
S'PMC2742691'
p4245
sasa(dp4246
g3
VCD007605 v. 2.2 Nutritional interventions for liver-transplanted patients.rm5
p4247
sg5
(lp4248
(dp4249
g8
V17947609.xml
p4250
sg10
VSTD-Pazirandeh-2007
p4251
sg12
S'PMC3202978'
p4252
sasa(dp4253
g3
VCD007022 v. 3.0 Teicoplanin versus vancomycin for proven or suspected infection.rm5
p4254
sg5
(lp4255
(dp4256
g8
V2529814.xml
p4257
sg10
VSTD-Smith-1989
p4258
sg12
S'PMC172623'
p4259
sa(dp4260
g8
V1826594.xml
p4261
sg10
VSTD-MMD_x002d_009-1992
p4262
sg12
S'PMC244945'
p4263
sa(dp4264
g8
V7811016.xml
p4265
sg10
VSTD-Menichetti-1994
p4266
sg12
S'PMC284681'
p4267
sasa(dp4268
g3
VCD007357 v. 4.0 Single dose oral etodolac for acute postoperative pain in adults.rm5
p4269
sg5
(lp4270
(dp4271
g8
V2934008.xml
p4272
sg10
VSTD-Nelson-1985
p4273
sg12
S'PMC2148530'
p4274
sasa(dp4275
g3
VCD007668 v. 2.0 Psychological interventions for antisocial personality disorder.rm5
p4276
sg5
(lp4277
(dp4278
g8
V17071020.xml
p4279
sg10
VSTD-Marlowe-2007
p4280
sg12
S'PMC1885231'
p4281
sa(dp4282
g8
V17334939.xml
p4283
sg10
VSTD-Havens-2007
p4284
sg12
S'PMC2231639'
p4285
sa(dp4286
g8
V17574801.xml
p4287
sg10
VSTD-Neufeld-2008
p4288
sg12
S'PMC2193670'
p4289
sasa(dp4290
g3
VCD000194 v. 9.0 Spironolactone versus placebo or in combination with steroids for hirsutism andor acne.rm5
p4291
sg5
(lp4292
(dp4293
g8
V2690044.xml
p4294
sg10
VSTD-McLellan-1989
p4295
sg12
S'PMC2429442'
p4296
sasa(dp4297
g3
VCD003483 v. 6.3 Naloxone for opiate-exposed newborn infants.rm5
p4298
sg5
(lp4299
(dp4300
g8
V884446.xml
p4301
sg10
VSTD-Wiener-1977b
p4302
sg12
S'PMC1631362'
p4303
sa(dp4304
g8
V328108.xml
p4305
sg10
VSTD-Wiener-1977a
p4306
sg12
S'PMC1631408'
p4307
sa(dp4308
g8
V990784.xml
p4309
sg10
VSTD-Evans-1976
p4310
sg12
S'PMC1689462'
p4311
sa(dp4312
g8
V383023.xml
p4313
sg10
VSTD-Brice-1979a
p4314
sg12
S'PMC1545576'
p4315
sasa(dp4316
g3
VCD005066 v. 6.0 Stroke liaison workers for stroke patients and carers an individual patient data meta-analysis.rm5
p4317
sg5
(lp4318
(dp4319
g8
V8664717.xml
p4320
sg10
VSTD-Bradford
p4321
sg12
S'PMC2351368'
p4322
sa(dp4323
g8
V9133884.xml
p4324
sg10
VSTD-Edinburgh
p4325
sg12
S'PMC2126479'
p4326
sa(dp4327
g8
V19542219.xml
p4328
sg10
VSTD-Melbourne-_x0028_SHIPS_x0029_
p4329
sg12
S'PMC2755679'
p4330
sasa(dp4331
g3
VCD001444 v. 6.4 Iron therapy for improving psychomotor development and cognitive function in children under the age .rm5
p4332
sg5
(lp4333
(dp4334
g8
V2429622.xml
p4335
sg10
VSTD-Aukett-1986
p4336
sg12
S'PMC1778027'
p4337
sasa(dp4338
g3
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p4339
sg5
(lp4340
(dp4341
g8
V12923337.xml
p4342
sg10
VSTD-Ataoglu-2003
p4343
sg12
S'PMC3055095'
p4344
sasa(dp4345
g3
VCD002941 v. 8.0 Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.rm5
p4346
sg5
(lp4347
(dp4348
g8
V17457158.xml
p4349
sg10
VSTD-Dellinger-2007
p4350
sg12
S'PMC1877078'
p4351
sasa(dp4352
g3
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p4353
sg5
(lp4354
(dp4355
g8
V11143188.xml
p4356
sg10
VSTD-Pepin-2000
p4357
sg12
S'PMC2560627'
p4358
sa(dp4359
g8
V17160135.xml
p4360
sg10
VSTD-Priotto-2006
p4361
sg12
S'PMC1687208'
p4362
sasa(dp4363
g3
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p4364
sg5
(lp4365
(dp4366
g8
V18558641.xml
p4367
sg10
VSTD-Benn-2008
p4368
sg12
S'PMC2432170'
p4369
sa(dp4370
g8
V12896935.xml
p4371
sg10
VSTD-Rahmathullah-2003
p4372
sg12
S'PMC167159'
p4373
sa(dp4374
g8
V20215360.xml
p4375
sg10
VSTD-Benn-2010
p4376
sg12
S'PMC2835853'
p4377
sasa(dp4378
g3
VCD008411 v. 4.0 Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age.rm5
p4379
sg5
(lp4380
(dp4381
g8
V9659093.xml
p4382
sg10
VSTD-Lewindon-1998
p4383
sg12
S'PMC1717567'
p4384
sasa(dp4385
g3
VCD002792 v. 8.0 Screening and case finding instruments for depression.rm5
p4386
sg5
(lp4387
(dp4388
g8
V7496238.xml
p4389
sg10
VSTD-Dowrick-1995
p4390
sg12
S'PMC2551186'
p4391
sa(dp4392
g8
V10840264.xml
p4393
sg10
VSTD-Whooley-2000
p4394
sg12
S'PMC1495458'
p4395
sasa(dp4396
g3
VCD010182 v. 3.0 Alginate dressings for venous leg ulcers.rm5
p4397
sg5
(lp4398
(dp4399
g8
V23179315.xml
p4400
sg10
VSTD-Smith-1994
p4401
sg12
S'PMC3644009'
p4402
sasa(dp4403
g3
VCD009286 v. 2.5 Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.rm5
p4404
sg5
(lp4405
(dp4406
g8
V18505948.xml
p4407
sg10
VSTD-Robinson-2008
p4408
sg12
S'PMC2743160'
p4409
sasa(dp4410
g3
VCD004610 v. 8.0 Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.rm5
p4411
sg5
(lp4412
(dp4413
g8
V18955525.xml
p4414
sg10
VSTD-Louie-2009
p4415
sg12
S'PMC2612138'
p4416
sa(dp4417
g8
V367509.xml
p4418
sg10
VSTD-Keighley-1978
p4419
sg12
S'PMC1609009'
p4420
sa(dp4421
g8
V1444298.xml
p4422
sg10
VSTD-de-Lalla-1992
p4423
sg12
S'PMC245474'
p4424
sasa(dp4425
g3
VCD006019 v. 5.0 Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.rm5
p4426
sg5
(lp4427
(dp4428
g8
V12101195.xml
p4429
sg10
VSTD-Selli-2002
p4430
sg12
S'PMC1769701'
p4431
sasa(dp4432
g3
VCD001800 v. 13.0 Exercise-based cardiac rehabilitation for coronary heart disease.rm5
p4433
sg5
(lp4434
(dp4435
g8
V10092561.xml
p4436
sg10
VSTD-Dugmore-1999
p4437
sg12
S'PMC1729018'
p4438
sa(dp4439
g8
V2271343.xml
p4440
sg10
VSTD-Bethell-1990
p4441
sg12
S'PMC1224812'
p4442
sasa(dp4443
g3
VCD005321 v. 3.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
p4444
sg5
(lp4445
(dp4446
g8
V23209545.xml
p4447
sg10
VSTD-Auerbach-2002a
p4448
sg12
S'PMC3507824'
p4449
sa(dp4450
g8
V8774159.xml
p4451
sg10
VSTD-Lohmander-1996
p4452
sg12
S'PMC1010204'
p4453
sa(dp4454
g8
V15331394.xml
p4455
sg10
VSTD-Pham-2004
p4456
sg12
S'PMC1754857'
p4457
sa(dp4458
g8
V7944639.xml
p4459
sg10
VSTD-Henderson-1994
p4460
sg12
S'PMC1005394'
p4461
sasa(dp4462
g3
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p4463
sg5
(lp4464
(dp4465
g8
V16536959.xml
p4466
sg10
VSTD-Muirhead-2006
p4467
sg12
S'PMC1828262'
p4468
sa(dp4469
g8
V17670909.xml
p4470
sg10
VSTD-Su-2007
p4471
sg12
S'PMC1989016'
p4472
sa(dp4473
g8
V21278959.xml
p4474
sg10
VSTD-Ellis-1984
p4475
sg12
S'PMC2153583'
p4476
sa(dp4477
g8
V14703543.xml
p4478
sg10
VSTD-Graffy-2004
p4479
sg12
S'PMC313903'
p4480
sa(dp4481
g8
V4037866.xml
p4482
sg10
VSTD-Jones-1985
p4483
sg12
S'PMC1777420'
p4484
sa(dp4485
g8
V10977833.xml
p4486
sg10
VSTD-Morrell-2000
p4487
sg12
S'PMC27472'
p4488
sa(dp4489
g8
V22733107.xml
p4490
sg10
VSTD-Sinclair-2007
p4491
sg12
S'PMC3471286'
p4492
sa(dp4493
g8
V9764260.xml
p4494
sg10
VSTD-Ransjo_x002d_Arvidson-1998
p4495
sg12
S'PMC1756723'
p4496
sa(dp4497
g8
V10361754.xml
p4498
sg10
VSTD-Froozani-1999
p4499
sg12
S'PMC2557680'
p4500
sa(dp4501
g8
V19181729.xml
p4502
sg10
VSTD-Hoddinott-2009
p4503
sg12
S'PMC2635594'
p4504
sa(dp4505
g8
V19854119.xml
p4506
sg10
VSTD-Pugh-2007
p4507
sg12
S'PMC2818063'
p4508
sa(dp4509
g8
V11800243.xml
p4510
sg10
VSTD-Dennis-2002
p4511
sg12
S'PMC99222'
p4512
sasa(dp4513
g3
VCD002848 v. 8.3 Rotavirus vaccine for preventing diarrhoea.rm5
p4514
sg5
(lp4515
(dp4516
g8
V2541168.xml
p4517
sg10
VSTD-Flores-1989
p4518
sg12
S'PMC267349'
p4519
sa(dp4520
g8
V8408569.xml
p4521
sg10
VSTD-Flores-1993
p4522
sg12
S'PMC265775'
p4523
sa(dp4524
g8
V9002329.xml
p4525
sg10
VSTD-Linhares-1996
p4526
sg12
S'PMC2486862'
p4527
sa(dp4528
g8
V2157737.xml
p4529
sg10
VSTD-Perez_x002d_Schael-1990c
p4530
sg12
S'PMC269661'
p4531
sasa(dp4532
g3
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p4533
sg5
(lp4534
(dp4535
g8
V16796402.xml
p4536
sg10
VSTD-Corbett-2006
p4537
sg12
S'PMC1483908'
p4538
sa(dp4539
g8
V18324469.xml
p4540
sg10
VSTD-Bing-2008
p4541
sg12
S'PMC2822543'
p4542
sa(dp4543
g8
V21106284.xml
p4544
sg10
VSTD-Essien-2010
p4545
sg12
S'PMC3059739'
p4546
sasa(dp4547
g3
VCD003662 v. 6.0 Corticosteroids for treating hypotension in preterm infants.rm5
p4548
sg5
(lp4549
(dp4550
g8
V9175947.xml
p4551
sg10
VSTD-Bourchier-1997
p4552
sg12
S'PMC1720650'
p4553
sasa(dp4554
g3
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p4555
sg5
(lp4556
(dp4557
g8
V21789385.xml
p4558
sg10
VSTD-Coskun-2011
p4559
sg12
S'PMC3109380'
p4560
sasa(dp4561
g3
VCD000008 v. 8.2 Acupuncture for chronic asthma.rm5
p4562
sg5
(lp4563
(dp4564
g8
V7040659.xml
p4565
sg10
VSTD-Dias-1982
p4566
sg12
S'PMC1437652'
p4567
sasa(dp4568
g3
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p4569
sg5
(lp4570
(dp4571
g8
V1069813.xml
p4572
sg10
VSTD-Evans-1976
p4573
sg12
S'PMC2129830'
p4574
sa(dp4575
g8
V4908340.xml
p4576
sg10
VSTD-Waldman-1969a
p4577
sg12
S'PMC2427722'
p4578
sa(dp4579
g8
V5235254.xml
p4580
sg10
VSTD-Forsyth-1967
p4581
sg12
S'PMC2130402'
p4582
sa(dp4583
g8
V4908340.xml
p4584
sg10
VSTD-Waldman-1969c
p4585
sg12
S'PMC2427722'
p4586
sa(dp4587
g8
V4908340.xml
p4588
sg10
VSTD-Waldman-1969b
p4589
sg12
S'PMC2427722'
p4590
sa(dp4591
g8
V4908340.xml
p4592
sg10
VSTD-Waldman-1969d
p4593
sg12
S'PMC2427722'
p4594
sa(dp4595
g8
V19149900.xml
p4596
sg10
VSTD-Beran-2009a
p4597
sg12
S'PMC2639595'
p4598
sa(dp4599
g8
V512351.xml
p4600
sg10
VSTD-Rocchi-1979b
p4601
sg12
S'PMC2130165'
p4602
sa(dp4603
g8
V512351.xml
p4604
sg10
VSTD-Rocchi-1979a
p4605
sg12
S'PMC2130165'
p4606
sa(dp4607
g8
V6822725.xml
p4608
sg10
VSTD-Goodeve-1983
p4609
sg12
S'PMC2134195'
p4610
sa(dp4611
g8
V328526.xml
p4612
sg10
VSTD-Spencer-1977
p4613
sg12
S'PMC274660'
p4614
sasa(dp4615
g3
VCD004539 v. 5.0 Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.rm5
p4616
sg5
(lp4617
(dp4618
g8
V6996625.xml
p4619
sg10
VSTD-Smith-1980
p4620
sg12
S'PMC1344856'
p4621
sa(dp4622
g8
V10903605.xml
p4623
sg10
VSTD-Cohn-2000
p4624
sg12
S'PMC1421138'
p4625
sa(dp4626
g8
V3548611.xml
p4627
sg10
VSTD-Gozenbach-1987
p4628
sg12
S'PMC1492722'
p4629
sa(dp4630
g8
V11141229.xml
p4631
sg10
VSTD-Solomkin-2001
p4632
sg12
S'PMC1421170'
p4633
sa(dp4634
g8
V9797234.xml
p4635
sg10
VSTD-Jaccard-1998
p4636
sg12
S'PMC105974'
p4637
sa(dp4638
g8
V1336347.xml
p4639
sg10
VSTD-Brismar-1992
p4640
sg12
S'PMC245542'
p4641
sa(dp4642
g8
V10898671.xml
p4643
sg10
VSTD-Dupont-2000
p4644
sg12
S'PMC90009'
p4645
sa(dp4646
g8
V8439209.xml
p4647
sg10
VSTD-Walker-1993
p4648
sg12
S'PMC1242749'
p4649
sa(dp4650
g8
V3545106.xml
p4651
sg10
VSTD-Berne-1987
p4652
sg12
S'PMC1492815'
p4653
sasa(dp4654
g3
VCD003510 v. 8.0 Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.rm5
p4655
sg5
(lp4656
(dp4657
g8
V12478070.xml
p4658
sg10
VSTD-Kiarie-2003
p4659
sg12
S'PMC3387271'
p4660
sa(dp4661
g8
V16103773.xml
p4662
sg10
VSTD-Chung-2005
p4663
sg12
S'PMC3381340'
p4664
sa(dp4665
g8
V18839781.xml
p4666
sg10
VSTD-Chung-2008
p4667
sg12
S'PMC2859833'
p4668
sa(dp4669
g8
V20554983.xml
p4670
sg10
VSTD-Mma-Bana
p4671
sg12
S'PMC2999916'
p4672
sasa(dp4673
g3
VCD003594 v. 12.0 Interventions for idiopathic steroid-resistant nephrotic syndrome in children.rm5
p4674
sg5
(lp4675
(dp4676
g8
V18481113.xml
p4677
sg10
VSTD-APN-2008
p4678
sg12
S'PMC2730636'
p4679
sasa(dp4680
g3
VCD007192 v. 3.0 Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in dr.rm5
p4681
sg5
(lp4682
(dp4683
g8
V23084638.xml
p4684
sg10
VSTD-BAXTER1991
p4685
sg12
S'PMC3479430'
p4686
sa(dp4687
g8
V1905051.xml
p4688
sg10
VSTD-SCHILLING1991
p4689
sg12
S'PMC1580245'
p4690
sa(dp4691
g8
V15226138.xml
p4692
sg10
VSTD-WECHSBERG2004
p4693
sg12
S'PMC1448416'
p4694
sasa(dp4695
g3
VCD003018 v. 6.2 Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5.rm5
p4696
sg5
(lp4697
(dp4698
g8
V20339911.xml
p4699
sg10
VSTD-Mikami-2010
p4700
sg12
S'PMC2903643'
p4701
sasa(dp4702
g3
VCD006045 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p4703
sg5
(lp4704
(dp4705
g8
V20391059.xml
p4706
sg10
VSTD-Surratt-2010
p4707
sg12
S'PMC2879022'
p4708
sasa(dp4709
g3
VCD007024 v. 3.0 Disulfiram for the treatment of cocaine dependence.rm5
p4710
sg5
(lp4711
(dp4712
g8
V14993114.xml
p4713
sg10
VSTD-Carroll-2004-arm-b
p4714
sg12
S'PMC3675448'
p4715
sa(dp4716
g8
V18079068.xml
p4717
sg10
VSTD-Pettinati-2008-arm-a
p4718
sg12
S'PMC2374760'
p4719
sa(dp4720
g8
V14993114.xml
p4721
sg10
VSTD-Carroll-2004-arm-a
p4722
sg12
S'PMC3675448'
p4723
sa(dp4724
g8
V18079068.xml
p4725
sg10
VSTD-Pettinati-2008-arm-b
p4726
sg12
S'PMC2374760'
p4727
sasa(dp4728
g3
VCD001460 v. 6.0 Penicillamine for treating rheumatoid arthritis.rm5
p4729
sg5
(lp4730
(dp4731
g8
V769707.xml
p4732
sg10
VSTD-Dixon-1975
p4733
sg12
S'PMC1006442'
p4734
sasa(dp4735
g3
VCD007415 v. 4.18 Temozolomide for high grade glioma.rm5
p4736
sg5
(lp4737
(dp4738
g8
V19506159.xml
p4739
sg10
VSTD-Clarke-2009
p4740
sg12
S'PMC2727290'
p4741
sasa(dp4742
g3
VCD001750 v. 8.20 Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.rm5
p4743
sg5
(lp4744
(dp4745
g8
V19225876.xml
p4746
sg10
VSTD-Ye-2009
p4747
sg12
S'PMC2654939'
p4748
sa(dp4749
g8
V18802744.xml
p4750
sg10
VSTD-Kurzawa-2008
p4751
sg12
S'PMC2582126'
p4752
sasa(dp4753
g3
VCD008439 v. 3.0 Monoclonal CCR5 antibody for treatment of people with HIV infection.rm5
p4754
sg5
(lp4755
(dp4756
g8
V20377413.xml
p4757
sg10
VSTD-Jacobson-2010
p4758
sg12
S'PMC2856743'
p4759
sasa(dp4760
g3
VCD004878 v. 10.0 Glucocorticoids for acute viral bronchiolitis in infants and young children.rm5
p4761
sg5
(lp4762
(dp4763
g8
V10648365.xml
p4764
sg10
VSTD-Cade-2000
p4765
sg12
S'PMC1718208'
p4766
sasa(dp4767
g3
VCD004274 v. 5.0 Interactive Health Communication Applications for people with chronic disease.rm5
p4768
sg5
(lp4769
(dp4770
g8
V11520380.xml
p4771
sg10
VSTD-Gustafson-2001
p4772
sg12
S'PMC1495237'
p4773
sa(dp4774
g8
V11141512.xml
p4775
sg10
VSTD-Shegog-2001
p4776
sg12
S'PMC134591'
p4777
sa(dp4778
g8
V11932129.xml
p4779
sg10
VSTD-Dragone-2002
p4780
sg12
S'PMC3307387'
p4781
sa(dp4782
g8
V12087119.xml
p4783
sg10
VSTD-Mahoney-2002
p4784
sg12
S'PMC346625'
p4785
sasa(dp4786
g3
VCD003274 v. 4.0 Budesonide versus placebo for chronic asthma in children and adults.rm5
p4787
sg5
(lp4788
(dp4789
g8
V8977599.xml
p4790
sg10
VSTD-Burke-1996
p4791
sg12
S'PMC472647'
p4792
sa(dp4793
g8
V3926141.xml
p4794
sg10
VSTD-Henriksen-1985
p4795
sg12
S'PMC1416830'
p4796
sa(dp4797
g8
V3044506.xml
p4798
sg10
VSTD-Gleeson-1988
p4799
sg12
S'PMC1834236'
p4800
sa(dp4801
g8
V1978947.xml
p4802
sg10
VSTD-Lorentzson-1990
p4803
sg12
S'PMC462715'
p4804
sasa(dp4805
g3
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p4806
sg5
(lp4807
(dp4808
g8
V21890526.xml
p4809
sg10
VSTD-Varkey-2011
p4810
sg12
S'PMC3236524'
p4811
sasa(dp4812
g3
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p4813
sg5
(lp4814
(dp4815
g8
V22069407.xml
p4816
sg10
VSTD-Bahadoran-2010
p4817
sg12
S'PMC3208940'
p4818
sasa(dp4819
g3
VCD008033 v. 3.2 Reduction versus abrupt cessation in smokers who want to quit.rm5
p4820
sg5
(lp4821
(dp4822
g8
V22852768.xml
p4823
sg10
VSTD-Riley-2005
p4824
sg12
S'PMC3479413'
p4825
sa(dp4826
g8
V20537810.xml
p4827
sg10
VSTD-Hughes-2010
p4828
sg12
S'PMC2930079'
p4829
sasa(dp4830
g3
VCD008243 v. 4.0 Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis.rm5
p4831
sg5
(lp4832
(dp4833
g8
V3389899.xml
p4834
sg10
VSTD-Williams-1988
p4835
sg12
S'PMC1778891'
p4836
sasa(dp4837
g3
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p4838
sg5
(lp4839
(dp4840
g8
V8757375.xml
p4841
sg10
VSTD-Lau-1996
p4842
sg12
S'PMC1235333'
p4843
sa(dp4844
g8
V19430829.xml
p4845
sg10
VSTD-Bertleff-2009
p4846
sg12
S'PMC2691927'
p4847
sa(dp4848
g8
V11882751.xml
p4849
sg10
VSTD-Siu-2002
p4850
sg12
S'PMC1422436'
p4851
sasa(dp4852
g3
VCD004634 v. 4.0 Follicular flushing during oocyte retrieval in assisted reproductive techniques.rm5
p4853
sg5
(lp4854
(dp4855
g8
V18675970.xml
p4856
sg10
VSTD-Levens-2009
p4857
sg12
S'PMC2745125'
p4858
sasa(dp4859
g3
VCD001535 v. 8.0 Antibiotic duration for treating uncomplicated symptomatic lower urinary tract infections in elderl.rm5
p4860
sg5
(lp4861
(dp4862
g8
V14970093.xml
p4863
sg10
VSTD-Vogel-2004
p4864
sg12
S'PMC332712'
p4865
sa(dp4866
g8
V8878607.xml
p4867
sg10
VSTD-Raz-1996
p4868
sg12
S'PMC163499'
p4869
sasa(dp4870
g3
VCD002849 v. 11.0 Anxiolytics for smoking cessation.rm5
p4871
sg5
(lp4872
(dp4873
g8
V6384510.xml
p4874
sg10
VSTD-Dow-1984
p4875
sg12
S'PMC1440107'
p4876
sasa(dp4877
g3
VCD004682 v. 7.0 Duration of antibacterial treatment for uncomplicated urinary tract infection in women.rm5
p4878
sg5
(lp4879
(dp4880
g8
V2513939.xml
p4881
sg10
VSTD-Trienekens-1989
p4882
sg12
S'PMC1838181'
p4883
sa(dp4884
g8
V1929311.xml
p4885
sg10
VSTD-Hooton-1991
p4886
sg12
S'PMC245194'
p4887
sa(dp4888
g8
V8471899.xml
p4889
sg10
VSTD-Trienekens-1993
p4890
sg12
S'PMC2379759'
p4891
sa(dp4892
g8
V6794832.xml
p4893
sg10
VSTD-Rapoport-1981
p4894
sg12
S'PMC1507721'
p4895
sasa(dp4896
g3
VCD005471 v. 5.0 Interventions to improve outpatient referrals from primary care to secondary care.rm5
p4897
sg5
(lp4898
(dp4899
g8
V10132454.xml
p4900
sg10
VSTD-Jones-1993
p4901
sg12
S'PMC1055149'
p4902
sa(dp4903
g8
V12817353.xml
p4904
sg10
VSTD-Banait-2000
p4905
sg12
S'PMC1314507'
p4906
sa(dp4907
g8
V8461728.xml
p4908
sg10
VSTD-Coulter-1993
p4909
sg12
S'PMC1676519'
p4910
sa(dp4911
g8
V16176738.xml
p4912
sg10
VSTD-Bridgman-2005
p4913
sg12
S'PMC1464070'
p4914
sa(dp4915
g8
V8280213.xml
p4916
sg10
VSTD-Emslie-1993
p4917
sg12
S'PMC1678278'
p4918
sa(dp4919
g8
V11375232.xml
p4920
sg10
VSTD-Morrison-2001
p4921
sg12
S'PMC31924'
p4922
sa(dp4923
g8
V7612338.xml
p4924
sg10
VSTD-O_x0027_Cathain-1995
p4925
sg12
S'PMC1239296'
p4926
sa(dp4927
g8
V8646099.xml
p4928
sg10
VSTD-Kammerling-1996
p4929
sg12
S'PMC2351139'
p4930
sasa(dp4931
g3
VCD005619 v. 3.0 Surgery for rotator cuff disease.rm5
p4932
sg5
(lp4933
(dp4934
g8
V8241852.xml
p4935
sg10
VSTD-Brox-1993
p4936
sg12
S'PMC1679023'
p4937
sasa(dp4938
g3
VCD006237 v. 4.0 Interventions to improve occupational health in depressed people.rm5
p4939
sg5
(lp4940
(dp4941
g8
V15550800.xml
p4942
sg10
VSTD-Rost-2004
p4943
sg12
S'PMC1350979'
p4944
sasa(dp4945
g3
VCD004587 v. 4.0 Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.rm5
p4946
sg5
(lp4947
(dp4948
g8
V17589978.xml
p4949
sg10
VSTD-Strozzi-2007
p4950
sg12
S'PMC2080548'
p4951
sasa(dp4952
g3
VCD002095 v. 12.0 Short-term treatment with proton pump inhibitors H2-receptor antagonists and prokinetics for gastro.rm5
p4953
sg5
(lp4954
(dp4955
g8
V10463897.xml
p4956
sg10
VSTD-Hatlebakk-1999
p4957
sg12
S'PMC28208'
p4958
sa(dp4959
g8
V9203934.xml
p4960
sg10
VSTD-Watson-1997
p4961
sg12
S'PMC1027158'
p4962
sa(dp4963
g8
V10024259.xml
p4964
sg10
VSTD-Bardhan-1999
p4965
sg12
S'PMC27748'
p4966
sasa(dp4967
g3
VCD006654 v. 6.0 Olanzapine versus other atypical antipsychotics for schizophrenia.rm5
p4968
sg5
(lp4969
(dp4970
g8
V17662577.xml
p4971
sg10
VSTD-Wynn-2007
p4972
sg12
S'PMC2716219'
p4973
sasa(dp4974
g3
VCD008228 v. 2.0 Face-down positioning or posturing after macular hole surgery.rm5
p4975
sg5
(lp4976
(dp4977
g8
V21941361.xml
p4978
sg10
VSTD-Lange-2011
p4979
sg12
S'PMC3272183'
p4980
sasa(dp4981
g3
VCD001230 v. 3.2 Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with m.rm5
p4982
sg5
(lp4983
(dp4984
g8
V12773358.xml
p4985
sg10
VSTD-Explore-2004_x002a_
p4986
sg12
S'PMC1447873'
p4987
sa(dp4988
g8
V15385902.xml
p4989
sg10
VSTD-R_x002d_B-2004-phone_x0040_
p4990
sg12
S'PMC2843590'
p4991
sa(dp4992
g8
V11236404.xml
p4993
sg10
VSTD-Rotheram_x002d_Borus-2001_x0040_
p4994
sg12
S'PMC1446609'
p4995
sa(dp4996
g8
V10076482.xml
p4997
sg10
VSTD-CDC-ACDP-1999_x0040_
p4998
sg12
S'PMC1508588'
p4999
sa(dp5000
g8
V15385902.xml
p5001
sg10
VSTD-R_x002d_B-2004-in-person_x0040_
p5002
sg12
S'PMC2843590'
p5003
sa(dp5004
g8
V1990853.xml
p5005
sg10
VSTD-Kelly-1991
p5006
sg12
S'PMC1404968'
p5007
sa(dp5008
g8
V11408300.xml
p5009
sg10
VSTD-Imrie-2001_x002a__x0040_
p5010
sg12
S'PMC32307'
p5011
sa(dp5012
g8
V2735479.xml
p5013
sg10
VSTD-Coates-1989_x0040_
p5014
sg12
S'PMC1349674'
p5015
sa(dp5016
g8
V17927556.xml
p5017
sg10
VSTD-Picciano-2001_x0023_
p5018
sg12
S'PMC3352672'
p5019
sa(dp5020
g8
V8712273.xml
p5021
sg10
VSTD-Kegeles-1996_x0040_
p5022
sg12
S'PMC1380625'
p5023
sasa(dp5024
g3
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p5025
sg5
(lp5026
(dp5027
g8
V19284644.xml
p5028
sg10
VSTD-Chen-2009
p5029
sg12
S'PMC2666722'
p5030
sa(dp5031
g8
V18461182.xml
p5032
sg10
VSTD-Cowling-2008
p5033
sg12
S'PMC2364646'
p5034
sa(dp5035
g8
V15473141.xml
p5036
sg10
VSTD-Teleman-2004
p5037
sg12
S'PMC2870165'
p5038
sa(dp5039
g8
V17666681.xml
p5040
sg10
VSTD-Wang-2007
p5041
sg12
S'PMC1963277'
p5042
sa(dp5043
g8
V20297744.xml
p5044
sg10
VSTD-Larson-2010
p5045
sg12
S'PMC2821845'
p5046
sa(dp5047
g8
V15030685.xml
p5048
sg10
VSTD-Wu-2004
p5049
sg12
S'PMC3322931'
p5050
sa(dp5051
g8
V19193267.xml
p5052
sg10
VSTD-MacIntyre-2009
p5053
sg12
S'PMC2662657'
p5054
sa(dp5055
g8
V15200846.xml
p5056
sg10
VSTD-Lau-2004a
p5057
sg12
S'PMC3323085'
p5058
sa(dp5059
g8
V2001109.xml
p5060
sg10
VSTD-Isaacs-1991
p5061
sg12
S'PMC1792812'
p5062
sa(dp5063
g8
V20353566.xml
p5064
sg10
VSTD-Cowling-2010
p5065
sg12
S'PMC3152767'
p5066
sa(dp5067
g8
V15215114.xml
p5068
sg10
VSTD-Turner-2004b
p5069
sg12
S'PMC434190'
p5070
sa(dp5071
g8
V15215114.xml
p5072
sg10
VSTD-Turner-2004a
p5073
sg12
S'PMC434190'
p5074
sasa(dp5075
g3
VCD005016 v. 7.0 High-flux versus low-flux membranes for end-stage kidney disease.rm5
p5076
sg5
(lp5077
(dp5078
g8
V20203165.xml
p5079
sg10
VSTD-Li-2010
p5080
sg12
S'PMC2849689'
p5081
sa(dp5082
g8
V19092122.xml
p5083
sg10
VSTD-MPO-2009
p5084
sg12
S'PMC2653681'
p5085
sasa(dp5086
g3
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p5087
sg5
(lp5088
(dp5089
g8
V17604300.xml
p5090
sg10
VSTD-Hickson-2007
p5091
sg12
S'PMC1914504'
p5092
sa(dp5093
g8
V22371721.xml
p5094
sg10
VSTD-Psaradellis-2010
p5095
sg12
S'PMC3278944'
p5096
sa(dp5097
g8
V18026577.xml
p5098
sg10
VSTD-Beausoleil-2007
p5099
sg12
S'PMC2658588'
p5100
sasa(dp5101
g3
VCD003641 v. 10.0 Surgery for obesity.rm5
p5102
sg5
(lp5103
(dp5104
g8
V10615935.xml
p5105
sg10
VSTD-de-Wit-1999
p5106
sg12
S'PMC1420944'
p5107
sa(dp5108
g8
V11524581.xml
p5109
sg10
VSTD-Nguyen-2006
p5110
sg12
S'PMC1422019'
p5111
sa(dp5112
g8
V3296971.xml
p5113
sg10
VSTD-Sugerman-1987
p5114
sg12
S'PMC1493086'
p5115
sa(dp5116
g8
V15024302.xml
p5117
sg10
VSTD-Lujan-2004
p5118
sg12
S'PMC1356246'
p5119
sa(dp5120
g8
V14631220.xml
p5121
sg10
VSTD-Morino-2003
p5122
sg12
S'PMC1356165'
p5123
sasa(dp5124
g3
VCD009755 v. 1.0 Micronutrient supplementation in pregnant women with HIV infection.rm5
p5125
sg5
(lp5126
(dp5127
g8
V18541571.xml
p5128
sg10
VSTD-Kupka-2008
p5129
sg12
S'PMC2474659'
p5130
sa(dp5131
g8
V19939985.xml
p5132
sg10
VSTD-Kawai-2010
p5133
sg12
S'PMC2806894'
p5134
sasa(dp5135
g3
VCD003539 v. 7.0 Interventions to improve antibiotic prescribing practices in ambulatory care.rm5
p5136
sg5
(lp5137
(dp5138
g8
V6726669.xml
p5139
sg10
VSTD-Harris-1984
p5140
sg12
S'PMC2573581'
p5141
sa(dp5142
g8
V11159657.xml
p5143
sg10
VSTD-Little-2001
p5144
sg12
S'PMC26576'
p5145
sa(dp5146
g8
V6891147.xml
p5147
sg10
VSTD-McConnell-1982
p5148
sg12
S'PMC1274191'
p5149
sa(dp5150
g8
V11255901.xml
p5151
sg10
VSTD-Dowell-2001
p5152
sg12
S'PMC1313951'
p5153
sa(dp5154
g8
V10024260.xml
p5155
sg10
VSTD-O_x0027_Connell-1999
p5156
sg12
S'PMC27749'
p5157
sa(dp5158
g8
V10671912.xml
p5159
sg10
VSTD-Ilett-2000
p5160
sg12
S'PMC2014897'
p5161
sa(dp5162
g8
V10478162.xml
p5163
sg10
VSTD-Hux-1999
p5164
sg12
S'PMC1230539'
p5165
sa(dp5166
g8
V10980076.xml
p5167
sg10
VSTD-Lagerlov-2000
p5168
sg12
S'PMC1743532'
p5169
sa(dp5170
g8
V10790817.xml
p5171
sg10
VSTD-Stewart-2000
p5172
sg12
S'PMC2144801'
p5173
sa(dp5174
g8
V12183309.xml
p5175
sg10
VSTD-Flottorp-2002
p5176
sg12
S'PMC117890'
p5177
sa(dp5178
g8
V11786454.xml
p5179
sg10
VSTD-Macfarlane-2002
p5180
sg12
S'PMC64506'
p5181
sasa(dp5182
g3
VCD004258 v. 7.0 Physiotherapy interventions for shoulder pain.rm5
p5183
sg5
(lp5184
(dp5185
g8
V9804720.xml
p5186
sg10
VSTD-van-der-Windt-1998
p5187
sg12
S'PMC28713'
p5188
sa(dp5189
g8
V2712613.xml
p5190
sg10
VSTD-Dacre1989
p5191
sg12
S'PMC1003749'
p5192
sa(dp5193
g8
V10334751.xml
p5194
sg10
VSTD-Winters-1997_x002f_9
p5195
sg12
S'PMC27885'
p5196
sa(dp5197
g8
V6742895.xml
p5198
sg10
VSTD-Bulgen-1984
p5199
sg12
S'PMC1001344'
p5200
sasa(dp5201
g3
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p5202
sg5
(lp5203
(dp5204
g8
V11870502.xml
p5205
sg10
VSTD-Atzpodien-2002
p5206
sg12
S'PMC2375173'
p5207
sa(dp5208
g8
V19001327.xml
p5209
sg10
VSTD-Atkins-2003
p5210
sg12
S'PMC2645104'
p5211
sa(dp5212
g8
V9579834.xml
p5213
sg10
VSTD-Johnston-1998
p5214
sg12
S'PMC2150174'
p5215
sasa(dp5216
g3
VCD003324 v. 10.0 Rehabilitation for distal radial fractures in adults.rm5
p5217
sg5
(lp5218
(dp5219
g8
V11374267.xml
p5220
sg10
VSTD-Christensen-2001
p5221
sg12
S'PMC3620612'
p5222
sasa(dp5223
g3
VCD003195 v. 6.4 Urodynamic studies for management of urinary incontinence in children and adults.rm5
p5224
sg5
(lp5225
(dp5226
g8
V22833787.xml
p5227
sg10
VSTD-Kristjansson-1999
p5228
sg12
S'PMC3402187'
p5229
sasa(dp5230
g3
VCD005230 v. 4.8 Complementary and miscellaneous interventions for nocturnal enuresis in children.rm5
p5231
sg5
(lp5232
(dp5233
g8
V19668674.xml
p5234
sg10
VSTD-Seabrook-2005
p5235
sg12
S'PMC2722618'
p5236
sa(dp5237
g8
V1192312.xml
p5238
sg10
VSTD-McKendry-1975
p5239
sg12
S'PMC1956570'
p5240
sasa(dp5241
g3
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p5242
sg5
(lp5243
(dp5244
g8
V9445122.xml
p5245
sg10
VSTD-Izbicki-1998
p5246
sg12
S'PMC1191184'
p5247
sa(dp5248
g8
V9744511.xml
p5249
sg10
VSTD-Shepherd-1998
p5250
sg12
S'PMC2063048'
p5251
sasa(dp5252
g3
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p5253
sg5
(lp5254
(dp5255
g8
V16236699.xml
p5256
sg10
VSTD-Lin-2005
p5257
sg12
S'PMC1550679'
p5258
sa(dp5259
g8
V15249261.xml
p5260
sg10
VSTD-Ross-2004
p5261
sg12
S'PMC1550594'
p5262
sa(dp5263
g8
V12950483.xml
p5264
sg10
VSTD-Katz-2003
p5265
sg12
S'PMC1494914'
p5266
sasa(dp5267
g3
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p5268
sg5
(lp5269
(dp5270
g8
V11691758.xml
p5271
sg10
VSTD-Sahota-2001
p5272
sg12
S'PMC59380'
p5273
sa(dp5274
g8
V19765270.xml
p5275
sg10
VSTD-Gentile-2009
p5276
sg12
S'PMC2758893'
p5277
sa(dp5278
g8
V19665037.xml
p5279
sg10
VSTD-Donnelly-2009
p5280
sg12
S'PMC2766439'
p5281
sa(dp5282
g8
V15107313.xml
p5283
sg10
VSTD-James-2004
p5284
sg12
S'PMC416601'
p5285
sa(dp5286
g8
V18312804.xml
p5287
sg10
VSTD-Webber-2008
p5288
sg12
S'PMC2275165'
p5289
sa(dp5290
g8
V17028105.xml
p5291
sg10
VSTD-Reilly-2006
p5292
sg12
S'PMC1647320'
p5293
sa(dp5294
g8
V16118370.xml
p5295
sg10
VSTD-Pate-2005
p5296
sg12
S'PMC1449401'
p5297
sa(dp5298
g8
V17718785.xml
p5299
sg10
VSTD-Lazaar-2007
p5300
sg12
S'PMC2040215'
p5301
sasa(dp5302
g3
VCD009009 v. 3.0 General health checks in adults for reducing morbidity and mortality from disease.rm5
p5303
sg5
(lp5304
(dp5305
g8
V7742676.xml
p5306
sg10
VSTD-OXCHECK-1989
p5307
sg12
S'PMC2549499'
p5308
sa(dp5309
g8
V4569090.xml
p5310
sg10
VSTD-New-York-1971
p5311
sg12
S'PMC1067443'
p5312
sa(dp5313
g8
V8124121.xml
p5314
sg10
VSTD-Family-Heart-1990
p5315
sg12
S'PMC2539278'
p5316
sasa(dp5317
g3
VCD008165 v. 2.0 Interventions to improve the appropriate use of polypharmacy for older people.rm5
p5318
sg5
(lp5319
(dp5320
g8
V12975221.xml
p5321
sg10
VSTD-Tamblyn-2003
p5322
sg12
S'PMC191278'
p5323
sasa(dp5324
g3
VCD000052 v. 12.3 Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.rm5
p5325
sg5
(lp5326
(dp5327
g8
V6428582.xml
p5328
sg10
VSTD-Freelander-1984
p5329
sg12
S'PMC1441767'
p5330
sa(dp5331
g8
V7741574.xml
p5332
sg10
VSTD-Parkin-1995
p5333
sg12
S'PMC1511081'
p5334
sa(dp5335
g8
V7741566.xml
p5336
sg10
VSTD-Lin-1995
p5337
sg12
S'PMC1511067'
p5338
sa(dp5339
g8
V10208945.xml
p5340
sg10
VSTD-Dewar-1999
p5341
sg12
S'PMC1717926'
p5342
sasa(dp5343
g3
VCD000526 v. 7.2 Interventions for treating tuberculous pericarditis.rm5
p5344
sg5
(lp5345
(dp5346
g8
V10908256.xml
p5347
sg10
VSTD-Hakim-2000
p5348
sg12
S'PMC1760932'
p5349
sasa(dp5350
g3
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p5351
sg5
(lp5352
(dp5353
g8
V12582801.xml
p5354
sg10
VSTD-Woodruff-2003
p5355
sg12
S'PMC3673685'
p5356
sa(dp5357
g8
V17683577.xml
p5358
sg10
VSTD-Rosenberg-2007
p5359
sg12
S'PMC1964758'
p5360
sasa(dp5361
g3
VCD003113 v. 7.0 Opioid therapy for treating rheumatoid arthritis pain.rm5
p5362
sg5
(lp5363
(dp5364
g8
V4584572.xml
p5365
sg10
VSTD-Nuki-1973
p5366
sg12
S'PMC1006142'
p5367
sasa(dp5368
g3
VCD001363 v. 7.0 Isoniazid for preventing tuberculosis in non-HIV infected persons.rm5
p5369
sg5
(lp5370
(dp5371
g8
V5321762.xml
p5372
sg10
VSTD-Egsmose-1965
p5373
sg12
S'PMC2475854'
p5374
sasa(dp5375
g3
VCD001352 v. 7.8 Surgery for degenerative lumbar spondylosis.rm5
p5376
sg5
(lp5377
(dp5378
g8
V14685830.xml
p5379
sg10
VSTD-Zucherman-2004
p5380
sg12
S'PMC3468027'
p5381
sa(dp5382
g8
V12955608.xml
p5383
sg10
VSTD-Madan-2003
p5384
sg12
S'PMC3467791'
p5385
sasa(dp5386
g3
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p5387
sg5
(lp5388
(dp5389
g8
V14718266.xml
p5390
sg10
VSTD-Griffiths-2004
p5391
sg12
S'PMC314511'
p5392
sa(dp5393
g8
V12236277.xml
p5394
sg10
VSTD-Siriwardena-2002
p5395
sg12
S'PMC1314414'
p5396
sa(dp5397
g8
V10480825.xml
p5398
sg10
VSTD-Kerse--1999
p5399
sg12
S'PMC28221'
p5400
sa(dp5401
g8
V15066200.xml
p5402
sg10
VSTD-Crotty-2004
p5403
sg12
S'PMC415557'
p5404
sa(dp5405
g8
V6891147.xml
p5406
sg10
VSTD-McConnell-1982
p5407
sg12
S'PMC1274191'
p5408
sa(dp5409
g8
V1540493.xml
p5410
sg10
VSTD-Newton_x002d_Syms-1992
p5411
sg12
S'PMC1381201'
p5412
sa(dp5413
g8
V16737349.xml
p5414
sg10
VSTD-Fretheim-2006
p5415
sg12
S'PMC1472698'
p5416
sa(dp5417
g8
V10551192.xml
p5418
sg10
VSTD-Borgiel-1999
p5419
sg12
S'PMC1230705'
p5420
sa(dp5421
g8
V14965404.xml
p5422
sg10
VSTD-Dey-2004
p5423
sg12
S'PMC1314775'
p5424
sa(dp5425
g8
V1571645.xml
p5426
sg10
VSTD-Cockburn--1992
p5427
sg12
S'PMC1881508'
p5428
sa(dp5429
g8
V10671913.xml
p5430
sg10
VSTD-Freemantle-2000
p5431
sg12
S'PMC2014899'
p5432
sa(dp5433
g8
V14734433.xml
p5434
sg10
VSTD-Martin-2004
p5435
sg12
S'PMC315525'
p5436
sa(dp5437
g8
V10847872.xml
p5438
sg10
VSTD-vanden-Hombergh-1999
p5439
sg12
S'PMC2483655'
p5440
sa(dp5441
g8
V10756610.xml
p5442
sg10
VSTD-Kaner-1999
p5443
sg12
S'PMC1313496'
p5444
sa(dp5445
g8
V3986727.xml
p5446
sg10
VSTD-Putnam-1985
p5447
sg12
S'PMC1346180'
p5448
sa(dp5449
g8
V11276541.xml
p5450
sg10
VSTD-Lemelin-2001
p5451
sg12
S'PMC80870'
p5452
sa(dp5453
g8
V12792007.xml
p5454
sg10
VSTD-Frijling-2003
p5455
sg12
S'PMC1743704'
p5456
sa(dp5457
g8
V16150741.xml
p5458
sg10
VSTD-Loeb-2005
p5459
sg12
S'PMC1226247'
p5460
sa(dp5461
g8
V10231255.xml
p5462
sg10
VSTD-Fender-1999
p5463
sg12
S'PMC27863'
p5464
sa(dp5465
g8
V10231256.xml
p5466
sg10
VSTD-Premaratne-1999
p5467
sg12
S'PMC27864'
p5468
sa(dp5469
g8
V11942445.xml
p5470
sg10
VSTD-Freemantle-2002
p5471
sg12
S'PMC1314269'
p5472
sa(dp5473
g8
V8520339.xml
p5474
sg10
VSTD-Feder-1995
p5475
sg12
S'PMC2543702'
p5476
sa(dp5477
g8
V9740569.xml
p5478
sg10
VSTD-Modell-1998
p5479
sg12
S'PMC28672'
p5480
sa(dp5481
g8
V11141128.xml
p5482
sg10
VSTD-van-Eijk-2001
p5483
sg12
S'PMC1119296'
p5484
sa(dp5485
g8
V16423097.xml
p5486
sg10
VSTD-Walsh-2005
p5487
sg12
S'PMC1490293'
p5488
sa(dp5489
g8
V10671912.xml
p5490
sg10
VSTD-Ilett-2000
p5491
sg12
S'PMC2014897'
p5492
sa(dp5493
g8
V9774287.xml
p5494
sg10
VSTD-Wyatt-1998
p5495
sg12
S'PMC28686'
p5496
sasa(dp5497
g3
VCD005373 v. 6.0 Inhaled beta2-agonists for non-specific chronic cough in children.rm5
p5498
sg5
(lp5499
(dp5500
g8
V9771244.xml
p5501
sg10
VSTD-Chang-1998
p5502
sg12
S'PMC1717639'
p5503
sasa(dp5504
g3
VCD001876 v. 8.0 Corticosteroids for tuberculous pleurisy.rm5
p5505
sg5
(lp5506
(dp5507
g8
V8553306.xml
p5508
sg10
VSTD-Galarza-1995
p5509
sg12
S'PMC1021356'
p5510
sasa(dp5511
g3
VCD002141 v. 10.0 Drugs for preventing lung cancer in healthy people.rm5
p5512
sg5
(lp5513
(dp5514
g8
V19066368.xml
p5515
sg10
VSTD-Gaziano-2009
p5516
sg12
S'PMC2774210'
p5517
sa(dp5518
g8
V19116389.xml
p5519
sg10
VSTD-Lin-2009
p5520
sg12
S'PMC2615459'
p5521
sa(dp5522
g8
V19066370.xml
p5523
sg10
VSTD-Lippman-2009
p5524
sg12
S'PMC3682779'
p5525
sasa(dp5526
g3
VCD002975 v. 7.0 Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome .rm5
p5527
sg5
(lp5528
(dp5529
g8
V326199.xml
p5530
sg10
VSTD-Allen-1977
p5531
sg12
S'PMC1544580'
p5532
sasa(dp5533
g3
VCD007878 v. 4.0 Catheter impregnation coating or bonding for reducing central venous catheter-related infections in.rm5
p5534
sg5
(lp5535
(dp5536
g8
V16041209.xml
p5537
sg10
VSTD-Darouiche-2005
p5538
sg12
S'PMC1357724'
p5539
sa(dp5540
g8
V8878569.xml
p5541
sg10
VSTD-Sherertz-1996
p5542
sg12
S'PMC163461'
p5543
sa(dp5544
g8
V14514774.xml
p5545
sg10
VSTD-Bong-2003
p5546
sg12
S'PMC1770068'
p5547
sasa(dp5548
g3
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p5549
sg5
(lp5550
(dp5551
g8
V12171964.xml
p5552
sg10
VSTD-Prantera-2002a
p5553
sg12
S'PMC1773351'
p5554
sa(dp5555
g8
V15113451.xml
p5556
sg10
VSTD-Schultz-2004
p5557
sg12
S'PMC394324'
p5558
sasa(dp5559
g3
VCD002111 v. 8.0 Biofeedback andor sphincter exercises for the treatment of faecal incontinence in adults.rm5
p5560
sg5
(lp5561
(dp5562
g8
V22013492.xml
p5563
sg10
VSTD-Schwandner-2011
p5564
sg12
S'PMC3196995'
p5565
sasa(dp5566
g3
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p5567
sg5
(lp5568
(dp5569
g8
V20357374.xml
p5570
sg10
VSTD-Callaway-2010
p5571
sg12
S'PMC2890340'
p5572
sasa(dp5573
g3
VMR000009 v. 8.2 Outcomes of patients who participate in randomized controlled trials compared to similar patients re.rm5
p5574
sg5
(lp5575
(dp5576
g8
V7488463.xml
p5577
sg10
VSTD-Strandberg-1995
p5578
sg12
S'PMC484055'
p5579
sa(dp5580
g8
V8616414.xml
p5581
sg10
VSTD-Mahon-1996
p5582
sg12
S'PMC2350863'
p5583
sa(dp5584
g8
V3089521.xml
p5585
sg10
VSTD-Dahan-1986
p5586
sg12
S'PMC1341050'
p5587
sa(dp5588
g8
V11282864.xml
p5589
sg10
VSTD-Chilvers-2001a
p5590
sg12
S'PMC30555'
p5591
sa(dp5592
g8
V11282864.xml
p5593
sg10
VSTD-Chilvers-2001b
p5594
sg12
S'PMC30555'
p5595
sa(dp5596
g8
V12237770.xml
p5597
sg10
VSTD-Bijker-2000b
p5598
sg12
S'PMC2364244'
p5599
sa(dp5600
g8
V8401094.xml
p5601
sg10
VSTD-Henshaw-1993a
p5602
sg12
S'PMC1678709'
p5603
sa(dp5604
g8
V8401094.xml
p5605
sg10
VSTD-Henshaw-1993b
p5606
sg12
S'PMC1678709'
p5607
sa(dp5608
g8
V12237770.xml
p5609
sg10
VSTD-Bijker-2000a
p5610
sg12
S'PMC2364244'
p5611
sasa(dp5612
g3
VCD000248 v. 6.0 Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or tr.rm5
p5613
sg5
(lp5614
(dp5615
g8
V1159434.xml
p5616
sg10
VSTD-Bradshaw-1975
p5617
sg12
S'PMC1083241'
p5618
sasa(dp5619
g3
VCD001797 v. 7.0 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
p5620
sg5
(lp5621
(dp5622
g8
V8429321.xml
p5623
sg10
VSTD-Vermeulen-1993
p5624
sg12
S'PMC1014761'
p5625
sasa(dp5626
g3
VCD004206 v. 4.0 Antiviral agents for treatment of herpes simplex virus infection in neonates.rm5
p5627
sg5
(lp5628
(dp5629
g8
V22341538.xml
p5630
sg10
VSTD-Whitley-1980
p5631
sg12
S'PMC3290126'
p5632
sasa(dp5633
g3
VCD003598 v. 8.0 Antihypertensive treatment for kidney transplant recipients.rm5
p5634
sg5
(lp5635
(dp5636
g8
V14616428.xml
p5637
sg10
VSTD-Kumana-2003
p5638
sg12
S'PMC1884301'
p5639
sasa(dp5640
g3
VCD006817 v. 4.0 Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encepha.rm5
p5641
sg5
(lp5642
(dp5643
g8
V16428356.xml
p5644
sg10
VSTD-Benders-2006
p5645
sg12
S'PMC2672696'
p5646
sasa(dp5647
g3
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p5648
sg5
(lp5649
(dp5650
g8
V21310836.xml
p5651
sg10
VSTD-Phelan-2011
p5652
sg12
S'PMC3057546'
p5653
sa(dp5654
g8
V20357374.xml
p5655
sg10
VSTD-Callaway-2010
p5656
sg12
S'PMC2890340'
p5657
sa(dp5658
g8
V20962162.xml
p5659
sg10
VSTD-Rhodes-2010
p5660
sg12
S'PMC2980957'
p5661
sa(dp5662
g8
V21429234.xml
p5663
sg10
VSTD-Korpi_x002d_Hyovalti-2011
p5664
sg12
S'PMC3078095'
p5665
sa(dp5666
g8
V19279301.xml
p5667
sg10
VSTD-Moses-2009
p5668
sg12
S'PMC2681032'
p5669
sa(dp5670
g8
V21610860.xml
p5671
sg10
VSTD-Luoto-2011
p5672
sg12
S'PMC3096610'
p5673
sasa(dp5674
g3
VCD001338 v. 7.0 Oral misoprostol for induction of labour.rm5
p5675
sg5
(lp5676
(dp5677
g8
V16455695.xml
p5678
sg10
VSTD-Dodd-2006
p5679
sg12
S'PMC1388124'
p5680
sasa(dp5681
g3
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p5682
sg5
(lp5683
(dp5684
g8
V10036122.xml
p5685
sg10
VSTD-Ott-1998
p5686
sg12
S'PMC3015252'
p5687
sasa(dp5688
g3
VCD000247 v. 11.0 Antibiotics for the common cold and acute purulent rhinitis.rm5
p5689
sg5
(lp5690
(dp5691
g8
V329949.xml
p5692
sg10
VSTD-Taylor--1977
p5693
sg12
S'PMC1631450'
p5694
sasa(dp5695
g3
VCD005030 v. 9.0 Interventions for prevention of drug use by young people delivered in non-school settings.rm5
p5696
sg5
(lp5697
(dp5698
g8
V12453815.xml
p5699
sg10
VSTD-Wu-2002
p5700
sg12
S'PMC1447358'
p5701
sa(dp5702
g8
V10691755.xml
p5703
sg10
VSTD-Biglan-2000
p5704
sg12
S'PMC1748303'
p5705
sa(dp5706
g8
V15066879.xml
p5707
sg10
VSTD-Flay-2004
p5708
sg12
S'PMC2386246'
p5709
sasa(dp5710
g3
VCD006174 v. 4.0 Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fe.rm5
p5711
sg5
(lp5712
(dp5713
g8
V18503103.xml
p5714
sg10
VSTD-Wiberg_x002d_Itzel-2008
p5715
sg12
S'PMC2413392'
p5716
sasa(dp5717
g3
VCD009261 v. 4.0 Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.rm5
p5718
sg5
(lp5719
(dp5720
g8
V21761149.xml
p5721
sg10
VSTD-Pachowsky-2011
p5722
sg12
S'PMC3311811'
p5723
sa(dp5724
g8
V17060762.xml
p5725
sg10
VSTD-Llanos-2006
p5726
sg12
S'PMC1856589'
p5727
sasa(dp5728
g3
VCD006178 v. 6.0 Antenatal lower genital tract infection screening and treatment programs for preventing preterm deli.rm5
p5729
sg5
(lp5730
(dp5731
g8
V15294856.xml
p5732
sg10
VSTD-Kiss-2004
p5733
sg12
S'PMC509340'
p5734
sasa(dp5735
g3
VCD006089 v. 8.1 Antibiotics for clinically diagnosed acute rhinosinusitis in adults.rm5
p5736
sg5
(lp5737
(dp5738
g8
V22337680.xml
p5739
sg10
VSTD-Garbutt-2012
p5740
sg12
S'PMC3667493'
p5741
sa(dp5742
g8
V9463979.xml
p5743
sg10
VSTD-Stalman-1997
p5744
sg12
S'PMC1410064'
p5745
sasa(dp5746
g3
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p5747
sg5
(lp5748
(dp5749
g8
V12530483.xml
p5750
sg10
VSTD-Scott-2002
p5751
sg12
S'PMC1784606'
p5752
sasa(dp5753
g3
VCD003429 v. 9.0 Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people .rm5
p5754
sg5
(lp5755
(dp5756
g8
V320230.xml
p5757
sg10
VSTD-Aronstam-1977
p5758
sg12
S'PMC476643'
p5759
sasa(dp5760
g3
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p5761
sg5
(lp5762
(dp5763
g8
V12671693.xml
p5764
sg10
VSTD-Boogaerts-2003
p5765
sg12
S'PMC2376376'
p5766
sa(dp5767
g8
V16570051.xml
p5768
sg10
VSTD-Wilkinson-2006
p5769
sg12
S'PMC2361228'
p5770
sasa(dp5771
g3
VCD003633 v. 3.0 Botulinum toxin type A therapy for cervical dystonia.rm5
p5772
sg5
(lp5773
(dp5774
g8
V1955900.xml
p5775
sg10
VSTD-Moore-1991
p5776
sg12
S'PMC1014522'
p5777
sa(dp5778
g8
V2213040.xml
p5779
sg10
VSTD-Blackie-1990
p5780
sg12
S'PMC488163'
p5781
sa(dp5782
g8
V9436721.xml
p5783
sg10
VSTD-Poewe-2000
p5784
sg12
S'PMC2169893'
p5785
sasa(dp5786
g3
VCD003626 v. 6.0 Bile acids for primary sclerosing cholangitis.rm5
p5787
sg5
(lp5788
(dp5789
g8
V19585548.xml
p5790
sg10
VSTD-Lindor-2009
p5791
sg12
S'PMC2758780'
p5792
sasa(dp5793
g3
VCD002824 v. 5.0 Intra-articular steroids and splintsrest for children with juvenile idiopathic arthritis and adults.rm5
p5794
sg5
(lp5795
(dp5796
g8
V12972485.xml
p5797
sg10
VSTD-Weitoft-2003
p5798
sg12
S'PMC1754327'
p5799
sasa(dp5800
g3
VCD006229 v. 2.2 Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p5801
sg5
(lp5802
(dp5803
g8
V11729380.xml
p5804
sg10
VSTD-Ros-2001
p5805
sg12
S'PMC1422133'
p5806
sasa(dp5807
g3
VCD007249 v. 3.0 Theory-based interventions for contraception.rm5
p5808
sg5
(lp5809
(dp5810
g8
V17218187.xml
p5811
sg10
VSTD-Floyd-2007
p5812
sg12
S'PMC2888541'
p5813
sa(dp5814
g8
V16183466.xml
p5815
sg10
VSTD-Ingersoll-2005
p5816
sg12
S'PMC2875062'
p5817
sa(dp5818
g8
V19752472.xml
p5819
sg10
VSTD-Barnet-2009
p5820
sg12
S'PMC2746510'
p5821
sa(dp5822
g8
V21126301.xml
p5823
sg10
VSTD-Kirby-2010
p5824
sg12
S'PMC3153424'
p5825
sa(dp5826
g8
V18395692.xml
p5827
sg10
VSTD-Peipert-2008
p5828
sg12
S'PMC2535847'
p5829
sa(dp5830
g8
V11889277.xml
p5831
sg10
VSTD-Coyle-2001
p5832
sg12
S'PMC1913682'
p5833
sa(dp5834
g8
V12065268.xml
p5835
sg10
VSTD-Wight-2002
p5836
sg12
S'PMC115856'
p5837
sasa(dp5838
g3
VCD004804 v. 6.0 Interventions for improving adherence to treatment in patients with high blood pressure in ambulator.rm5
p5839
sg5
(lp5840
(dp5841
g8
V911007.xml
p5842
sg10
VSTD-Gabriel-1977
p5843
sg12
S'PMC1653741'
p5844
sa(dp5845
g8
V369673.xml
p5846
sg10
VSTD-Johnson-1978
p5847
sg12
S'PMC1819059'
p5848
sa(dp5849
g8
V6375710.xml
p5850
sg10
VSTD-Asplund-1984
p5851
sg12
S'PMC1463452'
p5852
sasa(dp5853
g3
VCD003401 v. 6.0 Combined spinal-epidural versus epidural analgesia in labour.rm5
p5854
sg5
(lp5855
(dp5856
g8
V19095858.xml
p5857
sg10
VSTD-Goodman-2006
p5858
sg12
S'PMC2670780'
p5859
sasa(dp5860
g3
VCD005106 v. 9.0 Patient education for neck pain.rm5
p5861
sg5
(lp5862
(dp5863
g8
V15585539.xml
p5864
sg10
VSTD-Klaber-Moffet-2005
p5865
sg12
S'PMC543869'
p5866
sa(dp5867
g8
V19333174.xml
p5868
sg10
VSTD-Sherman-2009
p5869
sg12
S'PMC2664516'
p5870
sasa(dp5871
g3
VCD007362 v. 2.11 Sugammadex a selective reversal medication for preventing postoperative residual neuromuscular bloc.rm5
p5872
sg5
(lp5873
(dp5874
g8
V20809967.xml
p5875
sg10
VSTD-Lemmens-2007
p5876
sg12
S'PMC2944304'
p5877
sasa(dp5878
g3
VCD007355 v. 6.0 Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.rm5
p5879
sg5
(lp5880
(dp5881
g8
V22558179.xml
p5882
sg10
VSTD-Harrison-1996
p5883
sg12
S'PMC3340390'
p5884
sa(dp5885
g8
V8799525.xml
p5886
sg10
VSTD-Seymour-1996
p5887
sg12
S'PMC2042618'
p5888
sasa(dp5889
g3
VCD004982 v. 8.0 Treatment for superficial thrombophlebitis of the leg.rm5
p5890
sg5
(lp5891
(dp5892
g8
V22360152.xml
p5893
sg10
VSTD-Rathbun-2012
p5894
sg12
S'PMC3343207'
p5895
sasa(dp5896
g3
VCD001744 v. 10.0 Domiciliary oxygen for chronic obstructive pulmonary disease.rm5
p5897
sg5
(lp5898
(dp5899
g8
V9337824.xml
p5900
sg10
VSTD-Gorecka-1997
p5901
sg12
S'PMC1758616'
p5902
sasa(dp5903
g3
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p5904
sg5
(lp5905
(dp5906
g8
V7867131.xml
p5907
sg10
VSTD-Humphrey-1996
p5908
sg12
S'PMC2486738'
p5909
sa(dp5910
g8
V18558641.xml
p5911
sg10
VSTD-Benn-2008
p5912
sg12
S'PMC2432170'
p5913
sa(dp5914
g8
V20215360.xml
p5915
sg10
VSTD-Benn-2010
p5916
sg12
S'PMC2835853'
p5917
sasa(dp5918
g3
VCD008991 v. 2.0 Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.rm5
p5919
sg5
(lp5920
(dp5921
g8
V19788970.xml
p5922
sg10
VSTD-Owen-2009
p5923
sg12
S'PMC2768604'
p5924
sasa(dp5925
g3
VCD004416 v. 6.0 Oral evening primrose oil and borage oil for eczema.rm5
p5926
sg5
(lp5927
(dp5928
g8
V22905031.xml
p5929
sg10
VSTD-MacKie-Child-1990
p5930
sg12
S'PMC3417576'
p5931
sa(dp5932
g8
V22905031.xml
p5933
sg10
VSTD-MacKie-Adult-1990
p5934
sg12
S'PMC3417576'
p5935
sa(dp5936
g8
V14670885.xml
p5937
sg10
VSTD-Takwale-2003
p5938
sg12
S'PMC292992'
p5939
sa(dp5940
g8
V9014601.xml
p5941
sg10
VSTD-Hederos-1996
p5942
sg12
S'PMC1511801'
p5943
sasa(dp5944
g3
VCD000023 v. 20.0 Antibiotics for sore throat.rm5
p5945
sg5
(lp5946
(dp5947
g8
V10634735.xml
p5948
sg10
VSTD-Zwart-2000
p5949
sg12
S'PMC27262'
p5950
sa(dp5951
g8
V14656841.xml
p5952
sg10
VSTD-Zwart-2003
p5953
sg12
S'PMC286321'
p5954
sa(dp5955
g8
V9116551.xml
p5956
sg10
VSTD-Little-1997
p5957
sg12
S'PMC2126131'
p5958
sa(dp5959
g8
V14821407.xml
p5960
sg10
VSTD-Landsman-1951
p5961
sg12
S'PMC2068130'
p5962
sa(dp5963
g8
V9051558.xml
p5964
sg10
VSTD-Petersen-1997
p5965
sg12
S'PMC1497066'
p5966
sa(dp5967
g8
V9219402.xml
p5968
sg10
VSTD-Howe-1997
p5969
sg12
S'PMC1313000'
p5970
sa(dp5971
g8
V14821406.xml
p5972
sg10
VSTD-MacDonald-1951
p5973
sg12
S'PMC2068133'
p5974
sa(dp5975
g8
V8945796.xml
p5976
sg10
VSTD-Dagnelie-1996
p5977
sg12
S'PMC1239783'
p5978
sa(dp5979
g8
V329949.xml
p5980
sg10
VSTD-Taylor-1977
p5981
sg12
S'PMC1631450'
p5982
sasa(dp5983
g3
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p5984
sg5
(lp5985
(dp5986
g8
V15526058.xml
p5987
sg10
VSTD-Moorthy-2004b
p5988
sg12
S'PMC524376'
p5989
sasa(dp5990
g3
VCD002232 v. 8.9 Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.rm5
p5991
sg5
(lp5992
(dp5993
g8
V8215267.xml
p5994
sg10
VSTD-Gomez_x002d_Jimenez-1993
p5995
sg12
S'PMC188024'
p5996
sasa(dp5997
g3
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p5998
sg5
(lp5999
(dp6000
g8
V18759980.xml
p6001
sg10
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p6002
sg12
S'PMC2575601'
p6003
sasa(dp6004
g3
VCD001790 v. 7.0 Posture and fluids for preventing post-dural puncture headache.rm5
p6005
sg5
(lp6006
(dp6007
g8
V7131001.xml
p6008
sg10
VSTD-P_x002d_Hilton_x002d_Jones_x0028_D_x0029_
p6009
sg12
S'PMC1083170'
p6010
sasa(dp6011
g3
VCD004317 v. 8.0 Strategies to improve adherence and acceptability of hormonal methods of contraception.rm5
p6012
sg5
(lp6013
(dp6014
g8
V21126301.xml
p6015
sg10
VSTD-Kirby-2010
p6016
sg12
S'PMC3153424'
p6017
sasa(dp6018
g3
VCD003086 v. 10.2 Opioid antagonists for smoking cessation.rm5
p6019
sg5
(lp6020
(dp6021
g8
V20542391.xml
p6022
sg10
VSTD-Toll-2010a
p6023
sg12
S'PMC3771701'
p6024
sa(dp6025
g8
V18796184.xml
p6026
sg10
VSTD-_x00b0_O_x0027_Malley-1998
p6027
sg12
S'PMC3094855'
p6028
sasa(dp6029
g3
VCD003281 v. 6.0 Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting.rm5
p6030
sg5
(lp6031
(dp6032
g8
V3092933.xml
p6033
sg10
VSTD-Dundee-1986
p6034
sg12
S'PMC1341376'
p6035
sa(dp6036
g8
V2181138.xml
p6037
sg10
VSTD-Barsoum-1990
p6038
sg12
S'PMC1292503'
p6039
sasa(dp6040
g3
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p6041
sg5
(lp6042
(dp6043
g8
V19270819.xml
p6044
sg10
VSTD-Ko-2009
p6045
sg12
S'PMC2650992'
p6046
sasa(dp6047
g3
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p6048
sg5
(lp6049
(dp6050
g8
V11397745.xml
p6051
sg10
VSTD-Lennox-2001
p6052
sg12
S'PMC32255'
p6053
sa(dp6054
g8
V18155287.xml
p6055
sg10
VSTD-Prochaska-2008
p6056
sg12
S'PMC3384542'
p6057
sa(dp6058
g8
V17995993.xml
p6059
sg10
VSTD-Meyer-2008
p6060
sg12
S'PMC2253708'
p6061
sa(dp6062
g8
V18280668.xml
p6063
sg10
VSTD-Prokhorov-2008
p6064
sg12
S'PMC2365030'
p6065
sa(dp6066
g8
V18304363.xml
p6067
sg10
VSTD-Young-2008
p6068
sg12
S'PMC2268921'
p6069
sasa(dp6070
g3
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p6071
sg5
(lp6072
(dp6073
g8
V11744561.xml
p6074
sg10
VSTD-Stoltzfus-2001
p6075
sg12
S'PMC60982'
p6076
sa(dp6077
g8
V18414647.xml
p6078
sg10
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p6079
sg12
S'PMC2291568'
p6080
sa(dp6081
g8
V16790460.xml
p6082
sg10
VSTD-Alderman-2006-_x0028_Cluster_x0029_
p6083
sg12
S'PMC1502184'
p6084
sa(dp6085
g8
V20858280.xml
p6086
sg10
VSTD-Kirwan-2010
p6087
sg12
S'PMC3161357'
p6088
sa(dp6089
g8
V384815.xml
p6090
sg10
VSTD-Willett-1979
p6091
sg12
S'PMC1619153'
p6092
sasa(dp6093
g3
VCD001770 v. 17.10 Treatment of infantile spasms.rm5
p6094
sg5
(lp6095
(dp6096
g8
V8604274.xml
p6097
sg10
VSTD-Baram-1996
p6098
sg12
S'PMC3100715'
p6099
sasa(dp6100
g3
VCD004183 v. 10.0 Antioxidant supplements for preventing gastrointestinal cancers.rm5
p6101
sg5
(lp6102
(dp6103
g8
V17698683.xml
p6104
sg10
VSTD-WACS-2007
p6105
sg12
S'PMC2034519'
p6106
sasa(dp6107
g3
VCD008186 v. 2.0 Water-based exercises for improving activities of daily living after stroke.rm5
p6108
sg5
(lp6109
(dp6110
g8
V15179638.xml
p6111
sg10
VSTD-Chu-2004
p6112
sg12
S'PMC3181213'
p6113
sasa(dp6114
g3
VCD006923 v. 6.0 Regular treatment with formoterol for chronic asthma serious adverse events.rm5
p6115
sg5
(lp6116
(dp6117
g8
V9227720.xml
p6118
sg10
VSTD-van-der-Molen-1997
p6119
sg12
S'PMC1758577'
p6120
sasa(dp6121
g3
VCD007424 v. 2.0 Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in pat.rm5
p6122
sg5
(lp6123
(dp6124
g8
V17258669.xml
p6125
sg10
VSTD-Chalela-2007
p6126
sg12
S'PMC1859855'
p6127
sasa(dp6128
g3
VCD005185 v. 6.2 Thiazide diuretics and the risk of hip fracture.rm5
p6129
sg5
(lp6130
(dp6131
g8
V3083912.xml
p6132
sg10
VSTD-Rashiq-1986
p6133
sg12
S'PMC1339971'
p6134
sasa(dp6135
g3
VCD003905 v. 8.0 Surgical treatment options for carpal tunnel syndrome.rm5
p6136
sg5
(lp6137
(dp6138
g8
V16777857.xml
p6139
sg10
VSTD-Atroshi-2006
p6140
sg12
S'PMC1482334'
p6141
sasa(dp6142
g3
VCD000168 v. 10.0 Pre-operative traction for hip fractures in adults.rm5
p6143
sg5
(lp6144
(dp6145
g8
V12466869.xml
p6146
sg10
VSTD-Yip-2002
p6147
sg12
S'PMC3620974'
p6148
sasa(dp6149
g3
VCD006560 v. 4.0 Interventions for improving outcomes in patients with multimorbidity in primary care and community s.rm5
p6150
sg5
(lp6151
(dp6152
g8
V18626028.xml
p6153
sg10
VSTD-Bogner-2008
p6154
sg12
S'PMC2478504'
p6155
sa(dp6156
g8
V20008582.xml
p6157
sg10
VSTD-Hogg-2009
p6158
sg12
S'PMC2793206'
p6159
sasa(dp6160
g3
VCD005161 v. 6.0 Cyclosporin versus tacrolimus for liver transplanted patients.rm5
p6161
sg5
(lp6162
(dp6163
g8
V1721333.xml
p6164
sg10
VSTD-Fung-1991
p6165
sg12
S'PMC2950613'
p6166
sasa(dp6167
g3
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p6168
sg5
(lp6169
(dp6170
g8
V20607003.xml
p6171
sg10
VSTD-Narvekar-2010
p6172
sg12
S'PMC2890904'
p6173
sasa(dp6174
g3
VCD005080 v. 3.0 Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction af.rm5
p6175
sg5
(lp6176
(dp6177
g8
V16552194.xml
p6178
sg10
VSTD-Tang-2006
p6179
sg12
S'PMC1448972'
p6180
sa(dp6181
g8
V11807358.xml
p6182
sg10
VSTD-Vrijiland-2002
p6183
sg12
S'PMC1422414'
p6184
sasa(dp6185
g3
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p6186
sg5
(lp6187
(dp6188
g8
V22048460.xml
p6189
sg10
VSTD-Shim-2012
p6190
sg12
S'PMC3260973'
p6191
sa(dp6192
g8
V18568115.xml
p6193
sg10
VSTD-_x005e_Horst-2005
p6194
sg12
S'PMC2424122'
p6195
sa(dp6196
g8
V21407853.xml
p6197
sg10
VSTD-_x002a_Williams-2012
p6198
sg12
S'PMC2955947'
p6199
sa(dp6200
g8
V18344743.xml
p6201
sg10
VSTD-Weinberger-2008
p6202
sg12
S'PMC3675443'
p6203
sa(dp6204
g8
V18096137.xml
p6205
sg10
VSTD-_x002a_George-2008
p6206
sg12
S'PMC2693008'
p6207
sa(dp6208
g8
V21475970.xml
p6209
sg10
VSTD-_x002b_Tidey-2011
p6210
sg12
S'PMC3685403'
p6211
sa(dp6212
g8
V18550339.xml
p6213
sg10
VSTD-Kelly-2008
p6214
sg12
S'PMC2547986'
p6215
sa(dp6216
g8
V21198231.xml
p6217
sg10
VSTD-_x002b_Steinberg-2003
p6218
sg12
S'PMC3058670'
p6219
sa(dp6220
g8
V21376537.xml
p6221
sg10
VSTD-_x002a_Weiner-2011
p6222
sg12
S'PMC3691956'
p6223
sa(dp6224
g8
V21810630.xml
p6225
sg10
VSTD-Hong-2011
p6226
sg12
S'PMC3618988'
p6227
sasa(dp6228
g3
VCD000509 v. 11.0 Inhaled nitric oxide for respiratory failure in preterm infants.rm5
p6229
sg5
(lp6230
(dp6231
g8
V9462187.xml
p6232
sg10
VSTD-Subhedar-1997
p6233
sg12
S'PMC1720712'
p6234
sasa(dp6235
g3
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p6236
sg5
(lp6237
(dp6238
g8
V20067958.xml
p6239
sg10
VSTD-Ziegler-2010
p6240
sg12
S'PMC2845038'
p6241
sasa(dp6242
g3
VCD004910 v. 4.0 Effectiveness of shared care across the interface between primary and specialty care in chronic dise.rm5
p6243
sg5
(lp6244
(dp6245
g8
V8180540.xml
p6246
sg10
VSTD-DICE-1994
p6247
sg12
S'PMC2540045'
p6248
sa(dp6249
g8
V7748631.xml
p6250
sg10
VSTD-McGhee-1994
p6251
sg12
S'PMC1239016'
p6252
sa(dp6253
g8
V8148678.xml
p6254
sg10
VSTD-Drummond-1994
p6255
sg12
S'PMC2539573'
p6256
sa(dp6257
g8
V10480824.xml
p6258
sg10
VSTD-Llewelyn_x002d_Jones-1999
p6259
sg12
S'PMC28220'
p6260
sa(dp6261
g8
V15113492.xml
p6262
sg10
VSTD-Byng-2004
p6263
sg12
S'PMC1314850'
p6264
sasa(dp6265
g3
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p6266
sg5
(lp6267
(dp6268
g8
V17342250.xml
p6269
sg10
VSTD-Qu-2007
p6270
sg12
S'PMC1810361'
p6271
sasa(dp6272
g3
VCD001063 v. 5.0 Hands and knees posture in late pregnancy or labour for fetal malposition (lateral or posterior).rm5
p6273
sg5
(lp6274
(dp6275
g8
V14744821.xml
p6276
sg10
VSTD-Kariminia-2004
p6277
sg12
S'PMC351839'
p6278
sasa(dp6279
g3
VCD003710 v. 6.0 Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricul.rm5
p6280
sg5
(lp6281
(dp6282
g8
V1739528.xml
p6283
sg10
VSTD-Sulke-1992
p6284
sg12
S'PMC1024703'
p6285
sa(dp6286
g8
V3056477.xml
p6287
sg10
VSTD-Mitsuoka
p6288
sg12
S'PMC1216582'
p6289
sa(dp6290
g8
V3304370.xml
p6291
sg10
VSTD-Boon
p6292
sg12
S'PMC1277244'
p6293
sa(dp6294
g8
V7488454.xml
p6295
sg10
VSTD-Hargreaves
p6296
sg12
S'PMC484046'
p6297
sa(dp6298
g8
V3790382.xml
p6299
sg10
VSTD-Kenny
p6300
sg12
S'PMC1236894'
p6301
sa(dp6302
g8
V1827588.xml
p6303
sg10
VSTD-Oldroyd
p6304
sg12
S'PMC1024577'
p6305
sa(dp6306
g8
V6349666.xml
p6307
sg10
VSTD-Perrins
p6308
sg12
S'PMC481382'
p6309
sasa(dp6310
g3
VCD004808 v. 6.2 Contracts between patients and healthcare practitioners for improving patients' adherence to treatme.rm5
p6311
sg5
(lp6312
(dp6313
g8
V12196616.xml
p6314
sg10
VSTD-Morisky-2001
p6315
sg12
S'PMC1497389'
p6316
sa(dp6317
g8
V1184491.xml
p6318
sg10
VSTD-Aragona-1975
p6319
sg12
S'PMC1311852'
p6320
sasa(dp6321
g3
VCD007855 v. 2.0 Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.rm5
p6322
sg5
(lp6323
(dp6324
g8
V3113538.xml
p6325
sg10
VSTD-Campbell_x002d_Brown-1987
p6326
sg12
S'PMC1246728'
p6327
sasa(dp6328
g3
VCD004026 v. 6.0 Day hospital versus admission for acute psychiatric disorders.rm5
p6329
sg5
(lp6330
(dp6331
g8
V9161310.xml
p6332
sg10
VSTD-Creed_x002d_UK_x002d_1996
p6333
sg12
S'PMC2126667'
p6334
sa(dp6335
g8
V2188696.xml
p6336
sg10
VSTD-Creed_x002d_UK_x002d_1990
p6337
sg12
S'PMC1662770'
p6338
sasa(dp6339
g3
VCD000375 v. 7.0 Longchain polyunsaturated fatty acid supplementation in preterm infants.rm5
p6340
sg5
(lp6341
(dp6342
g8
V8949693.xml
p6343
sg10
VSTD-Fadella-1996
p6344
sg12
S'PMC1061173'
p6345
sasa(dp6346
g3
VCD001116 v. 9.2 Physical training for asthma.rm5
p6347
sg5
(lp6348
(dp6349
g8
V2116678.xml
p6350
sg10
VSTD-Cochrane-1990
p6351
sg12
S'PMC462468'
p6352
sa(dp6353
g8
V10325893.xml
p6354
sg10
VSTD-Matsumoto-1999
p6355
sg12
S'PMC1745437'
p6356
sasa(dp6357
g3
VCD001819 v. 6.0 Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants les.rm5
p6358
sg5
(lp6359
(dp6360
g8
V1586185.xml
p6361
sg10
VSTD-Macdonald-1992
p6362
sg12
S'PMC1590483'
p6363
sasa(dp6364
g3
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p6365
sg5
(lp6366
(dp6367
g8
V22026956.xml
p6368
sg10
VSTD-Bouzari-2011
p6369
sg12
S'PMC3217057'
p6370
sa(dp6371
g8
V22162919.xml
p6372
sg10
VSTD-Yekta-2011
p6373
sg12
S'PMC3233526'
p6374
sasa(dp6375
g3
VCD005463 v. 3.2 Individual and group-based parenting programmes for the treatment of physical child abuse and neglec.rm5
p6376
sg5
(lp6377
(dp6378
g8
V23476865.xml
p6379
sg10
VSTD-Egan-1983
p6380
sg12
S'PMC3582081'
p6381
sasa(dp6382
g3
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p6383
sg5
(lp6384
(dp6385
g8
V6416575.xml
p6386
sg10
VSTD-Boscoe-1983
p6387
sg12
S'PMC1549862'
p6388
sa(dp6389
g8
V17547746.xml
p6390
sg10
VSTD-Starobin-2007
p6391
sg12
S'PMC1892551'
p6392
sasa(dp6393
g3
VCD006267 v. 3.3 Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial .rm5
p6394
sg5
(lp6395
(dp6396
g8
V15570204.xml
p6397
sg10
VSTD-Maartense-2004a
p6398
sg12
S'PMC1356514'
p6399
sa(dp6400
g8
V16633002.xml
p6401
sg10
VSTD-Larson-2006
p6402
sg12
S'PMC1570559'
p6403
sasa(dp6404
g3
VCD000031 v. 17.0 Antidepressants for smoking cessation.rm5
p6405
sg5
(lp6406
(dp6407
g8
V17577801.xml
p6408
sg10
VSTD-Brown-2007
p6409
sg12
S'PMC2213513'
p6410
sa(dp6411
g8
V18441375.xml
p6412
sg10
VSTD-Aveyard-2008
p6413
sg12
S'PMC2405820'
p6414
sa(dp6415
g8
V18096137.xml
p6416
sg10
VSTD-George-2008
p6417
sg12
S'PMC2693008'
p6418
sa(dp6419
g8
V17889314.xml
p6420
sg10
VSTD-Grant-2007
p6421
sg12
S'PMC2064868'
p6422
sa(dp6423
g8
V17763111.xml
p6424
sg10
VSTD-Piper-2007
p6425
sg12
S'PMC3030120'
p6426
sa(dp6427
g8
V12182272.xml
p6428
sg10
VSTD-Niaura-2002
p6429
sg12
S'PMC1852538'
p6430
sa(dp6431
g8
V15681499.xml
p6432
sg10
VSTD-Holt-2005
p6433
sg12
S'PMC1747282'
p6434
sasa(dp6435
g3
VCD003971 v. 9.0 Methadone for cancer pain.rm5
p6436
sg5
(lp6437
(dp6438
g8
V14122903.xml
p6439
sg10
VSTD-Matts-1964
p6440
sg12
S'PMC2482577'
p6441
sasa(dp6442
g3
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p6443
sg5
(lp6444
(dp6445
g8
V18545884.xml
p6446
sg10
VSTD-Tan-2008
p6447
sg12
S'PMC2780654'
p6448
sasa(dp6449
g3
VCD006810 v. 4.2 Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.rm5
p6450
sg5
(lp6451
(dp6452
g8
V11257020.xml
p6453
sg10
VSTD-de-Lalla-2001
p6454
sg12
S'PMC90429'
p6455
sasa(dp6456
g3
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p6457
sg5
(lp6458
(dp6459
g8
V19549342.xml
p6460
sg10
VSTD-Wamalwa-2009
p6461
sg12
S'PMC2708138'
p6462
sasa(dp6463
g3
VCD010038 v. 2.2 Face to face interventions for informing or educating parents about early childhood vaccination.rm5
p6464
sg5
(lp6465
(dp6466
g8
V9549449.xml
p6467
sg10
VSTD-Bolam-1998
p6468
sg12
S'PMC28481'
p6469
sa(dp6470
g8
V21159080.xml
p6471
sg10
VSTD-Usman-2011
p6472
sg12
S'PMC3763701'
p6473
sasa(dp6474
g3
VCD002214 v. 6.0 Effectiveness of intermediate care in nursing-led in-patient units.rm5
p6475
sg5
(lp6476
(dp6477
g8
V11222419.xml
p6478
sg10
VSTD-Steiner-2001
p6479
sg12
S'PMC26560'
p6480
sasa(dp6481
g3
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p6482
sg5
(lp6483
(dp6484
g8
V19416499.xml
p6485
sg10
VSTD-Patel-2009
p6486
sg12
S'PMC2684117'
p6487
sa(dp6488
g8
V9370894.xml
p6489
sg10
VSTD-Roy-1997
p6490
sg12
S'PMC1717301'
p6491
sa(dp6492
g8
V19416499.xml
p6493
sg10
VSTD-Patel-2009a-_x0028_zinc_x0029_
p6494
sg12
S'PMC2684117'
p6495
sa(dp6496
g8
V19416499.xml
p6497
sg10
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p6498
sg12
S'PMC2684117'
p6499
sasa(dp6500
g3
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p6501
sg5
(lp6502
(dp6503
g8
V22768013.xml
p6504
sg10
VSTD-b-MOCCSG-1980
p6505
sg12
S'PMC3385043'
p6506
sa(dp6507
g8
V1739629.xml
p6508
sg10
VSTD-d-SGCTG-1986
p6509
sg12
S'PMC1977737'
p6510
sasa(dp6511
g3
VCD001815 v. 6.6 Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.rm5
p6512
sg5
(lp6513
(dp6514
g8
V10194995.xml
p6515
sg10
VSTD-Stenson-1998
p6516
sg12
S'PMC1720861'
p6517
sa(dp6518
g8
V11320044.xml
p6519
sg10
VSTD-Ng-PC-2001
p6520
sg12
S'PMC1721258'
p6521
sasa(dp6522
g3
VCD001209 v. 11.0 Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.rm5
p6523
sg5
(lp6524
(dp6525
g8
V2675752.xml
p6526
sg10
VSTD-Nicolle-1989
p6527
sg12
S'PMC176057'
p6528
sasa(dp6529
g3
VCD008535 v. 2.0 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease evidence from observati.rm5
p6530
sg5
(lp6531
(dp6532
g8
V19696520.xml
p6533
sg10
VSTD-Louis-2009
p6534
sg12
S'PMC2826448'
p6535
sa(dp6536
g8
V20669249.xml
p6537
sg10
VSTD-Simon-2010
p6538
sg12
S'PMC2939261'
p6539
sa(dp6540
g8
V20437557.xml
p6541
sg10
VSTD-Ritz-2010
p6542
sg12
S'PMC2917467'
p6543
sa(dp6544
g8
V17055323.xml
p6545
sg10
VSTD-Ton-2007
p6546
sg12
S'PMC1893113'
p6547
sasa(dp6548
g3
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p6549
sg5
(lp6550
(dp6551
g8
V2202445.xml
p6552
sg10
VSTD-Slama-1990
p6553
sg12
S'PMC1663307'
p6554
sa(dp6555
g8
V3922510.xml
p6556
sg10
VSTD-Marshall-1985
p6557
sg12
S'PMC1415622'
p6558
sa(dp6559
g8
V10814655.xml
p6560
sg10
VSTD-Lang-2000
p6561
sg12
S'PMC1731676'
p6562
sa(dp6563
g8
V370171.xml
p6564
sg10
VSTD-Rose-78_x002d_92
p6565
sg12
S'PMC1060968'
p6566
sa(dp6567
g8
V476401.xml
p6568
sg10
VSTD-Russell-1979
p6569
sg12
S'PMC1595592'
p6570
sa(dp6571
g8
V3592033.xml
p6572
sg10
VSTD-Janz-1987
p6573
sg12
S'PMC1647206'
p6574
sa(dp6575
g8
V17995993.xml
p6576
sg10
VSTD-Meyer-2008
p6577
sg12
S'PMC2253708'
p6578
sa(dp6579
g8
V2256010.xml
p6580
sg10
VSTD-BTS-1990a
p6581
sg12
S'PMC462779'
p6582
sa(dp6583
g8
V3082450.xml
p6584
sg10
VSTD-Richmond-1986
p6585
sg12
S'PMC1339727'
p6586
sa(dp6587
g8
V21274108.xml
p6588
sg10
VSTD-McDowell-1985
p6589
sg12
S'PMC2327690'
p6590
sa(dp6591
g8
V6426618.xml
p6592
sg10
VSTD-Jamrozik-1984
p6593
sg12
S'PMC1441184'
p6594
sa(dp6595
g8
V17372796.xml
p6596
sg10
VSTD-Unrod-2007
p6597
sg12
S'PMC1829425'
p6598
sa(dp6599
g8
V7074505.xml
p6600
sg10
VSTD-Stewart-1982
p6601
sg12
S'PMC1863274'
p6602
sa(dp6603
g8
V7037143.xml
p6604
sg10
VSTD-Wilson-1982
p6605
sg12
S'PMC1862918'
p6606
sa(dp6607
g8
V2256010.xml
p6608
sg10
VSTD-BTS-1990b
p6609
sg12
S'PMC462779'
p6610
sa(dp6611
g8
V6416593.xml
p6612
sg10
VSTD-Russell-1983
p6613
sg12
S'PMC1549849'
p6614
sasa(dp6615
g3
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p6616
sg5
(lp6617
(dp6618
g8
V21206792.xml
p6619
sg10
VSTD-Lalit-2004
p6620
sg12
S'PMC2950952'
p6621
sasa(dp6622
g3
VCD002194 v. 8.1 Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults.rm5
p6623
sg5
(lp6624
(dp6625
g8
V7849868.xml
p6626
sg10
VSTD-Ekberg-1994
p6627
sg12
S'PMC1128125'
p6628
sasa(dp6629
g3
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p6630
sg5
(lp6631
(dp6632
g8
V10735496.xml
p6633
sg10
VSTD-Windbichler-2000
p6634
sg12
S'PMC2363351'
p6635
sa(dp6636
g8
V15305182.xml
p6637
sg10
VSTD-Hall-2004
p6638
sg12
S'PMC2364769'
p6639
sasa(dp6640
g3
VCD006244 v. 6.0 Care delivery and self-management strategies for adults with epilepsy.rm5
p6641
sg5
(lp6642
(dp6643
g8
V10736906.xml
p6644
sg10
VSTD-Ridsdale-1999
p6645
sg12
S'PMC1313394'
p6646
sa(dp6647
g8
V11885833.xml
p6648
sg10
VSTD-Thapar-2002
p6649
sg12
S'PMC1314230'
p6650
sa(dp6651
g8
V9006472.xml
p6652
sg10
VSTD-Ridsdale-1997
p6653
sg12
S'PMC2125629'
p6654
sasa(dp6655
g3
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p6656
sg5
(lp6657
(dp6658
g8
V18000538.xml
p6659
sg10
VSTD-Kalilani-2007
p6660
sg12
S'PMC2048661'
p6661
sa(dp6662
g8
V16776817.xml
p6663
sg10
VSTD-Coulibaly-2006
p6664
sg12
S'PMC1533839'
p6665
sasa(dp6666
g3
VCD004348 v. 4.0 Setting and organization of care for persons living with HIVAIDS.rm5
p6667
sg5
(lp6668
(dp6669
g8
V9663974.xml
p6670
sg10
VSTD-Newschaffer-1998b
p6671
sg12
S'PMC3456288'
p6672
sa(dp6673
g8
V8601114.xml
p6674
sg10
VSTD-Smith-1996
p6675
sg12
S'PMC2350105'
p6676
sa(dp6677
g8
V9462490.xml
p6678
sg10
VSTD-Turner-1998
p6679
sg12
S'PMC1496898'
p6680
sa(dp6681
g8
V11556937.xml
p6682
sg10
VSTD-Keitz-2001
p6683
sg12
S'PMC1495270'
p6684
sasa(dp6685
g3
VCD003954 v. 4.0 Diazepam for treating tetanus.rm5
p6686
sg5
(lp6687
(dp6688
g8
V5917405.xml
p6689
sg10
VSTD-Hendrickse-1965
p6690
sg12
S'PMC1944076'
p6691
sasa(dp6692
g3
VCD000144 v. 6.0 Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.rm5
p6693
sg5
(lp6694
(dp6695
g8
V8151722.xml
p6696
sg10
VSTD-Sehgal-1994
p6697
sg12
S'PMC2607653'
p6698
sasa(dp6699
g3
VCD005059 v. 7.0 Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.rm5
p6700
sg5
(lp6701
(dp6702
g8
V11573049.xml
p6703
sg10
VSTD-Park-2001
p6704
sg12
S'PMC1422079'
p6705
sasa(dp6706
g3
VCD000478 v. 6.0 Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.rm5
p6707
sg5
(lp6708
(dp6709
g8
V1638191.xml
p6710
sg10
VSTD-Hawthorne-1992
p6711
sg12
S'PMC1882467'
p6712
sa(dp6713
g8
V4441827.xml
p6714
sg10
VSTD-Jewell-1974
p6715
sg12
S'PMC1612983'
p6716
sasa(dp6717
g3
VCD000448 v. 10.0 St John's wort for major depression.rm5
p6718
sg5
(lp6719
(dp6720
g8
V15708844.xml
p6721
sg10
VSTD-Szegedi-2005
p6722
sg12
S'PMC552808'
p6723
sa(dp6724
g8
V10968813.xml
p6725
sg10
VSTD-Woelk-2000
p6726
sg12
S'PMC27467'
p6727
sa(dp6728
g8
V12053635.xml
p6729
sg10
VSTD-van-Gurp-2002
p6730
sg12
S'PMC2214056'
p6731
sa(dp6732
g8
V16796730.xml
p6733
sg10
VSTD-Kasper-2006
p6734
sg12
S'PMC1538611'
p6735
sa(dp6736
g8
V10591711.xml
p6737
sg10
VSTD-Philipp-1999
p6738
sg12
S'PMC28296'
p6739
sasa(dp6740
g3
VCD005007 v. 5.3 Hyperbaric oxygenation for tumour sensitisation to radiotherapy.rm5
p6741
sg5
(lp6742
(dp6743
g8
V4854060.xml
p6744
sg10
VSTD-Van-Den-Brenk-1968
p6745
sg12
S'PMC2009013'
p6746
sasa(dp6747
g3
VCD001841 v. 7.0 First-line drugs for hypertension.rm5
p6748
sg5
(lp6749
(dp6750
g8
V9732338.xml
p6751
sg10
VSTD-UKPDS-39
p6752
sg12
S'PMC28660'
p6753
sa(dp6754
g8
V23704171.xml
p6755
sg10
VSTD-Carter
p6756
sg12
S'PMC3662830'
p6757
sa(dp6758
g8
V1445513.xml
p6759
sg10
VSTD-MRC_x002d_O
p6760
sg12
S'PMC1995577'
p6761
sa(dp6762
g8
V2861880.xml
p6763
sg10
VSTD-MRC_x002d_TMH
p6764
sg12
S'PMC1416260'
p6765
sasa(dp6766
g3
VCD003819 v. 4.2 Iodine supplementation for preventing iodine deficiency disorders in children.rm5
p6767
sg5
(lp6768
(dp6769
g8
V14315706.xml
p6770
sg10
VSTD-Sooch-1965
p6771
sg12
S'PMC2555234'
p6772
sasa(dp6773
g3
VCD006614 v. 4.0 Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at te.rm5
p6774
sg5
(lp6775
(dp6776
g8
V16115831.xml
p6777
sg10
VSTD-Stutchfield-2005
p6778
sg12
S'PMC1226243'
p6779
sasa(dp6780
g3
VCD006749 v. 4.2 Detoxification treatments for opiate dependent adolescents.rm5
p6781
sg5
(lp6782
(dp6783
g8
V18984887.xml
p6784
sg10
VSTD-Woody-2008
p6785
sg12
S'PMC2610690'
p6786
sasa(dp6787
g3
VCD003044 v. 7.0 Nonabsorbable disaccharides for hepatic encephalopathy.rm5
p6788
sg5
(lp6789
(dp6790
g8
V8432451.xml
p6791
sg10
VSTD-Blanc-1993-_x002d_-AHE
p6792
sg12
S'PMC1374099'
p6793
sasa(dp6794
g3
VCD002929 v. 10.0 Disposable surgical face masks for preventing surgical wound infection in clean surgery.rm5
p6795
sg5
(lp6796
(dp6797
g8
V6391343.xml
p6798
sg10
VSTD-Chamberlain-1984
p6799
sg12
S'PMC2494468'
p6800
sasa(dp6801
g3
VCD003514 v. 7.0 Bed rest with or without hospitalisation for hypertension during pregnancy.rm5
p6802
sg5
(lp6803
(dp6804
g8
V23642125.xml
p6805
sg10
VSTD-Crowther-1986
p6806
sg12
S'PMC3655914'
p6807
sasa(dp6808
g3
VCD007402 v. 4.0 Topical NSAIDs for acute pain in adults.rm5
p6809
sg5
(lp6810
(dp6811
g8
V15155436.xml
p6812
sg10
VSTD-Predel-2004
p6813
sg12
S'PMC1724805'
p6814
sa(dp6815
g8
V7804585.xml
p6816
sg10
VSTD-Campbell-1994
p6817
sg12
S'PMC1342427'
p6818
sasa(dp6819
g3
VCD007168 v. 3.0 Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.rm5
p6820
sg5
(lp6821
(dp6822
g8
V6767295.xml
p6823
sg10
VSTD-Weller-1980
p6824
sg12
S'PMC471218'
p6825
sasa(dp6826
g3
VCD005137 v. 5.0 Interventions for unilateral and bilateral refractive amblyopia.rm5
p6827
sg5
(lp6828
(dp6829
g8
V6337623.xml
p6830
sg10
VSTD-Nyman-1983
p6831
sg12
S'PMC1040004'
p6832
sa(dp6833
g8
V14644966.xml
p6834
sg10
VSTD-Clarke-2003
p6835
sg12
S'PMC286242'
p6836
sa(dp6837
g8
V17855283.xml
p6838
sg10
VSTD-Stewart-2007a
p6839
sg12
S'PMC2001048'
p6840
sa(dp6841
g8
V16751033.xml
p6842
sg10
VSTD-PEDIG-2006a
p6843
sg12
S'PMC1609192'
p6844
sa(dp6845
g8
V18789533.xml
p6846
sg10
VSTD-PEDIG-2008
p6847
sg12
S'PMC2615691'
p6848
sasa(dp6849
g3
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p6850
sg5
(lp6851
(dp6852
g8
V14645934.xml
p6853
sg10
VSTD-Brown-2003
p6854
sg12
S'PMC1766133'
p6855
sa(dp6856
g8
V17173716.xml
p6857
sg10
VSTD-Horn-2007
p6858
sg12
S'PMC1832131'
p6859
sa(dp6860
g8
V19822836.xml
p6861
sg10
VSTD-Peterson-2009
p6862
sg12
S'PMC2765261'
p6863
sa(dp6864
g8
V14645937.xml
p6865
sg10
VSTD-Robinson-2003
p6866
sg12
S'PMC1766134'
p6867
sasa(dp6868
g3
VCD001276 v. 9.0 Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronc.rm5
p6869
sg5
(lp6870
(dp6871
g8
V10193252.xml
p6872
sg10
VSTD-Yung-1998
p6873
sg12
S'PMC1717748'
p6874
sasa(dp6875
g3
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p6876
sg5
(lp6877
(dp6878
g8
V15166961.xml
p6879
sg10
VSTD-Abdalla-2004
p6880
sg12
S'PMC1356290'
p6881
sa(dp6882
g8
V20148084.xml
p6883
sg10
VSTD-McKay-2009
p6884
sg12
S'PMC2817867'
p6885
sa(dp6886
g8
V22066097.xml
p6887
sg10
VSTD-Kim-2011
p6888
sg12
S'PMC3204557'
p6889
sasa(dp6890
g3
VCD007388 v. 4.0 Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.rm5
p6891
sg5
(lp6892
(dp6893
g8
V18293201.xml
p6894
sg10
VSTD-USA-2005
p6895
sg12
S'PMC3070486'
p6896
sasa(dp6897
g3
VCD000332 v. 9.0 Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.rm5
p6898
sg5
(lp6899
(dp6900
g8
V8984939.xml
p6901
sg10
VSTD-Peeters-1996
p6902
sg12
S'PMC1010292'
p6903
sasa(dp6904
g3
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p6905
sg5
(lp6906
(dp6907
g8
V3907510.xml
p6908
sg10
VSTD-Webb-1985
p6909
sg12
S'PMC1777652'
p6910
sa(dp6911
g8
V20927359.xml
p6912
sg10
VSTD-Gajdos-2010
p6913
sg12
S'PMC2946956'
p6914
sasa(dp6915
g3
VCD001139 v. 5.0 Interventions for preventing and treating pelvic and back pain in pregnancy.rm5
p6916
sg5
(lp6917
(dp6918
g8
V15778231.xml
p6919
sg10
VSTD-Elden-2005
p6920
sg12
S'PMC555879'
p6921
sasa(dp6922
g3
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p6923
sg5
(lp6924
(dp6925
g8
V15931282.xml
p6926
sg10
VSTD-Meier-2003
p6927
sg12
S'PMC1069018'
p6928
sa(dp6929
g8
V18996930.xml
p6930
sg10
VSTD-Zeng-2008-_x0028_C_x0029_
p6931
sg12
S'PMC2577799'
p6932
sa(dp6933
g8
V5551272.xml
p6934
sg10
VSTD-Chanarin-1971
p6935
sg12
S'PMC1795515'
p6936
sa(dp6937
g8
V21439473.xml
p6938
sg10
VSTD-Butler-1968
p6939
sg12
S'PMC3076126'
p6940
sa(dp6941
g8
V12637400.xml
p6942
sg10
VSTD-Christian-2003-_x0028_C_x0029_
p6943
sg12
S'PMC151518'
p6944
sa(dp6945
g8
V14238675.xml
p6946
sg10
VSTD-Chanarin-1965
p6947
sg12
S'PMC2165857'
p6948
sasa(dp6949
g3
VCD003133 v. 10.0 Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.rm5
p6950
sg5
(lp6951
(dp6952
g8
V10398629.xml
p6953
sg10
VSTD-Lofdahl-1999
p6954
sg12
S'PMC28156'
p6955
sa(dp6956
g8
V12612295.xml
p6957
sg10
VSTD-Price-2003
p6958
sg12
S'PMC1746596'
p6959
sa(dp6960
g8
V12612294.xml
p6961
sg10
VSTD-Vaquerizo-2003
p6962
sg12
S'PMC1746619'
p6963
sasa(dp6964
g3
VCD003648 v. 8.0 Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.rm5
p6965
sg5
(lp6966
(dp6967
g8
V21177735.xml
p6968
sg10
VSTD-Humphrey-2006
p6969
sg12
S'PMC3007097'
p6970
sasa(dp6971
g3
VCD003838 v. 8.2 Diuretics for heart failure.rm5
p6972
sg5
(lp6973
(dp6974
g8
V8136670.xml
p6975
sg10
VSTD-De-Jong-1994
p6976
sg12
S'PMC2542786'
p6977
sa(dp6978
g8
V9284668.xml
p6979
sg10
VSTD-Walma-1997
p6980
sg12
S'PMC2127314'
p6981
sasa(dp6982
g3
VCD003388 v. 13.0 Psychological treatment of post-traumatic stress disorder (PTSD).rm5
p6983
sg5
(lp6984
(dp6985
g8
V12182270.xml
p6986
sg10
VSTD-Resick-2002
p6987
sg12
S'PMC2977927'
p6988
sa(dp6989
g8
V12182270.xml
p6990
sg10
VSTD-Resick-2002b
p6991
sg12
S'PMC2977927'
p6992
sasa(dp6993
g3
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p6994
sg5
(lp6995
(dp6996
g8
V20357377.xml
p6997
sg10
VSTD-Faglia-2010
p6998
sg12
S'PMC2890332'
p6999
sasa(dp7000
g3
VCD000504 v. 6.0 Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants.rm5
p7001
sg5
(lp7002
(dp7003
g8
V10634838.xml
p7004
sg10
VSTD-McClure-2000
p7005
sg12
S'PMC1721038'
p7006
sa(dp7007
g8
V15210658.xml
p7008
sg10
VSTD-van-Elburg-2004
p7009
sg12
S'PMC1721703'
p7010
sasa(dp7011
g3
VCD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
p7012
sg5
(lp7013
(dp7014
g8
V21540202.xml
p7015
sg10
VSTD-Hewlett-1999
p7016
sg12
S'PMC3086034'
p7017
sa(dp7018
g8
V11502614.xml
p7019
sg10
VSTD-Hill-2001
p7020
sg12
S'PMC1753835'
p7021
sasa(dp7022
g3
VCD001872 v. 6.15 Interventions for treating obesity in children.rm5
p7023
sg5
(lp7024
(dp7025
g8
V17481469.xml
p7026
sg10
VSTD-Berry-2007
p7027
sg12
S'PMC1945054'
p7028
sa(dp7029
g8
V16188958.xml
p7030
sg10
VSTD-Jiang-2005
p7031
sg12
S'PMC1720215'
p7032
sa(dp7033
g8
V10519718.xml
p7034
sg10
VSTD-Schwingshandl-1999
p7035
sg12
S'PMC1718135'
p7036
sa(dp7037
g8
V18239639.xml
p7038
sg10
VSTD-Epstein-2008a
p7039
sg12
S'PMC2408744'
p7040
sasa(dp7041
g3
VCD004531 v. 5.0 Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.rm5
p7042
sg5
(lp7043
(dp7044
g8
V8131255.xml
p7045
sg10
VSTD-Karbwang-1994
p7046
sg12
S'PMC2486514'
p7047
sasa(dp7048
g3
VCD006832 v. 2.2 Interventions for preventing critical illness polyneuropathy and critical illness myopathy.rm5
p7049
sg5
(lp7050
(dp7051
g8
V9339943.xml
p7052
sg10
VSTD-Watters-1997
p7053
sg12
S'PMC1191041'
p7054
sasa(dp7055
g3
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p7056
sg5
(lp7057
(dp7058
g8
V8761382.xml
p7059
sg10
VSTD-MRC-LU11
p7060
sg12
S'PMC2074683'
p7061
sasa(dp7062
g3
VCD005573 v. 4.0 Probiotics for induction of remission in ulcerative colitis.rm5
p7063
sg5
(lp7064
(dp7065
g8
V15647189.xml
p7066
sg10
VSTD-Furrie-2005
p7067
sg12
S'PMC1774839'
p7068
sasa(dp7069
g3
VCD001271 v. 4.4 Substitution of doctors by nurses in primary care.rm5
p7070
sg5
(lp7071
(dp7072
g8
V10764367.xml
p7073
sg10
VSTD-Venning-2000
p7074
sg12
S'PMC27348'
p7075
sa(dp7076
g8
V10764366.xml
p7077
sg10
VSTD-Kinnersley-2000
p7078
sg12
S'PMC27347'
p7079
sa(dp7080
g8
V11387182.xml
p7081
sg10
VSTD-Moher-2001
p7082
sg12
S'PMC32168'
p7083
sa(dp7084
g8
V10764365.xml
p7085
sg10
VSTD-Shum-2000
p7086
sg12
S'PMC27346'
p7087
sa(dp7088
g8
V9774295.xml
p7089
sg10
VSTD-Lattimer-1998
p7090
sg12
S'PMC28690'
p7091
sa(dp7092
g8
V4829073.xml
p7093
sg10
VSTD-Flynn-1974
p7094
sg12
S'PMC1775498'
p7095
sa(dp7096
g8
V9386883.xml
p7097
sg10
VSTD-McIntosh-1997
p7098
sg12
S'PMC2255191'
p7099
sasa(dp7100
g3
VCD008327 v. 1.0 Interventions for bone disease in children with chronic kidney disease.rm5
p7101
sg5
(lp7102
(dp7103
g8
V6357106.xml
p7104
sg10
VSTD-Eke-1983
p7105
sg12
S'PMC1628291'
p7106
sa(dp7107
g8
V3928054.xml
p7108
sg10
VSTD-Mak-1985
p7109
sg12
S'PMC1417527'
p7110
sasa(dp7111
g3
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p7112
sg5
(lp7113
(dp7114
g8
V11747326.xml
p7115
sg10
VSTD-Faithfull-2001
p7116
sg12
S'PMC2364007'
p7117
sasa(dp7118
g3
VCD005593 v. 9.0 Cholinesterase inhibitors for Alzheimer's disease.rm5
p7119
sg5
(lp7120
(dp7121
g8
V11110737.xml
p7122
sg10
VSTD-GAL_x002d_INT_x002d_1-Wilcock
p7123
sg12
S'PMC27547'
p7124
sasa(dp7125
g3
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p7126
sg5
(lp7127
(dp7128
g8
V17372669.xml
p7129
sg10
VSTD-de-Vries-2007a
p7130
sg12
S'PMC1913177'
p7131
sa(dp7132
g8
V15383785.xml
p7133
sg10
VSTD-Burger-2004
p7134
sg12
S'PMC1356459'
p7135
sasa(dp7136
g3
VCD008238 v. 3.0 Colony-stimulating factors for prevention and treatment of infectious complications in patients with.rm5
p7137
sg5
(lp7138
(dp7139
g8
V15761020.xml
p7140
sg10
VSTD-Amadori-2005
p7141
sg12
S'PMC1895135'
p7142
sasa(dp7143
g3
VCD009243 v. 3.0 Antispasmodics for labour.rm5
p7144
sg5
(lp7145
(dp7146
g8
V23515202.xml
p7147
sg10
VSTD-Sekhavat-2012
p7148
sg12
S'PMC3598277'
p7149
sa(dp7150
g8
V21495198.xml
p7151
sg10
VSTD-Makvandi-2010
p7152
sg12
S'PMC3081214'
p7153
sasa(dp7154
g3
VCD004148 v. 10.0 Effectiveness of brief alcohol interventions in primary care populations.rm5
p7155
sg5
(lp7156
(dp7157
g8
V3052668.xml
p7158
sg10
VSTD-Wallace-1988
p7159
sg12
S'PMC1834369'
p7160
sa(dp7161
g8
V3448228.xml
p7162
sg10
VSTD-Heather-1987
p7163
sg12
S'PMC1711039'
p7164
sa(dp7165
g8
V9386883.xml
p7166
sg10
VSTD-McIntosh-1997
p7167
sg12
S'PMC2255191'
p7168
sa(dp7169
g8
V10522717.xml
p7170
sg10
VSTD-Gentillelo-1999
p7171
sg12
S'PMC1420896'
p7172
sasa(dp7173
g3
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p7174
sg5
(lp7175
(dp7176
g8
V17497466.xml
p7177
sg10
VSTD-Horita-2007
p7178
sg12
S'PMC2409178'
p7179
sasa(dp7180
g3
VCD000089 v. 11.0 Family therapy for asthma in children.rm5
p7181
sg5
(lp7182
(dp7183
g8
V373642.xml
p7184
sg10
VSTD-Lask-1979
p7185
sg12
S'PMC1545376'
p7186
sasa(dp7187
g3
VCD002827 v. 10.0 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropat.rm5
p7188
sg5
(lp7189
(dp7190
g8
V9221964.xml
p7191
sg10
VSTD-Mariette-1997
p7192
sg12
S'PMC2169620'
p7193
sa(dp7194
g8
V10960293.xml
p7195
sg10
VSTD-Mariette-2000
p7196
sg12
S'PMC1737051'
p7197
sa(dp7198
g8
V7673949.xml
p7199
sg10
VSTD-Oksenhendler-1995
p7200
sg12
S'PMC486020'
p7201
sasa(dp7202
g3
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p7203
sg5
(lp7204
(dp7205
g8
V22427772.xml
p7206
sg10
VSTD-Soltanian-2010
p7207
sg12
S'PMC3302710'
p7208
sa(dp7209
g8
V22454655.xml
p7210
sg10
VSTD-Wang-2012
p7211
sg12
S'PMC3292236'
p7212
sa(dp7213
g8
V10911825.xml
p7214
sg10
VSTD-Randall-2000
p7215
sg12
S'PMC1298033'
p7216
sasa(dp7217
g3
VCD007575 v. 2.0 Interventions for nausea and vomiting in early pregnancy.rm5
p7218
sg5
(lp7219
(dp7220
g8
V4937061.xml
p7221
sg10
VSTD-McGuiness-1971
p7222
sg12
S'PMC2156454'
p7223
sasa(dp7224
g3
VCD001905 v. 10.0 Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in childr.rm5
p7225
sg5
(lp7226
(dp7227
g8
V10884257.xml
p7228
sg10
VSTD-Lahat-2000
p7229
sg12
S'PMC27427'
p7230
sasa(dp7231
g3
VCD000345 v. 7.0 Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for .rm5
p7232
sg5
(lp7233
(dp7234
g8
V8314497.xml
p7235
sg10
VSTD-Perez-1993
p7236
sg12
S'PMC1374020'
p7237
sasa(dp7238
g3
VCD002067 v. 10.0 Single dose oral aspirin for acute postoperative pain in adults.rm5
p7239
sg5
(lp7240
(dp7241
g8
V3190996.xml
p7242
sg10
VSTD-Holland-1988
p7243
sg12
S'PMC1386569'
p7244
sa(dp7245
g8
V1576068.xml
p7246
sg10
VSTD-Seymour-1992
p7247
sg12
S'PMC1381328'
p7248
sa(dp7249
g8
V2934008.xml
p7250
sg10
VSTD-Nelson-1985
p7251
sg12
S'PMC2148530'
p7252
sa(dp7253
g8
V4891424.xml
p7254
sg10
VSTD-Parkhouse-1969
p7255
sg12
S'PMC1946013'
p7256
sasa(dp7257
g3
VCD006564 v. 4.0 Dopamine agonist therapy in early Parkinson's disease.rm5
p7258
sg5
(lp7259
(dp7260
g8
V10449550.xml
p7261
sg10
VSTD-Sydney
p7262
sg12
S'PMC1736543'
p7263
sasa(dp7264
g3
VCD001768 v. 9.0 Follow-up strategies for women treated for early breast cancer.rm5
p7265
sg5
(lp7266
(dp7267
g8
V8811760.xml
p7268
sg10
VSTD-Grunfeld
p7269
sg12
S'PMC2351993'
p7270
sa(dp7271
g8
V9022429.xml
p7272
sg10
VSTD-Gulliford
p7273
sg12
S'PMC2125684'
p7274
sasa(dp7275
g3
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p7276
sg5
(lp7277
(dp7278
g8
V1807303.xml
p7279
sg10
VSTD-Lagro_x002d_Janssen-1991
p7280
sg12
S'PMC1371786'
p7281
sa(dp7282
g8
V10024253.xml
p7283
sg10
VSTD-B_x00f8_-1999
p7284
sg12
S'PMC27740'
p7285
sa(dp7286
g8
V18719756.xml
p7287
sg10
VSTD-Castro-2008
p7288
sg12
S'PMC2664121'
p7289
sasa(dp7290
g3
VCD003393 v. 6.0 Oestrogens alone or with amniotomy for cervical ripening or induction of labour.rm5
p7291
sg5
(lp7292
(dp7293
g8
V14033615.xml
p7294
sg10
VSTD-Klopper-1962
p7295
sg12
S'PMC1926558'
p7296
sa(dp7297
g8
V6781613.xml
p7298
sg10
VSTD-Tromans-1981
p7299
sg12
S'PMC1504503'
p7300
sasa(dp7301
g3
VCD008285 v. 2.0 Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer individual patien.rm5
p7302
sg5
(lp7303
(dp7304
g8
V22815624.xml
p7305
sg10
VSTD-Pras-1995
p7306
sg12
S'PMC3399783'
p7307
sasa(dp7308
g3
VCD006483 v. 3.8 Interactive computer-based interventions for sexual health promotion.rm5
p7309
sg5
(lp7310
(dp7311
g8
V16849391.xml
p7312
sg10
VSTD-Bowen-2007
p7313
sg12
S'PMC2639555'
p7314
sa(dp7315
g8
V15193576.xml
p7316
sg10
VSTD-Di-Noia-2004
p7317
sg12
S'PMC1524876'
p7318
sasa(dp7319
g3
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p7320
sg5
(lp7321
(dp7322
g8
V19066370.xml
p7323
sg10
VSTD-SELECT-2009
p7324
sg12
S'PMC3682779'
p7325
sa(dp7326
g8
V3918611.xml
p7327
sg10
VSTD-Salonen-1985
p7328
sg12
S'PMC1417771'
p7329
sa(dp7330
g8
V19531680.xml
p7331
sg10
VSTD-Epplein-2009
p7332
sg12
S'PMC2755047'
p7333
sa(dp7334
g8
V17209198.xml
p7335
sg10
VSTD-Peters-2007
p7336
sg12
S'PMC1839923'
p7337
sa(dp7338
g8
V16175184.xml
p7339
sg10
VSTD-Michaud-2005
p7340
sg12
S'PMC2361644'
p7341
sa(dp7342
g8
V18444134.xml
p7343
sg10
VSTD-Dong-2008
p7344
sg12
S'PMC2366201'
p7345
sa(dp7346
g8
V19687417.xml
p7347
sg10
VSTD-Peters-2008
p7348
sg12
S'PMC2729504'
p7349
sa(dp7350
g8
V3366933.xml
p7351
sg10
VSTD-Ringstad-1988
p7352
sg12
S'PMC1141475'
p7353
sasa(dp7354
g3
VCD002902 v. 9.0 Psychological interventions for coronary heart disease.rm5
p7355
sg5
(lp7356
(dp7357
g8
V8978226.xml
p7358
sg10
VSTD-Jones-1996
p7359
sg12
S'PMC2353074'
p7360
sa(dp7361
g8
V16423095.xml
p7362
sg10
VSTD-McLaughlin-2005
p7363
sg12
S'PMC1490273'
p7364
sasa(dp7365
g3
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p7366
sg5
(lp7367
(dp7368
g8
V8653819.xml
p7369
sg10
VSTD-aa-Rudenko-1996a
p7370
sg12
S'PMC2486837'
p7371
sa(dp7372
g8
V22110695.xml
p7373
sg10
VSTD-ba-Kissling-2011
p7374
sg12
S'PMC3216983'
p7375
sa(dp7376
g8
V21379316.xml
p7377
sg10
VSTD-ba-Valenciano-2011
p7378
sg12
S'PMC3019108'
p7379
sa(dp7380
g8
V15499051.xml
p7381
sg10
VSTD-aa-Principi-2003
p7382
sg12
S'PMC1719733'
p7383
sa(dp7384
g8
V18977968.xml
p7385
sg10
VSTD-ba-Eisenberg-2008a
p7386
sg12
S'PMC3695734'
p7387
sa(dp7388
g8
V18977968.xml
p7389
sg10
VSTD-ba-Eisenberg-2008b
p7390
sg12
S'PMC3695734'
p7391
sa(dp7392
g8
V21060780.xml
p7393
sg10
VSTD-ab-Mallory-2010
p7394
sg12
S'PMC2966412'
p7395
sasa(dp7396
g3
VCD005419 v. 4.0 Interventions for previously untreated patients with AIDS-associated Non-Hodgkins Lymphoma.rm5
p7397
sg5
(lp7398
(dp7399
g8
V15914552.xml
p7400
sg10
VSTD-AMCT_x002d_010--2005
p7401
sg12
S'PMC1895225'
p7402
sasa(dp7403
g3
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p7404
sg5
(lp7405
(dp7406
g8
V3103764.xml
p7407
sg10
VSTD-Macaulay-1988
p7408
sg12
S'PMC1245577'
p7409
sa(dp7410
g8
V17179687.xml
p7411
sg10
VSTD-Song-2006
p7412
sg12
S'PMC2721929'
p7413
sa(dp7414
g8
V18324952.xml
p7415
sg10
VSTD-Chancellor-2008
p7416
sg12
S'PMC2325270'
p7417
sa(dp7418
g8
V18678843.xml
p7419
sg10
VSTD-Burgio-2008
p7420
sg12
S'PMC3201984'
p7421
sasa(dp7422
g3
VCD003316 v. 6.0 Physical fitness training for stroke patients.rm5
p7423
sg5
(lp7424
(dp7425
g8
V17903837.xml
p7426
sg10
VSTD-Kim-2001
p7427
sg12
S'PMC3349651'
p7428
sasa(dp7429
g3
VCD003873 v. 5.0 Interventions for growth failure in childhood Crohn's disease.rm5
p7430
sg5
(lp7431
(dp7432
g8
V3548602.xml
p7433
sg10
VSTD-Sanderson-1987
p7434
sg12
S'PMC1778272'
p7435
sasa(dp7436
g3
VCD004602 v. 6.3 Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.rm5
p7437
sg5
(lp7438
(dp7439
g8
V8799525.xml
p7440
sg10
VSTD-Seymour-1996
p7441
sg12
S'PMC2042618'
p7442
sa(dp7443
g8
V3461725.xml
p7444
sg10
VSTD-Cooper-1986
p7445
sg12
S'PMC2175476'
p7446
sasa(dp7447
g3
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p7448
sg5
(lp7449
(dp7450
g8
V16372905.xml
p7451
sg10
VSTD-Bautmans-2005
p7452
sg12
S'PMC1368976'
p7453
sa(dp7454
g8
V18845605.xml
p7455
sg10
VSTD-Kerse-2008
p7456
sg12
S'PMC2565754'
p7457
sa(dp7458
g8
V19723707.xml
p7459
sg10
VSTD-Sackley-2009
p7460
sg12
S'PMC2736373'
p7461
sa(dp7462
g8
V21432349.xml
p7463
sg10
VSTD-Makita-2006
p7464
sg12
S'PMC2723343'
p7465
sa(dp7466
g8
V11186596.xml
p7467
sg10
VSTD-Tappen-2000
p7468
sg12
S'PMC1950269'
p7469
sa(dp7470
g8
V15233841.xml
p7471
sg10
VSTD-Chin-A-Paw-2004
p7472
sg12
S'PMC471553'
p7473
sa(dp7474
g8
V8184127.xml
p7475
sg10
VSTD-Tappen-1994
p7476
sg12
S'PMC1952655'
p7477
sasa(dp7478
g3
VCD007340 v. 3.0 Bariatric surgery for non-alcoholic steatohepatitis in obese patients.rm5
p7479
sg5
(lp7480
(dp7481
g8
V16192822.xml
p7482
sg10
VSTD-Mattar-2005
p7483
sg12
S'PMC1402345'
p7484
sasa(dp7485
g3
VCD006291 v. 4.0 Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgery.rm5
p7486
sg5
(lp7487
(dp7488
g8
V9215056.xml
p7489
sg10
VSTD-Chittenden-1997
p7490
sg12
S'PMC1722170'
p7491
sa(dp7492
g8
V15722306.xml
p7493
sg10
VSTD-R_x00fc_schen-2005
p7494
sg12
S'PMC1772574'
p7495
sasa(dp7496
g3
VCD001190 v. 14.0 Donepezil for dementia due to Alzheimer's disease.rm5
p7497
sg5
(lp7498
(dp7499
g8
V21455360.xml
p7500
sg10
VSTD-Study-315
p7501
sg12
S'PMC2962290'
p7502
sasa(dp7503
g3
VCD004379 v. 5.4 Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertil.rm5
p7504
sg5
(lp7505
(dp7506
g8
V18008156.xml
p7507
sg10
VSTD-Kucuk-2007
p7508
sg12
S'PMC3454992'
p7509
sasa(dp7510
g3
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p7511
sg5
(lp7512
(dp7513
g8
V8664133.xml
p7514
sg10
VSTD-Gebbia-1996
p7515
sg12
S'PMC2074540'
p7516
sasa(dp7517
g3
VCD005189 v. 11.0 Antibiotics for bronchiolitis in children.rm5
p7518
sg5
(lp7519
(dp7520
g8
V5323069.xml
p7521
sg10
VSTD-Field-1966
p7522
sg12
S'PMC1843176'
p7523
sasa(dp7524
g3
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p7525
sg5
(lp7526
(dp7527
g8
V21189872.xml
p7528
sg10
VSTD-Subrahmanyam-1996a
p7529
sg12
S'PMC2991644'
p7530
sa(dp7531
g8
V20640210.xml
p7532
sg10
VSTD-Subrahmanyam-1996c
p7533
sg12
S'PMC2894501'
p7534
sa(dp7535
g8
V17466071.xml
p7536
sg10
VSTD-Nilforoushzadeh-2007
p7537
sg12
S'PMC1891315'
p7538
sa(dp7539
g8
V20368852.xml
p7540
sg10
VSTD-Baghel-2009
p7541
sg12
S'PMC2845359'
p7542
sa(dp7543
g8
V20640210.xml
p7544
sg10
VSTD-Subrahmanyam-1993b
p7545
sg12
S'PMC2894501'
p7546
sasa(dp7547
g3
VCD001030 v. 11.2 Carbamazepine versus valproate monotherapy for epilepsy.rm5
p7548
sg5
(lp7549
(dp7550
g8
V8006647.xml
p7551
sg10
VSTD-Richens-1994
p7552
sg12
S'PMC1072969'
p7553
sa(dp7554
g8
V3928820.xml
p7555
sg10
VSTD-Callaghan-1985
p7556
sg12
S'PMC1028404'
p7557
sa(dp7558
g8
V7823066.xml
p7559
sg10
VSTD-Heller-1995
p7560
sg12
S'PMC1073267'
p7561
sasa(dp7562
g3
VCD001146 v. 8.0 Early ( 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.rm5
p7563
sg5
(lp7564
(dp7565
g8
V8984701.xml
p7566
sg10
VSTD-Wang-1996
p7567
sg12
S'PMC472613'
p7568
sa(dp7569
g8
V9462187.xml
p7570
sg10
VSTD-Subhedar-1997
p7571
sg12
S'PMC1720712'
p7572
sa(dp7573
g8
V8653433.xml
p7574
sg10
VSTD-Shinwell-1996
p7575
sg12
S'PMC2528319'
p7576
sasa(dp7577
g3
VCD010257 v. 1.2 Antibiotics for exacerbations of chronic obstructive pulmonary disease.rm5
p7578
sg5
(lp7579
(dp7580
g8
V13479695.xml
p7581
sg10
VSTD-Elmes-1957
p7582
sg12
S'PMC1963159'
p7583
sa(dp7584
g8
V7570411.xml
p7585
sg10
VSTD-Sachs-1995
p7586
sg12
S'PMC474649'
p7587
sa(dp7588
g8
V4872151.xml
p7589
sg10
VSTD-Pines-1968
p7590
sg12
S'PMC1991661'
p7591
sasa(dp7592
g3
VCD005031 v. 13.0 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificat.rm5
p7593
sg5
(lp7594
(dp7595
g8
V6725168.xml
p7596
sg10
VSTD-McCaul-1984
p7597
sg12
S'PMC1307916'
p7598
sa(dp7599
g8
V21277704.xml
p7600
sg10
VSTD-Katz-2011
p7601
sg12
S'PMC3090541'
p7602
sa(dp7603
g8
V19586142.xml
p7604
sg10
VSTD-Campbell-2009
p7605
sg12
S'PMC2779725'
p7606
sasa(dp7607
g3
VCD001332 v. 6.0 Anti-spasticity agents for multiple sclerosis.rm5
p7608
sg5
(lp7609
(dp7610
g8
V778344.xml
p7611
sg10
VSTD-Schmidt-1975
p7612
sg12
S'PMC492284'
p7613
sa(dp7614
g8
V10811692.xml
p7615
sg10
VSTD-Hyman-2000
p7616
sg12
S'PMC1736956'
p7617
sasa(dp7618
g3
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p7619
sg5
(lp7620
(dp7621
g8
V3907687.xml
p7622
sg10
VSTD-a01-MRC-LU02
p7623
sg12
S'PMC1977284'
p7624
sa(dp7625
g8
V7281085.xml
p7626
sg10
VSTD-c11-Gwent-1
p7627
sg12
S'PMC471474'
p7628
sa(dp7629
g8
V1691921.xml
p7630
sg10
VSTD-d04-RLW-8351
p7631
sg12
S'PMC1971367'
p7632
sa(dp7633
g8
V1691921.xml
p7634
sg10
VSTD-d06-Southampton
p7635
sg12
S'PMC1971367'
p7636
sasa(dp7637
g3
VCD004290 v. 8.0 Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in ki.rm5
p7638
sg5
(lp7639
(dp7640
g8
V17555465.xml
p7641
sg10
VSTD-Pescovitz-2004
p7642
sg12
S'PMC2198786'
p7643
sasa(dp7644
g3
VCD001167 v. 5.2 Antimicrobials for treating symptomatic non-typhoidal Salmonella infection.rm5
p7645
sg5
(lp7646
(dp7647
g8
V13159368.xml
p7648
sg10
VSTD-Macdonald-1954
p7649
sg12
S'PMC2011610'
p7650
sasa(dp7651
g3
VCD002901 v. 10.0 Digitalis for treatment of heart failure in patients in sinus rhythm.rm5
p7652
sg5
(lp7653
(dp7654
g8
V2503017.xml
p7655
sg10
VSTD-Pugh-1989
p7656
sg12
S'PMC1216711'
p7657
sasa(dp7658
g3
VCD004976 v. 8.5 Oral antihistamine-decongestant-analgesic combinations for the common cold.rm5
p7659
sg5
(lp7660
(dp7661
g8
V6996784.xml
p7662
sg10
VSTD-Bye-1980
p7663
sg12
S'PMC1713673'
p7664
sa(dp7665
g8
V2557947.xml
p7666
sg10
VSTD-Sperber-1989
p7667
sg12
S'PMC1807791'
p7668
sasa(dp7669
g3
VCD005259 v. 6.0 Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.rm5
p7670
sg5
(lp7671
(dp7672
g8
V21842298.xml
p7673
sg10
VSTD-Canata-2003
p7674
sg12
S'PMC3270172'
p7675
sasa(dp7676
g3
VCD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
p7677
sg5
(lp7678
(dp7679
g8
V19487381.xml
p7680
sg10
VSTD-Motzer_x0028_1_x0029_-2010
p7681
sg12
S'PMC3646307'
p7682
sa(dp7683
g8
V18936475.xml
p7684
sg10
VSTD-Rini-2010
p7685
sg12
S'PMC2651074'
p7686
sa(dp7687
g8
V12890841.xml
p7688
sg10
VSTD-Yang-2003
p7689
sg12
S'PMC2275324'
p7690
sa(dp7691
g8
V14562010.xml
p7692
sg10
VSTD-Madhusudan-2004
p7693
sg12
S'PMC2394342'
p7694
sasa(dp7695
g3
VCD006625 v. 3.0 Quetiapine versus other atypical antipsychotics for schizophrenia.rm5
p7696
sg5
(lp7697
(dp7698
g8
V23869281.xml
p7699
sg10
VSTD-Li-2003
p7700
sg12
S'PMC3707322'
p7701
sasa(dp7702
g3
VCD000329 v. 7.0 Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.rm5
p7703
sg5
(lp7704
(dp7705
g8
V7772106.xml
p7706
sg10
VSTD-Pinion-1994
p7707
sg12
S'PMC2541307'
p7708
sa(dp7709
g8
V1760601.xml
p7710
sg10
VSTD-Gannon-1991
p7711
sg12
S'PMC1671634'
p7712
sasa(dp7713
g3
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p7714
sg5
(lp7715
(dp7716
g8
V21385466.xml
p7717
sg10
VSTD-Rosenfeldt-2011
p7718
sg12
S'PMC3063826'
p7719
sasa(dp7720
g3
VCD009078 v. 3.2 Topical cyclosporine for atopic keratoconjunctivitis.rm5
p7721
sg5
(lp7722
(dp7723
g8
V16547328.xml
p7724
sg10
VSTD-Daniell-2006
p7725
sg12
S'PMC1857014'
p7726
sasa(dp7727
g3
VCD003286 v. 4.0 Specialist nurses in diabetes mellitus.rm5
p7728
sg5
(lp7729
(dp7730
g8
V10551191.xml
p7731
sg10
VSTD-Thompson-1999
p7732
sg12
S'PMC1230704'
p7733
sasa(dp7734
g3
VCD003493 v. 10.0 Transcranial magnetic stimulation for treating depression.rm5
p7735
sg5
(lp7736
(dp7737
g8
V11561046.xml
p7738
sg10
VSTD-Garc_x00ed_a_x002d_Toro-2001-c
p7739
sg12
S'PMC1763496'
p7740
sasa(dp7741
g3
VCD003439 v. 6.5 Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.rm5
p7742
sg5
(lp7743
(dp7744
g8
V19413793.xml
p7745
sg10
VSTD-Sargent-2009a
p7746
sg12
S'PMC3719160'
p7747
sa(dp7748
g8
V17600271.xml
p7749
sg10
VSTD-Gilpin-2007
p7750
sg12
S'PMC1931446'
p7751
sa(dp7752
g8
V8761227.xml
p7753
sg10
VSTD-While-1996
p7754
sg12
S'PMC2351819'
p7755
sa(dp7756
g8
V10705860.xml
p7757
sg10
VSTD-Biener-2000
p7758
sg12
S'PMC1446173'
p7759
sa(dp7760
g8
V20643725.xml
p7761
sg10
VSTD-Henriksen-2010
p7762
sg12
S'PMC3046636'
p7763
sa(dp7764
g8
V18948391.xml
p7765
sg10
VSTD-Sargent-2009b
p7766
sg12
S'PMC2707779'
p7767
sasa(dp7768
g3
VCD006375 v. 4.6 Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women.rm5
p7769
sg5
(lp7770
(dp7771
g8
V12114234.xml
p7772
sg10
VSTD-Ward-2002
p7773
sg12
S'PMC117136'
p7774
sasa(dp7775
g3
VCD004437 v. 6.0 Thrombolytic therapy for pulmonary embolism.rm5
p7776
sg5
(lp7777
(dp7778
g8
V4594580.xml
p7779
sg10
VSTD-Tibbutt-1974
p7780
sg12
S'PMC1633603'
p7781
sasa(dp7782
g3
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p7783
sg5
(lp7784
(dp7785
g8
V9328156.xml
p7786
sg10
VSTD-Kylmala-1997
p7787
sg12
S'PMC2228066'
p7788
sasa(dp7789
g3
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p7790
sg5
(lp7791
(dp7792
g8
V17887990.xml
p7793
sg10
VSTD-Morice-2007
p7794
sg12
S'PMC2228375'
p7795
sa(dp7796
g8
V12200524.xml
p7797
sg10
VSTD-Price-2002
p7798
sg12
S'PMC1746437'
p7799
sasa(dp7800
g3
VCD006443 v. 3.0 Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.rm5
p7801
sg5
(lp7802
(dp7803
g8
V1353742.xml
p7804
sg10
VSTD-Hawthorne-1992
p7805
sg12
S'PMC1379405'
p7806
sasa(dp7807
g3
VCD007440 v. 6.0 Single dose oral diflunisal for acute postoperative pain in adults.rm5
p7808
sg5
(lp7809
(dp7810
g8
V2490035.xml
p7811
sg10
VSTD-Lindenmuth-1989
p7812
sg12
S'PMC2190635'
p7813
sasa(dp7814
g3
VCD001263 v. 8.2 Interventions for treating melioidosis.rm5
p7815
sg5
(lp7816
(dp7817
g8
V16189075.xml
p7818
sg10
VSTD-Chaowagul-2005
p7819
sg12
S'PMC1251512'
p7820
sa(dp7821
g8
V1590682.xml
p7822
sg10
VSTD-Sookpranee-1992
p7823
sg12
S'PMC189245'
p7824
sasa(dp7825
g3
VCD007223 v. 4.0 Medical treatments for incomplete miscarriage.rm5
p7826
sg5
(lp7827
(dp7828
g8
V16707509.xml
p7829
sg10
VSTD-Trinder-2006
p7830
sg12
S'PMC1471967'
p7831
sasa(dp7832
g3
VCD004180 v. 5.0 Telephone consultation and triage effects on health care use and patient satisfaction.rm5
p7833
sg5
(lp7834
(dp7835
g8
V12446539.xml
p7836
sg10
VSTD-Richards-2002
p7837
sg12
S'PMC135495'
p7838
sa(dp7839
g8
V12014537.xml
p7840
sg10
VSTD-Jiwa-2002
p7841
sg12
S'PMC1314295'
p7842
sa(dp7843
g8
V11942448.xml
p7844
sg10
VSTD-McKinstry-2002
p7845
sg12
S'PMC1314272'
p7846
sa(dp7847
g8
V10574857.xml
p7848
sg10
VSTD-Thompson-1999
p7849
sg12
S'PMC28285'
p7850
sa(dp7851
g8
V9774295.xml
p7852
sg10
VSTD-Lattimer-1998
p7853
sg12
S'PMC28690'
p7854
sasa(dp7855
g3
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p7856
sg5
(lp7857
(dp7858
g8
V18299546.xml
p7859
sg10
VSTD-Majumdar-2008
p7860
sg12
S'PMC2244663'
p7861
sa(dp7862
g8
V12051212.xml
p7863
sg10
VSTD-Hollingworth-2002
p7864
sg12
S'PMC1314323'
p7865
sa(dp7866
g8
V8204331.xml
p7867
sg10
VSTD-Oakeshott-1994
p7868
sg12
S'PMC1238864'
p7869
sa(dp7870
g8
V14965404.xml
p7871
sg10
VSTD-Dey-2004
p7872
sg12
S'PMC1314775'
p7873
sa(dp7874
g8
V14521638.xml
p7875
sg10
VSTD-Schectman-2003
p7876
sg12
S'PMC1494929'
p7877
sa(dp7878
g8
V17356969.xml
p7879
sg10
VSTD-Solomon-2007a
p7880
sg12
S'PMC1824772'
p7881
sa(dp7882
g8
V17356966.xml
p7883
sg10
VSTD-Lafata-2007
p7884
sg12
S'PMC1824751'
p7885
sasa(dp7886
g3
VCD001541 v. 9.0 Interventions for ingrowing toenails.rm5
p7887
sg5
(lp7888
(dp7889
g8
V466336.xml
p7890
sg10
VSTD-Wallace-1979b
p7891
sg12
S'PMC1595877'
p7892
sa(dp7893
g8
V3416165.xml
p7894
sg10
VSTD-Sykes-1988c
p7895
sg12
S'PMC1834063'
p7896
sa(dp7897
g8
V3416165.xml
p7898
sg10
VSTD-Sykes-1988b
p7899
sg12
S'PMC1834063'
p7900
sasa(dp7901
g3
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p7902
sg5
(lp7903
(dp7904
g8
V17897478.xml
p7905
sg10
VSTD-Pavord-2007
p7906
sg12
S'PMC2174463'
p7907
sa(dp7908
g8
V14563743.xml
p7909
sg10
VSTD-Bjermer-2003
p7910
sg12
S'PMC218809'
p7911
sa(dp7912
g8
V20197425.xml
p7913
sg10
VSTD-Lemanske-2010
p7914
sg12
S'PMC2989902'
p7915
sasa(dp7916
g3
VCD001021 v. 12.0 Inhaled antibiotics for long-term therapy in cystic fibrosis.rm5
p7917
sg5
(lp7918
(dp7919
g8
V18716688.xml
p7920
sg10
VSTD-Nikolaizik-2008
p7921
sg12
S'PMC2679548'
p7922
sa(dp7923
g8
V18658109.xml
p7924
sg10
VSTD-McCoy-2008
p7925
sg12
S'PMC2577727'
p7926
sasa(dp7927
g3
VCD006888 v. 4.0 Ginkgo biloba for intermittent claudication.rm5
p7928
sg5
(lp7929
(dp7930
g8
V18628657.xml
p7931
sg10
VSTD-Gardner-2008
p7932
sg12
S'PMC2748261'
p7933
sasa(dp7934
g3
VCD005308 v. 8.0 Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea.rm5
p7935
sg5
(lp7936
(dp7937
g8
V9741373.xml
p7938
sg10
VSTD-Mortimore-1998
p7939
sg12
S'PMC1745186'
p7940
sasa(dp7941
g3
VCD007458 v. 2.3 Mobile phone messaging reminders for attendance at healthcare appointments.rm5
p7942
sg5
(lp7943
(dp7944
g8
V18196610.xml
p7945
sg10
VSTD-Chen-2008
p7946
sg12
S'PMC2170466'
p7947
sasa(dp7948
g3
VCD008037 v. 5.0 Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.rm5
p7949
sg5
(lp7950
(dp7951
g8
V11120904.xml
p7952
sg10
VSTD-Renner-2001
p7953
sg12
S'PMC1745899'
p7954
sasa(dp7955
g3
VCD007720 v. 6.3 Corticosteroids for pneumonia.rm5
p7956
sg5
(lp7957
(dp7958
g8
V12728156.xml
p7959
sg10
VSTD-van-Woensel-2003
p7960
sg12
S'PMC1746666'
p7961
sa(dp7962
g8
V4404939.xml
p7963
sg10
VSTD-McHardy-1972
p7964
sg12
S'PMC1786783'
p7965
sasa(dp7966
g3
VCD002025 v. 13.0 Buprenorphine for the management of opioid withdrawal.rm5
p7967
sg5
(lp7968
(dp7969
g8
V16042639.xml
p7970
sg10
VSTD-Ling-2005
p7971
sg12
S'PMC1480367'
p7972
sasa(dp7973
g3
VCD002225 v. 7.0 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.rm5
p7974
sg5
(lp7975
(dp7976
g8
V22815624.xml
p7977
sg10
VSTD-Pras-2000
p7978
sg12
S'PMC3399783'
p7979
sasa(dp7980
g3
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p7981
sg5
(lp7982
(dp7983
g8
V10492742.xml
p7984
sg10
VSTD-Petticrew-1999
p7985
sg12
S'PMC1756922'
p7986
sa(dp7987
g8
V21324139.xml
p7988
sg10
VSTD-Todd-1997
p7989
sg12
S'PMC3055815'
p7990
sa(dp7991
g8
V11087295.xml
p7992
sg10
VSTD-Riordan-2000
p7993
sg12
S'PMC1718573'
p7994
sa(dp7995
g8
V11444234.xml
p7996
sg10
VSTD-Sanders-2001
p7997
sg12
S'PMC1728360'
p7998
sa(dp7999
g8
V11978183.xml
p8000
sg10
VSTD-Timmer-2002
p8001
sg12
S'PMC115863'
p8002
sasa(dp8003
g3
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p8004
sg5
(lp8005
(dp8006
g8
V16043680.xml
p8007
sg10
VSTD-Aloia-2005
p8008
sg12
S'PMC1464166'
p8009
sa(dp8010
g8
V16183652.xml
p8011
sg10
VSTD-Campbell-2005
p8012
sg12
S'PMC1246082'
p8013
sa(dp8014
g8
V12609940.xml
p8015
sg10
VSTD-Trivedi-2003
p8016
sg12
S'PMC150177'
p8017
sa(dp8018
g8
V15860827.xml
p8019
sg10
VSTD-Porthouse-2005
p8020
sg12
S'PMC557150'
p8021
sa(dp8022
g8
V17874029.xml
p8023
sg10
VSTD-Chel-2008
p8024
sg12
S'PMC2277446'
p8025
sa(dp8026
g8
V9886454.xml
p8027
sg10
VSTD-Sato-1999a
p8028
sg12
S'PMC1736147'
p8029
sasa(dp8030
g3
VCD000389 v. 7.0 Mass media interventions effects on health services utilisation.rm5
p8031
sg5
(lp8032
(dp8033
g8
V3117190.xml
p8034
sg10
VSTD-Turner-1987
p8035
sg12
S'PMC1247354'
p8036
sasa(dp8037
g3
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p8038
sg5
(lp8039
(dp8040
g8
V2563951.xml
p8041
sg10
VSTD-Rachmilewitz-1989
p8042
sg12
S'PMC1835436'
p8043
sa(dp8044
g8
V2899536.xml
p8045
sg10
VSTD-Riley-1988
p8046
sg12
S'PMC1433642'
p8047
sa(dp8048
g8
V20049950.xml
p8049
sg10
VSTD-Ito-2010
p8050
sg12
S'PMC2972638'
p8051
sa(dp8052
g8
V2567266.xml
p8053
sg10
VSTD-Rao-1989
p8054
sg12
S'PMC1434223'
p8055
sa(dp8056
g8
V18080055.xml
p8057
sg10
VSTD-Hanauer-2007
p8058
sg12
S'PMC2658575'
p8059
sa(dp8060
g8
V18832520.xml
p8061
sg10
VSTD-Kruis-2009
p8062
sg12
S'PMC3269751'
p8063
sa(dp8064
g8
V2684804.xml
p8065
sg10
VSTD-Feurle-1989
p8066
sg12
S'PMC1434384'
p8067
sasa(dp8068
g3
VCD004137 v. 8.0 Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic.rm5
p8069
sg5
(lp8070
(dp8071
g8
V3081085.xml
p8072
sg10
VSTD-Hetherington-1986
p8073
sg12
S'PMC1339208'
p8074
sa(dp8075
g8
V2513026.xml
p8076
sg10
VSTD-Thompson-1989
p8077
sg12
S'PMC1838035'
p8078
sasa(dp8079
g3
VCD004068 v. 5.0 Postnatal parental education for optimizing infant general health and parent-infant relationships.rm5
p8080
sg5
(lp8081
(dp8082
g8
V9549449.xml
p8083
sg10
VSTD-Bolam-1998
p8084
sg12
S'PMC28481'
p8085
sa(dp8086
g8
V17273449.xml
p8087
sg10
VSTD-Goetter-2005
p8088
sg12
S'PMC1595267'
p8089
sasa(dp8090
g3
VCD005608 v. 2.0 Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eard.rm5
p8091
sg5
(lp8092
(dp8093
g8
V6412934.xml
p8094
sg10
VSTD-Browning-1983
p8095
sg12
S'PMC1549550'
p8096
sasa(dp8097
g3
VCD006040 v. 3.0 Reconstructive Techniques After Rectal Resection for Rectal Cancer.rm5
p8098
sg5
(lp8099
(dp8100
g8
V12131085.xml
p8101
sg10
VSTD-Ho-2002b
p8102
sg12
S'PMC1422548'
p8103
sa(dp8104
g8
V8678619.xml
p8105
sg10
VSTD-Hallbook-1996
p8106
sg12
S'PMC1235247'
p8107
sa(dp8108
g8
V12894014.xml
p8109
sg10
VSTD-Machado-2003
p8110
sg12
S'PMC1422690'
p8111
sasa(dp8112
g3
VCD002117 v. 7.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
p8113
sg5
(lp8114
(dp8115
g8
V8813873.xml
p8116
sg10
VSTD-Smellie-1996
p8117
sg12
S'PMC1511665'
p8118
sa(dp8119
g8
V22058522.xml
p8120
sg10
VSTD-Khorana-1972
p8121
sg12
S'PMC3013192'
p8122
sa(dp8123
g8
V4911961.xml
p8124
sg10
VSTD-Alderton-1970_x0023_
p8125
sg12
S'PMC1930205'
p8126
sa(dp8127
g8
V6478342.xml
p8128
sg10
VSTD-Netley-1984
p8129
sg12
S'PMC1483635'
p8130
sa(dp8131
g8
V1192312.xml
p8132
sg10
VSTD-McKendry-1975
p8133
sg12
S'PMC1956570'
p8134
sa(dp8135
g8
V4883146.xml
p8136
sg10
VSTD-Shaffer-1968_x0023_
p8137
sg12
S'PMC2020147'
p8138
sa(dp8139
g8
V4753483.xml
p8140
sg10
VSTD-Hodes-1973
p8141
sg12
S'PMC2157147'
p8142
sasa(dp8143
g3
VCD000057 v. 7.0 Clomiphene citrate for unexplained subfertility in women.rm5
p8144
sg5
(lp8145
(dp8146
g8
V18687718.xml
p8147
sg10
VSTD-Battacharya-2008
p8148
sg12
S'PMC2505091'
p8149
sasa(dp8150
g3
VCD003877 v. 6.0 Sedation of children undergoing dental treatment.rm5
p8151
sg5
(lp8152
(dp8153
g8
V12779109.xml
p8154
sg10
VSTD-Bui-2002
p8155
sg12
S'PMC2007405'
p8156
sa(dp8157
g8
V7645790.xml
p8158
sg10
VSTD-Abrams-1993
p8159
sg12
S'PMC2148744'
p8160
sa(dp8161
g8
V9790003.xml
p8162
sg10
VSTD-Roelofse-1998
p8163
sg12
S'PMC2148942'
p8164
sa(dp8165
g8
V16048152.xml
p8166
sg10
VSTD-Lam-2005
p8167
sg12
S'PMC2527044'
p8168
sasa(dp8169
g3
VCD002166 v. 7.0 Physical training for bronchiectasis.rm5
p8170
sg5
(lp8171
(dp8172
g8
V15994254.xml
p8173
sg10
VSTD-Newall-2000b
p8174
sg12
S'PMC1747238'
p8175
sasa(dp8176
g3
VCD008268 v. 4.0 Corticosteroids as standalone or add-on treatment for sore throat.rm5
p8177
sg5
(lp8178
(dp8179
g8
V15808038.xml
p8180
sg10
VSTD-Kiderman-2005
p8181
sg12
S'PMC1463093'
p8182
sasa(dp8183
g3
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p8184
sg5
(lp8185
(dp8186
g8
V19508995.xml
p8187
sg10
VSTD-Cao-2009
p8188
sg12
S'PMC2726958'
p8189
sa(dp8190
g8
V21127322.xml
p8191
sg10
VSTD-Roncalli-2010
p8192
sg12
S'PMC3386167'
p8193
sa(dp8194
g8
V20826249.xml
p8195
sg10
VSTD-Traverse-2010
p8196
sg12
S'PMC2939727'
p8197
sa(dp8198
g8
V16775089.xml
p8199
sg10
VSTD-Ge-2006
p8200
sg12
S'PMC1861266'
p8201
sasa(dp8202
g3
VCD000330 v. 12.0 Enemas during labour.rm5
p8203
sg5
(lp8204
(dp8205
g8
V16545140.xml
p8206
sg10
VSTD-Cuervo-2006
p8207
sg12
S'PMC1468428'
p8208
sasa(dp8209
g3
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p8210
sg5
(lp8211
(dp8212
g8
V17984757.xml
p8213
sg10
VSTD-Potter-2008
p8214
sg12
S'PMC2745056'
p8215
sa(dp8216
g8
V18671876.xml
p8217
sg10
VSTD-Bahwere-2008
p8218
sg12
S'PMC2536666'
p8219
sa(dp8220
g8
V20072773.xml
p8221
sg10
VSTD-Gillespie-2009
p8222
sg12
S'PMC2770289'
p8223
sasa(dp8224
g3
VCD007544 v. 2.0 Spiritual and religious interventions for well-being of adults in the terminal phase of disease.rm5
p8225
sg5
(lp8226
(dp8227
g8
V19678461.xml
p8228
sg10
VSTD-Downey-2009
p8229
sg12
S'PMC2858762'
p8230
sasa(dp8231
g3
VCD005203 v. 4.0 Dietary exclusions for established atopic eczema.rm5
p8232
sg5
(lp8233
(dp8234
g8
V7492155.xml
p8235
sg10
VSTD-Mabin-1995
p8236
sg12
S'PMC1511267'
p8237
sa(dp8238
g8
V3089466.xml
p8239
sg10
VSTD-Cant-1986
p8240
sg12
S'PMC1341170'
p8241
sasa(dp8242
g3
VCD006245 v. 7.0 Care delivery and self-management strategies for children with epilepsy.rm5
p8243
sg5
(lp8244
(dp8245
g8
V10856009.xml
p8246
sg10
VSTD-Tieffenberg-2000
p8247
sg12
S'PMC3456130'
p8248
sasa(dp8249
g3
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p8250
sg5
(lp8251
(dp8252
g8
V19350335.xml
p8253
sg10
VSTD-Zwick-2009
p8254
sg12
S'PMC2745452'
p8255
sa(dp8256
g8
V20419009.xml
p8257
sg10
VSTD-Rijal-2010
p8258
sg12
S'PMC2856397'
p8259
sa(dp8260
g8
V17323092.xml
p8261
sg10
VSTD-Sud-2008
p8262
sg12
S'PMC2323422'
p8263
sasa(dp8264
g3
VCD004212 v. 6.0 Opioids for neonates receiving mechanical ventilation.rm5
p8265
sg5
(lp8266
(dp8267
g8
V10194990.xml
p8268
sg10
VSTD-Lago-1998
p8269
sg12
S'PMC1720853'
p8270
sa(dp8271
g8
V8949692.xml
p8272
sg10
VSTD-Saarenmaa-1996
p8273
sg12
S'PMC1061172'
p8274
sasa(dp8275
g3
VCD007519 v. 3.0 Celiac plexus block for pancreatic cancer pain in adults.rm5
p8276
sg5
(lp8277
(dp8278
g8
V7683868.xml
p8279
sg10
VSTD-Lillemoe-1993
p8280
sg12
S'PMC1242819'
p8281
sasa(dp8282
g3
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p8283
sg5
(lp8284
(dp8285
g8
V5291743.xml
p8286
sg10
VSTD-Lidwell-1971
p8287
sg12
S'PMC2130854'
p8288
sa(dp8289
g8
V21543962.xml
p8290
sg10
VSTD-Chlan-1998
p8291
sg12
S'PMC3124305'
p8292
sa(dp8293
g8
V18493472.xml
p8294
sg10
VSTD-Kotwal-1998
p8295
sg12
S'PMC2362603'
p8296
sa(dp8297
g8
V18620100.xml
p8298
sg10
VSTD-Barnason-1995_x002f_1996
p8299
sg12
S'PMC2583060'
p8300
sasa(dp8301
g3
VCD009490 v. 1.0 Support surfaces for treating pressure ulcers.rm5
p8302
sg5
(lp8303
(dp8304
g8
V16740528.xml
p8305
sg10
VSTD-Nixon-2006
p8306
sg12
S'PMC1479635'
p8307
sasa(dp8308
g3
VCD005328 v. 4.0 Intraarticular corticosteroid for treatment of osteoarthritis of the knee.rm5
p8309
sg5
(lp8310
(dp8311
g8
V8976640.xml
p8312
sg10
VSTD-Jones-1996
p8313
sg12
S'PMC1010319'
p8314
sa(dp8315
g8
V13786828.xml
p8316
sg10
VSTD-Wright-1960
p8317
sg12
S'PMC1007152'
p8318
sa(dp8319
g8
V7794044.xml
p8320
sg10
VSTD-Gaffney-1995
p8321
sg12
S'PMC1005598'
p8322
sasa(dp8323
g3
VCD007296 v. 2.0 Early versus Delayed Refeeding for Children with Acute Diarrhoea.rm5
p8324
sg5
(lp8325
(dp8326
g8
V8731625.xml
p8327
sg10
VSTD-Hoghton-1996
p8328
sg12
S'PMC1239579'
p8329
sa(dp8330
g8
V2647038.xml
p8331
sg10
VSTD-Conway-1989
p8332
sg12
S'PMC1791816'
p8333
sa(dp8334
g8
V3918683.xml
p8335
sg10
VSTD-Khin_x002d_Maung_x002d_U-1985
p8336
sg12
S'PMC1417304'
p8337
sasa(dp8338
g3
VCD009307 v. 1.0 Universal multi-component prevention programs for alcohol misuse in young people.rm5
p8339
sg5
(lp8340
(dp8341
g8
V19736331.xml
p8342
sg10
VSTD-Hawkins-2009
p8343
sg12
S'PMC2740999'
p8344
sa(dp8345
g8
V17478265.xml
p8346
sg10
VSTD-Spoth-2007
p8347
sg12
S'PMC2869212'
p8348
sa(dp8349
g8
V8669519.xml
p8350
sg10
VSTD-Perry-1996
p8351
sg12
S'PMC1380436'
p8352
sa(dp8353
g8
V15376818.xml
p8354
sg10
VSTD-Schinke-2004
p8355
sg12
S'PMC2795165'
p8356
sasa(dp8357
g3
VCD006784 v. 5.0 Antibiotic therapy for Shigella dysentery.rm5
p8358
sg5
(lp8359
(dp8360
g8
V3518625.xml
p8361
sg10
VSTD-Kabir-1986
p8362
sg12
S'PMC180459'
p8363
sa(dp8364
g8
V2675757.xml
p8365
sg10
VSTD-Gotuzzo-1989
p8366
sg12
S'PMC176069'
p8367
sa(dp8368
g8
V4574641.xml
p8369
sg10
VSTD-Haltalin-1973
p8370
sg12
S'PMC1648332'
p8371
sasa(dp8372
g3
VCD003917 v. 10.0 Cardioprotective interventions for cancer patients receiving anthracyclines.rm5
p8373
sg5
(lp8374
(dp8375
g8
V19584400.xml
p8376
sg10
VSTD-Schwartz-2009
p8377
sg12
S'PMC2744567'
p8378
sasa(dp8379
g3
VCD009308 v. 1.0 Universal family-based prevention programs for alcohol misuse in young people.rm5
p8380
sg5
(lp8381
(dp8382
g8
V19118394.xml
p8383
sg10
VSTD-Schinke-2009a
p8384
sg12
S'PMC2629623'
p8385
sa(dp8386
g8
V19682490.xml
p8387
sg10
VSTD-Schinke-2009b
p8388
sg12
S'PMC2783411'
p8389
sa(dp8390
g8
V19632053.xml
p8391
sg10
VSTD-Schinke-2009c
p8392
sg12
S'PMC2741484'
p8393
sasa(dp8394
g3
VCD005571 v. 7.0 Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.rm5
p8395
sg5
(lp8396
(dp8397
g8
V10506041.xml
p8398
sg10
VSTD-Preclik-1999
p8399
sg12
S'PMC28241'
p8400
sasa(dp8401
g3
VCD004827 v. 6.3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
p8402
sg5
(lp8403
(dp8404
g8
V18252070.xml
p8405
sg10
VSTD-Conway-2007
p8406
sg12
S'PMC2084134'
p8407
sa(dp8408
g8
V15546485.xml
p8409
sg10
VSTD-Destura-unpublished
p8410
sg12
S'PMC543444'
p8411
sasa(dp8412
g3
VCD003941 v. 8.0 Patient reminder and recall systems to improve immunization rates.rm5
p8413
sg5
(lp8414
(dp8415
g8
V9686713.xml
p8416
sg10
VSTD-Baker-1998T96
p8417
sg12
S'PMC1496989'
p8418
sa(dp8419
g8
V8341774.xml
p8420
sg10
VSTD-Stehr_x002d_Green1993T10
p8421
sg12
S'PMC1403403'
p8422
sa(dp8423
g8
V7361966.xml
p8424
sg10
VSTD-Young1980T63
p8425
sg12
S'PMC1619400'
p8426
sa(dp8427
g8
V12236273.xml
p8428
sg10
VSTD-Hull2002T511
p8429
sg12
S'PMC1314410'
p8430
sa(dp8431
g8
V1544078.xml
p8432
sg10
VSTD-Rosser1992T47
p8433
sg12
S'PMC1488617'
p8434
sa(dp8435
g8
V1913409.xml
p8436
sg10
VSTD-Rosser1991T61
p8437
sg12
S'PMC1335900'
p8438
sa(dp8439
g8
V3565663.xml
p8440
sg10
VSTD-Mullooly1987T67
p8441
sg12
S'PMC1647052'
p8442
sa(dp8443
g8
V1544078.xml
p8444
sg10
VSTD-McDowell1986T46
p8445
sg12
S'PMC1488617'
p8446
sa(dp8447
g8
V9481466.xml
p8448
sg10
VSTD-Hogg1998T101
p8449
sg12
S'PMC2277568'
p8450
sa(dp8451
g8
V21263970.xml
p8452
sg10
VSTD-Lukasik1987T85
p8453
sg12
S'PMC2218648'
p8454
sasa(dp8455
g3
VCD007176 v. 7.4 Antioxidant supplements for prevention of mortality in healthy participants and patients with variou.rm5
p8456
sg5
(lp8457
(dp8458
g8
V17698683.xml
p8459
sg10
VSTD-WACS-2007Low
p8460
sg12
S'PMC2034519'
p8461
sa(dp8462
g8
V11594943.xml
p8463
sg10
VSTD-AREDS-2001Low
p8464
sg12
S'PMC1472812'
p8465
sa(dp8466
g8
V18997197.xml
p8467
sg10
VSTD-PHS-2008Low
p8468
sg12
S'PMC2586922'
p8469
sa(dp8470
g8
V19066370.xml
p8471
sg10
VSTD-SELECT-2009Low
p8472
sg12
S'PMC3682779'
p8473
sa(dp8474
g8
V16081445.xml
p8475
sg10
VSTD-MAVIS-2005-Low
p8476
sg12
S'PMC1183131'
p8477
sa(dp8478
g8
V15315997.xml
p8479
sg10
VSTD-Meydani-2004Low
p8480
sg12
S'PMC2377357'
p8481
sasa(dp8482
g3
VCD008133 v. 1.0 The impact of contracting out on health outcomes and use of health services in low and middle-income.rm5
p8483
sg5
(lp8484
(dp8485
g8
V23569973.xml
p8486
sg10
VSTD-Ali-2005
p8487
sg12
S'PMC3609347'
p8488
sasa(dp8489
g3
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p8490
sg5
(lp8491
(dp8492
g8
V18513453.xml
p8493
sg10
VSTD-Leach-2008
p8494
sg12
S'PMC2443129'
p8495
sa(dp8496
g8
V19434268.xml
p8497
sg10
VSTD-Choung-2008
p8498
sg12
S'PMC2671765'
p8499
sasa(dp8500
g3
VCD001706 v. 9.0 Arthroplasties (with and without bone cement) for proximal femoral fractures in adults.rm5
p8501
sg5
(lp8502
(dp8503
g8
V19130162.xml
p8504
sg10
VSTD-Figved-2009
p8505
sg12
S'PMC2866935'
p8506
sa(dp8507
g8
V17431621.xml
p8508
sg10
VSTD-Mouzopoulos-2008
p8509
sg12
S'PMC2323425'
p8510
sasa(dp8511
g3
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p8512
sg5
(lp8513
(dp8514
g8
V19239703.xml
p8515
sg10
VSTD-Huh-2009
p8516
sg12
S'PMC2688140'
p8517
sasa(dp8518
g3
VCD006717 v. 3.0 Patellar taping for patellofemoral pain syndrome in adults.rm5
p8519
sg5
(lp8520
(dp8521
g8
V10976083.xml
p8522
sg10
VSTD-Clark-2000a
p8523
sg12
S'PMC1753277'
p8524
sasa(dp8525
g3
VCD003326 v. 9.0 Tissue adhesives for traumatic lacerations in children and adults.rm5
p8526
sg5
(lp8527
(dp8528
g8
V12204985.xml
p8529
sg10
VSTD-Mattick-2002a
p8530
sg12
S'PMC1725943'
p8531
sasa(dp8532
g3
VCD002990 v. 11.0 Self-management education for patients with chronic obstructive pulmonary disease.rm5
p8533
sg5
(lp8534
(dp8535
g8
V1926024.xml
p8536
sg10
VSTD-Littlejohns-1991
p8537
sg12
S'PMC463273'
p8538
sa(dp8539
g8
V3101821.xml
p8540
sg10
VSTD-Cockcroft-1987
p8541
sg12
S'PMC1245234'
p8542
sasa(dp8543
g3
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p8544
sg5
(lp8545
(dp8546
g8
V16137357.xml
p8547
sg10
VSTD-Bollen-2005
p8548
sg12
S'PMC1269459'
p8549
sasa(dp8550
g3
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p8551
sg5
(lp8552
(dp8553
g8
V12617741.xml
p8554
sg10
VSTD-Dyhr-2003
p8555
sg12
S'PMC154111'
p8556
sasa(dp8557
g3
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p8558
sg5
(lp8559
(dp8560
g8
V14180526.xml
p8561
sg10
VSTD-Harkins-1964
p8562
sg12
S'PMC1927374'
p8563
sa(dp8564
g8
V21495198.xml
p8565
sg10
VSTD-Makvandi-2011
p8566
sg12
S'PMC3081214'
p8567
sasa(dp8568
g3
VCD003534 v. 9.2 Fluticasone at different doses for chronic asthma in adults and children.rm5
p8569
sg5
(lp8570
(dp8571
g8
V10491451.xml
p8572
sg10
VSTD-Meijer-1999
p8573
sg12
S'PMC1745367'
p8574
sa(dp8575
g8
V12765916.xml
p8576
sg10
VSTD-Verona-2003
p8577
sg12
S'PMC1763114'
p8578
sasa(dp8579
g3
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p8580
sg5
(lp8581
(dp8582
g8
V17233848.xml
p8583
sg10
VSTD-Vichinsky-2007
p8584
sg12
S'PMC1974786'
p8585
sasa(dp8586
g3
VCD003020 v. 9.0 School-based prevention for illicit drugs' use.rm5
p8587
sg5
(lp8588
(dp8589
g8
V14600049.xml
p8590
sg10
VSTD-Ellickson-2003
p8591
sg12
S'PMC1448059'
p8592
sasa(dp8593
g3
VCD002229 v. 11.6 Hormone therapy for preventing cardiovascular disease in post-menopausal women.rm5
p8594
sg5
(lp8595
(dp8596
g8
V17626056.xml
p8597
sg10
VSTD-WISDOM-2007
p8598
sg12
S'PMC1939792'
p8599
sasa(dp8600
g3
VCD004022 v. 8.7 Effects of low sodium diet versus high sodium diet on blood pressure renin aldosterone catecholam.rm5
p8601
sg5
(lp8602
(dp8603
g8
V6401551.xml
p8604
sg10
VSTD-_x0031_018-SE-Watt-1983
p8605
sg12
S'PMC1546779'
p8606
sa(dp8607
g8
V6418295.xml
p8608
sg10
VSTD-_x0031_027-P-Fagerberg-1984
p8609
sg12
S'PMC1444105'
p8610
sa(dp8611
g8
V19620517.xml
p8612
sg10
VSTD-_x0031_200-SE-Pimenta-2009
p8613
sg12
S'PMC2771382'
p8614
sa(dp8615
g8
V7833222.xml
p8616
sg10
VSTD-_x0031_107-SE-MacFadyen-1994
p8617
sg12
S'PMC1364776'
p8618
sa(dp8619
g8
V3933736.xml
p8620
sg10
VSTD-_x0031_035-SE-Watt-1985-b
p8621
sg12
S'PMC1418187'
p8622
sa(dp8623
g8
V3103761.xml
p8624
sg10
VSTD-_x0031_047-MacGregor-1987
p8625
sg12
S'PMC1245574'
p8626
sa(dp8627
g8
V6432119.xml
p8628
sg10
VSTD-_x0031_024-P-Erwteman-1984
p8629
sg12
S'PMC1442440'
p8630
sa(dp8631
g8
V3933736.xml
p8632
sg10
VSTD-_x0031_034-SE-Watt-1985
p8633
sg12
S'PMC1418187'
p8634
sa(dp8635
g8
V19140039.xml
p8636
sg10
VSTD-_x0031_199-P-Meland-2009
p8637
sg12
S'PMC3410469'
p8638
sasa(dp8639
g3
VCD008664 v. 2.0 Thalidomide for managing cancer cachexia.rm5
p8640
sg5
(lp8641
(dp8642
g8
V20156909.xml
p8643
sg10
VSTD-Mantovani-2010a
p8644
sg12
S'PMC3227938'
p8645
sa(dp8646
g8
V15753541.xml
p8647
sg10
VSTD-Gordon-2005
p8648
sg12
S'PMC1774430'
p8649
sasa(dp8650
g3
VCD001936 v. 4.0 Allergen injection immunotherapy for seasonal allergic rhinitis.rm5
p8651
sg5
(lp8652
(dp8653
g8
V1998791.xml
p8654
sg10
VSTD-Varney-1991
p8655
sg12
S'PMC1668945'
p8656
sasa(dp8657
g3
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p8658
sg5
(lp8659
(dp8660
g8
V21804705.xml
p8661
sg10
VSTD-Bafna-2011
p8662
sg12
S'PMC3146157'
p8663
sa(dp8664
g8
V22247722.xml
p8665
sg10
VSTD-Montazeri-2011
p8666
sg12
S'PMC3252769'
p8667
sasa(dp8668
g3
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p8669
sg5
(lp8670
(dp8671
g8
V21959870.xml
p8672
sg10
VSTD-Fujisaka-2011
p8673
sg12
S'PMC3241560'
p8674
sa(dp8675
g8
V10408844.xml
p8676
sg10
VSTD-Thatcher-1999b
p8677
sg12
S'PMC2362337'
p8678
sa(dp8679
g8
V10408844.xml
p8680
sg10
VSTD-Thatcher-1999a
p8681
sg12
S'PMC2362337'
p8682
sa(dp8683
g8
V12671693.xml
p8684
sg10
VSTD-Boogaerts-2003
p8685
sg12
S'PMC2376376'
p8686
sa(dp8687
g8
V12799626.xml
p8688
sg10
VSTD-Smith-2003b
p8689
sg12
S'PMC2741110'
p8690
sa(dp8691
g8
V12799626.xml
p8692
sg10
VSTD-Smith-2003c
p8693
sg12
S'PMC2741110'
p8694
sa(dp8695
g8
V12799626.xml
p8696
sg10
VSTD-Smith-2003a
p8697
sg12
S'PMC2741110'
p8698
sa(dp8699
g8
V18037478.xml
p8700
sg10
VSTD-Thomas-2008
p8701
sg12
S'PMC2350198'
p8702
sa(dp8703
g8
V16570051.xml
p8704
sg10
VSTD-Wilkinson-2006
p8705
sg12
S'PMC2361228'
p8706
sa(dp8707
g8
V20798194.xml
p8708
sg10
VSTD-Pronzato-2010
p8709
sg12
S'PMC3228044'
p8710
sa(dp8711
g8
V9667681.xml
p8712
sg10
VSTD-Sweeney-1998
p8713
sg12
S'PMC2150364'
p8714
sa(dp8715
g8
V10408844.xml
p8716
sg10
VSTD-Thatcher-1999
p8717
sg12
S'PMC2362337'
p8718
sa(dp8719
g8
V12799626.xml
p8720
sg10
VSTD-Smith-2003
p8721
sg12
S'PMC2741110'
p8722
sa(dp8723
g8
V12671693.xml
p8724
sg10
VSTD-Boogaerts-Coiffier-2001
p8725
sg12
S'PMC2376376'
p8726
sasa(dp8727
g3
VCD005197 v. 7.0 Anti-pseudomonal beta-lactams for the initial empirical treatment of febrile neutropenia comparis.rm5
p8728
sg5
(lp8729
(dp8730
g8
V23100925.xml
p8731
sg10
VSTD-Ghalaut-2007
p8732
sg12
S'PMC3453121'
p8733
sa(dp8734
g8
V2201252.xml
p8735
sg10
VSTD-Liang-1990
p8736
sg12
S'PMC175977'
p8737
sasa(dp8738
g3
VCD003978 v. 7.0 Prescription of prosthetic ankle-foot mechanisms after lower limb amputation.rm5
p8739
sg5
(lp8740
(dp8741
g8
V15234485.xml
p8742
sg10
VSTD-Underwood-2004
p8743
sg12
S'PMC3471981'
p8744
sasa(dp8745
g3
VCD005496 v. 6.0 Probiotics for prevention of necrotizing enterocolitis in preterm infants.rm5
p8746
sg5
(lp8747
(dp8748
g8
V9135288.xml
p8749
sg10
VSTD-Kitajima-1997
p8750
sg12
S'PMC1720633'
p8751
sa(dp8752
g8
V16971641.xml
p8753
sg10
VSTD-Mohan-2006
p8754
sg12
S'PMC1698302'
p8755
sa(dp8756
g8
V8285750.xml
p8757
sg10
VSTD-Millar-1993
p8758
sg12
S'PMC1029589'
p8759
sasa(dp8760
g3
VCD005309 v. 8.0 Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and chil.rm5
p8761
sg5
(lp8762
(dp8763
g8
V12324672.xml
p8764
sg10
VSTD-Currie-2002
p8765
sg12
S'PMC1746197'
p8766
sasa(dp8767
g3
VCD007414 v. 5.6 Maintenance chemotherapy for ovarian cancer.rm5
p8768
sg5
(lp8769
(dp8770
g8
V21529904.xml
p8771
sg10
VSTD-Mannel-2011
p8772
sg12
S'PMC3110746'
p8773
sasa(dp8774
g3
VCD007239 v. 4.0 Interventions for preventing mastitis after childbirth.rm5
p8775
sg5
(lp8776
(dp8777
g8
V17032458.xml
p8778
sg10
VSTD-Amir-2004
p8779
sg12
S'PMC1630426'
p8780
sasa(dp8781
g3
VCD006338 v. 9.2 Chest physiotherapy for pneumonia in adults.rm5
p8782
sg5
(lp8783
(dp8784
g8
V3924221.xml
p8785
sg10
VSTD-Britton-1985
p8786
sg12
S'PMC1416077'
p8787
sasa(dp8788
g3
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p8789
sg5
(lp8790
(dp8791
g8
V15804355.xml
p8792
sg10
VSTD-Galloway-2005
p8793
sg12
S'PMC1087493'
p8794
sa(dp8795
g8
V15899557.xml
p8796
sg10
VSTD-Hulse-2005
p8797
sg12
S'PMC1646626'
p8798
sasa(dp8799
g3
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p8800
sg5
(lp8801
(dp8802
g8
V19066176.xml
p8803
sg10
VSTD-Keystone-2009
p8804
sg12
S'PMC2674549'
p8805
sasa(dp8806
g3
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p8807
sg5
(lp8808
(dp8809
g8
V17043424.xml
p8810
sg10
VSTD-Jun-2006
p8811
sg12
S'PMC2722000'
p8812
sasa(dp8813
g3
VCD000366 v. 8.0 Inositol for respiratory distress syndrome in preterm infants.rm5
p8814
sg5
(lp8815
(dp8816
g8
V3539028.xml
p8817
sg10
VSTD-Hallman-1986
p8818
sg12
S'PMC1778095'
p8819
sasa(dp8820
g3
VCD002099 v. 4.0 Nursing record systems effects on nursing practice and healthcare outcomes.rm5
p8821
sg5
(lp8822
(dp8823
g8
V6508341.xml
p8824
sg10
VSTD-Lakhani-1984
p8825
sg12
S'PMC1628817'
p8826
sa(dp8827
g8
V1807627.xml
p8828
sg10
VSTD-Spranzo--1993
p8829
sg12
S'PMC2247491'
p8830
sasa(dp8831
g3
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p8832
sg5
(lp8833
(dp8834
g8
V12011193.xml
p8835
sg10
VSTD-Mutrie-2002
p8836
sg12
S'PMC1732165'
p8837
sa(dp8838
g8
V18684108.xml
p8839
sg10
VSTD-TAPESTRY-Herts-2003
p8840
sg12
S'PMC2676106'
p8841
sa(dp8842
g8
V17699538.xml
p8843
sg10
VSTD-McKee-2007
p8844
sg12
S'PMC2703799'
p8845
sa(dp8846
g8
V12495948.xml
p8847
sg10
VSTD-Rowland-2003
p8848
sg12
S'PMC1719287'
p8849
sa(dp8850
g8
V19413910.xml
p8851
sg10
VSTD-Mendoza-2009
p8852
sg12
S'PMC2680829'
p8853
sa(dp8854
g8
V23894666.xml
p8855
sg10
VSTD-TAPESTRY-Dublin-2003
p8856
sg12
S'PMC3720922'
p8857
sasa(dp8858
g3
VCD003617 v. 6.55 Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.rm5
p8859
sg5
(lp8860
(dp8861
g8
V19052125.xml
p8862
sg10
VSTD-Di-Bisceglie-2008
p8863
sg12
S'PMC2606037'
p8864
sasa(dp8865
g3
VCD003965 v. 11.0 Immunosuppressive agents for treating IgA nephropathy.rm5
p8866
sg5
(lp8867
(dp8868
g8
V3120928.xml
p8869
sg10
VSTD-Lai-1987
p8870
sg12
S'PMC1248243'
p8871
sasa(dp8872
g3
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p8873
sg5
(lp8874
(dp8875
g8
V17697359.xml
p8876
sg10
VSTD-Gombocz-2007
p8877
sg12
S'PMC2206488'
p8878
sa(dp8879
g8
V16998584.xml
p8880
sg10
VSTD-Akech-2006
p8881
sg12
S'PMC1569382'
p8882
sa(dp8883
g8
V1690974.xml
p8884
sg10
VSTD-Gold-1990
p8885
sg12
S'PMC1358036'
p8886
sasa(dp8887
g3
VCD000934 v. 8.0 Alternative versus standard packages of antenatal care for low-risk pregnancy.rm5
p8888
sg5
(lp8889
(dp8890
g8
V8595286.xml
p8891
sg10
VSTD-England-1996
p8892
sg12
S'PMC2350357'
p8893
sasa(dp8894
g3
VCD003408 v. 10.4 Pulmonary artery catheters for adult patients in intensive care.rm5
p8895
sg5
(lp8896
(dp8897
g8
V1929610.xml
p8898
sg10
VSTD-Berlauk-1991
p8899
sg12
S'PMC1358649'
p8900
sa(dp8901
g8
V9339929.xml
p8902
sg10
VSTD-Bender-1997
p8903
sg12
S'PMC1191013'
p8904
sasa(dp8905
g3
VCD004147 v. 10.0 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alon.rm5
p8906
sg5
(lp8907
(dp8908
g8
V21159452.xml
p8909
sg10
VSTD-Chawarski-2011
p8910
sg12
S'PMC3076517'
p8911
sa(dp8912
g8
V19101098.xml
p8913
sg10
VSTD-Epstein-2009
p8914
sg12
S'PMC2943844'
p8915
sa(dp8916
g8
V18489017.xml
p8917
sg10
VSTD-Bickel-2008
p8918
sg12
S'PMC2746734'
p8919
sa(dp8920
g8
V19653788.xml
p8921
sg10
VSTD-Chopra-2009
p8922
sg12
S'PMC2852314'
p8923
sa(dp8924
g8
V18068905.xml
p8925
sg10
VSTD-Ghitza-2008
p8926
sg12
S'PMC2271179'
p8927
sa(dp8928
g8
V17241493.xml
p8929
sg10
VSTD-Luthar-2000
p8930
sg12
S'PMC2190295'
p8931
sa(dp8932
g8
V17574801.xml
p8933
sg10
VSTD-Neufeld-2008
p8934
sg12
S'PMC2193670'
p8935
sasa(dp8936
g3
VCD003312 v. 4.0 Selenium supplementation to prevent short-term morbidity in preterm neonates.rm5
p8937
sg5
(lp8938
(dp8939
g8
V8777677.xml
p8940
sg10
VSTD-Daniels-1996
p8941
sg12
S'PMC2528339'
p8942
sasa(dp8943
g3
VCD001747 v. 11.0 Galantamine for Alzheimer's disease and mild cognitive impairment.rm5
p8944
sg5
(lp8945
(dp8946
g8
V11110737.xml
p8947
sg10
VSTD-GAL_x002d_INT_x002d_1-Wilcock
p8948
sg12
S'PMC27547'
p8949
sa(dp8950
g8
V11606667.xml
p8951
sg10
VSTD-GAL_x002d_INT_x002d_2-Rockwood
p8952
sg12
S'PMC1737604'
p8953
sasa(dp8954
g3
VCD006855 v. 3.0 Personal assistance for older adults (65) without dementia.rm5
p8955
sg5
(lp8956
(dp8957
g8
V6405641.xml
p8958
sg10
VSTD-Sherwood-1983
p8959
sg12
S'PMC1650873'
p8960
sa(dp8961
g8
V17244293.xml
p8962
sg10
VSTD-Carlson-2007
p8963
sg12
S'PMC1955332'
p8964
sa(dp8965
g8
V8885860.xml
p8966
sg10
VSTD-Feldman-1996
p8967
sg12
S'PMC1070133'
p8968
sasa(dp8969
g3
VCD004567 v. 5.0 Antioxidant vitamin supplementation for preventing and slowing the progression of age-related catara.rm5
p8970
sg5
(lp8971
(dp8972
g8
V9799882.xml
p8973
sg10
VSTD-ATBC-1998
p8974
sg12
S'PMC1756731'
p8975
sa(dp8976
g8
V16556618.xml
p8977
sg10
VSTD-APC-2006
p8978
sg12
S'PMC1857154'
p8979
sa(dp8980
g8
V21060040.xml
p8981
sg10
VSTD-PHS-II-2010
p8982
sg12
S'PMC3051399'
p8983
sa(dp8984
g8
V11594943.xml
p8985
sg10
VSTD-AREDS-2001
p8986
sg12
S'PMC1472812'
p8987
sasa(dp8988
g3
VCD005215 v. 6.0 Interventions for preventing unintended pregnancies among adolescents.rm5
p8989
sg5
(lp8990
(dp8991
g8
V12016180.xml
p8992
sg10
VSTD-Graham-2002
p8993
sg12
S'PMC111106'
p8994
sa(dp8995
g8
V17118950.xml
p8996
sg10
VSTD-Henderson-2007
p8997
sg12
S'PMC1779834'
p8998
sa(dp8999
g8
V15117710.xml
p9000
sg10
VSTD-Coyle-2004
p9001
sg12
S'PMC1448347'
p9002
sa(dp9003
g8
V17463382.xml
p9004
sg10
VSTD-Dilorio-2007
p9005
sg12
S'PMC1874204'
p9006
sa(dp9007
g8
V16894074.xml
p9008
sg10
VSTD-Villarruel-2006
p9009
sg12
S'PMC3034476'
p9010
sa(dp9011
g8
V16682420.xml
p9012
sg10
VSTD-Walker-2006
p9013
sg12
S'PMC1463960'
p9014
sa(dp9015
g8
V12065268.xml
p9016
sg10
VSTD-Wight-2002
p9017
sg12
S'PMC115856'
p9018
sasa(dp9019
g3
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p9020
sg5
(lp9021
(dp9022
g8
V20683766.xml
p9023
sg10
VSTD-Bent-2011
p9024
sg12
S'PMC3076562'
p9025
sasa(dp9026
g3
VCD001324 v. 10.0 Interventions for emergency contraception.rm5
p9027
sg5
(lp9028
(dp9029
g8
V17077229.xml
p9030
sg10
VSTD-Creinin-2006
p9031
sg12
S'PMC2853373'
p9032
sa(dp9033
g8
V1458074.xml
p9034
sg10
VSTD-Webb-1992
p9035
sg12
S'PMC1883543'
p9036
sa(dp9037
g8
V23300530.xml
p9038
sg10
VSTD-Lou-C-2002
p9039
sg12
S'PMC3530567'
p9040
sasa(dp9041
g3
VCD004079 v. 5.0 Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and car.rm5
p9042
sg5
(lp9043
(dp9044
g8
V11932472.xml
p9045
sg10
VSTD-Giardiello-2002
p9046
sg12
S'PMC2225537'
p9047
sasa(dp9048
g3
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p9049
sg5
(lp9050
(dp9051
g8
V19506919.xml
p9052
sg10
VSTD-Berg-2009
p9053
sg12
S'PMC2899375'
p9054
sa(dp9055
g8
V21596740.xml
p9056
sg10
VSTD-Hellum-2011
p9057
sg12
S'PMC3100911'
p9058
sasa(dp9059
g3
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p9060
sg5
(lp9061
(dp9062
g8
V6134565.xml
p9063
sg10
VSTD-Dew-1983a
p9064
sg12
S'PMC1548114'
p9065
sa(dp9066
g8
V20049949.xml
p9067
sg10
VSTD-Ito-2010
p9068
sg12
S'PMC2972641'
p9069
sa(dp9070
g8
V19920971.xml
p9071
sg10
VSTD-Kane-2008a
p9072
sg12
S'PMC2770408'
p9073
sa(dp9074
g8
V18272546.xml
p9075
sg10
VSTD-Kamm-2008
p9076
sg12
S'PMC2564831'
p9077
sa(dp9078
g8
V7959238.xml
p9079
sg10
VSTD-Travis-1994
p9080
sg12
S'PMC1375708'
p9081
sa(dp9082
g8
V22081522.xml
p9083
sg10
VSTD-Hawthorne-2011
p9084
sg12
S'PMC3746130'
p9085
sa(dp9086
g8
V1347280.xml
p9087
sg10
VSTD-Kiilerich-1992
p9088
sg12
S'PMC1373939'
p9089
sa(dp9090
g8
V11709512.xml
p9091
sg10
VSTD-Kruis-2001
p9092
sg12
S'PMC1728533'
p9093
sa(dp9094
g8
V2898422.xml
p9095
sg10
VSTD-Ireland-1988
p9096
sg12
S'PMC1433723'
p9097
sasa(dp9098
g3
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p9099
sg5
(lp9100
(dp9101
g8
V20494434.xml
p9102
sg10
VSTD-Green-2010
p9103
sg12
S'PMC2890859'
p9104
sa(dp9105
g8
V22825926.xml
p9106
sg10
VSTD-Siller-2012
p9107
sg12
S'PMC3511916'
p9108
sa(dp9109
g8
V20145986.xml
p9110
sg10
VSTD-Kasari-2010
p9111
sg12
S'PMC2922697'
p9112
sasa(dp9113
g3
VCD006965 v. 6.0 Effects of restricted caffeine intake by mother on fetal neonatal and pregnancy outcome.rm5
p9114
sg5
(lp9115
(dp9116
g8
V17259189.xml
p9117
sg10
VSTD-Bech-2007
p9118
sg12
S'PMC1804137'
p9119
sasa(dp9120
g3
VCD002286 v. 7.3 Feverfew for preventing migraine.rm5
p9121
sg5
(lp9122
(dp9123
g8
V3929876.xml
p9124
sg10
VSTD-Johnson-1985
p9125
sg12
S'PMC1418227'
p9126
sasa(dp9127
g3
VCD006641 v. 3.0 Separate care for new mother and infant versus rooming-in for increasing the duration of breastfeedi.rm5
p9128
sg5
(lp9129
(dp9130
g8
V17488524.xml
p9131
sg10
VSTD-Bystrova-2008
p9132
sg12
S'PMC1878468'
p9133
sasa(dp9134
g3
VCD005454 v. 11.0 Antidepressants for neuropathic pain.rm5
p9135
sg5
(lp9136
(dp9137
g8
V2271367.xml
p9138
sg10
VSTD-Sindrup-1990b
p9139
sg12
S'PMC1368167'
p9140
sa(dp9141
g8
V2574958.xml
p9142
sg10
VSTD-Hampf-1989
p9143
sg12
S'PMC2148641'
p9144
sa(dp9145
g8
V6419955.xml
p9146
sg10
VSTD-Feinmann-1984
p9147
sg12
S'PMC1444752'
p9148
sa(dp9149
g8
V10848721.xml
p9150
sg10
VSTD-McCleane-2000a
p9151
sg12
S'PMC2015036'
p9152
sasa(dp9153
g3
VCD004957 v. 4.0 Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chron.rm5
p9154
sg5
(lp9155
(dp9156
g8
V9624068.xml
p9157
sg10
VSTD-Shepperd-1998
p9158
sg12
S'PMC28578'
p9159
sasa(dp9160
g3
VCD006743 v. 5.0 Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients .rm5
p9161
sg5
(lp9162
(dp9163
g8
V6404289.xml
p9164
sg10
VSTD-Jaffe-1983
p9165
sg12
S'PMC481332'
p9166
sa(dp9167
g8
V1449918.xml
p9168
sg10
VSTD-Hargreaves-1992
p9169
sg12
S'PMC1025134'
p9170
sa(dp9171
g8
V7426142.xml
p9172
sg10
VSTD-Norris-1980
p9173
sg12
S'PMC482762'
p9174
sasa(dp9175
g3
VCD008416 v. 2.2 Multimedia educational interventions for consumers about prescribed and over-the-counter medications.rm5
p9176
sg5
(lp9177
(dp9178
g8
V6848154.xml
p9179
sg10
VSTD-Self-1983
p9180
sg12
S'PMC1874805'
p9181
sa(dp9182
g8
V23770676.xml
p9183
sg10
VSTD-Acosta-2009
p9184
sg12
S'PMC3732483'
p9185
sa(dp9186
g8
V18398664.xml
p9187
sg10
VSTD-Schwarz-2008a
p9188
sg12
S'PMC2517895'
p9189
sasa(dp9190
g3
VCD006020 v. 6.0 Parenting interventions for the prevention of unintentional injuries in childhood.rm5
p9191
sg5
(lp9192
(dp9193
g8
V11861228.xml
p9194
sg10
VSTD-Emond-2002
p9195
sg12
S'PMC1719107'
p9196
sa(dp9197
g8
V8518642.xml
p9198
sg10
VSTD-Johnson-1993
p9199
sg12
S'PMC1677859'
p9200
sa(dp9201
g8
V17068074.xml
p9202
sg10
VSTD-Barlow-2007
p9203
sg12
S'PMC2083433'
p9204
sasa(dp9205
g3
VCD006003 v. 6.2 Routine abdominal drainage for uncomplicated open cholecystectomy.rm5
p9206
sg5
(lp9207
(dp9208
g8
V6614773.xml
p9209
sg10
VSTD-McCormack-1983
p9210
sg12
S'PMC2494372'
p9211
sa(dp9212
g8
V6721407.xml
p9213
sg10
VSTD-Salam-1984
p9214
sg12
S'PMC2492550'
p9215
sa(dp9216
g8
V7081917.xml
p9217
sg10
VSTD-Fraser-1982
p9218
sg12
S'PMC2493965'
p9219
sasa(dp9220
g3
VCD005060 v. 6.0 Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.rm5
p9221
sg5
(lp9222
(dp9223
g8
V18420662.xml
p9224
sg10
VSTD-O_x0027_Kane-2008
p9225
sg12
S'PMC2394643'
p9226
sa(dp9227
g8
V17591623.xml
p9228
sg10
VSTD-DiGEM-trial-2007
p9229
sg12
S'PMC1925177'
p9230
sasa(dp9231
g3
VCD004640 v. 11.0 Magnesium supplementation for the management of primary hypertension in adults.rm5
p9232
sg5
(lp9233
(dp9234
g8
V3092972.xml
p9235
sg10
VSTD-Henderson-1986
p9236
sg12
S'PMC1341513'
p9237
sasa(dp9238
g3
VCD003338 v. 9.0 Conservative treatments for whiplash.rm5
p9239
sg5
(lp9240
(dp9241
g8
V2511939.xml
p9242
sg10
VSTD-McKinney-1989
p9243
sg12
S'PMC1837927'
p9244
sa(dp9245
g8
V15107368.xml
p9246
sg10
VSTD-Schnabel-2004
p9247
sg12
S'PMC1726332'
p9248
sa(dp9249
g8
V3081211.xml
p9250
sg10
VSTD-Mealy-1986
p9251
sg12
S'PMC1339641'
p9252
sasa(dp9253
g3
VCD000323 v. 8.1 Interventions for dysphagia and nutritional support in acute and subacute stroke.rm5
p9254
sg5
(lp9255
(dp9256
g8
V21441148.xml
p9257
sg10
VSTD-Kumar-2011
p9258
sg12
S'PMC3116809'
p9259
sa(dp9260
g8
V8555849.xml
p9261
sg10
VSTD-Norton-1996
p9262
sg12
S'PMC2349687'
p9263
sasa(dp9264
g3
VCD002978 v. 3.0 Oral oestrogen and combined oestrogenprogestogen therapy versus placebo for hot flushes.rm5
p9265
sg5
(lp9266
(dp9267
g8
V6268783.xml
p9268
sg10
VSTD-Coope-1981
p9269
sg12
S'PMC1971963'
p9270
sa(dp9271
g8
V172181.xml
p9272
sg10
VSTD-Coope-1975
p9273
sg12
S'PMC1674796'
p9274
sasa(dp9275
g3
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p9276
sg5
(lp9277
(dp9278
g8
V21214940.xml
p9279
sg10
VSTD-Sesay-2011
p9280
sg12
S'PMC3024263'
p9281
sa(dp9282
g8
V21304925.xml
p9283
sg10
VSTD-Konate-2011
p9284
sg12
S'PMC3032552'
p9285
sa(dp9286
g8
V19098989.xml
p9287
sg10
VSTD-Kweku-2008
p9288
sg12
S'PMC2602973'
p9289
sa(dp9290
g8
V21304923.xml
p9291
sg10
VSTD-Dicko-2011
p9292
sg12
S'PMC3032550'
p9293
sa(dp9294
g8
V18611271.xml
p9295
sg10
VSTD-Dicko-2008
p9296
sg12
S'PMC2500037'
p9297
sasa(dp9298
g3
VCD001144 v. 7.0 Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preter.rm5
p9299
sg5
(lp9300
(dp9301
g8
V8323356.xml
p9302
sg10
VSTD-Kari-1993
p9303
sg12
S'PMC1029304'
p9304
sasa(dp9305
g3
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p9306
sg5
(lp9307
(dp9308
g8
V17627707.xml
p9309
sg10
VSTD-Sandrini-2007
p9310
sg12
S'PMC1974802'
p9311
sa(dp9312
g8
V17164991.xml
p9313
sg10
VSTD-Tfelt_x002d_Hansen-2006
p9314
sg12
S'PMC3452229'
p9315
sasa(dp9316
g3
VCD003031 v. 7.0 Prophylactic drug management for febrile seizures in children.rm5
p9317
sg5
(lp9318
(dp9319
g8
V7305427.xml
p9320
sg10
VSTD-Bacon-1981b
p9321
sg12
S'PMC1627392'
p9322
sa(dp9323
g8
V3907504.xml
p9324
sg10
VSTD-Knudsen-1985b
p9325
sg12
S'PMC1777614'
p9326
sa(dp9327
g8
V8660037.xml
p9328
sg10
VSTD-Knudsen-1996
p9329
sg12
S'PMC1511589'
p9330
sa(dp9331
g8
V1260273.xml
p9332
sg10
VSTD-Heckmatt-1976
p9333
sg12
S'PMC1639342'
p9334
sa(dp9335
g8
V6770760.xml
p9336
sg10
VSTD-Ngwane-1980
p9337
sg12
S'PMC1626746'
p9338
sasa(dp9339
g3
VCD007427 v. 2.0 Physical tests for shoulder impingements and local lesions of bursa tendon or labrum that may accom.rm5
p9340
sg5
(lp9341
(dp9342
g8
V10627426.xml
p9343
sg10
VSTD-Calis-2000
p9344
sg12
S'PMC1752990'
p9345
sa(dp9346
g8
V11796399.xml
p9347
sg10
VSTD-Naredo--2002
p9348
sg12
S'PMC1754006'
p9349
sasa(dp9350
g3
VCD004171 v. 5.11 Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.rm5
p9351
sg5
(lp9352
(dp9353
g8
V17414601.xml
p9354
sg10
VSTD-Figueras-2007
p9355
sg12
S'PMC1877032'
p9356
sasa(dp9357
g3
VCD001175 v. 6.7 Computer-generated reminders delivered on paper to healthcare professionals; effects on professional.rm5
p9358
sg5
(lp9359
(dp9360
g8
V12595407.xml
p9361
sg10
VSTD-Oniki-2003
p9362
sg12
S'PMC150371'
p9363
sa(dp9364
g8
V19933787.xml
p9365
sg10
VSTD-McAlister-2009
p9366
sg12
S'PMC2789127'
p9367
sa(dp9368
g8
V8563365.xml
p9369
sg10
VSTD-Nilasena-1995
p9370
sg12
S'PMC2579172'
p9371
sa(dp9372
g8
V9383135.xml
p9373
sg10
VSTD-Rossi-1997
p9374
sg12
S'PMC1497186'
p9375
sa(dp9376
g8
V1913409.xml
p9377
sg10
VSTD-Rosser-1991
p9378
sg12
S'PMC1335900'
p9379
sasa(dp9380
g3
VCD002203 v. 10.0 Macrolide antibiotics for cystic fibrosis.rm5
p9381
sg5
(lp9382
(dp9383
g8
V11867823.xml
p9384
sg10
VSTD-Wolter-2002
p9385
sg12
S'PMC1746273'
p9386
sa(dp9387
g8
V16809416.xml
p9388
sg10
VSTD-Clement-2006
p9389
sg12
S'PMC2104771'
p9390
sasa(dp9391
g3
VCD001035 v. 8.0 Interventions for encouraging sexual behaviours intended to prevent cervical cancer.rm5
p9392
sg5
(lp9393
(dp9394
g8
V18703460.xml
p9395
sg10
VSTD-Choi-2008
p9396
sg12
S'PMC2636470'
p9397
sa(dp9398
g8
V15625713.xml
p9399
sg10
VSTD-Morrison_x002d_Beedy-2005
p9400
sg12
S'PMC2430924'
p9401
sa(dp9402
g8
V19762662.xml
p9403
sg10
VSTD-Kershaw-2009
p9404
sg12
S'PMC2759789'
p9405
sa(dp9406
g8
V11728891.xml
p9407
sg10
VSTD-Jaworski-2001
p9408
sg12
S'PMC2423731'
p9409
sa(dp9410
g8
V18395692.xml
p9411
sg10
VSTD-Peipert-2008
p9412
sg12
S'PMC2535847'
p9413
sasa(dp9414
g3
VCD003570 v. 5.0 Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis.rm5
p9415
sg5
(lp9416
(dp9417
g8
V10992533.xml
p9418
sg10
VSTD-Thio-B-2000
p9419
sg12
S'PMC1745622'
p9420
sa(dp9421
g8
V10992533.xml
p9422
sg10
VSTD-Thio-A-2000
p9423
sg12
S'PMC1745622'
p9424
sa(dp9425
g8
V10992533.xml
p9426
sg10
VSTD-Thio-C-2000
p9427
sg12
S'PMC1745622'
p9428
sasa(dp9429
g3
VCD007124 v. 5.0 Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.rm5
p9430
sg5
(lp9431
(dp9432
g8
V1888646.xml
p9433
sg10
VSTD-McKee-1991
p9434
sg12
S'PMC1368499'
p9435
sasa(dp9436
g3
VCD006243 v. 4.0 Trastuzumab containing regimens for early breast cancer.rm5
p9437
sg5
(lp9438
(dp9439
g8
V21991949.xml
p9440
sg10
VSTD-BCIRG006
p9441
sg12
S'PMC3268553'
p9442
sasa(dp9443
g3
VCD006213 v. 9.0 Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.rm5
p9444
sg5
(lp9445
(dp9446
g8
V1606429.xml
p9447
sg10
VSTD-Khawaja-1992
p9448
sg12
S'PMC1881859'
p9449
sasa(dp9450
g3
VCD004109 v. 4.0 High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and c.rm5
p9451
sg5
(lp9452
(dp9453
g8
V10325913.xml
p9454
sg10
VSTD-Jatakanon-1999
p9455
sg12
S'PMC1745406'
p9456
sa(dp9457
g8
V1978947.xml
p9458
sg10
VSTD-Lorentzson-1990
p9459
sg12
S'PMC462715'
p9460
sasa(dp9461
g3
VCD003557 v. 8.2 Antibiotics and antiseptics for venous leg ulcers.rm5
p9462
sg5
(lp9463
(dp9464
g8
V2669345.xml
p9465
sg10
VSTD-Holloway-1989
p9466
sg12
S'PMC1026946'
p9467
sa(dp9468
g8
V3926169.xml
p9469
sg10
VSTD-Ormiston-1985
p9470
sg12
S'PMC1416577'
p9471
sasa(dp9472
g3
VCD003816 v. 4.9 'Human' insulin versus animal insulin in people with diabetes mellitus.rm5
p9473
sg5
(lp9474
(dp9475
g8
V6416510.xml
p9476
sg10
VSTD-Greene-1983
p9477
sg12
S'PMC1549780'
p9478
sa(dp9479
g8
V6421424.xml
p9480
sg10
VSTD-Holman-1984
p9481
sg12
S'PMC1444374'
p9482
sa(dp9483
g8
V8443479.xml
p9484
sg10
VSTD-Maran-1993
p9485
sg12
S'PMC1676615'
p9486
sa(dp9487
g8
V6416511.xml
p9488
sg10
VSTD-Mann-1983
p9489
sg12
S'PMC1549785'
p9490
sa(dp9491
g8
V1932903.xml
p9492
sg10
VSTD-Egger-1991
p9493
sg12
S'PMC1671054'
p9494
sasa(dp9495
g3
VCD008634 v. 2.0 Psychosocial interventions for reducing antipsychotic medication in care home residents.rm5
p9496
sg5
(lp9497
(dp9498
g8
V16543297.xml
p9499
sg10
VSTD-Fossey-2006
p9500
sg12
S'PMC1420717'
p9501
sasa(dp9502
g3
VCD001107 v. 3.0 Inhaled steroids for episodic viral wheeze of childhood.rm5
p9503
sg5
(lp9504
(dp9505
g8
V9353508.xml
p9506
sg10
VSTD-Duoll-1997
p9507
sg12
S'PMC2127557'
p9508
sa(dp9509
g8
V8435016.xml
p9510
sg10
VSTD-Connett--1993
p9511
sg12
S'PMC1029187'
p9512
sa(dp9513
g8
V7763063.xml
p9514
sg10
VSTD-Wilson-1995
p9515
sg12
S'PMC1511243'
p9516
sa(dp9517
g8
V2189367.xml
p9518
sg10
VSTD-Wilson-1990
p9519
sg12
S'PMC1792186'
p9520
sasa(dp9521
g3
VCD006562 v. 3.0 5-FU for genital warts in non-immunocompromised individuals.rm5
p9522
sg5
(lp9523
(dp9524
g8
V922458.xml
p9525
sg10
VSTD-Wallin-1977
p9526
sg12
S'PMC1045406'
p9527
sasa(dp9528
g3
VCD001261 v. 5.0 Vaccines for preventing typhoid fever.rm5
p9529
sg5
(lp9530
(dp9531
g8
V8432597.xml
p9532
sg10
VSTD-Cryz-1993
p9533
sg12
S'PMC302854'
p9534
sa(dp9535
g8
V6998594.xml
p9536
sg10
VSTD-Wahdan-1980a
p9537
sg12
S'PMC2395909'
p9538
sa(dp9539
g8
V11477965.xml
p9540
sg10
VSTD-Yang-2001
p9541
sg12
S'PMC2566475'
p9542
sa(dp9543
g8
V6998594.xml
p9544
sg10
VSTD-Wahdan-1980b
p9545
sg12
S'PMC2395909'
p9546
sasa(dp9547
g3
VCD001821 v. 8.0 Orthotic devices for the treatment of tennis elbow.rm5
p9548
sg5
(lp9549
(dp9550
g8
V16550446.xml
p9551
sg10
VSTD-Burton-1988
p9552
sg12
S'PMC3454541'
p9553
sasa(dp9554
g3
VCD001145 v. 7.0 Late (7 days) postnatal corticosteroids for chronic lung disease in preterm infants.rm5
p9555
sg5
(lp9556
(dp9557
g8
V8323356.xml
p9558
sg10
VSTD-Kari-1993
p9559
sg12
S'PMC1029304'
p9560
sasa(dp9561
g3
VCD006232 v. 5.2 Routine abdominal drainage for uncomplicated liver resection.rm5
p9562
sg5
(lp9563
(dp9564
g8
V14745327.xml
p9565
sg10
VSTD-Liu-2004
p9566
sg12
S'PMC1356212'
p9567
sasa(dp9568
g3
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p9569
sg5
(lp9570
(dp9571
g8
V22419941.xml
p9572
sg10
VSTD-Szewczyk-2010
p9573
sg12
S'PMC3298351'
p9574
sa(dp9575
g8
V9582132.xml
p9576
sg10
VSTD-Morrell-1998
p9577
sg12
S'PMC28546'
p9578
sa(dp9579
g8
V9682649.xml
p9580
sg10
VSTD-Scriven-1998
p9581
sg12
S'PMC2503021'
p9582
sasa(dp9583
g3
VCD004057 v. 9.0 Individual patient education for low back pain.rm5
p9584
sg5
(lp9585
(dp9586
g8
V2556518.xml
p9587
sg10
VSTD-Roland-1989
p9588
sg12
S'PMC1711929'
p9589
sa(dp9590
g8
V15967762.xml
p9591
sg10
VSTD-Jellema-2005
p9592
sg12
S'PMC558614'
p9593
sa(dp9594
g8
V15377573.xml
p9595
sg10
VSTD-Frost-2004
p9596
sg12
S'PMC518892'
p9597
sasa(dp9598
g3
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p9599
sg5
(lp9600
(dp9601
g8
V11459901.xml
p9602
sg10
VSTD-Rapha_x00eb_l-2001
p9603
sg12
S'PMC1737513'
p9604
sa(dp9605
g8
V21745374.xml
p9606
sg10
VSTD-El_x002d_Bayoumi-2011
p9607
sg12
S'PMC3387601'
p9608
sasa(dp9609
g3
VCD001283 v. 11.1 Dietary marine fatty acids (fish oil) for asthma in adults and children.rm5
p9610
sg5
(lp9611
(dp9612
g8
V3353893.xml
p9613
sg10
VSTD-Arm-1988
p9614
sg12
S'PMC1020747'
p9615
sasa(dp9616
g3
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p9617
sg5
(lp9618
(dp9619
g8
V18377127.xml
p9620
sg10
VSTD-Petry-2008
p9621
sg12
S'PMC2738749'
p9622
sa(dp9623
g8
V19721120.xml
p9624
sg10
VSTD-Grant-2009
p9625
sg12
S'PMC2801822'
p9626
sa(dp9627
g8
V19967577.xml
p9628
sg10
VSTD-Carlbring-2010
p9629
sg12
S'PMC2882846'
p9630
sa(dp9631
g8
V19686527.xml
p9632
sg10
VSTD-Petry-2009
p9633
sg12
S'PMC2758481'
p9634
sasa(dp9635
g3
VCD008997 v. 2.0 Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stag.rm5
p9636
sg5
(lp9637
(dp9638
g8
V12631671.xml
p9639
sg10
VSTD-Tebutt-2003
p9640
sg12
S'PMC1773619'
p9641
sasa(dp9642
g3
VCD006186 v. 4.0 Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular .rm5
p9643
sg5
(lp9644
(dp9645
g8
V10514159.xml
p9646
sg10
VSTD-PATAF
p9647
sg12
S'PMC28250'
p9648
sasa(dp9649
g3
VCD004726 v. 4.3 Education of children and adolescents for the prevention of dog bite injuries.rm5
p9650
sg5
(lp9651
(dp9652
g8
V10834894.xml
p9653
sg10
VSTD-Chapman-2000
p9654
sg12
S'PMC27395'
p9655
sasa(dp9656
g3
VCD005268 v. 2.2 Individual patient education for people with type 2 diabetes mellitus.rm5
p9657
sg5
(lp9658
(dp9659
g8
V9219407.xml
p9660
sg10
VSTD-Hawthorne-1997
p9661
sg12
S'PMC1313005'
p9662
sasa(dp9663
g3
VCD003264 v. 11.0 Growth hormone for children with chronic kidney disease.rm5
p9664
sg5
(lp9665
(dp9666
g8
V20522533.xml
p9667
sg10
VSTD-Santos-2010-_x0028_preD_x002f_Dial_x0029_
p9668
sg12
S'PMC2893059'
p9669
sa(dp9670
g8
V10210991.xml
p9671
sg10
VSTD-Maxwell-1998a-_x0028_TP_x0029_
p9672
sg12
S'PMC1717762'
p9673
sa(dp9674
g8
V10210991.xml
p9675
sg10
VSTD-Maxwell-1998b-_x0028_TP_x0029_
p9676
sg12
S'PMC1717762'
p9677
sasa(dp9678
g3
VCD001484 v. 9.0 Elastic compression stockings for prevention of deep vein thrombosis.rm5
p9679
sg5
(lp9680
(dp9681
g8
V788855.xml
p9682
sg10
VSTD-Holford-1976
p9683
sg12
S'PMC1689300'
p9684
sasa(dp9685
g3
VCD000227 v. 9.0 Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-men.rm5
p9686
sg5
(lp9687
(dp9688
g8
V12609940.xml
p9689
sg10
VSTD-Trivedi-2003
p9690
sg12
S'PMC150177'
p9691
sa(dp9692
g8
V15860827.xml
p9693
sg10
VSTD-Porthouse-2005
p9694
sg12
S'PMC557150'
p9695
sa(dp9696
g8
V9886454.xml
p9697
sg10
VSTD-Sato-1999a
p9698
sg12
S'PMC1736147'
p9699
sasa(dp9700
g3
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p9701
sg5
(lp9702
(dp9703
g8
V16055451.xml
p9704
sg10
VSTD-Melchart-2005
p9705
sg12
S'PMC1184247'
p9706
sa(dp9707
g8
V17955168.xml
p9708
sg10
VSTD-Endres-2007
p9709
sg12
S'PMC3476149'
p9710
sasa(dp9711
g3
VCD004731 v. 9.0 Protein substitute for children and adults with phenylketonuria.rm5
p9712
sg5
(lp9713
(dp9714
g8
V16547085.xml
p9715
sg10
VSTD-MacDonald-2006b
p9716
sg12
S'PMC2082836'
p9717
sasa(dp9718
g3
VCD008456 v. 2.0 Psychosocial interventions for the management of chronic orofacial pain.rm5
p9719
sg5
(lp9720
(dp9721
g8
V20655662.xml
p9722
sg10
VSTD-Litt-2010
p9723
sg12
S'PMC2939176'
p9724
sasa(dp9725
g3
VCD007991 v. 2.16 Zinc supplementation for mental and motor development in children.rm5
p9726
sg5
(lp9727
(dp9728
g8
V20484548.xml
p9729
sg10
VSTD-Katz-2010
p9730
sg12
S'PMC2884332'
p9731
sasa(dp9732
g3
VCD006734 v. 4.0 Interventions for preventing late postnatal mother-to-child transmission of HIV.rm5
p9733
sg5
(lp9734
(dp9735
g8
V18525036.xml
p9736
sg10
VSTD-Kuhn-2008
p9737
sg12
S'PMC2577610'
p9738
sasa(dp9739
g3
VCD007411 v. 11.0 Antioxidants for male subfertility.rm5
p9740
sg5
(lp9741
(dp9742
g8
V22659579.xml
p9743
sg10
VSTD-Safarinejad-2009
p9744
sg12
S'PMC3720081'
p9745
sasa(dp9746
g3
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p9747
sg5
(lp9748
(dp9749
g8
V18472878.xml
p9750
sg10
VSTD-Watts-1994
p9751
sg12
S'PMC2366143'
p9752
sasa(dp9753
g3
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p9754
sg5
(lp9755
(dp9756
g8
V9678143.xml
p9757
sg10
VSTD-Hibbard-1998
p9758
sg12
S'PMC1784771'
p9759
sasa(dp9760
g3
VCD003487 v. 5.2 Transpyloric versus gastric tube feeding for preterm infants.rm5
p9761
sg5
(lp9762
(dp9763
g8
V3082297.xml
p9764
sg10
VSTD-Laing-1986
p9765
sg12
S'PMC1777578'
p9766
sa(dp9767
g8
V1586185.xml
p9768
sg10
VSTD-Macdonald-1992
p9769
sg12
S'PMC1590483'
p9770
sa(dp9771
g8
V6810764.xml
p9772
sg10
VSTD-Whitfield-1982
p9773
sg12
S'PMC1627713'
p9774
sasa(dp9775
g3
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p9776
sg5
(lp9777
(dp9778
g8
V20937130.xml
p9779
sg10
VSTD-Webster-2010a
p9780
sg12
S'PMC2958861'
p9781
sasa(dp9782
g3
VCD009073 v. 2.0 Pedicle screw fixation for traumatic fractures of the thoracic and lumbar spine.rm5
p9783
sg5
(lp9784
(dp9785
g8
V20495932.xml
p9786
sg10
VSTD-Farrokhi-2010
p9787
sg12
S'PMC2989232'
p9788
sasa(dp9789
g3
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p9790
sg5
(lp9791
(dp9792
g8
V5079408.xml
p9793
sg10
VSTD-Daniel-1972
p9794
sg12
S'PMC1215343'
p9795
sa(dp9796
g8
V6372855.xml
p9797
sg10
VSTD-Hung-1984
p9798
sg12
S'PMC1040361'
p9799
sa(dp9800
g8
V19668521.xml
p9801
sg10
VSTD-Colin-2007a
p9802
sg12
S'PMC2704535'
p9803
sa(dp9804
g8
V19668521.xml
p9805
sg10
VSTD-Colin-2007b
p9806
sg12
S'PMC2704535'
p9807
sa(dp9808
g8
V6179534.xml
p9809
sg10
VSTD-de-Koning-1982
p9810
sg12
S'PMC1039837'
p9811
sa(dp9812
g8
V14193681.xml
p9813
sg10
VSTD-MacKenzie-1964
p9814
sg12
S'PMC505953'
p9815
sa(dp9816
g8
V14249189.xml
p9817
sg10
VSTD-Davidson-1964
p9818
sg12
S'PMC506041'
p9819
sa(dp9820
g8
V418546.xml
p9821
sg10
VSTD-Laibson-1977
p9822
sg12
S'PMC1311553'
p9823
sa(dp9824
g8
V7000170.xml
p9825
sg10
VSTD-Coster-1980
p9826
sg12
S'PMC1043812'
p9827
sa(dp9828
g8
V7043864.xml
p9829
sg10
VSTD-Yeakley-1981
p9830
sg12
S'PMC1312181'
p9831
sa(dp9832
g8
V23801989.xml
p9833
sg10
VSTD-Yamazaki-1984b
p9834
sg12
S'PMC3689032'
p9835
sa(dp9836
g8
V23671647.xml
p9837
sg10
VSTD-Kitano-1985
p9838
sg12
S'PMC3650034'
p9839
sa(dp9840
g8
V14189714.xml
p9841
sg10
VSTD-Luntz-1963
p9842
sg12
S'PMC505831'
p9843
sa(dp9844
g8
V6809036.xml
p9845
sg10
VSTD-La-Lau-1982
p9846
sg12
S'PMC1039836'
p9847
sa(dp9848
g8
V111704.xml
p9849
sg10
VSTD-Coster-1979
p9850
sg12
S'PMC1043501'
p9851
sa(dp9852
g8
V23801989.xml
p9853
sg10
VSTD-Yamazaki-1984c
p9854
sg12
S'PMC3689032'
p9855
sa(dp9856
g8
V7000171.xml
p9857
sg10
VSTD-Collum-1980
p9858
sg12
S'PMC1043813'
p9859
sa(dp9860
g8
V1751456.xml
p9861
sg10
VSTD-Power-1991
p9862
sg12
S'PMC1042518'
p9863
sa(dp9864
g8
V3904820.xml
p9865
sg10
VSTD-Collum-1985
p9866
sg12
S'PMC1040757'
p9867
sa(dp9868
g8
V3521717.xml
p9869
sg10
VSTD-Collum-1986
p9870
sg12
S'PMC1041036'
p9871
sa(dp9872
g8
V2669938.xml
p9873
sg10
VSTD-Van-Bijsterveld-1989
p9874
sg12
S'PMC1041826'
p9875
sa(dp9876
g8
V7044411.xml
p9877
sg10
VSTD-Young-1982
p9878
sg12
S'PMC1039800'
p9879
sa(dp9880
g8
V6766733.xml
p9881
sg10
VSTD-Van-Bijsterveld-1980
p9882
sg12
S'PMC1039344'
p9883
sasa(dp9884
g3
VCD003724 v. 6.0 Antidepressant drugs for narcolepsy.rm5
p9885
sg5
(lp9886
(dp9887
g8
V6766990.xml
p9888
sg10
VSTD-Schachter-1980
p9889
sg12
S'PMC490494'
p9890
sa(dp9891
g8
V1968069.xml
p9892
sg10
VSTD-Mitler-1990
p9893
sg12
S'PMC2254143'
p9894
sasa(dp9895
g3
VCD006765 v. 4.2 Chuanxiong preparations for preventing stroke.rm5
p9896
sg5
(lp9897
(dp9898
g8
V23970729.xml
p9899
sg10
VSTD-Wang-2006
p9900
sg12
S'PMC3747914'
p9901
sasa(dp9902
g3
VCD003135 v. 7.0 Fluticasone versus placebo for chronic asthma in adults and children.rm5
p9903
sg5
(lp9904
(dp9905
g8
V10212103.xml
p9906
sg10
VSTD-van-Rensen-1999
p9907
sg12
S'PMC1763792'
p9908
sa(dp9909
g8
V14694242.xml
p9910
sg10
VSTD-Phillips-2004
p9911
sg12
S'PMC1758859'
p9912
sa(dp9913
g8
V15681495.xml
p9914
sg10
VSTD-Jayaram-2005
p9915
sg12
S'PMC1747311'
p9916
sa(dp9917
g8
V10319057.xml
p9918
sg10
VSTD-Faul-1998
p9919
sg12
S'PMC1745308'
p9920
sa(dp9921
g8
V12775860.xml
p9922
sg10
VSTD-Sovij_x00e4_rvi-2003
p9923
sg12
S'PMC1746689'
p9924
sa(dp9925
g8
V11923548.xml
p9926
sg10
VSTD-Ward-2001
p9927
sg12
S'PMC1746305'
p9928
sasa(dp9929
g3
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p9930
sg5
(lp9931
(dp9932
g8
V14710214.xml
p9933
sg10
VSTD-Albrecht-2004
p9934
sg12
S'PMC2395315'
p9935
sa(dp9936
g8
V8512828.xml
p9937
sg10
VSTD-Francini-1993
p9938
sg12
S'PMC1968505'
p9939
sasa(dp9940
g3
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p9941
sg5
(lp9942
(dp9943
g8
V19666658.xml
p9944
sg10
VSTD-Fan-2009
p9945
sg12
S'PMC2781155'
p9946
sa(dp9947
g8
V18385391.xml
p9948
sg10
VSTD-Cheng-2008
p9949
sg12
S'PMC2440276'
p9950
sa(dp9951
g8
V19158369.xml
p9952
sg10
VSTD-McIntyre-2009
p9953
sg12
S'PMC2637599'
p9954
sa(dp9955
g8
V18199805.xml
p9956
sg10
VSTD-Ferreira-2008
p9957
sg12
S'PMC2396748'
p9958
sa(dp9959
g8
V18579668.xml
p9960
sg10
VSTD-FORESEE-Study-2008
p9961
sg12
S'PMC2518797'
p9962
sa(dp9963
g8
V19056618.xml
p9964
sg10
VSTD-Sprague-2009a
p9965
sg12
S'PMC2615694'
p9966
sa(dp9967
g8
V18193489.xml
p9968
sg10
VSTD-Tzanakis-2008
p9969
sg12
S'PMC2268719'
p9970
sasa(dp9971
g3
VCD004402 v. 10.4 Steroids for symptom control in infectious mononucleosis.rm5
p9972
sg5
(lp9973
(dp9974
g8
V4556193.xml
p9975
sg10
VSTD-Bolden-1972
p9976
sg12
S'PMC2156555'
p9977
sasa(dp9978
g3
VCD002238 v. 8.0 Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).rm5
p9979
sg5
(lp9980
(dp9981
g8
V13293381.xml
p9982
sg10
VSTD-Mayon_x002d_White-1956
p9983
sg12
S'PMC1979017'
p9984
sasa(dp9985
g3
VCD006634 v. 2.0 Probiotics for induction of remission in Crohn's disease.rm5
p9986
sg5
(lp9987
(dp9988
g8
V15113451.xml
p9989
sg10
VSTD-Schultz-2004
p9990
sg12
S'PMC394324'
p9991
sasa(dp9992
g3
VCD005569 v. 3.0 Chuanxiong-type preparations for acute ischemic stroke.rm5
p9993
sg5
(lp9994
(dp9995
g8
V22645373.xml
p9996
sg10
VSTD-Fan-2003
p9997
sg12
S'PMC3386091'
p9998
sasa(dp9999
g3
VCD003494 v. 11.0 Psychosocial interventions by general practitioners.rm5
p10000
sg5
(lp10001
(dp10002
g8
V7873952.xml
p10003
sg10
VSTD-Mynors_x002d_Wallis-1995
p10004
sg12
S'PMC2548821'
p10005
sa(dp10006
g8
V10617523.xml
p10007
sg10
VSTD-Mynors_x002d_Wallis-2000
p10008
sg12
S'PMC27250'
p10009
sa(dp10010
g8
V9386883.xml
p10011
sg10
VSTD-McIntosh-1997
p10012
sg12
S'PMC2255191'
p10013
sasa(dp10014
g3
VCD003472 v. 4.0 Exercise therapy for patellofemoral pain syndrome.rm5
p10015
sg5
(lp10016
(dp10017
g8
V10976083.xml
p10018
sg10
VSTD-Clark-2000
p10019
sg12
S'PMC1753277'
p10020
sasa(dp10021
g3
VCD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
p10022
sg5
(lp10023
(dp10024
g8
V326349.xml
p10025
sg10
VSTD-Hillstroem-1977
p10026
sg12
S'PMC1045390'
p10027
sa(dp10028
g8
V769913.xml
p10029
sg10
VSTD-Hayward-1976
p10030
sg12
S'PMC1045214'
p10031
sa(dp10032
g8
V4348437.xml
p10033
sg10
VSTD-Lean-1972
p10034
sg12
S'PMC1044856'
p10035
sa(dp10036
g8
V322823.xml
p10037
sg10
VSTD-Notowicz-1977
p10038
sg12
S'PMC1045370'
p10039
sa(dp10040
g8
V4939601.xml
p10041
sg10
VSTD-Evans-1971
p10042
sg12
S'PMC1799017'
p10043
sa(dp10044
g8
V5015963.xml
p10045
sg10
VSTD-McClean-1972
p10046
sg12
S'PMC1048274'
p10047
sa(dp10048
g8
V389352.xml
p10049
sg10
VSTD-Thin-1979
p10050
sg12
S'PMC1045680'
p10051
sa(dp10052
g8
V4913962.xml
p10053
sg10
VSTD-Evans-1970
p10054
sg12
S'PMC1700140'
p10055
sa(dp10056
g8
V7039761.xml
p10057
sg10
VSTD-Austin-1982
p10058
sg12
S'PMC1046021'
p10059
sa(dp10060
g8
V1092425.xml
p10061
sg10
VSTD-Wigfield-1975
p10062
sg12
S'PMC1045112'
p10063
sa(dp10064
g8
V13426568.xml
p10065
sg10
VSTD-Barnes-1957
p10066
sg12
S'PMC1973492'
p10067
sa(dp10068
g8
V1098732.xml
p10069
sg10
VSTD-Roy-1975
p10070
sg12
S'PMC1046566'
p10071
sa(dp10072
g8
V23761847.xml
p10073
sg10
VSTD-Block-1972
p10074
sg12
S'PMC3675863'
p10075
sa(dp10076
g8
V963493.xml
p10077
sg10
VSTD-Eriksson-1976
p10078
sg12
S'PMC1045280'
p10079
sasa(dp10080
g3
VCD002309 v. 5.4 Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.rm5
p10081
sg5
(lp10082
(dp10083
g8
V17573446.xml
p10084
sg10
VSTD-Grootendorst-2007
p10085
sg12
S'PMC2094292'
p10086
sasa(dp10087
g3
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p10088
sg5
(lp10089
(dp10090
g8
V18591307.xml
p10091
sg10
VSTD-Brubaker-2008
p10092
sg12
S'PMC2614233'
p10093
sa(dp10094
g8
V19834635.xml
p10095
sg10
VSTD-Dietz-2010
p10096
sg12
S'PMC2808513'
p10097
sa(dp10098
g8
V22183220.xml
p10099
sg10
VSTD-Sung-2012
p10100
sg12
S'PMC3244827'
p10101
sa(dp10102
g8
V19583714.xml
p10103
sg10
VSTD-Carey-2009
p10104
sg12
S'PMC2774153'
p10105
sa(dp10106
g8
V22716974.xml
p10107
sg10
VSTD-Wei-2011
p10108
sg12
S'PMC3433843'
p10109
sasa(dp10110
g3
VCD004856 v. 6.0 Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adol.rm5
p10111
sg5
(lp10112
(dp10113
g8
V18356758.xml
p10114
sg10
VSTD-Freeman--2008
p10115
sg12
S'PMC2820297'
p10116
sasa(dp10117
g3
VCD005523 v. 4.0 Aquatic exercise for the treatment of knee and hip osteoarthritis.rm5
p10118
sg5
(lp10119
(dp10120
g8
V14644853.xml
p10121
sg10
VSTD-Foley-2003
p10122
sg12
S'PMC1754378'
p10123
sasa(dp10124
g3
VCD009219 v. 3.0 Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.rm5
p10125
sg5
(lp10126
(dp10127
g8
V19813275.xml
p10128
sg10
VSTD-Katzenstein-2009
p10129
sg12
S'PMC2795100'
p10130
sasa(dp10131
g3
VCD009584 v. 2.0 Specially formulated foods for treating children with moderate acute malnutrition in low- and middle.rm5
p10132
sg5
(lp10133
(dp10134
g8
V22170366.xml
p10135
sg10
VSTD-LaGrone-2012
p10136
sg12
S'PMC3238461'
p10137
sa(dp10138
g8
V19225128.xml
p10139
sg10
VSTD-Matilsky-2009
p10140
sg12
S'PMC3151028'
p10141
sa(dp10142
g8
V20871416.xml
p10143
sg10
VSTD-Hossain-2011
p10144
sg12
S'PMC3020319'
p10145
sasa(dp10146
g3
VCD003197 v. 8.0 Low dosage tricyclic antidepressants for depression.rm5
p10147
sg5
(lp10148
(dp10149
g8
V10591711.xml
p10150
sg10
VSTD-Philipp_x0028_100_x0029_
p10151
sg12
S'PMC28296'
p10152
sa(dp10153
g8
V4923928.xml
p10154
sg10
VSTD-Blashki_x0028_75_x0026_150_x0029_
p10155
sg12
S'PMC1795147'
p10156
sa(dp10157
g8
V8018452.xml
p10158
sg10
VSTD-Tan_x0028_70_x0029_
p10159
sg12
S'PMC1364731'
p10160
sasa(dp10161
g3
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p10162
sg5
(lp10163
(dp10164
g8
V19400893.xml
p10165
sg10
VSTD-Feary-2009a
p10166
sg12
S'PMC2728895'
p10167
sasa(dp10168
g3
VCD002776 v. 4.0 Prophylactic vitamin K for vitamin K deficiency bleeding in neonates.rm5
p10169
sg5
(lp10170
(dp10171
g8
V1444522.xml
p10172
sg10
VSTD-Cornelissen-1992
p10173
sg12
S'PMC1793939'
p10174
sa(dp10175
g8
V9875038.xml
p10176
sg10
VSTD-Greer-1998
p10177
sg12
S'PMC1717721'
p10178
sasa(dp10179
g3
VCD005584 v. 5.0 Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleed.rm5
p10180
sg5
(lp10181
(dp10182
g8
V8200551.xml
p10183
sg10
VSTD-Choudari-1994
p10184
sg12
S'PMC1374741'
p10185
sa(dp10186
g8
V10205211.xml
p10187
sg10
VSTD-Lin-1999
p10188
sg12
S'PMC1727515'
p10189
sa(dp10190
g8
V8406150.xml
p10191
sg10
VSTD-Lin-1993
p10192
sg12
S'PMC1375450'
p10193
sa(dp10194
g8
V1955161.xml
p10195
sg10
VSTD-Loizou-1991
p10196
sg12
S'PMC1379366'
p10197
sa(dp10198
g8
V9158465.xml
p10199
sg10
VSTD-Chung-1997
p10200
sg12
S'PMC2126544'
p10201
sasa(dp10202
g3
VCD002798 v. 11.0 Benzodiazepine receptor antagonists for hepatic encephalopathy.rm5
p10203
sg5
(lp10204
(dp10205
g8
V8977350.xml
p10206
sg10
VSTD-Gyr-1996
p10207
sg12
S'PMC1383318'
p10208
sasa(dp10209
g3
VCD004789 v. 7.0 D-penicillamine for primary biliary cirrhosis.rm5
p10210
sg5
(lp10211
(dp10212
g8
V3881323.xml
p10213
sg10
VSTD-Neuberger-1985
p10214
sg12
S'PMC1432420'
p10215
sasa(dp10216
g3
VCD006117 v. 10.0 Sertraline versus other antidepressive agents for depression.rm5
p10217
sg5
(lp10218
(dp10219
g8
V12053635.xml
p10220
sg10
VSTD-Van-Gurp-2002
p10221
sg12
S'PMC2214056'
p10222
sasa(dp10223
g3
VCD009660 v. 2.0 Psychological interventions for parents of children and adolescents with chronic illness.rm5
p10224
sg5
(lp10225
(dp10226
g8
V19091806.xml
p10227
sg10
VSTD-Stehl-2009
p10228
sg12
S'PMC2734126'
p10229
sa(dp10230
g8
V20686425.xml
p10231
sg10
VSTD-Barakat-2010
p10232
sg12
S'PMC2950888'
p10233
sa(dp10234
g8
V20216531.xml
p10235
sg10
VSTD-Levy-2010
p10236
sg12
S'PMC2887246'
p10237
sa(dp10238
g8
V20167185.xml
p10239
sg10
VSTD-Lehmkuhl-2010
p10240
sg12
S'PMC2825642'
p10241
sa(dp10242
g8
V22108765.xml
p10243
sg10
VSTD-Kashikar_x002d_Zuck-2012
p10244
sg12
S'PMC3690664'
p10245
sa(dp10246
g8
V19091804.xml
p10247
sg10
VSTD-Askins-2009
p10248
sg12
S'PMC2684487'
p10249
sa(dp10250
g8
V18540868.xml
p10251
sg10
VSTD-Ambrosino-2008
p10252
sg12
S'PMC2936820'
p10253
sa(dp10254
g8
V21890828.xml
p10255
sg10
VSTD-Wade-2011
p10256
sg12
S'PMC3387908'
p10257
sa(dp10258
g8
V21522034.xml
p10259
sg10
VSTD-Grey-2011
p10260
sg12
S'PMC3134246'
p10261
sa(dp10262
g8
V373642.xml
p10263
sg10
VSTD-Lask-1979
p10264
sg12
S'PMC1545376'
p10265
sa(dp10266
g8
V19695776.xml
p10267
sg10
VSTD-Palermo-2009
p10268
sg12
S'PMC2760656'
p10269
sasa(dp10270
g3
VCD006836 v. 4.0 Bone grafts and bone substitutes for treating distal radial fractures in adults.rm5
p10271
sg5
(lp10272
(dp10273
g8
V11954842.xml
p10274
sg10
VSTD-Widman-2002
p10275
sg12
S'PMC3620860'
p10276
sasa(dp10277
g3
VCD002018 v. 6.0 Antidepressant treatment for post-natal depression.rm5
p10278
sg5
(lp10279
(dp10280
g8
V9099116.xml
p10281
sg10
VSTD-Appleby-1997
p10282
sg12
S'PMC2126383'
p10283
sasa(dp10284
g3
VCD006373 v. 3.0 Interventions for treating functional dysphonia in adults.rm5
p10285
sg5
(lp10286
(dp10287
g8
V11566828.xml
p10288
sg10
VSTD-MacKenzie-2001
p10289
sg12
S'PMC55924'
p10290
sasa(dp10291
g3
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p10292
sg5
(lp10293
(dp10294
g8
V15505268.xml
p10295
sg10
VSTD-Dormuth-2004
p10296
sg12
S'PMC526331'
p10297
sa(dp10298
g8
V17547760.xml
p10299
sg10
VSTD-Perria-2007
p10300
sg12
S'PMC1904445'
p10301
sa(dp10302
g8
V12448802.xml
p10303
sg10
VSTD-Black-2002
p10304
sg12
S'PMC1743616'
p10305
sa(dp10306
g8
V17610535.xml
p10307
sg10
VSTD-Kabir-2007
p10308
sg12
S'PMC2000662'
p10309
sa(dp10310
g8
V11701573.xml
p10311
sg10
VSTD-Mason-2001
p10312
sg12
S'PMC59683'
p10313
sa(dp10314
g8
V8204331.xml
p10315
sg10
VSTD-Oakeshott-1994
p10316
sg12
S'PMC1238864'
p10317
sasa(dp10318
g3
VCD001434 v. 12.5 Topical treatments for fungal infections of the skin and nails of the foot..rm5
p10319
sg5
(lp10320
(dp10321
g8
V8401048.xml
p10322
sg10
VSTD-Evans-1993b
p10323
sg12
S'PMC1679014'
p10324
sasa(dp10325
g3
VCD005351 v. 3.2 Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.rm5
p10326
sg5
(lp10327
(dp10328
g8
V14988338.xml
p10329
sg10
VSTD-Crane-2004
p10330
sg12
S'PMC1726258'
p10331
sasa(dp10332
g3
VCD003433 v. 7.0 Beta radiation for glaucoma surgery.rm5
p10333
sg5
(lp10334
(dp10335
g8
V17023435.xml
p10336
sg10
VSTD-Kirwan-2006
p10337
sg12
S'PMC1633773'
p10338
sasa(dp10339
g3
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p10340
sg5
(lp10341
(dp10342
g8
V15667657.xml
p10343
sg10
VSTD-Carey-2005
p10344
sg12
S'PMC547907'
p10345
sasa(dp10346
g3
VCD008300 v. 2.2 Treating BCG-induced disease in children.rm5
p10347
sg5
(lp10348
(dp10349
g8
V7826118.xml
p10350
sg10
VSTD-Banani-1994
p10351
sg12
S'PMC1030063'
p10352
sasa(dp10353
g3
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p10354
sg5
(lp10355
(dp10356
g8
V21454449.xml
p10357
sg10
VSTD-Norrkoping
p10358
sg12
S'PMC3069219'
p10359
sa(dp10360
g8
V22228146.xml
p10361
sg10
VSTD-PLCO
p10362
sg12
S'PMC3260132'
p10363
sasa(dp10364
g3
VCD001016 v. 5.0 Cyclical progestogens for heavy menstrual bleeding.rm5
p10365
sg5
(lp10366
(dp10367
g8
V1835005.xml
p10368
sg10
VSTD-Bonduelle-1991
p10369
sg12
S'PMC2399106'
p10370
sasa(dp10371
g3
VCD005590 v. 5.0 Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.rm5
p10372
sg5
(lp10373
(dp10374
g8
V2327768.xml
p10375
sg10
VSTD-Liang-1990
p10376
sg12
S'PMC171559'
p10377
sasa(dp10378
g3
VCD005113 v. 5.0 Adalimumab for treating rheumatoid arthritis.rm5
p10379
sg5
(lp10380
(dp10381
g8
V14644854.xml
p10382
sg10
VSTD-Van-de-Putte-2003
p10383
sg12
S'PMC1754401'
p10384
sa(dp10385
g8
V15082480.xml
p10386
sg10
VSTD-Van-de-Putte-2004
p10387
sg12
S'PMC1755008'
p10388
sasa(dp10389
g3
VCD004890 v. 7.0 Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct .rm5
p10390
sg5
(lp10391
(dp10392
g8
V11600473.xml
p10393
sg10
VSTD-Yasuda-2001
p10394
sg12
S'PMC1728521'
p10395
sa(dp10396
g8
V12865276.xml
p10397
sg10
VSTD-Vlavianos-2003
p10398
sg12
S'PMC1773772'
p10399
sasa(dp10400
g3
VCD009779 v. 2.0 Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative mana.rm5
p10401
sg5
(lp10402
(dp10403
g8
V17197959.xml
p10404
sg10
VSTD-Oria-2007
p10405
sg12
S'PMC1867927'
p10406
sasa(dp10407
g3
VCD006754 v. 5.0 Anticonvulsants for cocaine dependence.rm5
p10408
sg5
(lp10409
(dp10410
g8
V7555621.xml
p10411
sg10
VSTD-Montoya-1994
p10412
sg12
S'PMC2633654'
p10413
sasa(dp10414
g3
VCD008886 v. 2.0 Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis ankylosing .rm5
p10415
sg5
(lp10416
(dp10417
g8
V4555545.xml
p10418
sg10
VSTD-Beales-1972
p10419
sg12
S'PMC1788331'
p10420
sa(dp10421
g8
V389264.xml
p10422
sg10
VSTD-Grennan-1979
p10423
sg12
S'PMC1429811'
p10424
sa(dp10425
g8
V4571392.xml
p10426
sg10
VSTD-Sperryn-1973
p10427
sg12
S'PMC1006067'
p10428
sasa(dp10429
g3
VCD006546 v. 4.0 Kinship care for the safety permanency and well-being of children removed from the home for maltre.rm5
p10430
sg5
(lp10431
(dp10432
g8
V19436468.xml
p10433
sg10
VSTD-Belanger-2002
p10434
sg12
S'PMC2661342'
p10435
sa(dp10436
g8
V22529281.xml
p10437
sg10
VSTD-Jonson_x002d_Reid-2003
p10438
sg12
S'PMC3340591'
p10439
sa(dp10440
g8
V23517028.xml
p10441
sg10
VSTD-Christopher-1998
p10442
sg12
S'PMC3654563'
p10443
sasa(dp10444
g3
VCD001025 v. 14.0 Counselling for mental health and psychosocial problems in primary care.rm5
p10445
sg5
(lp10446
(dp10447
g8
V9624744.xml
p10448
sg10
VSTD-Harvey-1998
p10449
sg12
S'PMC1410004'
p10450
sa(dp10451
g8
V11282864.xml
p10452
sg10
VSTD-Chilvers-2001
p10453
sg12
S'PMC30555'
p10454
sasa(dp10455
g3
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p10456
sg5
(lp10457
(dp10458
g8
V7082061.xml
p10459
sg10
VSTD-Bennett-1982
p10460
sg12
S'PMC1352659'
p10461
sa(dp10462
g8
V9876706.xml
p10463
sg10
VSTD-Rosen-1998
p10464
sg12
S'PMC3015270'
p10465
sasa(dp10466
g3
VCD002943 v. 6.0 Strategies for increasing the participation of women in community breast cancer screening.rm5
p10467
sg5
(lp10468
(dp10469
g8
V7646664.xml
p10470
sg10
VSTD-Lantz-1995
p10471
sg12
S'PMC1615506'
p10472
sa(dp10473
g8
V1566953.xml
p10474
sg10
VSTD-Lerman-1992
p10475
sg12
S'PMC1694134'
p10476
sa(dp10477
g8
V8138773.xml
p10478
sg10
VSTD-Sutton-1994
p10479
sg12
S'PMC1059897'
p10480
sa(dp10481
g8
V1641433.xml
p10482
sg10
VSTD-Sung-1992
p10483
sg12
S'PMC1403667'
p10484
sa(dp10485
g8
V9402779.xml
p10486
sg10
VSTD-Atri-1997
p10487
sg12
S'PMC2127854'
p10488
sa(dp10489
g8
V9357355.xml
p10490
sg10
VSTD-Janz-1997
p10491
sg12
S'PMC1381136'
p10492
sasa(dp10493
g3
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p10494
sg5
(lp10495
(dp10496
g8
V14514935.xml
p10497
sg10
VSTD-Barbanel-2003
p10498
sg12
S'PMC1746491'
p10499
sa(dp10500
g8
V17662113.xml
p10501
sg10
VSTD-Willems-2007a
p10502
sg12
S'PMC2000864'
p10503
sa(dp10504
g8
V12609944.xml
p10505
sg10
VSTD-Pinnock-2003
p10506
sg12
S'PMC150181'
p10507
sa(dp10508
g8
V15720933.xml
p10509
sg10
VSTD-Pinnock-2005
p10510
sg12
S'PMC1463186'
p10511
sa(dp10512
g8
V17761059.xml
p10513
sg10
VSTD-Pinnock-2007
p10514
sg12
S'PMC2151786'
p10515
sa(dp10516
g8
V16378560.xml
p10517
sg10
VSTD-Gruffydd_x002d_Jones-2005
p10518
sg12
S'PMC1570530'
p10519
sasa(dp10520
g3
VCD008990 v. 2.0 Recombinant human growth hormone for treating burns and donor sites.rm5
p10521
sg5
(lp10522
(dp10523
g8
V2121109.xml
p10524
sg10
VSTD-Herndon-1990
p10525
sg12
S'PMC1358272'
p10526
sa(dp10527
g8
V8024354.xml
p10528
sg10
VSTD-Gilpin-1994
p10529
sg12
S'PMC1234282'
p10530
sa(dp10531
g8
V16772783.xml
p10532
sg10
VSTD-Przkora-2006
p10533
sg12
S'PMC1479605'
p10534
sasa(dp10535
g3
VCD008179 v. 2.1 Non-pharmacological interventions for caregivers of stroke survivors.rm5
p10536
sg5
(lp10537
(dp10538
g8
V14703521.xml
p10539
sg10
VSTD-Kalra-2004
p10540
sg12
S'PMC313879'
p10541
sasa(dp10542
g3
VCD001880 v. 10.0 Nutritional supplementation for hip fracture aftercare in older people.rm5
p10543
sg5
(lp10544
(dp10545
g8
V22232695.xml
p10546
sg10
VSTD-Madigan-1994
p10547
sg12
S'PMC3268331'
p10548
sa(dp10549
g8
V6416514.xml
p10550
sg10
VSTD-Bastow-1983
p10551
sg12
S'PMC1549800'
p10552
sasa(dp10553
g3
VCD008976 v. 2.0 Gemcitabine for unresectable locally advanced or metastatic bladder cancer.rm5
p10554
sg5
(lp10555
(dp10556
g8
V19786668.xml
p10557
sg10
VSTD-De-Santis-2009
p10558
sg12
S'PMC2792956'
p10559
sasa(dp10560
g3
VCD004105 v. 5.0 Prophylactic antibiotic therapy for chronic bronchitis.rm5
p10561
sg5
(lp10562
(dp10563
g8
V4899454.xml
p10564
sg10
VSTD-Johnston-1969
p10565
sg12
S'PMC1629696'
p10566
sa(dp10567
g8
V13824401.xml
p10568
sg10
VSTD-Francis-1960
p10569
sg12
S'PMC1966487'
p10570
sa(dp10571
g8
V14452159.xml
p10572
sg10
VSTD-Johnston-1961
p10573
sg12
S'PMC1970174'
p10574
sa(dp10575
g8
V13824401.xml
p10576
sg10
VSTD-Francis-1960-arm-1
p10577
sg12
S'PMC1966487'
p10578
sa(dp10579
g8
V13824401.xml
p10580
sg10
VSTD-Francis-1960-arm-2
p10581
sg12
S'PMC1966487'
p10582
sasa(dp10583
g3
VCD007443 v. 2.0 Probiotics for maintenance of remission in ulcerative colitis.rm5
p10584
sg5
(lp10585
(dp10586
g8
V15479682.xml
p10587
sg10
VSTD-Kruis-2004
p10588
sg12
S'PMC1774300'
p10589
sasa(dp10590
g3
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p10591
sg5
(lp10592
(dp10593
g8
V17147808.xml
p10594
sg10
VSTD-Sadighi-2006
p10595
sg12
S'PMC1693922'
p10596
sa(dp10597
g8
V15942629.xml
p10598
sg10
VSTD-Moehler-2005
p10599
sg12
S'PMC2361806'
p10600
sa(dp10601
g8
V7533517.xml
p10602
sg10
VSTD-Pyrh_x00f6_nen-1995
p10603
sg12
S'PMC2033628'
p10604
sasa(dp10605
g3
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p10606
sg5
(lp10607
(dp10608
g8
V18475602.xml
p10609
sg10
VSTD-de-Benedictis-1994b
p10610
sg12
S'PMC2365597'
p10611
sasa(dp10612
g3
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p10613
sg5
(lp10614
(dp10615
g8
V19565120.xml
p10616
sg10
VSTD-Ly-2009
p10617
sg12
S'PMC2686207'
p10618
sa(dp10619
g8
V20177574.xml
p10620
sg10
VSTD-Bachewar-2009
p10621
sg12
S'PMC2825021'
p10622
sasa(dp10623
g3
VCD005538 v. 8.0 Diclofenac for acute pain in children.rm5
p10624
sg5
(lp10625
(dp10626
g8
V10743430.xml
p10627
sg10
VSTD-Lambert-2000
p10628
sg12
S'PMC2503543'
p10629
sasa(dp10630
g3
VCD004231 v. 6.0 Inhaled corticosteroids for non-specific chronic cough in children.rm5
p10631
sg5
(lp10632
(dp10633
g8
V10373132.xml
p10634
sg10
VSTD-Davies-1999
p10635
sg12
S'PMC1717983'
p10636
sa(dp10637
g8
V9771244.xml
p10638
sg10
VSTD-Chang-1998
p10639
sg12
S'PMC1717639'
p10640
sasa(dp10641
g3
VCD004154 v. 12.0 Clobazam as an add-on in the management of refractory epilepsy.rm5
p10642
sg5
(lp10643
(dp10644
g8
V6404410.xml
p10645
sg10
VSTD-Allen-1983
p10646
sg12
S'PMC1547272'
p10647
sasa(dp10648
g3
VCD007210 v. 2.2 Maintenance treatments for opiate dependent adolescent.rm5
p10649
sg5
(lp10650
(dp10651
g8
V18984887.xml
p10652
sg10
VSTD-Woody-2008
p10653
sg12
S'PMC2610690'
p10654
sasa(dp10655
g3
VCD003171 v. 6.0 Surgical interventions for bilateral congenital cataract.rm5
p10656
sg5
(lp10657
(dp10658
g8
V10216048.xml
p10659
sg10
VSTD-Eckstein-1999
p10660
sg12
S'PMC1723028'
p10661
sasa(dp10662
g3
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p10663
sg5
(lp10664
(dp10665
g8
V20422000.xml
p10666
sg10
VSTD-Popelut-2010
p10667
sg12
S'PMC2858083'
p10668
sa(dp10669
g8
V18955452.xml
p10670
sg10
VSTD-Booth-2008
p10671
sg12
S'PMC2651075'
p10672
sa(dp10673
g8
V17550302.xml
p10674
sg10
VSTD-Bero-2007
p10675
sg12
S'PMC1885451'
p10676
sa(dp10677
g8
V12213183.xml
p10678
sg10
VSTD-Clifford-2002
p10679
sg12
S'PMC126226'
p10680
sa(dp10681
g8
V11463678.xml
p10682
sg10
VSTD-Kemmeren-2001
p10683
sg12
S'PMC34722'
p10684
sa(dp10685
g8
V20679560.xml
p10686
sg10
VSTD-Bourgeois-2010
p10687
sg12
S'PMC3374868'
p10688
sa(dp10689
g8
V19213766.xml
p10690
sg10
VSTD-Jefferson-2009
p10691
sg12
S'PMC2643439'
p10692
sa(dp10693
g8
V20015404.xml
p10694
sg10
VSTD-Rasmussen-2009
p10695
sg12
S'PMC2811705'
p10696
sa(dp10697
g8
V14970094.xml
p10698
sg10
VSTD-Bhandari-2004
p10699
sg12
S'PMC332713'
p10700
sa(dp10701
g8
V12153921.xml
p10702
sg10
VSTD-Kjaergard-2002
p10703
sg12
S'PMC117638'
p10704
sa(dp10705
g8
V19503811.xml
p10706
sg10
VSTD-Rattinger-2009
p10707
sg12
S'PMC2688752'
p10708
sa(dp10709
g8
V10834855.xml
p10710
sg10
VSTD-Chard-2000
p10711
sg12
S'PMC1753176'
p10712
sasa(dp10713
g3
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p10714
sg5
(lp10715
(dp10716
g8
V19168537.xml
p10717
sg10
VSTD-Ekeberg-2009
p10718
sg12
S'PMC2769057'
p10719
sasa(dp10720
g3
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p10721
sg5
(lp10722
(dp10723
g8
V18447940.xml
p10724
sg10
VSTD-Xiao-2008
p10725
sg12
S'PMC2447617'
p10726
sasa(dp10727
g3
VCD003053 v. 10.2 Insulin-sensitising drugs (metformin rosiglitazone pioglitazone D-chiro-inositol) for women with .rm5
p10728
sg5
(lp10729
(dp10730
g8
V19396538.xml
p10731
sg10
VSTD-Siebert-2009
p10732
sg12
S'PMC2682185'
p10733
sa(dp10734
g8
V16769748.xml
p10735
sg10
VSTD-Moll-2006
p10736
sg12
S'PMC1482338'
p10737
sa(dp10738
g8
V11994052.xml
p10739
sg10
VSTD-Sturrock-2002
p10740
sg12
S'PMC1874363'
p10741
sa(dp10742
g8
V21193187.xml
p10743
sg10
VSTD-Ladson-2011
p10744
sg12
S'PMC3073705'
p10745
sa(dp10746
g8
V18505764.xml
p10747
sg10
VSTD-Legro-2007
p10748
sg12
S'PMC2515084'
p10749
sasa(dp10750
g3
VCD003968 v. 11.0 Psychological therapies for the management of chronic and recurrent pain in children and adolescents.rm5
p10751
sg5
(lp10752
(dp10753
g8
V20686425.xml
p10754
sg10
VSTD-Barakat-2010
p10755
sg12
S'PMC2950888'
p10756
sa(dp10757
g8
V20216531.xml
p10758
sg10
VSTD-Levy-2010
p10759
sg12
S'PMC2887246'
p10760
sa(dp10761
g8
V22108765.xml
p10762
sg10
VSTD-Kashikar_x002d_Zuck-2012
p10763
sg12
S'PMC3690664'
p10764
sa(dp10765
g8
V19695776.xml
p10766
sg10
VSTD-Palermo-2009
p10767
sg12
S'PMC2760656'
p10768
sasa(dp10769
g3
VCD000407 v. 19.0 Oral steroids for long-term use in cystic fibrosis.rm5
p10770
sg5
(lp10771
(dp10772
g8
V8067791.xml
p10773
sg10
VSTD-Greally-1994
p10774
sg12
S'PMC1029909'
p10775
sasa(dp10776
g3
VCD006175 v. 4.0 Progesterone for preventing pre-eclampsia and its complications.rm5
p10777
sg5
(lp10778
(dp10779
g8
V23171812.xml
p10780
sg10
VSTD-Dalton-1962
p10781
sg12
S'PMC3557890'
p10782
sasa(dp10783
g3
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p10784
sg5
(lp10785
(dp10786
g8
V15453912.xml
p10787
sg10
VSTD-van-de-Vusse-2004
p10788
sg12
S'PMC523854'
p10789
sa(dp10790
g8
V10071116.xml
p10791
sg10
VSTD-Gorson-1999
p10792
sg12
S'PMC1736215'
p10793
sasa(dp10794
g3
VCD008533 v. 4.0 Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.rm5
p10795
sg5
(lp10796
(dp10797
g8
V10493479.xml
p10798
sg10
VSTD-Lillemoe-1999
p10799
sg12
S'PMC1420877'
p10800
sa(dp10801
g8
V14631226.xml
p10802
sg10
VSTD-Van-Heek-2003
p10803
sg12
S'PMC1356171'
p10804
sasa(dp10805
g3
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p10806
sg5
(lp10807
(dp10808
g8
V23056757.xml
p10809
sg10
VSTD-Rashidi-2011
p10810
sg12
S'PMC3446117'
p10811
sasa(dp10812
g3
VCD004415 v. 4.4 Interventions for actinic keratoses.rm5
p10813
sg5
(lp10814
(dp10815
g8
V18067628.xml
p10816
sg10
VSTD-Ulrich-2007
p10817
sg12
S'PMC2493058'
p10818
sa(dp10819
g8
V17223873.xml
p10820
sg10
VSTD-Perrett-2007
p10821
sg12
S'PMC2423222'
p10822
sasa(dp10823
g3
VCD002783 v. 7.0 Thrombolysis for acute deep vein thrombosis.rm5
p10824
sg5
(lp10825
(dp10826
g8
V5774077.xml
p10827
sg10
VSTD-Kakkar-1969
p10828
sg12
S'PMC1982488'
p10829
sasa(dp10830
g3
VCD009427 v. 2.0 Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.rm5
p10831
sg5
(lp10832
(dp10833
g8
V15834030.xml
p10834
sg10
VSTD-Fowler-2005
p10835
sg12
S'PMC1739638'
p10836
sasa(dp10837
g3
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p10838
sg5
(lp10839
(dp10840
g8
V3036020.xml
p10841
sg10
VSTD-Chudry-1987
p10842
sg12
S'PMC1778341'
p10843
sa(dp10844
g8
V18475602.xml
p10845
sg10
VSTD-De-Benedictis-1994b
p10846
sg12
S'PMC2365597'
p10847
sasa(dp10848
g3
VCD006798 v. 3.4 Day-case versus overnight stay for laparoscopic cholecystectomy.rm5
p10849
sg5
(lp10850
(dp10851
g8
V9860471.xml
p10852
sg10
VSTD-Keulemans-1998
p10853
sg12
S'PMC1191590'
p10854
sasa(dp10855
g3
VCD000011 v. 8.4 Interventions for enhancing medication adherence.rm5
p10856
sg5
(lp10857
(dp10858
g8
V14551096.xml
p10859
sg10
VSTD-O_x0027_Donnell-2003
p10860
sg12
S'PMC214016'
p10861
sa(dp10862
g8
V8611831.xml
p10863
sg10
VSTD-Kemp-1996
p10864
sg12
S'PMC2350295'
p10865
sa(dp10866
g8
V369673.xml
p10867
sg10
VSTD-Johnson-1978
p10868
sg12
S'PMC1819059'
p10869
sa(dp10870
g8
V10473477.xml
p10871
sg10
VSTD-Peveler-1999
p10872
sg12
S'PMC28214'
p10873
sa(dp10874
g8
V9640129.xml
p10875
sg10
VSTD-Brus-1998
p10876
sg12
S'PMC1752549'
p10877
sa(dp10878
g8
V16042672.xml
p10879
sg10
VSTD-Sadik-2005
p10880
sg12
S'PMC1884928'
p10881
sa(dp10882
g8
V11851640.xml
p10883
sg10
VSTD-Al_x002d_Eidan-2002
p10884
sg12
S'PMC1874294'
p10885
sa(dp10886
g8
V11897728.xml
p10887
sg10
VSTD-Stevens-2002
p10888
sg12
S'PMC1071673'
p10889
sa(dp10890
g8
V11502614.xml
p10891
sg10
VSTD-Hill-2001
p10892
sg12
S'PMC1753835'
p10893
sasa(dp10894
g3
VCD005224 v. 4.0 Immunosuppressive agents for myasthenia gravis.rm5
p10895
sg5
(lp10896
(dp10897
g8
V8229026.xml
p10898
sg10
VSTD-Gajdos-1993
p10899
sg12
S'PMC489815'
p10900
sasa(dp10901
g3
VCD004003 v. 7.3 Environmental sanitary interventions for preventing active trachoma.rm5
p10902
sg5
(lp10903
(dp10904
g8
V20409284.xml
p10905
sg10
VSTD-Abdou-2010
p10906
sg12
S'PMC2867063'
p10907
sa(dp10908
g8
V21785663.xml
p10909
sg10
VSTD-Stoller-2011
p10910
sg12
S'PMC3139980'
p10911
sasa(dp10912
g3
VCD007622 v. 2.0 Group versus conventional antenatal care for women.rm5
p10913
sg5
(lp10914
(dp10915
g8
V17666608.xml
p10916
sg10
VSTD-Ickovics-2007a
p10917
sg12
S'PMC2276878'
p10918
sasa(dp10919
g3
VCD009748 v. 3.5 Motivational interviewing for improving outcomes in youth living with HIV.rm5
p10920
sg5
(lp10921
(dp10922
g8
V21783053.xml
p10923
sg10
VSTD-Healthy-Choices-2009
p10924
sg12
S'PMC3282587'
p10925
sasa(dp10926
g3
VCD000542 v. 8.0 Enteral nutritional therapy for induction of remission in Crohn's disease.rm5
p10927
sg5
(lp10928
(dp10929
g8
V1773955.xml
p10930
sg10
VSTD-A_x003a_-Rigaud-1991
p10931
sg12
S'PMC1379249'
p10932
sa(dp10933
g8
V11709513.xml
p10934
sg10
VSTD-A_x003a_-Leiper-2001
p10935
sg12
S'PMC1728544'
p10936
sa(dp10937
g8
V7890238.xml
p10938
sg10
VSTD-A_x003a_-Mansfield-1995
p10939
sg12
S'PMC1382354'
p10940
sa(dp10941
g8
V8314510.xml
p10942
sg10
VSTD-B_x003a_-Gonzalez_x002d_Huix-_x0027_93
p10943
sg12
S'PMC1374261'
p10944
sa(dp10945
g8
V1905672.xml
p10946
sg10
VSTD-A_x003a_-Raouf-1991
p10947
sg12
S'PMC1378894'
p10948
sa(dp10949
g8
V12117873.xml
p10950
sg10
VSTD-A_x003a_-Gassull-2002
p10951
sg12
S'PMC1773299'
p10952
sa(dp10953
g8
V8020806.xml
p10954
sg10
VSTD-A_x003a_-Royall-1994
p10955
sg12
S'PMC1374879'
p10956
sasa(dp10957
g3
VCD006340 v. 4.0 Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children.rm5
p10958
sg5
(lp10959
(dp10960
g8
V18805335.xml
p10961
sg10
VSTD-Szefler-2008
p10962
sg12
S'PMC2610850'
p10963
sasa(dp10964
g3
VCD007884 v. 2.12 Endoscopic or surgical intervention for painful obstructive chronic pancreatitis.rm5
p10965
sg5
(lp10966
(dp10967
g8
V8489308.xml
p10968
sg10
VSTD-Nealon-1993
p10969
sg12
S'PMC1242821'
p10970
sasa(dp10971
g3
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p10972
sg5
(lp10973
(dp10974
g8
V11815493.xml
p10975
sg10
VSTD-Brown-2002
p10976
sg12
S'PMC2134805'
p10977
sa(dp10978
g8
V9219407.xml
p10979
sg10
VSTD-Hawthorne-1997
p10980
sg12
S'PMC1313005'
p10981
sa(dp10982
g8
V16709243.xml
p10983
sg10
VSTD-Baradaran-2006
p10984
sg12
S'PMC1489930'
p10985
sasa(dp10986
g3
VCD007102 v. 5.2 First-line chemotherapy in low-risk gestational trophoblastic neoplasia.rm5
p10987
sg5
(lp10988
(dp10989
g8
V21263100.xml
p10990
sg10
VSTD-Osborne-2011
p10991
sg12
S'PMC3068058'
p10992
sasa(dp10993
g3
VCD002048 v. 6.0 Auranofin versus placebo in rheumatoid arthritis.rm5
p10994
sg5
(lp10995
(dp10996
g8
V3872636.xml
p10997
sg10
VSTD-Prouse-1982
p10998
sg12
S'PMC1001616'
p10999
sasa(dp11000
g3
VCD007624 v. 3.0 Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture .rm5
p11001
sg5
(lp11002
(dp11003
g8
V18751772.xml
p11004
sg10
VSTD-Allegrante-2007
p11005
sg12
S'PMC2504100'
p11006
sasa(dp11007
g3
VCD000103 v. 4.0 Haemodilution for acute ischaemic stroke.rm5
p11008
sg5
(lp11009
(dp11010
g8
V795498.xml
p11011
sg10
VSTD-Kaste-1976
p11012
sg12
S'PMC1690349'
p11013
sasa(dp11014
g3
VCD003575 v. 14.0 Interventions for treating collagenous colitis.rm5
p11015
sg5
(lp11016
(dp11017
g8
V12524408.xml
p11018
sg10
VSTD-Bonderup-2003
p11019
sg12
S'PMC1774966'
p11020
sasa(dp11021
g3
VCD001329 v. 7.0 Lactational amenorrhea for family planning.rm5
p11022
sg5
(lp11023
(dp11024
g8
V8876092.xml
p11025
sg10
VSTD-Ramos-1996
p11026
sg12
S'PMC2352260'
p11027
sasa(dp11028
g3
VCD003511 v. 8.0 Progestogen for preventing miscarriage.rm5
p11029
sg5
(lp11030
(dp11031
g8
V13977012.xml
p11032
sg10
VSTD-Shearman-1963
p11033
sg12
S'PMC2123785'
p11034
sasa(dp11035
g3
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p11036
sg5
(lp11037
(dp11038
g8
V2069842.xml
p11039
sg10
VSTD-Gray-1991
p11040
sg12
S'PMC1972556'
p11041
sa(dp11042
g8
V10749603.xml
p11043
sg10
VSTD-Vaillant-2000
p11044
sg12
S'PMC1421018'
p11045
sa(dp11046
g8
V11720425.xml
p11047
sg10
VSTD-Taal-2001
p11048
sg12
S'PMC2363941'
p11049
sasa(dp11050
g3
VCD005963 v. 8.0 Advance treatment directives for people with severe mental illness.rm5
p11051
sg5
(lp11052
(dp11053
g8
V15240438.xml
p11054
sg10
VSTD-Henderson-2004-a
p11055
sg12
S'PMC478218'
p11056
sasa(dp11057
g3
VCD008107 v. 2.0 Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomac.rm5
p11058
sg5
(lp11059
(dp11060
g8
V21060024.xml
p11061
sg10
VSTD-EORTC-40954-2010
p11062
sg12
S'PMC3020693'
p11063
sasa(dp11064
g3
VCD003802 v. 9.0 Melatonin for the treatment of dementia.rm5
p11065
sg5
(lp11066
(dp11067
g8
V19155748.xml
p11068
sg10
VSTD-Gehrman-2009
p11069
sg12
S'PMC2630117'
p11070
sasa(dp11071
g3
VCD009269 v. 2.2 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit d.rm5
p11072
sg5
(lp11073
(dp11074
g8
V21849027.xml
p11075
sg10
VSTD-Feldman-2011
p11076
sg12
S'PMC3191344'
p11077
sa(dp11078
g8
V19836904.xml
p11079
sg10
VSTD-Nyamathi-2010
p11080
sg12
S'PMC3383096'
p11081
sasa(dp11082
g3
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p11083
sg5
(lp11084
(dp11085
g8
V18475414.xml
p11086
sg10
VSTD-Mikamo-_x0028_1_x0029_-1995
p11087
sg12
S'PMC2364408'
p11088
sa(dp11089
g8
V16338779.xml
p11090
sg10
VSTD-Seidman-2005
p11091
sg12
S'PMC1784583'
p11092
sa(dp11093
g8
V8381643.xml
p11094
sg10
VSTD-Stein-1993
p11095
sg12
S'PMC187610'
p11096
sa(dp11097
g8
V1312506.xml
p11098
sg10
VSTD-Tobin-1992
p11099
sg12
S'PMC1194795'
p11100
sa(dp11101
g8
V2071126.xml
p11102
sg10
VSTD-Boag-1991
p11103
sg12
S'PMC1194678'
p11104
sa(dp11105
g8
V18475414.xml
p11106
sg10
VSTD-Mikamo-_x0028_2_x0029_-1995
p11107
sg12
S'PMC2364408'
p11108
sasa(dp11109
g3
VCD003257 v. 9.0 Symptomatic treatment of the cough in whooping cough.rm5
p11110
sg5
(lp11111
(dp11112
g8
V4568265.xml
p11113
sg10
VSTD-Zoumboulakis-1973
p11114
sg12
S'PMC1647791'
p11115
sasa(dp11116
g3
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p11117
sg5
(lp11118
(dp11119
g8
V17699944.xml
p11120
sg10
VSTD-Menon-2007
p11121
sg12
S'PMC2636008'
p11122
sasa(dp11123
g3
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p11124
sg5
(lp11125
(dp11126
g8
V17593956.xml
p11127
sg10
VSTD-Luabeya-2007
p11128
sg12
S'PMC1891438'
p11129
sa(dp11130
g8
V7625499.xml
p11131
sg10
VSTD-Coutsoudis-1995
p11132
sg12
S'PMC1615817'
p11133
sasa(dp11134
g3
VCD007313 v. 5.0 Combination formoterol and budesonide as maintenance and reliever therapy versus current best practi.rm5
p11135
sg5
(lp11136
(dp11137
g8
V18186995.xml
p11138
sg10
VSTD-Sovani-2008
p11139
sg12
S'PMC2148237'
p11140
sasa(dp11141
g3
VCD006189 v. 2.0 Oral steroids for adhesive capsulitis.rm5
p11142
sg5
(lp11143
(dp11144
g8
V13160496.xml
p11145
sg10
VSTD-Blockey-1954
p11146
sg12
S'PMC2085434'
p11147
sa(dp11148
g8
V15479896.xml
p11149
sg10
VSTD-Buchbinder-2004
p11150
sg12
S'PMC1754804'
p11151
sasa(dp11152
g3
VCD003094 v. 9.0 Treatments for iron-deficiency anaemia in pregnancy.rm5
p11153
sg5
(lp11154
(dp11155
g8
V17435611.xml
p11156
sg10
VSTD-Saha-2007
p11157
sg12
S'PMC1924983'
p11158
sasa(dp11159
g3
VCD003901 v. 5.0 Regular treatment with long acting beta agonists versus daily regular treatment with short acting be.rm5
p11160
sg5
(lp11161
(dp11162
g8
V10950898.xml
p11163
sg10
VSTD-Byrnes-2000
p11164
sg12
S'PMC1745864'
p11165
sa(dp11166
g8
V8493629.xml
p11167
sg10
VSTD-Lundback-1993
p11168
sg12
S'PMC464292'
p11169
sa(dp11170
g8
V8098238.xml
p11171
sg10
VSTD-Castle-1993
p11172
sg12
S'PMC1676982'
p11173
sa(dp11174
g8
V10319056.xml
p11175
sg10
VSTD-Taylor-1998
p11176
sg12
S'PMC1745306'
p11177
sasa(dp11178
g3
VCD001392 v. 8.0 Prolonged antibiotics for purulent bronchiectasis in children and adults.rm5
p11179
sg5
(lp11180
(dp11181
g8
V13446452.xml
p11182
sg10
VSTD-MRC-1957
p11183
sg12
S'PMC1961737'
p11184
sasa(dp11185
g3
VCD005391 v. 4.6 Workload and surgeons specialty for outcome after colorectal cancer surgery.rm5
p11186
sg5
(lp11187
(dp11188
g8
V16551415.xml
p11189
sg10
VSTD-Ng-2006
p11190
sg12
S'PMC1964052'
p11191
sa(dp11192
g8
V10493487.xml
p11193
sg10
VSTD-Harmon-1999
p11194
sg12
S'PMC1420885'
p11195
sa(dp11196
g8
V15020356.xml
p11197
sg10
VSTD-Urbach-2004
p11198
sg12
S'PMC381322'
p11199
sa(dp11200
g8
V16948883.xml
p11201
sg10
VSTD-Simunovic-2006
p11202
sg12
S'PMC3207572'
p11203
sa(dp11204
g8
V12409664.xml
p11205
sg10
VSTD-Schrag-2002
p11206
sg12
S'PMC1422616'
p11207
sa(dp11208
g8
V17122626.xml
p11209
sg10
VSTD-Rogers-2006
p11210
sg12
S'PMC1856632'
p11211
sasa(dp11212
g3
VCD007949 v. 2.2 Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.rm5
p11213
sg5
(lp11214
(dp11215
g8
V10373134.xml
p11216
sg10
VSTD-Akpinarli-1999
p11217
sg12
S'PMC1717973'
p11218
sa(dp11219
g8
V10999872.xml
p11220
sg10
VSTD-Heuck-2000
p11221
sg12
S'PMC1718508'
p11222
sasa(dp11223
g3
VCD005417 v. 3.0 Home-based care for reducing morbidity and mortality in people infected with HIVAIDS.rm5
p11224
sg5
(lp11225
(dp11226
g8
V16772251.xml
p11227
sg10
VSTD-Dolan-2006
p11228
sg12
S'PMC3205443'
p11229
sasa(dp11230
g3
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p11231
sg5
(lp11232
(dp11233
g8
V10166596.xml
p11234
sg10
VSTD-Baker-1997
p11235
sg12
S'PMC1055438'
p11236
sa(dp11237
g8
V10980076.xml
p11238
sg10
VSTD-Lagerl_x00f8_v-2000
p11239
sg12
S'PMC1743532'
p11240
sa(dp11241
g8
V10847872.xml
p11242
sg10
VSTD-Van-den-Hombergh-1999
p11243
sg12
S'PMC2483655'
p11244
sa(dp11245
g8
V19366977.xml
p11246
sg10
VSTD-O_x0027_Connor-2009
p11247
sg12
S'PMC2699722'
p11248
sa(dp11249
g8
V17973175.xml
p11250
sg10
VSTD-Thomas-2007
p11251
sg12
S'PMC2219846'
p11252
sa(dp11253
g8
V12879828.xml
p11254
sg10
VSTD-Baker-2003A
p11255
sg12
S'PMC1314570'
p11256
sa(dp11257
g8
V18093108.xml
p11258
sg10
VSTD-Schneider-2008
p11259
sg12
S'PMC2440309'
p11260
sa(dp11261
g8
V16199745.xml
p11262
sg10
VSTD-Eltayeb-2005
p11263
sg12
S'PMC1745049'
p11264
sa(dp11265
g8
V19920081.xml
p11266
sg10
VSTD-Svetkey-2009
p11267
sg12
S'PMC2784648'
p11268
sa(dp11269
g8
V11387182.xml
p11270
sg10
VSTD-Moher-2001
p11271
sg12
S'PMC32168'
p11272
sa(dp11273
g8
V20479363.xml
p11274
sg10
VSTD-Laskshminarayan-2010
p11275
sg12
S'PMC2875128'
p11276
sa(dp11277
g8
V6891147.xml
p11278
sg10
VSTD-McConnell-1982
p11279
sg12
S'PMC1274191'
p11280
sa(dp11281
g8
V10478162.xml
p11282
sg10
VSTD-Hux-1999
p11283
sg12
S'PMC1230539'
p11284
sa(dp11285
g8
V12668540.xml
p11286
sg10
VSTD-Pimlott-2003
p11287
sg12
S'PMC151988'
p11288
sa(dp11289
g8
V14521638.xml
p11290
sg10
VSTD-Schectman-2003
p11291
sg12
S'PMC1494929'
p11292
sa(dp11293
g8
V15720929.xml
p11294
sg10
VSTD-Mitchell-2005
p11295
sg12
S'PMC1463214'
p11296
sa(dp11297
g8
V9807540.xml
p11298
sg10
VSTD-Hillman-1998
p11299
sg12
S'PMC1508575'
p11300
sa(dp11301
g8
V12236277.xml
p11302
sg10
VSTD-Siriwardena-2002
p11303
sg12
S'PMC1314414'
p11304
sa(dp11305
g8
V1556235.xml
p11306
sg10
VSTD-Gama-1992
p11307
sg12
S'PMC495487'
p11308
sa(dp11309
g8
V15576543.xml
p11310
sg10
VSTD-Verstappen-2004
p11311
sg12
S'PMC1466745'
p11312
sa(dp11313
g8
V8347386.xml
p11314
sg10
VSTD-Buntinx-1993
p11315
sg12
S'PMC1372391'
p11316
sa(dp11317
g8
V9949744.xml
p11318
sg10
VSTD-Fairbrother-1999
p11319
sg12
S'PMC1508536'
p11320
sa(dp11321
g8
V12792007.xml
p11322
sg10
VSTD-Frijiling-2003
p11323
sg12
S'PMC1743704'
p11324
sa(dp11325
g8
V17389537.xml
p11326
sg10
VSTD-Wadland-2007
p11327
sg12
S'PMC1838696'
p11328
sa(dp11329
g8
V9734786.xml
p11330
sg10
VSTD-Kinsinger-1998
p11331
sg12
S'PMC1497003'
p11332
sa(dp11333
g8
V11743151.xml
p11334
sg10
VSTD-Vingerhoets-2001
p11335
sg12
S'PMC1743447'
p11336
sa(dp11337
g8
V17456241.xml
p11338
sg10
VSTD-Foster-2007
p11339
sg12
S'PMC1868738'
p11340
sa(dp11341
g8
V10024260.xml
p11342
sg10
VSTD-O_x0027_Connell-1999
p11343
sg12
S'PMC27749'
p11344
sa(dp11345
g8
V3092976.xml
p11346
sg10
VSTD-McAlister-1986
p11347
sg12
S'PMC1341518'
p11348
sa(dp11349
g8
V9663162.xml
p11350
sg10
VSTD-Mayer-1998
p11351
sg12
S'PMC1508276'
p11352
sa(dp11353
g8
V16609732.xml
p11354
sg10
VSTD-Herrin-2006
p11355
sg12
S'PMC1426180'
p11356
sa(dp11357
g8
V9233326.xml
p11358
sg10
VSTD-McCartney-1997
p11359
sg12
S'PMC2127027'
p11360
sasa(dp11361
g3
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p11362
sg5
(lp11363
(dp11364
g8
V18547413.xml
p11365
sg10
VSTD-Hemminki-2008
p11366
sg12
S'PMC2442595'
p11367
sa(dp11368
g8
V17540908.xml
p11369
sg10
VSTD-Montgomery-2007
p11370
sg12
S'PMC1895676'
p11371
sasa(dp11372
g3
VCD001894 v. 12.0 Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm in.rm5
p11373
sg5
(lp11374
(dp11375
g8
V9513842.xml
p11376
sg10
VSTD-Hurst-1998
p11377
sg12
S'PMC3455419'
p11378
sa(dp11379
g8
V11212860.xml
p11380
sg10
VSTD-Baruffi-2000
p11381
sg12
S'PMC3455458'
p11382
sa(dp11383
g8
V20467801.xml
p11384
sg10
VSTD-Kutlu-2010
p11385
sg12
S'PMC2941589'
p11386
sa(dp11387
g8
V10911572.xml
p11388
sg10
VSTD-Isik-2000
p11389
sg12
S'PMC3455664'
p11390
sasa(dp11391
g3
VCD003772 v. 12.0 Antibiotics for acute pyelonephritis in children.rm5
p11392
sg5
(lp11393
(dp11394
g8
V17611232.xml
p11395
sg10
VSTD-Montini-2003
p11396
sg12
S'PMC1955287'
p11397
sa(dp11398
g8
V11207174.xml
p11399
sg10
VSTD-Benador-2001
p11400
sg12
S'PMC1718672'
p11401
sa(dp11402
g8
V1510446.xml
p11403
sg10
VSTD-Vigano-1992
p11404
sg12
S'PMC191611'
p11405
sasa(dp11406
g3
VCD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
p11407
sg5
(lp11408
(dp11409
g8
V17166221.xml
p11410
sg10
VSTD-Magpie-2006
p11411
sg12
S'PMC2063969'
p11412
sa(dp11413
g8
V18753646.xml
p11414
sg10
VSTD-Rouse-2008
p11415
sg12
S'PMC2803083'
p11416
sasa(dp11417
g3
VCD003535 v. 10.0 Anticholinergic therapy for chronic asthma in children over two years of age.rm5
p11418
sg5
(lp11419
(dp11420
g8
V6461943.xml
p11421
sg10
VSTD-Mann-1982
p11422
sg12
S'PMC459250'
p11423
sa(dp11424
g8
V2958950.xml
p11425
sg10
VSTD-Sly-1987
p11426
sg12
S'PMC460756'
p11427
sasa(dp11428
g3
VCD001399 v. 15.0 Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.rm5
p11429
sg5
(lp11430
(dp11431
g8
V6441523.xml
p11432
sg10
VSTD-Langford-1983
p11433
sg12
S'PMC1628912'
p11434
sa(dp11435
g8
V17585011.xml
p11436
sg10
VSTD-D_x00f6_ring-2007
p11437
sg12
S'PMC1904125'
p11438
sasa(dp11439
g3
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p11440
sg5
(lp11441
(dp11442
g8
V19450268.xml
p11443
sg10
VSTD-Kneyber-2009
p11444
sg12
S'PMC2717432'
p11445
sasa(dp11446
g3
VCD001122 v. 12.0 Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary .rm5
p11447
sg5
(lp11448
(dp11449
g8
V10911573.xml
p11450
sg10
VSTD-Al_x002d_Mizyen-2000
p11451
sg12
S'PMC3455662'
p11452
sasa(dp11453
g3
VCD004418 v. 13.0 Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized a.rm5
p11454
sg5
(lp11455
(dp11456
g8
V1323954.xml
p11457
sg10
VSTD-Carbon-1992
p11458
sg12
S'PMC189443'
p11459
sasa(dp11460
g3
VCD003352 v. 8.0 Dopamine agonists for the treatment of cocaine dependence.rm5
p11461
sg5
(lp11462
(dp11463
g8
V17134849.xml
p11464
sg10
VSTD-Mooney-2007-b
p11465
sg12
S'PMC2693095'
p11466
sa(dp11467
g8
V20545388.xml
p11468
sg10
VSTD-Schmitz-2010
p11469
sg12
S'PMC3164487'
p11470
sa(dp11471
g8
V17134849.xml
p11472
sg10
VSTD-Mooney-2007-a
p11473
sg12
S'PMC2693095'
p11474
sa(dp11475
g8
V18164144.xml
p11476
sg10
VSTD-Schmitz-2008
p11477
sg12
S'PMC2293271'
p11478
sasa(dp11479
g3
VCD005305 v. 4.0 Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.rm5
p11480
sg5
(lp11481
(dp11482
g8
V15504763.xml
p11483
sg10
VSTD-Man-2004
p11484
sg12
S'PMC529363'
p11485
sasa(dp11486
g3
VCD004509 v. 6.0 Testosterone for peri and postmenopausal women.rm5
p11487
sg5
(lp11488
(dp11489
g8
V3107663.xml
p11490
sg10
VSTD-Burger-1987
p11491
sg12
S'PMC1246001'
p11492
sasa(dp11493
g3
VCD000143 v. 10.0 Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in p.rm5
p11494
sg5
(lp11495
(dp11496
g8
V8323357.xml
p11497
sg10
VSTD-Chan-1993
p11498
sg12
S'PMC1029305'
p11499
sa(dp11500
g8
V7796237.xml
p11501
sg10
VSTD-So-1995
p11502
sg12
S'PMC2528452'
p11503
sa(dp11504
g8
V9797626.xml
p11505
sg10
VSTD-Davis-1998
p11506
sg12
S'PMC1720820'
p11507
sasa(dp11508
g3
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p11509
sg5
(lp11510
(dp11511
g8
V12085247.xml
p11512
sg10
VSTD-Razavi-2002
p11513
sg12
S'PMC2364281'
p11514
sa(dp11515
g8
V22041948.xml
p11516
sg10
VSTD-Tulsky-2011
p11517
sg12
S'PMC3368370'
p11518
sa(dp11519
g8
V20628395.xml
p11520
sg10
VSTD-Lienard-2010
p11521
sg12
S'PMC2906741'
p11522
sa(dp11523
g8
V17893379.xml
p11524
sg10
VSTD-Stewart-2007
p11525
sg12
S'PMC2000315'
p11526
sasa(dp11527
g3
VCD004433 v. 5.0 Constraint-induced movement therapy for upper extremities in stroke patients.rm5
p11528
sg5
(lp11529
(dp11530
g8
V15537995.xml
p11531
sg10
VSTD-Alberts-2004
p11532
sg12
S'PMC3579584'
p11533
sasa(dp11534
g3
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p11535
sg5
(lp11536
(dp11537
g8
V16824233.xml
p11538
sg10
VSTD-Elsinga-2006
p11539
sg12
S'PMC1552064'
p11540
sa(dp11541
g8
V17218187.xml
p11542
sg10
VSTD-Floyd-2007
p11543
sg12
S'PMC2888541'
p11544
sa(dp11545
g8
V17156466.xml
p11546
sg10
VSTD-Lumley-2006
p11547
sg12
S'PMC1712341'
p11548
sasa(dp11549
g3
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p11550
sg5
(lp11551
(dp11552
g8
V12113422.xml
p11553
sg10
VSTD-Reis-Neto-2002
p11554
sg12
S'PMC3043413'
p11555
sa(dp11556
g8
V12500834.xml
p11557
sg10
VSTD-Chen-2002
p11558
sg12
S'PMC3043440'
p11559
sa(dp11560
g8
V10749610.xml
p11561
sg10
VSTD-Leung-2000-a
p11562
sg12
S'PMC1421025'
p11563
sa(dp11564
g8
V12616116.xml
p11565
sg10
VSTD-Morino-2003
p11566
sg12
S'PMC1514324'
p11567
sasa(dp11568
g3
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p11569
sg5
(lp11570
(dp11571
g8
V19958521.xml
p11572
sg10
VSTD-BRAIN-2009
p11573
sg12
S'PMC2794266'
p11574
sasa(dp11575
g3
VCD003980 v. 7.0 Exercise therapy for multiple sclerosis.rm5
p11576
sg5
(lp11577
(dp11578
g8
V11160464.xml
p11579
sg10
VSTD-Wiles-2001
p11580
sg12
S'PMC1737210'
p11581
sasa(dp11582
g3
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p11583
sg5
(lp11584
(dp11585
g8
V7981078.xml
p11586
sg10
VSTD-Riccardi-1994
p11587
sg12
S'PMC2033710'
p11588
sa(dp11589
g8
V10755397.xml
p11590
sg10
VSTD-Riccardi-2000
p11591
sg12
S'PMC2374495'
p11592
sasa(dp11593
g3
VCD001740 v. 7.0 Corticosteroids for acute severe asthma in hospitalised patients.rm5
p11594
sg5
(lp11595
(dp11596
g8
V1412113.xml
p11597
sg10
VSTD-Morell-1992
p11598
sg12
S'PMC463918'
p11599
sa(dp11600
g8
V1412112.xml
p11601
sg10
VSTD-Bowler-1992
p11602
sg12
S'PMC463917'
p11603
sasa(dp11604
g3
VCD005339 v. 4.0 Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunct.rm5
p11605
sg5
(lp11606
(dp11607
g8
V6697270.xml
p11608
sg10
VSTD-Bow-1984
p11609
sg12
S'PMC1875734'
p11610
sasa(dp11611
g3
VCD000333 v. 9.0 Exercise for preventing and treating osteoporosis in postmenopausal women.rm5
p11612
sg5
(lp11613
(dp11614
g8
V3121055.xml
p11615
sg10
VSTD-Chow-1987
p11616
sg12
S'PMC1248603'
p11617
sasa(dp11618
g3
VCD008811 v. 2.0 Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extrac.rm5
p11619
sg5
(lp11620
(dp11621
g8
V12770957.xml
p11622
sg10
VSTD-Gogate-2003
p11623
sg12
S'PMC1771720'
p11624
sasa(dp11625
g3
VCD003786 v. 7.0 Exercise for treating fibromyalgia syndrome.rm5
p11626
sg5
(lp11627
(dp11628
g8
V12142304.xml
p11629
sg10
VSTD-Richards-2002
p11630
sg12
S'PMC117444'
p11631
sa(dp11632
g8
V11114277.xml
p11633
sg10
VSTD-Hakkinen-2001
p11634
sg12
S'PMC1753355'
p11635
sa(dp11636
g8
V14962965.xml
p11637
sg10
VSTD-Cedraschi-2004
p11638
sg12
S'PMC1754921'
p11639
sasa(dp11640
g3
VCD000532 v. 5.0 On-site mental health workers delivering psychological therapy and psychosocial interventions to pat.rm5
p11641
sg5
(lp11642
(dp11643
g8
V14601351.xml
p11644
sg10
VSTD-Richards-2003
p11645
sg12
S'PMC1314708'
p11646
sa(dp11647
g8
V9624745.xml
p11648
sg10
VSTD-Baker-1996
p11649
sg12
S'PMC1410018'
p11650
sa(dp11651
g8
V3746764.xml
p11652
sg10
VSTD-Blakey-1986
p11653
sg12
S'PMC1960439'
p11654
sa(dp11655
g8
V3267741.xml
p11656
sg10
VSTD-Benson-1988
p11657
sg12
S'PMC1711670'
p11658
sa(dp11659
g8
V6428555.xml
p11660
sg10
VSTD-Robson-1984
p11661
sg12
S'PMC1441852'
p11662
sa(dp11663
g8
V7086742.xml
p11664
sg10
VSTD-Earll-1982
p11665
sg12
S'PMC1970973'
p11666
sa(dp11667
g8
V17359606.xml
p11668
sg10
VSTD-Lester-2007
p11669
sg12
S'PMC2042545'
p11670
sa(dp11671
g8
V9624744.xml
p11672
sg10
VSTD-Harvey-1998
p11673
sg12
S'PMC1410004'
p11674
sa(dp11675
g8
V11099285.xml
p11676
sg10
VSTD-King-2000b
p11677
sg12
S'PMC27543'
p11678
sa(dp11679
g8
V11099285.xml
p11680
sg10
VSTD-King-2000a
p11681
sg12
S'PMC27543'
p11682
sasa(dp11683
g3
VCD003460 v. 9.0 Bulking agents antispasmodics and antidepressants for the treatment of irritable bowel syndrome.rm5
p11684
sg5
(lp11685
(dp11686
g8
V32949.xml
p11687
sg10
VSTD-Ritchie-1979
p11688
sg12
S'PMC1597979'
p11689
sa(dp11690
g8
V3030904.xml
p11691
sg10
VSTD-Lucey-1987
p11692
sg12
S'PMC1432984'
p11693
sa(dp11694
g8
V3322956.xml
p11695
sg10
VSTD-Prior-1987
p11696
sg12
S'PMC1433676'
p11697
sa(dp11698
g8
V16401691.xml
p11699
sg10
VSTD-Tack-2006a
p11700
sg12
S'PMC1856276'
p11701
sa(dp11702
g8
V2182401.xml
p11703
sg10
VSTD-Dobrilla-1990
p11704
sg12
S'PMC1378284'
p11705
sasa(dp11706
g3
VCD005996 v. 5.0 Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.rm5
p11707
sg5
(lp11708
(dp11709
g8
V16518579.xml
p11710
sg10
VSTD-Duvan-2006
p11711
sg12
S'PMC3455434'
p11712
sasa(dp11713
g3
VCD007031 v. 3.0 Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.rm5
p11714
sg5
(lp11715
(dp11716
g8
V15206989.xml
p11717
sg10
VSTD-Lee-2004
p11718
sg12
S'PMC1884548'
p11719
sasa(dp11720
g3
VCD003597 v. 6.0 Quinolones for uncomplicated acute cystitis in women.rm5
p11721
sg5
(lp11722
(dp11723
g8
V8384818.xml
p11724
sg10
VSTD-Nicolle-1993
p11725
sg12
S'PMC187709'
p11726
sa(dp11727
g8
V7695309.xml
p11728
sg10
VSTD-Jardin-1995
p11729
sg12
S'PMC162511'
p11730
sa(dp11731
g8
V9736546.xml
p11732
sg10
VSTD-Henry-1998
p11733
sg12
S'PMC105806'
p11734
sasa(dp11735
g3
VCD010245 v. 3.0 Tranexamic acid for reducing mortality in emergency and urgent surgery.rm5
p11736
sg5
(lp11737
(dp11738
g8
V21455360.xml
p11739
sg10
VSTD-Pfizer-2011
p11740
sg12
S'PMC2962290'
p11741
sasa(dp11742
g3
VCD001054 v. 10.4 Community screening for visual impairment in the elderly.rm5
p11743
sg5
(lp11744
(dp11745
g8
V2112022.xml
p11746
sg10
VSTD-McEwan-1990
p11747
sg12
S'PMC1371072'
p11748
sa(dp11749
g8
V14593039.xml
p11750
sg10
VSTD-Smeeth-2003
p11751
sg12
S'PMC261660'
p11752
sa(dp11753
g8
V7977921.xml
p11754
sg10
VSTD-Wagner-1994
p11755
sg12
S'PMC1615188'
p11756
sa(dp11757
g8
V1392755.xml
p11758
sg10
VSTD-Vetter-1992
p11759
sg12
S'PMC1882829'
p11760
sa(dp11761
g8
V6229314.xml
p11762
sg10
VSTD-Vetter-1984
p11763
sg12
S'PMC1444201'
p11764
sa(dp11765
g8
V8343668.xml
p11766
sg10
VSTD-Van-Rossum-1993
p11767
sg12
S'PMC1678489'
p11768
sasa(dp11769
g3
VCD006491 v. 5.0 Drugs for preventing malaria in travellers.rm5
p11770
sg5
(lp11771
(dp11772
g8
V14604928.xml
p11773
sg10
VSTD-Schlagenhauf-2003a
p11774
sg12
S'PMC261741'
p11775
sasa(dp11776
g3
VCD007906 v. 4.0 Intensive case management for severe mental illness.rm5
p11777
sg5
(lp11778
(dp11779
g8
V16543298.xml
p11780
sg10
VSTD-REACT_x002d_UK
p11781
sg12
S'PMC1432213'
p11782
sa(dp11783
g8
V11111259.xml
p11784
sg10
VSTD-Shern_x002d_USA1
p11785
sg12
S'PMC1446423'
p11786
sa(dp11787
g8
V10357291.xml
p11788
sg10
VSTD-Salkever_x002d_SCarolina
p11789
sg12
S'PMC1089024'
p11790
sasa(dp11791
g3
VCD003628 v. 6.0 Artificial and bioartificial support systems for liver failure.rm5
p11792
sg5
(lp11793
(dp11794
g8
V710967.xml
p11795
sg10
VSTD-Denis-1978
p11796
sg12
S'PMC1412181'
p11797
sasa(dp11798
g3
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p11799
sg5
(lp11800
(dp11801
g8
V15726120.xml
p11802
sg10
VSTD-Icli-F-2005
p11803
sg12
S'PMC2361864'
p11804
sa(dp11805
g8
V8431375.xml
p11806
sg10
VSTD-Fraser-S-1993
p11807
sg12
S'PMC1968186'
p11808
sa(dp11809
g8
V12439707.xml
p11810
sg10
VSTD-Bonneterre--J-2002
p11811
sg12
S'PMC2408916'
p11812
sa(dp11813
g8
V766800.xml
p11814
sg10
VSTD-Rubens-RD-1975
p11815
sg12
S'PMC2025018'
p11816
sasa(dp11817
g3
VCD004647 v. 3.0 Ileostomy or colostomy for temporary decompression of colorectal anastomosis.rm5
p11818
sg5
(lp11819
(dp11820
g8
V3566123.xml
p11821
sg10
VSTD-Khoury-1986
p11822
sg12
S'PMC2498441'
p11823
sasa(dp11824
g3
VCD000021 v. 6.0 Anti-D administration after childbirth for preventing Rhesus alloimmunisation.rm5
p11825
sg5
(lp11826
(dp11827
g8
V4977545.xml
p11828
sg10
VSTD-Western-Canada-1968
p11829
sg12
S'PMC1946029'
p11830
sa(dp11831
g8
V4207590.xml
p11832
sg10
VSTD-MRC-1974
p11833
sg12
S'PMC1610688'
p11834
sa(dp11835
g8
V4177613.xml
p11836
sg10
VSTD-Netherlands-1968
p11837
sg12
S'PMC1912672'
p11838
sasa(dp11839
g3
VCD006878 v. 3.0 Covering ileo- or colostomy in anterior resection for rectal carcinoma.rm5
p11840
sg5
(lp11841
(dp11842
g8
V17667498.xml
p11843
sg10
VSTD-Matthiessen-2007
p11844
sg12
S'PMC1933561'
p11845
sasa(dp11846
g3
VCD004445 v. 8.0 The 'WHO Safe Communities' model for the prevention of injury in whole populations.rm5
p11847
sg5
(lp11848
(dp11849
g8
V9788086.xml
p11850
sg10
VSTD-Harstad_x002c_-Norway
p11851
sg12
S'PMC1730374'
p11852
sa(dp11853
g8
V9346020.xml
p11854
sg10
VSTD-Lidkoping_x002c_-Sweden
p11855
sg12
S'PMC1067586'
p11856
sa(dp11857
g8
V11928967.xml
p11858
sg10
VSTD-Shire-of-Bulla_x002c_-Australia
p11859
sg12
S'PMC1730817'
p11860
sa(dp11861
g8
V9346020.xml
p11862
sg10
VSTD-Falkoping_x002c_-Sweden
p11863
sg12
S'PMC1067586'
p11864
sasa(dp11865
g3
VCD005092 v. 3.0 Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully b.rm5
p11866
sg5
(lp11867
(dp11868
g8
V15208209.xml
p11869
sg10
VSTD-Collins-2004
p11870
sg12
S'PMC487729'
p11871
sasa(dp11872
g3
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p11873
sg5
(lp11874
(dp11875
g8
V21205128.xml
p11876
sg10
VSTD-LEAD_x002d_3-2006
p11877
sg12
S'PMC3084519'
p11878
sa(dp11879
g8
V23943707.xml
p11880
sg10
VSTD-Kanda-1998
p11881
sg12
S'PMC3699156'
p11882
sa(dp11883
g8
V21409314.xml
p11884
sg10
VSTD-Alvarsson-2010
p11885
sg12
S'PMC3061612'
p11886
sasa(dp11887
g3
VCD006456 v. 3.0 Therapeutic interventions for symptomatic treatment in Huntington's disease.rm5
p11888
sg5
(lp11889
(dp11890
g8
V6236286.xml
p11891
sg10
VSTD-Quinn-N
p11892
sg12
S'PMC1027949'
p11893
sa(dp11894
g8
V9221965.xml
p11895
sg10
VSTD-van-Vugt-J
p11896
sg12
S'PMC2169648'
p11897
sasa(dp11898
g3
VCD004239 v. 5.2 Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surger.rm5
p11899
sg5
(lp11900
(dp11901
g8
V10360304.xml
p11902
sg10
VSTD-Flach-1998
p11903
sg12
S'PMC1298410'
p11904
sasa(dp11905
g3
VCD009113 v. 1.0 Universal school-based prevention programs for alcohol misuse in young people.rm5
p11906
sg5
(lp11907
(dp11908
g8
V18675294.xml
p11909
sg10
VSTD-Sun-2008
p11910
sg12
S'PMC2784033'
p11911
sa(dp11912
g8
V18343607.xml
p11913
sg10
VSTD-Kellam-2008
p11914
sg12
S'PMC2512256'
p11915
sa(dp11916
g8
V19440837.xml
p11917
sg10
VSTD-Johnson-2009
p11918
sg12
S'PMC3735174'
p11919
sa(dp11920
g8
V19004157.xml
p11921
sg10
VSTD-Werch-2008
p11922
sg12
S'PMC2898909'
p11923
sa(dp11924
g8
V14600049.xml
p11925
sg10
VSTD-Ellickson-2003
p11926
sg12
S'PMC1448059'
p11927
sa(dp11928
g8
V20307126.xml
p11929
sg10
VSTD-Werch-2010
p11930
sg12
S'PMC2845326'
p11931
sa(dp11932
g8
V15547059.xml
p11933
sg10
VSTD-Bond-2004
p11934
sg12
S'PMC1732649'
p11935
sasa(dp11936
g3
VCD003985 v. 8.0 Non-legislative interventions for the promotion of cycle helmet wearing by children.rm5
p11937
sg5
(lp11938
(dp11939
g8
V9887419.xml
p11940
sg10
VSTD-Britt-1998
p11941
sg12
S'PMC1730419'
p11942
sa(dp11943
g8
V15033841.xml
p11944
sg10
VSTD-Kendrick-2004
p11945
sg12
S'PMC1719862'
p11946
sa(dp11947
g8
V9666367.xml
p11948
sg10
VSTD-Hendrickson-1998
p11949
sg12
S'PMC1730341'
p11950
sa(dp11951
g8
V1853997.xml
p11952
sg10
VSTD-Cushman-1991b
p11953
sg12
S'PMC1405730'
p11954
sa(dp11955
g8
V9666365.xml
p11956
sg10
VSTD-Macarthur-1998
p11957
sg12
S'PMC1730356'
p11958
sa(dp11959
g8
V8561241.xml
p11960
sg10
VSTD-Farley-1996
p11961
sg12
S'PMC1380359'
p11962
sa(dp11963
g8
V9113846.xml
p11964
sg10
VSTD-Kim-1997
p11965
sg12
S'PMC1067762'
p11966
sa(dp11967
g8
V9346001.xml
p11968
sg10
VSTD-Wright-1995
p11969
sg12
S'PMC1067557'
p11970
sa(dp11971
g8
V12966021.xml
p11972
sg10
VSTD-Azeredo-2003
p11973
sg12
S'PMC1731011'
p11974
sa(dp11975
g8
V10875675.xml
p11976
sg10
VSTD-Lee-2000
p11977
sg12
S'PMC1730614'
p11978
sasa(dp11979
g3
VCD003091 v. 5.2 Dressings for the prevention of surgical site infection.rm5
p11980
sg5
(lp11981
(dp11982
g8
V3671224.xml
p11983
sg10
VSTD-Law-1987
p11984
sg12
S'PMC2428199'
p11985
sa(dp11986
g8
V22096550.xml
p11987
sg10
VSTD-Hewlett-1996
p11988
sg12
S'PMC3214045'
p11989
sasa(dp11990
g3
VCD004083 v. 5.0 Peribulbar versus retrobulbar anaesthesia for cataract surgery.rm5
p11991
sg5
(lp11992
(dp11993
g8
V8110669.xml
p11994
sg10
VSTD-Ali_x002d_Melkkila-1993
p11995
sg12
S'PMC504652'
p11996
sasa(dp11997
g3
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p11998
sg5
(lp11999
(dp12000
g8
V9713447.xml
p12001
sg10
VSTD-Bourbeau-1998
p12002
sg12
S'PMC1745246'
p12003
sa(dp12004
g8
V2068695.xml
p12005
sg10
VSTD-Auffarth-1991
p12006
sg12
S'PMC1020969'
p12007
sa(dp12008
g8
V19014549.xml
p12009
sg10
VSTD-Calverley-2008
p12010
sg12
S'PMC2644301'
p12011
sa(dp12012
g8
V2180105.xml
p12013
sg10
VSTD-Weir-1990a
p12014
sg12
S'PMC462320'
p12015
sa(dp12016
g8
V17557771.xml
p12017
sg10
VSTD-Bourbeau-2007
p12018
sg12
S'PMC2117108'
p12019
sa(dp12020
g8
V12149529.xml
p12021
sg10
VSTD-Verhoeven-2002
p12022
sg12
S'PMC1746396'
p12023
sa(dp12024
g8
V20037682.xml
p12025
sg10
VSTD-Schermer-2009
p12026
sg12
S'PMC2793071'
p12027
sa(dp12028
g8
V1412119.xml
p12029
sg10
VSTD-Wempe-1992
p12030
sg12
S'PMC463924'
p12031
sa(dp12032
g8
V10807619.xml
p12033
sg10
VSTD-Burge-2000
p12034
sg12
S'PMC27372'
p12035
sa(dp12036
g8
V10343624.xml
p12037
sg10
VSTD-van-Grunsven-1999
p12038
sg12
S'PMC1745350'
p12039
sa(dp12040
g8
V15741434.xml
p12041
sg10
VSTD-Brightling-2005
p12042
sg12
S'PMC1747331'
p12043
sasa(dp12044
g3
VCD001112 v. 8.3 Caffeine for asthma.rm5
p12045
sg5
(lp12046
(dp12047
g8
V2205947.xml
p12048
sg10
VSTD-Colacone-1990
p12049
sg12
S'PMC462648'
p12050
sasa(dp12051
g3
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p12052
sg5
(lp12053
(dp12054
g8
V19259615.xml
p12055
sg10
VSTD-Halm-2009
p12056
sg12
S'PMC2690844'
p12057
sasa(dp12058
g3
VCD003079 v. 8.0 Benzodiazepines for psychosis-induced aggression or agitation.rm5
p12059
sg5
(lp12060
(dp12061
g8
V23135283.xml
p12062
sg10
VSTD-Clonazepam-2007_x002c_-CHN
p12063
sg12
S'PMC3531732'
p12064
sa(dp12065
g8
V14512476.xml
p12066
sg10
VSTD-Midazolam-2003_x002c_-BZ
p12067
sg12
S'PMC200800'
p12068
sasa(dp12069
g3
VCD009189 v. 2.43 Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection.rm5
p12070
sg5
(lp12071
(dp12072
g8
V15385902.xml
p12073
sg10
VSTD-Rotheram_x002d_Borus-2004
p12074
sg12
S'PMC2843590'
p12075
sa(dp12076
g8
V21457056.xml
p12077
sg10
VSTD-Kalichman-2011
p12078
sg12
S'PMC3085946'
p12079
sasa(dp12080
g3
VCD003000 v. 9.0 Education interventions for adults who attend the emergency room for acute asthma.rm5
p12081
sg5
(lp12082
(dp12083
g8
V8296253.xml
p12084
sg10
VSTD-Yoon-1993
p12085
sg12
S'PMC464888'
p12086
sa(dp12087
g8
V12324673.xml
p12088
sg10
VSTD-Osman-2002
p12089
sg12
S'PMC1746210'
p12090
sasa(dp12091
g3
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p12092
sg5
(lp12093
(dp12094
g8
V20595477.xml
p12095
sg10
VSTD-Krudsood-2010
p12096
sg12
S'PMC2912575'
p12097
sa(dp12098
g8
V18503714.xml
p12099
sg10
VSTD-Matsegui-2008
p12100
sg12
S'PMC2409363'
p12101
sa(dp12102
g8
V21631932.xml
p12103
sg10
VSTD-Kofoed-2011
p12104
sg12
S'PMC3123603'
p12105
sasa(dp12106
g3
VCD009159 v. 2.0 Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogenei.rm5
p12107
sg5
(lp12108
(dp12109
g8
V17272503.xml
p12110
sg10
VSTD-Champlin-2007
p12111
sg12
S'PMC1885491'
p12112
sasa(dp12113
g3
VCD001277 v. 10.0 Breathing exercises for asthma.rm5
p12114
sg5
(lp12115
(dp12116
g8
V3931802.xml
p12117
sg10
VSTD-Nagarathna-1985
p12118
sg12
S'PMC1417003'
p12119
sa(dp12120
g8
V12554890.xml
p12121
sg10
VSTD-Thomas-2003
p12122
sg12
S'PMC1746567'
p12123
sasa(dp12124
g3
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p12125
sg5
(lp12126
(dp12127
g8
V10982577.xml
p12128
sg10
VSTD-Lichtenstein-2000
p12129
sg12
S'PMC1748368'
p12130
sa(dp12131
g8
V15365111.xml
p12132
sg10
VSTD-Etter-2004
p12133
sg12
S'PMC1763345'
p12134
sa(dp12135
g8
V3529480.xml
p12136
sg10
VSTD-Campbell-1986
p12137
sg12
S'PMC1020629'
p12138
sa(dp12139
g8
V11397745.xml
p12140
sg10
VSTD-Lennox-2001
p12141
sg12
S'PMC32255'
p12142
sa(dp12143
g8
V3592033.xml
p12144
sg10
VSTD-Janz-1987
p12145
sg12
S'PMC1647206'
p12146
sa(dp12147
g8
V17995993.xml
p12148
sg10
VSTD-Meyer-2008
p12149
sg12
S'PMC2253708'
p12150
sa(dp12151
g8
V8518571.xml
p12152
sg10
VSTD-ICRF-1994
p12153
sg12
S'PMC1677770'
p12154
sa(dp12155
g8
V6402162.xml
p12156
sg10
VSTD-BTS-1983
p12157
sg12
S'PMC1546807'
p12158
sa(dp12159
g8
V10688938.xml
p12160
sg10
VSTD-Orleans-2000
p12161
sg12
S'PMC1766256'
p12162
sa(dp12163
g8
V6437257.xml
p12164
sg10
VSTD-Davis-1984
p12165
sg12
S'PMC1652036'
p12166
sasa(dp12167
g3
VCD006356 v. 4.0 Effects of glucocorticoids on radiological progression in rheumatoid arthritis.rm5
p12168
sg5
(lp12169
(dp12170
g8
V10531077.xml
p12171
sg10
VSTD-Hansen-1999
p12172
sg12
S'PMC1752793'
p12173
sa(dp12174
g8
V13856637.xml
p12175
sg10
VSTD-Joint-1959
p12176
sg12
S'PMC1007099'
p12177
sa(dp12178
g8
V15760929.xml
p12179
sg10
VSTD-Choy-2005
p12180
sg12
S'PMC1755652'
p12181
sa(dp12182
g8
V15194574.xml
p12183
sg10
VSTD-Capell-2004
p12184
sg12
S'PMC1755058'
p12185
sa(dp12186
g8
V13470729.xml
p12187
sg10
VSTD-Empire-1957
p12188
sg12
S'PMC1006963'
p12189
sa(dp12190
g8
V13275875.xml
p12191
sg10
VSTD-Empire-1955
p12192
sg12
S'PMC1006832'
p12193
sasa(dp12194
g3
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p12195
sg5
(lp12196
(dp12197
g8
V16136045.xml
p12198
sg10
VSTD-Donskov_x0028_ii_x0029_-2005
p12199
sg12
S'PMC2361635'
p12200
sa(dp12201
g8
V9703284.xml
p12202
sg10
VSTD-Jayson-1998
p12203
sg12
S'PMC2063040'
p12204
sa(dp12205
g8
V7841054.xml
p12206
sg10
VSTD-DeMulder-1995
p12207
sg12
S'PMC2033601'
p12208
sa(dp12209
g8
V16136045.xml
p12210
sg10
VSTD-Donskov_x0028_i_x0029_-2005
p12211
sg12
S'PMC2361635'
p12212
sa(dp12213
g8
V9579838.xml
p12214
sg10
VSTD-Henriksson-1998
p12215
sg12
S'PMC2150170'
p12216
sa(dp12217
g8
V12915604.xml
p12218
sg10
VSTD-Yang-2003_x0028_ii_x0029_
p12219
sg12
S'PMC2275327'
p12220
sa(dp12221
g8
V12915604.xml
p12222
sg10
VSTD-Yang-2003_x0028_i_x0029_
p12223
sg12
S'PMC2275327'
p12224
sa(dp12225
g8
V11710825.xml
p12226
sg10
VSTD-Atzpodien-2001
p12227
sg12
S'PMC2375150'
p12228
sasa(dp12229
g3
VCD004145 v. 10.0 Oral substitution treatment of injecting opioid users for prevention of HIV infection.rm5
p12230
sg5
(lp12231
(dp12232
g8
V9722818.xml
p12233
sg10
VSTD-Brooner-1998
p12234
sg12
S'PMC1307735'
p12235
sa(dp12236
g8
V17931826.xml
p12237
sg10
VSTD-Willner_x002d_Reid-2008
p12238
sg12
S'PMC2600879'
p12239
sa(dp12240
g8
V8944860.xml
p12241
sg10
VSTD-Stark-1996
p12242
sg12
S'PMC1060345'
p12243
sa(dp12244
g8
V10976608.xml
p12245
sg10
VSTD-Thiede-2000
p12246
sg12
S'PMC3456044'
p12247
sasa(dp12248
g3
VCD001911 v. 10.0 Carbamazepine versus phenytoin monotherapy for epilepsy.rm5
p12249
sg5
(lp12250
(dp12251
g8
V3928820.xml
p12252
sg10
VSTD-Callaghan-1985
p12253
sg12
S'PMC1028404'
p12254
sa(dp12255
g8
V7823066.xml
p12256
sg10
VSTD-Heller-1995
p12257
sg12
S'PMC1073267'
p12258
sasa(dp12259
g3
VCD004399 v. 6.1 Medical versus surgical interventions for open angle glaucoma.rm5
p12260
sg5
(lp12261
(dp12262
g8
V3067743.xml
p12263
sg10
VSTD-Glasgow-Trial-1988
p12264
sg12
S'PMC1041614'
p12265
sasa(dp12266
g3
VCD004696 v. 6.0 Nutrient-enriched formula versus standard term formula for preterm infants following hospital discha.rm5
p12267
sg5
(lp12268
(dp12269
g8
V1575558.xml
p12270
sg10
VSTD-Lucas-1992
p12271
sg12
S'PMC1793654'
p12272
sasa(dp12273
g3
VCD003087 v. 9.0 Double gloving to reduce surgical cross-infection.rm5
p12274
sg5
(lp12275
(dp12276
g8
V11423598.xml
p12277
sg10
VSTD-Thomas-2001
p12278
sg12
S'PMC1760980'
p12279
sa(dp12280
g8
V8659967.xml
p12281
sg10
VSTD-Wilson-1996
p12282
sg12
S'PMC2502654'
p12283
sasa(dp12284
g3
VCD009377 v. 2.3 Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).rm5
p12285
sg5
(lp12286
(dp12287
g8
V17954515.xml
p12288
sg10
VSTD-Huf-2007
p12289
sg12
S'PMC2043463'
p12290
sasa(dp12291
g3
VCD003807 v. 5.2 Interventions for preventing oral candidiasis for patients with cancer receiving treatment.rm5
p12292
sg5
(lp12293
(dp12294
g8
V10560360.xml
p12295
sg10
VSTD-Huijgens-1999
p12296
sg12
S'PMC1023076'
p12297
sasa(dp12298
g3
VCD004929 v. 5.0 Prophylactic nasogastric decompression after abdominal surgery.rm5
p12299
sg5
(lp12300
(dp12301
g8
V1929130.xml
p12302
sg10
VSTD-Nathan-1991
p12303
sg12
S'PMC2499492'
p12304
sa(dp12305
g8
V4037908.xml
p12306
sg10
VSTD-Cheadle-1985
p12307
sg12
S'PMC1250919'
p12308
sa(dp12309
g8
V2658880.xml
p12310
sg10
VSTD-Wolff-1989
p12311
sg12
S'PMC1494121'
p12312
sasa(dp12313
g3
VCD006439 v. 4.0 Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum.rm5
p12314
sg5
(lp12315
(dp12316
g8
V14960519.xml
p12317
sg10
VSTD-Hurlstone-2004
p12318
sg12
S'PMC1773964'
p12319
sa(dp12320
g8
V19139000.xml
p12321
sg10
VSTD-Stoffel-2008
p12322
sg12
S'PMC2701380'
p12323
sasa(dp12324
g3
VCD004080 v. 7.0 Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for po.rm5
p12325
sg5
(lp12326
(dp12327
g8
V7618972.xml
p12328
sg10
VSTD-Reissman-1995
p12329
sg12
S'PMC1234758'
p12330
sa(dp12331
g8
V9339943.xml
p12332
sg10
VSTD-Watters-1997
p12333
sg12
S'PMC1191041'
p12334
sa(dp12335
g8
V9038665.xml
p12336
sg10
VSTD-Beier_x002d_Holgersen-1996
p12337
sg12
S'PMC1383455'
p12338
sa(dp12339
g8
V9351723.xml
p12340
sg10
VSTD-Heslin-1997
p12341
sg12
S'PMC1191079'
p12342
sasa(dp12343
g3
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p12344
sg5
(lp12345
(dp12346
g8
V21371991.xml
p12347
sg10
VSTD-Whittaker-2011
p12348
sg12
S'PMC3221331'
p12349
sa(dp12350
g8
V16046689.xml
p12351
sg10
VSTD-Rodgers-2005
p12352
sg12
S'PMC1748056'
p12353
sa(dp12354
g8
V21722952.xml
p12355
sg10
VSTD-Free-2011
p12356
sg12
S'PMC3143315'
p12357
sasa(dp12358
g3
VCD003271 v. 5.0 Budesonide at different doses for chronic asthma.rm5
p12359
sg5
(lp12360
(dp12361
g8
V1878641.xml
p12362
sg10
VSTD-Wolthers-1991
p12363
sg12
S'PMC1670402'
p12364
sasa(dp12365
g3
VCD003517 v. 5.0 Optimal duration of exclusive breastfeeding.rm5
p12366
sg5
(lp12367
(dp12368
g8
V10496824.xml
p12369
sg10
VSTD-Oddy-1999
p12370
sg12
S'PMC314207'
p12371
sa(dp12372
g8
V3566318.xml
p12373
sg10
VSTD-Savilahti-1987a
p12374
sg12
S'PMC1778320'
p12375
sasa(dp12376
g3
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p12377
sg5
(lp12378
(dp12379
g8
V17362472.xml
p12380
sg10
VSTD-COMPASS
p12381
sg12
S'PMC1920547'
p12382
sasa(dp12383
g3
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p12384
sg5
(lp12385
(dp12386
g8
V19042940.xml
p12387
sg10
VSTD-McMurdo-2009
p12388
sg12
S'PMC2639265'
p12389
sa(dp12390
g8
V21148516.xml
p12391
sg10
VSTD-Barbosa_x002d_Cesnik-2011
p12392
sg12
S'PMC3060891'
p12393
sa(dp12394
g8
V11431298.xml
p12395
sg10
VSTD-Kontiokari-2001
p12396
sg12
S'PMC33514'
p12397
sasa(dp12398
g3
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p12399
sg5
(lp12400
(dp12401
g8
V10982577.xml
p12402
sg10
VSTD-Lichtenstein-2000
p12403
sg12
S'PMC1748368'
p12404
sa(dp12405
g8
V10373999.xml
p12406
sg10
VSTD-Reid-1999
p12407
sg12
S'PMC1230362'
p12408
sa(dp12409
g8
V10224982.xml
p12410
sg10
VSTD-McBride-1999b
p12411
sg12
S'PMC1508743'
p12412
sa(dp12413
g8
V9357351.xml
p12414
sg10
VSTD-Lando-1997
p12415
sg12
S'PMC1381132'
p12416
sa(dp12417
g8
V1536333.xml
p12418
sg10
VSTD-Lando-1992
p12419
sg12
S'PMC1694411'
p12420
sa(dp12421
g8
V18048633.xml
p12422
sg10
VSTD-Hollis-2007
p12423
sg12
S'PMC2598511'
p12424
sa(dp12425
g8
V9396102.xml
p12426
sg10
VSTD-Ossip_x002d_Klein-1997
p12427
sg12
S'PMC1759567'
p12428
sa(dp12429
g8
V19225061.xml
p12430
sg10
VSTD-Sood-2009
p12431
sg12
S'PMC2773358'
p12432
sa(dp12433
g8
V18048636.xml
p12434
sg10
VSTD-Rabius-2007
p12435
sg12
S'PMC2598518'
p12436
sa(dp12437
g8
V11818305.xml
p12438
sg10
VSTD-Hennrikus-2002
p12439
sg12
S'PMC1447056'
p12440
sa(dp12441
g8
V18618189.xml
p12442
sg10
VSTD-Holmes_x002d_Rovner-2008
p12443
sg12
S'PMC2517997'
p12444
sa(dp12445
g8
V18304363.xml
p12446
sg10
VSTD-Young-2008
p12447
sg12
S'PMC2268921'
p12448
sa(dp12449
g8
V18783459.xml
p12450
sg10
VSTD-Joyce-2008
p12451
sg12
S'PMC2614005'
p12452
sasa(dp12453
g3
VCD008815 v. 3.0 Progestin-only contraceptives effects on weight.rm5
p12454
sg5
(lp12455
(dp12456
g8
V19766950.xml
p12457
sg10
VSTD-Bonny-2009
p12458
sg12
S'PMC2749597'
p12459
sasa(dp12460
g3
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p12461
sg5
(lp12462
(dp12463
g8
V16174135.xml
p12464
sg10
VSTD-Grootendorst-2005
p12465
sg12
S'PMC1361214'
p12466
sa(dp12467
g8
V10750472.xml
p12468
sg10
VSTD-Bursey-2000
p12469
sg12
S'PMC1231278'
p12470
sa(dp12471
g8
V17622192.xml
p12472
sg10
VSTD-Fretheim-2007
p12473
sg12
S'PMC1904466'
p12474
sa(dp12475
g8
V12126319.xml
p12476
sg10
VSTD-Marshall-2002
p12477
sg12
S'PMC116151'
p12478
sa(dp12479
g8
V17441934.xml
p12480
sg10
VSTD-Sakshaug-2007
p12481
sg12
S'PMC2048565'
p12482
sa(dp12483
g8
V14703526.xml
p12484
sg10
VSTD-Schneeweiss-2004
p12485
sg12
S'PMC313925'
p12486
sasa(dp12487
g3
VCD007166 v. 3.0 Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinsons disea.rm5
p12488
sg5
(lp12489
(dp12490
g8
V12876237.xml
p12491
sg10
VSTD-COMTI-_x0028_E_x0029__x003a_-UK_x002f_Irish
p12492
sg12
S'PMC1738605'
p12493
sa(dp12494
g8
V10201413.xml
p12495
sg10
VSTD-DA-_x0028_Pr_x0029__x003a_-Aust_x002f_Germ
p12496
sg12
S'PMC1736320'
p12497
sa(dp12498
g8
V9343116.xml
p12499
sg10
VSTD-COMTI-_x0028_T_x0029__x003a_-Europe
p12500
sg12
S'PMC2169755'
p12501
sasa(dp12502
g3
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p12503
sg5
(lp12504
(dp12505
g8
V17705879.xml
p12506
sg10
VSTD-Lee-2007
p12507
sg12
S'PMC2206510'
p12508
sasa(dp12509
g3
VCD001015 v. 10.0 Lecithin for dementia and cognitive impairment.rm5
p12510
sg5
(lp12511
(dp12512
g8
V3897460.xml
p12513
sg10
VSTD-Levy-1983
p12514
sg12
S'PMC1028443'
p12515
sasa(dp12516
g3
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p12517
sg5
(lp12518
(dp12519
g8
V19880578.xml
p12520
sg10
VSTD-Ebbert-2009
p12521
sg12
S'PMC2784490'
p12522
sa(dp12523
g8
V9949754.xml
p12524
sg10
VSTD-Walsh-1999
p12525
sg12
S'PMC1508522'
p12526
sa(dp12527
g8
V21134997.xml
p12528
sg10
VSTD-Fagerstrom-2010
p12529
sg12
S'PMC2997603'
p12530
sa(dp12531
g8
V20439384.xml
p12532
sg10
VSTD-Walsh-2010
p12533
sg12
S'PMC2902861'
p12534
sa(dp12535
g8
V20060229.xml
p12536
sg10
VSTD-Ebbert-2010a
p12537
sg12
S'PMC2850207'
p12538
sa(dp12539
g8
V7856783.xml
p12540
sg10
VSTD-Stevens-1995
p12541
sg12
S'PMC1615327'
p12542
sa(dp12543
g8
V14645935.xml
p12544
sg10
VSTD-Stotts-2003
p12545
sg12
S'PMC1766135'
p12546
sa(dp12547
g8
V17353101.xml
p12548
sg10
VSTD-Dale-2007
p12549
sg12
S'PMC1994655'
p12550
sasa(dp12551
g3
VCD002971 v. 6.0 Formula milk versus donor breast milk for feeding preterm or low birth weight infants.rm5
p12552
sg5
(lp12553
(dp12554
g8
V558739.xml
p12555
sg10
VSTD-Davies-1977
p12556
sg12
S'PMC1544654'
p12557
sa(dp12558
g8
V6476868.xml
p12559
sg10
VSTD-Lucas-1984b
p12560
sg12
S'PMC1628628'
p12561
sa(dp12562
g8
V6476868.xml
p12563
sg10
VSTD-Lucas-1984a
p12564
sg12
S'PMC1628628'
p12565
sasa(dp12566
g3
VCD001127 v. 14.0 Dornase alfa for cystic fibrosis.rm5
p12567
sg5
(lp12568
(dp12569
g8
V10319054.xml
p12570
sg10
VSTD-Ballmann-2002
p12571
sg12
S'PMC1745320'
p12572
sasa(dp12573
g3
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p12574
sg5
(lp12575
(dp12576
g8
V17359519.xml
p12577
sg10
VSTD-White-2007
p12578
sg12
S'PMC1831486'
p12579
sa(dp12580
g8
V10024707.xml
p12581
sg10
VSTD-Waite-1998
p12582
sg12
S'PMC1313196'
p12583
sa(dp12584
g8
V3417584.xml
p12585
sg10
VSTD-Leung-1991
p12586
sg12
S'PMC1286114'
p12587
sa(dp12588
g8
V12356614.xml
p12589
sg10
VSTD-Bier-2002
p12590
sg12
S'PMC1447300'
p12591
sa(dp12592
g8
V3933739.xml
p12593
sg10
VSTD-Clavel-1985
p12594
sg12
S'PMC1418170'
p12595
sasa(dp12596
g3
VCD006251 v. 7.0 Interventions to prevent injuries in construction workers.rm5
p12597
sg5
(lp12598
(dp12599
g8
V14965079.xml
p12600
sg10
VSTD-Wickizer-2004
p12601
sg12
S'PMC1360996'
p12602
sasa(dp12603
g3
VCD001532 v. 11.0 Interventions for primary vesicoureteric reflux.rm5
p12604
sg5
(lp12605
(dp12606
g8
V5652710.xml
p12607
sg10
VSTD-Scott-1968
p12608
sg12
S'PMC2019943'
p12609
sasa(dp12610
g3
VCD003643 v. 10.0 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.rm5
p12611
sg5
(lp12612
(dp12613
g8
V21688301.xml
p12614
sg10
VSTD-Muscle-Study-Group-2011
p12615
sg12
S'PMC3170432'
p12616
sasa(dp12617
g3
VCD001929 v. 11.0 Massage for low-back pain.rm5
p12618
sg5
(lp12619
(dp12620
g8
V16215330.xml
p12621
sg10
VSTD-Geisser-2005a
p12622
sg12
S'PMC1360691'
p12623
sa(dp12624
g8
V16399707.xml
p12625
sg10
VSTD-Hsieh-2006
p12626
sg12
S'PMC1325109'
p12627
sa(dp12628
g8
V10906914.xml
p12629
sg10
VSTD-Preyde-2000
p12630
sg12
S'PMC1231369'
p12631
sasa(dp12632
g3
VCD006114 v. 6.0 Fluvoxamine versus other anti-depressive agents for depression.rm5
p12633
sg5
(lp12634
(dp12635
g8
V6407503.xml
p12636
sg10
VSTD-de-Wilde-1983
p12637
sg12
S'PMC1427657'
p12638
sa(dp12639
g8
V6407504.xml
p12640
sg10
VSTD-Itil-1983
p12641
sg12
S'PMC1427663'
p12642
sa(dp12643
g8
V6407502.xml
p12644
sg10
VSTD-Dick-1983
p12645
sg12
S'PMC1427654'
p12646
sasa(dp12647
g3
VCD001808 v. 9.0 Prophylactic oxytocin for the third stage of labour.rm5
p12648
sg5
(lp12649
(dp12650
g8
V14066183.xml
p12651
sg10
VSTD-Bonham-1963
p12652
sg12
S'PMC1873904'
p12653
sasa(dp12654
g3
VCD003017 v. 5.2 Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) .rm5
p12655
sg5
(lp12656
(dp12657
g8
V7717738.xml
p12658
sg10
VSTD-Symon-1995
p12659
sg12
S'PMC1510964'
p12660
sasa(dp12661
g3
VCD007471 v. 3.0 Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in ante.rm5
p12662
sg5
(lp12663
(dp12664
g8
V12028976.xml
p12665
sg10
VSTD-Chiarelli-2002
p12666
sg12
S'PMC113274'
p12667
sa(dp12668
g8
V20607084.xml
p12669
sg10
VSTD-Dannecker-2004
p12670
sg12
S'PMC2896999'
p12671
sa(dp12672
g8
V11440920.xml
p12673
sg10
VSTD-Glazener-2001
p12674
sg12
S'PMC1120656'
p12675
sasa(dp12676
g3
VCD001863 v. 8.0 Education for contraceptive use by women after childbirth.rm5
p12677
sg5
(lp12678
(dp12679
g8
V9549449.xml
p12680
sg10
VSTD-Bolam-1998
p12681
sg12
S'PMC28481'
p12682
sa(dp12683
g8
V19752472.xml
p12684
sg10
VSTD-Barnet-2009
p12685
sg12
S'PMC2746510'
p12686
sasa(dp12687
g3
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p12688
sg5
(lp12689
(dp12690
g8
V17593956.xml
p12691
sg10
VSTD-Luabeya-2007
p12692
sg12
S'PMC1891438'
p12693
sa(dp12694
g8
V12052800.xml
p12695
sg10
VSTD-Bhandari-2002b
p12696
sg12
S'PMC115208'
p12697
sa(dp12698
g8
V12052800.xml
p12699
sg10
VSTD-Bhandari-2002a
p12700
sg12
S'PMC115208'
p12701
sasa(dp12702
g3
VMR000006 v. 5.0 Publication bias in clinical trials due to statistical significance or direction of trial results.rm5
p12703
sg5
(lp12704
(dp12705
g8
V9310565.xml
p12706
sg10
VSTD-Stern-1997
p12707
sg12
S'PMC2127436'
p12708
sa(dp12709
g8
V9723823.xml
p12710
sg10
VSTD-Bardy-1998
p12711
sg12
S'PMC1873669'
p12712
sasa(dp12713
g3
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p12714
sg5
(lp12715
(dp12716
g8
V8664135.xml
p12717
sg10
VSTD-Mohide-1996
p12718
sg12
S'PMC2074537'
p12719
sasa(dp12720
g3
VCD001904 v. 9.4 Carbamazepine versus phenobarbitone monotherapy for epilepsy.rm5
p12721
sg5
(lp12722
(dp12723
g8
V7823066.xml
p12724
sg10
VSTD-Heller-1995
p12725
sg12
S'PMC1073267'
p12726
sasa(dp12727
g3
VCD003642 v. 3.0 Chinese herbal medicines for type 2 diabetes mellitus.rm5
p12728
sg5
(lp12729
(dp12730
g8
V23901377.xml
p12731
sg10
VSTD-Yang-TB-2002
p12732
sg12
S'PMC3689487'
p12733
sasa(dp12734
g3
VCD004583 v. 3.0 Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.rm5
p12735
sg5
(lp12736
(dp12737
g8
V9810966.xml
p12738
sg10
VSTD-Desai-1998
p12739
sg12
S'PMC2170369'
p12740
sasa(dp12741
g3
VCD000406 v. 16.0 Oral calorie supplements for cystic fibrosis.rm5
p12742
sg5
(lp12743
(dp12744
g8
V16467348.xml
p12745
sg10
VSTD-Poustie-2006
p12746
sg12
S'PMC1403226'
p12747
sasa(dp12748
g3
VCD001364 v. 16.0 Zinc for the common cold.rm5
p12749
sg5
(lp12750
(dp12751
g8
V2665639.xml
p12752
sg10
VSTD-Smith-1989
p12753
sg12
S'PMC172506'
p12754
sa(dp12755
g8
V2820298.xml
p12756
sg10
VSTD-Farr-1987a
p12757
sg12
S'PMC174900'
p12758
sa(dp12759
g8
V3307620.xml
p12760
sg10
VSTD-Douglas-1987
p12761
sg12
S'PMC174915'
p12762
sasa(dp12763
g3
VCD004304 v. 5.1 Vitamins for epilepsy.rm5
p12764
sg5
(lp12765
(dp12766
g8
V4776883.xml
p12767
sg10
VSTD-Christiansen-1973a
p12768
sg12
S'PMC1587877'
p12769
sa(dp12770
g8
V4922754.xml
p12771
sg10
VSTD-Grant-1970
p12772
sg12
S'PMC1820248'
p12773
sasa(dp12774
g3
VCD003255 v. 10.0 Condom effectiveness in reducing heterosexual HIV transmission.rm5
p12775
sg5
(lp12776
(dp12777
g8
V3143442.xml
p12778
sg10
VSTD-van-der-Ende-1988
p12779
sg12
S'PMC1834851'
p12780
sa(dp12781
g8
V1628088.xml
p12782
sg10
VSTD-Allen-1992
p12783
sg12
S'PMC1881972'
p12784
sasa(dp12785
g3
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p12786
sg5
(lp12787
(dp12788
g8
V18476202.xml
p12789
sg10
VSTD-Hemsell-1993
p12790
sg12
S'PMC2364680'
p12791
sasa(dp12792
g3
VCD001461 v. 6.0 Azathioprine for treating rheumatoid arthritis.rm5
p12793
sg5
(lp12794
(dp12795
g8
V7020612.xml
p12796
sg10
VSTD-Woodland-1981
p12797
sg12
S'PMC1000728'
p12798
sasa(dp12799
g3
VCD006257 v. 7.0 Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the .rm5
p12800
sg5
(lp12801
(dp12802
g8
V2507061.xml
p12803
sg10
VSTD-Parving-1989
p12804
sg12
S'PMC1837371'
p12805
sa(dp12806
g8
V14960504.xml
p12807
sg10
VSTD-DIABHYCAR-2004
p12808
sg12
S'PMC351842'
p12809
sa(dp12810
g8
V3038254.xml
p12811
sg10
VSTD-Marre-1987
p12812
sg12
S'PMC1246608'
p12813
sasa(dp12814
g3
VCD004335 v. 11.0 Community-based interventions for the prevention of burns and scalds in children.rm5
p12815
sg5
(lp12816
(dp12817
g8
V2817165.xml
p12818
sg10
VSTD-Guyer-1989
p12819
sg12
S'PMC1349806'
p12820
sa(dp12821
g8
V7058964.xml
p12822
sg10
VSTD-MacKay-1982
p12823
sg12
S'PMC1649800'
p12824
sasa(dp12825
g3
VCD006640 v. 4.12 Tranexamic acid for upper gastrointestinal bleeding.rm5
p12826
sg5
(lp12827
(dp12828
g8
V11511559.xml
p12829
sg10
VSTD-Hawkey-2001
p12830
sg12
S'PMC1728427'
p12831
sa(dp12832
g8
V789186.xml
p12833
sg10
VSTD-Biggs-1976
p12834
sg12
S'PMC1411285'
p12835
sa(dp12836
g8
V3101804.xml
p12837
sg10
VSTD-Holstein-1987
p12838
sg12
S'PMC1245035'
p12839
sasa(dp12840
g3
VCD006575 v. 2.0 Virtual reality training for surgical trainees in laparoscopic surgery.rm5
p12841
sg5
(lp12842
(dp12843
g8
V12368674.xml
p12844
sg10
VSTD-Seymour-2002
p12845
sg12
S'PMC1422600'
p12846
sasa(dp12847
g3
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p12848
sg5
(lp12849
(dp12850
g8
V18581586.xml
p12851
sg10
VSTD-Leykin-2008
p12852
sg12
S'PMC2615351'
p12853
sasa(dp12854
g3
VCD000490 v. 6.2 Antibiotics for asymptomatic bacteriuria in pregnancy.rm5
p12855
sg5
(lp12856
(dp12857
g8
V5792611.xml
p12858
sg10
VSTD-Williams-1969
p12859
sg12
S'PMC1984002'
p12860
sa(dp12861
g8
V3115406.xml
p12862
sg10
VSTD-Foley-1987
p12863
sg12
S'PMC1247109'
p12864
sasa(dp12865
g3
VCD005508 v. 3.0 Beta blockers for peripheral arterial disease.rm5
p12866
sg5
(lp12867
(dp12868
g8
V1747577.xml
p12869
sg10
VSTD-Solomon-1991
p12870
sg12
S'PMC1671261'
p12871
sa(dp12872
g8
V6378235.xml
p12873
sg10
VSTD-Lepantalo-1984a
p12874
sg12
S'PMC1463567'
p12875
sasa(dp12876
g3
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p12877
sg5
(lp12878
(dp12879
g8
V6228197.xml
p12880
sg10
VSTD-Henry-1983
p12881
sg12
S'PMC1628387'
p12882
sa(dp12883
g8
V11983043.xml
p12884
sg10
VSTD-Totapally-2002
p12885
sg12
S'PMC111183'
p12886
sa(dp12887
g8
V1533504.xml
p12888
sg10
VSTD-Wang-1992
p12889
sg12
S'PMC1793648'
p12890
sa(dp12891
g8
V1929514.xml
p12892
sg10
VSTD-Ho-1991
p12893
sg12
S'PMC1793026'
p12894
sasa(dp12895
g3
VCD004406 v. 8.4 Different antibiotic treatments for group A streptococcal pharyngitis.rm5
p12896
sg5
(lp12897
(dp12898
g8
V23403631.xml
p12899
sg10
VSTD-McCarty-1992a
p12900
sg12
S'PMC3618531'
p12901
sa(dp12902
g8
V8980757.xml
p12903
sg10
VSTD-Watkins-1997
p12904
sg12
S'PMC163662'
p12905
sasa(dp12906
g3
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p12907
sg5
(lp12908
(dp12909
g8
V18362256.xml
p12910
sg10
VSTD-Djulbegovic-2008
p12911
sg12
S'PMC2773511'
p12912
sa(dp12913
g8
V21542934.xml
p12914
sg10
VSTD-Dent-2011
p12915
sg12
S'PMC3113983'
p12916
sasa(dp12917
g3
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p12918
sg5
(lp12919
(dp12920
g8
V8494706.xml
p12921
sg10
VSTD-Downer-1993
p12922
sg12
S'PMC1968469'
p12923
sa(dp12924
g8
V12799626.xml
p12925
sg10
VSTD-Smith-2003
p12926
sg12
S'PMC2741110'
p12927
sa(dp12928
g8
V12671693.xml
p12929
sg10
VSTD-Boogaerts-2003
p12930
sg12
S'PMC2376376'
p12931
sa(dp12932
g8
V10408844.xml
p12933
sg10
VSTD-Thatcher-1999
p12934
sg12
S'PMC2362337'
p12935
sa(dp12936
g8
V16570051.xml
p12937
sg10
VSTD-Wilkinson-2006
p12938
sg12
S'PMC2361228'
p12939
sasa(dp12940
g3
VCD002843 v. 5.0 Strategies for partner notification for sexually transmitted diseases.rm5
p12941
sg5
(lp12942
(dp12943
g8
V9722821.xml
p12944
sg10
VSTD-Levy-1998
p12945
sg12
S'PMC1307738'
p12946
sa(dp12947
g8
V835764.xml
p12948
sg10
VSTD-Potterat-et-al_x002c_-1977
p12949
sg12
S'PMC1653534'
p12950
sa(dp12951
g8
V9487169.xml
p12952
sg10
VSTD-Andersen-et-al_x002c_-1998
p12953
sg12
S'PMC2665537'
p12954
sa(dp12955
g8
V2249964.xml
p12956
sg10
VSTD-Montesinos_x002c_-1990
p12957
sg12
S'PMC1286239'
p12958
sasa(dp12959
g3
VCD009351 v. 2.0 Inhaled analgesia for pain management in labour.rm5
p12960
sg5
(lp12961
(dp12962
g8
V5440545.xml
p12963
sg10
VSTD-MRC-1970
p12964
sg12
S'PMC1699836'
p12965
sa(dp12966
g8
V4895338.xml
p12967
sg10
VSTD-Jones-1969
p12968
sg12
S'PMC1984038'
p12969
sa(dp12970
g8
V4895339.xml
p12971
sg10
VSTD-Jones-1969a
p12972
sg12
S'PMC1984080'
p12973
sasa(dp12974
g3
VCD005372 v. 5.0 Oxygen therapy during exercise training in chronic obstructive pulmonary disease.rm5
p12975
sg5
(lp12976
(dp12977
g8
V10856310.xml
p12978
sg10
VSTD-Garrod-2000
p12979
sg12
S'PMC1745814'
p12980
sasa(dp12981
g3
VCD001878 v. 6.0 Non-invasive physical treatments for chronicrecurrent headache.rm5
p12982
sg5
(lp12983
(dp12984
g8
V6355460.xml
p12985
sg10
VSTD-Howe-1983
p12986
sg12
S'PMC1973006'
p12987
sasa(dp12988
g3
VCD000996 v. 6.0 Inhaled steroids for bronchiectasis.rm5
p12989
sg5
(lp12990
(dp12991
g8
V15741443.xml
p12992
sg10
VSTD-Tsang-2005
p12993
sg12
S'PMC1747352'
p12994
sasa(dp12995
g3
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p12996
sg5
(lp12997
(dp12998
g8
V22137413.xml
p12999
sg10
VSTD-Wright-2011
p13000
sg12
S'PMC3223774'
p13001
sa(dp13002
g8
V19686525.xml
p13003
sg10
VSTD-Madlung_x002d_Kratzer-2009
p13004
sg12
S'PMC2773536'
p13005
sasa(dp13006
g3
VCD002863 v. 7.0 Oral beta-blockers for mild to moderate hypertension during pregnancy.rm5
p13007
sg5
(lp13008
(dp13009
g8
V2242456.xml
p13010
sg10
VSTD-Scotland-1990
p13011
sg12
S'PMC1663720'
p13012
sa(dp13013
g8
V6407638.xml
p13014
sg10
VSTD-England-1983
p13015
sg12
S'PMC1548251'
p13016
sa(dp13017
g8
V3929874.xml
p13018
sg10
VSTD-Australia-1985
p13019
sg12
S'PMC1418204'
p13020
sasa(dp13021
g3
VCD005112 v. 5.0 Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.rm5
p13022
sg5
(lp13023
(dp13024
g8
V12801957.xml
p13025
sg10
VSTD-Probert-2003
p13026
sg12
S'PMC1773722'
p13027
sasa(dp13028
g3
VCD005187 v. 7.0 Influenza vaccination for healthcare workers who work with the elderly.rm5
p13029
sg5
(lp13030
(dp13031
g8
V17142257.xml
p13032
sg10
VSTD-Hayward-2006
p13033
sg12
S'PMC1702427'
p13034
sasa(dp13035
g3
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p13036
sg5
(lp13037
(dp13038
g8
V16840441.xml
p13039
sg10
VSTD-Bramwell-2006c
p13040
sg12
S'PMC1526944'
p13041
sa(dp13042
g8
V7950558.xml
p13043
sg10
VSTD-Bucher-1994
p13044
sg12
S'PMC2541000'
p13045
sa(dp13046
g8
V11458479.xml
p13047
sg10
VSTD-Misselbrook-2001
p13048
sg12
S'PMC1313976'
p13049
sa(dp13050
g8
V15143111.xml
p13051
sg10
VSTD-Adily-2004
p13052
sg12
S'PMC1732789'
p13053
sa(dp13054
g8
V14687273.xml
p13055
sg10
VSTD-Sheridan-2003
p13056
sg12
S'PMC1494938'
p13057
sa(dp13058
g8
V19707575.xml
p13059
sg10
VSTD-Carling-2009
p13060
sg12
S'PMC2724738'
p13061
sa(dp13062
g8
V19030110.xml
p13063
sg10
VSTD-Carling-2008
p13064
sg12
S'PMC2585274'
p13065
sa(dp13066
g8
V10571703.xml
p13067
sg10
VSTD-Nikolajevic_x002d_S-1999
p13068
sg12
S'PMC1496748'
p13069
sa(dp13070
g8
V7580661.xml
p13071
sg10
VSTD-Fahey-1995
p13072
sg12
S'PMC2551363'
p13073
sa(dp13074
g8
V16840441.xml
p13075
sg10
VSTD-Bramwell-2006d
p13076
sg12
S'PMC1526944'
p13077
sa(dp13078
g8
V16840441.xml
p13079
sg10
VSTD-Bramwell-2006b
p13080
sg12
S'PMC1526944'
p13081
sa(dp13082
g8
V16840441.xml
p13083
sg10
VSTD-Bramwell-2006a
p13084
sg12
S'PMC1526944'
p13085
sa(dp13086
g8
V8978112.xml
p13087
sg10
VSTD-Cranney-1996
p13088
sg12
S'PMC1239820'
p13089
sasa(dp13090
g3
VCD004228 v. 4.0 Psychological andor educational interventions for reducing alcohol consumption in pregnant women an.rm5
p13091
sg5
(lp13092
(dp13093
g8
V17194863.xml
p13094
sg10
VSTD-O_x0027_Connor-2007
p13095
sg12
S'PMC1781394'
p13096
sasa(dp13097
g3
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p13098
sg5
(lp13099
(dp13100
g8
V23056681.xml
p13101
sg10
VSTD-Sharafi-2010
p13102
sg12
S'PMC3446002'
p13103
sasa(dp13104
g3
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p13105
sg5
(lp13106
(dp13107
g8
V16884530.xml
p13108
sg10
VSTD-Lorente-2006
p13109
sg12
S'PMC1750976'
p13110
sa(dp13111
g8
V11178222.xml
p13112
sg10
VSTD-Thomachot-2001
p13113
sg12
S'PMC29053'
p13114
sasa(dp13115
g3
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p13116
sg5
(lp13117
(dp13118
g8
V21398619.xml
p13119
sg10
VSTD-NSABP-B_x002d_24-Trial-2011
p13120
sg12
S'PMC3107729'
p13121
sa(dp13122
g8
V21145284.xml
p13123
sg10
VSTD-UK-ANZ-Trial-2011
p13124
sg12
S'PMC3018565'
p13125
sasa(dp13126
g3
VCD007570 v. 4.0 Lactulose versus Polyethylene Glycol for Chronic Constipation.rm5
p13127
sg5
(lp13128
(dp13129
g8
V9895382.xml
p13130
sg10
VSTD-Attar-1999
p13131
sg12
S'PMC1727381'
p13132
sa(dp13133
g8
V15479678.xml
p13134
sg10
VSTD-Voskuijl-2004
p13135
sg12
S'PMC1774276'
p13136
sasa(dp13137
g3
VCD001506 v. 10.0 Nebulised hypertonic saline for cystic fibrosis.rm5
p13138
sg5
(lp13139
(dp13140
g8
V9404379.xml
p13141
sg10
VSTD-Robinson-1997
p13142
sg12
S'PMC1758438'
p13143
sa(dp13144
g8
V10319054.xml
p13145
sg10
VSTD-Ballmann-1998
p13146
sg12
S'PMC1745320'
p13147
sa(dp13148
g8
V6767295.xml
p13149
sg10
VSTD-Weller-1980
p13150
sg12
S'PMC471218'
p13151
sasa(dp13152
g3
VCD005272 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p13153
sg5
(lp13154
(dp13155
g8
V11796805.xml
p13156
sg10
VSTD-Ray-2001
p13157
sg12
S'PMC3455875'
p13158
sa(dp13159
g8
V15213569.xml
p13160
sg10
VSTD-Basu-2004
p13161
sg12
S'PMC2826108'
p13162
sa(dp13163
g8
V17067252.xml
p13164
sg10
VSTD-Li-2006
p13165
sg12
S'PMC1933388'
p13166
sa(dp13167
g8
V17591662.xml
p13168
sg10
VSTD-Hoke-2007
p13169
sg12
S'PMC2598714'
p13170
sa(dp13171
g8
V18543095.xml
p13172
sg10
VSTD-Chiao-2009
p13173
sg12
S'PMC3103188'
p13174
sa(dp13175
g8
V15800098.xml
p13176
sg10
VSTD-Feldblum-2005
p13177
sg12
S'PMC1764680'
p13178
sa(dp13179
g8
V19716639.xml
p13180
sg10
VSTD-Swendeman-2009
p13181
sg12
S'PMC2824563'
p13182
sa(dp13183
g8
V18799768.xml
p13184
sg10
VSTD-Patterson-2008
p13185
sg12
S'PMC2633868'
p13186
sasa(dp13187
g3
VCD003836 v. 6.0 Bed rest for acute uncomplicated myocardial infarction.rm5
p13188
sg5
(lp13189
(dp13190
g8
V971383.xml
p13191
sg10
VSTD-Hayes-1976
p13192
sg12
S'PMC483116'
p13193
sa(dp13194
g8
V389259.xml
p13195
sg10
VSTD-West-1979
p13196
sg12
S'PMC482171'
p13197
sa(dp13198
g8
V4835462.xml
p13199
sg10
VSTD-Hayes-1974
p13200
sg12
S'PMC1611338'
p13201
sasa(dp13202
g3
VCD008565 v. 3.2 Statins for women with polycystic ovary syndrome not actively trying to conceive.rm5
p13203
sg5
(lp13204
(dp13205
g8
V19890022.xml
p13206
sg10
VSTD-Banaszewska-2009
p13207
sg12
S'PMC2795658'
p13208
sasa(dp13209
g3
VCD007216 v. 1.0 Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis.rm5
p13210
sg5
(lp13211
(dp13212
g8
V16484504.xml
p13213
sg10
VSTD-Ogata-2006
p13214
sg12
S'PMC1860021'
p13215
sasa(dp13216
g3
VCD000093 v. 9.0 Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsula.rm5
p13217
sg5
(lp13218
(dp13219
g8
V9728307.xml
p13220
sg10
VSTD-Park-1998
p13221
sg12
S'PMC3619600'
p13222
sasa(dp13223
g3
VCD007043 v. 4.0 Copper containing intra-uterine devices versus depot progestogens for contraception.rm5
p13224
sg5
(lp13225
(dp13226
g8
V17689627.xml
p13227
sg10
VSTD-Stringer-2007
p13228
sg12
S'PMC2730754'
p13229
sasa(dp13230
g3
VCD004854 v. 6.0 Interventions for helping people recognise early signs of recurrence in bipolar disorder.rm5
p13231
sg5
(lp13232
(dp13233
g8
V9888904.xml
p13234
sg10
VSTD-Perry-1999
p13235
sg12
S'PMC27688'
p13236
sasa(dp13237
g3
VCD007187 v. 3.0 Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.rm5
p13238
sg5
(lp13239
(dp13240
g8
V6357258.xml
p13241
sg10
VSTD-Chadha-1983
p13242
sg12
S'PMC1428071'
p13243
sa(dp13244
g8
V6753893.xml
p13245
sg10
VSTD-Weinberger-1982
p13246
sg12
S'PMC1427520'
p13247
sa(dp13248
g8
V3555588.xml
p13249
sg10
VSTD-Kayanakis-1987
p13250
sg12
S'PMC1386051'
p13251
sasa(dp13252
g3
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p13253
sg5
(lp13254
(dp13255
g8
V10632830.xml
p13256
sg10
VSTD-Wolf-2000
p13257
sg12
S'PMC1495322'
p13258
sa(dp13259
g8
V12084693.xml
p13260
sg10
VSTD-McBride-2002
p13261
sg12
S'PMC1447199'
p13262
sa(dp13263
g8
V17389534.xml
p13264
sg10
VSTD-Krist-2007
p13265
sg12
S'PMC1838687'
p13266
sa(dp13267
g8
V14521639.xml
p13268
sg10
VSTD-Frosch-2003
p13269
sg12
S'PMC1494924'
p13270
sa(dp13271
g8
V19209172.xml
p13272
sg10
VSTD-Vodermaier-2009
p13273
sg12
S'PMC2653746'
p13274
sa(dp13275
g8
V16129870.xml
p13276
sg10
VSTD-McAlister-2005
p13277
sg12
S'PMC1188186'
p13278
sa(dp13279
g8
V17005051.xml
p13280
sg10
VSTD-Sheridan-2006
p13281
sg12
S'PMC1626460'
p13282
sa(dp13283
g8
V12939889.xml
p13284
sg10
VSTD-Montgomery-2003
p13285
sg12
S'PMC1314618'
p13286
sa(dp13287
g8
V17540908.xml
p13288
sg10
VSTD-Montgomery-2007
p13289
sg12
S'PMC1895676'
p13290
sa(dp13291
g8
V15280342.xml
p13292
sg10
VSTD-Green-2004
p13293
sg12
S'PMC1237120'
p13294
sa(dp13295
g8
V18760888.xml
p13296
sg10
VSTD-Volk-2008
p13297
sg12
S'PMC2867348'
p13298
sa(dp13299
g8
V11532844.xml
p13300
sg10
VSTD-Murray-2001b
p13301
sg12
S'PMC48137'
p13302
sa(dp13303
g8
V11532845.xml
p13304
sg10
VSTD-Murray-2001a
p13305
sg12
S'PMC48138'
p13306
sa(dp13307
g8
V11561335.xml
p13308
sg10
VSTD-Dodin-2001
p13309
sg12
S'PMC2018543'
p13310
sa(dp13311
g8
V19210013.xml
p13312
sg10
VSTD-Schwartz-2009
p13313
sg12
S'PMC3580845'
p13314
sa(dp13315
g8
V11089711.xml
p13316
sg10
VSTD-Morgan-2000
p13317
sg12
S'PMC1495608'
p13318
sa(dp13319
g8
V16173330.xml
p13320
sg10
VSTD-Myers-2005a
p13321
sg12
S'PMC2576013'
p13322
sa(dp13323
g8
V17214891.xml
p13324
sg10
VSTD-Thomson-2007
p13325
sg12
S'PMC1781432'
p13326
sasa(dp13327
g3
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p13328
sg5
(lp13329
(dp13330
g8
V11604444.xml
p13331
sg10
VSTD-Kendrick-2001
p13332
sg12
S'PMC1763305'
p13333
sa(dp13334
g8
V15173366.xml
p13335
sg10
VSTD-Bentley-2004
p13336
sg12
S'PMC1733848'
p13337
sa(dp13338
g8
V3094776.xml
p13339
sg10
VSTD-Simes-1986
p13340
sg12
S'PMC1341916'
p13341
sa(dp13342
g8
V10213724.xml
p13343
sg10
VSTD-Welton-1999
p13344
sg12
S'PMC27847'
p13345
sa(dp13346
g8
V18946893.xml
p13347
sg10
VSTD-Weinfurt-2008b
p13348
sg12
S'PMC2908285'
p13349
sa(dp13350
g8
V18386101.xml
p13351
sg10
VSTD-Weinfurt-2008a
p13352
sg12
S'PMC2517900'
p13353
sa(dp13354
g8
V16877628.xml
p13355
sg10
VSTD-Trevena-2006
p13356
sg12
S'PMC2563378'
p13357
sa(dp13358
g8
V18245061.xml
p13359
sg10
VSTD-Jeste-2009
p13360
sg12
S'PMC2696362'
p13361
sa(dp13362
g8
V17848908.xml
p13363
sg10
VSTD-Hutchison-2007
p13364
sg12
S'PMC2360384'
p13365
sasa(dp13366
g3
VCD004269 v. 10.6 Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorde.rm5
p13367
sg5
(lp13368
(dp13369
g8
V20164484.xml
p13370
sg10
VSTD-Slichter-2010
p13371
sg12
S'PMC2951321'
p13372
sasa(dp13373
g3
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p13374
sg5
(lp13375
(dp13376
g8
V20427088.xml
p13377
sg10
VSTD-DRCRnet
p13378
sg12
S'PMC2937272'
p13379
sa(dp13380
g8
V20980427.xml
p13381
sg10
VSTD-RESOLVE
p13382
sg12
S'PMC2963502'
p13383
sasa(dp13384
g3
VCD000990 v. 8.6 Exercise for intermittent claudication.rm5
p13385
sg5
(lp13386
(dp13387
g8
V2647051.xml
p13388
sg10
VSTD-Lundgren-1989
p13389
sg12
S'PMC1493950'
p13390
sasa(dp13391
g3
VCD000349 v. 4.2 Guidelines in professions allied to medicine.rm5
p13392
sg5
(lp13393
(dp13394
g8
V128907.xml
p13395
sg10
VSTD-Greenfield-1975b
p13396
sg12
S'PMC1129908'
p13397
sasa(dp13398
g3
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p13399
sg5
(lp13400
(dp13401
g8
V1503915.xml
p13402
sg10
VSTD-Dixon-1992
p13403
sg12
S'PMC1977824'
p13404
sa(dp13405
g8
V367510.xml
p13406
sg10
VSTD-Priestman-1978
p13407
sg12
S'PMC1608971'
p13408
sasa(dp13409
g3
VCD003586 v. 5.0 Cognitive rehabilitation for spatial neglect following stroke.rm5
p13410
sg5
(lp13411
(dp13412
g8
V12122183.xml
p13413
sg10
VSTD-Zeloni-2002
p13414
sg12
S'PMC1737996'
p13415
sasa(dp13416
g3
VCD002045 v. 9.1 Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.rm5
p13417
sg5
(lp13418
(dp13419
g8
V36048.xml
p13420
sg10
VSTD-Caldwell-1979
p13421
sg12
S'PMC1397199'
p13422
sasa(dp13423
g3
VCD006632 v. 5.0 Clinical pathways effects on professional practice patient outcomes length of stay and hospital c.rm5
p13424
sg5
(lp13425
(dp13426
g8
V12389836.xml
p13427
sg10
VSTD-Cole-2002
p13428
sg12
S'PMC126506'
p13429
sa(dp13430
g8
V12052813.xml
p13431
sg10
VSTD-Brattebo-2002
p13432
sg12
S'PMC1123333'
p13433
sasa(dp13434
g3
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p13435
sg5
(lp13436
(dp13437
g8
V19125205.xml
p13438
sg10
VSTD-Brookfield-2009
p13439
sg12
S'PMC2612742'
p13440
sa(dp13441
g8
V10638991.xml
p13442
sg10
VSTD-Stockton-2000
p13443
sg12
S'PMC2363169'
p13444
sasa(dp13445
g3
VCD006777 v. 3.0 Framing of health information messages.rm5
p13446
sg5
(lp13447
(dp13448
g8
V20209127.xml
p13449
sg10
VSTD-Carling-2010
p13450
sg12
S'PMC2830888'
p13451
sa(dp13452
g8
V8722765.xml
p13453
sg10
VSTD-Kroll-2005
p13454
sg12
S'PMC1207298'
p13455
sa(dp13456
g8
V15099176.xml
p13457
sg10
VSTD-Mann-2004
p13458
sg12
S'PMC2575807'
p13459
sa(dp13460
g8
V1566953.xml
p13461
sg10
VSTD-Lerman-1992
p13462
sg12
S'PMC1694134'
p13463
sa(dp13464
g8
V22282878.xml
p13465
sg10
VSTD-Steward-2002
p13466
sg12
S'PMC3482419'
p13467
sa(dp13468
g8
V14687272.xml
p13469
sg10
VSTD-Lewis-2003
p13470
sg12
S'PMC1494949'
p13471
sasa(dp13472
g3
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p13473
sg5
(lp13474
(dp13475
g8
V17273450.xml
p13476
sg10
VSTD-Schlickau-2005a
p13477
sg12
S'PMC1595264'
p13478
sa(dp13479
g8
V19181730.xml
p13480
sg10
VSTD-MacArthur-2009
p13481
sg12
S'PMC2636685'
p13482
sasa(dp13483
g3
VCD004961 v. 5.0 Intramedullary nails for extracapsular hip fractures in adults.rm5
p13484
sg5
(lp13485
(dp13486
g8
V16736148.xml
p13487
sg10
VSTD-Efstathopoulos-2007
p13488
sg12
S'PMC2267541'
p13489
sa(dp13490
g8
V12466870.xml
p13491
sg10
VSTD-Herrera-2002
p13492
sg12
S'PMC3620972'
p13493
sasa(dp13494
g3
VCD006460 v. 6.0 Conventional occlusion versus pharmacologic penalization for amblyopia.rm5
p13495
sg5
(lp13496
(dp13497
g8
V9135409.xml
p13498
sg10
VSTD-Foley_x002d_Nolan-1997
p13499
sg12
S'PMC1721990'
p13500
sa(dp13501
g8
V17502505.xml
p13502
sg10
VSTD-PEDIG-2002
p13503
sg12
S'PMC2614923'
p13504
sasa(dp13505
g3
VCD004937 v. 6.12 Effect of longer-term modest salt reduction on blood pressure.rm5
p13506
sg5
(lp13507
(dp13508
g8
V3933736.xml
p13509
sg10
VSTD-Watt-1985-_x0028_LL_x0029_
p13510
sg12
S'PMC1418187'
p13511
sa(dp13512
g8
V6432119.xml
p13513
sg10
VSTD-Erwteman-1984
p13514
sg12
S'PMC1442440'
p13515
sa(dp13516
g8
V3933736.xml
p13517
sg10
VSTD-Watt-1985-_x0028_HH_x0029_
p13518
sg12
S'PMC1418187'
p13519
sa(dp13520
g8
V6401551.xml
p13521
sg10
VSTD-Watt-1983
p13522
sg12
S'PMC1546779'
p13523
sasa(dp13524
g3
VCD001753 v. 11.0 Vaccines for preventing influenza in people with cystic fibrosis.rm5
p13525
sg5
(lp13526
(dp13527
g8
V10770746.xml
p13528
sg10
VSTD-Schaad-2000
p13529
sg12
S'PMC89839'
p13530
sasa(dp13531
g3
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p13532
sg5
(lp13533
(dp13534
g8
V10348767.xml
p13535
sg10
VSTD-Girgis-1999-EGY
p13536
sg12
S'PMC89293'
p13537
sa(dp13538
g8
V8849259.xml
p13539
sg10
VSTD-Vinh-1996-VNM
p13540
sg12
S'PMC163238'
p13541
sa(dp13542
g8
V12709347.xml
p13543
sg10
VSTD-Gasem-2003-IDN
p13544
sg12
S'PMC153327'
p13545
sa(dp13546
g8
V21531174.xml
p13547
sg10
VSTD-Arjyal-2011
p13548
sg12
S'PMC3108101'
p13549
sa(dp13550
g8
V9124864.xml
p13551
sg10
VSTD-Unal-1996-TUR
p13552
sg12
S'PMC163645'
p13553
sa(dp13554
g8
V17145784.xml
p13555
sg10
VSTD-Parry-2007-VNM
p13556
sg12
S'PMC1803150'
p13557
sa(dp13558
g8
V17593957.xml
p13559
sg10
VSTD-Pandit-2007-NPL
p13560
sg12
S'PMC1891439'
p13561
sa(dp13562
g8
V10858343.xml
p13563
sg10
VSTD-Chinh-2000-VNM
p13564
sg12
S'PMC89974'
p13565
sa(dp13566
g8
V18493312.xml
p13567
sg10
VSTD-Dolecek-2008-VNM
p13568
sg12
S'PMC2374894'
p13569
sa(dp13570
g8
V7986000.xml
p13571
sg10
VSTD-Smith-1994-VNM
p13572
sg12
S'PMC284627'
p13573
sasa(dp13574
g3
VCD008296 v. 3.2 Paliperidone palmitate for schizophrenia.rm5
p13575
sg5
(lp13576
(dp13577
g8
V20555312.xml
p13578
sg10
VSTD-Nasrallah-2010
p13579
sg12
S'PMC3055301'
p13580
sasa(dp13581
g3
VCD009447 v. 2.0 Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in p.rm5
p13582
sg5
(lp13583
(dp13584
g8
V11224634.xml
p13585
sg10
VSTD-McLeod-2001
p13586
sg12
S'PMC1421263'
p13587
sasa(dp13588
g3
VCD001496 v. 4.0 Gastro-oesophageal reflux treatment for asthma in adults and children.rm5
p13589
sg5
(lp13590
(dp13591
g8
V7022737.xml
p13592
sg10
VSTD-Goodall-1981
p13593
sg12
S'PMC471453'
p13594
sa(dp13595
g8
V2648642.xml
p13596
sg10
VSTD-Ekstrom-1989
p13597
sg12
S'PMC461658'
p13598
sa(dp13599
g8
V8016006.xml
p13600
sg10
VSTD-Ford-1994
p13601
sg12
S'PMC2397596'
p13602
sa(dp13603
g8
V3146369.xml
p13604
sg10
VSTD-Nagel-1988
p13605
sg12
S'PMC1835086'
p13606
sasa(dp13607
g3
VCD004704 v. 8.0 Mass media interventions for smoking cessation in adults.rm5
p13608
sg5
(lp13609
(dp13610
g8
V10982571.xml
p13611
sg10
VSTD-McVey-2000
p13612
sg12
S'PMC1748378'
p13613
sa(dp13614
g8
V9224191.xml
p13615
sg10
VSTD-Jenkins-1997
p13616
sg12
S'PMC1380945'
p13617
sa(dp13618
g8
V6414597.xml
p13619
sg10
VSTD-North-Coast-QFL-1983
p13620
sg12
S'PMC1549317'
p13621
sasa(dp13622
g3
VCD008524 v. 4.0 Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 year.rm5
p13623
sg5
(lp13624
(dp13625
g8
V20038852.xml
p13626
sg10
VSTD-Lima-2010
p13627
sg12
S'PMC2830290'
p13628
sa(dp13629
g8
V1739794.xml
p13630
sg10
VSTD-Daulaire-1992
p13631
sg12
S'PMC1881470'
p13632
sa(dp13633
g8
V11498488.xml
p13634
sg10
VSTD-Rahman-2001
p13635
sg12
S'PMC37318'
p13636
sa(dp13637
g8
V9002334.xml
p13638
sg10
VSTD-Pant-1996
p13639
sg12
S'PMC2486860'
p13640
sasa(dp13641
g3
VCD007823 v. 3.0 Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable.rm5
p13642
sg5
(lp13643
(dp13644
g8
V2961314.xml
p13645
sg10
VSTD-Chang-1987
p13646
sg12
S'PMC1493315'
p13647
sasa(dp13648
g3
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p13649
sg5
(lp13650
(dp13651
g8
V21088056.xml
p13652
sg10
VSTD-Thunander-2010
p13653
sg12
S'PMC3022338'
p13654
sasa(dp13655
g3
VCD001242 v. 4.0 Dopamine versus dobutamine for hypotensive preterm infants.rm5
p13656
sg5
(lp13657
(dp13658
g8
V8346957.xml
p13659
sg10
VSTD-Roze-1993
p13660
sg12
S'PMC1029401'
p13661
sasa(dp13662
g3
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p13663
sg5
(lp13664
(dp13665
g8
V22253488.xml
p13666
sg10
VSTD-Manche-2011
p13667
sg12
S'PMC3259671'
p13668
sa(dp13669
g8
V21573091.xml
p13670
sg10
VSTD-Hatch-2011
p13671
sg12
S'PMC3090298'
p13672
sasa(dp13673
g3
VCD003760 v. 8.3 Behavioural and cognitive behavioural training interventions for assisting foster carers in the mana.rm5
p13674
sg5
(lp13675
(dp13676
g8
V11259226.xml
p13677
sg10
VSTD-Minnis-2001
p13678
sg12
S'PMC1718714'
p13679
sasa(dp13680
g3
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p13681
sg5
(lp13682
(dp13683
g8
V19564902.xml
p13684
sg10
VSTD-Eddleston-2009
p13685
sg12
S'PMC2696321'
p13686
sasa(dp13687
g3
VCD003833 v. 10.0 Omega-3 fatty acids for intermittent claudication.rm5
p13688
sg5
(lp13689
(dp13690
g8
V6320945.xml
p13691
sg10
VSTD-Woodcock-1984
p13692
sg12
S'PMC1444358'
p13693
sasa(dp13694
g3
VCD000991 v. 5.0 Intravenous fluids for abdominal aortic surgery.rm5
p13695
sg5
(lp13696
(dp13697
g8
V1690974.xml
p13698
sg10
VSTD-Gold-1990
p13699
sg12
S'PMC1358036'
p13700
sasa(dp13701
g3
VCD003043 v. 5.0 Ursodeoxycholic acid andor antibiotics for prevention of biliary stent occlusion.rm5
p13702
sg5
(lp13703
(dp13704
g8
V7829015.xml
p13705
sg10
VSTD-Ghosh-1994
p13706
sg12
S'PMC1375266'
p13707
sasa(dp13708
g3
VCD008895 v. 2.2 Patient education in the management of coronary heart disease.rm5
p13709
sg5
(lp13710
(dp13711
g8
V7950723.xml
p13712
sg10
VSTD-Cupples-1994
p13713
sg12
S'PMC2541257'
p13714
sa(dp13715
g8
V18084052.xml
p13716
sg10
VSTD-Clark-2009
p13717
sg12
S'PMC3331992'
p13718
sasa(dp13719
g3
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p13720
sg5
(lp13721
(dp13722
g8
V19064532.xml
p13723
sg10
VSTD-Muniyappa-2008
p13724
sg12
S'PMC2969165'
p13725
sa(dp13726
g8
V19583878.xml
p13727
sg10
VSTD-Ried-2009
p13728
sg12
S'PMC2712451'
p13729
sa(dp13730
g8
V23572796.xml
p13731
sg10
VSTD-Al_x002d_Faris-2008
p13732
sg12
S'PMC3551122'
p13733
sa(dp13734
g8
V15712594.xml
p13735
sg10
VSTD-Fraga-2005
p13736
sg12
S'PMC2270716'
p13737
sasa(dp13738
g3
VCD006950 v. 3.0 Bone morphogenetic protein (BMP) for fracture healing in adults.rm5
p13739
sg5
(lp13740
(dp13741
g8
V11314793.xml
p13742
sg10
VSTD-Friedlaender-2001
p13743
sg12
S'PMC1425155'
p13744
sasa(dp13745
g3
VCD008225 v. 2.6 Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct probl.rm5
p13746
sg5
(lp13747
(dp13748
g8
V17350966.xml
p13749
sg10
VSTD-Hutchings-2007a
p13750
sg12
S'PMC1839187'
p13751
sa(dp13752
g8
V17350965.xml
p13753
sg10
VSTD-Edwards-2007
p13754
sg12
S'PMC1839236'
p13755
sa(dp13756
g8
V11473908.xml
p13757
sg10
VSTD-Scott-2001a
p13758
sg12
S'PMC35270'
p13759
sasa(dp13760
g3
VCD006411 v. 7.2 Educational games for health professionals.rm5
p13761
sg5
(lp13762
(dp13763
g8
V21959057.xml
p13764
sg10
VSTD-Burke--2001
p13765
sg12
S'PMC3202064'
p13766
sa(dp13767
g8
V20841574.xml
p13768
sg10
VSTD-Telner-2010
p13769
sg12
S'PMC2939136'
p13770
sasa(dp13771
g3
VCD005354 v. 7.0 Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology.rm5
p13772
sg5
(lp13773
(dp13774
g8
V14609434.xml
p13775
sg10
VSTD-Dickey-2003
p13776
sg12
S'PMC270000'
p13777
sasa(dp13778
g3
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p13779
sg5
(lp13780
(dp13781
g8
V16061499.xml
p13782
sg10
VSTD-GESICA-2005-_x0028_DIAL_x0029_
p13783
sg12
S'PMC1188105'
p13784
sa(dp13785
g8
V16533388.xml
p13786
sg10
VSTD-DeWalt-2006
p13787
sg12
S'PMC1475568'
p13788
sasa(dp13789
g3
VCD004441 v. 8.0 Population-based interventions for the prevention of fall-related injuries in older people.rm5
p13790
sg5
(lp13791
(dp13792
g8
V8944864.xml
p13793
sg10
VSTD-Ytterstad-1996
p13794
sg12
S'PMC1060349'
p13795
sasa(dp13796
g3
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p13797
sg5
(lp13798
(dp13799
g8
V9585747.xml
p13800
sg10
VSTD-Malotte-1998
p13801
sg12
S'PMC1508952'
p13802
sa(dp13803
g8
V19858174.xml
p13804
sg10
VSTD-Martins-2009
p13805
sg12
S'PMC2767482'
p13806
sa(dp13807
g8
V12196616.xml
p13808
sg10
VSTD-Morisky-2001
p13809
sg12
S'PMC1497389'
p13810
sasa(dp13811
g3
VCD000512 v. 4.0 Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity a.rm5
p13812
sg5
(lp13813
(dp13814
g8
V15930233.xml
p13815
sg10
VSTD-Bell-2005
p13816
sg12
S'PMC2866196'
p13817
sasa(dp13818
g3
VCD009823 v. 3.0 Interventions for promoting reintegration and reducing harmful behaviour and lifestyles in street-co.rm5
p13819
sg5
(lp13820
(dp13821
g8
V17940861.xml
p13822
sg10
VSTD-Slesnick-2007_x002f_08
p13823
sg12
S'PMC2430633'
p13824
sa(dp13825
g8
V19522781.xml
p13826
sg10
VSTD-Slesnick-2009-EBFT
p13827
sg12
S'PMC2697451'
p13828
sa(dp13829
g8
V15878048.xml
p13830
sg10
VSTD-Slesnick-2005
p13831
sg12
S'PMC1933523'
p13832
sa(dp13833
g8
V22443839.xml
p13834
sg10
VSTD-Milburn-2012
p13835
sg12
S'PMC3313467'
p13836
sa(dp13837
g8
V11861229.xml
p13838
sg10
VSTD-Tischler-2002
p13839
sg12
S'PMC1719131'
p13840
sa(dp13841
g8
V19522781.xml
p13842
sg10
VSTD-Slesnick-2009-FFT
p13843
sg12
S'PMC2697451'
p13844
sasa(dp13845
g3
VCD004597 v. 8.0 Eicosapentaenoic acid (EPA an omega-3 fatty acid from fish oils) for the treatment of cancer cachex.rm5
p13846
sg5
(lp13847
(dp13848
g8
V12970142.xml
p13849
sg10
VSTD-Fearon-2003
p13850
sg12
S'PMC1773823'
p13851
sasa(dp13852
g3
VCD004790 v. 4.0 Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.rm5
p13853
sg5
(lp13854
(dp13855
g8
V9279183.xml
p13856
sg10
VSTD-Poovorawan-1997
p13857
sg12
S'PMC1720659'
p13858
sasa(dp13859
g3
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p13860
sg5
(lp13861
(dp13862
g8
V21652750.xml
p13863
sg10
VSTD-Cockayne-2011
p13864
sg12
S'PMC3109952'
p13865
sa(dp13866
g8
V19675691.xml
p13867
sg10
VSTD-Fuchs-2004
p13868
sg12
S'PMC2703213'
p13869
sa(dp13870
g8
V3255811.xml
p13871
sg10
VSTD-Steele-1988a
p13872
sg12
S'PMC1711371'
p13873
sa(dp13874
g8
V20837684.xml
p13875
sg10
VSTD-Bruggink-2010
p13876
sg12
S'PMC2952009'
p13877
sasa(dp13878
g3
VCD005411 v. 3.2 Systemic interventions for recurrent aphthous stomatitis (mouth ulcers).rm5
p13879
sg5
(lp13880
(dp13881
g8
V321087.xml
p13882
sg10
VSTD-Meyer-1977
p13883
sg12
S'PMC1605575'
p13884
sasa(dp13885
g3
VCD002738 v. 5.0 Beclomethasone versus placebo for chronic asthma.rm5
p13886
sg5
(lp13887
(dp13888
g8
V851928.xml
p13889
sg10
VSTD-Kerigan-1977
p13890
sg12
S'PMC1879363'
p13891
sa(dp13892
g8
V8024293.xml
p13893
sg10
VSTD-Chan-1993
p13894
sg12
S'PMC1029424'
p13895
sa(dp13896
g8
V4357135.xml
p13897
sg10
VSTD-Cameron-1973
p13898
sg12
S'PMC1587268'
p13899
sasa(dp13900
g3
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p13901
sg5
(lp13902
(dp13903
g8
V12439707.xml
p13904
sg10
VSTD-TXT-Group
p13905
sg12
S'PMC2408916'
p13906
sa(dp13907
g8
V11986765.xml
p13908
sg10
VSTD-Talbot
p13909
sg12
S'PMC2375384'
p13910
sasa(dp13911
g3
VCD004440 v. 3.0 Recombinant growth hormone for idiopathic short stature in children and adolescents.rm5
p13912
sg5
(lp13913
(dp13914
g8
V7979491.xml
p13915
sg10
VSTD-McCaughey-1994
p13916
sg12
S'PMC1029971'
p13917
sa(dp13918
g8
V12193430.xml
p13919
sg10
VSTD-Kamp-2002
p13920
sg12
S'PMC1719235'
p13921
sasa(dp13922
g3
VCD008879 v. 2.0 Pre-operative Nutrition Support in Patients Undergoing Gastrointestinal Surgery..rm5
p13923
sg5
(lp13924
(dp13925
g8
V19152452.xml
p13926
sg10
VSTD-Gunerhan-2009
p13927
sg12
S'PMC2653369'
p13928
sasa(dp13929
g3
VCD002246 v. 6.0 Interventions for promoting smoke alarm ownership and function.rm5
p13930
sg5
(lp13931
(dp13932
g8
V20141242.xml
p13933
sg10
VSTD-Mathews-1988
p13934
sg12
S'PMC2849101'
p13935
sa(dp13936
g8
V7065320.xml
p13937
sg10
VSTD-Miller-1982
p13938
sg12
S'PMC1649895'
p13939
sa(dp13940
g8
V9596598.xml
p13941
sg10
VSTD-Clamp-1998
p13942
sg12
S'PMC28560'
p13943
sa(dp13944
g8
V7058963.xml
p13945
sg10
VSTD-Project-Burn-1979
p13946
sg12
S'PMC1649807'
p13947
sa(dp13948
g8
V8484447.xml
p13949
sg10
VSTD-Schwarz-1993
p13950
sg12
S'PMC1694716'
p13951
sa(dp13952
g8
V12411355.xml
p13953
sg10
VSTD-DiGuiseppi-2002
p13954
sg12
S'PMC131023'
p13955
sa(dp13956
g8
V11144634.xml
p13957
sg10
VSTD-Johnston-2000
p13958
sg12
S'PMC1730673'
p13959
sa(dp13960
g8
V10195971.xml
p13961
sg10
VSTD-Kendrick-1999
p13962
sg12
S'PMC27827'
p13963
sa(dp13964
g8
V19005266.xml
p13965
sg10
VSTD-Hendrickson-2000
p13966
sg12
S'PMC2699618'
p13967
sa(dp13968
g8
V15604156.xml
p13969
sg10
VSTD-Watson-2005
p13970
sg12
S'PMC544992'
p13971
sa(dp13972
g8
V11928967.xml
p13973
sg10
VSTD-Ozanne_x002d_Smith-2002
p13974
sg12
S'PMC1730817'
p13975
sa(dp13976
g8
V2817165.xml
p13977
sg10
VSTD-SCIPP-1989
p13978
sg12
S'PMC1349806'
p13979
sasa(dp13980
g3
VCD004099 v. 4.0 Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabet.rm5
p13981
sg5
(lp13982
(dp13983
g8
V1268789.xml
p13984
sg10
VSTD-Spaulding-1976
p13985
sg12
S'PMC1957107'
p13986
sasa(dp13987
g3
VCD005091 v. 4.0 One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or prov.rm5
p13988
sg5
(lp13989
(dp13990
g8
V1346956.xml
p13991
sg10
VSTD-Skopnik-1992
p13992
sg12
S'PMC1590339'
p13993
sa(dp13994
g8
V20878961.xml
p13995
sg10
VSTD-Hagan-2002
p13996
sg12
S'PMC3315829'
p13997
sasa(dp13998
g3
VCD000243 v. 10.0 Antibiotics for acute maxillary sinusitis.rm5
p13999
sg5
(lp14000
(dp14001
g8
V8760738.xml
p14002
sg10
VSTD-Lindbaek-1996a
p14003
sg12
S'PMC2351776'
p14004
sa(dp14005
g8
V8760738.xml
p14006
sg10
VSTD-Lindbaek-1996b
p14007
sg12
S'PMC2351776'
p14008
sa(dp14009
g8
V12936972.xml
p14010
sg10
VSTD-Henry-2003
p14011
sg12
S'PMC182642'
p14012
sa(dp14013
g8
V9210677.xml
p14014
sg10
VSTD-Gwaltney-1997
p14015
sg12
S'PMC163951'
p14016
sasa(dp14017
g3
VCD001106 v. 7.0 Continuous positive airways pressure for obstructive sleep apnoea in adults.rm5
p14018
sg5
(lp14019
(dp14020
g8
V9196520.xml
p14021
sg10
VSTD-Ferguson-1997
p14022
sg12
S'PMC1758547'
p14023
sa(dp14024
g8
V9708223.xml
p14025
sg10
VSTD-Engleman-1998
p14026
sg12
S'PMC1745223'
p14027
sa(dp14028
g8
V15860720.xml
p14029
sg10
VSTD-Marshall-2005
p14030
sg12
S'PMC1758913'
p14031
sa(dp14032
g8
V9059469.xml
p14033
sg10
VSTD-Engleman-1997
p14034
sg12
S'PMC1758499'
p14035
sasa(dp14036
g3
VCD006933 v. 3.2 Methods of decreasing infection to improve outcomes after liver resections.rm5
p14037
sg5
(lp14038
(dp14039
g8
V17060763.xml
p14040
sg10
VSTD-Sugawara-2006
p14041
sg12
S'PMC1856608'
p14042
sa(dp14043
g8
V10903599.xml
p14044
sg10
VSTD-Wiezer-2000
p14045
sg12
S'PMC1421132'
p14046
sasa(dp14047
g3
VCD002312 v. 5.0 Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneu.rm5
p14048
sg5
(lp14049
(dp14050
g8
V9176531.xml
p14051
sg10
VSTD-Davies-1997
p14052
sg12
S'PMC1758567'
p14053
sasa(dp14054
g3
VCD000100 v. 6.0 Vaccines for preventing hepatitis B in health-care workers.rm5
p14055
sg5
(lp14056
(dp14057
g8
V9040320.xml
p14058
sg10
VSTD-Zuckerman-1997
p14059
sg12
S'PMC2125835'
p14060
sasa(dp14061
g3
VCD003200 v. 7.0 Exercise therapy for chronic fatigue syndrome.rm5
p14062
sg5
(lp14063
(dp14064
g8
V11179154.xml
p14065
sg10
VSTD-Powell-2001
p14066
sg12
S'PMC26565'
p14067
sa(dp14068
g8
V9180065.xml
p14069
sg10
VSTD-Fulcher-1997
p14070
sg12
S'PMC2126868'
p14071
sasa(dp14072
g3
VCD002969 v. 6.0 Interventions for improving communication with children and adolescents about their cancer.rm5
p14073
sg5
(lp14074
(dp14075
g8
V11932129.xml
p14076
sg10
VSTD-Dragone-2002
p14077
sg12
S'PMC3307387'
p14078
sasa(dp14079
g3
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p14080
sg5
(lp14081
(dp14082
g8
V19116007.xml
p14083
sg10
VSTD-Lindell-2008
p14084
sg12
S'PMC2649916'
p14085
sa(dp14086
g8
V19553018.xml
p14087
sg10
VSTD-Litt-2009
p14088
sg12
S'PMC2735598'
p14089
sa(dp14090
g8
V18086516.xml
p14091
sg10
VSTD-Ersek-2008
p14092
sg12
S'PMC2536565'
p14093
sasa(dp14094
g3
VCD001509 v. 6.0 Sphincterotomy for biliary sphincter of Oddi dysfunction.rm5
p14095
sg5
(lp14096
(dp14097
g8
V10601063.xml
p14098
sg10
VSTD-Toouli-2000
p14099
sg12
S'PMC1727795'
p14100
sasa(dp14101
g3
VCD003665 v. 7.0 Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.rm5
p14102
sg5
(lp14103
(dp14104
g8
V12819167.xml
p14105
sg10
VSTD-Pathak-2003
p14106
sg12
S'PMC1721575'
p14107
sa(dp14108
g8
V6407714.xml
p14109
sg10
VSTD-Chiswick-1983
p14110
sg12
S'PMC1548339'
p14111
sasa(dp14112
g3
VCD004843 v. 10.2 Music for pain relief.rm5
p14113
sg5
(lp14114
(dp14115
g8
V18493472.xml
p14116
sg10
VSTD-Kotwal-1998
p14117
sg12
S'PMC2362603'
p14118
sasa(dp14119
g3
VCD000223 v. 7.0 Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.rm5
p14120
sg5
(lp14121
(dp14122
g8
V8977608.xml
p14123
sg10
VSTD-Angus-1996
p14124
sg12
S'PMC472663'
p14125
sasa(dp14126
g3
VCD000051 v. 10.0 Cephalic version by postural management for breech presentation.rm5
p14127
sg5
(lp14128
(dp14129
g8
V16814225.xml
p14130
sg10
VSTD-Founds-2006
p14131
sg12
S'PMC3628770'
p14132
sasa(dp14133
g3
VCD005649 v. 3.3 Treatment Foster Care for improving outcomes in children and young people.rm5
p14134
sg5
(lp14135
(dp14136
g8
V16392991.xml
p14137
sg10
VSTD-Leve-2005
p14138
sg12
S'PMC1904478'
p14139
sasa(dp14140
g3
VCD005623 v. 7.0 Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-maligna.rm5
p14141
sg5
(lp14142
(dp14143
g8
V12399344.xml
p14144
sg10
VSTD-Hermiz-2002
p14145
sg12
S'PMC130059'
p14146
sa(dp14147
g8
V11923552.xml
p14148
sg10
VSTD-Neder-2002
p14149
sg12
S'PMC1746295'
p14150
sa(dp14151
g8
V12454299.xml
p14152
sg10
VSTD-Bourjeily_x002d_Habr-2002
p14153
sg12
S'PMC1758803'
p14154
sa(dp14155
g8
V10102851.xml
p14156
sg10
VSTD-Bredin-1999
p14157
sg12
S'PMC27809'
p14158
sa(dp14159
g8
V16109163.xml
p14160
sg10
VSTD-Vickers-2005
p14161
sg12
S'PMC1208905'
p14162
sa(dp14163
g8
V12433764.xml
p14164
sg10
VSTD-Moore-2002
p14165
sg12
S'PMC133453'
p14166
sasa(dp14167
g3
VCD006742 v. 5.0 Pharmacotherapy for mild hypertension.rm5
p14168
sg5
(lp14169
(dp14170
g8
V2861880.xml
p14171
sg10
VSTD-MRC
p14172
sg12
S'PMC1416260'
p14173
sasa(dp14174
g3
VCD003680 v. 13.6 Group-based parent-training programmes for improving emotional and behavioural adjustment in childre.rm5
p14175
sg5
(lp14176
(dp14177
g8
V17350966.xml
p14178
sg10
VSTD-Hutchings-2007
p14179
sg12
S'PMC1839187'
p14180
sasa(dp14181
g3
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p14182
sg5
(lp14183
(dp14184
g8
V19368417.xml
p14185
sg10
VSTD-Rennard-2009
p14186
sg12
S'PMC3580134'
p14187
sasa(dp14188
g3
VCD008870 v. 2.0 Aminosalicylates for induction of remission or response in Crohn's disease.rm5
p14189
sg5
(lp14190
(dp14191
g8
V6114023.xml
p14192
sg10
VSTD-Van-Hees-1981
p14193
sg12
S'PMC1419240'
p14194
sasa(dp14195
g3
VCD005979 v. 5.0 Pharmaceutical policies effects of reference pricing other pricing and purchasing policies.rm5
p14196
sg5
(lp14197
(dp14198
g8
V16174135.xml
p14199
sg10
VSTD-Grootendorst-2002
p14200
sg12
S'PMC1361214'
p14201
sa(dp14202
g8
V10463052.xml
p14203
sg10
VSTD-Narine-2001
p14204
sg12
S'PMC1230507'
p14205
sa(dp14206
g8
V12126319.xml
p14207
sg10
VSTD-Marshall-2002
p14208
sg12
S'PMC116151'
p14209
sa(dp14210
g8
V11944760.xml
p14211
sg10
VSTD-Schneeweiss-2002
p14212
sg12
S'PMC99452'
p14213
sasa(dp14214
g3
VCD007394 v. 2.0 Galactomannan detection for invasive aspergillosis in immunocompromized patients.rm5
p14215
sg5
(lp14216
(dp14217
g8
V15872239.xml
p14218
sg10
VSTD-White-2005
p14219
sg12
S'PMC1153728'
p14220
sa(dp14221
g8
V15634986.xml
p14222
sg10
VSTD-Pazos-2005
p14223
sg12
S'PMC540165'
p14224
sa(dp14225
g8
V14766869.xml
p14226
sg10
VSTD-Challier-2004
p14227
sg12
S'PMC344496'
p14228
sa(dp14229
g8
V15184460.xml
p14230
sg10
VSTD-Kawazu-2004
p14231
sg12
S'PMC427860'
p14232
sa(dp14233
g8
V12734275.xml
p14234
sg10
VSTD-Pinel-2003
p14235
sg12
S'PMC154675'
p14236
sa(dp14237
g8
V8586691.xml
p14238
sg10
VSTD-Verweij-1995
p14239
sg12
S'PMC228662'
p14240
sa(dp14241
g8
V10889818.xml
p14242
sg10
VSTD-Williamson-2000
p14243
sg12
S'PMC1731188'
p14244
sasa(dp14245
g3
VCD001495 v. 7.0 Short-acting beta2-agonists for stable chronic obstructive pulmonary disease.rm5
p14246
sg5
(lp14247
(dp14248
g8
V7013150.xml
p14249
sg10
VSTD-Wilson-1980
p14250
sg12
S'PMC471402'
p14251
sa(dp14252
g8
V2038732.xml
p14253
sg10
VSTD-Tandon-1990
p14254
sg12
S'PMC463088'
p14255
sa(dp14256
g8
V1984814.xml
p14257
sg10
VSTD-Jaeschke-1991
p14258
sg12
S'PMC1452523'
p14259
sasa(dp14260
g3
VCD004950 v. 5.0 Breastfeeding or breast milk for procedural pain in neonates.rm5
p14261
sg5
(lp14262
(dp14263
g8
V12511452.xml
p14264
sg10
VSTD-Carbajal-2003
p14265
sg12
S'PMC139493'
p14266
sasa(dp14267
g3
VCD003437 v. 4.2 Interventions for treating depression after stroke.rm5
p14268
sg5
(lp14269
(dp14270
g8
V2738596.xml
p14271
sg10
VSTD-Towle-1989
p14272
sg12
S'PMC1032308'
p14273
sasa(dp14274
g3
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p14275
sg5
(lp14276
(dp14277
g8
V16967054.xml
p14278
sg10
VSTD-Aranda-2006
p14279
sg12
S'PMC2360523'
p14280
sa(dp14281
g8
V20658835.xml
p14282
sg10
VSTD-Low-2010
p14283
sg12
S'PMC3128513'
p14284
sasa(dp14285
g3
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p14286
sg5
(lp14287
(dp14288
g8
V15333311.xml
p14289
sg10
VSTD-Bayne_x002d_Smith-2004
p14290
sg12
S'PMC1448490'
p14291
sa(dp14292
g8
V19826296.xml
p14293
sg10
VSTD-Dorgo-2009
p14294
sg12
S'PMC2907740'
p14295
sa(dp14296
g8
V21534677.xml
p14297
sg10
VSTD-Wilson-2011
p14298
sg12
S'PMC3417297'
p14299
sa(dp14300
g8
V18718012.xml
p14301
sg10
VSTD-Jones-2008
p14302
sg12
S'PMC2556688'
p14303
sa(dp14304
g8
V20179126.xml
p14305
sg10
VSTD-Kriemler-2010
p14306
sg12
S'PMC2827713'
p14307
sa(dp14308
g8
V19765270.xml
p14309
sg10
VSTD-Gentile-2009
p14310
sg12
S'PMC2758893'
p14311
sa(dp14312
g8
V18622011.xml
p14313
sg10
VSTD-Neumark_x002d_Sztainer-2009
p14314
sg12
S'PMC2682640'
p14315
sa(dp14316
g8
V19665037.xml
p14317
sg10
VSTD-Donnelly-2009
p14318
sg12
S'PMC2766439'
p14319
sa(dp14320
g8
V9618627.xml
p14321
sg10
VSTD-Ewart-1998
p14322
sg12
S'PMC1508242'
p14323
sa(dp14324
g8
V20965379.xml
p14325
sg10
VSTD-Neumark_x002d_Sztainer-2010
p14326
sg12
S'PMC2978965'
p14327
sa(dp14328
g8
V18312804.xml
p14329
sg10
VSTD-Webber-2008
p14330
sg12
S'PMC2275165'
p14331
sa(dp14332
g8
V15351759.xml
p14333
sg10
VSTD-Trevino-2004
p14334
sg12
S'PMC1364479'
p14335
sasa(dp14336
g3
VCD006286 v. 4.2 Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoida.rm5
p14337
sg5
(lp14338
(dp14339
g8
V23119911.xml
p14340
sg10
VSTD-Lepcha-2002
p14341
sg12
S'PMC3450470'
p14342
sasa(dp14343
g3
VCD007354 v. 7.0 Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in.rm5
p14344
sg5
(lp14345
(dp14346
g8
V6788319.xml
p14347
sg10
VSTD-Woodcock-1981
p14348
sg12
S'PMC1506180'
p14349
sasa(dp14350
g3
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p14351
sg5
(lp14352
(dp14353
g8
V18218147.xml
p14354
sg10
VSTD-Poikolainen-2008
p14355
sg12
S'PMC2265283'
p14356
sasa(dp14357
g3
VCD000998 v. 11.0 Nutritional supplementation for stable chronic obstructive pulmonary disease.rm5
p14358
sg5
(lp14359
(dp14360
g8
V12947128.xml
p14361
sg10
VSTD-Steiner-2003
p14362
sg12
S'PMC1746806'
p14363
sasa(dp14364
g3
VCD007621 v. 5.0 Natalizumab for relapsing remitting multiple sclerosis.rm5
p14365
sg5
(lp14366
(dp14367
g8
V19255407.xml
p14368
sg10
VSTD-GLANCE-2009
p14369
sg12
S'PMC2821836'
p14370
sasa(dp14371
g3
VCD001730 v. 5.0 Medical day hospital care for the elderly versus alternative forms of care.rm5
p14372
sg5
(lp14373
(dp14374
g8
V6437487.xml
p14375
sg10
VSTD-Tucker-1984
p14376
sg12
S'PMC1443331'
p14377
sa(dp14378
g8
V1998929.xml
p14379
sg10
VSTD-Eagle-1991
p14380
sg12
S'PMC1453052'
p14381
sasa(dp14382
g3
VCD003600 v. 10.6 Modification of the home environment for the reduction of injuries.rm5
p14383
sg5
(lp14384
(dp14385
g8
V11563205.xml
p14386
sg10
VSTD-Hogan-2001
p14387
sg12
S'PMC81411'
p14388
sa(dp14389
g8
V12521968.xml
p14390
sg10
VSTD-Shaw-2003
p14391
sg12
S'PMC139930'
p14392
sa(dp14393
g8
V16183652.xml
p14394
sg10
VSTD-Campbell-2005
p14395
sg12
S'PMC1246082'
p14396
sa(dp14397
g8
V9596598.xml
p14398
sg10
VSTD-Clamp-1998
p14399
sg12
S'PMC28560'
p14400
sa(dp14401
g8
V12130606.xml
p14402
sg10
VSTD-Day-2002
p14403
sg12
S'PMC117228'
p14404
sa(dp14405
g8
V10195971.xml
p14406
sg10
VSTD-Kendrick-1999
p14407
sg12
S'PMC27827'
p14408
sa(dp14409
g8
V15805440.xml
p14410
sg10
VSTD-King-2005
p14411
sg12
S'PMC1730192'
p14412
sa(dp14413
g8
V16203842.xml
p14414
sg10
VSTD-Hendrickson-2005
p14415
sg12
S'PMC1730268'
p14416
sa(dp14417
g8
V15604156.xml
p14418
sg10
VSTD-Watson-2005
p14419
sg12
S'PMC544992'
p14420
sa(dp14421
g8
V1392755.xml
p14422
sg10
VSTD-Vetter-1992
p14423
sg12
S'PMC1882829'
p14424
sa(dp14425
g8
V11039967.xml
p14426
sg10
VSTD-Van-Haastregt-2000b
p14427
sg12
S'PMC27508'
p14428
sasa(dp14429
g3
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p14430
sg5
(lp14431
(dp14432
g8
V12240812.xml
p14433
sg10
VSTD-Davies-2002
p14434
sg12
S'PMC121963'
p14435
sa(dp14436
g8
V17403764.xml
p14437
sg10
VSTD-Schouten-2007
p14438
sg12
S'PMC2653154'
p14439
sa(dp14440
g8
V16737346.xml
p14441
sg10
VSTD-Fretheim-2006
p14442
sg12
S'PMC1472695'
p14443
sa(dp14444
g8
V11593835.xml
p14445
sg10
VSTD-Baker-2001
p14446
sg12
S'PMC1314102'
p14447
sa(dp14448
g8
V12183309.xml
p14449
sg10
VSTD-Flottorp-2002
p14450
sg12
S'PMC117890'
p14451
sa(dp14452
g8
V10478162.xml
p14453
sg10
VSTD-Hux-1999
p14454
sg12
S'PMC1230539'
p14455
sa(dp14456
g8
V12392122.xml
p14457
sg10
VSTD-Langham-2002
p14458
sg12
S'PMC1316085'
p14459
sasa(dp14460
g3
VCD009296 v. 2.3 Nurse versus physician-led care for the management of asthma.rm5
p14461
sg5
(lp14462
(dp14463
g8
V14586050.xml
p14464
sg10
VSTD-Kamps-2003
p14465
sg12
S'PMC1746504'
p14466
sasa(dp14467
g3
VCD002869 v. 6.0 Individual or group antenatal education for childbirth or parenthood or both.rm5
p14468
sg5
(lp14469
(dp14470
g8
V11189800.xml
p14471
sg10
VSTD-Klerman-2001
p14472
sg12
S'PMC1446489'
p14473
sasa(dp14474
g3
VCD000356 v. 8.0 Hospital at home early discharge.rm5
p14475
sg5
(lp14476
(dp14477
g8
V9624068.xml
p14478
sg10
VSTD-Shepperd-1998
p14479
sg12
S'PMC28578'
p14480
sa(dp14481
g8
V11828049.xml
p14482
sg10
VSTD-Ojoo-2002
p14483
sg12
S'PMC1746235'
p14484
sa(dp14485
g8
V11050257.xml
p14486
sg10
VSTD-Cotton-2002
p14487
sg12
S'PMC1745631'
p14488
sa(dp14489
g8
V11050258.xml
p14490
sg10
VSTD-Skwarska-2000
p14491
sg12
S'PMC1745644'
p14492
sa(dp14493
g8
V98548.xml
p14494
sg10
VSTD-Adler-1978
p14495
sg12
S'PMC1060932'
p14496
sa(dp14497
g8
V9624074.xml
p14498
sg10
VSTD-Richards-1998
p14499
sg12
S'PMC28581'
p14500
sa(dp14501
g8
V15486143.xml
p14502
sg10
VSTD-Booth-2004
p14503
sg12
S'PMC1768555'
p14504
sa(dp14505
g8
V9366727.xml
p14506
sg10
VSTD-Rudd-1997
p14507
sg12
S'PMC2127677'
p14508
sasa(dp14509
g3
VCD009756 v. 2.0 Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV i.rm5
p14510
sg5
(lp14511
(dp14512
g8
V21252632.xml
p14513
sg10
VSTD-Pop_x002d_Eleches-2011
p14514
sg12
S'PMC3718389'
p14515
sasa(dp14516
g3
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p14517
sg5
(lp14518
(dp14519
g8
V11379605.xml
p14520
sg10
VSTD-Cameron-2001
p14521
sg12
S'PMC2363881'
p14522
sasa(dp14523
g3
VCD003758 v. 5.0 Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.rm5
p14524
sg5
(lp14525
(dp14526
g8
V5301383.xml
p14527
sg10
VSTD-Hawking-1967
p14528
sg12
S'PMC2554262'
p14529
sa(dp14530
g8
V5308697.xml
p14531
sg10
VSTD-Davis-1969
p14532
sg12
S'PMC2427415'
p14533
sasa(dp14534
g3
VCD008121 v. 3.0 Second-generation antipsychotics for major depressive disorder and dysthymia.rm5
p14535
sg5
(lp14536
(dp14537
g8
V17928573.xml
p14538
sg10
VSTD-Rapaport-2006
p14539
sg12
S'PMC2788739'
p14540
sa(dp14541
g8
V18586273.xml
p14542
sg10
VSTD-Keitner-2009
p14543
sg12
S'PMC3685867'
p14544
sasa(dp14545
g3
VCD006108 v. 9.0 Exercise for vasomotor menopausal symptoms.rm5
p14546
sg5
(lp14547
(dp14548
g8
V19169167.xml
p14549
sg10
VSTD-Elavsky-2009
p14550
sg12
S'PMC2728615'
p14551
sasa(dp14552
g3
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p14553
sg5
(lp14554
(dp14555
g8
V15647105.xml
p14556
sg10
VSTD-Keiser-2005
p14557
sg12
S'PMC548524'
p14558
sasa(dp14559
g3
VCD001481 v. 5.0 Interventions to improve the management of diabetes mellitus in primary care outpatient and communi.rm5
p14560
sg5
(lp14561
(dp14562
g8
V8563365.xml
p14563
sg10
VSTD-Nilasena-1995
p14564
sg12
S'PMC2579172'
p14565
sa(dp14566
g8
V8461815.xml
p14567
sg10
VSTD-Hurwitz-1993
p14568
sg12
S'PMC1676949'
p14569
sa(dp14570
g8
V8180540.xml
p14571
sg10
VSTD-Naji-1994
p14572
sg12
S'PMC2540045'
p14573
sa(dp14574
g8
V9794859.xml
p14575
sg10
VSTD-Kinmonth-1998
p14576
sg12
S'PMC28704'
p14577
sa(dp14578
g8
V8520339.xml
p14579
sg10
VSTD-Feder-1995
p14580
sg12
S'PMC2543702'
p14581
sasa(dp14582
g3
VCD005360 v. 8.0 Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.rm5
p14583
sg5
(lp14584
(dp14585
g8
V11063500.xml
p14586
sg10
VSTD-Chow-2000
p14587
sg12
S'PMC95987'
p14588
sasa(dp14589
g3
VCD005096 v. 8.2 Chinese herbal medicines for induction of remission in advanced or late gastric cancer.rm5
p14590
sg5
(lp14591
(dp14592
g8
V23882420.xml
p14593
sg10
VSTD-Wang-2010
p14594
sg12
S'PMC3719192'
p14595
sa(dp14596
g8
V23983775.xml
p14597
sg10
VSTD-Xie-2006
p14598
sg12
S'PMC3747414'
p14599
sasa(dp14600
g3
VCD007912 v. 1.2 Exercise for osteoarthritis of the hip.rm5
p14601
sg5
(lp14602
(dp14603
g8
V14644853.xml
p14604
sg10
VSTD-Foley-2003
p14605
sg12
S'PMC1754378'
p14606
sasa(dp14607
g3
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p14608
sg5
(lp14609
(dp14610
g8
V12948399.xml
p14611
sg10
VSTD-Veldt-2003
p14612
sg12
S'PMC222984'
p14613
sa(dp14614
g8
V9862245.xml
p14615
sg10
VSTD-Khakoo-1998
p14616
sg12
S'PMC1873804'
p14617
sasa(dp14618
g3
VCD004931 v. 5.0 Intragastric balloon for obesity.rm5
p14619
sg5
(lp14620
(dp14621
g8
V2767500.xml
p14622
sg10
VSTD-Ramhamdany-1989
p14623
sg12
S'PMC1434178'
p14624
sasa(dp14625
g3
VCD000527 v. 10.0 Artemisinin derivatives for treating severe malaria.rm5
p14626
sg5
(lp14627
(dp14628
g8
V1486675.xml
p14629
sg10
VSTD-Win-MYA-89_x002d_91
p14630
sg12
S'PMC2393408'
p14631
sasa(dp14632
g3
VCD003235 v. 7.0 Emergency interventions for hyperkalaemia.rm5
p14633
sg5
(lp14634
(dp14635
g8
V8129434.xml
p14636
sg10
VSTD-McClure-1994
p14637
sg12
S'PMC1029715'
p14638
sasa(dp14639
g3
VCD001291 v. 9.0 Community interventions for preventing smoking in young people.rm5
p14640
sg5
(lp14641
(dp14642
g8
V19736331.xml
p14643
sg10
VSTD-Hawkins-2009
p14644
sg12
S'PMC2740999'
p14645
sa(dp14646
g8
V10691755.xml
p14647
sg10
VSTD-Biglan-2000
p14648
sg12
S'PMC1748303'
p14649
sa(dp14650
g8
V19299670.xml
p14651
sg10
VSTD-Perry-2008
p14652
sg12
S'PMC2667859'
p14653
sa(dp14654
g8
V9706752.xml
p14655
sg10
VSTD-Tang-1997
p14656
sg12
S'PMC1759627'
p14657
sa(dp14658
g8
V9584038.xml
p14659
sg10
VSTD-Vartiainen-1998
p14660
sg12
S'PMC1508381'
p14661
sa(dp14662
g8
V19103639.xml
p14663
sg10
VSTD-Klein-2009
p14664
sg12
S'PMC2741406'
p14665
sasa(dp14666
g3
VCD005170 v. 7.2 Pharmacotherapy for anxiety disorders in children and adolescents.rm5
p14667
sg5
(lp14668
(dp14669
g8
V18974308.xml
p14670
sg10
VSTD-Walkup-2008
p14671
sg12
S'PMC2702984'
p14672
sasa(dp14673
g3
VCD000987 v. 4.0 Vitamin E for intermittent claudication.rm5
p14674
sg5
(lp14675
(dp14676
g8
V14007174.xml
p14677
sg10
VSTD-Williams-1962
p14678
sg12
S'PMC1849381'
p14679
sasa(dp14680
g3
VCD003054 v. 5.3 Exercise or exercise and diet for preventing type 2 diabetes mellitus.rm5
p14681
sg5
(lp14682
(dp14683
g8
V17922167.xml
p14684
sg10
VSTD-Bo-2007
p14685
sg12
S'PMC2219825'
p14686
sa(dp14687
g8
V11832527.xml
p14688
sg10
VSTD-DPP-2002
p14689
sg12
S'PMC1370926'
p14690
sasa(dp14691
g3
VCD007286 v. 3.0 Antiepileptic drugs as prophylaxis for post-craniotomy seizures.rm5
p14692
sg5
(lp14693
(dp14694
g8
V10486394.xml
p14695
sg10
VSTD-Beenen-1999
p14696
sg12
S'PMC1736591'
p14697
sa(dp14698
g8
V1402964.xml
p14699
sg10
VSTD-Foy-1992
p14700
sg12
S'PMC1015096'
p14701
sasa(dp14702
g3
VCD009414 v. 2.1 Interventions for preventing or reducing domestic violence against pregnant women.rm5
p14703
sg5
(lp14704
(dp14705
g8
V18201643.xml
p14706
sg10
VSTD-Calderon-2008
p14707
sg12
S'PMC2242423'
p14708
sa(dp14709
g8
V21153559.xml
p14710
sg10
VSTD-Zlotnick-2011
p14711
sg12
S'PMC3042850'
p14712
sa(dp14713
g8
V20145196.xml
p14714
sg10
VSTD-Cripe-2010
p14715
sg12
S'PMC3741342'
p14716
sa(dp14717
g8
V20093899.xml
p14718
sg10
VSTD-Kiely-2010
p14719
sg12
S'PMC2917915'
p14720
sasa(dp14721
g3
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p14722
sg5
(lp14723
(dp14724
g8
V19318702.xml
p14725
sg10
VSTD-O_x0027_Sullivan-2009
p14726
sg12
S'PMC2660391'
p14727
sasa(dp14728
g3
VCD004659 v. 5.0 Antiplatelet agents for preventing pre-eclampsia and its complications.rm5
p14729
sg5
(lp14730
(dp14731
g8
V22815699.xml
p14732
sg10
VSTD-Netherlands-1989
p14733
sg12
S'PMC3398037'
p14734
sasa(dp14735
g3
VCD003602 v. 6.0 Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.rm5
p14736
sg5
(lp14737
(dp14738
g8
V19057729.xml
p14739
sg10
VSTD-Bouchard-2008
p14740
sg12
S'PMC2592568'
p14741
sasa(dp14742
g3
VCD003638 v. 4.0 Interventions for improving adherence to treatment recommendations in people with type 2 diabetes me.rm5
p14743
sg5
(lp14744
(dp14745
g8
V6721016.xml
p14746
sg10
VSTD-Hopper-1984
p14747
sg12
S'PMC1651641'
p14748
sasa(dp14749
g3
VCD005478 v. 3.0 Naftidrofuryl for acute stroke.rm5
p14750
sg5
(lp14751
(dp14752
g8
V367511.xml
p14753
sg10
VSTD-Admani-1978
p14754
sg12
S'PMC1608980'
p14755
sasa(dp14756
g3
VCD004676 v. 8.0 School feeding for improving the physical and psychosocial health of disadvantaged students.rm5
p14757
sg5
(lp14758
(dp14759
g8
V14839578.xml
p14760
sg10
VSTD-Tisdall-1951
p14761
sg12
S'PMC1821925'
p14762
sa(dp14763
g8
V6892711.xml
p14764
sg10
VSTD-Baker-1980-_x0028_-boys_x0029_
p14765
sg12
S'PMC1052036'
p14766
sa(dp14767
g8
V6892711.xml
p14768
sg10
VSTD-Baker-total-1980
p14769
sg12
S'PMC1052036'
p14770
sa(dp14771
g8
V6892711.xml
p14772
sg10
VSTD-Baker-girls-1980
p14773
sg12
S'PMC1052036'
p14774
sasa(dp14775
g3
VCD000249 v. 7.2 Antifibrinolytics for heavy menstrual bleeding.rm5
p14776
sg5
(lp14777
(dp14778
g8
V8806245.xml
p14779
sg10
VSTD-Bonnar-1996
p14780
sg12
S'PMC2352023'
p14781
sa(dp14782
g8
V4919554.xml
p14783
sg10
VSTD-Callender-1970
p14784
sg12
S'PMC1819762'
p14785
sasa(dp14786
g3
VCD003162 v. 8.0 The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo.rm5
p14787
sg5
(lp14788
(dp14789
g8
V16549410.xml
p14790
sg10
VSTD-von-Brevern-2006
p14791
sg12
S'PMC2077628'
p14792
sasa(dp14793
g3
VCD003004 v. 7.0 Perioperative fluid volume optimization following proximal femoral fracture.rm5
p14794
sg5
(lp14795
(dp14796
g8
V9361539.xml
p14797
sg10
VSTD-Sinclair-1997
p14798
sg12
S'PMC2127619'
p14799
sasa(dp14800
g3
VCD005965 v. 3.0 Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.rm5
p14801
sg5
(lp14802
(dp14803
g8
V9449273.xml
p14804
sg10
VSTD-Van-Vugt-1998a
p14805
sg12
S'PMC105468'
p14806
sasa(dp14807
g3
VCD002008 v. 10.0 Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adul.rm5
p14808
sg5
(lp14809
(dp14810
g8
V10807893.xml
p14811
sg10
VSTD-Beattie-2000
p14812
sg12
S'PMC1756438'
p14813
sa(dp14814
g8
V3929906.xml
p14815
sg10
VSTD-Chandra-1985
p14816
sg12
S'PMC1416637'
p14817
sasa(dp14818
g3
VCD002042 v. 8.0 Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.rm5
p14819
sg5
(lp14820
(dp14821
g8
V22168590.xml
p14822
sg10
VSTD-Carson-2011
p14823
sg12
S'PMC3268062'
p14824
sasa(dp14825
g3
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p14826
sg5
(lp14827
(dp14828
g8
V18596121.xml
p14829
sg10
VSTD-Bao--2008
p14830
sg12
S'PMC2551567'
p14831
sa(dp14832
g8
V7272867.xml
p14833
sg10
VSTD-Clark-1981
p14834
sg12
S'PMC1862250'
p14835
sa(dp14836
g8
V20833738.xml
p14837
sg10
VSTD-MAINTAIN-Nephritis-Study
p14838
sg12
S'PMC3002764'
p14839
sa(dp14840
g8
V15082482.xml
p14841
sg10
VSTD-Yee-2004
p14842
sg12
S'PMC1755006'
p14843
sa(dp14844
g8
V19369404.xml
p14845
sg10
VSTD-Appel-2009
p14846
sg12
S'PMC2678035'
p14847
sasa(dp14848
g3
VCD001017 v. 5.2 Danazol for heavy menstrual bleeding.rm5
p14849
sg5
(lp14850
(dp14851
g8
V1835005.xml
p14852
sg10
VSTD-Bonduelle-1991
p14853
sg12
S'PMC2399106'
p14854
sasa(dp14855
g3
VCD006171 v. 3.1 Prenatal education for congenital toxoplasmosis.rm5
p14856
sg5
(lp14857
(dp14858
g8
V23725556.xml
p14859
sg10
VSTD-Wallon-2006
p14860
sg12
S'PMC3761389'
p14861
sa(dp14862
g8
V2606162.xml
p14863
sg10
VSTD-Carter-1989
p14864
sg12
S'PMC2249529'
p14865
sasa(dp14866
g3
VCD006418 v. 3.0 Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.rm5
p14867
sg5
(lp14868
(dp14869
g8
V17085459.xml
p14870
sg10
VSTD-Zar-2007
p14871
sg12
S'PMC1779846'
p14872
sasa(dp14873
g3
VCD003961 v. 9.0 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.rm5
p14874
sg5
(lp14875
(dp14876
g8
V1721361.xml
p14877
sg10
VSTD-Shapiro-1991
p14878
sg12
S'PMC3035844'
p14879
sasa(dp14880
g3
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p14881
sg5
(lp14882
(dp14883
g8
V20679560.xml
p14884
sg10
VSTD-Bourgeois-2010
p14885
sg12
S'PMC3374868'
p14886
sa(dp14887
g8
V19435763.xml
p14888
sg10
VSTD-Charles-2009
p14889
sg12
S'PMC2680945'
p14890
sa(dp14891
g8
V14703540.xml
p14892
sg10
VSTD-Soares-2004
p14893
sg12
S'PMC313900'
p14894
sa(dp14895
g8
V15451835.xml
p14896
sg10
VSTD-Chan-2004b
p14897
sg12
S'PMC517858'
p14898
sa(dp14899
g8
V19901314.xml
p14900
sg10
VSTD-Ewart-2009
p14901
sg12
S'PMC2775624'
p14902
sasa(dp14903
g3
VCD003519 v. 6.0 Early skin-to-skin contact for mothers and their healthy newborn infants.rm5
p14904
sg5
(lp14905
(dp14906
g8
V21297814.xml
p14907
sg10
VSTD-Thomson-1979
p14908
sg12
S'PMC2383381'
p14909
sasa(dp14910
g3
VCD003967 v. 11.0 Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.rm5
p14911
sg5
(lp14912
(dp14913
g8
V8257180.xml
p14914
sg10
VSTD-Morris-1992
p14915
sg12
S'PMC1029623'
p14916
sasa(dp14917
g3
VCD006700 v. 2.0 Acyclovir for treating primary herpetic gingivostomatitis.rm5
p14918
sg5
(lp14919
(dp14920
g8
V9224082.xml
p14921
sg10
VSTD-Amir-1997b
p14922
sg12
S'PMC2126953'
p14923
sasa(dp14924
g3
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p14925
sg5
(lp14926
(dp14927
g8
V19127261.xml
p14928
sg10
VSTD-Neuhaus-2009
p14929
sg12
S'PMC2634726'
p14930
sasa(dp14931
g3
VCD004935 v. 9.0 Relaxation therapies for the management of primary hypertension in adults.rm5
p14932
sg5
(lp14933
(dp14934
g8
V8490471.xml
p14935
sg10
VSTD-Johnston-1993
p14936
sg12
S'PMC1677411'
p14937
sa(dp14938
g8
V468751.xml
p14939
sg10
VSTD-Blanchard-1979
p14940
sg12
S'PMC1311352'
p14941
sa(dp14942
g8
V2196946.xml
p14943
sg10
VSTD-van-Montfrans-1990
p14944
sg12
S'PMC1662994'
p14945
sa(dp14946
g8
V3122919.xml
p14947
sg10
VSTD-Patel-1988
p14948
sg12
S'PMC2544650'
p14949
sasa(dp14950
g3
VCD000545 v. 10.6 Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.rm5
p14951
sg5
(lp14952
(dp14953
g8
V8549944.xml
p14954
sg10
VSTD-Candy-1995
p14955
sg12
S'PMC1382873'
p14956
sasa(dp14957
g3
VCD004101 v. 7.11 Psychological interventions for symptomatic management of non-specific chest pain in patients with n.rm5
p14958
sg5
(lp14959
(dp14960
g8
V16627548.xml
p14961
sg10
VSTD-Jones-2006
p14962
sg12
S'PMC1856426'
p14963
sasa(dp14964
g3
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p14965
sg5
(lp14966
(dp14967
g8
V15668708.xml
p14968
sg10
VSTD-MAM-01-GOCSI
p14969
sg12
S'PMC2362097'
p14970
sasa(dp14971
g3
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p14972
sg5
(lp14973
(dp14974
g8
V16195287.xml
p14975
sg10
VSTD-Guinea_x002d_Bissau-2005
p14976
sg12
S'PMC1239973'
p14977
sa(dp14978
g8
V21176086.xml
p14979
sg10
VSTD-Pakistan-2011
p14980
sg12
S'PMC3041931'
p14981
sa(dp14982
g8
V19249659.xml
p14983
sg10
VSTD-Tibet-2009
p14984
sg12
S'PMC2791828'
p14985
sasa(dp14986
g3
VCD006687 v. 4.0 Oral vasodilators for primary Raynaud's phenomenon.rm5
p14987
sg5
(lp14988
(dp14989
g8
V2049258.xml
p14990
sg10
VSTD-Challenor-1991
p14991
sg12
S'PMC1368337'
p14992
sasa(dp14993
g3
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p14994
sg5
(lp14995
(dp14996
g8
V20428302.xml
p14997
sg10
VSTD-Peuskens-2007
p14998
sg12
S'PMC2860517'
p14999
sa(dp15000
g8
V20724402.xml
p15001
sg10
VSTD-Chen-2010
p15002
sg12
S'PMC2924475'
p15003
sa(dp15004
g8
V21927264.xml
p15005
sg10
VSTD-Channabasavanna-1987
p15006
sg12
S'PMC3172444'
p15007
sa(dp15008
g8
V4936538.xml
p15009
sg10
VSTD-Leff-1971
p15010
sg12
S'PMC1798790'
p15011
sa(dp15012
g8
V4571196.xml
p15013
sg10
VSTD-Hirsch-1973
p15014
sg12
S'PMC1588639'
p15015
sasa(dp15016
g3
VCD002011 v. 8.0 Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.rm5
p15017
sg5
(lp15018
(dp15019
g8
V3524474.xml
p15020
sg10
VSTD-Tyrrell-1986
p15021
sg12
S'PMC1777841'
p15022
sasa(dp15023
g3
VCD002785 v. 5.0 Chelation therapy for atherosclerotic cardiovascular disease.rm5
p15024
sg5
(lp15025
(dp15026
g8
V2108254.xml
p15027
sg10
VSTD-Olszewer-1990
p15028
sg12
S'PMC2626030'
p15029
sasa(dp15030
g3
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p15031
sg5
(lp15032
(dp15033
g8
V9231932.xml
p15034
sg10
VSTD-Pyrhonen-1997
p15035
sg12
S'PMC2223944'
p15036
sasa(dp15037
g3
VCD001084 v. 6.0 Pharmacotherapy for Behcet's syndrome.rm5
p15038
sg5
(lp15039
(dp15040
g8
V1390495.xml
p15041
sg10
VSTD-Oryazgan-1992
p15042
sg12
S'PMC504238'
p15043
sasa(dp15044
g3
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p15045
sg5
(lp15046
(dp15047
g8
V20525274.xml
p15048
sg10
VSTD-Fernandez-2010
p15049
sg12
S'PMC2898783'
p15050
sa(dp15051
g8
V19490659.xml
p15052
sg10
VSTD-Chirico-2009
p15053
sg12
S'PMC2687544'
p15054
sa(dp15055
g8
V23919494.xml
p15056
sg10
VSTD-Bentley-2011
p15057
sg12
S'PMC3735492'
p15058
sa(dp15059
g8
V19967425.xml
p15060
sg10
VSTD-Nuijten-2010
p15061
sg12
S'PMC2816247'
p15062
sasa(dp15063
g3
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p15064
sg5
(lp15065
(dp15066
g8
V11357205.xml
p15067
sg10
VSTD-Roberts-2001
p15068
sg12
S'PMC2566389'
p15069
sa(dp15070
g8
V2985691.xml
p15071
sg10
VSTD-Kirchhoff-1985
p15072
sg12
S'PMC2129411'
p15073
sa(dp15074
g8
V16046440.xml
p15075
sg10
VSTD-Crump-2004_x002d_i
p15076
sg12
S'PMC1199021'
p15077
sa(dp15078
g8
V10490440.xml
p15079
sg10
VSTD-Conroy-1999
p15080
sg12
S'PMC1718112'
p15081
sa(dp15082
g8
V10098789.xml
p15083
sg10
VSTD-Quick-1999
p15084
sg12
S'PMC2809591'
p15085
sa(dp15086
g8
V16501712.xml
p15087
sg10
VSTD-Chiller-2004
p15088
sg12
S'PMC2626515'
p15089
sa(dp15090
g8
V16046440.xml
p15091
sg10
VSTD-Crump-2004_x002d_ii
p15092
sg12
S'PMC1199021'
p15093
sa(dp15094
g8
V11749745.xml
p15095
sg10
VSTD-Colford-2002
p15096
sg12
S'PMC2730258'
p15097
sasa(dp15098
g3
VCD007815 v. 2.124 Quetiapine versus typical antipsychotic medications for schizophrenia.rm5
p15099
sg5
(lp15100
(dp15101
g8
V11291531.xml
p15102
sg10
VSTD-vs-HLP-_x002d_-Purdon-2001
p15103
sg12
S'PMC1407745'
p15104
sasa(dp15105
g3
VCD003261 v. 7.0 Interventions for impetigo.rm5
p15106
sg5
(lp15107
(dp15108
g8
V11809642.xml
p15109
sg10
VSTD-Koning-2003
p15110
sg12
S'PMC64791'
p15111
sa(dp15112
g8
V3149884.xml
p15113
sg10
VSTD-Goldfarb-1988
p15114
sg12
S'PMC176017'
p15115
sa(dp15116
g8
V666305.xml
p15117
sg10
VSTD-Ginsburg-1978
p15118
sg12
S'PMC352342'
p15119
sa(dp15120
g8
V1605593.xml
p15121
sg10
VSTD-Dagan-1992
p15122
sg12
S'PMC188356'
p15123
sa(dp15124
g8
V9087480.xml
p15125
sg10
VSTD-Tack-1997
p15126
sg12
S'PMC163785'
p15127
sasa(dp15128
g3
VCD004538 v. 5.28 Public release of performance data in changing the behaviour of healthcare consumers professionals .rm5
p15129
sg5
(lp15130
(dp15131
g8
V12236394.xml
p15132
sg10
VSTD-Farley-2002b
p15133
sg12
S'PMC1464003'
p15134
sasa(dp15135
g3
VCD003787 v. 7.0 Therapeutic ultrasound for the treatment of rheumatoid arthritis.rm5
p15136
sg5
(lp15137
(dp15138
g8
V23238661.xml
p15139
sg10
VSTD-Konrad-1994
p15140
sg12
S'PMC3609515'
p15141
sasa(dp15142
g3
VCD001256 v. 9.0 Interventions for preventing lower limb soft-tissue running injuries.rm5
p15143
sg5
(lp15144
(dp15145
g8
V3056045.xml
p15146
sg10
VSTD-Gardner-1988
p15147
sg12
S'PMC1349736'
p15148
sa(dp15149
g8
V16388054.xml
p15150
sg10
VSTD-Withnall-2006
p15151
sg12
S'PMC1325079'
p15152
sasa(dp15153
g3
VCD006220 v. 4.0 Cognition-based interventions for healthy older people and people with mild cognitive impairment.rm5
p15154
sg5
(lp15155
(dp15156
g8
V16807197.xml
p15157
sg10
VSTD-Margrett-2006
p15158
sg12
S'PMC2856450'
p15159
sa(dp15160
g8
V12425704.xml
p15161
sg10
VSTD-Ball-2002
p15162
sg12
S'PMC2916176'
p15163
sa(dp15164
g8
V16888038.xml
p15165
sg10
VSTD-Mahncke-2006
p15166
sg12
S'PMC1526649'
p15167
sasa(dp15168
g3
VCD007810 v. 5.0 Adenoidectomy for otitis media in children.rm5
p15169
sg5
(lp15170
(dp15171
g8
V14769785.xml
p15172
sg10
VSTD-Koivunen-2004
p15173
sg12
S'PMC351838'
p15174
sa(dp15175
g8
V19819563.xml
p15176
sg10
VSTD-Casselbrant-2009
p15177
sg12
S'PMC2787742'
p15178
sa(dp15179
g8
V2196954.xml
p15180
sg10
VSTD-Black-1990
p15181
sg12
S'PMC1663097'
p15182
sasa(dp15183
g3
VCD006756 v. 4.0 Cesarean delivery for the prevention of anal incontinence.rm5
p15184
sg5
(lp15185
(dp15186
g8
V16741640.xml
p15187
sg10
VSTD-Varma-2006
p15188
sg12
S'PMC1557355'
p15189
sa(dp15190
g8
V11868640.xml
p15191
sg10
VSTD-Eason-2002
p15192
sg12
S'PMC99311'
p15193
sasa(dp15194
g3
VCD001919 v. 7.0 Information provision for stroke patients and their caregivers.rm5
p15195
sg5
(lp15196
(dp15197
g8
V15130977.xml
p15198
sg10
VSTD-Kalra-2004
p15199
sg12
S'PMC406319'
p15200
sasa(dp15201
g3
VCD001439 v. 11.0 Antibiotics versus placebo for prevention of postoperative infection after appendicectomy..rm5
p15202
sg5
(lp15203
(dp15204
g8
V7025769.xml
p15205
sg10
VSTD-Busuttil-1981-A
p15206
sg12
S'PMC1345331'
p15207
sa(dp15208
g8
V764935.xml
p15209
sg10
VSTD-Willis-1976
p15210
sg12
S'PMC1638715'
p15211
sa(dp15212
g8
V2647050.xml
p15213
sg10
VSTD-Bauer-1989
p15214
sg12
S'PMC1493927'
p15215
sasa(dp15216
g3
VCD009528 v. 2.0 Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic f.rm5
p15217
sg5
(lp15218
(dp15219
g8
V20963843.xml
p15220
sg10
VSTD-Moskowitz-2011
p15221
sg12
S'PMC3479399'
p15222
sasa(dp15223
g3
VCD004868 v. 5.0 Late erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight inf.rm5
p15224
sg5
(lp15225
(dp15226
g8
V19635302.xml
p15227
sg10
VSTD-Bierer-2009
p15228
sg12
S'PMC3086684'
p15229
sa(dp15230
g8
V8346946.xml
p15231
sg10
VSTD-Bechensteen-1993
p15232
sg12
S'PMC1029391'
p15233
sa(dp15234
g8
V8466265.xml
p15235
sg10
VSTD-Emmerson-1993
p15236
sg12
S'PMC1590386'
p15237
sa(dp15238
g8
V9175950.xml
p15239
sg10
VSTD-Griffiths-1997
p15240
sg12
S'PMC1720643'
p15241
sasa(dp15242
g3
VCD003417 v. 4.2 Group based training for self-management strategies in people with type 2 diabetes mellitus.rm5
p15243
sg5
(lp15244
(dp15245
g8
V11815493.xml
p15246
sg10
VSTD-Brown-2002
p15247
sg12
S'PMC2134805'
p15248
sasa(dp15249
g3
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p15250
sg5
(lp15251
(dp15252
g8
V17958887.xml
p15253
sg10
VSTD-Namutangula-2007
p15254
sg12
S'PMC2147028'
p15255
sasa(dp15256
g3
VCD001548 v. 10.0 Single dose oral ibuprofen for acute postoperative pain in adults.rm5
p15257
sg5
(lp15258
(dp15259
g8
V10383546.xml
p15260
sg10
VSTD-Seymour-1999
p15261
sg12
S'PMC2014251'
p15262
sa(dp15263
g8
V11724223.xml
p15264
sg10
VSTD-Medve-2001
p15265
sg12
S'PMC2007376'
p15266
sa(dp15267
g8
V2015175.xml
p15268
sg10
VSTD-Seymour-1991-_x0028_study-2_x0029_
p15269
sg12
S'PMC1368416'
p15270
sa(dp15271
g8
V2015175.xml
p15272
sg10
VSTD-Seymour-1991-_x0028_study-1_x0029_
p15273
sg12
S'PMC1368416'
p15274
sasa(dp15275
g3
VCD005270 v. 1.2 Long-term non-pharmacological weight loss interventions for adults with prediabetes.rm5
p15276
sg5
(lp15277
(dp15278
g8
V11832527.xml
p15279
sg10
VSTD-DPP-2002
p15280
sg12
S'PMC1370926'
p15281
sa(dp15282
g8
V11092283.xml
p15283
sg10
VSTD-DPP-2000
p15284
sg12
S'PMC1360735'
p15285
sa(dp15286
g8
V12453955.xml
p15287
sg10
VSTD-DPP-2002a
p15288
sg12
S'PMC1282458'
p15289
sa(dp15290
g8
V3655634.xml
p15291
sg10
VSTD-Jarrett-1987
p15292
sg12
S'PMC1052600'
p15293
sa(dp15294
g8
V10189543.xml
p15295
sg10
VSTD-DPP-1999
p15296
sg12
S'PMC1351026'
p15297
sasa(dp15298
g3
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p15299
sg5
(lp15300
(dp15301
g8
V18638594.xml
p15302
sg10
VSTD-Singh-2008
p15303
sg12
S'PMC2676172'
p15304
sa(dp15305
g8
V20525997.xml
p15306
sg10
VSTD-Welder-2010
p15307
sg12
S'PMC2918453'
p15308
sa(dp15309
g8
V20946227.xml
p15310
sg10
VSTD-SToP-AF-2011
p15311
sg12
S'PMC3022954'
p15312
sa(dp15313
g8
V19265025.xml
p15314
sg10
VSTD-Rosenson-2009
p15315
sg12
S'PMC2681027'
p15316
sa(dp15317
g8
V20195400.xml
p15318
sg10
VSTD-Park-2010
p15319
sg12
S'PMC2829413'
p15320
sa(dp15321
g8
V18492126.xml
p15322
sg10
VSTD-Miramadi-2008
p15323
sg12
S'PMC2526235'
p15324
sa(dp15325
g8
V20298928.xml
p15326
sg10
VSTD-Koh-2010
p15327
sg12
S'PMC3016087'
p15328
sa(dp15329
g8
V21519514.xml
p15330
sg10
VSTD-Cho-2011
p15331
sg12
S'PMC3079135'
p15332
sa(dp15333
g8
V17184550.xml
p15334
sg10
VSTD-PULSAR--2006
p15335
sg12
S'PMC1779361'
p15336
sa(dp15337
g8
V20031551.xml
p15338
sg10
VSTD-STRENGTH-2008
p15339
sg12
S'PMC2995295'
p15340
sa(dp15341
g8
V17214829.xml
p15342
sg10
VSTD-Kom-2007
p15343
sg12
S'PMC2000588'
p15344
sasa(dp15345
g3
VCD004356 v. 6.0 Short-term ambulatory oxygen for chronic obstructive pulmonary disease.rm5
p15346
sg5
(lp15347
(dp15348
g8
V3238640.xml
p15349
sg10
VSTD-Davidson-1988
p15350
sg12
S'PMC461601'
p15351
sa(dp15352
g8
V871805.xml
p15353
sg10
VSTD-Leggett-1977
p15354
sg12
S'PMC1630967'
p15355
sa(dp15356
g8
V1481177.xml
p15357
sg10
VSTD-Leach-1992
p15358
sg12
S'PMC464043'
p15359
sa(dp15360
g8
V10325901.xml
p15361
sg10
VSTD-Garrod-1999
p15362
sg12
S'PMC1745430'
p15363
sa(dp15364
g8
V10856310.xml
p15365
sg10
VSTD-Garrod-2000
p15366
sg12
S'PMC1745814'
p15367
sasa(dp15368
g3
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p15369
sg5
(lp15370
(dp15371
g8
V21900148.xml
p15372
sg10
VSTD-Louie-2011
p15373
sg12
S'PMC3198285'
p15374
sa(dp15375
g8
V19279301.xml
p15376
sg10
VSTD-Moses-2009
p15377
sg12
S'PMC2681032'
p15378
sasa(dp15379
g3
VCD000400 v. 8.0 Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.rm5
p15380
sg5
(lp15381
(dp15382
g8
V8806245.xml
p15383
sg10
VSTD-Bonnar-1996
p15384
sg12
S'PMC2352023'
p15385
sasa(dp15386
g3
VCD007796 v. 2.2 Chinese herbal medicine for diabetic peripheral neuropathy.rm5
p15387
sg5
(lp15388
(dp15389
g8
V24058521.xml
p15390
sg10
VSTD-Hu-2005
p15391
sg12
S'PMC3776804'
p15392
sasa(dp15393
g3
VCD003237 v. 7.2 Modes of administration of antibiotics for symptomatic severe urinary tract infections.rm5
p15394
sg5
(lp15395
(dp15396
g8
V11777865.xml
p15397
sg10
VSTD-Sanchez-2002
p15398
sg12
S'PMC1725780'
p15399
sasa(dp15400
g3
VCD006396 v. 4.0 Interventions to prevent occupational noise-induced hearing loss.rm5
p15401
sg5
(lp15402
(dp15403
g8
V21193566.xml
p15404
sg10
VSTD-Rabinowitz-2011
p15405
sg12
S'PMC3738059'
p15406
sasa(dp15407
g3
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p15408
sg5
(lp15409
(dp15410
g8
V19014494.xml
p15411
sg10
VSTD-Del-Giglio-2008
p15412
sg12
S'PMC2628928'
p15413
sasa(dp15414
g3
VCD004264 v. 7.0 Physical methods versus drug placebo or no treatment for managing fever in children.rm5
p15415
sg5
(lp15416
(dp15417
g8
V1463951.xml
p15418
sg10
VSTD-Kinmonth-1992
p15419
sg12
S'PMC1883680'
p15420
sa(dp15421
g8
V3978484.xml
p15422
sg10
VSTD-Newman-1985
p15423
sg12
S'PMC1345783'
p15424
sasa(dp15425
g3
VCD003163 v. 6.0 Topical nasal steroids for intermittent and persistent allergic rhinitis in children.rm5
p15426
sg5
(lp15427
(dp15428
g8
V380773.xml
p15429
sg10
VSTD-Sarsfield-1979
p15430
sg12
S'PMC1596085'
p15431
sasa(dp15432
g3
VCD003062 v. 5.0 Cot-nursing versus incubator care for preterm infants.rm5
p15433
sg5
(lp15434
(dp15435
g8
V2730122.xml
p15436
sg10
VSTD-Sarman-1989b
p15437
sg12
S'PMC1792015'
p15438
sa(dp15439
g8
V2923482.xml
p15440
sg10
VSTD-Sarman-1989a
p15441
sg12
S'PMC1590066'
p15442
sasa(dp15443
g3
VMR000021 v. 4.0 Incentives and disincentives to participation by clinicians in randomised controlled trials.rm5
p15444
sg5
(lp15445
(dp15446
g8
V9101682.xml
p15447
sg10
VSTD-Kuyvenhoven-1997
p15448
sg12
S'PMC1312903'
p15449
sasa(dp15450
g3
VCD005182 v. 7.0 Interventions used to improve control of blood pressure in patients with hypertension.rm5
p15451
sg5
(lp15452
(dp15453
g8
V7114339.xml
p15454
sg10
VSTD-Earp-1982
p15455
sg12
S'PMC1650178'
p15456
sa(dp15457
g8
V9824519.xml
p15458
sg10
VSTD-Bogden-1998
p15459
sg12
S'PMC1497023'
p15460
sa(dp15461
g8
V17132351.xml
p15462
sg10
VSTD-McKinstry-2006
p15463
sg12
S'PMC1927092'
p15464
sa(dp15465
g8
V369673.xml
p15466
sg10
VSTD-Johnson-1978
p15467
sg12
S'PMC1819059'
p15468
sa(dp15469
g8
V2495053.xml
p15470
sg10
VSTD-Robson-1989
p15471
sg12
S'PMC1835698'
p15472
sa(dp15473
g8
V1899945.xml
p15474
sg10
VSTD-Midanik-1991
p15475
sg12
S'PMC1580210'
p15476
sa(dp15477
g8
V1252881.xml
p15478
sg10
VSTD-Bulpitt-1976
p15479
sg12
S'PMC1639159'
p15480
sa(dp15481
g8
V10358675.xml
p15482
sg10
VSTD-Krieger-1999
p15483
sg12
S'PMC1508657'
p15484
sa(dp15485
g8
V16595786.xml
p15486
sg10
VSTD-Tobe-2006
p15487
sg12
S'PMC1435956'
p15488
sa(dp15489
g8
V3503941.xml
p15490
sg10
VSTD-Watkins-1987
p15491
sg12
S'PMC1711180'
p15492
sa(dp15493
g8
V10710578.xml
p15494
sg10
VSTD-Montgomery-2000
p15495
sg12
S'PMC27312'
p15496
sa(dp15497
g8
V3092976.xml
p15498
sg10
VSTD-McAlister-1986
p15499
sg12
S'PMC1341518'
p15500
sa(dp15501
g8
V6849473.xml
p15502
sg10
VSTD-Morisky-1983
p15503
sg12
S'PMC1650522'
p15504
sa(dp15505
g8
V15333056.xml
p15506
sg10
VSTD-Hunt-2004
p15507
sg12
S'PMC1492526'
p15508
sa(dp15509
g8
V16115830.xml
p15510
sg10
VSTD-McManus-2005
p15511
sg12
S'PMC1199029'
p15512
sasa(dp15513
g3
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p15514
sg5
(lp15515
(dp15516
g8
V12771395.xml
p15517
sg10
VSTD-van-der-Klink-2003
p15518
sg12
S'PMC1740545'
p15519
sa(dp15520
g8
V17549228.xml
p15521
sg10
VSTD-Bakker-2007
p15522
sg12
S'PMC1885369'
p15523
sasa(dp15524
g3
VCD002173 v. 10.0 Inhaled sodium cromoglycate for asthma in children.rm5
p15525
sg5
(lp15526
(dp15527
g8
V3929698.xml
p15528
sg10
VSTD-Cogswell-1985
p15529
sg12
S'PMC1777416'
p15530
sa(dp15531
g8
V6230059.xml
p15532
sg10
VSTD-Henry-1984
p15533
sg12
S'PMC1628434'
p15534
sa(dp15535
g8
V6791596.xml
p15536
sg10
VSTD-Glass-1981
p15537
sg12
S'PMC1627266'
p15538
sa(dp15539
g8
V413493.xml
p15540
sg10
VSTD-Hiller-1977
p15541
sg12
S'PMC1544812'
p15542
sa(dp15543
g8
V6775752.xml
p15544
sg10
VSTD-Edmunds-1980
p15545
sg12
S'PMC1714307'
p15546
sa(dp15547
g8
V7979527.xml
p15548
sg10
VSTD-Furfaro-1994
p15549
sg12
S'PMC1030013'
p15550
sasa(dp15551
g3
VCD004870 v. 7.2 Acupuncture for neck disorders.rm5
p15552
sg5
(lp15553
(dp15554
g8
V11431299.xml
p15555
sg10
VSTD-Irnich-2001
p15556
sg12
S'PMC33515'
p15557
sasa(dp15558
g3
VCD006657 v. 4.0 Indoor residual spraying for preventing malaria.rm5
p15559
sg5
(lp15560
(dp15561
g8
V17255227.xml
p15562
sg10
VSTD-Sharp-2007
p15563
sg12
S'PMC3749812'
p15564
sasa(dp15565
g3
VCD003204 v. 5.0 Iodised salt for preventing iodine deficiency disorders.rm5
p15566
sg5
(lp15567
(dp15568
g8
V14315706.xml
p15569
sg10
VSTD-Sooch-1965
p15570
sg12
S'PMC2555234'
p15571
sasa(dp15572
g3
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p15573
sg5
(lp15574
(dp15575
g8
V19880433.xml
p15576
sg10
VSTD-Oh-2010
p15577
sg12
S'PMC2826100'
p15578
sa(dp15579
g8
V20467301.xml
p15580
sg10
VSTD-Dodd-2010
p15581
sg12
S'PMC2891044'
p15582
sasa(dp15583
g3
VCD001867 v. 11.0 Opioid antagonists for alcohol dependence.rm5
p15584
sg5
(lp15585
(dp15586
g8
V19673746.xml
p15587
sg10
VSTD-Brown-2009
p15588
sg12
S'PMC3040070'
p15589
sa(dp15590
g8
V17664051.xml
p15591
sg10
VSTD-Pettinati-2008b
p15592
sg12
S'PMC2600888'
p15593
sa(dp15594
g8
V18079068.xml
p15595
sg10
VSTD-Pettinati-2008a
p15596
sg12
S'PMC2374760'
p15597
sa(dp15598
g8
V19874153.xml
p15599
sg10
VSTD-Schmitz-2009
p15600
sg12
S'PMC2907651'
p15601
sa(dp15602
g8
V15956269.xml
p15603
sg10
VSTD-Oslin-2005
p15604
sg12
S'PMC3172720'
p15605
sa(dp15606
g8
V18482155.xml
p15607
sg10
VSTD-O_x0027_Malley-2008
p15608
sg12
S'PMC2746027'
p15609
sasa(dp15610
g3
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p15611
sg5
(lp15612
(dp15613
g8
V12971556.xml
p15614
sg10
VSTD-Krudsood-2003
p15615
sg12
S'PMC3123522'
p15616
sa(dp15617
g8
V15839740.xml
p15618
sg10
VSTD-Sutherland-2005
p15619
sg12
S'PMC1087200'
p15620
sasa(dp15621
g3
VCD003147 v. 6.0 Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.rm5
p15622
sg5
(lp15623
(dp15624
g8
V2038733.xml
p15625
sg10
VSTD-van-der-Schans-1991
p15626
sg12
S'PMC463090'
p15627
sa(dp15628
g8
V3524474.xml
p15629
sg10
VSTD-Tyrrell-1986
p15630
sg12
S'PMC1777841'
p15631
sa(dp15632
g8
V3296295.xml
p15633
sg10
VSTD-Hofmeyr-1986
p15634
sg12
S'PMC460551'
p15635
sasa(dp15636
g3
VCD001520 v. 11.0 Melatonin for the prevention and treatment of jet lag.rm5
p15637
sg5
(lp15638
(dp15639
g8
V2496815.xml
p15640
sg10
VSTD-Petrie-1989
p15641
sg12
S'PMC1835985'
p15642
sasa(dp15643
g3
VCD006308 v. 4.0 Workplace interventions for treatment of occupational asthma.rm5
p15644
sg5
(lp15645
(dp15646
g8
V7112471.xml
p15647
sg10
VSTD-Burge-1982
p15648
sg12
S'PMC459315'
p15649
sa(dp15650
g8
V9038799.xml
p15651
sg10
VSTD-Lin-1996
p15652
sg12
S'PMC1128593'
p15653
sasa(dp15654
g3
VCD004287 v. 8.0 Tissue adhesives for closure of surgical incisions.rm5
p15655
sg5
(lp15656
(dp15657
g8
V17394707.xml
p15658
sg10
VSTD-Ridgway-2007
p15659
sg12
S'PMC1964725'
p15660
sasa(dp15661
g3
VCD001211 v. 13.2 Antibiotics versus placebo for acute bacterial conjunctivitis.rm5
p15662
sg5
(lp15663
(dp15664
g8
V16378561.xml
p15665
sg10
VSTD-Rietveld-2005
p15666
sg12
S'PMC1570507'
p15667
sasa(dp15668
g3
VCD001270 v. 6.0 Teaching critical appraisal skills in healthcare settings.rm5
p15669
sg5
(lp15670
(dp15671
g8
V15585061.xml
p15672
sg10
VSTD-Taylor-2004
p15673
sg12
S'PMC539272'
p15674
sasa(dp15675
g3
VCD008147 v. 2.0 Supplementary vitamin E selenium cysteine and riboflavin for preventing kwashiorkor in preschool c.rm5
p15676
sg5
(lp15677
(dp15678
g8
V15851401.xml
p15679
sg10
VSTD-Ciliberto-2005
p15680
sg12
S'PMC557886'
p15681
sasa(dp15682
g3
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p15683
sg5
(lp15684
(dp15685
g8
V6979982.xml
p15686
sg10
VSTD-Silverman-1982
p15687
sg12
S'PMC1352475'
p15688
sa(dp15689
g8
V16943938.xml
p15690
sg10
VSTD-Eslami-2005
p15691
sg12
S'PMC1502073'
p15692
sa(dp15693
g8
V8038000.xml
p15694
sg10
VSTD-Butler-1993
p15695
sg12
S'PMC1025229'
p15696
sa(dp15697
g8
V21358799.xml
p15698
sg10
VSTD-Chavan-2010
p15699
sg12
S'PMC3034455'
p15700
sa(dp15701
g8
V6610435.xml
p15702
sg10
VSTD-Ormerod-1984
p15703
sg12
S'PMC481561'
p15704
sasa(dp15705
g3
VCD004871 v. 10.0 Massage for mechanical neck disorders.rm5
p15706
sg5
(lp15707
(dp15708
g8
V11431299.xml
p15709
sg10
VSTD-Irnich-2001
p15710
sg12
S'PMC33515'
p15711
sa(dp15712
g8
V19066648.xml
p15713
sg10
VSTD-Briem-2007
p15714
sg12
S'PMC2565604'
p15715
sa(dp15716
g8
V19333174.xml
p15717
sg10
VSTD-Sherman-2009
p15718
sg12
S'PMC2664516'
p15719
sasa(dp15720
g3
VCD002213 v. 7.5 Interprofessional education effects on professional practice and healthcare outcomes (update).rm5
p15721
sg5
(lp15722
(dp15723
g8
V20219315.xml
p15724
sg10
VSTD-Helitzer-2011
p15725
sg12
S'PMC3539754'
p15726
sa(dp15727
g8
V12546286.xml
p15728
sg10
VSTD-Morey-2002
p15729
sg12
S'PMC1464040'
p15730
sa(dp15731
g8
V17693668.xml
p15732
sg10
VSTD-Taylor-2007
p15733
sg12
S'PMC2464938'
p15734
sasa(dp15735
g3
VCD009899 v. 1.0 Exercise and mobilisation interventions for carpal tunnel syndrome.rm5
p15736
sg5
(lp15737
(dp15738
g8
V19801812.xml
p15739
sg10
VSTD-Bialosky-2009
p15740
sg12
S'PMC2864088'
p15741
sasa(dp15742
g3
VCD002277 v. 10.0 Intravenous immunoglobulin for myasthenia gravis.rm5
p15743
sg5
(lp15744
(dp15745
g8
V21562253.xml
p15746
sg10
VSTD-Barth-2011
p15747
sg12
S'PMC3109880'
p15748
sasa(dp15749
g3
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p15750
sg5
(lp15751
(dp15752
g8
V20500832.xml
p15753
sg10
VSTD-FACS-2010
p15754
sg12
S'PMC2886041'
p15755
sasa(dp15756
g3
VCD008712 v. 4.0 Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.rm5
p15757
sg5
(lp15758
(dp15759
g8
V14551096.xml
p15760
sg10
VSTD-O_x0027_Donnell-2003
p15761
sg12
S'PMC214016'
p15762
sa(dp15763
g8
V8611831.xml
p15764
sg10
VSTD-Kemp-1998
p15765
sg12
S'PMC2350295'
p15766
sasa(dp15767
g3
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p15768
sg5
(lp15769
(dp15770
g8
V17062657.xml
p15771
sg10
VSTD-DiFrancisco-2007
p15772
sg12
S'PMC2465144'
p15773
sa(dp15774
g8
V9987467.xml
p15775
sg10
VSTD-Jette-1999
p15776
sg12
S'PMC1508501'
p15777
sa(dp15778
g8
V14644853.xml
p15779
sg10
VSTD-Foley-2003
p15780
sg12
S'PMC1754378'
p15781
sa(dp15782
g8
V10690445.xml
p15783
sg10
VSTD-Rhodes-2000
p15784
sg12
S'PMC1724140'
p15785
sa(dp15786
g8
V2141834.xml
p15787
sg10
VSTD-Collier-1997
p15788
sg12
S'PMC213374'
p15789
sa(dp15790
g8
V16183776.xml
p15791
sg10
VSTD-Fatouros-2005
p15792
sg12
S'PMC1725040'
p15793
sa(dp15794
g8
V1549826.xml
p15795
sg10
VSTD-Simpson-1992
p15796
sg12
S'PMC463573'
p15797
sa(dp15798
g8
V17134517.xml
p15799
sg10
VSTD-Sims-2006
p15800
sg12
S'PMC1698486'
p15801
sasa(dp15802
g3
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p15803
sg5
(lp15804
(dp15805
g8
V17686152.xml
p15806
sg10
VSTD-Kluger-2007
p15807
sg12
S'PMC2206502'
p15808
sasa(dp15809
g3
VCD007779 v. 4.0 Levomepromazine for schizophrenia.rm5
p15810
sg5
(lp15811
(dp15812
g8
V16862245.xml
p15813
sg10
VSTD-Lal-2006
p15814
sg12
S'PMC1488906'
p15815
sasa(dp15816
g3
VCD002913 v. 6.2 Budesonide for maintenance of remission in Crohn's disease.rm5
p15817
sg5
(lp15818
(dp15819
g8
V8881815.xml
p15820
sg10
VSTD-Lofberg-1996
p15821
sg12
S'PMC1383237'
p15822
sa(dp15823
g8
V11156638.xml
p15824
sg10
VSTD-Cortot-2001
p15825
sg12
S'PMC1728198'
p15826
sa(dp15827
g8
V9616309.xml
p15828
sg10
VSTD-Gross-1998
p15829
sg12
S'PMC1727061'
p15830
sasa(dp15831
g3
VCD005993 v. 5.0 Procaine treatments for cognition and dementia.rm5
p15832
sg5
(lp15833
(dp15834
g8
V13691281.xml
p15835
sg10
VSTD-Cashman-1961
p15836
sg12
S'PMC1953822'
p15837
sasa(dp15838
g3
VCD001939 v. 8.0 Branched-chain amino acids for hepatic encephalopathy.rm5
p15839
sg5
(lp15840
(dp15841
g8
V3539709.xml
p15842
sg10
VSTD-Rossi-1986-_x002d_-AHE
p15843
sg12
S'PMC1434629'
p15844
sasa(dp15845
g3
VCD001728 v. 13.0 Heated humidified air for the common cold.rm5
p15846
sg5
(lp15847
(dp15848
g8
V2500196.xml
p15849
sg10
VSTD-Tyrrell-1989a
p15850
sg12
S'PMC1836535'
p15851
sa(dp15852
g8
V2500196.xml
p15853
sg10
VSTD-Tyrrell-1989b
p15854
sg12
S'PMC1836535'
p15855
sasa(dp15856
g3
VCD001694 v. 8.0 Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.rm5
p15857
sg5
(lp15858
(dp15859
g8
V9279180.xml
p15860
sg10
VSTD-Prabhu-1997
p15861
sg12
S'PMC1720662'
p15862
sasa(dp15863
g3
VCD001764 v. 17.0 Psychosocial and pharmacological treatments for deliberate self harm.rm5
p15864
sg5
(lp15865
(dp15866
g8
V6824553.xml
p15867
sg10
VSTD-Montgomery-1983
p15868
sg12
S'PMC1427879'
p15869
sasa(dp15870
g3
VCD004252 v. 7.2 Muscle relaxants for non-specific low-back pain.rm5
p15871
sg5
(lp15872
(dp15873
g8
V4262210.xml
p15874
sg10
VSTD-Hindle-1972
p15875
sg12
S'PMC1518609'
p15876
sasa(dp15877
g3
VCD004876 v. 9.0 Vaccines for preventing influenza in the elderly.rm5
p15878
sg5
(lp15879
(dp15880
g8
V8557090.xml
p15881
sg10
VSTD-Fleming-1995
p15882
sg12
S'PMC2271576'
p15883
sa(dp15884
g8
V9425463.xml
p15885
sg10
VSTD-Puig_x002d_Barber_x00e0_-1997
p15886
sg12
S'PMC1060539'
p15887
sa(dp15888
g8
V10487646.xml
p15889
sg10
VSTD-Nicholson-1999
p15890
sg12
S'PMC2810733'
p15891
sa(dp15892
g8
V9042032.xml
p15893
sg10
VSTD-Ahmed-1997
p15894
sg12
S'PMC2808769'
p15895
sa(dp15896
g8
V8877126.xml
p15897
sg10
VSTD-Keitel-1996
p15898
sg12
S'PMC170397'
p15899
sa(dp15900
g8
V8241913.xml
p15901
sg10
VSTD-Govaert-1993
p15902
sg12
S'PMC1679213'
p15903
sa(dp15904
g8
V7830018.xml
p15905
sg10
VSTD-Mukerjee-1994
p15906
sg12
S'PMC1060042'
p15907
sa(dp15908
g8
V3963278.xml
p15909
sg10
VSTD-Horman-1986
p15910
sg12
S'PMC1646616'
p15911
sasa(dp15912
g3
VCD003677 v. 8.0 Surgical approach to hysterectomy for benign gynaecological disease.rm5
p15913
sg5
(lp15914
(dp15915
g8
V14711749.xml
p15916
sg10
VSTD-Garry-2004
p15917
sg12
S'PMC314503'
p15918
sasa(dp15919
g3
VCD005244 v. 9.2 Interventions in the alcohol server setting for preventing injuries.rm5
p15920
sg5
(lp15921
(dp15922
g8
V10728540.xml
p15923
sg10
VSTD-Warburton-2000
p15924
sg12
S'PMC1730594'
p15925
sa(dp15926
g8
V22942862.xml
p15927
sg10
VSTD-McKnight-1991
p15928
sg12
S'PMC3153620'
p15929
sa(dp15930
g8
V1990858.xml
p15931
sg10
VSTD-Howard_x002d_Pitney-1991
p15932
sg12
S'PMC1404951'
p15933
sa(dp15934
g8
V3605473.xml
p15935
sg10
VSTD-Russ-1987
p15936
sg12
S'PMC1647259'
p15937
sasa(dp15938
g3
VCD002024 v. 15.2 Alpha2-adrenergic agonists for the management of opioid withdrawal.rm5
p15939
sg5
(lp15940
(dp15941
g8
V18508207.xml
p15942
sg10
VSTD-Yu-2008
p15943
sg12
S'PMC2613766'
p15944
sasa(dp15945
g3
VCD004257 v. 6.0 Acetaminophen for osteoarthritis.rm5
p15946
sg5
(lp15947
(dp15948
g8
V15082468.xml
p15949
sg10
VSTD-Pincus-a-2004
p15950
sg12
S'PMC1755088'
p15951
sa(dp15952
g8
V15308513.xml
p15953
sg10
VSTD-Boureau-2004
p15954
sg12
S'PMC1755112'
p15955
sa(dp15956
g8
V15249319.xml
p15957
sg10
VSTD-Miceli_x002d_Richard-2004
p15958
sg12
S'PMC1755093'
p15959
sa(dp15960
g8
V15082468.xml
p15961
sg10
VSTD-Pincus-b-2004
p15962
sg12
S'PMC1755088'
p15963
sasa(dp15964
g3
VCD007911 v. 2.0 Cryotherapy following total knee replacement.rm5
p15965
sg5
(lp15966
(dp15967
g8
V11561502.xml
p15968
sg10
VSTD-Gibbons-2001
p15969
sg12
S'PMC3620829'
p15970
sasa(dp15971
g3
VCD001914 v. 8.0 Oral protein calorie supplementation for children with chronic disease.rm5
p15972
sg5
(lp15973
(dp15974
g8
V16467348.xml
p15975
sg10
VSTD-Poustie-2006
p15976
sg12
S'PMC1403226'
p15977
sasa(dp15978
g3
VCD001083 v. 7.0 Cyclosporine for treating rheumatoid arthritis.rm5
p15979
sg5
(lp15980
(dp15981
g8
V3281603.xml
p15982
sg10
VSTD-Dougados-1988
p15983
sg12
S'PMC1003464'
p15984
sasa(dp15985
g3
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p15986
sg5
(lp15987
(dp15988
g8
V3353895.xml
p15989
sg10
VSTD-Dorward-1988
p15990
sg12
S'PMC1020749'
p15991
sa(dp15992
g8
V17359604.xml
p15993
sg10
VSTD-de-Vries-2007
p15994
sg12
S'PMC2042544'
p15995
sa(dp15996
g8
V8511730.xml
p15997
sg10
VSTD-Warner-1993
p15998
sg12
S'PMC464427'
p15999
sa(dp16000
g8
V12079502.xml
p16001
sg10
VSTD-Sheikh-2002
p16002
sg12
S'PMC116603'
p16003
sa(dp16004
g8
V7001667.xml
p16005
sg10
VSTD-Burr-1980A
p16006
sg12
S'PMC471322'
p16007
sa(dp16008
g8
V7001668.xml
p16009
sg10
VSTD-Burr-1980B
p16010
sg12
S'PMC471323'
p16011
sasa(dp16012
g3
VCD001390 v. 7.0 Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmo.rm5
p16013
sg5
(lp16014
(dp16015
g8
V16227328.xml
p16016
sg10
VSTD-Alfageme-2006
p16017
sg12
S'PMC2080738'
p16018
sa(dp16019
g8
V3545418.xml
p16020
sg10
VSTD-Leech-1987
p16021
sg12
S'PMC1492041'
p16022
sasa(dp16023
g3
VCD007868 v. 3.0 Fluoride toothpastes of different concentrations for preventing dental caries in children and adoles.rm5
p16024
sg5
(lp16025
(dp16026
g8
V14485790.xml
p16027
sg10
VSTD-Peterson-1967
p16028
sg12
S'PMC1914640'
p16029
sasa(dp16030
g3
VMR000001 v. 5.0 Handsearching versus electronic searching to identify reports of randomized trials.rm5
p16031
sg5
(lp16032
(dp16033
g8
V7718048.xml
p16034
sg10
VSTD-Dickersin-1994
p16035
sg12
S'PMC2541778'
p16036
sa(dp16037
g8
V8343701.xml
p16038
sg10
VSTD-Jadad-1993b
p16039
sg12
S'PMC1678459'
p16040
sa(dp16041
g8
V11597966.xml
p16042
sg10
VSTD-Silagy-1993
p16043
sg12
S'PMC57801'
p16044
sa(dp16045
g8
V10166598.xml
p16046
sg10
VSTD-Cullum-1997
p16047
sg12
S'PMC1055436'
p16048
sasa(dp16049
g3
VCD006221 v. 4.0 Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.rm5
p16050
sg5
(lp16051
(dp16052
g8
V18482290.xml
p16053
sg10
VSTD-von-Muhlen-2007
p16054
sg12
S'PMC2574781'
p16055
sasa(dp16056
g3
VCD007524 v. 3.0 Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adul.rm5
p16057
sg5
(lp16058
(dp16059
g8
V9771245.xml
p16060
sg10
VSTD-Garrett-1998
p16061
sg12
S'PMC1717626'
p16062
sa(dp16063
g8
V15223858.xml
p16064
sg10
VSTD-Fitzgerald-2004
p16065
sg12
S'PMC1747069'
p16066
sasa(dp16067
g3
VCD008754 v. 2.1 Memory Rehabilitation for people with multiple sclerosis.rm5
p16068
sg5
(lp16069
(dp16070
g8
V11784832.xml
p16071
sg10
VSTD-Lincoln-2002
p16072
sg12
S'PMC1737698'
p16073
sasa(dp16074
g3
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p16075
sg5
(lp16076
(dp16077
g8
V15056388.xml
p16078
sg10
VSTD-Sokal-2004
p16079
sg12
S'PMC406425'
p16080
sasa(dp16081
g3
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p16082
sg5
(lp16083
(dp16084
g8
V15980998.xml
p16085
sg10
VSTD-Ryu-2006
p16086
sg12
S'PMC3489408'
p16087
sa(dp16088
g8
V10823430.xml
p16089
sg10
VSTD-Zoega-2000
p16090
sg12
S'PMC3611372'
p16091
sa(dp16092
g8
V17684777.xml
p16093
sg10
VSTD-Stulik-2007
p16094
sg12
S'PMC2078301'
p16095
sa(dp16096
g8
V19763634.xml
p16097
sg10
VSTD-Lofgren-2010
p16098
sg12
S'PMC2899760'
p16099
sa(dp16100
g8
V19015851.xml
p16101
sg10
VSTD-Ruetten-2009
p16102
sg12
S'PMC2899164'
p16103
sa(dp16104
g8
V18301927.xml
p16105
sg10
VSTD-Dai-2008
p16106
sg12
S'PMC2367424'
p16107
sa(dp16108
g8
V17342510.xml
p16109
sg10
VSTD-Lind-2007
p16110
sg12
S'PMC2200784'
p16111
sasa(dp16112
g3
VCD007999 v. 2.52 Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.rm5
p16113
sg5
(lp16114
(dp16115
g8
V20233195.xml
p16116
sg10
VSTD-Hsu-2010
p16117
sg12
S'PMC2829694'
p16118
sa(dp16119
g8
V19523014.xml
p16120
sg10
VSTD-Tsai-2009
p16121
sg12
S'PMC2675043'
p16122
sasa(dp16123
g3
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p16124
sg5
(lp16125
(dp16126
g8
V1691921.xml
p16127
sg10
VSTD-Southampton
p16128
sg12
S'PMC1971367'
p16129
sa(dp16130
g8
V1691921.xml
p16131
sg10
VSTD-RLW-8351
p16132
sg12
S'PMC1971367'
p16133
sa(dp16134
g8
V15454647.xml
p16135
sg10
VSTD-BLT2
p16136
sg12
S'PMC1746842'
p16137
sa(dp16138
g8
V15454647.xml
p16139
sg10
VSTD-BLT1
p16140
sg12
S'PMC1746842'
p16141
sa(dp16142
g8
V10945489.xml
p16143
sg10
VSTD-Manchester-1
p16144
sg12
S'PMC2374661'
p16145
sasa(dp16146
g3
VCD008112 v. 5.0 Spinal manipulative therapy for chronic low-back pain.rm5
p16147
sg5
(lp16148
(dp16149
g8
V15556955.xml
p16150
sg10
VSTD-UK-BEAM-trial-2004
p16151
sg12
S'PMC535454'
p16152
sa(dp16153
g8
V16341712.xml
p16154
sg10
VSTD-Gudavalli-2006
p16155
sg12
S'PMC3233943'
p16156
sa(dp16157
g8
V1532760.xml
p16158
sg10
VSTD-Koes-1992
p16159
sg12
S'PMC1881307'
p16160
sasa(dp16161
g3
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p16162
sg5
(lp16163
(dp16164
g8
V18476110.xml
p16165
sg10
VSTD-Charleston-1996
p16166
sg12
S'PMC2364502'
p16167
sasa(dp16168
g3
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p16169
sg5
(lp16170
(dp16171
g8
V19169651.xml
p16172
sg10
VSTD-Lim-2009
p16173
sg12
S'PMC2687520'
p16174
sasa(dp16175
g3
VCD000026 v. 12.0 Routine versus selective antifungal administration for control of fungal infections in patients with.rm5
p16176
sg5
(lp16177
(dp16178
g8
V7596933.xml
p16179
sg10
VSTD-Yamac-1995
p16180
sg12
S'PMC2398107'
p16181
sasa(dp16182
g3
VCD002000 v. 7.0 Bypass surgery for chronic lower limb ischaemia.rm5
p16183
sg5
(lp16184
(dp16185
g8
V2647051.xml
p16186
sg10
VSTD-Lundgren-1989
p16187
sg12
S'PMC1493950'
p16188
sasa(dp16189
g3
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p16190
sg5
(lp16191
(dp16192
g8
V18312661.xml
p16193
sg10
VSTD-Itoh-2008
p16194
sg12
S'PMC2268695'
p16195
sasa(dp16196
g3
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p16197
sg5
(lp16198
(dp16199
g8
V18411239.xml
p16200
sg10
VSTD-Charron_x002d_Prochownik-2008
p16201
sg12
S'PMC2453657'
p16202
sasa(dp16203
g3
VCD002064 v. 8.2 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sc.rm5
p16204
sg5
(lp16205
(dp16206
g8
V19029516.xml
p16207
sg10
VSTD-Sorenson-2008
p16208
sg12
S'PMC2617770'
p16209
sasa(dp16210
g3
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p16211
sg5
(lp16212
(dp16213
g8
V7491551.xml
p16214
sg10
VSTD-Bootsma-1995
p16215
sg12
S'PMC475016'
p16216
sa(dp16217
g8
V9828851.xml
p16218
sg10
VSTD-Fitzgerald-1998
p16219
sg12
S'PMC1745293'
p16220
sa(dp16221
g8
V12324672.xml
p16222
sg10
VSTD-Currie-2002
p16223
sg12
S'PMC1746197'
p16224
sa(dp16225
g8
V18475734.xml
p16226
sg10
VSTD-Ringdal-1996
p16227
sg12
S'PMC2365805'
p16228
sa(dp16229
g8
V11182010.xml
p16230
sg10
VSTD-Harrison-2001
p16231
sg12
S'PMC1758787'
p16232
sa(dp16233
g8
V8211872.xml
p16234
sg10
VSTD-Fabbri-1993
p16235
sg12
S'PMC464708'
p16236
sa(dp16237
g8
V14694242.xml
p16238
sg10
VSTD-Phillips-2004
p16239
sg12
S'PMC1758859'
p16240
sa(dp16241
g8
V10325897.xml
p16242
sg10
VSTD-Hughes-1999b
p16243
sg12
S'PMC1745450'
p16244
sa(dp16245
g8
V8215522.xml
p16246
sg10
VSTD-Gustafsson-1993
p16247
sg12
S'PMC1029458'
p16248
sasa(dp16249
g3
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p16250
sg5
(lp16251
(dp16252
g8
V18458145.xml
p16253
sg10
VSTD-Fonseca-2008
p16254
sg12
S'PMC2494667'
p16255
sasa(dp16256
g3
VCD004547 v. 4.0 Chinese medicinal herbs for cholelithiasis.rm5
p16257
sg5
(lp16258
(dp16259
g8
V23695700.xml
p16260
sg10
VSTD-Su-2012
p16261
sg12
S'PMC3674284'
p16262
sasa(dp16263
g3
VCD004554 v. 4.0 Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.rm5
p16264
sg5
(lp16265
(dp16266
g8
V8558148.xml
p16267
sg10
VSTD-Ruottinen-1996-_x0028_a_x0029_
p16268
sg12
S'PMC486187'
p16269
sa(dp16270
g8
V12876237.xml
p16271
sg10
VSTD-Brooks-UK_x002d_IRISH-2003
p16272
sg12
S'PMC1738605'
p16273
sa(dp16274
g8
V9343116.xml
p16275
sg10
VSTD-Baas-1997
p16276
sg12
S'PMC2169755'
p16277
sasa(dp16278
g3
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p16279
sg5
(lp16280
(dp16281
g8
V17375049.xml
p16282
sg10
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p16283
sg12
S'PMC2360162'
p16284
sa(dp16285
g8
V11720425.xml
p16286
sg10
VSTD-Taal-2001-_x0028_NACCP_x0029_
p16287
sg12
S'PMC2363941'
p16288
sasa(dp16289
g3
VCD000969 v. 11.0 Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.rm5
p16290
sg5
(lp16291
(dp16292
g8
V10348768.xml
p16293
sg10
VSTD-Nucci-1999
p16294
sg12
S'PMC89294'
p16295
sa(dp16296
g8
V10348763.xml
p16297
sg10
VSTD-Nath-1999
p16298
sg12
S'PMC89289'
p16299
sasa(dp16300
g3
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p16301
sg5
(lp16302
(dp16303
g8
V18520677.xml
p16304
sg10
VSTD-Pope-2008
p16305
sg12
S'PMC2632747'
p16306
sa(dp16307
g8
V20205841.xml
p16308
sg10
VSTD-Leon-2010
p16309
sg12
S'PMC2825497'
p16310
sa(dp16311
g8
V17388666.xml
p16312
sg10
VSTD-Gregson-2007
p16313
sg12
S'PMC1831737'
p16314
sasa(dp16315
g3
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p16316
sg5
(lp16317
(dp16318
g8
V20714820.xml
p16319
sg10
VSTD-Glasgow-2010
p16320
sg12
S'PMC2988142'
p16321
sa(dp16322
g8
V20299481.xml
p16323
sg10
VSTD-Lorig-2010
p16324
sg12
S'PMC2875437'
p16325
sa(dp16326
g8
V21788632.xml
p16327
sg10
VSTD-Quinn-2011
p16328
sg12
S'PMC3161305'
p16329
sa(dp16330
g8
V21270188.xml
p16331
sg10
VSTD-Lim-2011
p16332
sg12
S'PMC3024339'
p16333
sasa(dp16334
g3
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p16335
sg5
(lp16336
(dp16337
g8
V9949754.xml
p16338
sg10
VSTD-Walsh-1999
p16339
sg12
S'PMC1508522'
p16340
sa(dp16341
g8
V7856783.xml
p16342
sg10
VSTD-Stevens-1995
p16343
sg12
S'PMC1615327'
p16344
sa(dp16345
g8
V20466951.xml
p16346
sg10
VSTD-Gordon-2010b
p16347
sg12
S'PMC2882418'
p16348
sa(dp16349
g8
V17475005.xml
p16350
sg10
VSTD-Binnie-2007
p16351
sg12
S'PMC1871574'
p16352
sa(dp16353
g8
V20675426.xml
p16354
sg10
VSTD-Gordon-2010a
p16355
sg12
S'PMC3780769'
p16356
sa(dp16357
g8
V19405969.xml
p16358
sg10
VSTD-Nohlert-2009
p16359
sg12
S'PMC2685131'
p16360
sasa(dp16361
g3
VCD005147 v. 6.0 Training to recognise the early signs of recurrence in schizophrenia.rm5
p16362
sg5
(lp16363
(dp16364
g8
V18930378.xml
p16365
sg10
VSTD-Horan-2009
p16366
sg12
S'PMC2653055'
p16367
sasa(dp16368
g3
VCD002316 v. 9.14 Inhaled steroids for acute asthma following emergency department discharge.rm5
p16369
sg5
(lp16370
(dp16371
g8
V8958890.xml
p16372
sg10
VSTD-Levy-1996
p16373
sg12
S'PMC1090518'
p16374
sasa(dp16375
g3
VCD004439 v. 5.0 Antibiotics for treating chronic osteomyelitis in adults.rm5
p16376
sg5
(lp16377
(dp16378
g8
V2183710.xml
p16379
sg10
VSTD-Gentry-1990
p16380
sg12
S'PMC171517'
p16381
sa(dp16382
g8
V2039205.xml
p16383
sg10
VSTD-Gentry-1991
p16384
sg12
S'PMC245046'
p16385
sa(dp16386
g8
V10602739.xml
p16387
sg10
VSTD-Greenberg-2000
p16388
sg12
S'PMC89644'
p16389
sa(dp16390
g8
V3524419.xml
p16391
sg10
VSTD-Sheftel-1986
p16392
sg12
S'PMC180374'
p16393
sasa(dp16394
g3
VCD001007 v. 8.0 Group behaviour therapy programmes for smoking cessation.rm5
p16395
sg5
(lp16396
(dp16397
g8
V11495176.xml
p16398
sg10
VSTD-Brown-2001
p16399
sg12
S'PMC1832078'
p16400
sa(dp16401
g8
V17577801.xml
p16402
sg10
VSTD-Brown-2007
p16403
sg12
S'PMC2213513'
p16404
sa(dp16405
g8
V2327531.xml
p16406
sg10
VSTD-Lando-1990
p16407
sg12
S'PMC1404660'
p16408
sa(dp16409
g8
V21274108.xml
p16410
sg10
VSTD-McDowell-1985
p16411
sg12
S'PMC2327690'
p16412
sa(dp16413
g8
V2782506.xml
p16414
sg10
VSTD-DePaul-1987
p16415
sg12
S'PMC1350178'
p16416
sasa(dp16417
g3
VCD007457 v. 2.0 Mobile phone messaging for preventive health care.rm5
p16418
sg5
(lp16419
(dp16420
g8
V16046689.xml
p16421
sg10
VSTD-Rodgers-2005
p16422
sg12
S'PMC1748056'
p16423
sa(dp16424
g8
V18984496.xml
p16425
sg10
VSTD-Shapiro-2008
p16426
sg12
S'PMC2592683'
p16427
sasa(dp16428
g3
VCD000313 v. 7.9 Discharge planning from hospital to home.rm5
p16429
sg5
(lp16430
(dp16431
g8
V19189907.xml
p16432
sg10
VSTD-Jack-2009
p16433
sg12
S'PMC2738592'
p16434
sa(dp16435
g8
V1737315.xml
p16436
sg10
VSTD-Moher-1992
p16437
sg12
S'PMC1488427'
p16438
sa(dp16439
g8
V18452048.xml
p16440
sg10
VSTD-Balaban-2008
p16441
sg12
S'PMC2517968'
p16442
sasa(dp16443
g3
VCD002249 v. 5.0 Clomiphene and anti-oestrogens for ovulation induction in PCOS.rm5
p16444
sg5
(lp16445
(dp16446
g8
V11804430.xml
p16447
sg10
VSTD-Hassan-2001
p16448
sg12
S'PMC3455693'
p16449
sasa(dp16450
g3
VCD007180 v. 3.0 Interventions to improve disposal of human excreta for preventing diarrhoea.rm5
p16451
sg5
(lp16452
(dp16453
g8
V4982076.xml
p16454
sg10
VSTD-Rubenstein-1965
p16455
sg12
S'PMC2031530'
p16456
sa(dp16457
g8
V18205977.xml
p16458
sg10
VSTD-Garrett-2008
p16459
sg12
S'PMC2870746'
p16460
sa(dp16461
g8
V13465958.xml
p16462
sg10
VSTD-McCabe-1957
p16463
sg12
S'PMC2031363'
p16464
sasa(dp16465
g3
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p16466
sg5
(lp16467
(dp16468
g8
V16052221.xml
p16469
sg10
VSTD-van-Sprundel-2005
p16470
sg12
S'PMC2361560'
p16471
sa(dp16472
g8
V11154619.xml
p16473
sg10
VSTD-Hatcher-2001
p16474
sg12
S'PMC26594'
p16475
sa(dp16476
g8
V736655.xml
p16477
sg10
VSTD-Horton-1978
p16478
sg12
S'PMC1397010'
p16479
sasa(dp16480
g3
VCD001745 v. 8.0 Community interventions for reducing smoking among adults.rm5
p16481
sg5
(lp16482
(dp16483
g8
V9224191.xml
p16484
sg10
VSTD-Jenkins-1997
p16485
sg12
S'PMC1380945'
p16486
sa(dp16487
g8
V9807532.xml
p16488
sg10
VSTD-Fisher-1998
p16489
sg12
S'PMC1508568'
p16490
sa(dp16491
g8
V10846513.xml
p16492
sg10
VSTD-Secker_x002d_Walker-2000
p16493
sg12
S'PMC1446253'
p16494
sa(dp16495
g8
V6414597.xml
p16496
sg10
VSTD-Egger-1983
p16497
sg12
S'PMC1549317'
p16498
sa(dp16499
g8
V10396552.xml
p16500
sg10
VSTD-Weinehall-1999
p16501
sg12
S'PMC1756863'
p16502
sa(dp16503
g8
V7856779.xml
p16504
sg10
VSTD-Lando-1995
p16505
sg12
S'PMC1615309'
p16506
sa(dp16507
g8
V9302957.xml
p16508
sg10
VSTD-Baxter-1997
p16509
sg12
S'PMC2127433'
p16510
sa(dp16511
g8
V7762709.xml
p16512
sg10
VSTD-Carleton-1995
p16513
sg12
S'PMC1615494'
p16514
sa(dp16515
g8
V7856777.xml
p16516
sg10
VSTD-COMMIT-1995
p16517
sg12
S'PMC1615326'
p16518
sa(dp16519
g8
V10589309.xml
p16520
sg10
VSTD-O_x0027_Loughlin-1999
p16521
sg12
S'PMC1509008'
p16522
sa(dp16523
g8
V8633737.xml
p16524
sg10
VSTD-Brownson-1996
p16525
sg12
S'PMC1380329'
p16526
sa(dp16527
g8
V9549451.xml
p16528
sg10
VSTD-Tudor_x002d_Smith-1998
p16529
sg12
S'PMC28483'
p16530
sasa(dp16531
g3
VCD003992 v. 6.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
p16532
sg5
(lp16533
(dp16534
g8
V12838298.xml
p16535
sg10
VSTD-Innes-2003
p16536
sg12
S'PMC2394220'
p16537
sa(dp16538
g8
V11083625.xml
p16539
sg10
VSTD-Giamarellou-2000
p16540
sg12
S'PMC90190'
p16541
sasa(dp16542
g3
VCD000396 v. 11.0 Non-steroidal anti-inflammatory drugs for low back pain.rm5
p16543
sg5
(lp16544
(dp16545
g8
V4232743.xml
p16546
sg10
VSTD-Jacobs-1968
p16547
sg12
S'PMC1986152'
p16548
sa(dp16549
g8
V6462116.xml
p16550
sg10
VSTD-Berry-1982
p16551
sg12
S'PMC1000895'
p16552
sa(dp16553
g8
V23642377.xml
p16554
sg10
VSTD-Jaffe-1974
p16555
sg12
S'PMC3737287'
p16556
sasa(dp16557
g3
VCD004674 v. 4.0 Calorie controlled diet for chronic asthma.rm5
p16558
sg5
(lp16559
(dp16560
g8
V10731173.xml
p16561
sg10
VSTD-Stenius-2000
p16562
sg12
S'PMC27319'
p16563
sasa(dp16564
g3
VCD003935 v. 12.0 Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal h.rm5
p16565
sg5
(lp16566
(dp16567
g8
V20227053.xml
p16568
sg10
VSTD-McEvoy-2010
p16569
sg12
S'PMC2878893'
p16570
sasa(dp16571
g3
VCD005087 v. 7.0 Sodium channel blockers for cystic fibrosis.rm5
p16572
sg5
(lp16573
(dp16574
g8
V8554360.xml
p16575
sg10
VSTD-Bowler-1995
p16576
sg12
S'PMC1511379'
p16577
sasa(dp16578
g3
VCD003521 v. 5.0 Complementary and alternative therapies for pain management in labour.rm5
p16579
sg5
(lp16580
(dp16581
g8
V3081212.xml
p16582
sg10
VSTD-Freeman-1986
p16583
sg12
S'PMC1339642'
p16584
sasa(dp16585
g3
VCD008481 v. 3.0 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.rm5
p16586
sg5
(lp16587
(dp16588
g8
V11502515.xml
p16589
sg10
VSTD-Wysocki-2001
p16590
sg12
S'PMC90678'
p16591
sa(dp16592
g8
V17620371.xml
p16593
sg10
VSTD-Sakka-2007
p16594
sg12
S'PMC2043189'
p16595
sa(dp16596
g8
V16869814.xml
p16597
sg10
VSTD-van-Zanten-2007
p16598
sg12
S'PMC2000713'
p16599
sa(dp16600
g8
V16940077.xml
p16601
sg10
VSTD-Lau-2006
p16602
sg12
S'PMC1635208'
p16603
sa(dp16604
g8
V10792202.xml
p16605
sg10
VSTD-Angus-2000
p16606
sg12
S'PMC2014958'
p16607
sasa(dp16608
g3
VCD002300 v. 14.0 Cisapride treatment for gastro-oesophageal reflux in children.rm5
p16609
sg5
(lp16610
(dp16611
g8
V3300570.xml
p16612
sg10
VSTD-Cucchiara-1987
p16613
sg12
S'PMC1778411'
p16614
sa(dp16615
g8
V1599300.xml
p16616
sg10
VSTD-Greally-1992
p16617
sg12
S'PMC1793694'
p16618
sasa(dp16619
g3
VCD003140 v. 11.0 Benzo-pyrones for reducing and controlling lymphoedema of the limbs.rm5
p16620
sg5
(lp16621
(dp16622
g8
V8251778.xml
p16623
sg10
VSTD-Casley_x002d_Smith-1993_x0028_2_x0029_
p16624
sg12
S'PMC1679230'
p16625
sasa(dp16626
g3
VCD004383 v. 5.2 Specialist home-based nursing services for children with acute and chronic illnesses.rm5
p16627
sg5
(lp16628
(dp16629
g8
V12390903.xml
p16630
sg10
VSTD-Sartain-2001
p16631
sg12
S'PMC1763073'
p16632
sasa(dp16633
g3
VCD005477 v. 5.0 Single layer versus double layer suture anastomosis of the gastrointestinal tract.rm5
p16634
sg5
(lp16635
(dp16636
g8
V10816626.xml
p16637
sg10
VSTD-Burch-2000
p16638
sg12
S'PMC1421072'
p16639
sasa(dp16640
g3
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p16641
sg5
(lp16642
(dp16643
g8
V19070889.xml
p16644
sg10
VSTD-Kitchener-2009
p16645
sg12
S'PMC2646126'
p16646
sasa(dp16647
g3
VCD004158 v. 5.0 Rehabilitation following carpal tunnel release.rm5
p16648
sg5
(lp16649
(dp16650
g8
V12562974.xml
p16651
sg10
VSTD-Stevinson-2003
p16652
sg12
S'PMC539394'
p16653
sasa(dp16654
g3
VCD001036 v. 9.0 Collection devices for obtaining cervical cytology samples.rm5
p16655
sg5
(lp16656
(dp16657
g8
V2759604.xml
p16658
sg10
VSTD-Goorney-1989
p16659
sg12
S'PMC1194323'
p16660
sa(dp16661
g8
V8819441.xml
p16662
sg10
VSTD-Dey-1996
p16663
sg12
S'PMC2352129'
p16664
sa(dp16665
g8
V2265842.xml
p16666
sg10
VSTD-Szarewski-1990
p16667
sg12
S'PMC1194584'
p16668
sa(dp16669
g8
V3101790.xml
p16670
sg10
VSTD-Wolfendale-1987
p16671
sg12
S'PMC1245047'
p16672
sasa(dp16673
g3
VCD005472 v. 6.2 Acupuncture for insomnia.rm5
p16674
sg5
(lp16675
(dp16676
g8
V22542781.xml
p16677
sg10
VSTD-Lai-2010
p16678
sg12
S'PMC3429157'
p16679
sa(dp16680
g8
V19725255.xml
p16681
sg10
VSTD-Yeung-2009a
p16682
sg12
S'PMC2717194'
p16683
sa(dp16684
g8
V11903057.xml
p16685
sg10
VSTD-Du-2007
p16686
sg12
S'PMC1222461'
p16687
sasa(dp16688
g3
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p16689
sg5
(lp16690
(dp16691
g8
V20485304.xml
p16692
sg10
VSTD-Merenstein-2010
p16693
sg12
S'PMC2906750'
p16694
sa(dp16695
g8
V21477383.xml
p16696
sg10
VSTD-West-2011
p16697
sg12
S'PMC3083335'
p16698
sasa(dp16699
g3
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p16700
sg5
(lp16701
(dp16702
g8
V15845509.xml
p16703
sg10
VSTD-Garc_x00ed_a-2005
p16704
sg12
S'PMC1087340'
p16705
sa(dp16706
g8
V2807523.xml
p16707
sg10
VSTD-Migasena-1989a
p16708
sg12
S'PMC259791'
p16709
sa(dp16710
g8
V7822046.xml
p16711
sg10
VSTD-Lagos-1995
p16712
sg12
S'PMC173056'
p16713
sa(dp16714
g8
V8359923.xml
p16715
sg10
VSTD-Gotuzzo-1993
p16716
sg12
S'PMC281106'
p16717
sa(dp16718
g8
V9615498.xml
p16719
sg10
VSTD-Perry-1998
p16720
sg12
S'PMC2305629'
p16721
sa(dp16722
g8
V11895960.xml
p16723
sg10
VSTD-Cohen-2002
p16724
sg12
S'PMC127885'
p16725
sa(dp16726
g8
V18523643.xml
p16727
sg10
VSTD-Mahalanabis-2008
p16728
sg12
S'PMC2396289'
p16729
sa(dp16730
g8
V10569747.xml
p16731
sg10
VSTD-Tacket-1999
p16732
sg12
S'PMC97039'
p16733
sa(dp16734
g8
V1398956.xml
p16735
sg10
VSTD-Kotloff-1992
p16736
sg12
S'PMC257485'
p16737
sa(dp16738
g8
V9916056.xml
p16739
sg10
VSTD-Ben_x00ed_tez-1999
p16740
sg12
S'PMC96352'
p16741
sa(dp16742
g8
V11884967.xml
p16743
sg10
VSTD-Trach-2002
p16744
sg12
S'PMC2567633'
p16745
sasa(dp16746
g3
VCD000174 v. 7.0 Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.rm5
p16747
sg5
(lp16748
(dp16749
g8
V3516077.xml
p16750
sg10
VSTD-Rennie-1986a
p16751
sg12
S'PMC1777724'
p16752
sasa(dp16753
g3
VCD001857 v. 7.0 Interventions for preventing injuries in problem drinkers.rm5
p16754
sg5
(lp16755
(dp16756
g8
V8669518.xml
p16757
sg10
VSTD-WHO-BISG-1996
p16758
sg12
S'PMC1380435'
p16759
sa(dp16760
g8
V10522717.xml
p16761
sg10
VSTD-Gentilello-1999
p16762
sg12
S'PMC1420896'
p16763
sasa(dp16764
g3
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p16765
sg5
(lp16766
(dp16767
g8
V20670733.xml
p16768
sg10
VSTD-Algotar-200_x03bc_g-2010
p16769
sg12
S'PMC2913148'
p16770
sa(dp16771
g8
V20670733.xml
p16772
sg10
VSTD-Algotar-2010
p16773
sg12
S'PMC2913148'
p16774
sa(dp16775
g8
V20670733.xml
p16776
sg10
VSTD-Algotar-800_x03bc_g-2010
p16777
sg12
S'PMC2913148'
p16778
sa(dp16779
g8
V23028897.xml
p16780
sg10
VSTD-UK-PRECISE
p16781
sg12
S'PMC3446875'
p16782
sasa(dp16783
g3
VCD001920 v. 5.0 Physiotherapy treatment approaches for the recovery of postural control and lower limb function foll.rm5
p16784
sg5
(lp16785
(dp16786
g8
V15774435.xml
p16787
sg10
VSTD-Lincoln-2003
p16788
sg12
S'PMC1739598'
p16789
sa(dp16790
g8
V1559090.xml
p16791
sg10
VSTD-Wade-1992
p16792
sg12
S'PMC1881332'
p16793
sasa(dp16794
g3
VCD009094 v. 1.0 The impact of user fees on access to health services in low- and middle-income countries.rm5
p16795
sg5
(lp16796
(dp16797
g8
V15112007.xml
p16798
sg10
VSTD-Burnham-2004
p16799
sg12
S'PMC2585922'
p16800
sa(dp16801
g8
V11477970.xml
p16802
sg10
VSTD-Wilkinson-2001
p16803
sg12
S'PMC2566476'
p16804
sa(dp16805
g8
V12973646.xml
p16806
sg10
VSTD-Ridde-2003
p16807
sg12
S'PMC2572499'
p16808
sasa(dp16809
g3
VCD005014 v. 8.5 Home safety education and provision of safety equipment for injury prevention.rm5
p16810
sg5
(lp16811
(dp16812
g8
V596497.xml
p16813
sg10
VSTD-Dershewitz-1977
p16814
sg12
S'PMC1653806'
p16815
sa(dp16816
g8
V21464382.xml
p16817
sg10
VSTD-Phelan-2010
p16818
sg12
S'PMC3693223'
p16819
sa(dp16820
g8
V8484447.xml
p16821
sg10
VSTD-Schwarz-1993
p16822
sg12
S'PMC1694716'
p16823
sa(dp16824
g8
V12411356.xml
p16825
sg10
VSTD-Rowland-2002
p16826
sg12
S'PMC131024'
p16827
sa(dp16828
g8
V9346097.xml
p16829
sg10
VSTD-Schelp-1987
p16830
sg12
S'PMC1067711'
p16831
sa(dp16832
g8
V14576891.xml
p16833
sg10
VSTD-Mock-2003
p16834
sg12
S'PMC2572517'
p16835
sa(dp16836
g8
V6812798.xml
p16837
sg10
VSTD-Colver-1982
p16838
sg12
S'PMC1500158'
p16839
sa(dp16840
g8
V10875670.xml
p16841
sg10
VSTD-Coggan-2000
p16842
sg12
S'PMC1730604'
p16843
sa(dp16844
g8
V15604156.xml
p16845
sg10
VSTD-Watson-2005
p16846
sg12
S'PMC544992'
p16847
sa(dp16848
g8
V11932115.xml
p16849
sg10
VSTD-Nansel-2002
p16850
sg12
S'PMC2387242'
p16851
sa(dp16852
g8
V17446248.xml
p16853
sg10
VSTD-Kendrick-2007
p16854
sg12
S'PMC2610598'
p16855
sa(dp16856
g8
V16105365.xml
p16857
sg10
VSTD-Kendrick-2005
p16858
sg12
S'PMC1463224'
p16859
sa(dp16860
g8
V17906313.xml
p16861
sg10
VSTD-Nansel-2008
p16862
sg12
S'PMC2562892'
p16863
sa(dp16864
g8
V20495474.xml
p16865
sg10
VSTD-Kolko-2001
p16866
sg12
S'PMC3057358'
p16867
sa(dp16868
g8
V7065320.xml
p16869
sg10
VSTD-Miller-1982
p16870
sg12
S'PMC1649895'
p16871
sa(dp16872
g8
V10574875.xml
p16873
sg10
VSTD-Ohn-2005
p16874
sg12
S'PMC1117156'
p16875
sa(dp16876
g8
V16203842.xml
p16877
sg10
VSTD-Hendrickson-2002
p16878
sg12
S'PMC1730268'
p16879
sa(dp16880
g8
V17567977.xml
p16881
sg10
VSTD-Yorkston-2007
p16882
sg12
S'PMC2598383'
p16883
sa(dp16884
g8
V9338837.xml
p16885
sg10
VSTD-Schlesinger-1966
p16886
sg12
S'PMC1067824'
p16887
sa(dp16888
g8
V11861228.xml
p16889
sg10
VSTD-Emond-2002
p16890
sg12
S'PMC1719107'
p16891
sa(dp16892
g8
V12411355.xml
p16893
sg10
VSTD-DiGuiseppi-2002
p16894
sg12
S'PMC131023'
p16895
sa(dp16896
g8
V10195971.xml
p16897
sg10
VSTD-Kendrick-1999
p16898
sg12
S'PMC27827'
p16899
sa(dp16900
g8
V11928967.xml
p16901
sg10
VSTD-Ozanne_x002d_Smith-2002
p16902
sg12
S'PMC1730817'
p16903
sa(dp16904
g8
V2817165.xml
p16905
sg10
VSTD-Guyer-1989
p16906
sg12
S'PMC1349806'
p16907
sa(dp16908
g8
V7058963.xml
p16909
sg10
VSTD-McLoughlin-1982
p16910
sg12
S'PMC1649807'
p16911
sa(dp16912
g8
V9596598.xml
p16913
sg10
VSTD-Clamp-1998
p16914
sg12
S'PMC28560'
p16915
sa(dp16916
g8
V9346020.xml
p16917
sg10
VSTD-Svanstrom-1995
p16918
sg12
S'PMC1067586'
p16919
sa(dp16920
g8
V17018679.xml
p16921
sg10
VSTD-Hwang-2006
p16922
sg12
S'PMC2563473'
p16923
sa(dp16924
g8
V21637293.xml
p16925
sg10
VSTD-Matthews-1988
p16926
sg12
S'PMC3214915'
p16927
sa(dp16928
g8
V11928968.xml
p16929
sg10
VSTD-Lindqvist-1998a
p16930
sg12
S'PMC1730829'
p16931
sa(dp16932
g8
V7058964.xml
p16933
sg10
VSTD-Mackay-2002
p16934
sg12
S'PMC1649800'
p16935
sa(dp16936
g8
V12966017.xml
p16937
sg10
VSTD-Sznajder-2003
p16938
sg12
S'PMC1730977'
p16939
sa(dp16940
g8
V11144634.xml
p16941
sg10
VSTD-Johnston-2000
p16942
sg12
S'PMC1730673'
p16943
sasa(dp16944
g3
VCD003145 v. 5.0 Short term benefits for laparoscopic colorectal resection.rm5
p16945
sg5
(lp16946
(dp16947
g8
V10749610.xml
p16948
sg10
VSTD-Leung-2000
p16949
sg12
S'PMC1421025'
p16950
sa(dp16951
g8
V12454514.xml
p16952
sg10
VSTD-Braga-2002-b
p16953
sg12
S'PMC1422642'
p16954
sasa(dp16955
g3
VCD003036 v. 10.0 Immediate post-partum insertion of intrauterine devices.rm5
p16956
sg5
(lp16957
(dp16958
g8
V20966692.xml
p16959
sg10
VSTD-Chen-2009
p16960
sg12
S'PMC3104850'
p16961
sasa(dp16962
g3
VCD001756 v. 10.0 Mechanical devices for urinary incontinence in women.rm5
p16963
sg5
(lp16964
(dp16965
g8
V20177294.xml
p16966
sg10
VSTD-Richter-2010
p16967
sg12
S'PMC2914312'
p16968
sasa(dp16969
g3
VCD001454 v. 10.0 Diuretics for respiratory distress syndrome in preterm infants.rm5
p16970
sg5
(lp16971
(dp16972
g8
V16204359.xml
p16973
sg10
VSTD-Cattarelli-2006
p16974
sg12
S'PMC2672685'
p16975
sa(dp16976
g8
V1103753.xml
p16977
sg10
VSTD-Savage-1975
p16978
sg12
S'PMC1545637'
p16979
sasa(dp16980
g3
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p16981
sg5
(lp16982
(dp16983
g8
V16231970.xml
p16984
sg10
VSTD-ANRS-1265
p16985
sg12
S'PMC1262556'
p16986
sasa(dp16987
g3
VCD000510 v. 7.0 Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm inf.rm5
p16988
sg5
(lp16989
(dp16990
g8
V20472939.xml
p16991
sg10
VSTD-SUPPORT-2010
p16992
sg12
S'PMC3071534'
p16993
sasa(dp16994
g3
VMR000011 v. 6.0 Time to publication for results of clinical trials.rm5
p16995
sg5
(lp16996
(dp16997
g8
V9310565.xml
p16998
sg10
VSTD-Stern-1997
p16999
sg12
S'PMC2127436'
p17000
sasa(dp17001
g3
VCD002950 v. 10.2 Antidepressants for cocaine dependence and problematic cocaine use.rm5
p17002
sg5
(lp17003
(dp17004
g8
V21266301.xml
p17005
sg10
VSTD-Winstanley-2011
p17006
sg12
S'PMC3078567'
p17007
sasa(dp17008
g3
VCD007530 v. 1.7 Vascular occlusion for elective liver resections.rm5
p17009
sg5
(lp17010
(dp17011
g8
V9409569.xml
p17012
sg10
VSTD-Man-1997
p17013
sg12
S'PMC1191142'
p17014
sasa(dp17015
g3
VCD002925 v. 6.0 Therapy-based rehabilitation services for stroke patients at home.rm5
p17016
sg5
(lp17017
(dp17018
g8
V6780105.xml
p17019
sg10
VSTD-London-1981
p17020
sg12
S'PMC1504295'
p17021
sa(dp17022
g8
V10698876.xml
p17023
sg10
VSTD-Glasgow-2000
p17024
sg12
S'PMC27300'
p17025
sasa(dp17026
g3
VCD000053 v. 6.6 Drugs for treating urinary schistosomiasis.rm5
p17027
sg5
(lp17028
(dp17029
g8
V519476.xml
p17030
sg10
VSTD-McMahon-1979
p17031
sg12
S'PMC1597073'
p17032
sa(dp17033
g8
V6401550.xml
p17034
sg10
VSTD-Pugh-1983
p17035
sg12
S'PMC1546776'
p17036
sasa(dp17037
g3
VCD004401 v. 9.2 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
p17038
sg5
(lp17039
(dp17040
g8
V7051984.xml
p17041
sg10
VSTD-Schwartz-1982a
p17042
sg12
S'PMC1627732'
p17043
sa(dp17044
g8
V18513453.xml
p17045
sg10
VSTD-Leach-2008
p17046
sg12
S'PMC2443129'
p17047
sasa(dp17048
g3
VCD004343 v. 3.0 Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infant.rm5
p17049
sg5
(lp17050
(dp17051
g8
V8198414.xml
p17052
sg10
VSTD-EC-Trial-Group-1994
p17053
sg12
S'PMC1061041'
p17054
sasa(dp17055
g3
VCD008819 v. 2.2 Compression stockings for the initial treatment of varicose veins in patients without venous ulcerat.rm5
p17056
sg5
(lp17057
(dp17058
g8
V3917751.xml
p17059
sg10
VSTD-Chant-1985
p17060
sg12
S'PMC1417967'
p17061
sasa(dp17062
g3
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p17063
sg5
(lp17064
(dp17065
g8
V22058537.xml
p17066
sg10
VSTD-Dube-1981
p17067
sg12
S'PMC3012941'
p17068
sasa(dp17069
g3
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p17070
sg5
(lp17071
(dp17072
g8
V17362472.xml
p17073
sg10
VSTD-Kuna-2007
p17074
sg12
S'PMC1920547'
p17075
sa(dp17076
g8
V20874458.xml
p17077
sg10
VSTD-Maspero-2010
p17078
sg12
S'PMC2993043'
p17079
sasa(dp17080
g3
VCD004740 v. 3.0 Interventions for acute otitis externa.rm5
p17081
sg5
(lp17082
(dp17083
g8
V14630756.xml
p17084
sg10
VSTD-van-Balen-2003
p17085
sg12
S'PMC274056'
p17086
sasa(dp17087
g3
VCD002102 v. 6.0 Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma.rm5
p17088
sg5
(lp17089
(dp17090
g8
V3056288.xml
p17091
sg10
VSTD-Gerard-1988a
p17092
sg12
S'PMC1493780'
p17093
sasa(dp17094
g3
VCD006400 v. 2.2 Dietary interventions for rheumatoid arthritis.rm5
p17095
sg5
(lp17096
(dp17097
g8
V17308218.xml
p17098
sg10
VSTD-Podas-2007
p17099
sg12
S'PMC2805936'
p17100
sa(dp17101
g8
V17613557.xml
p17102
sg10
VSTD-McKellar-2007
p17103
sg12
S'PMC1955146'
p17104
sa(dp17105
g8
V12594104.xml
p17106
sg10
VSTD-Sk_x00f6_ldstam-2003
p17107
sg12
S'PMC1754463'
p17108
sasa(dp17109
g3
VCD007020 v. 7.0 Antioxidant micronutrients for lung disease in cystic fibrosis.rm5
p17110
sg5
(lp17111
(dp17112
g8
V11120904.xml
p17113
sg10
VSTD-Renner-2001
p17114
sg12
S'PMC1745899'
p17115
sasa(dp17116
g3
VCD006722 v. 3.0 Psychostimulants for depression.rm5
p17117
sg5
(lp17118
(dp17119
g8
V23522244.xml
p17120
sg10
VSTD-Wheatley-1969-b
p17121
sg12
S'PMC3606375'
p17122
sa(dp17123
g8
V23522244.xml
p17124
sg10
VSTD-Wheatley-1969-a
p17125
sg12
S'PMC3606375'
p17126
sa(dp17127
g8
V2664088.xml
p17128
sg10
VSTD-Cantello-1989
p17129
sg12
S'PMC1032022'
p17130
sa(dp17131
g8
V13904675.xml
p17132
sg10
VSTD-Hare-1962
p17133
sg12
S'PMC1959255'
p17134
sa(dp17135
g8
V14097430.xml
p17136
sg10
VSTD-Hare-1964
p17137
sg12
S'PMC1815021'
p17138
sa(dp17139
g8
V13514499.xml
p17140
sg10
VSTD-Robin-1958
p17141
sg12
S'PMC497294'
p17142
sasa(dp17143
g3
VCD003914 v. 9.0 Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.rm5
p17144
sg5
(lp17145
(dp17146
g8
V1510394.xml
p17147
sg10
VSTD-Ramphal-1992
p17148
sg12
S'PMC188836'
p17149
sa(dp17150
g8
V3551829.xml
p17151
sg10
VSTD-Verhagen-1987
p17152
sg12
S'PMC174690'
p17153
sa(dp17154
g8
V3909956.xml
p17155
sg10
VSTD-De-Pauw-1985
p17156
sg12
S'PMC180337'
p17157
sa(dp17158
g8
V1829879.xml
p17159
sg10
VSTD-Novakova-1991
p17160
sg12
S'PMC245077'
p17161
sa(dp17162
g8
V2959198.xml
p17163
sg10
VSTD-Del-Favero-1987
p17164
sg12
S'PMC174882'
p17165
sasa(dp17166
g3
VCD003002 v. 9.4 Drug therapy for obstructive sleep apnoea in adults.rm5
p17167
sg5
(lp17168
(dp17169
g8
V14694248.xml
p17170
sg10
VSTD-Kiely-2004
p17171
sg12
S'PMC1758841'
p17172
sa(dp17173
g8
V20614859.xml
p17174
sg10
VSTD-Prasad-2010
p17175
sg12
S'PMC2894441'
p17176
sa(dp17177
g8
V18548827.xml
p17178
sg10
VSTD-Marshall-2008
p17179
sg12
S'PMC2442407'
p17180
sa(dp17181
g8
V21269278.xml
p17182
sg10
VSTD-Eckert-2011
p17183
sg12
S'PMC3415379'
p17184
sasa(dp17185
g3
VCD001479 v. 12.0 Vitamin A for treating measles in children.rm5
p17186
sg5
(lp17187
(dp17188
g8
V3101849.xml
p17189
sg10
VSTD-Barclay-1987
p17190
sg12
S'PMC1245303'
p17191
sasa(dp17192
g3
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p17193
sg5
(lp17194
(dp17195
g8
V18427286.xml
p17196
sg10
VSTD-Dorman-2008
p17197
sg12
S'PMC2666004'
p17198
sa(dp17199
g8
V12067170.xml
p17200
sg10
VSTD-Harley-2002
p17201
sg12
S'PMC3686948'
p17202
sa(dp17203
g8
V7580360.xml
p17204
sg10
VSTD-Penta-de-Peppo-1995
p17205
sg12
S'PMC325258'
p17206
sa(dp17207
g8
V19843776.xml
p17208
sg10
VSTD-Desai-2009
p17209
sg12
S'PMC2789288'
p17210
sa(dp17211
g8
V19730217.xml
p17212
sg10
VSTD-Berenholtz-2009
p17213
sg12
S'PMC2772136'
p17214
sa(dp17215
g8
V17988379.xml
p17216
sg10
VSTD-Jimenez-2007
p17217
sg12
S'PMC2246206'
p17218
sa(dp17219
g8
V18361800.xml
p17220
sg10
VSTD-Apostolakis-2008
p17221
sg12
S'PMC2287179'
p17222
sa(dp17223
g8
V15224162.xml
p17224
sg10
VSTD-Yamasaki-2004
p17225
sg12
S'PMC3474476'
p17226
sa(dp17227
g8
V16432349.xml
p17228
sg10
VSTD-Wu-2006
p17229
sg12
S'PMC1448924'
p17230
sasa(dp17231
g3
VCD007338 v. 3.0 Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p17232
sg5
(lp17233
(dp17234
g8
V17457160.xml
p17235
sg10
VSTD-Hashimoto-2007
p17236
sg12
S'PMC1877080'
p17237
sasa(dp17238
g3
VCD009672 v. 2.0 Hormone therapy for sexual function in perimenopausal and postmenopausal women.rm5
p17239
sg5
(lp17240
(dp17241
g8
V19505307.xml
p17242
sg10
VSTD-Estonian-blind-trial
p17243
sg12
S'PMC2702282'
p17244
sa(dp17245
g8
V19505307.xml
p17246
sg10
VSTD-Estonian-non_x002d_blind-trial
p17247
sg12
S'PMC2702282'
p17248
sasa(dp17249
g3
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p17250
sg5
(lp17251
(dp17252
g8
V21835046.xml
p17253
sg10
VSTD-Peng-2011
p17254
sg12
S'PMC3177872'
p17255
sa(dp17256
g8
V20300220.xml
p17257
sg10
VSTD-Schmidt-2010
p17258
sg12
S'PMC2840249'
p17259
sa(dp17260
g8
V19720920.xml
p17261
sg10
VSTD-Krouse-2009
p17262
sg12
S'PMC2754912'
p17263
sa(dp17264
g8
V12894013.xml
p17265
sg10
VSTD-Engel-2003
p17266
sg12
S'PMC1422675'
p17267
sa(dp17268
g8
V10735495.xml
p17269
sg10
VSTD-Allal-2000
p17270
sg12
S'PMC2363346'
p17271
sa(dp17272
g8
V21808871.xml
p17273
sg10
VSTD-Campos_x002d_Lobato-2011
p17274
sg12
S'PMC3129949'
p17275
sa(dp17276
g8
V11176118.xml
p17277
sg10
VSTD-Grumann-2001
p17278
sg12
S'PMC1421194'
p17279
sa(dp17280
g8
V19862692.xml
p17281
sg10
VSTD-Smith_x002d_Gagen-2009
p17282
sg12
S'PMC2911491'
p17283
sasa(dp17284
g3
VCD004466 v. 5.0 Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft.rm5
p17285
sg5
(lp17286
(dp17287
g8
V2799743.xml
p17288
sg10
VSTD-Jenkins-1989
p17289
sg12
S'PMC461992'
p17290
sasa(dp17291
g3
VCD009339 v. 2.0 Weight loss interventions for chronic asthma.rm5
p17292
sg5
(lp17293
(dp17294
g8
V10731173.xml
p17295
sg10
VSTD-Stenius-Aarniaala-2000
p17296
sg12
S'PMC27319'
p17297
sasa(dp17298
g3
VCD003458 v. 7.0 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).rm5
p17299
sg5
(lp17300
(dp17301
g8
V17915574.xml
p17302
sg10
VSTD-Martinuzzi-2007
p17303
sg12
S'PMC2949319'
p17304
sasa(dp17305
g3
VCD000352 v. 11.0 Planned hospital birth versus planned home birth.rm5
p17306
sg5
(lp17307
(dp17308
g8
V8605464.xml
p17309
sg10
VSTD-Dowswell-1996
p17310
sg12
S'PMC2350434'
p17311
sasa(dp17312
g3
VCD010256 v. 1.14 Intravenous beta2-agonists versus intravenous aminophylline for acute asthma.rm5
p17313
sg5
(lp17314
(dp17315
g8
V319876.xml
p17316
sg10
VSTD-Femi_x002d_Pearse-1977
p17317
sg12
S'PMC1605098'
p17318
sa(dp17319
g8
V12668792.xml
p17320
sg10
VSTD-Roberts-2003
p17321
sg12
S'PMC1746646'
p17322
sa(dp17323
g8
V1106817.xml
p17324
sg10
VSTD-Williams-1975
p17325
sg12
S'PMC1675841'
p17326
sa(dp17327
g8
V383024.xml
p17328
sg10
VSTD-Hambleton-1979
p17329
sg12
S'PMC1545558'
p17330
sa(dp17331
g8
V638577.xml
p17332
sg10
VSTD-Johnson-1978
p17333
sg12
S'PMC1603977'
p17334
sasa(dp17335
g3
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p17336
sg5
(lp17337
(dp17338
g8
V10074017.xml
p17339
sg10
VSTD-SHIP-1999
p17340
sg12
S'PMC27782'
p17341
sa(dp17342
g8
V10356008.xml
p17343
sg10
VSTD-Feder-1999
p17344
sg12
S'PMC27895'
p17345
sa(dp17346
g8
V9930042.xml
p17347
sg10
VSTD-Campbell-1998
p17348
sg12
S'PMC1728827'
p17349
sa(dp17350
g8
V12399345.xml
p17351
sg10
VSTD-Eccles-2002
p17352
sg12
S'PMC130060'
p17353
sa(dp17354
g8
V12386042.xml
p17355
sg10
VSTD-Kiessling-2002
p17356
sg12
S'PMC129638'
p17357
sa(dp17358
g8
V11387182.xml
p17359
sg10
VSTD-Moher-2001b-_x0028_nurse-led_x0029_
p17360
sg12
S'PMC32168'
p17361
sa(dp17362
g8
V7950723.xml
p17363
sg10
VSTD-Cupples-1994a
p17364
sg12
S'PMC2541257'
p17365
sa(dp17366
g8
V19875426.xml
p17367
sg10
VSTD-SPHERE
p17368
sg12
S'PMC2770592'
p17369
sa(dp17370
g8
V11387182.xml
p17371
sg10
VSTD-Moher-2001a-_x0028_GP-led_x0029_
p17372
sg12
S'PMC32168'
p17373
sasa(dp17374
g3
VCD005451 v. 14.0 Carbamazepine for acute and chronic pain in adults.rm5
p17375
sg5
(lp17376
(dp17377
g8
V5327969.xml
p17378
sg10
VSTD-Campbell-1966
p17379
sg12
S'PMC496031'
p17380
sasa(dp17381
g3
VCD004366 v. 11.2 Exercise for depression.rm5
p17382
sg5
(lp17383
(dp17384
g8
V17062659.xml
p17385
sg10
VSTD-Knubben-2007
p17386
sg12
S'PMC2465130'
p17387
sa(dp17388
g8
V17846259.xml
p17389
sg10
VSTD-Blumenthal-2007
p17390
sg12
S'PMC2702700'
p17391
sa(dp17392
g8
V17164159.xml
p17393
sg10
VSTD-Brenes-2007
p17394
sg12
S'PMC2885010'
p17395
sa(dp17396
g8
V1433121.xml
p17397
sg10
VSTD-Veale--1992
p17398
sg12
S'PMC1293641'
p17399
sa(dp17400
g8
V3926074.xml
p17401
sg10
VSTD-Martinsen-1985
p17402
sg12
S'PMC1416251'
p17403
sa(dp17404
g8
V22836201.xml
p17405
sg10
VSTD-Mutrie-1988
p17406
sg12
S'PMC3505536'
p17407
sa(dp17408
g8
V18297481.xml
p17409
sg10
VSTD-Williams-2008
p17410
sg12
S'PMC2475651'
p17411
sa(dp17412
g8
V17620123.xml
p17413
sg10
VSTD-Pilu-2007
p17414
sg12
S'PMC1976311'
p17415
sasa(dp17416
g3
VCD003438 v. 9.8 Interventions for increasing pedestrian and cyclist visibility for the prevention of death and injur.rm5
p17417
sg5
(lp17418
(dp17419
g8
V23263729.xml
p17420
sg10
VSTD-Kumagai-1999
p17421
sg12
S'PMC3589943'
p17422
sasa(dp17423
g3
VCD005033 v. 6.0 Perioperative blood transfusions and recurrence of colorectal cancer.rm5
p17424
sg5
(lp17425
(dp17426
g8
V1466616.xml
p17427
sg10
VSTD-Tartter-1992
p17428
sg12
S'PMC1242709'
p17429
sa(dp17430
g8
V3924274.xml
p17431
sg10
VSTD-Frankish-1985
p17432
sg12
S'PMC1415976'
p17433
sa(dp17434
g8
V8379630.xml
p17435
sg10
VSTD-Sene-1993
p17436
sg12
S'PMC2497917'
p17437
sa(dp17438
g8
V3605994.xml
p17439
sg10
VSTD-Creasy-1987
p17440
sg12
S'PMC2498481'
p17441
sa(dp17442
g8
V2405765.xml
p17443
sg10
VSTD-Cheslyn_x002d_Curtis-1990
p17444
sg12
S'PMC2499079'
p17445
sasa(dp17446
g3
VCD005609 v. 3.4 Interventions to increase clinical incident reporting in health care.rm5
p17447
sg5
(lp17448
(dp17449
g8
V17545341.xml
p17450
sg10
VSTD-Evans-2007
p17451
sg12
S'PMC2465009'
p17452
sasa(dp17453
g3
VCD000277 v. 7.0 Calcium antagonists for aneurysmal subarachnoid haemorrhage.rm5
p17454
sg5
(lp17455
(dp17456
g8
V2496789.xml
p17457
sg10
VSTD-Pickard-1989
p17458
sg12
S'PMC1835889'
p17459
sasa(dp17460
g3
VCD003215 v. 5.0 Base administration or fluid bolus for preventing morbidity and mortality in preterm infants with me.rm5
p17461
sg5
(lp17462
(dp17463
g8
V15210676.xml
p17464
sg10
VSTD-Lawn-2005
p17465
sg12
S'PMC1721729'
p17466
sasa(dp17467
g3
VCD007007 v. 3.0 Screening women for intimate partner violence in healthcare settings.rm5
p17468
sg5
(lp17469
(dp17470
g8
V21185737.xml
p17471
sg10
VSTD-Humphreys-2011
p17472
sg12
S'PMC3053017'
p17473
sa(dp17474
g8
V16076821.xml
p17475
sg10
VSTD-Carroll-2005
p17476
sg12
S'PMC1180654'
p17477
sa(dp17478
g8
V21182802.xml
p17479
sg10
VSTD-Kataoka-2010
p17480
sg12
S'PMC3017017'
p17481
sasa(dp17482
g3
VCD000191 v. 8.2 Silver acetate for smoking cessation.rm5
p17483
sg5
(lp17484
(dp17485
g8
V2256009.xml
p17486
sg10
VSTD-Jensen-1990
p17487
sg12
S'PMC462778'
p17488
sasa(dp17489
g3
VCD008494 v. 2.0 Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens .rm5
p17490
sg5
(lp17491
(dp17492
g8
V19531928.xml
p17493
sg10
VSTD-ART_x002d_LINC-2009
p17494
sg12
S'PMC2956749'
p17495
sasa(dp17496
g3
VCD004435 v. 8.2 Oral appliances for obstructive sleep apnoea.rm5
p17497
sg5
(lp17498
(dp17499
g8
V9196520.xml
p17500
sg10
VSTD-Ferguson-1997
p17501
sg12
S'PMC1758547'
p17502
sa(dp17503
g8
V17121868.xml
p17504
sg10
VSTD-Lam-2007
p17505
sg12
S'PMC2092459'
p17506
sasa(dp17507
g3
VCD004417 v. 13.0 Delayed antibiotics for respiratory infections.rm5
p17508
sg5
(lp17509
(dp17510
g8
V11255901.xml
p17511
sg10
VSTD-Dowell-2001
p17512
sg12
S'PMC1313951'
p17513
sa(dp17514
g8
V9116551.xml
p17515
sg10
VSTD-Little-1997
p17516
sg12
S'PMC2126131'
p17517
sa(dp17518
g8
V11159657.xml
p17519
sg10
VSTD-Little-2001
p17520
sg12
S'PMC26576'
p17521
sasa(dp17522
g3
VCD006527 v. 4.2 Educational interventions for the prevention of eye injuries.rm5
p17523
sg5
(lp17524
(dp17525
g8
V16118310.xml
p17526
sg10
VSTD-Eime-2005
p17527
sg12
S'PMC1725311'
p17528
sasa(dp17529
g3
VCD008722 v. 2.0 Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in.rm5
p17530
sg5
(lp17531
(dp17532
g8
V6423045.xml
p17533
sg10
VSTD-McCulloch-1983
p17534
sg12
S'PMC1550062'
p17535
sasa(dp17536
g3
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p17537
sg5
(lp17538
(dp17539
g8
V18802161.xml
p17540
sg10
VSTD-Ell-2008
p17541
sg12
S'PMC2653113'
p17542
sa(dp17543
g8
V17504586.xml
p17544
sg10
VSTD-Chew_x002d_Graham-2007
p17545
sg12
S'PMC2047010'
p17546
sa(dp17547
g8
V16330624.xml
p17548
sg10
VSTD-Cole-2006
p17549
sg12
S'PMC1319344'
p17550
sa(dp17551
g8
V22032247.xml
p17552
sg10
VSTD-Chaney-2011
p17553
sg12
S'PMC3219630'
p17554
sa(dp17555
g8
V21384219.xml
p17556
sg10
VSTD-Simon-2011
p17557
sg12
S'PMC3138593'
p17558
sa(dp17559
g8
V20123819.xml
p17560
sg10
VSTD-Vera-2010
p17561
sg12
S'PMC2900833'
p17562
sa(dp17563
g8
V17804354.xml
p17564
sg10
VSTD-Ell-2007
p17565
sg12
S'PMC1986637'
p17566
sa(dp17567
g8
V19734392.xml
p17568
sg10
VSTD-Gjerdingen-2009
p17569
sg12
S'PMC2791714'
p17570
sa(dp17571
g8
V20805900.xml
p17572
sg10
VSTD-Hilty-2007
p17573
sg12
S'PMC2922348'
p17574
sa(dp17575
g8
V12534758.xml
p17576
sg10
VSTD-Hedrick-2003
p17577
sg12
S'PMC1494801'
p17578
sa(dp17579
g8
V20040705.xml
p17580
sg10
VSTD-Bogner-2010
p17581
sg12
S'PMC2858776'
p17582
sa(dp17583
g8
V17338822.xml
p17584
sg10
VSTD-Landis-2007
p17585
sg12
S'PMC1838423'
p17586
sa(dp17587
g8
V21478777.xml
p17588
sg10
VSTD-Piette-2011
p17589
sg12
S'PMC3117978'
p17590
sa(dp17591
g8
V17492326.xml
p17592
sg10
VSTD-Fortney-2007
p17593
sg12
S'PMC2305730'
p17594
sa(dp17595
g8
V20628129.xml
p17596
sg10
VSTD-Kroenke-2010
p17597
sg12
S'PMC3010214'
p17598
sa(dp17599
g8
V10688563.xml
p17600
sg10
VSTD-Simon-2000a
p17601
sg12
S'PMC27299'
p17602
sa(dp17603
g8
V10688563.xml
p17604
sg10
VSTD-Simon-2000b
p17605
sg12
S'PMC27299'
p17606
sa(dp17607
g8
V12236381.xml
p17608
sg10
VSTD-Rubenstein-2002
p17609
sg12
S'PMC1464007'
p17610
sa(dp17611
g8
V15345600.xml
p17612
sg10
VSTD-Dietrich-2004
p17613
sg12
S'PMC516659'
p17614
sa(dp17615
g8
V9604408.xml
p17616
sg10
VSTD-Mann-1998
p17617
sg12
S'PMC1409896'
p17618
sa(dp17619
g8
V19918088.xml
p17620
sg10
VSTD-Rollman-2009
p17621
sg12
S'PMC3010227'
p17622
sa(dp17623
g8
V19832996.xml
p17624
sg10
VSTD-Richards-2012
p17625
sg12
S'PMC2770465'
p17626
sa(dp17627
g8
V20483968.xml
p17628
sg10
VSTD-Roy_x002d_Byrne-2010
p17629
sg12
S'PMC2928714'
p17630
sa(dp17631
g8
V12399343.xml
p17632
sg10
VSTD-Rost-2001a
p17633
sg12
S'PMC130058'
p17634
sa(dp17635
g8
V20882400.xml
p17636
sg10
VSTD-Waitzkin-2011
p17637
sg12
S'PMC3051073'
p17638
sa(dp17639
g8
V20684786.xml
p17640
sg10
VSTD-Buszewicz-2010
p17641
sg12
S'PMC2923105'
p17642
sa(dp17643
g8
V17976288.xml
p17644
sg10
VSTD-McMahon-2007
p17645
sg12
S'PMC2169311'
p17646
sa(dp17647
g8
V15753242.xml
p17648
sg10
VSTD-Roy_x002d_Byrne-2005
p17649
sg12
S'PMC1237029'
p17650
sa(dp17651
g8
V20966373.xml
p17652
sg10
VSTD-Yeung-2010
p17653
sg12
S'PMC2978195'
p17654
sa(dp17655
g8
V18626028.xml
p17656
sg10
VSTD-Bogner-2008
p17657
sg12
S'PMC2478504'
p17658
sa(dp17659
g8
V21190455.xml
p17660
sg10
VSTD-Katon-2010
p17661
sg12
S'PMC3312811'
p17662
sa(dp17663
g8
V20097780.xml
p17664
sg10
VSTD-Ell-2010
p17665
sg12
S'PMC2845010'
p17666
sa(dp17667
g8
V18498013.xml
p17668
sg10
VSTD-Ross-2008
p17669
sg12
S'PMC2518035'
p17670
sasa(dp17671
g3
VCD004122 v. 8.2 Preoperative hair removal to reduce surgical site infection.rm5
p17672
sg5
(lp17673
(dp17674
g8
V791444.xml
p17675
sg10
VSTD-Powis-1976
p17676
sg12
S'PMC1689580'
p17677
sasa(dp17678
g3
VCD002986 v. 10.0 Ionisers for chronic asthma.rm5
p17679
sg5
(lp17680
(dp17681
g8
V6351332.xml
p17682
sg10
VSTD-Ben_x002d_Dov-1983
p17683
sg12
S'PMC459615'
p17684
sa(dp17685
g8
V6474386.xml
p17686
sg10
VSTD-Lipin-1984
p17687
sg12
S'PMC1020511'
p17688
sa(dp17689
g8
V6364442.xml
p17690
sg10
VSTD-Nogrady-1983
p17691
sg12
S'PMC459697'
p17692
sa(dp17693
g8
V8511730.xml
p17694
sg10
VSTD-Warner-1993
p17695
sg12
S'PMC464427'
p17696
sasa(dp17697
g3
VCD007302 v. 4.0 Vigabatrin for refractory partial epilepsy.rm5
p17698
sg5
(lp17699
(dp17700
g8
V8089668.xml
p17701
sg10
VSTD-Grunewald-1994
p17702
sg12
S'PMC1073126'
p17703
sasa(dp17704
g3
VCD000254 v. 14.2 Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degen.rm5
p17705
sg5
(lp17706
(dp17707
g8
V11594942.xml
p17708
sg10
VSTD-AREDS
p17709
sg12
S'PMC1462955'
p17710
sasa(dp17711
g3
VCD001191 v. 16.4 Rivastigmine for Alzheimer's disease.rm5
p17712
sg5
(lp17713
(dp17714
g8
V23341737.xml
p17715
sg10
VSTD-Lopez_x002d_Pousa-2005
p17716
sg12
S'PMC3546803'
p17717
sa(dp17718
g8
V17353259.xml
p17719
sg10
VSTD-B304
p17720
sg12
S'PMC2117538'
p17721
sa(dp17722
g8
V15722369.xml
p17723
sg10
VSTD-Ballard-2005
p17724
sg12
S'PMC556156'
p17725
sasa(dp17726
g3
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p17727
sg5
(lp17728
(dp17729
g8
V20640118.xml
p17730
sg10
VSTD-Saxena-2009
p17731
sg12
S'PMC2900101'
p17732
sasa(dp17733
g3
VCD002733 v. 10.0 Influenza vaccine for patients with chronic obstructive pulmonary disease.rm5
p17734
sg5
(lp17735
(dp17736
g8
V8241913.xml
p17737
sg10
VSTD-Govaert-1993
p17738
sg12
S'PMC1679213'
p17739
sasa(dp17740
g3
VCD004177 v. 6.0 Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.rm5
p17741
sg5
(lp17742
(dp17743
g8
V10333832.xml
p17744
sg10
VSTD-Ginsberg-1999
p17745
sg12
S'PMC1230312'
p17746
sasa(dp17747
g3
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p17748
sg5
(lp17749
(dp17750
g8
V786190.xml
p17751
sg10
VSTD-Schumer-1976
p17752
sg12
S'PMC1344393'
p17753
sa(dp17754
g8
V12133187.xml
p17755
sg10
VSTD-Yildiz-2002
p17756
sg12
S'PMC125315'
p17757
sasa(dp17758
g3
VCD008422 v. 2.0 Vitamin D for the management of multiple sclerosis.rm5
p17759
sg5
(lp17760
(dp17761
g8
V20427749.xml
p17762
sg10
VSTD-Burton-2010
p17763
sg12
S'PMC2882221'
p17764
sasa(dp17765
g3
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p17766
sg5
(lp17767
(dp17768
g8
V19793473.xml
p17769
sg10
VSTD-Uludag-2009
p17770
sg12
S'PMC3015970'
p17771
sa(dp17772
g8
V11103159.xml
p17773
sg10
VSTD-Harling-2000
p17774
sg12
S'PMC2503474'
p17775
sasa(dp17776
g3
VCD002307 v. 8.2 Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.rm5
p17777
sg5
(lp17778
(dp17779
g8
V821168.xml
p17780
sg10
VSTD-Godfrey-1976
p17781
sg12
S'PMC470375'
p17782
sa(dp17783
g8
V6218645.xml
p17784
sg10
VSTD-Tullett-1982
p17785
sg12
S'PMC459417'
p17786
sa(dp17787
g8
V6797085.xml
p17788
sg10
VSTD-Neijens-1981a
p17789
sg12
S'PMC1020434'
p17790
sa(dp17791
g8
V154747.xml
p17792
sg10
VSTD-Thompson-1978
p17793
sg12
S'PMC470965'
p17794
sasa(dp17795
g3
VCD007504 v. 4.0 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolesc.rm5
p17796
sg5
(lp17797
(dp17798
g8
V20478877.xml
p17799
sg10
VSTD-TORDIA
p17800
sg12
S'PMC3257891'
p17801
sa(dp17802
g8
V18391133.xml
p17803
sg10
VSTD-TADS
p17804
sg12
S'PMC2587406'
p17805
sa(dp17806
g8
V18281410.xml
p17807
sg10
VSTD-Emslie-2008
p17808
sg12
S'PMC2824429'
p17809
sa(dp17810
g8
V18978634.xml
p17811
sg10
VSTD-Kennard-2008
p17812
sg12
S'PMC2826176'
p17813
sasa(dp17814
g3
VCD008175 v. 1.2 Vitamin D compounds for people with chronic kidney disease not requiring dialysis.rm5
p17815
sg5
(lp17816
(dp17817
g8
V7677827.xml
p17818
sg10
VSTD-Hamdy-1995
p17819
sg12
S'PMC2548761'
p17820
sasa(dp17821
g3
VCD004407 v. 8.2 Vaccines for measles mumps and rubella in children.rm5
p17822
sg5
(lp17823
(dp17824
g8
V15723921.xml
p17825
sg10
VSTD-Miller-2005
p17826
sg12
S'PMC1720314'
p17827
sa(dp17828
g8
V15908618.xml
p17829
sg10
VSTD-Bremner-2005
p17830
sg12
S'PMC1720414'
p17831
sa(dp17832
g8
V1586818.xml
p17833
sg10
VSTD-Benjamin-1992
p17834
sg12
S'PMC1881909'
p17835
sa(dp17836
g8
V10435956.xml
p17837
sg10
VSTD-Schlegel-1999
p17838
sg12
S'PMC32261'
p17839
sa(dp17840
g8
V16834879.xml
p17841
sg10
VSTD-Mackenzie-2006
p17842
sg12
S'PMC1872063'
p17843
sa(dp17844
g8
V15249303.xml
p17845
sg10
VSTD-McKeever-2004
p17846
sg12
S'PMC1448377'
p17847
sa(dp17848
g8
V3291787.xml
p17849
sg10
VSTD-Robertson-1988
p17850
sg12
S'PMC1778844'
p17851
sa(dp17852
g8
V8242506.xml
p17853
sg10
VSTD-Freeman-1993
p17854
sg12
S'PMC1485961'
p17855
sa(dp17856
g8
V12534647.xml
p17857
sg10
VSTD-Black-2003
p17858
sg12
S'PMC1884189'
p17859
sa(dp17860
g8
V15837703.xml
p17861
sg10
VSTD-Seagroatt-2005
p17862
sg12
S'PMC557892'
p17863
sasa(dp17864
g3
VCD000967 v. 13.0 Quetiapine for schizophrenia.rm5
p17865
sg5
(lp17866
(dp17867
g8
V11291531.xml
p17868
sg10
VSTD-Canada-2000
p17869
sg12
S'PMC1407745'
p17870
sasa(dp17871
g3
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p17872
sg5
(lp17873
(dp17874
g8
V19954550.xml
p17875
sg10
VSTD-Spittle-2009a
p17876
sg12
S'PMC2797495'
p17877
sa(dp17878
g8
V9797618.xml
p17879
sg10
VSTD-APIP-1998
p17880
sg12
S'PMC1720827'
p17881
sasa(dp17882
g3
VCD001534 v. 10.0 Long-term antibiotics for preventing recurrent urinary tract infection in children.rm5
p17883
sg5
(lp17884
(dp17885
g8
V1095132.xml
p17886
sg10
VSTD-Stansfeld-1975
p17887
sg12
S'PMC1673626'
p17888
sasa(dp17889
g3
VCD002886 v. 4.0 Corticosteroids for hospitalised children with acute asthma.rm5
p17890
sg5
(lp17891
(dp17892
g8
V8135557.xml
p17893
sg10
VSTD-Connett-1994
p17894
sg12
S'PMC1029734'
p17895
sasa(dp17896
g3
VCD000279 v. 7.0 Strategies for detecting colon cancer andor dysplasia in patients with inflammatory bowel disease.rm5
p17897
sg5
(lp17898
(dp17899
g8
V9659169.xml
p17900
sg10
VSTD-Karlen-1998a
p17901
sg12
S'PMC1727094'
p17902
sasa(dp17903
g3
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p17904
sg5
(lp17905
(dp17906
g8
V19171056.xml
p17907
sg10
VSTD-Taniguchi-2009
p17908
sg12
S'PMC2688118'
p17909
sasa(dp17910
g3
VCD006480 v. 4.0 Mono and multifaceted inhalant andor food allergen reduction interventions for preventing asthma in.rm5
p17911
sg5
(lp17912
(dp17913
g8
V12775858.xml
p17914
sg10
VSTD-Isle-of-Wight-2003
p17915
sg12
S'PMC1746711'
p17916
sasa(dp17917
g3
VCD003177 v. 5.0 Omega 3 fatty acids for prevention and treatment of cardiovascular disease.rm5
p17918
sg5
(lp17919
(dp17920
g8
V4469034.xml
p17921
sg10
VSTD-zLondon-Kingsbury-94
p17922
sg12
S'PMC2495782'
p17923
sa(dp17924
g8
V6812744.xml
p17925
sg10
VSTD-zFinnish-Miettinen
p17926
sg12
S'PMC1500325'
p17927
sa(dp17928
g8
V1353742.xml
p17929
sg10
VSTD-Hawthorne-1992
p17930
sg12
S'PMC1379405'
p17931
sasa(dp17932
g3
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p17933
sg5
(lp17934
(dp17935
g8
V17629923.xml
p17936
sg10
VSTD-Houghton-2007
p17937
sg12
S'PMC1971055'
p17938
sa(dp17939
g8
V16449264.xml
p17940
sg10
VSTD-Koopmans-2006
p17941
sg12
S'PMC2104614'
p17942
sa(dp17943
g8
V12200524.xml
p17944
sg10
VSTD-Price-2002
p17945
sg12
S'PMC1746437'
p17946
sa(dp17947
g8
V9227720.xml
p17948
sg10
VSTD-van-der-Molen-1997
p17949
sg12
S'PMC1758577'
p17950
sa(dp17951
g8
V10373134.xml
p17952
sg10
VSTD-Akpinarli-1999
p17953
sg12
S'PMC1717973'
p17954
sasa(dp17955
g3
VCD007886 v. 2.0 Energy source instruments for laparoscopic colectomy.rm5
p17956
sg5
(lp17957
(dp17958
g8
V16327500.xml
p17959
sg10
VSTD-Morino-2005
p17960
sg12
S'PMC1409879'
p17961
sasa(dp17962
g3
VCD001955 v. 11.6 Glucocorticoids for croup.rm5
p17963
sg5
(lp17964
(dp17965
g8
V5324105.xml
p17966
sg10
VSTD-Skowron-1966-A_x0026_B
p17967
sg12
S'PMC1936541'
p17968
sa(dp17969
g8
V8466237.xml
p17970
sg10
VSTD-Husby-1993
p17971
sg12
S'PMC1793858'
p17972
sa(dp17973
g8
V16624882.xml
p17974
sg10
VSTD-Sparrow--2006
p17975
sg12
S'PMC2082835'
p17976
sa(dp17977
g8
V9068309.xml
p17978
sg10
VSTD-Godden-1997
p17979
sg12
S'PMC1717068'
p17980
sa(dp17981
g8
V8688774.xml
p17982
sg10
VSTD-Geelhoed-1996a
p17983
sg12
S'PMC2351559'
p17984
sa(dp17985
g8
V5324105.xml
p17986
sg10
VSTD-Skowron-1966a
p17987
sg12
S'PMC1936541'
p17988
sa(dp17989
g8
V5324105.xml
p17990
sg10
VSTD-Skowron-1966b
p17991
sg12
S'PMC1936541'
p17992
sasa(dp17993
g3
VCD003146 v. 9.0 Blood transfusion for preventing stroke in people with sickle cell disease.rm5
p17994
sg5
(lp17995
(dp17996
g8
V17243135.xml
p17997
sg10
VSTD-STOP-2-2005
p17998
sg12
S'PMC2867598'
p17999
sasa(dp18000
g3
VCD005428 v. 6.0 Antibiotic prophylaxis for short-term catheter bladder drainage in adults.rm5
p18001
sg5
(lp18002
(dp18003
g8
V848927.xml
p18004
sg10
VSTD-Britt-1977
p18005
sg12
S'PMC351960'
p18006
sasa(dp18007
g3
VCD004096 v. 4.0 Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.rm5
p18008
sg5
(lp18009
(dp18010
g8
V12236844.xml
p18011
sg10
VSTD-Wise-1989
p18012
sg12
S'PMC1874432'
p18013
sasa(dp18014
g3
VCD007491 v. 5.2 Hospital at home admission avoidance.rm5
p18015
sg5
(lp18016
(dp18017
g8
V11082090.xml
p18018
sg10
VSTD-Davies-2000
p18019
sg12
S'PMC27532'
p18020
sa(dp18021
g8
V10591717.xml
p18022
sg10
VSTD-Wilson-1999
p18023
sg12
S'PMC28299'
p18024
sa(dp18025
g8
V15604157.xml
p18026
sg10
VSTD-Corwin-2005
p18027
sg12
S'PMC544431'
p18028
sasa(dp18029
g3
VCD001247 v. 7.3 Cooling therapy for acute stroke.rm5
p18030
sg5
(lp18031
(dp18032
g8
V11918829.xml
p18033
sg10
VSTD-Dippel-2003a
p18034
sg12
S'PMC101394'
p18035
sasa(dp18036
g3
VCD004963 v. 6.0 Exercise for improving balance in older people.rm5
p18037
sg5
(lp18038
(dp18039
g8
V9366737.xml
p18040
sg10
VSTD-Campbell--1997
p18041
sg12
S'PMC2127698'
p18042
sasa(dp18043
g3
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p18044
sg5
(lp18045
(dp18046
g8
V2540788.xml
p18047
sg10
VSTD-Spiro-1989
p18048
sg12
S'PMC2247136'
p18049
sasa(dp18050
g3
VCD008862 v. 3.0 Repetitive transcranial magnetic stimulation for improving function after stroke.rm5
p18051
sg5
(lp18052
(dp18053
g8
V17709994.xml
p18054
sg10
VSTD-Malcolm-2006
p18055
sg12
S'PMC2605430'
p18056
sasa(dp18057
g3
VCD003415 v. 8.0 Progesterone for premenstrual syndrome.rm5
p18058
sg5
(lp18059
(dp18060
g8
V8554838.xml
p18061
sg10
VSTD-Magill-1995
p18062
sg12
S'PMC1239433'
p18063
sasa(dp18064
g3
VCD006321 v. 3.0 Human growth hormone and glutamine for patients with short bowel syndrome.rm5
p18065
sg5
(lp18066
(dp18067
g8
V16244538.xml
p18068
sg10
VSTD-Byrne-2005
p18069
sg12
S'PMC1409868'
p18070
sa(dp18071
g8
V8998124.xml
p18072
sg10
VSTD-Elleg_x00e5_rd-1997
p18073
sg12
S'PMC1190610'
p18074
sa(dp18075
g8
V10896910.xml
p18076
sg10
VSTD-Szkudlarek-2000
p18077
sg12
S'PMC1727998'
p18078
sasa(dp18079
g3
VCD001832 v. 9.0 Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningi.rm5
p18080
sg5
(lp18081
(dp18082
g8
V6322681.xml
p18083
sg10
VSTD-Congeni-1984
p18084
sg12
S'PMC185431'
p18085
sa(dp18086
g8
V4073858.xml
p18087
sg10
VSTD-Bryan-1985
p18088
sg12
S'PMC180254'
p18089
sasa(dp18090
g3
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p18091
sg5
(lp18092
(dp18093
g8
V17285226.xml
p18094
sg10
VSTD-Wintzen-2007
p18095
sg12
S'PMC1915648'
p18096
sasa(dp18097
g3
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p18098
sg5
(lp18099
(dp18100
g8
V18556683.xml
p18101
sg10
VSTD-Koninckx-2008
p18102
sg12
S'PMC2517154'
p18103
sasa(dp18104
g3
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p18105
sg5
(lp18106
(dp18107
g8
V21062666.xml
p18108
sg10
VSTD-Dondorp-2010
p18109
sg12
S'PMC3033534'
p18110
sasa(dp18111
g3
VCD008880 v. 3.0 Spinal manipulative therapy for acute low-back pain.rm5
p18112
sg5
(lp18113
(dp18114
g8
V4274488.xml
p18115
sg10
VSTD-Glover-1974
p18116
sg12
S'PMC1009544'
p18117
sa(dp18118
g8
V9883955.xml
p18119
sg10
VSTD-Seferlis-1998
p18120
sg12
S'PMC3611294'
p18121
sasa(dp18122
g3
VCD006231 v. 2.0 Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p18123
sg5
(lp18124
(dp18125
g8
V7618966.xml
p18126
sg10
VSTD-Essen-1995
p18127
sg12
S'PMC1234752'
p18128
sasa(dp18129
g3
VCD007629 v. 1.2 Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion.rm5
p18130
sg5
(lp18131
(dp18132
g8
V14631221.xml
p18133
sg10
VSTD-Clavien-2003
p18134
sg12
S'PMC1356166'
p18135
sasa(dp18136
g3
VCD005070 v. 5.0 Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproducti.rm5
p18137
sg5
(lp18138
(dp18139
g8
V11464575.xml
p18140
sg10
VSTD-Balasch-2001
p18141
sg12
S'PMC3455335'
p18142
sasa(dp18143
g3
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p18144
sg5
(lp18145
(dp18146
g8
V18213383.xml
p18147
sg10
VSTD-De-Jong-2008
p18148
sg12
S'PMC2194921'
p18149
sasa(dp18150
g3
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p18151
sg5
(lp18152
(dp18153
g8
V17309791.xml
p18154
sg10
VSTD-Amirabdollahian-2007
p18155
sg12
S'PMC1819386'
p18156
sa(dp18157
g8
V16790067.xml
p18158
sg10
VSTD-Kahn-2006
p18159
sg12
S'PMC1550245'
p18160
sasa(dp18161
g3
VCD005493 v. 7.10 Botulinum toxin injections for adults with overactive bladder syndrome.rm5
p18162
sg5
(lp18163
(dp18164
g8
V19375091.xml
p18165
sg10
VSTD-Flynn-2009
p18166
sg12
S'PMC2730562'
p18167
sa(dp18168
g8
V18499184.xml
p18169
sg10
VSTD-Brubaker-2008
p18170
sg12
S'PMC2597793'
p18171
sasa(dp18172
g3
VCD007224 v. 3.0 Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease.rm5
p18173
sg5
(lp18174
(dp18175
g8
V19185140.xml
p18176
sg10
VSTD-BHACAS-I-_x002b_II-2002
p18177
sg12
S'PMC2836483'
p18178
sa(dp18179
g8
V12458242.xml
p18180
sg10
VSTD-Zamvar-2002
p18181
sg12
S'PMC136922'
p18182
sa(dp18183
g8
V19641693.xml
p18184
sg10
VSTD-Gasz-2004
p18185
sg12
S'PMC2716259'
p18186
sa(dp18187
g8
V16740529.xml
p18188
sg10
VSTD-Al_x002d_Ruzzeh-2006
p18189
sg12
S'PMC1476725'
p18190
sasa(dp18191
g3
VCD004136 v. 12.2 Antihypertensive agents for preventing diabetic kidney disease.rm5
p18192
sg5
(lp18193
(dp18194
g8
V19571282.xml
p18195
sg10
VSTD-RASS-Study-2002
p18196
sg12
S'PMC2978030'
p18197
sa(dp18198
g8
V9732338.xml
p18199
sg10
VSTD-UKPDS-Study-1998
p18200
sg12
S'PMC28660'
p18201
sa(dp18202
g8
V19225038.xml
p18203
sg10
VSTD-ADVANCE-Study-2009
p18204
sg12
S'PMC2663832'
p18205
sasa(dp18206
g3
VCD008536 v. 3.3 Short and long term effects of tibolone in postmenopausal women.rm5
p18207
sg5
(lp18208
(dp18209
g8
V18703472.xml
p18210
sg10
VSTD-Cummings-2008
p18211
sg12
S'PMC3684062'
p18212
sa(dp18213
g8
V23926488.xml
p18214
sg10
VSTD-Ziaei-2010a
p18215
sg12
S'PMC3719303'
p18216
sasa(dp18217
g3
VCD006973 v. 3.0 Interventions for increasing ankle range of motion in patients with neuromuscular disease.rm5
p18218
sg5
(lp18219
(dp18220
g8
V18822155.xml
p18221
sg10
VSTD-Redmond-2004
p18222
sg12
S'PMC2553778'
p18223
sasa(dp18224
g3
VCD002199 v. 13.0 Operative procedures for fissure in ano.rm5
p18225
sg5
(lp18226
(dp18227
g8
V23449341.xml
p18228
sg10
VSTD-Ellis-2004
p18229
sg12
S'PMC3348733'
p18230
sa(dp18231
g8
V6432173.xml
p18232
sg10
VSTD-Jensen-1984
p18233
sg12
S'PMC1442742'
p18234
sasa(dp18235
g3
VCD007139 v. 3.0 Alprazolam for depression.rm5
p18236
sg5
(lp18237
(dp18238
g8
V21897464.xml
p18239
sg10
VSTD-Murthy-1991
p18240
sg12
S'PMC2988295'
p18241
sasa(dp18242
g3
VCD001983 v. 7.0 Calcitonin for preventing and treating corticosteroid-induced osteoporosis.rm5
p18243
sg5
(lp18244
(dp18245
g8
V7831624.xml
p18246
sg10
VSTD-Luengo-1994
p18247
sg12
S'PMC475269'
p18248
sasa(dp18249
g3
VCD004429 v. 4.0 Intravenous immunoglobulin for multifocal motor neuropathy.rm5
p18250
sg5
(lp18251
(dp18252
g8
V7673950.xml
p18253
sg10
VSTD-van-den-Berg-1995a
p18254
sg12
S'PMC486021'
p18255
sasa(dp18256
g3
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p18257
sg5
(lp18258
(dp18259
g8
V1929610.xml
p18260
sg10
VSTD-Berlauk-1991
p18261
sg12
S'PMC1358649'
p18262
sa(dp18263
g8
V20698956.xml
p18264
sg10
VSTD-Jhanji-2010
p18265
sg12
S'PMC2945135'
p18266
sa(dp18267
g8
V15242867.xml
p18268
sg10
VSTD-Mckendry-2004
p18269
sg12
S'PMC498021'
p18270
sa(dp18271
g8
V9361539.xml
p18272
sg10
VSTD-Sinclair-1997
p18273
sg12
S'PMC2127619'
p18274
sa(dp18275
g8
V10213716.xml
p18276
sg10
VSTD-Wilson-1999
p18277
sg12
S'PMC27840'
p18278
sa(dp18279
g8
V21624138.xml
p18280
sg10
VSTD-Cecconi-2011
p18281
sg12
S'PMC3218998'
p18282
sa(dp18283
g8
V16356219.xml
p18284
sg10
VSTD-Pearse-2005
p18285
sg12
S'PMC1414018'
p18286
sa(dp18287
g8
V9339929.xml
p18288
sg10
VSTD-Bender-1997
p18289
sg12
S'PMC1191013'
p18290
sa(dp18291
g8
V20156348.xml
p18292
sg10
VSTD-Mayer-2010
p18293
sg12
S'PMC2875533'
p18294
sasa(dp18295
g3
VCD000253 v. 17.6 Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.rm5
p18296
sg5
(lp18297
(dp18298
g8
V17353403.xml
p18299
sg10
VSTD-PHS-I
p18300
sg12
S'PMC1821351'
p18301
sasa(dp18302
g3
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p18303
sg5
(lp18304
(dp18305
g8
V8911291.xml
p18306
sg10
VSTD-PROSPECT-1996
p18307
sg12
S'PMC1335066'
p18308
sa(dp18309
g8
V9703292.xml
p18310
sg10
VSTD-Cote-1998
p18311
sg12
S'PMC2063039'
p18312
sasa(dp18313
g3
VCD006442 v. 2.2 Psychological treatments for the management of irritable bowel syndrome.rm5
p18314
sg5
(lp18315
(dp18316
g8
V16093252.xml
p18317
sg10
VSTD-Kennedy-2005
p18318
sg12
S'PMC1188111'
p18319
sasa(dp18320
g3
VCD010067 v. 2.5 Slum upgrading strategies involving physical environment and infrastructure interventions and their .rm5
p18321
sg5
(lp18322
(dp18323
g8
V24027373.xml
p18324
sg10
VSTD-Joshi-2002
p18325
sg12
S'PMC3770113'
p18326
sasa(dp18327
g3
VCD006885 v. 4.0 Intravesical Bacillus Calmette-Gurin versus epirubicin for Ta and T1 bladder cancer.rm5
p18328
sg5
(lp18329
(dp18330
g8
V20034729.xml
p18331
sg10
VSTD-Sylvester-2010
p18332
sg12
S'PMC2889174'
p18333
sasa(dp18334
g3
VCD007431 v. 4.0 Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain.rm5
p18335
sg5
(lp18336
(dp18337
g8
V11971050.xml
p18338
sg10
VSTD-Vroomen-2002-_x0028_prim-care_x0029_
p18339
sg12
S'PMC1737860'
p18340
sa(dp18341
g8
V11931063.xml
p18342
sg10
VSTD-Demircan-2002
p18343
sg12
S'PMC3610488'
p18344
sa(dp18345
g8
V3346682.xml
p18346
sg10
VSTD-Kerr-1988
p18347
sg12
S'PMC1031525'
p18348
sasa(dp18349
g3
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p18350
sg5
(lp18351
(dp18352
g8
V17372796.xml
p18353
sg10
VSTD-Unrod-2007
p18354
sg12
S'PMC1829425'
p18355
sa(dp18356
g8
V3812837.xml
p18357
sg10
VSTD-Cohen-_x0028_Doc_x0029_-1989
p18358
sg12
S'PMC1646917'
p18359
sa(dp18360
g8
V20466951.xml
p18361
sg10
VSTD-Gordon-2010
p18362
sg12
S'PMC2882418'
p18363
sa(dp18364
g8
V9825420.xml
p18365
sg10
VSTD-Sinclair-1998
p18366
sg12
S'PMC1763872'
p18367
sa(dp18368
g8
V17707898.xml
p18369
sg10
VSTD-Hymowitz-2007
p18370
sg12
S'PMC2258138'
p18371
sa(dp18372
g8
V17297068.xml
p18373
sg10
VSTD-Twardella-2007
p18374
sg12
S'PMC2598437'
p18375
sasa(dp18376
g3
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p18377
sg5
(lp18378
(dp18379
g8
V12213183.xml
p18380
sg10
VSTD-Clifford-2002
p18381
sg12
S'PMC126226'
p18382
sasa(dp18383
g3
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p18384
sg5
(lp18385
(dp18386
g8
V20003224.xml
p18387
sg10
VSTD-Leehey-2009
p18388
sg12
S'PMC2796994'
p18389
sa(dp18390
g8
V20100734.xml
p18391
sg10
VSTD-Chen-2010
p18392
sg12
S'PMC2902890'
p18393
sasa(dp18394
g3
VCD003897 v. 11.0 Interleukin 2 receptor antagonists for kidney transplant recipients.rm5
p18395
sg5
(lp18396
(dp18397
g8
V19470677.xml
p18398
sg10
VSTD-Noel-2009
p18399
sg12
S'PMC2689909'
p18400
sasa(dp18401
g3
VCD000531 v. 4.5 Target payments in primary care effects on professional practice and health care outcomes.rm5
p18402
sg5
(lp18403
(dp18404
g8
V1392710.xml
p18405
sg10
VSTD-Ritchie-1992
p18406
sg12
S'PMC1881680'
p18407
sasa(dp18408
g3
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p18409
sg5
(lp18410
(dp18411
g8
V15313991.xml
p18412
sg10
VSTD-Bookman-2004
p18413
sg12
S'PMC509045'
p18414
sa(dp18415
g8
V16086839.xml
p18416
sg10
VSTD-Baer-2005
p18417
sg12
S'PMC1201146'
p18418
sa(dp18419
g8
V17363401.xml
p18420
sg10
VSTD-Roth-2004
p18421
sg12
S'PMC1955127'
p18422
sasa(dp18423
g3
VCD005181 v. 8.2 Interferon beta for secondary progressive multiple sclerosis.rm5
p18424
sg5
(lp18425
(dp18426
g8
V15090564.xml
p18427
sg10
VSTD-Andersen-2004-_x0028_Nordic_x0029_
p18428
sg12
S'PMC1763573'
p18429
sasa(dp18430
g3
VCD002314 v. 5.0 Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent andor ch.rm5
p18431
sg5
(lp18432
(dp18433
g8
V17204725.xml
p18434
sg10
VSTD-Lazarus-2007
p18435
sg12
S'PMC1899291'
p18436
sa(dp18437
g8
V15681495.xml
p18438
sg10
VSTD-Jayaram-2005
p18439
sg12
S'PMC1747311'
p18440
sasa(dp18441
g3
VCD002752 v. 9.0 Clinical service organisation for heart failure.rm5
p18442
sg5
(lp18443
(dp18444
g8
V15997043.xml
p18445
sg10
VSTD-Ducharme-2005
p18446
sg12
S'PMC1167811'
p18447
sa(dp18448
g8
V9930041.xml
p18449
sg10
VSTD-Cline-1998
p18450
sg12
S'PMC1728835'
p18451
sa(dp18452
g8
V15310688.xml
p18453
sg10
VSTD-Mejhert-2004
p18454
sg12
S'PMC1768467'
p18455
sa(dp18456
g8
V11576977.xml
p18457
sg10
VSTD-Blue-2001
p18458
sg12
S'PMC56888'
p18459
sa(dp18460
g8
V17452390.xml
p18461
sg10
VSTD-Holland-2007
p18462
sg12
S'PMC1877883'
p18463
sasa(dp18464
g3
VCD003082 v. 12.0 Haloperidol versus placebo for schizophrenia.rm5
p18465
sg5
(lp18466
(dp18467
g8
V24019874.xml
p18468
sg10
VSTD-Howard-1974
p18469
sg12
S'PMC3760896'
p18470
sasa(dp18471
g3
VCD007513 v. 3.0 Circuit class therapy for improving mobility after stroke.rm5
p18472
sg5
(lp18473
(dp18474
g8
V15743283.xml
p18475
sg10
VSTD-Marigold-2005
p18476
sg12
S'PMC3226796'
p18477
sa(dp18478
g8
V16181164.xml
p18479
sg10
VSTD-Pang-2005
p18480
sg12
S'PMC3226792'
p18481
sasa(dp18482
g3
VCD007198 v. 3.3 Information and communication technology in patient education and support for people with schizophre.rm5
p18483
sg5
(lp18484
(dp18485
g8
V23502432.xml
p18486
sg10
VSTD-Valimaki-2010
p18487
sg12
S'PMC3627772'
p18488
sasa(dp18489
g3
VCD003552 v. 9.0 Skin patch and vaginal ring versus combined oral contraceptives for contraception.rm5
p18490
sg5
(lp18491
(dp18492
g8
V18082856.xml
p18493
sg10
VSTD-Stewart-2007
p18494
sg12
S'PMC3163239'
p18495
sasa(dp18496
g3
VCD009231 v. 2.2 Hospital at home home-based end of life care.rm5
p18497
sg5
(lp18498
(dp18499
g8
V1737710.xml
p18500
sg10
VSTD-Hughes-1992
p18501
sg12
S'PMC1069857'
p18502
sasa(dp18503
g3
VCD007160 v. 3.0 Oxygen therapy for acute myocardial infarction.rm5
p18504
sg5
(lp18505
(dp18506
g8
V773507.xml
p18507
sg10
VSTD-Rawles-1976
p18508
sg12
S'PMC1639993'
p18509
sasa(dp18510
g3
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p18511
sg5
(lp18512
(dp18513
g8
V602256.xml
p18514
sg10
VSTD-Cowett-1977
p18515
sg12
S'PMC2595562'
p18516
sa(dp18517
g8
V4783004.xml
p18518
sg10
VSTD-Bard-1973
p18519
sg12
S'PMC1648593'
p18520
sasa(dp18521
g3
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p18522
sg5
(lp18523
(dp18524
g8
V17513285.xml
p18525
sg10
VSTD-Stepnowsky-2007
p18526
sg12
S'PMC1874716'
p18527
sasa(dp18528
g3
VCD008679 v. 2.0 Follow-up for improving psychological well being for women after a miscarriage.rm5
p18529
sg5
(lp18530
(dp18531
g8
V19630553.xml
p18532
sg10
VSTD-Swanson-2009
p18533
sg12
S'PMC2825726'
p18534
sasa(dp18535
g3
VCD002739 v. 6.0 Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction.rm5
p18536
sg5
(lp18537
(dp18538
g8
V1771604.xml
p18539
sg10
VSTD-Vathenen-1991
p18540
sg12
S'PMC1021035'
p18541
sasa(dp18542
g3
VCD008901 v. 2.0 Recombinant growth hormone therapy for cystic fibrosis in children and young adults.rm5
p18543
sg5
(lp18544
(dp18545
g8
V14670773.xml
p18546
sg10
VSTD-Schibler-2003
p18547
sg12
S'PMC1719415'
p18548
sasa(dp18549
g3
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p18550
sg5
(lp18551
(dp18552
g8
V19023429.xml
p18553
sg10
VSTD-Halpern-2008
p18554
sg12
S'PMC2582655'
p18555
sa(dp18556
g8
V18091987.xml
p18557
sg10
VSTD-Peterson-2007
p18558
sg12
S'PMC2129116'
p18559
sa(dp18560
g8
V21330907.xml
p18561
sg10
VSTD-Abdool-Karim-2011
p18562
sg12
S'PMC3083640'
p18563
sa(dp18564
g8
V20643915.xml
p18565
sg10
VSTD-Abdool-Karim-2010
p18566
sg12
S'PMC3001187'
p18567
sa(dp18568
g8
V20851460.xml
p18569
sg10
VSTD-McCormack-2010
p18570
sg12
S'PMC2956883'
p18571
sa(dp18572
g8
V18213382.xml
p18573
sg10
VSTD-Feldblum-2008
p18574
sg12
S'PMC2190795'
p18575
sasa(dp18576
g3
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p18577
sg5
(lp18578
(dp18579
g8
V14735178.xml
p18580
sg10
VSTD-Ahmedzai-2004
p18581
sg12
S'PMC2409543'
p18582
sa(dp18583
g8
V9014795.xml
p18584
sg10
VSTD-Chua-1996
p18585
sg12
S'PMC484598'
p18586
sasa(dp18587
g3
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p18588
sg5
(lp18589
(dp18590
g8
V18096042.xml
p18591
sg10
VSTD-Innes-2007
p18592
sg12
S'PMC2265270'
p18593
sasa(dp18594
g3
VCD000326 v. 6.0 Educational interventions for asthma in children.rm5
p18595
sg5
(lp18596
(dp18597
g8
V9093336.xml
p18598
sg10
VSTD-Madge-1997
p18599
sg12
S'PMC1758505'
p18600
sa(dp18601
g8
V1747614.xml
p18602
sg10
VSTD-Hill-1991
p18603
sg12
S'PMC1671468'
p18604
sa(dp18605
g8
V3545094.xml
p18606
sg10
VSTD-Mitchell-1986
p18607
sg12
S'PMC1778203'
p18608
sa(dp18609
g8
V4037168.xml
p18610
sg10
VSTD-McNabb-1985
p18611
sg12
S'PMC1646372'
p18612
sa(dp18613
g8
V8185365.xml
p18614
sg10
VSTD-Charlton-1994
p18615
sg12
S'PMC1029785'
p18616
sa(dp18617
g8
V2293801.xml
p18618
sg10
VSTD-Shields-1990
p18619
sg12
S'PMC1404528'
p18620
sasa(dp18621
g3
VMR000016 v. 7.0 Editorial peer review for improving the quality of reports of biomedical studies.rm5
p18622
sg5
(lp18623
(dp18624
g8
V10844878.xml
p18625
sg10
VSTD-Resch-2000
p18626
sg12
S'PMC1297969'
p18627
sa(dp18628
g8
V9872878.xml
p18629
sg10
VSTD-van-Rooyen-1999
p18630
sg12
S'PMC27670'
p18631
sa(dp18632
g8
V8883984.xml
p18633
sg10
VSTD-Weller-1996
p18634
sg12
S'PMC226156'
p18635
sa(dp18636
g8
V14996698.xml
p18637
sg10
VSTD-Schroter-2004
p18638
sg12
S'PMC381220'
p18639
sasa(dp18640
g3
VCD003670 v. 9.0 Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mor.rm5
p18641
sg5
(lp18642
(dp18643
g8
V13489318.xml
p18644
sg10
VSTD-Forfar-1958
p18645
sg12
S'PMC2027064'
p18646
sasa(dp18647
g3
VCD008469 v. 3.0 Home-based educational interventions for children with asthma.rm5
p18648
sg5
(lp18649
(dp18650
g8
V3545094.xml
p18651
sg10
VSTD-Mitchell-1986-Europeans
p18652
sg12
S'PMC1778203'
p18653
sa(dp18654
g8
V3545094.xml
p18655
sg10
VSTD-Mitchell-1986-Polynesians
p18656
sg12
S'PMC1778203'
p18657
sa(dp18658
g8
V3545094.xml
p18659
sg10
VSTD-Mitchell-1986
p18660
sg12
S'PMC1778203'
p18661
sa(dp18662
g8
V16754825.xml
p18663
sg10
VSTD-Butz-2006
p18664
sg12
S'PMC2269706'
p18665
sasa(dp18666
g3
VCD004251 v. 9.2 Electrotherapy for neck pain.rm5
p18667
sg5
(lp18668
(dp18669
g8
V12356613.xml
p18670
sg10
VSTD-Hurwitz-2002
p18671
sg12
S'PMC1447299'
p18672
sasa(dp18673
g3
VCD003898 v. 8.10 Inhaled magnesium sulfate in the treatment of acute asthma.rm5
p18674
sg5
(lp18675
(dp18676
g8
V16627836.xml
p18677
sg10
VSTD-Aggarwal-2006
p18678
sg12
S'PMC2564084'
p18679
sasa(dp18680
g3
VCD005043 v. 6.1 Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial wel.rm5
p18681
sg5
(lp18682
(dp18683
g8
V20848241.xml
p18684
sg10
VSTD-Sullivan-1991a
p18685
sg12
S'PMC3032855'
p18686
sasa(dp18687
g3
VCD002305 v. 10.0 Antidepressants for people with both schizophrenia and depression.rm5
p18688
sg5
(lp18689
(dp18690
g8
V18953116.xml
p18691
sg10
VSTD-Becker-1983
p18692
sg12
S'PMC3372084'
p18693
sasa(dp18694
g3
VCD002745 v. 7.2 Amantadine and rimantadine for influenza A in children and the elderly.rm5
p18695
sg5
(lp18696
(dp18697
g8
V6476812.xml
p18698
sg10
VSTD-Patriarca-1984
p18699
sg12
S'PMC179927'
p18700
sa(dp18701
g8
V8619572.xml
p18702
sg10
VSTD-Monto-1995
p18703
sg12
S'PMC162919'
p18704
sasa(dp18705
g3
VCD003073 v. 7.0 Prevention of infection in arterial reconstruction.rm5
p18706
sg5
(lp18707
(dp18708
g8
V6998390.xml
p18709
sg10
VSTD-Pitt-1980
p18710
sg12
S'PMC1344917'
p18711
sa(dp18712
g8
V6375599.xml
p18713
sg10
VSTD-Hasselgren-1984
p18714
sg12
S'PMC1250399'
p18715
sa(dp18716
g8
V3408172.xml
p18717
sg10
VSTD-Earnshaw-1988
p18718
sg12
S'PMC2498719'
p18719
sa(dp18720
g8
V686894.xml
p18721
sg10
VSTD-Kaiser-1978
p18722
sg12
S'PMC1396974'
p18723
sa(dp18724
g8
V6638856.xml
p18725
sg10
VSTD-Chester-1983
p18726
sg12
S'PMC2494433'
p18727
sasa(dp18728
g3
VCD000376 v. 8.0 Longchain polyunsaturated fatty acid supplementation in infants born at term.rm5
p18729
sg5
(lp18730
(dp18731
g8
V9196357.xml
p18732
sg10
VSTD-Milan-1995
p18733
sg12
S'PMC1717175'
p18734
sasa(dp18735
g3
VCD007503 v. 3.0 Antidepressants for depression in physically ill people.rm5
p18736
sg5
(lp18737
(dp18738
g8
V8018452.xml
p18739
sg10
VSTD-Tan-1994
p18740
sg12
S'PMC1364731'
p18741
sa(dp18742
g8
V24058553.xml
p18743
sg10
VSTD-Xue-2004
p18744
sg12
S'PMC3772925'
p18745
sa(dp18746
g8
V19092112.xml
p18747
sg10
VSTD-Menza-2009
p18748
sg12
S'PMC2677475'
p18749
sa(dp18750
g8
V19092112.xml
p18751
sg10
VSTD-Menza-2009-_x0028_paroxetine_x0029_
p18752
sg12
S'PMC2677475'
p18753
sa(dp18754
g8
V19092112.xml
p18755
sg10
VSTD-Menza-2009_x0028_nortriptyline_x0029_
p18756
sg12
S'PMC2677475'
p18757
sa(dp18758
g8
V20679638.xml
p18759
sg10
VSTD-Weintraub-2009
p18760
sg12
S'PMC2918470'
p18761
sasa(dp18762
g3
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p18763
sg5
(lp18764
(dp18765
g8
V20427683.xml
p18766
sg10
VSTD-Londahl-2010
p18767
sg12
S'PMC2858204'
p18768
sasa(dp18769
g3
VCD008738 v. 2.0 Antibiotic prophylaxis for preventing burn wound infection.rm5
p18770
sg5
(lp18771
(dp18772
g8
V15729064.xml
p18773
sg10
VSTD-De-La-Cal-2005
p18774
sg12
S'PMC1356980'
p18775
sasa(dp18776
g3
VCD001814 v. 5.0 Developmental care for promoting development and preventing morbidity in preterm infants.rm5
p18777
sg5
(lp18778
(dp18779
g8
V3096460.xml
p18780
sg10
VSTD-Mann-1986
p18781
sg12
S'PMC1342106'
p18782
sasa(dp18783
g3
VCD006676 v. 4.8 Locomotor training for walking after spinal cord injury.rm5
p18784
sg5
(lp18785
(dp18786
g8
V21051593.xml
p18787
sg10
VSTD-Field_x002d_Fote-2011
p18788
sg12
S'PMC3017322'
p18789
sa(dp18790
g8
V21903010.xml
p18791
sg10
VSTD-Alexeeva-2011
p18792
sg12
S'PMC3152808'
p18793
sasa(dp18794
g3
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p18795
sg5
(lp18796
(dp18797
g8
V18417444.xml
p18798
sg10
VSTD-Nguyen-2008
p18799
sg12
S'PMC2483918'
p18800
sasa(dp18801
g3
VCD005958 v. 6.6 Manual material handling advice and assistive devices for preventing and treating back pain in worke.rm5
p18802
sg5
(lp18803
(dp18804
g8
V15613603.xml
p18805
sg10
VSTD-Hartvigsen-2005
p18806
sg12
S'PMC1740861'
p18807
sasa(dp18808
g3
VCD001921 v. 4.0 Eversion versus conventional carotid endarterectomy for preventing stroke.rm5
p18809
sg5
(lp18810
(dp18811
g8
V10862204.xml
p18812
sg10
VSTD-Ballotta-2000
p18813
sg12
S'PMC1421116'
p18814
sasa(dp18815
g3
VCD004626 v. 10.7 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high.rm5
p18816
sg5
(lp18817
(dp18818
g8
V22022003.xml
p18819
sg10
VSTD-N0265041749
p18820
sg12
S'PMC3195130'
p18821
sasa(dp18822
g3
VCD003248 v. 8.7 Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion .rm5
p18823
sg5
(lp18824
(dp18825
g8
V18194383.xml
p18826
sg10
VSTD-Strauss-2008
p18827
sg12
S'PMC2883857'
p18828
sa(dp18829
g8
V8443480.xml
p18830
sg10
VSTD-Kinmond-1993
p18831
sg12
S'PMC1676623'
p18832
sa(dp18833
g8
V16585320.xml
p18834
sg10
VSTD-Mercer-2006
p18835
sg12
S'PMC1564438'
p18836
sasa(dp18837
g3
VCD001497 v. 6.0 Interventions for preventing tobacco sales to minors.rm5
p18838
sg5
(lp18839
(dp18840
g8
V9618623.xml
p18841
sg10
VSTD-Erie-County-1995
p18842
sg12
S'PMC1508243'
p18843
sa(dp18844
g8
V9618624.xml
p18845
sg10
VSTD-Harlem-1993
p18846
sg12
S'PMC1508216'
p18847
sa(dp18848
g8
V10841587.xml
p18849
sg10
VSTD-California-1995
p18850
sg12
S'PMC1766282'
p18851
sa(dp18852
g8
V8926225.xml
p18853
sg10
VSTD-Chicago-1993
p18854
sg12
S'PMC1283996'
p18855
sa(dp18856
g8
V9702146.xml
p18857
sg10
VSTD-TPOP-1996
p18858
sg12
S'PMC1508321'
p18859
sa(dp18860
g8
V1594748.xml
p18861
sg10
VSTD-Everett-1990
p18862
sg12
S'PMC1403659'
p18863
sa(dp18864
g8
V1503160.xml
p18865
sg10
VSTD-St-Paul-1990
p18866
sg12
S'PMC1694336'
p18867
sasa(dp18868
g3
VCD008262 v. 2.2 Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise.rm5
p18869
sg5
(lp18870
(dp18871
g8
V17261562.xml
p18872
sg10
VSTD-Sellwood-2007a
p18873
sg12
S'PMC2465319'
p18874
sasa(dp18875
g3
VCD001969 v. 6.4 Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated ve.rm5
p18876
sg5
(lp18877
(dp18878
g8
V10212082.xml
p18879
sg10
VSTD-Fok-1999
p18880
sg12
S'PMC1720936'
p18881
sasa(dp18882
g3
VCD004374 v. 3.0 Short term urinary catheter policies following urogenital surgery in adults.rm5
p18883
sg5
(lp18884
(dp18885
g8
V22778750.xml
p18886
sg10
VSTD-Wyman-1987
p18887
sg12
S'PMC3384962'
p18888
sasa(dp18889
g3
VCD001738 v. 6.0 Antibiotic prophylaxis for mammalian bites.rm5
p18890
sg5
(lp18891
(dp18892
g8
V3895210.xml
p18893
sg10
VSTD-Jones-1985
p18894
sg12
S'PMC2418305'
p18895
sasa(dp18896
g3
VCD002920 v. 8.0 Nutrition support for bone marrow transplant patients.rm5
p18897
sg5
(lp18898
(dp18899
g8
V1953094.xml
p18900
sg10
VSTD-Scheltinga-1991
p18901
sg12
S'PMC1358534'
p18902
sasa(dp18903
g3
VCD002056 v. 5.0 Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm inf.rm5
p18904
sg5
(lp18905
(dp18906
g8
V8215566.xml
p18907
sg10
VSTD-Gill-1993
p18908
sg12
S'PMC1029493'
p18909
sasa(dp18910
g3
VCD004248 v. 4.0 Progressive resistive exercise interventions for adults living with HIVAIDS.rm5
p18911
sg5
(lp18912
(dp18913
g8
V10683055.xml
p18914
sg10
VSTD-Bhasin-2000
p18915
sg12
S'PMC3173037'
p18916
sasa(dp18917
g3
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p18918
sg5
(lp18919
(dp18920
g8
V16868539.xml
p18921
sg10
VSTD-GICOG
p18922
sg12
S'PMC2360651'
p18923
sa(dp18924
g8
V20619634.xml
p18925
sg10
VSTD-NSGO_x002c_-MaNGO-and-EORTC
p18926
sg12
S'PMC3552301'
p18927
sa(dp18928
g8
V20619634.xml
p18929
sg10
VSTD-MaNGO
p18930
sg12
S'PMC3552301'
p18931
sasa(dp18932
g3
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p18933
sg5
(lp18934
(dp18935
g8
V16897618.xml
p18936
sg10
VSTD-Oosterhof-2006
p18937
sg12
S'PMC3476076'
p18938
sa(dp18939
g8
V6364997.xml
p18940
sg10
VSTD-Lewis-1984
p18941
sg12
S'PMC1001217'
p18942
sasa(dp18943
g3
VCD005652 v. 5.0 Psychological therapies for people with borderline personality disorder.rm5
p18944
sg5
(lp18945
(dp18946
g8
V18281407.xml
p18947
sg10
VSTD-Blum-2008
p18948
sg12
S'PMC3608469'
p18949
sa(dp18950
g8
V17032158.xml
p18951
sg10
VSTD-Davidson-2006
p18952
sg12
S'PMC1852259'
p18953
sasa(dp18954
g3
VCD005124 v. 4.0 Antenatal psychosocial assessment for reducing perinatal mental health morbidity.rm5
p18955
sg5
(lp18956
(dp18957
g8
V16076821.xml
p18958
sg10
VSTD-Carroll-2005
p18959
sg12
S'PMC1180654'
p18960
sasa(dp18961
g3
VCD002982 v. 9.0 Psychological interventions for adults with asthma.rm5
p18962
sg5
(lp18963
(dp18964
g8
V3094804.xml
p18965
sg10
VSTD-Ewer-1986
p18966
sg12
S'PMC1341848'
p18967
sasa(dp18968
g3
VCD003288 v. 6.0 Protein and energy supplementation in elderly people at risk from malnutrition.rm5
p18969
sg5
(lp18970
(dp18971
g8
V22232695.xml
p18972
sg10
VSTD-Madigan-1994
p18973
sg12
S'PMC3268331'
p18974
sa(dp18975
g8
V12947128.xml
p18976
sg10
VSTD-Steiner-2003
p18977
sg12
S'PMC1746806'
p18978
sasa(dp18979
g3
VCD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
p18980
sg5
(lp18981
(dp18982
g8
V23259013.xml
p18983
sg10
VSTD-Goldstein-1986
p18984
sg12
S'PMC3516240'
p18985
sa(dp18986
g8
V8561240.xml
p18987
sg10
VSTD-Rowland-1996
p18988
sg12
S'PMC1380358'
p18989
sa(dp18990
g8
V1771873.xml
p18991
sg10
VSTD-Murdock-1991
p18992
sg12
S'PMC1003016'
p18993
sa(dp18994
g8
V7281654.xml
p18995
sg10
VSTD-Luna-1981
p18996
sg12
S'PMC1273021'
p18997
sasa(dp18998
g3
VCD003161 v. 7.4 Cognitive behavioural interventions for sleep problems in adults aged 60.rm5
p18999
sg5
(lp19000
(dp19001
g8
V18517044.xml
p19002
sg10
VSTD-McCurry-1998
p19003
sg12
S'PMC2398744'
p19004
sasa(dp19005
g3
VCD004574 v. 4.0 Interventions for treating mallet finger injuries.rm5
p19006
sg5
(lp19007
(dp19008
g8
V8216604.xml
p19009
sg10
VSTD-Maitra-1993
p19010
sg12
S'PMC1285998'
p19011
sasa(dp19012
g3
VCD001292 v. 7.0 Individual behavioural counselling for smoking cessation.rm5
p19013
sg5
(lp19014
(dp19015
g8
V17483139.xml
p19016
sg10
VSTD-Aveyard-2007
p19017
sg12
S'PMC2094265'
p19018
sa(dp19019
g8
V10800431.xml
p19020
sg10
VSTD-Glasgow-2000
p19021
sg12
S'PMC1446229'
p19022
sa(dp19023
g8
V12775857.xml
p19024
sg10
VSTD-Molyneux-2003
p19025
sg12
S'PMC1746718'
p19026
sasa(dp19027
g3
VCD003470 v. 3.0 Pharmacotherapy for patellofemoral pain syndrome.rm5
p19028
sg5
(lp19029
(dp19030
g8
V7008711.xml
p19031
sg10
VSTD-Bentley-1981
p19032
sg12
S'PMC1000652'
p19033
sasa(dp19034
g3
VCD001543 v. 6.0 Shouldice technique versus other open techniques for inguinal hernia repair.rm5
p19035
sg5
(lp19036
(dp19037
g8
V8526578.xml
p19038
sg10
VSTD-Hay-1995
p19039
sg12
S'PMC1235020'
p19040
sasa(dp19041
g3
VCD005029 v. 5.0 Treatment for ataxia in multiple sclerosis.rm5
p19042
sg5
(lp19043
(dp19044
g8
V11160464.xml
p19045
sg10
VSTD-Wiles-2001
p19046
sg12
S'PMC1737210'
p19047
sasa(dp19048
g3
VCD008343 v. 3.0 Preoperative alcohol cessation prior to elective surgery.rm5
p19049
sg5
(lp19050
(dp19051
g8
V10323814.xml
p19052
sg10
VSTD-T_x00f8_nnesen-1999a
p19053
sg12
S'PMC27867'
p19054
sasa(dp19055
g3
VCD008013 v. 3.0 Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in.rm5
p19056
sg5
(lp19057
(dp19058
g8
V19596010.xml
p19059
sg10
VSTD-Saps-2009
p19060
sg12
S'PMC2827243'
p19061
sasa(dp19062
g3
VCD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
p19063
sg5
(lp19064
(dp19065
g8
V23902583.xml
p19066
sg10
VSTD-Briggs-1984
p19067
sg12
S'PMC3765382'
p19068
sa(dp19069
g8
V4601508.xml
p19070
sg10
VSTD-Anderson-1974f
p19071
sg12
S'PMC1947567'
p19072
sa(dp19073
g8
V4601508.xml
p19074
sg10
VSTD-Anderson-1974e
p19075
sg12
S'PMC1947567'
p19076
sa(dp19077
g8
V4601508.xml
p19078
sg10
VSTD-Anderson-1974b
p19079
sg12
S'PMC1947567'
p19080
sa(dp19081
g8
V4601508.xml
p19082
sg10
VSTD-Anderson-1974c
p19083
sg12
S'PMC1947567'
p19084
sa(dp19085
g8
V4601508.xml
p19086
sg10
VSTD-Anderson-1974a
p19087
sg12
S'PMC1947567'
p19088
sa(dp19089
g8
V4601508.xml
p19090
sg10
VSTD-Anderson-1974d
p19091
sg12
S'PMC1947567'
p19092
sa(dp19093
g8
V338079.xml
p19094
sg10
VSTD-Tyrrell-1977
p19095
sg12
S'PMC479021'
p19096
sa(dp19097
g8
V4290259.xml
p19098
sg10
VSTD-Walker-1967
p19099
sg12
S'PMC1841434'
p19100
sa(dp19101
g8
V788820.xml
p19102
sg10
VSTD-Elwood-1976
p19103
sg12
S'PMC478963'
p19104
sa(dp19105
g8
V1091343.xml
p19106
sg10
VSTD-Anderson-1975a
p19107
sg12
S'PMC1958969'
p19108
sa(dp19109
g8
V1091343.xml
p19110
sg10
VSTD-Anderson-1975b
p19111
sg12
S'PMC1958969'
p19112
sa(dp19113
g8
V9284173.xml
p19114
sg10
VSTD-Elliot-1973
p19115
sg12
S'PMC175560'
p19116
sasa(dp19117
g3
VCD000335 v. 14.0 Exercise therapy for treatment of non-specific low back pain.rm5
p19118
sg5
(lp19119
(dp19120
g8
V2931153.xml
p19121
sg10
VSTD-Gilbert-1985
p19122
sg12
S'PMC1417150'
p19123
sa(dp19124
g8
V9883955.xml
p19125
sg10
VSTD-Seferlis-1998
p19126
sg12
S'PMC3611294'
p19127
sa(dp19128
g8
V15377573.xml
p19129
sg10
VSTD-Frost-2004
p19130
sg12
S'PMC518892'
p19131
sa(dp19132
g8
V10426734.xml
p19133
sg10
VSTD-Moffett-1999
p19134
sg12
S'PMC28176'
p19135
sa(dp19136
g8
V10906914.xml
p19137
sg10
VSTD-Preyde-2000
p19138
sg12
S'PMC1231369'
p19139
sa(dp19140
g8
V7833752.xml
p19141
sg10
VSTD-Frost-1995
p19142
sg12
S'PMC2548554'
p19143
sasa(dp19144
g3
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p19145
sg5
(lp19146
(dp19147
g8
V17426908.xml
p19148
sg10
VSTD-Van-Koningsveld-2004
p19149
sg12
S'PMC2778673'
p19150
sasa(dp19151
g3
VCD001351 v. 12.0 Acupuncture and dry-needling for low back pain.rm5
p19152
sg5
(lp19153
(dp19154
g8
V6218776.xml
p19155
sg10
VSTD-MacDonald-1983
p19156
sg12
S'PMC2494194'
p19157
sasa(dp19158
g3
VCD003676 v. 7.0 Paracetamol versus placebo or physical methods for treating fever in children.rm5
p19159
sg5
(lp19160
(dp19161
g8
V1463951.xml
p19162
sg10
VSTD-Kinmonth-1992
p19163
sg12
S'PMC1883680'
p19164
sasa(dp19165
g3
VCD006398 v. 4.0 Interventions for preventing injuries in the agricultural industry.rm5
p19166
sg5
(lp19167
(dp19168
g8
V14758405.xml
p19169
sg10
VSTD-Roberts-2003
p19170
sg12
S'PMC1693668'
p19171
sa(dp19172
g8
V15451744.xml
p19173
sg10
VSTD-Lee-2004
p19174
sg12
S'PMC1448528'
p19175
sa(dp19176
g8
V16507741.xml
p19177
sg10
VSTD-Gadomski-2006
p19178
sg12
S'PMC1470549'
p19179
sasa(dp19180
g3
VCD002116 v. 6.0 Drug treatment for faecal incontinence in adults.rm5
p19181
sg5
(lp19182
(dp19183
g8
V11171825.xml
p19184
sg10
VSTD-Cheetham-2001-_x0023_
p19185
sg12
S'PMC1760141'
p19186
sasa(dp19187
g3
VCD004236 v. 7.0 EMLA and Amethocaine for reduction of children's pain associated with needle insertion.rm5
p19188
sg5
(lp19189
(dp19190
g8
V10735838.xml
p19191
sg10
VSTD-Arrowsmith-2000
p19192
sg12
S'PMC1718269'
p19193
sasa(dp19194
g3
VCD001279 v. 9.0 Anticholinergic drugs for wheeze in children under the age of two years.rm5
p19195
sg5
(lp19196
(dp19197
g8
V1533504.xml
p19198
sg10
VSTD-Wang-1992
p19199
sg12
S'PMC1793648'
p19200
sa(dp19201
g8
V6230059.xml
p19202
sg10
VSTD-Henry-1984
p19203
sg12
S'PMC1628434'
p19204
sasa(dp19205
g3
VCD004116 v. 6.0 Herbal medicines for treatment of irritable bowel syndrome.rm5
p19206
sg5
(lp19207
(dp19208
g8
V21202743.xml
p19209
sg10
VSTD-Ye-LJ-2000
p19210
sg12
S'PMC2961892'
p19211
sa(dp19212
g8
V17375186.xml
p19213
sg10
VSTD-Gu-XX-1999
p19214
sg12
S'PMC1810433'
p19215
sa(dp19216
g8
V20040062.xml
p19217
sg10
VSTD-Xie-YD-2001
p19218
sg12
S'PMC3208021'
p19219
sa(dp19220
g8
V23788040.xml
p19221
sg10
VSTD-Xu-XP-2002
p19222
sg12
S'PMC3702287'
p19223
sasa(dp19224
g3
VCD004011 v. 5.0 Strategies for the removal of short-term indwelling urethral catheters in adults.rm5
p19225
sg5
(lp19226
(dp19227
g8
V22778750.xml
p19228
sg10
VSTD-Wyman-1987
p19229
sg12
S'PMC3384962'
p19230
sasa(dp19231
g3
VCD004288 v. 7.0 Surgical hand antisepsis to reduce surgical site infection.rm5
p19232
sg5
(lp19233
(dp19234
g8
V16460630.xml
p19235
sg10
VSTD-Hajipour-2006
p19236
sg12
S'PMC1963628'
p19237
sasa(dp19238
g3
VCD005937 v. 4.0 Treatments for suppression of lactation.rm5
p19239
sg5
(lp19240
(dp19241
g8
V4883649.xml
p19242
sg10
VSTD-Firth-1969
p19243
sg12
S'PMC1982084'
p19244
sa(dp19245
g8
V1676318.xml
p19246
sg10
VSTD-European-1991
p19247
sg12
S'PMC1670075'
p19248
sa(dp19249
g8
V4556543.xml
p19250
sg10
VSTD-Varga-1972
p19251
sg12
S'PMC1788467'
p19252
sa(dp19253
g8
V334356.xml
p19254
sg10
VSTD-Yuen-1977
p19255
sg12
S'PMC1880136'
p19256
sa(dp19257
g8
V4883650.xml
p19258
sg10
VSTD-Senior-1969
p19259
sg12
S'PMC1982066'
p19260
sasa(dp19261
g3
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p19262
sg5
(lp19263
(dp19264
g8
V19624838.xml
p19265
sg10
VSTD-Worth-2009
p19266
sg12
S'PMC2720945'
p19267
sa(dp19268
g8
V2866607.xml
p19269
sg10
VSTD-McGavin-1985
p19270
sg12
S'PMC1020560'
p19271
sasa(dp19272
g3
VCD001203 v. 4.0 Bromocriptine for levodopa-induced motor complications in Parkinson's disease.rm5
p19273
sg5
(lp19274
(dp19275
g8
V366085.xml
p19276
sg10
VSTD-Bateman-1978
p19277
sg12
S'PMC493239'
p19278
sasa(dp19279
g3
VCD002146 v. 7.0 Pharmacotherapy for hypertension in women of different races.rm5
p19280
sg5
(lp19281
(dp19282
g8
V1445513.xml
p19283
sg10
VSTD-MRC-elderly
p19284
sg12
S'PMC1995577'
p19285
sa(dp19286
g8
V3094811.xml
p19287
sg10
VSTD-Coope
p19288
sg12
S'PMC1341855'
p19289
sasa(dp19290
g3
VCD001188 v. 9.0 Nursing interventions for smoking cessation.rm5
p19291
sg5
(lp19292
(dp19293
g8
V10514155.xml
p19294
sg10
VSTD-Steptoe-1999
p19295
sg12
S'PMC28246'
p19296
sa(dp19297
g8
V14644967.xml
p19298
sg10
VSTD-Quist_x002d_Paulsen-2003
p19299
sg12
S'PMC286243'
p19300
sa(dp19301
g8
V8124120.xml
p19302
sg10
VSTD-OXCHECK-1994
p19303
sg12
S'PMC2539253'
p19304
sa(dp19305
g8
V3592033.xml
p19306
sg10
VSTD-Janz-1987
p19307
sg12
S'PMC1647206'
p19308
sa(dp19309
g8
V8124121.xml
p19310
sg10
VSTD-Family-Heart-1994
p19311
sg12
S'PMC2539278'
p19312
sa(dp19313
g8
V10343421.xml
p19314
sg10
VSTD-Lancaster-1999
p19315
sg12
S'PMC1313370'
p19316
sa(dp19317
g8
V9093045.xml
p19318
sg10
VSTD-Carlsson-1997
p19319
sg12
S'PMC484693'
p19320
sa(dp19321
g8
V9930042.xml
p19322
sg10
VSTD-Campbell-1998
p19323
sg12
S'PMC1728827'
p19324
sa(dp19325
g8
V11786452.xml
p19326
sg10
VSTD-Hajek-2002
p19327
sg12
S'PMC64504'
p19328
sa(dp19329
g8
V2556540.xml
p19330
sg10
VSTD-Sanders-1989a
p19331
sg12
S'PMC1711904'
p19332
sa(dp19333
g8
V2556540.xml
p19334
sg10
VSTD-Sanders-1989b
p19335
sg12
S'PMC1711904'
p19336
sasa(dp19337
g3
VCD003744 v. 3.0 Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for or.rm5
p19338
sg5
(lp19339
(dp19340
g8
V9536833.xml
p19341
sg10
VSTD-Lyon-1998
p19342
sg12
S'PMC1720741'
p19343
sasa(dp19344
g3
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p19345
sg5
(lp19346
(dp19347
g8
V8688342.xml
p19348
sg10
VSTD-Moroni-1996
p19349
sg12
S'PMC2074576'
p19350
sasa(dp19351
g3
VCD004796 v. 6.0 Manipulative therapies for infantile colic.rm5
p19352
sg5
(lp19353
(dp19354
g8
V11159288.xml
p19355
sg10
VSTD-Olafsdottir-2001
p19356
sg12
S'PMC1718650'
p19357
sasa(dp19358
g3
VCD006090 v. 8.0 Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of a.rm5
p19359
sg5
(lp19360
(dp19361
g8
V11498488.xml
p19362
sg10
VSTD-Rahman-2001
p19363
sg12
S'PMC37318'
p19364
sa(dp19365
g8
V7819847.xml
p19366
sg10
VSTD-Bhandari-1994
p19367
sg12
S'PMC2541323'
p19368
sasa(dp19369
g3
VCD001957 v. 16.0 Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like illness.rm5
p19370
sg5
(lp19371
(dp19372
g8
V2655683.xml
p19373
sg10
VSTD-Ferley-1989
p19374
sg12
S'PMC1379831'
p19375
sasa(dp19376
g3
VCD006956 v. 3.2 Laparoscopic versus Open surgery for small bowel Crohn's disease.rm5
p19377
sg5
(lp19378
(dp19379
g8
V16432345.xml
p19380
sg10
VSTD-Maartense-2006
p19381
sg12
S'PMC1448907'
p19382
sasa(dp19383
g3
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p19384
sg5
(lp19385
(dp19386
g8
V18614482.xml
p19387
sg10
VSTD-Webster-2008
p19388
sg12
S'PMC2483870'
p19389
sa(dp19390
g8
V15239872.xml
p19391
sg10
VSTD-Barker-2004
p19392
sg12
S'PMC1964197'
p19393
sa(dp19394
g8
V20831782.xml
p19395
sg10
VSTD-Rickard-2010
p19396
sg12
S'PMC2944158'
p19397
sasa(dp19398
g3
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p19399
sg5
(lp19400
(dp19401
g8
V17690340.xml
p19402
sg10
VSTD-Canani-2007
p19403
sg12
S'PMC1949444'
p19404
sa(dp19405
g8
V17287932.xml
p19406
sg10
VSTD-Henker-2007a
p19407
sg12
S'PMC1802727'
p19408
sa(dp19409
g8
V17760859.xml
p19410
sg10
VSTD-Frigerio-1986
p19411
sg12
S'PMC2171037'
p19412
sa(dp19413
g8
V9862821.xml
p19414
sg10
VSTD-Kowalska_x002d_Duplaga-1999
p19415
sg12
S'PMC1760063'
p19416
sasa(dp19417
g3
VCD004320 v. 5.0 Stapled versus handsewn methods for ileocolic anastomoses.rm5
p19418
sg5
(lp19419
(dp19420
g8
V7857145.xml
p19421
sg10
VSTD-Docherty-1995
p19422
sg12
S'PMC1234951'
p19423
sasa(dp19424
g3
VCD005634 v. 7.2 Specialist breast care nurses for supportive care of women with breast cancer.rm5
p19425
sg5
(lp19426
(dp19427
g8
V7192170.xml
p19428
sg10
VSTD-Maguire-1980
p19429
sg12
S'PMC1714830'
p19430
sa(dp19431
g8
V8608288.xml
p19432
sg10
VSTD-McArdle-1996
p19433
sg12
S'PMC2350687'
p19434
sasa(dp19435
g3
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p19436
sg5
(lp19437
(dp19438
g8
V14710215.xml
p19439
sg10
VSTD-Delvaux-2004
p19440
sg12
S'PMC2395320'
p19441
sasa(dp19442
g3
VCD008888 v. 2.0 Inhaled corticosteroids for subacute cough in children.rm5
p19443
sg5
(lp19444
(dp19445
g8
V10086941.xml
p19446
sg10
VSTD-Fox-1999
p19447
sg12
S'PMC1717884'
p19448
sasa(dp19449
g3
VCD002009 v. 13.0 Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.rm5
p19450
sg5
(lp19451
(dp19452
g8
V9713009.xml
p19453
sg10
VSTD-Vic-1998
p19454
sg12
S'PMC1717599'
p19455
sasa(dp19456
g3
VCD002876 v. 8.0 Tiotropium for stable chronic obstructive pulmonary disease.rm5
p19457
sg5
(lp19458
(dp19459
g8
V14514937.xml
p19460
sg10
VSTD-Calverley-2003
p19461
sg12
S'PMC1746483'
p19462
sa(dp19463
g8
V12728159.xml
p19464
sg10
VSTD-Brusasco-2003
p19465
sg12
S'PMC1746668'
p19466
sa(dp19467
g8
V10722768.xml
p19468
sg10
VSTD-van-Noord-2000
p19469
sg12
S'PMC1745719'
p19470
sasa(dp19471
g3
VCD008743 v. 2.8 Use of electronic health records to support smoking cessation.rm5
p19472
sg5
(lp19473
(dp19474
g8
V21287886.xml
p19475
sg10
VSTD-Lindholm-2010
p19476
sg12
S'PMC3587763'
p19477
sa(dp19478
g8
V18465176.xml
p19479
sg10
VSTD-Koplan-2008
p19480
sg12
S'PMC2517966'
p19481
sa(dp19482
g8
V19398690.xml
p19483
sg10
VSTD-Linder-2009
p19484
sg12
S'PMC3005286'
p19485
sasa(dp19486
g3
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p19487
sg5
(lp19488
(dp19489
g8
V22427771.xml
p19490
sg10
VSTD-Tehraninejad-2010
p19491
sg12
S'PMC3302709'
p19492
sasa(dp19493
g3
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p19494
sg5
(lp19495
(dp19496
g8
V22111718.xml
p19497
sg10
VSTD-Zeiger-2011
p19498
sg12
S'PMC3247621'
p19499
sa(dp19500
g8
V17634183.xml
p19501
sg10
VSTD-Turpeinen-2008
p19502
sg12
S'PMC2532957'
p19503
sasa(dp19504
g3
VCD001860 v. 9.6 Antibiotics for trachoma.rm5
p19505
sg5
(lp19506
(dp19507
g8
V4952467.xml
p19508
sg10
VSTD-Shukla-1966
p19509
sg12
S'PMC506219'
p19510
sa(dp19511
g8
V6992856.xml
p19512
sg10
VSTD-Darougar-1980
p19513
sg12
S'PMC1043672'
p19514
sa(dp19515
g8
V17005549.xml
p19516
sg10
VSTD-Cochereau-2007
p19517
sg12
S'PMC1954762'
p19518
sasa(dp19519
g3
VCD005952 v. 3.0 Therapy-based rehabilitation services for patients living at home more than one year after stroke.rm5
p19520
sg5
(lp19521
(dp19522
g8
V1559090.xml
p19523
sg10
VSTD-Wade-1992
p19524
sg12
S'PMC1881332'
p19525
sasa(dp19526
g3
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p19527
sg5
(lp19528
(dp19529
g8
V20505173.xml
p19530
sg10
VSTD-CREST-2010
p19531
sg12
S'PMC2932446'
p19532
sa(dp19533
g8
V20189239.xml
p19534
sg10
VSTD-ICSS-2010
p19535
sg12
S'PMC2849002'
p19536
sasa(dp19537
g3
VCD001316 v. 8.0 Steroids radiotherapy chemotherapy and stents for superior vena caval obstruction in carcinoma of .rm5
p19538
sg5
(lp19539
(dp19540
g8
V6310812.xml
p19541
sg10
VSTD-Spiro-1983
p19542
sg12
S'PMC459595'
p19543
sa(dp19544
g8
V8553270.xml
p19545
sg10
VSTD-Stock-1995
p19546
sg12
S'PMC475086'
p19547
sa(dp19548
g8
V7694384.xml
p19549
sg10
VSTD-Watkinson-1993
p19550
sg12
S'PMC464777'
p19551
sasa(dp19552
g3
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p19553
sg5
(lp19554
(dp19555
g8
V18442423.xml
p19556
sg10
VSTD-Lenssen-2008
p19557
sg12
S'PMC2386789'
p19558
sa(dp19559
g8
V16504087.xml
p19560
sg10
VSTD-Lenssen-2003
p19561
sg12
S'PMC1403777'
p19562
sasa(dp19563
g3
VCD004872 v. 7.0 Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyng.rm5
p19564
sg5
(lp19565
(dp19566
g8
V8849215.xml
p19567
sg10
VSTD-Pacifico-1996
p19568
sg12
S'PMC163247'
p19569
sa(dp19570
g8
V20401325.xml
p19571
sg10
VSTD-Milatovic-1991
p19572
sg12
S'PMC2855147'
p19573
sasa(dp19574
g3
VCD001941 v. 5.0 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and ches.rm5
p19575
sg5
(lp19576
(dp19577
g8
V16299118.xml
p19578
sg10
VSTD-Ward-2005
p19579
sg12
S'PMC1747266'
p19580
sasa(dp19581
g3
VCD008264 v. 2.0 Antibiotics for leptospirosis.rm5
p19582
sg5
(lp19583
(dp19584
g8
V17638700.xml
p19585
sg10
VSTD-Phimda-2007
p19586
sg12
S'PMC2043199'
p19587
sasa(dp19588
g3
VCD006633 v. 5.0 Clozapine versus other atypical antipsychotics for schizophrenia.rm5
p19589
sg5
(lp19590
(dp19591
g8
V23869281.xml
p19592
sg10
VSTD-Li--2003
p19593
sg12
S'PMC3707322'
p19594
sasa(dp19595
g3
VCD004886 v. 3.9 Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated .rm5
p19596
sg5
(lp19597
(dp19598
g8
V2513931.xml
p19599
sg10
VSTD-Sharma-1989
p19600
sg12
S'PMC1838188'
p19601
sasa(dp19602
g3
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p19603
sg5
(lp19604
(dp19605
g8
V17901438.xml
p19606
sg10
VSTD-Juster-2007
p19607
sg12
S'PMC2040364'
p19608
sa(dp19609
g8
V16319361.xml
p19610
sg10
VSTD-Mulcahy-2005
p19611
sg12
S'PMC1748138'
p19612
sa(dp19613
g8
V19165321.xml
p19614
sg10
VSTD-Fern_x00e1_ndez-2009
p19615
sg12
S'PMC2621339'
p19616
sa(dp19617
g8
V16046685.xml
p19618
sg10
VSTD-Farrelly-2005
p19619
sg12
S'PMC1748080'
p19620
sa(dp19621
g8
V16728756.xml
p19622
sg10
VSTD-Eagan-2006
p19623
sg12
S'PMC2564667'
p19624
sa(dp19625
g8
V19151105.xml
p19626
sg10
VSTD-Hyland-2009
p19627
sg12
S'PMC2720733'
p19628
sa(dp19629
g8
V16754947.xml
p19630
sg10
VSTD-Fong-2006
p19631
sg12
S'PMC2593063'
p19632
sa(dp19633
g8
V15066887.xml
p19634
sg10
VSTD-Sargent-2004
p19635
sg12
S'PMC404491'
p19636
sa(dp19637
g8
V17760974.xml
p19638
sg10
VSTD-Gal_x00e1_n-2007
p19639
sg12
S'PMC2034550'
p19640
sa(dp19641
g8
V16230313.xml
p19642
sg10
VSTD-Allwright-2005
p19643
sg12
S'PMC1283274'
p19644
sa(dp19645
g8
V17652238.xml
p19646
sg10
VSTD-Fernando-2007
p19647
sg12
S'PMC2598530'
p19648
sa(dp19649
g8
V11988448.xml
p19650
sg10
VSTD-Gilpin-2002
p19651
sg12
S'PMC1447162'
p19652
sa(dp19653
g8
V17827487.xml
p19654
sg10
VSTD-Akhtar-2007
p19655
sg12
S'PMC1976539'
p19656
sa(dp19657
g8
V16380571.xml
p19658
sg10
VSTD-Abrams-2006
p19659
sg12
S'PMC1470494'
p19660
sa(dp19661
g8
V17827485.xml
p19662
sg10
VSTD-Haw-2007
p19663
sg12
S'PMC1976488'
p19664
sasa(dp19665
g3
VCD005338 v. 5.0 Therapeutic communities for substance related disorder.rm5
p19666
sg5
(lp19667
(dp19668
g8
V7573630.xml
p19669
sg10
VSTD-McCusker-1995
p19670
sg12
S'PMC1615635'
p19671
sa(dp19672
g8
V9357345.xml
p19673
sg10
VSTD-McCusker-1997a
p19674
sg12
S'PMC1381126'
p19675
sasa(dp19676
g3
VCD003449 v. 11.0 Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.rm5
p19677
sg5
(lp19678
(dp19679
g8
V19897857.xml
p19680
sg10
VSTD-Warner-2010
p19681
sg12
S'PMC2806180'
p19682
sa(dp19683
g8
V19369294.xml
p19684
sg10
VSTD-Weisberg-2009
p19685
sg12
S'PMC2710284'
p19686
sa(dp19687
g8
V23614904.xml
p19688
sg10
VSTD-Parker-1980
p19689
sg12
S'PMC3735938'
p19690
sasa(dp19691
g3
VCD003666 v. 6.1 Volume-targeted versus pressure-limited ventilation in the neonate.rm5
p19692
sg5
(lp19693
(dp19694
g8
V9462190.xml
p19695
sg10
VSTD-Sinha-1997
p19696
sg12
S'PMC1720717'
p19697
sasa(dp19698
g3
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p19699
sg5
(lp19700
(dp19701
g8
V10325795.xml
p19702
sg10
VSTD-Ramenghi-1999
p19703
sg12
S'PMC1720910'
p19704
sa(dp19705
g8
V8777660.xml
p19706
sg10
VSTD-Ramenghi-1996a
p19707
sg12
S'PMC2528545'
p19708
sa(dp19709
g8
V8777661.xml
p19710
sg10
VSTD-Ramenghi-1996b
p19711
sg12
S'PMC2528524'
p19712
sa(dp19713
g8
V8215552.xml
p19714
sg10
VSTD-Rushforth-1993
p19715
sg12
S'PMC1029529'
p19716
sa(dp19717
g8
V19448377.xml
p19718
sg10
VSTD-Alsaedi-2009
p19719
sg12
S'PMC2813645'
p19720
sa(dp19721
g8
V16428355.xml
p19722
sg10
VSTD-Boyle-2006
p19723
sg12
S'PMC2672697'
p19724
sa(dp19725
g8
V10574854.xml
p19726
sg10
VSTD-Carbajal-1999
p19727
sg12
S'PMC28282'
p19728
sa(dp19729
g8
V15871991.xml
p19730
sg10
VSTD-Ogawa-2005
p19731
sg12
S'PMC1721952'
p19732
sa(dp19733
g8
V20817247.xml
p19734
sg10
VSTD-Slater-2010
p19735
sg12
S'PMC2958259'
p19736
sa(dp19737
g8
V14711847.xml
p19738
sg10
VSTD-Acharya-2004
p19739
sg12
S'PMC1721636'
p19740
sa(dp19741
g8
V18591525.xml
p19742
sg10
VSTD-Taddio-2008
p19743
sg12
S'PMC2464480'
p19744
sa(dp19745
g8
V7787595.xml
p19746
sg10
VSTD-Haouari-1995
p19747
sg12
S'PMC2549876'
p19748
sasa(dp19749
g3
VCD009241 v. 2.0 Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.rm5
p19750
sg5
(lp19751
(dp19752
g8
V2514824.xml
p19753
sg10
VSTD-Saunders-1989
p19754
sg12
S'PMC1838287'
p19755
sasa(dp19756
g3
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p19757
sg5
(lp19758
(dp19759
g8
V18686739.xml
p19760
sg10
VSTD-Tonnel-2008
p19761
sg12
S'PMC2629970'
p19762
sa(dp19763
g8
V20714373.xml
p19764
sg10
VSTD-Bateman-2010b
p19765
sg12
S'PMC2921687'
p19766
sa(dp19767
g8
V12728159.xml
p19768
sg10
VSTD-Brusasco-2003
p19769
sg12
S'PMC1746668'
p19770
sa(dp19771
g8
V18060091.xml
p19772
sg10
VSTD-Chan-2007
p19773
sg12
S'PMC2677771'
p19774
sa(dp19775
g8
V17605774.xml
p19776
sg10
VSTD-Freeman-2007
p19777
sg12
S'PMC1913915'
p19778
sa(dp19779
g8
V21503263.xml
p19780
sg10
VSTD-Trooster-2011
p19781
sg12
S'PMC3078679'
p19782
sa(dp19783
g8
V21103404.xml
p19784
sg10
VSTD-Cooper-2010
p19785
sg12
S'PMC2981152'
p19786
sasa(dp19787
g3
VCD001006 v. 11.0 Mass media interventions for preventing smoking in young people.rm5
p19788
sg5
(lp19789
(dp19790
g8
V2014859.xml
p19791
sg10
VSTD-Bauman-1991
p19792
sg12
S'PMC1405075'
p19793
sa(dp19794
g8
V20537841.xml
p19795
sg10
VSTD-Flynn-2010
p19796
sg12
S'PMC2898197'
p19797
sasa(dp19798
g3
VCD001737 v. 9.2 Skin grafting for venous leg ulcers.rm5
p19799
sg5
(lp19800
(dp19801
g8
V3105681.xml
p19802
sg10
VSTD-Poskitt-1987
p19803
sg12
S'PMC1245732'
p19804
sasa(dp19805
g3
VCD004874 v. 10.0 Antibiotics for community-acquired pneumonia in children.rm5
p19806
sg5
(lp19807
(dp19808
g8
V11827905.xml
p19809
sg10
VSTD-CATCHUP-2002
p19810
sg12
S'PMC1761064'
p19811
sa(dp19812
g8
V17567657.xml
p19813
sg10
VSTD-Atkinson-2007
p19814
sg12
S'PMC2094276'
p19815
sa(dp19816
g8
V2194687.xml
p19817
sg10
VSTD-Keeley-1990
p19818
sg12
S'PMC2393134'
p19819
sa(dp19820
g8
V18182412.xml
p19821
sg10
VSTD-Asghar-2008
p19822
sg12
S'PMC2190277'
p19823
sa(dp19824
g8
V9124837.xml
p19825
sg10
VSTD-Roord-1996
p19826
sg12
S'PMC163618'
p19827
sasa(dp19828
g3
VCD000094 v. 6.0 Gangliosides for acute ischaemic stroke.rm5
p19829
sg5
(lp19830
(dp19831
g8
V3066849.xml
p19832
sg10
VSTD-Hoffbrand-1988
p19833
sg12
S'PMC1033029'
p19834
sasa(dp19835
g3
VCD008054 v. 2.2 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.rm5
p19836
sg5
(lp19837
(dp19838
g8
V11302900.xml
p19839
sg10
VSTD-Rebello-2001
p19840
sg12
S'PMC30583'
p19841
sa(dp19842
g8
V14511396.xml
p19843
sg10
VSTD-Guyot-2003
p19844
sg12
S'PMC222910'
p19845
sa(dp19846
g8
V19828739.xml
p19847
sg10
VSTD-Cattani-2009
p19848
sg12
S'PMC2786669'
p19849
sa(dp19850
g8
V11022584.xml
p19851
sg10
VSTD-Lytwyn-2000
p19852
sg12
S'PMC80165'
p19853
sasa(dp19854
g3
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p19855
sg5
(lp19856
(dp19857
g8
V19434268.xml
p19858
sg10
VSTD-Choung-2008
p19859
sg12
S'PMC2671765'
p19860
sasa(dp19861
g3
VCD000368 v. 12.0 Intercessory prayer for the alleviation of ill health.rm5
p19862
sg5
(lp19863
(dp19864
g8
V11751349.xml
p19865
sg10
VSTD-Leibovici-2001
p19866
sg12
S'PMC61047'
p19867
sasa(dp19868
g3
VCD004054 v. 4.0 Psychological and educational interventions for atopic eczema in children.rm5
p19869
sg5
(lp19870
(dp19871
g8
V16627509.xml
p19872
sg10
VSTD-Staab-2006
p19873
sg12
S'PMC1444870'
p19874
sasa(dp19875
g3
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p19876
sg5
(lp19877
(dp19878
g8
V18809603.xml
p19879
sg10
VSTD-Kushner-2008
p19880
sg12
S'PMC2652083'
p19881
sa(dp19882
g8
V14520438.xml
p19883
sg10
VSTD-Bertuzzi-2003
p19884
sg12
S'PMC2394317'
p19885
sa(dp19886
g8
V7907853.xml
p19887
sg10
VSTD-Mitchell-1994
p19888
sg12
S'PMC1029751'
p19889
sasa(dp19890
g3
VCD006589 v. 5.5 Oral iron supplements for children in malaria-endemic areas.rm5
p19891
sg5
(lp19892
(dp19893
g8
V20889877.xml
p19894
sg10
VSTD-Gara-2010
p19895
sg12
S'PMC2946754'
p19896
sa(dp19897
g8
V12756979.xml
p19898
sg10
VSTD-Zlotkin-2003
p19899
sg12
S'PMC2572396'
p19900
sa(dp19901
g8
V15613506.xml
p19902
sg10
VSTD-Aggarwal-2005
p19903
sg12
S'PMC1720080'
p19904
sasa(dp19905
g3
VCD008066 v. 4.0 Transtheoretical model for dietary and physical exercise modification in weight loss management for .rm5
p19906
sg5
(lp19907
(dp19908
g8
V18055007.xml
p19909
sg10
VSTD-Johnson-2008
p19910
sg12
S'PMC2327253'
p19911
sa(dp19912
g8
V11211636.xml
p19913
sg10
VSTD-Steptoe-2001
p19914
sg12
S'PMC1446539'
p19915
sasa(dp19916
g3
VCD001928 v. 6.0 Calcium antagonists for acute ischemic stroke.rm5
p19917
sg5
(lp19918
(dp19919
g8
V23809206.xml
p19920
sg10
VSTD-Lowe--1989
p19921
sg12
S'PMC3773236'
p19922
sasa(dp19923
g3
VCD008643 v. 4.3 Red flags to screen for vertebral fracture in patients presenting with low-back pain.rm5
p19924
sg5
(lp19925
(dp19926
g8
V21655423.xml
p19927
sg10
VSTD-Roman-2010
p19928
sg12
S'PMC3103109'
p19929
sa(dp19930
g8
V1533126.xml
p19931
sg10
VSTD-Gibson-1992
p19932
sg12
S'PMC1285823'
p19933
sasa(dp19934
g3
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p19935
sg5
(lp19936
(dp19937
g8
V17176279.xml
p19938
sg10
VSTD-Leung-2006
p19939
sg12
S'PMC1804104'
p19940
sasa(dp19941
g3
VCD008250 v. 2.0 Breathing exercises for chronic obstructive pulmonary disease.rm5
p19942
sg5
(lp19943
(dp19944
g8
V20418993.xml
p19945
sg10
VSTD-Katiyar-2006
p19946
sg12
S'PMC2856361'
p19947
sa(dp19948
g8
V1633520.xml
p19949
sg10
VSTD-Chauhan-1992
p19950
sg12
S'PMC1882360'
p19951
sa(dp19952
g8
V19249998.xml
p19953
sg10
VSTD-Donesky_x002d_Cuenco-2009
p19954
sg12
S'PMC3051406'
p19955
sa(dp19956
g8
V14337735.xml
p19957
sg10
VSTD-Saunders-1965
p19958
sg12
S'PMC1846091'
p19959
sasa(dp19960
g3
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p19961
sg5
(lp19962
(dp19963
g8
V12616120.xml
p19964
sg10
VSTD-Zmora-2003
p19965
sg12
S'PMC1514315'
p19966
sa(dp19967
g8
V20433721.xml
p19968
sg10
VSTD-Scabini-2010
p19969
sg12
S'PMC2873340'
p19970
sasa(dp19971
g3
VCD004073 v. 6.0 Vitamin supplementation for preventing miscarriage.rm5
p19972
sg5
(lp19973
(dp19974
g8
V1489222.xml
p19975
sg10
VSTD-Kirke-1992
p19976
sg12
S'PMC1793975'
p19977
sasa(dp19978
g3
VCD008208 v. 4.0 Non-invasive brain stimulation techniques for chronic pain.rm5
p19979
sg5
(lp19980
(dp19981
g8
V15026508.xml
p19982
sg10
VSTD-Lefaucheur-2004
p19983
sg12
S'PMC1739005'
p19984
sa(dp19985
g8
V15897507.xml
p19986
sg10
VSTD-Khedr-2005
p19987
sg12
S'PMC1739662'
p19988
sa(dp19989
g8
V19594842.xml
p19990
sg10
VSTD-Borckardt-2009
p19991
sg12
S'PMC2863136'
p19992
sasa(dp19993
g3
VCD001072 v. 6.0 Continuous positive airway pressure versus theophylline for apnea in preterm infants.rm5
p19994
sg5
(lp19995
(dp19996
g8
V6753769.xml
p19997
sg10
VSTD-Jones-1982
p19998
sg12
S'PMC1627926'
p19999
sasa(dp20000
g3
VCD003769 v. 9.0 Antibiotic prophylaxis for hernia repair..rm5
p20001
sg5
(lp20002
(dp20003
g8
V15570201.xml
p20004
sg10
VSTD-Aufenacker-2004
p20005
sg12
S'PMC1356511'
p20006
sa(dp20007
g8
V11141221.xml
p20008
sg10
VSTD-Yerdel-2001
p20009
sg12
S'PMC1421162'
p20010
sasa(dp20011
g3
VCD008413 v. 2.0 Double-bundle versus single-bundle reconstruction for anterior cruciate ligament rupture in adults.rm5
p20012
sg5
(lp20013
(dp20014
g8
V20734043.xml
p20015
sg10
VSTD-Araki-2011
p20016
sg12
S'PMC3047641'
p20017
sa(dp20018
g8
V19509412.xml
p20019
sg10
VSTD-Song-2009
p20020
sg12
S'PMC3740368'
p20021
sasa(dp20022
g3
VCD008858 v. 2.0 Vaccines for preventing herpes zoster in older adults.rm5
p20023
sg5
(lp20024
(dp20025
g8
V22048110.xml
p20026
sg10
VSTD-Murray-2011
p20027
sg12
S'PMC3323493'
p20028
sa(dp20029
g8
V18077611.xml
p20030
sg10
VSTD-Gilderman-2008
p20031
sg12
S'PMC2238040'
p20032
sasa(dp20033
g3
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p20034
sg5
(lp20035
(dp20036
g8
V18949217.xml
p20037
sg10
VSTD-Baqui_x002d_CARE-INDIA-2008
p20038
sg12
S'PMC2649510'
p20039
sa(dp20040
g8
V17591348.xml
p20041
sg10
VSTD-Syed-2006
p20042
sg12
S'PMC3001155'
p20043
sa(dp20044
g8
V23826502.xml
p20045
sg10
VSTD-Bhutta-2010
p20046
sg12
S'PMC3700035'
p20047
sa(dp20048
g8
V18568274.xml
p20049
sg10
VSTD-Bhutta-2008
p20050
sg12
S'PMC2647462'
p20051
sa(dp20052
g8
V17591349.xml
p20053
sg10
VSTD-Bari-2006
p20054
sg12
S'PMC3001156'
p20055
sasa(dp20056
g3
VCD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
p20057
sg5
(lp20058
(dp20059
g8
V3545418.xml
p20060
sg10
VSTD-Leech-1987
p20061
sg12
S'PMC1492041'
p20062
sa(dp20063
g8
V16227328.xml
p20064
sg10
VSTD-Alfageme-2006
p20065
sg12
S'PMC2080738'
p20066
sa(dp20067
g8
V20211953.xml
p20068
sg10
VSTD-Maruyama-2010
p20069
sg12
S'PMC2834887'
p20070
sasa(dp20071
g3
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p20072
sg5
(lp20073
(dp20074
g8
V12764515.xml
p20075
sg10
VSTD-Ferrari-2003-BRA
p20076
sg12
S'PMC2572425'
p20077
sa(dp20078
g8
V19296834.xml
p20079
sg10
VSTD-Tweyongyere-2009-UGA
p20080
sg12
S'PMC2666740'
p20081
sa(dp20082
g8
V678831.xml
p20083
sg10
VSTD-Omer-1978-SDN
p20084
sg12
S'PMC1606234'
p20085
sa(dp20086
g8
V21695161.xml
p20087
sg10
VSTD-Olliaro-2011-TZA
p20088
sg12
S'PMC3114749'
p20089
sa(dp20090
g8
V396054.xml
p20091
sg10
VSTD-Katz-1979b-BRA
p20092
sg12
S'PMC2395863'
p20093
sa(dp20094
g8
V21695161.xml
p20095
sg10
VSTD-Olliaro-2011-MRT
p20096
sg12
S'PMC3114749'
p20097
sa(dp20098
g8
V396054.xml
p20099
sg10
VSTD-Katz-1979a-BRA
p20100
sg12
S'PMC2395863'
p20101
sa(dp20102
g8
V21695161.xml
p20103
sg10
VSTD-Olliaro-2011-BRA
p20104
sg12
S'PMC3114749'
p20105
sasa(dp20106
g3
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p20107
sg5
(lp20108
(dp20109
g8
V19538406.xml
p20110
sg10
VSTD-Bergstrom-2009
p20111
sg12
S'PMC2759981'
p20112
sasa(dp20113
g3
VCD003893 v. 8.0 Methyldopa for primary hypertension.rm5
p20114
sg5
(lp20115
(dp20116
g8
V6378235.xml
p20117
sg10
VSTD-Lepantalo-1984
p20118
sg12
S'PMC1463567'
p20119
sa(dp20120
g8
V776350.xml
p20121
sg10
VSTD-Petrie-1976
p20122
sg12
S'PMC1687472'
p20123
sa(dp20124
g8
V7020900.xml
p20125
sg10
VSTD-Fernandez-1980
p20126
sg12
S'PMC1704774'
p20127
sasa(dp20128
g3
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p20129
sg5
(lp20130
(dp20131
g8
V10092691.xml
p20132
sg10
VSTD-Edwards-1999
p20133
sg12
S'PMC1745469'
p20134
sa(dp20135
g8
V18475604.xml
p20136
sg10
VSTD-Fiocchi-1994
p20137
sg12
S'PMC2365600'
p20138
sasa(dp20139
g3
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p20140
sg5
(lp20141
(dp20142
g8
V16536959.xml
p20143
sg10
VSTD-Muirhead-2006
p20144
sg12
S'PMC1828262'
p20145
sa(dp20146
g8
V18364043.xml
p20147
sg10
VSTD-Kouyate-2008
p20148
sg12
S'PMC2287184'
p20149
sa(dp20150
g8
V10589314.xml
p20151
sg10
VSTD-Olds-2002
p20152
sg12
S'PMC1509014'
p20153
sa(dp20154
g8
V14703543.xml
p20155
sg10
VSTD-Graffy-2004
p20156
sg12
S'PMC313903'
p20157
sa(dp20158
g8
V12196616.xml
p20159
sg10
VSTD-Morisky-2001
p20160
sg12
S'PMC1497389'
p20161
sa(dp20162
g8
V16507741.xml
p20163
sg10
VSTD-Gadomski-2006
p20164
sg12
S'PMC1470549'
p20165
sa(dp20166
g8
V19181730.xml
p20167
sg10
VSTD-MacArthur-2009
p20168
sg12
S'PMC2636685'
p20169
sa(dp20170
g8
V10977833.xml
p20171
sg10
VSTD-Morrell-2000
p20172
sg12
S'PMC27472'
p20173
sa(dp20174
g8
V10969426.xml
p20175
sg10
VSTD-Schuler-2000
p20176
sg12
S'PMC3143381'
p20177
sa(dp20178
g8
V17591349.xml
p20179
sg10
VSTD-Bari-2006
p20180
sg12
S'PMC3001156'
p20181
sa(dp20182
g8
V19147637.xml
p20183
sg10
VSTD-Dennis-2009
p20184
sg12
S'PMC2628301'
p20185
sa(dp20186
g8
V8518642.xml
p20187
sg10
VSTD-Johnson-1993
p20188
sg12
S'PMC1677859'
p20189
sa(dp20190
g8
V18686554.xml
p20191
sg10
VSTD-Zaman-2008
p20192
sg12
S'PMC2740673'
p20193
sa(dp20194
g8
V18026625.xml
p20195
sg10
VSTD-Wang-2007
p20196
sg12
S'PMC2636406'
p20197
sa(dp20198
g8
V434277.xml
p20199
sg10
VSTD-Colombo-1979
p20200
sg12
S'PMC1619135'
p20201
sasa(dp20202
g3
VCD001216 v. 8.0 Screening for colorectal cancer using the faecal occult blood test Hemoccult.rm5
p20203
sg5
(lp20204
(dp20205
g8
V12010887.xml
p20206
sg10
VSTD-Nottingham-2002
p20207
sg12
S'PMC1773232'
p20208
sa(dp20209
g8
V10486370.xml
p20210
sg10
VSTD-Nottingham-1999
p20211
sg12
S'PMC1727686'
p20212
sa(dp20213
g8
V11772963.xml
p20214
sg10
VSTD-Funen-2002
p20215
sg12
S'PMC1773083'
p20216
sasa(dp20217
g3
VCD002834 v. 7.0 Interventions targeted at women to encourage the uptake of cervical screening.rm5
p20218
sg5
(lp20219
(dp20220
g8
V11291370.xml
p20221
sg10
VSTD-Allen-2001
p20222
sg12
S'PMC1446631'
p20223
sa(dp20224
g8
V2495053.xml
p20225
sg10
VSTD-Robson-1989
p20226
sg12
S'PMC1835698'
p20227
sa(dp20228
g8
V12883063.xml
p20229
sg10
VSTD-Adab-2003
p20230
sg12
S'PMC1732533'
p20231
sa(dp20232
g8
V9294390.xml
p20233
sg10
VSTD-Buehler-1997
p20234
sg12
S'PMC1227965'
p20235
sa(dp20236
g8
V1958248.xml
p20237
sg10
VSTD-McAvoy-1991
p20238
sg12
S'PMC1669184'
p20239
sa(dp20240
g8
V11983755.xml
p20241
sg10
VSTD-Taylor-2002
p20242
sg12
S'PMC1592333'
p20243
sa(dp20244
g8
V1479324.xml
p20245
sg10
VSTD-Lancaster-1992
p20246
sg12
S'PMC1059645'
p20247
sa(dp20248
g8
V2504359.xml
p20249
sg10
VSTD-Pierce-1989
p20250
sg12
S'PMC1837038'
p20251
sa(dp20252
g8
V17329652.xml
p20253
sg10
VSTD-Mock-2007
p20254
sg12
S'PMC1963308'
p20255
sa(dp20256
g8
V3115368.xml
p20257
sg10
VSTD-Wilson-1987
p20258
sg12
S'PMC1247036'
p20259
sasa(dp20260
g3
VCD005129 v. 8.0 Immunoglobulins vaccines or interferon for preventing cytomegalovirus disease in solid organ transp.rm5
p20261
sg5
(lp20262
(dp20263
g8
V7492123.xml
p20264
sg10
VSTD-Aguado-95_x002d_Heart_x002f_GCV
p20265
sg12
S'PMC162800'
p20266
sasa(dp20267
g3
VCD001055 v. 7.0 Interventions for promoting smoking cessation during pregnancy.rm5
p20268
sg5
(lp20269
(dp20270
g8
V9240113.xml
p20271
sg10
VSTD-Walsh-1997
p20272
sg12
S'PMC1380897'
p20273
sa(dp20274
g8
V16096304.xml
p20275
sg10
VSTD-Tappin-2005
p20276
sg12
S'PMC1184246'
p20277
sa(dp20278
g8
V16565456.xml
p20279
sg10
VSTD-Campbell-2006
p20280
sg12
S'PMC2563553'
p20281
sa(dp20282
g8
V2293809.xml
p20283
sg10
VSTD-Mayer-1990
p20284
sg12
S'PMC1404549'
p20285
sa(dp20286
g8
V10224982.xml
p20287
sg10
VSTD-McBride-1999
p20288
sg12
S'PMC1508743'
p20289
sa(dp20290
g8
V6881407.xml
p20291
sg10
VSTD-Bauman-1983
p20292
sg12
S'PMC1651063'
p20293
sa(dp20294
g8
V10982910.xml
p20295
sg10
VSTD-Cinciripini-2000
p20296
sg12
S'PMC1766306'
p20297
sa(dp20298
g8
V856371.xml
p20299
sg10
VSTD-Donovan-1977
p20300
sg12
S'PMC478984'
p20301
sa(dp20302
g8
V10982912.xml
p20303
sg10
VSTD-Donatelle-2000
p20304
sg12
S'PMC1766304'
p20305
sa(dp20306
g8
V12773727.xml
p20307
sg10
VSTD-Lawrence-2003
p20308
sg12
S'PMC1747729'
p20309
sa(dp20310
g8
V10982916.xml
p20311
sg10
VSTD-Strecher-2000
p20312
sg12
S'PMC1766311'
p20313
sa(dp20314
g8
V7856781.xml
p20315
sg10
VSTD-Kendrick-1995
p20316
sg12
S'PMC1615299'
p20317
sa(dp20318
g8
V17888856.xml
p20319
sg10
VSTD-Pollak-2007
p20320
sg12
S'PMC3602964'
p20321
sa(dp20322
g8
V10982914.xml
p20323
sg10
VSTD-Solomon-2000
p20324
sg12
S'PMC1766314'
p20325
sa(dp20326
g8
V18482424.xml
p20327
sg10
VSTD-Heil-2008
p20328
sg12
S'PMC2731575'
p20329
sa(dp20330
g8
V4061709.xml
p20331
sg10
VSTD-Windsor-1985
p20332
sg12
S'PMC1646449'
p20333
sa(dp20334
g8
V2913837.xml
p20335
sg10
VSTD-Ershoff-1989
p20336
sg12
S'PMC1349930'
p20337
sa(dp20338
g8
V8427323.xml
p20339
sg10
VSTD-Windsor-1993
p20340
sg12
S'PMC1694576'
p20341
sa(dp20342
g8
V12480850.xml
p20343
sg10
VSTD-Moore-2002
p20344
sg12
S'PMC138509'
p20345
sasa(dp20346
g3
VCD000171 v. 12.0 Treatment of latent tuberculosis infection in HIV infected persons.rm5
p20347
sg5
(lp20348
(dp20349
g8
V17065029.xml
p20350
sg10
VSTD-Whalen-1997
p20351
sg12
S'PMC2860292'
p20352
sasa(dp20353
g3
VCD000553 v. 6.0 Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.rm5
p20354
sg5
(lp20355
(dp20356
g8
V11171831.xml
p20357
sg10
VSTD-P_x002d_Layrargues-2001
p20358
sg12
S'PMC1760139'
p20359
sa(dp20360
g8
V3307653.xml
p20361
sg10
VSTD-Rikkers-1987
p20362
sg12
S'PMC1493196'
p20363
sa(dp20364
g8
V2405792.xml
p20365
sg10
VSTD-Spina-1990
p20366
sg12
S'PMC1357962'
p20367
sasa(dp20368
g3
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p20369
sg5
(lp20370
(dp20371
g8
V12512504.xml
p20372
sg10
VSTD-Karatzas-2002
p20373
sg12
S'PMC153443'
p20374
sa(dp20375
g8
V12225613.xml
p20376
sg10
VSTD-Tugrul-2002
p20377
sg12
S'PMC125317'
p20378
sasa(dp20379
g3
VCD002290 v. 11.0 Non-corticosteroid treatment for nephrotic syndrome in children.rm5
p20380
sg5
(lp20381
(dp20382
g8
V4574639.xml
p20383
sg10
VSTD-Barratt-1973
p20384
sg12
S'PMC1648329'
p20385
sa(dp20386
g8
V4574639.xml
p20387
sg10
VSTD-Barratt-1970
p20388
sg12
S'PMC1648329'
p20389
sa(dp20390
g8
V879831.xml
p20391
sg10
VSTD-Barratt-1977
p20392
sg12
S'PMC1544692'
p20393
sa(dp20394
g8
V2248508.xml
p20395
sg10
VSTD-Ueda-1990
p20396
sg12
S'PMC1792340'
p20397
sasa(dp20398
g3
VCD008943 v. 3.0 Combination pharmacotherapy for the treatment of neuropathic pain in adults.rm5
p20399
sg5
(lp20400
(dp20401
g8
V10848721.xml
p20402
sg10
VSTD-McCleane-2000
p20403
sg12
S'PMC2015036'
p20404
sa(dp20405
g8
V17182183.xml
p20406
sg10
VSTD-Khoromi-2007
p20407
sg12
S'PMC1974876'
p20408
sa(dp20409
g8
V20496177.xml
p20410
sg10
VSTD-Barton-2011
p20411
sg12
S'PMC3338170'
p20412
sasa(dp20413
g3
VCD000213 v. 7.0 Thrombolysis for acute ischaemic stroke.rm5
p20414
sg5
(lp20415
(dp20416
g8
V19097942.xml
p20417
sg10
VSTD-DIAS-2-2008
p20418
sg12
S'PMC2730486'
p20419
sasa(dp20420
g3
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p20421
sg5
(lp20422
(dp20423
g8
V14759940.xml
p20424
sg10
VSTD-Unger-2004-_x0028_FLAVOR_x0029_
p20425
sg12
S'PMC1448241'
p20426
sa(dp20427
g8
V8435601.xml
p20428
sg10
VSTD-Nutbeam-1993-_x0028_FSE_x0029_
p20429
sg12
S'PMC1676653'
p20430
sa(dp20431
g8
V18675294.xml
p20432
sg10
VSTD-Sun-2008-_x0028_Cognitive_x0029_
p20433
sg12
S'PMC2784033'
p20434
sa(dp20435
g8
V12933772.xml
p20436
sg10
VSTD-Crone-2003
p20437
sg12
S'PMC1732562'
p20438
sa(dp20439
g8
V10691755.xml
p20440
sg10
VSTD-Biglan-2000
p20441
sg12
S'PMC1748303'
p20442
sa(dp20443
g8
V9772850.xml
p20444
sg10
VSTD-Kellam-1998-_x0028_GBG_x0029_
p20445
sg12
S'PMC1508467'
p20446
sa(dp20447
g8
V20655946.xml
p20448
sg10
VSTD-Rohrbach-2010a
p20449
sg12
S'PMC2939247'
p20450
sa(dp20451
g8
V19157042.xml
p20452
sg10
VSTD-Hecht-2008
p20453
sg12
S'PMC2892822'
p20454
sa(dp20455
g8
V18468543.xml
p20456
sg10
VSTD-Campbell-2008
p20457
sg12
S'PMC2387195'
p20458
sa(dp20459
g8
V19440519.xml
p20460
sg10
VSTD-Johnson-2009
p20461
sg12
S'PMC2681204'
p20462
sa(dp20463
g8
V10514156.xml
p20464
sg10
VSTD-Aveyard-1999
p20465
sg12
S'PMC28247'
p20466
sa(dp20467
g8
V3957152.xml
p20468
sg10
VSTD-Schinke-1986c
p20469
sg12
S'PMC1839926'
p20470
sa(dp20471
g8
V8669519.xml
p20472
sg10
VSTD-Perry-1996
p20473
sg12
S'PMC1380436'
p20474
sa(dp20475
g8
V10589310.xml
p20476
sg10
VSTD-Cameron-1999
p20477
sg12
S'PMC1509003'
p20478
sa(dp20479
g8
V14600049.xml
p20480
sg10
VSTD-Ellickson-2003
p20481
sg12
S'PMC1448059'
p20482
sa(dp20483
g8
V3090603.xml
p20484
sg10
VSTD-Schinke-1986a
p20485
sg12
S'PMC1477741'
p20486
sa(dp20487
g8
V4003636.xml
p20488
sg10
VSTD-Schinke-1985a
p20489
sg12
S'PMC1646189'
p20490
sa(dp20491
g8
V9842390.xml
p20492
sg10
VSTD-Noland-1998
p20493
sg12
S'PMC1509045'
p20494
sa(dp20495
g8
V17605536.xml
p20496
sg10
VSTD-Spoth-2007
p20497
sg12
S'PMC2848497'
p20498
sa(dp20499
g8
V19299670.xml
p20500
sg10
VSTD-Perry-2009
p20501
sg12
S'PMC2667859'
p20502
sasa(dp20503
g3
VCD002160 v. 11.0 Inhaled versus oral steroids for adults with chronic asthma.rm5
p20504
sg5
(lp20505
(dp20506
g8
V4558306.xml
p20507
sg10
VSTD-Lal-1972
p20508
sg12
S'PMC1785512'
p20509
sa(dp20510
g8
V3194866.xml
p20511
sg10
VSTD-Jenkins-1988
p20512
sg12
S'PMC461253'
p20513
sa(dp20514
g8
V8153939.xml
p20515
sg10
VSTD-Bosman-1994
p20516
sg12
S'PMC474084'
p20517
sasa(dp20518
g3
VCD006124 v. 4.1 Laparoscopic versus open nephrectomy for live kidney donors.rm5
p20519
sg5
(lp20520
(dp20521
g8
V16847014.xml
p20522
sg10
VSTD-Kok-2006
p20523
sg12
S'PMC1523437'
p20524
sasa(dp20525
g3
VCD004930 v. 6.0 Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal sur.rm5
p20526
sg5
(lp20527
(dp20528
g8
V15383800.xml
p20529
sg10
VSTD-Wolff-2004
p20530
sg12
S'PMC1356474'
p20531
sasa(dp20532
g3
VCD006432 v. 3.0 Simultaneous bilateral training for improving arm function after stroke.rm5
p20533
sg5
(lp20534
(dp20535
g8
V15494583.xml
p20536
sg10
VSTD-Luft-2004
p20537
sg12
S'PMC2930817'
p20538
sasa(dp20539
g3
VCD005038 v. 5.0 Massage for promoting mental and physical health in typically developing infants under the age of si.rm5
p20540
sg5
(lp20541
(dp20542
g8
V23625101.xml
p20543
sg10
VSTD-Oswalt-2007
p20544
sg12
S'PMC3639498'
p20545
sasa(dp20546
g3
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p20547
sg5
(lp20548
(dp20549
g8
V18476121.xml
p20550
sg10
VSTD-Edwards-1996
p20551
sg12
S'PMC2364515'
p20552
sa(dp20553
g8
V18476128.xml
p20554
sg10
VSTD-Martin-1997
p20555
sg12
S'PMC2364533'
p20556
sa(dp20557
g8
V18476049.xml
p20558
sg10
VSTD-Rosenn-1995
p20559
sg12
S'PMC2364446'
p20560
sa(dp20561
g8
V18475393.xml
p20562
sg10
VSTD-Turrentine-1995
p20563
sg12
S'PMC2364394'
p20564
sasa(dp20565
g3
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p20566
sg5
(lp20567
(dp20568
g8
V15946379.xml
p20569
sg10
VSTD-Khanna-2005
p20570
sg12
S'PMC1156915'
p20571
sasa(dp20572
g3
VCD001452 v. 10.0 Venepuncture versus heel lance for blood sampling in term neonates.rm5
p20573
sg5
(lp20574
(dp20575
g8
V9377140.xml
p20576
sg10
VSTD-Shah-1997
p20577
sg12
S'PMC1720690'
p20578
sa(dp20579
g8
V15871991.xml
p20580
sg10
VSTD-Ogawa-2005
p20581
sg12
S'PMC1721952'
p20582
sasa(dp20583
g3
VCD006039 v. 6.0 Resection versus no intervention or other surgical interventions for colorectal cancer liver metasta.rm5
p20584
sg5
(lp20585
(dp20586
g8
V9065296.xml
p20587
sg10
VSTD-Korpan-1997
p20588
sg12
S'PMC1190648'
p20589
sasa(dp20590
g3
VCD004126 v. 5.3 Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing su.rm5
p20591
sg5
(lp20592
(dp20593
g8
V8868976.xml
p20594
sg10
VSTD-Boldt-1996
p20595
sg12
S'PMC484507'
p20596
sasa(dp20597
g3
VCD004618 v. 4.0 Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perfor.rm5
p20598
sg5
(lp20599
(dp20600
g8
V6412934.xml
p20601
sg10
VSTD-Browning-1983a
p20602
sg12
S'PMC1549550'
p20603
sasa(dp20604
g3
VMR000010 v. 6.0 Grey literature in meta-analyses of randomized trials of health care interventions.rm5
p20605
sg5
(lp20606
(dp20607
g8
V23645909.xml
p20608
sg10
VSTD-Hopewell-2004
p20609
sg12
S'PMC3646177'
p20610
sasa(dp20611
g3
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p20612
sg5
(lp20613
(dp20614
g8
V20832366.xml
p20615
sg10
VSTD-Smithuis-2010-MMR
p20616
sg12
S'PMC2947715'
p20617
sa(dp20618
g8
V20409302.xml
p20619
sg10
VSTD-Awab-2010-AFG
p20620
sg12
S'PMC2864284'
p20621
sa(dp20622
g8
V17570973.xml
p20623
sg10
VSTD-Krudsood-2007-THA
p20624
sg12
S'PMC2526312'
p20625
sa(dp20626
g8
V17366451.xml
p20627
sg10
VSTD-Hasugian-2007-IDN
p20628
sg12
S'PMC2532501'
p20629
sa(dp20630
g8
V17336652.xml
p20631
sg10
VSTD-Ratcliff-2007-IDN
p20632
sg12
S'PMC2532500'
p20633
sa(dp20634
g8
V16179089.xml
p20635
sg10
VSTD-Hutagalung-2005-THA
p20636
sg12
S'PMC1261533'
p20637
sa(dp20638
g8
V21267072.xml
p20639
sg10
VSTD-Poravuth-2010-ASIA
p20640
sg12
S'PMC3022577'
p20641
sasa(dp20642
g3
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p20643
sg5
(lp20644
(dp20645
g8
V10926587.xml
p20646
sg10
VSTD-Bolliger-2000
p20647
sg12
S'PMC27447'
p20648
sa(dp20649
g8
V18242008.xml
p20650
sg10
VSTD-Hanson-2008
p20651
sg12
S'PMC2441529'
p20652
sa(dp20653
g8
V19943947.xml
p20654
sg10
VSTD-Kralikova-2009
p20655
sg12
S'PMC2792228'
p20656
sasa(dp20657
g3
VCD005162 v. 6.0 Terlipressin for hepatorenal syndrome.rm5
p20658
sg5
(lp20659
(dp20660
g8
V18471513.xml
p20661
sg10
VSTD-Sanyal-2008
p20662
sg12
S'PMC3730280'
p20663
sasa(dp20664
g3
VCD001533 v. 12.0 Corticosteroid therapy for nephrotic syndrome in children.rm5
p20665
sg5
(lp20666
(dp20667
g8
V346147.xml
p20668
sg10
VSTD-Leisti-1978
p20669
sg12
S'PMC1603701'
p20670
sa(dp20671
g8
V3933645.xml
p20672
sg10
VSTD-Imbasciali-1985
p20673
sg12
S'PMC1417455'
p20674
sasa(dp20675
g3
VCD002855 v. 8.0 Medical methods for first trimester abortion.rm5
p20676
sg5
(lp20677
(dp20678
g8
V8400972.xml
p20679
sg10
VSTD-WHO-1993-GP1pv
p20680
sg12
S'PMC1678631'
p20681
sasa(dp20682
g3
VCD008211 v. 3.0 Transparent Cap Colonoscopy versus Standard Colonoscopy to Improve Caecal Intubation.rm5
p20683
sg5
(lp20684
(dp20685
g8
V20712051.xml
p20686
sg10
VSTD-Tee-2010
p20687
sg12
S'PMC2923764'
p20688
sasa(dp20689
g3
VCD005252 v. 3.0 Avoidance of bottles during the establishment of breast feeds in preterm infants.rm5
p20690
sg5
(lp20691
(dp20692
g8
V15208209.xml
p20693
sg10
VSTD-Collins-2004
p20694
sg12
S'PMC487729'
p20695
sasa(dp20696
g3
VCD004307 v. 10.0 Competitions and incentives for smoking cessation.rm5
p20697
sg5
(lp20698
(dp20699
g8
V11818305.xml
p20700
sg10
VSTD-Hennrikus-2002
p20701
sg12
S'PMC1447056'
p20702
sa(dp20703
g8
V8362997.xml
p20704
sg10
VSTD-Gomel-1993
p20705
sg12
S'PMC1694995'
p20706
sa(dp20707
g8
V23626740.xml
p20708
sg10
VSTD-Paxton-1980
p20709
sg12
S'PMC3633932'
p20710
sa(dp20711
g8
V3946702.xml
p20712
sg10
VSTD-Klesges-1986
p20713
sg12
S'PMC1646475'
p20714
sa(dp20715
g8
V19443788.xml
p20716
sg10
VSTD-Tevyaw-2009
p20717
sg12
S'PMC2688604'
p20718
sasa(dp20719
g3
VCD008922 v. 2.0 Muscle relaxants for pain management in rheumatoid arthritis.rm5
p20720
sg5
(lp20721
(dp20722
g8
V787518.xml
p20723
sg10
VSTD-Bayley-1976
p20724
sg12
S'PMC2158317'
p20725
sasa(dp20726
g3
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p20727
sg5
(lp20728
(dp20729
g8
V14644853.xml
p20730
sg10
VSTD-Foley-2003
p20731
sg12
S'PMC1754378'
p20732
sa(dp20733
g8
V12364304.xml
p20734
sg10
VSTD-Thomas-2002
p20735
sg12
S'PMC128377'
p20736
sa(dp20737
g8
V10343535.xml
p20738
sg10
VSTD-O_x0027_Reilly-1999
p20739
sg12
S'PMC1752761'
p20740
sa(dp20741
g8
V15924620.xml
p20742
sg10
VSTD-Thorstensson-2005
p20743
sg12
S'PMC1187893'
p20744
sa(dp20745
g8
V15897310.xml
p20746
sg10
VSTD-Bennell-2005
p20747
sg12
S'PMC1755542'
p20748
sa(dp20749
g8
V17056608.xml
p20750
sg10
VSTD-Hay-2006
p20751
sg12
S'PMC1635605'
p20752
sasa(dp20753
g3
VCD006018 v. 4.0 Adjuvant chemotherapy for invasive bladder cancer (individual patient data).rm5
p20754
sg5
(lp20755
(dp20756
g8
V23533552.xml
p20757
sg10
VSTD-Otto-2001-_x0028_unpublished_x0029_
p20758
sg12
S'PMC3607090'
p20759
sasa(dp20760
g3
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p20761
sg5
(lp20762
(dp20763
g8
V19805679.xml
p20764
sg10
VSTD-Walker-2012
p20765
sg12
S'PMC2773219'
p20766
sa(dp20767
g8
V16381364.xml
p20768
sg10
VSTD-Zorlu-2005
p20769
sg12
S'PMC3015649'
p20770
sasa(dp20771
g3
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p20772
sg5
(lp20773
(dp20774
g8
V17563841.xml
p20775
sg10
VSTD-Misra-2007
p20776
sg12
S'PMC3476139'
p20777
sa(dp20778
g8
V15579612.xml
p20779
sg10
VSTD-Misra-2004
p20780
sg12
S'PMC1743152'
p20781
sasa(dp20782
g3
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p20783
sg5
(lp20784
(dp20785
g8
V17215967.xml
p20786
sg10
VSTD-Li-2006
p20787
sg12
S'PMC1764949'
p20788
sa(dp20789
g8
V18799004.xml
p20790
sg10
VSTD-De-La-Rosa-2008
p20791
sg12
S'PMC2592751'
p20792
sa(dp20793
g8
V19142552.xml
p20794
sg10
VSTD-Chan-2008
p20795
sg12
S'PMC2671976'
p20796
sasa(dp20797
g3
VCD004359 v. 6.0 Nurse specialist care for bronchiectasis.rm5
p20798
sg5
(lp20799
(dp20800
g8
V12149523.xml
p20801
sg10
VSTD-Sharples-2002
p20802
sg12
S'PMC1746394'
p20803
sasa(dp20804
g3
VCD004241 v. 6.6 Medical interventions for fungal keratitis.rm5
p20805
sg5
(lp20806
(dp20807
g8
V9828778.xml
p20808
sg10
VSTD-Rahman-1998
p20809
sg12
S'PMC1722716'
p20810
sa(dp20811
g8
V14507756.xml
p20812
sg10
VSTD-Prajna-2003
p20813
sg12
S'PMC1920780'
p20814
sa(dp20815
g8
V3281706.xml
p20816
sg10
VSTD-Mohan-1988
p20817
sg12
S'PMC1041404'
p20818
sa(dp20819
g8
V20547942.xml
p20820
sg10
VSTD-Prajna-2010
p20821
sg12
S'PMC3774126'
p20822
sasa(dp20823
g3
VCD000296 v. 6.0 Budesonide for induction of remission in Crohn's disease.rm5
p20824
sg5
(lp20825
(dp20826
g8
V9301500.xml
p20827
sg10
VSTD-Campieri-1997
p20828
sg12
S'PMC1891473'
p20829
sasa(dp20830
g3
VCD003480 v. 5.0 Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in prete.rm5
p20831
sg5
(lp20832
(dp20833
g8
V1996894.xml
p20834
sg10
VSTD-Rennie-1991
p20835
sg12
S'PMC1590349'
p20836
sasa(dp20837
g3
VCD006782 v. 4.0 Interventions for preventing hamstring injuries.rm5
p20838
sg5
(lp20839
(dp20840
g8
V21967753.xml
p20841
sg10
VSTD-Hoskins-2008
p20842
sg12
S'PMC3204266'
p20843
sasa(dp20844
g3
VCD004477 v. 7.0 Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.rm5
p20845
sg5
(lp20846
(dp20847
g8
V3516085.xml
p20848
sg10
VSTD-Holcroft-1986a
p20849
sg12
S'PMC1251120'
p20850
sasa(dp20851
g3
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p20852
sg5
(lp20853
(dp20854
g8
V19081791.xml
p20855
sg10
VSTD-Li-2008
p20856
sg12
S'PMC2597744'
p20857
sasa(dp20858
g3
VCD005292 v. 5.2 Herbal preparations for uterine fibroids.rm5
p20859
sg5
(lp20860
(dp20861
g8
V23813869.xml
p20862
sg10
VSTD-Liu-LY-2010
p20863
sg12
S'PMC3759346'
p20864
sa(dp20865
g8
V21201460.xml
p20866
sg10
VSTD-Zhu-FH-2006
p20867
sg12
S'PMC2960419'
p20868
sasa(dp20869
g3
VCD006577 v. 3.0 Music for stress and anxiety reduction in coronary heart disease patients.rm5
p20870
sg5
(lp20871
(dp20872
g8
V23813962.xml
p20873
sg10
VSTD-Chan-2007
p20874
sg12
S'PMC3757333'
p20875
sasa(dp20876
g3
VCD003225 v. 11.0 Propranolol for migraine prophylaxis.rm5
p20877
sg5
(lp20878
(dp20879
g8
V4604977.xml
p20880
sg10
VSTD-Wideroe-1974
p20881
sg12
S'PMC1611139'
p20882
sasa(dp20883
g3
VCD002948 v. 5.0 Herbal therapy for treating rheumatoid arthritis.rm5
p20884
sg5
(lp20885
(dp20886
g8
V19687490.xml
p20887
sg10
VSTD-Goldbach_x002d_Mansky-2009
p20888
sg12
S'PMC2938780'
p20889
sa(dp20890
g8
V2673080.xml
p20891
sg10
VSTD-Pattrick-1989
p20892
sg12
S'PMC1003814'
p20893
sa(dp20894
g8
V2833184.xml
p20895
sg10
VSTD-Belch-1988
p20896
sg12
S'PMC1003460'
p20897
sasa(dp20898
g3
VCD000262 v. 11.0 Antibiotics for treating bacterial vaginosis in pregnancy.rm5
p20899
sg5
(lp20900
(dp20901
g8
V19951217.xml
p20902
sg10
VSTD-Mitchell-2009
p20903
sg12
S'PMC2864467'
p20904
sa(dp20905
g8
V15294856.xml
p20906
sg10
VSTD-Kiss-2004
p20907
sg12
S'PMC509340'
p20908
sasa(dp20909
g3
VCD000501 v. 10.0 Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthw.rm5
p20910
sg5
(lp20911
(dp20912
g8
V11124916.xml
p20913
sg10
VSTD-Wardle-2001
p20914
sg12
S'PMC1721189'
p20915
sasa(dp20916
g3
VCD001206 v. 10.0 Pharmacotherapy for social anxiety disorder.rm5
p20917
sg5
(lp20918
(dp20919
g8
V6834370.xml
p20920
sg10
VSTD-James-1983
p20921
sg12
S'PMC1438733'
p20922
sasa(dp20923
g3
VCD008933 v. 3.0 Immunomodulators and immunosuppressants for multiple sclerosis a network meta-analysis.rm5
p20924
sg5
(lp20925
(dp20926
g8
V9048709.xml
p20927
sg10
VSTD-Edan-1997
p20928
sg12
S'PMC486720'
p20929
sa(dp20930
g8
V15090564.xml
p20931
sg10
VSTD-Andersen-2004
p20932
sg12
S'PMC1763573'
p20933
sa(dp20934
g8
V1783915.xml
p20935
sg10
VSTD-Likosky-1991
p20936
sg12
S'PMC1014677'
p20937
sasa(dp20938
g3
VCD004434 v. 8.2 Endothelin receptor antagonists for pulmonary arterial hypertension.rm5
p20939
sg5
(lp20940
(dp20941
g8
V20175775.xml
p20942
sg10
VSTD-ASSET_x002d_1
p20943
sg12
S'PMC2914575'
p20944
sasa(dp20945
g3
VCD001554 v. 8.0 Local corticosteroid injection for carpal tunnel syndrome.rm5
p20946
sg5
(lp20947
(dp20948
g8
V10506042.xml
p20949
sg10
VSTD-Dammers-1999
p20950
sg12
S'PMC28242'
p20951
sa(dp20952
g8
V11053073.xml
p20953
sg10
VSTD-O_x0027_Gradaigh-2000
p20954
sg12
S'PMC1753030'
p20955
sasa(dp20956
g3
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p20957
sg5
(lp20958
(dp20959
g8
V16622437.xml
p20960
sg10
VSTD-Wattchow-2006
p20961
sg12
S'PMC2361245'
p20962
sasa(dp20963
g3
VCD004185 v. 9.0 Fluoxetine versus other types of pharmacotherapy for depression.rm5
p20964
sg5
(lp20965
(dp20966
g8
V3263876.xml
p20967
sg10
VSTD-Upward-1988
p20968
sg12
S'PMC1386560'
p20969
sa(dp20970
g8
V9074306.xml
p20971
sg10
VSTD-Lapierre-1997
p20972
sg12
S'PMC1188834'
p20973
sasa(dp20974
g3
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p20975
sg5
(lp20976
(dp20977
g8
V18769904.xml
p20978
sg10
VSTD-Basu-2008a
p20979
sg12
S'PMC2701394'
p20980
sa(dp20981
g8
V19688338.xml
p20982
sg10
VSTD-Russell_x002d_Jones-2009
p20983
sg12
S'PMC2744824'
p20984
sa(dp20985
g8
V11118008.xml
p20986
sg10
VSTD-Hundal-2000
p20987
sg12
S'PMC2995498'
p20988
sa(dp20989
g8
V589351.xml
p20990
sg10
VSTD-Clarke-1977
p20991
sg12
S'PMC1632725'
p20992
sa(dp20993
g8
V17493545.xml
p20994
sg10
VSTD-Lingvay-2007
p20995
sg12
S'PMC1994788'
p20996
sa(dp20997
g8
V17403121.xml
p20998
sg10
VSTD-Home-2007
p20999
sg12
S'PMC1974817'
p21000
sa(dp21001
g8
V19622782.xml
p21002
sg10
VSTD-Phillips-2009
p21003
sg12
S'PMC2739702'
p21004
sa(dp21005
g8
V19267711.xml
p21006
sg10
VSTD-Gupta-2009
p21007
sg12
S'PMC2748337'
p21008
sa(dp21009
g8
V17846932.xml
p21010
sg10
VSTD-Vahatalo-2007
p21011
sg12
S'PMC3379773'
p21012
sa(dp21013
g8
V2647992.xml
p21014
sg10
VSTD-Rains-1989
p21015
sg12
S'PMC1292002'
p21016
sa(dp21017
g8
V19289857.xml
p21018
sg10
VSTD-Zinman-2009
p21019
sg12
S'PMC2699702'
p21020
sa(dp21021
g8
V19114612.xml
p21022
sg10
VSTD-List-2009
p21023
sg12
S'PMC2660449'
p21024
sa(dp21025
g8
V19366970.xml
p21026
sg10
VSTD-Nauck-2009b
p21027
sg12
S'PMC2699710'
p21028
sa(dp21029
g8
V18931095.xml
p21030
sg10
VSTD-Nauck-2009a
p21031
sg12
S'PMC2606836'
p21032
sa(dp21033
g8
V3192752.xml
p21034
sg10
VSTD-McBain-1988
p21035
sg12
S'PMC1141646'
p21036
sa(dp21037
g8
V6428619.xml
p21038
sg10
VSTD-Peacock-1984
p21039
sg12
S'PMC1442249'
p21040
sa(dp21041
g8
V6403102.xml
p21042
sg10
VSTD-Lord-1983
p21043
sg12
S'PMC1547150'
p21044
sasa(dp21045
g3
VCD003664 v. 5.0 Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.rm5
p21046
sg5
(lp21047
(dp21048
g8
V9279143.xml
p21049
sg10
VSTD-Oldaeus-1997
p21050
sg12
S'PMC1717242'
p21051
sasa(dp21052
g3
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p21053
sg5
(lp21054
(dp21055
g8
V21681863.xml
p21056
sg10
VSTD-Masia_x002d_Warner-2011
p21057
sg12
S'PMC3128648'
p21058
sa(dp21059
g8
V22588377.xml
p21060
sg10
VSTD-McNally-Keehn-2012
p21061
sg12
S'PMC3537891'
p21062
sa(dp21063
g8
V21356037.xml
p21064
sg10
VSTD-Melfsen-2011
p21065
sg12
S'PMC3058082'
p21066
sa(dp21067
g8
V22735897.xml
p21068
sg10
VSTD-White-2012
p21069
sg12
S'PMC3494811'
p21070
sa(dp21071
g8
V18974308.xml
p21072
sg10
VSTD-Walkup-2008
p21073
sg12
S'PMC2702984'
p21074
sasa(dp21075
g3
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p21076
sg5
(lp21077
(dp21078
g8
V20004065.xml
p21079
sg10
VSTD-Schnoll-2010b
p21080
sg12
S'PMC2834192'
p21081
sa(dp21082
g8
V20124230.xml
p21083
sg10
VSTD-Schnoll-2010a
p21084
sg12
S'PMC3782858'
p21085
sa(dp21086
g8
V12149533.xml
p21087
sg10
VSTD-Hand-2002
p21088
sg12
S'PMC1746389'
p21089
sa(dp21090
g8
V12775857.xml
p21091
sg10
VSTD-Molyneux-2003
p21092
sg12
S'PMC1746718'
p21093
sa(dp21094
g8
V1503165.xml
p21095
sg10
VSTD-Pirie-1992
p21096
sg12
S'PMC1694323'
p21097
sa(dp21098
g8
V9924052.xml
p21099
sg10
VSTD-Blondal-1999
p21100
sg12
S'PMC27708'
p21101
sa(dp21102
g8
V19549054.xml
p21103
sg10
VSTD-Cooney-2009
p21104
sg12
S'PMC2753831'
p21105
sa(dp21106
g8
V3922510.xml
p21107
sg10
VSTD-Marshall-1985
p21108
sg12
S'PMC1415622'
p21109
sa(dp21110
g8
V22323576.xml
p21111
sg10
VSTD-T_x00f8_nnesen-2012
p21112
sg12
S'PMC3432241'
p21113
sa(dp21114
g8
V9462488.xml
p21115
sg10
VSTD-Ahluwalia-1998
p21116
sg12
S'PMC1496888'
p21117
sa(dp21118
g8
V20537810.xml
p21119
sg10
VSTD-Hughes-2010
p21120
sg12
S'PMC2930079'
p21121
sa(dp21122
g8
V19884613.xml
p21123
sg10
VSTD-Piper-2009
p21124
sg12
S'PMC2933113'
p21125
sa(dp21126
g8
V18827129.xml
p21127
sg10
VSTD-Oncken-2008
p21128
sg12
S'PMC2630492'
p21129
sa(dp21130
g8
V7640544.xml
p21131
sg10
VSTD-Gourlay-1995
p21132
sg12
S'PMC2550432'
p21133
sa(dp21134
g8
V6402162.xml
p21135
sg10
VSTD-Br-Thor-Society-1983
p21136
sg12
S'PMC1546807'
p21137
sa(dp21138
g8
V8019282.xml
p21139
sg10
VSTD-ICRF-1994
p21140
sg12
S'PMC2540289'
p21141
sa(dp21142
g8
V10926587.xml
p21143
sg10
VSTD-Bolliger-2000a
p21144
sg12
S'PMC27447'
p21145
sa(dp21146
g8
V20008701.xml
p21147
sg10
VSTD-Smith-2009
p21148
sg12
S'PMC2891174'
p21149
sa(dp21150
g8
V3933739.xml
p21151
sg10
VSTD-Clavel-1985
p21152
sg12
S'PMC1418170'
p21153
sa(dp21154
g8
V19339135.xml
p21155
sg10
VSTD-Gariti-2009
p21156
sg12
S'PMC2778325'
p21157
sa(dp21158
g8
V6434084.xml
p21159
sg10
VSTD-Jamrozik-1984
p21160
sg12
S'PMC1442980'
p21161
sa(dp21162
g8
V20379614.xml
p21163
sg10
VSTD-Rose-2010
p21164
sg12
S'PMC2896464'
p21165
sa(dp21166
g8
V17763111.xml
p21167
sg10
VSTD-Piper-2007
p21168
sg12
S'PMC3030120'
p21169
sa(dp21170
g8
V17888856.xml
p21171
sg10
VSTD-Pollak-2007
p21172
sg12
S'PMC3602964'
p21173
sa(dp21174
g8
V6416593.xml
p21175
sg10
VSTD-Russell-1983
p21176
sg12
S'PMC1549849'
p21177
sa(dp21178
g8
V10553392.xml
p21179
sg10
VSTD-Hays-1999
p21180
sg12
S'PMC1508975'
p21181
sasa(dp21182
g3
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p21183
sg5
(lp21184
(dp21185
g8
V18204830.xml
p21186
sg10
VSTD-Rosenstock-2008
p21187
sg12
S'PMC2235909'
p21188
sa(dp21189
g8
V20200301.xml
p21190
sg10
VSTD-Swinnen-2010a
p21191
sg12
S'PMC2875419'
p21192
sasa(dp21193
g3
VCD007335 v. 3.0 Interventions to improve question formulation in professional practice and self-directed learning.rm5
p21194
sg5
(lp21195
(dp21196
g8
V11999177.xml
p21197
sg10
VSTD-Bradley-2002
p21198
sg12
S'PMC100764'
p21199
sa(dp21200
g8
V11716797.xml
p21201
sg10
VSTD-Villanueva-2001
p21202
sg12
S'PMC59901'
p21203
sasa(dp21204
g3
VCD006612 v. 4.0 Homocysteine-lowering interventions for preventing cardiovascular events.rm5
p21205
sg5
(lp21206
(dp21207
g8
V21115589.xml
p21208
sg10
VSTD-SU.FOL.OM3-2010
p21209
sg12
S'PMC2993045'
p21210
sa(dp21211
g8
V18460663.xml
p21212
sg10
VSTD-WAFACS-2008
p21213
sg12
S'PMC2684623'
p21214
sa(dp21215
g8
V19118243.xml
p21216
sg10
VSTD-BVAIT-2009
p21217
sg12
S'PMC2701290'
p21218
sasa(dp21219
g3
VCD002127 v. 5.0 Mitoxantrone for multiple sclerosis.rm5
p21220
sg5
(lp21221
(dp21222
g8
V9048709.xml
p21223
sg10
VSTD-Edan-1997
p21224
sg12
S'PMC486720'
p21225
sasa(dp21226
g3
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p21227
sg5
(lp21228
(dp21229
g8
V18947426.xml
p21230
sg10
VSTD-Westerbeek-2010
p21231
sg12
S'PMC2579424'
p21232
sa(dp21233
g8
V16873437.xml
p21234
sg10
VSTD-Moro-2006
p21235
sg12
S'PMC2066015'
p21236
sasa(dp21237
g3
VCD002242 v. 6.0 Antibiotic treatment for travellers' diarrhoea.rm5
p21238
sg5
(lp21239
(dp21240
g8
V6385838.xml
p21241
sg10
VSTD-DuPont-1984
p21242
sg12
S'PMC284111'
p21243
sa(dp21244
g8
V1482152.xml
p21245
sg10
VSTD-Ericsson-1992
p21246
sg12
S'PMC245552'
p21247
sa(dp21248
g8
V3524436.xml
p21249
sg10
VSTD-Ericsson-1986
p21250
sg12
S'PMC180497'
p21251
sa(dp21252
g8
V1590705.xml
p21253
sg10
VSTD-DuPont-1992b
p21254
sg12
S'PMC189232'
p21255
sasa(dp21256
g3
VCD004378 v. 4.0 Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm .rm5
p21257
sg5
(lp21258
(dp21259
g8
V10575581.xml
p21260
sg10
VSTD-Ertzeid-1999
p21261
sg12
S'PMC3455375'
p21262
sasa(dp21263
g3
VCD005095 v. 5.0 Enteral iron supplementation in preterm and low birth weight infants.rm5
p21264
sg5
(lp21265
(dp21266
g8
V10375362.xml
p21267
sg10
VSTD-Griffin-1999
p21268
sg12
S'PMC1720946'
p21269
sa(dp21270
g8
V13149207.xml
p21271
sg10
VSTD-Coles-1954
p21272
sg12
S'PMC2011580'
p21273
sa(dp21274
g8
V15613506.xml
p21275
sg10
VSTD-Aggarwal-2005
p21276
sg12
S'PMC1720080'
p21277
sasa(dp21278
g3
VCD008388 v. 2.0 Interventions for visual field defects in patients with stroke.rm5
p21279
sg5
(lp21280
(dp21281
g8
V17536049.xml
p21282
sg10
VSTD-Spitzyna-2007
p21283
sg12
S'PMC2651560'
p21284
sasa(dp21285
g3
VCD005374 v. 3.0 Oral corticosteroids for stable chronic obstructive pulmonary disease.rm5
p21286
sg5
(lp21287
(dp21288
g8
V4603999.xml
p21289
sg10
VSTD-Evans-1974
p21290
sg12
S'PMC470171'
p21291
sa(dp21292
g8
V3538487.xml
p21293
sg10
VSTD-Mitchell-1986
p21294
sg12
S'PMC460405'
p21295
sa(dp21296
g8
V8511727.xml
p21297
sg10
VSTD-Weir-1993
p21298
sg12
S'PMC464423'
p21299
sa(dp21300
g8
V2180105.xml
p21301
sg10
VSTD-Weir-1990
p21302
sg12
S'PMC462320'
p21303
sa(dp21304
g8
V1412119.xml
p21305
sg10
VSTD-Wempe-1992
p21306
sg12
S'PMC463924'
p21307
sasa(dp21308
g3
VCD007966 v. 2.19 Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.rm5
p21309
sg5
(lp21310
(dp21311
g8
V18971491.xml
p21312
sg10
VSTD-Morris-2008
p21313
sg12
S'PMC2821221'
p21314
sa(dp21315
g8
V19043499.xml
p21316
sg10
VSTD-Jangaard-2007
p21317
sg12
S'PMC2532565'
p21318
sasa(dp21319
g3
VCD009063 v. 2.0 Pregabalin for chronic prostatitis.rm5
p21320
sg5
(lp21321
(dp21322
g8
V20876412.xml
p21323
sg10
VSTD-Pontari-2010
p21324
sg12
S'PMC3767281'
p21325
sasa(dp21326
g3
VCD000499 v. 6.0 Kinesthetic stimulation for treating apnea in preterm infants.rm5
p21327
sg5
(lp21328
(dp21329
g8
V7092314.xml
p21330
sg10
VSTD-Tuck-1982
p21331
sg12
S'PMC1627664'
p21332
sasa(dp21333
g3
VCD009689 v. 2.0 Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment f.rm5
p21334
sg5
(lp21335
(dp21336
g8
V20434603.xml
p21337
sg10
VSTD-Weber-2010
p21338
sg12
S'PMC2880820'
p21339
sasa(dp21340
g3
VCD004517 v. 8.0 Music therapy for depression.rm5
p21341
sg5
(lp21342
(dp21343
g8
V18746179.xml
p21344
sg10
VSTD-Hendricks-1999
p21345
sg12
S'PMC1634668'
p21346
sasa(dp21347
g3
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p21348
sg5
(lp21349
(dp21350
g8
V15312215.xml
p21351
sg10
VSTD-Emet-2004
p21352
sg12
S'PMC522835'
p21353
sa(dp21354
g8
V19114891.xml
p21355
sg10
VSTD-Charunwatthana-2009
p21356
sg12
S'PMC2731834'
p21357
sa(dp21358
g8
V1954453.xml
p21359
sg10
VSTD-Keays-1991
p21360
sg12
S'PMC1671790'
p21361
sa(dp21362
g8
V19524577.xml
p21363
sg10
VSTD-Lee-2009
p21364
sg12
S'PMC3189485'
p21365
sasa(dp21366
g3
VCD003840 v. 10.0 Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.rm5
p21367
sg5
(lp21368
(dp21369
g8
V8491391.xml
p21370
sg10
VSTD-Bianchi-Porro-1993
p21371
sg12
S'PMC1374304'
p21372
sa(dp21373
g8
V1392995.xml
p21374
sg10
VSTD-Hosking-1992
p21375
sg12
S'PMC1882868'
p21376
sa(dp21377
g8
V9274470.xml
p21378
sg10
VSTD-Lam-1997
p21379
sg12
S'PMC1027226'
p21380
sa(dp21381
g8
V9055715.xml
p21382
sg10
VSTD-Axon-1997
p21383
sg12
S'PMC2126021'
p21384
sa(dp21385
g8
V9301496.xml
p21386
sg10
VSTD-Bardhan-1997
p21387
sg12
S'PMC1891448'
p21388
sasa(dp21389
g3
VCD006880 v. 2.4 Techniques for liver parenchymal transection in liver resection.rm5
p21390
sg5
(lp21391
(dp21392
g8
V16327491.xml
p21393
sg10
VSTD-Lesurtel-2005
p21394
sg12
S'PMC1409877'
p21395
sasa(dp21396
g3
VCD009934 v. 2.0 Green and black tea for the primary prevention of cardiovascular disease.rm5
p21397
sg5
(lp21398
(dp21399
g8
V20807303.xml
p21400
sg10
VSTD-Stendell_x002d_Hollis-2010
p21401
sg12
S'PMC2966548'
p21402
sa(dp21403
g8
V17892999.xml
p21404
sg10
VSTD-Mukamal-2007
p21405
sg12
S'PMC2084262'
p21406
sasa(dp21407
g3
VCD001108 v. 9.0 Azoles for allergic bronchopulmonary aspergillosis associated with asthma.rm5
p21408
sg5
(lp21409
(dp21410
g8
V3303424.xml
p21411
sg10
VSTD-Shale-1987
p21412
sg12
S'PMC460599'
p21413
sasa(dp21414
g3
VCD004299 v. 3.0 Interventions for cellulitis and erysipelas.rm5
p21415
sg5
(lp21416
(dp21417
g8
V11451697.xml
p21418
sg10
VSTD-Tarshis-2001
p21419
sg12
S'PMC90654'
p21420
sa(dp21421
g8
V15917519.xml
p21422
sg10
VSTD-Weigelt-2005
p21423
sg12
S'PMC1140485'
p21424
sa(dp21425
g8
V12386036.xml
p21426
sg10
VSTD-Bernard-2002
p21427
sg12
S'PMC129632'
p21428
sa(dp21429
g8
V15843702.xml
p21430
sg10
VSTD-Leman-2005
p21431
sg12
S'PMC1726763'
p21432
sasa(dp21433
g3
VCD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
p21434
sg5
(lp21435
(dp21436
g8
V1503165.xml
p21437
sg10
VSTD-_x0031_-Pirie-1992
p21438
sg12
S'PMC1694323'
p21439
sa(dp21440
g8
V1585959.xml
p21441
sg10
VSTD-_x0031_-Hall-1992
p21442
sg12
S'PMC1694191'
p21443
sa(dp21444
g8
V1503165.xml
p21445
sg10
VSTD-_x0032_-NRT-Pirie-1992
p21446
sg12
S'PMC1694323'
p21447
sa(dp21448
g8
V18263663.xml
p21449
sg10
VSTD-_x0032_-VA-Aubin-2008
p21450
sg12
S'PMC2569194'
p21451
sa(dp21452
g8
V20308641.xml
p21453
sg10
VSTD-_x0031_-Levine-2010
p21454
sg12
S'PMC3113531'
p21455
sa(dp21456
g8
V18777992.xml
p21457
sg10
VSTD-_x0032_-NRT-Pack-2008
p21458
sg12
S'PMC3174063'
p21459
sa(dp21460
g8
V9924052.xml
p21461
sg10
VSTD-_x0032_-NRT-Blondal-1999
p21462
sg12
S'PMC27708'
p21463
sa(dp21464
g8
V10454403.xml
p21465
sg10
VSTD-_x0031_-Danielsson-1999
p21466
sg12
S'PMC28202'
p21467
sa(dp21468
g8
V17763111.xml
p21469
sg10
VSTD-_x0032_-AD-Piper-2007
p21470
sg12
S'PMC3030120'
p21471
sa(dp21472
g8
V20542391.xml
p21473
sg10
VSTD-_x0031_-Toll-2010
p21474
sg12
S'PMC3771701'
p21475
sa(dp21476
g8
V7640544.xml
p21477
sg10
VSTD-_x0032_-NRT-Gourlay-1995
p21478
sg12
S'PMC2550432'
p21479
sasa(dp21480
g3
VCD004800 v. 6.0 Sulfasalazine for ankylosing spondylitis.rm5
p21481
sg5
(lp21482
(dp21483
g8
V2872857.xml
p21484
sg10
VSTD-Feltelius-1986
p21485
sg12
S'PMC1001898'
p21486
sa(dp21487
g8
V2876744.xml
p21488
sg10
VSTD-Dougados-1986
p21489
sg12
S'PMC1341708'
p21490
sasa(dp21491
g3
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p21492
sg5
(lp21493
(dp21494
g8
V19812130.xml
p21495
sg10
VSTD-Kuijper-2009
p21496
sg12
S'PMC2758937'
p21497
sa(dp21498
g8
V12946968.xml
p21499
sg10
VSTD-Viljanen-2006
p21500
sg12
S'PMC188429'
p21501
sa(dp21502
g8
V21303529.xml
p21503
sg10
VSTD-Martel-2011
p21504
sg12
S'PMC3045999'
p21505
sasa(dp21506
g3
VCD009138 v. 2.0 Amitriptyline versus placebo for major depressive disorder.rm5
p21507
sg5
(lp21508
(dp21509
g8
V8297924.xml
p21510
sg10
VSTD-Kusalic-1993
p21511
sg12
S'PMC1188546'
p21512
sa(dp21513
g8
V4923928.xml
p21514
sg10
VSTD-Blashki-1971
p21515
sg12
S'PMC1795147'
p21516
sa(dp21517
g8
V7873952.xml
p21518
sg10
VSTD-Mynors_x002d_Wallis-1995
p21519
sg12
S'PMC2548821'
p21520
sasa(dp21521
g3
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p21522
sg5
(lp21523
(dp21524
g8
V19216794.xml
p21525
sg10
VSTD-Str_x00f6_hlein-2009
p21526
sg12
S'PMC2644666'
p21527
sa(dp21528
g8
V18483372.xml
p21529
sg10
VSTD-Gulley-2008
p21530
sg12
S'PMC2673097'
p21531
sa(dp21532
g8
V17652518.xml
p21533
sg10
VSTD-Odunsi-2007
p21534
sg12
S'PMC1937553'
p21535
sa(dp21536
g8
V17652518.xml
p21537
sg10
VSTD-Odunsi-2007a
p21538
sg12
S'PMC1937553'
p21539
sasa(dp21540
g3
VCD002828 v. 9.0 Corticosteroids for myasthenia gravis.rm5
p21541
sg5
(lp21542
(dp21543
g8
V8229026.xml
p21544
sg10
VSTD-Gajdos-1993
p21545
sg12
S'PMC489815'
p21546
sasa(dp21547
g3
VCD005533 v. 3.0 Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in ad.rm5
p21548
sg5
(lp21549
(dp21550
g8
V10325895.xml
p21551
sg10
VSTD-Van-Noord-1999
p21552
sg12
S'PMC1745431'
p21553
sa(dp21554
g8
V10999872.xml
p21555
sg10
VSTD-Heuck-2000
p21556
sg12
S'PMC1718508'
p21557
sasa(dp21558
g3
VCD000198 v. 12.0 Support during pregnancy for women at increased risk of low birthweight babies.rm5
p21559
sg5
(lp21560
(dp21561
g8
V11519238.xml
p21562
sg10
VSTD-Brooten-2001
p21563
sg12
S'PMC3544939'
p21564
sa(dp21565
g8
V11189800.xml
p21566
sg10
VSTD-Klerman-2001
p21567
sg12
S'PMC1446489'
p21568
sasa(dp21569
g3
VCD007005 v. 2.0 Arthrographic distension for adhesive capsulitis (frozen shoulder).rm5
p21570
sg5
(lp21571
(dp21572
g8
V14962967.xml
p21573
sg10
VSTD-Buchbinder-2004
p21574
sg12
S'PMC1754915'
p21575
sa(dp21576
g8
V1855018.xml
p21577
sg10
VSTD-Jacobs-1991
p21578
sg12
S'PMC1670184'
p21579
sasa(dp21580
g3
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p21581
sg5
(lp21582
(dp21583
g8
V16641904.xml
p21584
sg10
VSTD-Manegold-2003
p21585
sg12
S'PMC2361263'
p21586
sasa(dp21587
g3
VCD007017 v. 4.2 Pharmaceutical policies effects of cap and co-payment on rational drug use.rm5
p21588
sg5
(lp21589
(dp21590
g8
V15809411.xml
p21591
sg10
VSTD-Huskamp-2005
p21592
sg12
S'PMC1403292'
p21593
sa(dp21594
g8
V11599328.xml
p21595
sg10
VSTD-Kozyrskyj-2001
p21596
sg12
S'PMC81497'
p21597
sa(dp21598
g8
V10029499.xml
p21599
sg10
VSTD-Cromwell-1999
p21600
sg12
S'PMC1070338'
p21601
sasa(dp21602
g3
VCD002109 v. 7.0 Antibiotics for community acquired pneumonia in adult outpatients.rm5
p21603
sg5
(lp21604
(dp21605
g8
V16189077.xml
p21606
sg10
VSTD-D_x0027_Ignazio-2005
p21607
sg12
S'PMC1251562'
p21608
sasa(dp21609
g3
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p21610
sg5
(lp21611
(dp21612
g8
V17361345.xml
p21613
sg10
VSTD-van-der-Kooi-2007
p21614
sg12
S'PMC2779375'
p21615
sasa(dp21616
g3
VCD000405 v. 10.0 Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants.rm5
p21617
sg5
(lp21618
(dp21619
g8
V9828735.xml
p21620
sg10
VSTD-Siu-1998
p21621
sg12
S'PMC1720837'
p21622
sasa(dp21623
g3
VCD008231 v. 3.0 Intranasal ipratropium bromide for the common cold.rm5
p21624
sg5
(lp21625
(dp21626
g8
V2855297.xml
p21627
sg10
VSTD-Gaffey-1988
p21628
sg12
S'PMC175945'
p21629
sasa(dp21630
g3
VCD001733 v. 13.0 Pentoxifylline for treating venous leg ulcers.rm5
p21631
sg5
(lp21632
(dp21633
g8
V10506039.xml
p21634
sg10
VSTD-Dale-1999
p21635
sg12
S'PMC28239'
p21636
sa(dp21637
g8
V2256974.xml
p21638
sg10
VSTD-Colgan-1990
p21639
sg12
S'PMC1662706'
p21640
sasa(dp21641
g3
VCD000096 v. 7.0 Glycerol for acute stroke.rm5
p21642
sg5
(lp21643
(dp21644
g8
V2310658.xml
p21645
sg10
VSTD-Yu-1993
p21646
sg12
S'PMC1380136'
p21647
sasa(dp21648
g3
VCD009287 v. 2.0 Media campaigns for the prevention of illicit drug use in young people.rm5
p21649
sg5
(lp21650
(dp21651
g8
V19728091.xml
p21652
sg10
VSTD-Schwinn-2010
p21653
sg12
S'PMC2822104'
p21654
sa(dp21655
g8
V11818299.xml
p21656
sg10
VSTD-Fishbein-2002
p21657
sg12
S'PMC1447050'
p21658
sa(dp21659
g8
V20565152.xml
p21660
sg10
VSTD-Lee-2010
p21661
sg12
S'PMC2891541'
p21662
sa(dp21663
g8
V21271357.xml
p21664
sg10
VSTD-Slater-2011
p21665
sg12
S'PMC3042048'
p21666
sa(dp21667
g8
V11211642.xml
p21668
sg10
VSTD-Palmgreen-2001
p21669
sg12
S'PMC1446528'
p21670
sa(dp21671
g8
V20970090.xml
p21672
sg10
VSTD-Fang-2010
p21673
sg12
S'PMC2964276'
p21674
sa(dp21675
g8
V21421952.xml
p21676
sg10
VSTD-Carpenter-2011
p21677
sg12
S'PMC3076395'
p21678
sasa(dp21679
g3
VCD006574 v. 4.0 Abdominal lift for laparoscopic cholecystectomy.rm5
p21680
sg5
(lp21681
(dp21682
g8
V15075657.xml
p21683
sg10
VSTD-Alijani-2004
p21684
sg12
S'PMC1356238'
p21685
sasa(dp21686
g3
VCD000212 v. 7.0 Interventions for treating psoriatic arthritis.rm5
p21687
sg5
(lp21688
(dp21689
g8
V3883917.xml
p21690
sg10
VSTD-Hopkins-1985
p21691
sg12
S'PMC1001603'
p21692
sa(dp21693
g8
V8250615.xml
p21694
sg10
VSTD-McKendry-1993
p21695
sg12
S'PMC1005197'
p21696
sasa(dp21697
g3
VCD007635 v. 2.0 Fast track surgery versus conventional recovery strategies for colorectal surgery.rm5
p21698
sg5
(lp21699
(dp21700
g8
V17522511.xml
p21701
sg10
VSTD-Khoo-2007
p21702
sg12
S'PMC1876970'
p21703
sasa(dp21704
g3
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p21705
sg5
(lp21706
(dp21707
g8
V17388666.xml
p21708
sg10
VSTD-Gregson-2007
p21709
sg12
S'PMC1831737'
p21710
sasa(dp21711
g3
VCD002097 v. 6.15 Primary care professionals providing non-urgent care in hospital emergency departments.rm5
p21712
sg5
(lp21713
(dp21714
g8
V7640592.xml
p21715
sg10
VSTD-Dale-1995
p21716
sg12
S'PMC2550494'
p21717
sa(dp21718
g8
V8620132.xml
p21719
sg10
VSTD-Murphy-1996
p21720
sg12
S'PMC2350641'
p21721
sa(dp21722
g8
V10622016.xml
p21723
sg10
VSTD-Gibney-1999
p21724
sg12
S'PMC1313317'
p21725
sasa(dp21726
g3
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p21727
sg5
(lp21728
(dp21729
g8
V19729522.xml
p21730
sg10
VSTD-Echeverry-2009
p21731
sg12
S'PMC2782968'
p21732
sa(dp21733
g8
V17570858.xml
p21734
sg10
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p21735
sg12
S'PMC1914073'
p21736
sa(dp21737
g8
V21478777.xml
p21738
sg10
VSTD-Piette-2011
p21739
sg12
S'PMC3117978'
p21740
sa(dp21741
g8
V12747810.xml
p21742
sg10
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p21743
sg12
S'PMC165418'
p21744
sa(dp21745
g8
V24058553.xml
p21746
sg10
VSTD-Xue-2004
p21747
sg12
S'PMC3772925'
p21748
sa(dp21749
g8
V21216855.xml
p21750
sg10
VSTD-van-Bastelaar-2011
p21751
sg12
S'PMC3024341'
p21752
sasa(dp21753
g3
VCD004404 v. 9.0 Antibiotics for whooping cough (pertussis).rm5
p21754
sg5
(lp21755
(dp21756
g8
V4336846.xml
p21757
sg10
VSTD-Adcock-1972
p21758
sg12
S'PMC1648034'
p21759
sasa(dp21760
g3
VCD007095 v. 5.0 Xylitol for preventing acute otitis media in children up to 12 years of age.rm5
p21761
sg5
(lp21762
(dp21763
g8
V8916749.xml
p21764
sg10
VSTD-Uhari-1996
p21765
sg12
S'PMC2352484'
p21766
sasa(dp21767
g3
VCD001796 v. 8.0 Aerobic exercise interventions for adults living with HIVAIDS.rm5
p21768
sg5
(lp21769
(dp21770
g8
V16772251.xml
p21771
sg10
VSTD-Dolan-2006
p21772
sg12
S'PMC3205443'
p21773
sa(dp21774
g8
V18320351.xml
p21775
sg10
VSTD-Mutimura-2008a
p21776
sg12
S'PMC3167195'
p21777
sasa(dp21778
g3
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p21779
sg5
(lp21780
(dp21781
g8
V1853495.xml
p21782
sg10
VSTD-Campbell-1991
p21783
sg12
S'PMC2448633'
p21784
sa(dp21785
g8
V14578725.xml
p21786
sg10
VSTD-Bisgaard-2003
p21787
sg12
S'PMC1356141'
p21788
sa(dp21789
g8
V1234491.xml
p21790
sg10
VSTD-Dundee-1975
p21791
sg12
S'PMC1402493'
p21792
sa(dp21793
g8
V3885984.xml
p21794
sg10
VSTD-Waldmann-1985
p21795
sg12
S'PMC1463742'
p21796
sa(dp21797
g8
V9876753.xml
p21798
sg10
VSTD-Dabbous-1998
p21799
sg12
S'PMC3015295'
p21800
sa(dp21801
g8
V14633758.xml
p21802
sg10
VSTD-Joris-2003
p21803
sg12
S'PMC1343506'
p21804
sa(dp21805
g8
V23119952.xml
p21806
sg10
VSTD-Usmani-2003
p21807
sg12
S'PMC3451062'
p21808
sa(dp21809
g8
V15190136.xml
p21810
sg10
VSTD-Apfel-2004
p21811
sg12
S'PMC1307533'
p21812
sa(dp21813
g8
V11371485.xml
p21814
sg10
VSTD-Fujii-2001e
p21815
sg12
S'PMC1724019'
p21816
sasa(dp21817
g3
VCD002958 v. 6.0 Early postnatal discharge from hospital for healthy mothers and term infants.rm5
p21818
sg5
(lp21819
(dp21820
g8
V7936522.xml
p21821
sg10
VSTD-Brooten-1994
p21822
sg12
S'PMC3694422'
p21823
sasa(dp21824
g3
VCD007857 v. 3.4 Parenteral versus oral iron therapy for adults and children with chronic kidney disease.rm5
p21825
sg5
(lp21826
(dp21827
g8
V19176796.xml
p21828
sg10
VSTD-Provenzano-2009-HD
p21829
sg12
S'PMC2637590'
p21830
sa(dp21831
g8
V18525001.xml
p21832
sg10
VSTD-Spinowitz-2008-CKD
p21833
sg12
S'PMC2488268'
p21834
sasa(dp21835
g3
VCD007830 v. 2.0 Treadmill training for patients with Parkinson's disease.rm5
p21836
sg5
(lp21837
(dp21838
g8
V18534554.xml
p21839
sg10
VSTD-Fisher-2008
p21840
sg12
S'PMC2989816'
p21841
sasa(dp21842
g3
VCD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
p21843
sg5
(lp21844
(dp21845
g8
V23818874.xml
p21846
sg10
VSTD-ThanMYA91
p21847
sg12
S'PMC3688502'
p21848
sa(dp21849
g8
V23818874.xml
p21850
sg10
VSTD-ThanMYA97
p21851
sg12
S'PMC3688502'
p21852
sa(dp21853
g8
V8205643.xml
p21854
sg10
VSTD-KarbwangTHI92b
p21855
sg12
S'PMC2486535'
p21856
sa(dp21857
g8
V8131255.xml
p21858
sg10
VSTD-KarbwangTHI92a
p21859
sg12
S'PMC2486514'
p21860
sa(dp21861
g8
V23818874.xml
p21862
sg10
VSTD-ThanMYA93b
p21863
sg12
S'PMC3688502'
p21864
sa(dp21865
g8
V23818874.xml
p21866
sg10
VSTD-ThanMYA93c
p21867
sg12
S'PMC3688502'
p21868
sa(dp21869
g8
V23818874.xml
p21870
sg10
VSTD-ThanMYA93a
p21871
sg12
S'PMC3688502'
p21872
sa(dp21873
g8
V23818874.xml
p21874
sg10
VSTD-ThanMYA96a
p21875
sg12
S'PMC3688502'
p21876
sa(dp21877
g8
V8799526.xml
p21878
sg10
VSTD-AlinTAZ94
p21879
sg12
S'PMC2042621'
p21880
sa(dp21881
g8
V23818874.xml
p21882
sg10
VSTD-ThanMYA94a
p21883
sg12
S'PMC3688502'
p21884
sa(dp21885
g8
V23818874.xml
p21886
sg10
VSTD-ThanMYA90_x002d_91
p21887
sg12
S'PMC3688502'
p21888
sasa(dp21889
g3
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p21890
sg5
(lp21891
(dp21892
g8
V15450119.xml
p21893
sg10
VSTD-_x0030_13-Papanikolaou-2004
p21894
sg12
S'PMC524504'
p21895
sasa(dp21896
g3
VCD004762 v. 9.0 Drug treatment for myotonia.rm5
p21897
sg5
(lp21898
(dp21899
g8
V7045292.xml
p21900
sg10
VSTD-Finlay-1982
p21901
sg12
S'PMC1083128'
p21902
sa(dp21903
g8
V3553433.xml
p21904
sg10
VSTD-Grant-1987
p21905
sg12
S'PMC1031492'
p21906
sasa(dp21907
g3
VCD005111 v. 5.0 Acupuncture for treatment of irritable bowel syndrome.rm5
p21908
sg5
(lp21909
(dp21910
g8
V16150852.xml
p21911
sg10
VSTD-Schneider-2006
p21912
sg12
S'PMC1856122'
p21913
sa(dp21914
g8
V19455132.xml
p21915
sg10
VSTD-Lembo-2009
p21916
sg12
S'PMC2694961'
p21917
sasa(dp21918
g3
VCD009014 v. 2.8 Allergen-specific oral immunotherapy for peanut allergy.rm5
p21919
sg5
(lp21920
(dp21921
g8
V21377034.xml
p21922
sg10
VSTD-Varshney-2011
p21923
sg12
S'PMC3060783'
p21924
sasa(dp21925
g3
VCD004421 v. 8.0 Taxanes for adjuvant treatment of early breast cancer.rm5
p21926
sg5
(lp21927
(dp21928
g8
V19819914.xml
p21929
sg10
VSTD-FinHer
p21930
sg12
S'PMC2860103'
p21931
sasa(dp21932
g3
VCD000099 v. 7.0 Growth hormone for in vitro fertilization.rm5
p21933
sg5
(lp21934
(dp21935
g8
V18392675.xml
p21936
sg10
VSTD-Kueuk-2008
p21937
sg12
S'PMC2582075'
p21938
sasa(dp21939
g3
VCD006964 v. 5.0 Strategies for communicating contraceptive effectiveness.rm5
p21940
sg5
(lp21941
(dp21942
g8
V21410332.xml
p21943
sg10
VSTD-Stephenson-2011
p21944
sg12
S'PMC3115412'
p21945
sasa(dp21946
g3
VCD000567 v. 15.0 Colloids versus crystalloids for fluid resuscitation in critically ill patients.rm5
p21947
sg5
(lp21948
(dp21949
g8
V2443087.xml
p21950
sg10
VSTD-Vassar-1991
p21951
sg12
S'PMC1493198'
p21952
sa(dp21953
g8
V6342554.xml
p21954
sg10
VSTD-Goodwin-1983
p21955
sg12
S'PMC1353023'
p21956
sa(dp21957
g8
V6847271.xml
p21958
sg10
VSTD-Shires-1983
p21959
sg12
S'PMC1353021'
p21960
sa(dp21961
g8
V21178763.xml
p21962
sg10
VSTD-Bulger-2011
p21963
sg12
S'PMC3232054'
p21964
sa(dp21965
g8
V8683491.xml
p21966
sg10
VSTD-Evans-1996
p21967
sg12
S'PMC1295671'
p21968
sasa(dp21969
g3
VCD007786 v. 3.0 Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in ch.rm5
p21970
sg5
(lp21971
(dp21972
g8
V7492164.xml
p21973
sg10
VSTD-Dick-1995
p21974
sg12
S'PMC1511304'
p21975
sa(dp21976
g8
V519355.xml
p21977
sg10
VSTD-Swann-1979
p21978
sg12
S'PMC1597274'
p21979
sa(dp21980
g8
V3013104.xml
p21981
sg10
VSTD-Dalzell-1986
p21982
sg12
S'PMC1777777'
p21983
sasa(dp21984
g3
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p21985
sg5
(lp21986
(dp21987
g8
V9651260.xml
p21988
sg10
VSTD-Perneger-1998
p21989
sg12
S'PMC28595'
p21990
sa(dp21991
g8
V12907482.xml
p21992
sg10
VSTD-CCBH-_x0028_A_x0029_-2002
p21993
sg12
S'PMC169643'
p21994
sa(dp21995
g8
V17002810.xml
p21996
sg10
VSTD-RIOTT-2010
p21997
sg12
S'PMC1613238'
p21998
sasa(dp21999
g3
VCD009131 v. 2.0 Neuropsychological rehabilitation for multiple sclerosis.rm5
p22000
sg5
(lp22001
(dp22002
g8
V11784832.xml
p22003
sg10
VSTD-Lincoln-2002
p22004
sg12
S'PMC1737698'
p22005
sasa(dp22006
g3
VCD005256 v. 2.0 Early introduction of lipids to parenterally-fed preterm infants.rm5
p22007
sg5
(lp22008
(dp22009
g8
V8215565.xml
p22010
sg10
VSTD-Brownlee-1993
p22011
sg12
S'PMC1029492'
p22012
sasa(dp22013
g3
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p22014
sg5
(lp22015
(dp22016
g8
V10881642.xml
p22017
sg10
VSTD-McElhinney-2000
p22018
sg12
S'PMC2449154'
p22019
sasa(dp22020
g3
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p22021
sg5
(lp22022
(dp22023
g8
V19246357.xml
p22024
sg10
VSTD-Sacks-high-protein-2009
p22025
sg12
S'PMC2763382'
p22026
sa(dp22027
g8
V14288105.xml
p22028
sg10
VSTD-Rose-1965
p22029
sg12
S'PMC2166702'
p22030
sa(dp22031
g8
V17635889.xml
p22032
sg10
VSTD-WHEL-2007
p22033
sg12
S'PMC2083253'
p22034
sa(dp22035
g8
V19246357.xml
p22036
sg10
VSTD-Sacks-low-protein-2009
p22037
sg12
S'PMC2763382'
p22038
sa(dp22039
g8
V8111257.xml
p22040
sg10
VSTD-Rivellese-1994
p22041
sg12
S'PMC2539301'
p22042
sa(dp22043
g8
V19542011.xml
p22044
sg10
VSTD-Strychar-2009
p22045
sg12
S'PMC2732152'
p22046
sasa(dp22047
g3
VCD008063 v. 4.0 Motivational interviewing for substance abuse.rm5
p22048
sg5
(lp22049
(dp22050
g8
V17032098.xml
p22051
sg10
VSTD-Carey-2006
p22052
sg12
S'PMC2442891'
p22053
sa(dp22054
g8
V18077833.xml
p22055
sg10
VSTD-Parsons-2009
p22056
sg12
S'PMC2666542'
p22057
sa(dp22058
g8
V19170454.xml
p22059
sg10
VSTD-Walters-2009
p22060
sg12
S'PMC2704891'
p22061
sa(dp22062
g8
V19538921.xml
p22063
sg10
VSTD-Schaus-2009
p22064
sg12
S'PMC2701092'
p22065
sa(dp22066
g8
V20053238.xml
p22067
sg10
VSTD-Bernstein-2009
p22068
sg12
S'PMC2910362'
p22069
sa(dp22070
g8
V17869051.xml
p22071
sg10
VSTD-Martin-2008
p22072
sg12
S'PMC2996851'
p22073
sa(dp22074
g8
V19207347.xml
p22075
sg10
VSTD-Walitzer-2008
p22076
sg12
S'PMC2802221'
p22077
sa(dp22078
g8
V16169159.xml
p22079
sg10
VSTD-Carroll-2006a
p22080
sg12
S'PMC2386852'
p22081
sa(dp22082
g8
V17032099.xml
p22083
sg10
VSTD-Carroll-2006b
p22084
sg12
S'PMC2148500'
p22085
sa(dp22086
g8
V18083322.xml
p22087
sg10
VSTD-Winhusen-2008
p22088
sg12
S'PMC2546520'
p22089
sa(dp22090
g8
V19803579.xml
p22091
sg10
VSTD-Carroll-2009
p22092
sg12
S'PMC2792592'
p22093
sa(dp22094
g8
V17663610.xml
p22095
sg10
VSTD-Ball-2007b
p22096
sg12
S'PMC2148493'
p22097
sa(dp22098
g8
V19634958.xml
p22099
sg10
VSTD-Morgenstern-2009
p22100
sg12
S'PMC2758623'
p22101
sa(dp22102
g8
V20402990.xml
p22103
sg10
VSTD-Stein-2010
p22104
sg12
S'PMC2858363'
p22105
sa(dp22106
g8
V19290699.xml
p22107
sg10
VSTD-Thush-2009
p22108
sg12
S'PMC3140345'
p22109
sa(dp22110
g8
V16187809.xml
p22111
sg10
VSTD-Borsari-2005
p22112
sg12
S'PMC2663045'
p22113
sa(dp22114
g8
V16822119.xml
p22115
sg10
VSTD-Walker-2006
p22116
sg12
S'PMC2587139'
p22117
sa(dp22118
g8
V16150764.xml
p22119
sg10
VSTD-UKATT-2005
p22120
sg12
S'PMC1200586'
p22121
sa(dp22122
g8
V20673621.xml
p22123
sg10
VSTD-Mastroleo-2010
p22124
sg12
S'PMC2937069'
p22125
sa(dp22126
g8
V17707594.xml
p22127
sg10
VSTD-Barnett-2007
p22128
sg12
S'PMC2000456'
p22129
sa(dp22130
g8
V16996224.xml
p22131
sg10
VSTD-Kadden-2007
p22132
sg12
S'PMC1903379'
p22133
sasa(dp22134
g3
VCD001785 v. 10.0 Laparoscopic techniques versus open techniques for inguinal hernia repair.rm5
p22135
sg5
(lp22136
(dp22137
g8
V9657784.xml
p22138
sg10
VSTD-Whipps-Cross-1998
p22139
sg12
S'PMC28600'
p22140
sa(dp22141
g8
V10450737.xml
p22142
sg10
VSTD-SCUR-1999
p22143
sg12
S'PMC1420865'
p22144
sa(dp22145
g8
V7580639.xml
p22146
sg10
VSTD-Oxford-1995
p22147
sg12
S'PMC2550988'
p22148
sasa(dp22149
g3
VCD001308 v. 5.0 Bladder training for urinary incontinence in adults.rm5
p22150
sg5
(lp22151
(dp22152
g8
V7002250.xml
p22153
sg10
VSTD-Jarvis-1980
p22154
sg12
S'PMC1714748'
p22155
sasa(dp22156
g3
VCD007954 v. 1.2 Antidepressants versus placebo for depression in primary care.rm5
p22157
sg5
(lp22158
(dp22159
g8
V7873952.xml
p22160
sg10
VSTD-Mynors_x002d_Wallis-1995
p22161
sg12
S'PMC2548821'
p22162
sa(dp22163
g8
V4923928.xml
p22164
sg10
VSTD-Blashki-_x0028_75mg_x0029_-1971
p22165
sg12
S'PMC1795147'
p22166
sa(dp22167
g8
V4923928.xml
p22168
sg10
VSTD-Blashki-_x0028_150-mg_x0029_-1971
p22169
sg12
S'PMC1795147'
p22170
sa(dp22171
g8
V3076905.xml
p22172
sg10
VSTD-Hollyman-1988
p22173
sg12
S'PMC1711591'
p22174
sa(dp22175
g8
V10591711.xml
p22176
sg10
VSTD-Philipp-1999
p22177
sg12
S'PMC28296'
p22178
sa(dp22179
g8
V10221945.xml
p22180
sg10
VSTD-Malt--1999
p22181
sg12
S'PMC34546'
p22182
sasa(dp22183
g3
VCD000947 v. 8.0 Continuous and interrupted suturing techniques for repair of episiotomy or second-degree tears.rm5
p22184
sg5
(lp22185
(dp22186
g8
V24059980.xml
p22187
sg10
VSTD-Zafar-2008
p22188
sg12
S'PMC3734022'
p22189
sasa(dp22190
g3
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p22191
sg5
(lp22192
(dp22193
g8
V12877755.xml
p22194
sg10
VSTD-Barrowman-2003
p22195
sg12
S'PMC212708'
p22196
sa(dp22197
g8
V22415239.xml
p22198
sg10
VSTD-Weller-1998
p22199
sg12
S'PMC3314787'
p22200
sa(dp22201
g8
V11158556.xml
p22202
sg10
VSTD-Ioannidis-2001
p22203
sg12
S'PMC14669'
p22204
sasa(dp22205
g3
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p22206
sg5
(lp22207
(dp22208
g8
V19127261.xml
p22209
sg10
VSTD-Neuhaus-2009
p22210
sg12
S'PMC2634726'
p22211
sa(dp22212
g8
V21041710.xml
p22213
sg10
VSTD-Kocher-2011
p22214
sg12
S'PMC3058272'
p22215
sasa(dp22216
g3
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p22217
sg5
(lp22218
(dp22219
g8
V19017582.xml
p22220
sg10
VSTD-McKay-2008
p22221
sg12
S'PMC2630830'
p22222
sa(dp22223
g8
V21504883.xml
p22224
sg10
VSTD-Ciccolo-2011
p22225
sg12
S'PMC3150692'
p22226
sa(dp22227
g8
V18418791.xml
p22228
sg10
VSTD-Kinnunen-2008
p22229
sg12
S'PMC3695732'
p22230
sasa(dp22231
g3
VCD006085 v. 4.0 Antiamoebic drugs for treating amoebic colitis.rm5
p22232
sg5
(lp22233
(dp22234
g8
V4315969.xml
p22235
sg10
VSTD-Rubidge-1970
p22236
sg12
S'PMC2020286'
p22237
sasa(dp22238
g3
VCD005275 v. 7.0 Insoles for prevention and treatment of back pain.rm5
p22239
sg5
(lp22240
(dp22241
g8
V15668775.xml
p22242
sg10
VSTD-Shabat-2005
p22243
sg12
S'PMC3489231'
p22244
sasa(dp22245
g3
VCD005953 v. 3.0 Extracranial-intracranial arterial bypass surgery for occlusive carotid artery disease.rm5
p22246
sg5
(lp22247
(dp22248
g8
V6707653.xml
p22249
sg10
VSTD-Thomas-1984
p22250
sg12
S'PMC1027683'
p22251
sasa(dp22252
g3
VCD003537 v. 4.0 Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary d.rm5
p22253
sg5
(lp22254
(dp22255
g8
V8066559.xml
p22256
sg10
VSTD-Kerstjens-1994
p22257
sg12
S'PMC475051'
p22258
sa(dp22259
g8
V11254817.xml
p22260
sg10
VSTD-Tattersfield-2001
p22261
sg12
S'PMC1746016'
p22262
sasa(dp22263
g3
VCD006731 v. 6.0 Pharmaceutical policies effects of financial incentives for prescribers.rm5
p22264
sg5
(lp22265
(dp22266
g8
V9406488.xml
p22267
sg10
VSTD-Corney-1997
p22268
sg12
S'PMC1313103'
p22269
sa(dp22270
g8
V8978232.xml
p22271
sg10
VSTD-Harris-1996
p22272
sg12
S'PMC2353056'
p22273
sa(dp22274
g8
V10562740.xml
p22275
sg10
VSTD-Wilson-1999
p22276
sg12
S'PMC1313438'
p22277
sa(dp22278
g8
V7496289.xml
p22279
sg10
VSTD-Wilson-1995
p22280
sg12
S'PMC2551250'
p22281
sa(dp22282
g8
V9251548.xml
p22283
sg10
VSTD-Rafferty-1997
p22284
sg12
S'PMC2127119'
p22285
sa(dp22286
g8
V8646099.xml
p22287
sg10
VSTD-Kammerling-1996
p22288
sg12
S'PMC2351139'
p22289
sa(dp22290
g8
V8251847.xml
p22291
sg10
VSTD-Bradlow-1993
p22292
sg12
S'PMC1679320'
p22293
sasa(dp22294
g3
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p22295
sg5
(lp22296
(dp22297
g8
V9328156.xml
p22298
sg10
VSTD-Kylmala-1997
p22299
sg12
S'PMC2228066'
p22300
sasa(dp22301
g3
VCD005455 v. 4.0 Choice of instruments for assisted vaginal delivery.rm5
p22302
sg5
(lp22303
(dp22304
g8
V22685661.xml
p22305
sg10
VSTD-Mustafa-2002
p22306
sg12
S'PMC3366228'
p22307
sasa(dp22308
g3
VCD006913 v. 5.0 Psychological interventions for treatment of inflammatory bowel disease.rm5
p22309
sg5
(lp22310
(dp22311
g8
V18831071.xml
p22312
sg10
VSTD-Szigethy-2007
p22313
sg12
S'PMC2638168'
p22314
sa(dp22315
g8
V15479685.xml
p22316
sg10
VSTD-Kennedy-2004
p22317
sg12
S'PMC1774266'
p22318
sasa(dp22319
g3
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p22320
sg5
(lp22321
(dp22322
g8
V18270586.xml
p22323
sg10
VSTD-Opiyo-2008
p22324
sg12
S'PMC2229665'
p22325
sasa(dp22326
g3
VCD000125 v. 12.8 Local opinion leaders effects on professional practice and health care outcomes.rm5
p22327
sg5
(lp22328
(dp22329
g8
V18299546.xml
p22330
sg10
VSTD-Majumdar-2008
p22331
sg12
S'PMC2244663'
p22332
sa(dp22333
g8
V19933787.xml
p22334
sg10
VSTD-McAlister-2009
p22335
sg12
S'PMC2789127'
p22336
sasa(dp22337
g3
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p22338
sg5
(lp22339
(dp22340
g8
V11720426.xml
p22341
sg10
VSTD-Sculier-2001
p22342
sg12
S'PMC2363948'
p22343
sasa(dp22344
g3
VCD004012 v. 7.0 Washout policies in long-term indwelling urinary catheterisation in adults.rm5
p22345
sg5
(lp22346
(dp22347
g8
V16859225.xml
p22348
sg10
VSTD-Waites-2006
p22349
sg12
S'PMC1864807'
p22350
sasa(dp22351
g3
VCD001769 v. 12.0 Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic.rm5
p22352
sg5
(lp22353
(dp22354
g8
V3928820.xml
p22355
sg10
VSTD-Callaghan-1985
p22356
sg12
S'PMC1028404'
p22357
sa(dp22358
g8
V3919805.xml
p22359
sg10
VSTD-Turnbull-1985
p22360
sg12
S'PMC1418605'
p22361
sa(dp22362
g8
V7823066.xml
p22363
sg10
VSTD-Heller-1995
p22364
sg12
S'PMC1073267'
p22365
sasa(dp22366
g3
VCD003697 v. 5.0 Statins and fibrates for preventing melanoma.rm5
p22367
sg5
(lp22368
(dp22369
g8
V12433762.xml
p22370
sg10
VSTD-LEADER-2002
p22371
sg12
S'PMC133451'
p22372
sa(dp22373
g8
V4578364.xml
p22374
sg10
VSTD-WHO-1973
p22375
sg12
S'PMC2481013'
p22376
sasa(dp22377
g3
VCD005660 v. 5.0 Analgesia in patients with acute abdominal pain.rm5
p22378
sg5
(lp22379
(dp22380
g8
V1393034.xml
p22381
sg10
VSTD-Attard-1992
p22382
sg12
S'PMC1883284'
p22383
sasa(dp22384
g3
VCD004805 v. 12.0 Combined calcium magnesium and potassium supplementation for the management of primary hypertension.rm5
p22385
sg5
(lp22386
(dp22387
g8
V2207419.xml
p22388
sg10
VSTD-Patki-1990
p22389
sg12
S'PMC1663843'
p22390
sa(dp22391
g8
V7920126.xml
p22392
sg10
VSTD-Geleijnse-1994
p22393
sg12
S'PMC2540967'
p22394
sasa(dp22395
g3
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p22396
sg5
(lp22397
(dp22398
g8
V17622343.xml
p22399
sg10
VSTD-Vedder-2007
p22400
sg12
S'PMC1913555'
p22401
sasa(dp22402
g3
VCD001708 v. 10.0 Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults.rm5
p22403
sg5
(lp22404
(dp22405
g8
V18056740.xml
p22406
sg10
VSTD-Frihagen-2007
p22407
sg12
S'PMC2137068'
p22408
sa(dp22409
g8
V17431621.xml
p22410
sg10
VSTD-Mouzopoulos-2008
p22411
sg12
S'PMC2323425'
p22412
sasa(dp22413
g3
VCD006771 v. 3.4 Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.rm5
p22414
sg5
(lp22415
(dp22416
g8
V3109574.xml
p22417
sg10
VSTD-Walker-1987
p22418
sg12
S'PMC1246354'
p22419
sasa(dp22420
g3
VCD001290 v. 7.0 Interventions for educating children who are at risk of asthma-related emergency department attendan.rm5
p22421
sg5
(lp22422
(dp22423
g8
V9093336.xml
p22424
sg10
VSTD-Madge-1997
p22425
sg12
S'PMC1758505'
p22426
sa(dp22427
g8
V3545094.xml
p22428
sg10
VSTD-Mitchell-1986
p22429
sg12
S'PMC1778203'
p22430
sa(dp22431
g8
V4037168.xml
p22432
sg10
VSTD-McNabb-1985
p22433
sg12
S'PMC1646372'
p22434
sa(dp22435
g8
V8185365.xml
p22436
sg10
VSTD-Charlton-1994
p22437
sg12
S'PMC1029785'
p22438
sa(dp22439
g8
V10325723.xml
p22440
sg10
VSTD-Wesseldine-1999
p22441
sg12
S'PMC1717832'
p22442
sa(dp22443
g8
V7974314.xml
p22444
sg10
VSTD-Garrett-1994
p22445
sg12
S'PMC475232'
p22446
sa(dp22447
g8
V16754825.xml
p22448
sg10
VSTD-Butz-2006
p22449
sg12
S'PMC2269706'
p22450
sa(dp22451
g8
V11809988.xml
p22452
sg10
VSTD-Stevens-2002
p22453
sg12
S'PMC1746177'
p22454
sasa(dp22455
g3
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p22456
sg5
(lp22457
(dp22458
g8
V19523207.xml
p22459
sg10
VSTD-Westlake-2009
p22460
sg12
S'PMC2708184'
p22461
sasa(dp22462
g3
VCD000984 v. 10.0 Interventions to change the behaviour of health professionals and the organisation of care to promot.rm5
p22463
sg5
(lp22464
(dp22465
g8
V10396539.xml
p22466
sg10
VSTD-Pritchard-1999
p22467
sg12
S'PMC1756872'
p22468
sa(dp22469
g8
V14604931.xml
p22470
sg10
VSTD-Moore-2003
p22471
sg12
S'PMC261745'
p22472
sasa(dp22473
g3
VCD003442 v. 4.0 Compliance therapy for schizophrenia.rm5
p22474
sg5
(lp22475
(dp22476
g8
V14551096.xml
p22477
sg10
VSTD-O_x0027_Donnell-2003
p22478
sg12
S'PMC214016'
p22479
sasa(dp22480
g3
VCD003999 v. 6.23 Relapse prevention interventions for smoking cessation.rm5
p22481
sg5
(lp22482
(dp22483
g8
V17854434.xml
p22484
sg10
VSTD-Ruger-2008
p22485
sg12
S'PMC2775431'
p22486
sa(dp22487
g8
V10224982.xml
p22488
sg10
VSTD-McBride-1999
p22489
sg12
S'PMC1508743'
p22490
sa(dp22491
g8
V9003138.xml
p22492
sg10
VSTD-Lando-1996
p22493
sg12
S'PMC1380734'
p22494
sa(dp22495
g8
V10982911.xml
p22496
sg10
VSTD-Van_x0027_t-Hof-2000
p22497
sg12
S'PMC1766291'
p22498
sa(dp22499
g8
V11786452.xml
p22500
sg10
VSTD-Hajek-2002
p22501
sg12
S'PMC64504'
p22502
sasa(dp22503
g3
VCD001103 v. 9.0 Dressings for healing venous leg ulcers.rm5
p22504
sg5
(lp22505
(dp22506
g8
V22941749.xml
p22507
sg10
VSTD-Lindholm-1994
p22508
sg12
S'PMC3644018'
p22509
sa(dp22510
g8
V23179315.xml
p22511
sg10
VSTD-Smith-1994
p22512
sg12
S'PMC3644009'
p22513
sa(dp22514
g8
V23555325.xml
p22515
sg10
VSTD-Grotewohl-1994
p22516
sg12
S'PMC3608232'
p22517
sa(dp22518
g8
V3926169.xml
p22519
sg10
VSTD-Ormiston-1988
p22520
sg12
S'PMC1416577'
p22521
sasa(dp22522
g3
VCD007412 v. 4.0 Active versus expectant management for women in the third stage of labour.rm5
p22523
sg5
(lp22524
(dp22525
g8
V3144366.xml
p22526
sg10
VSTD-Prendiville-1988
p22527
sg12
S'PMC1834913'
p22528
sasa(dp22529
g3
VCD003269 v. 7.0 Anticholinergic agents for chronic asthma in adults.rm5
p22530
sg5
(lp22531
(dp22532
g8
V6458919.xml
p22533
sg10
VSTD-Kreisman-1981
p22534
sg12
S'PMC471515'
p22535
sa(dp22536
g8
V7619569.xml
p22537
sg10
VSTD-van-Schayck-1995
p22538
sg12
S'PMC1239228'
p22539
sa(dp22540
g8
V3074291.xml
p22541
sg10
VSTD-Bellia-1988
p22542
sg12
S'PMC2428919'
p22543
sa(dp22544
g8
V2943050.xml
p22545
sg10
VSTD-Taylor-1986
p22546
sg12
S'PMC460313'
p22547
sa(dp22548
g8
V1837744.xml
p22549
sg10
VSTD-van-Schayck-1991a
p22550
sg12
S'PMC1671690'
p22551
sa(dp22552
g8
V1829865.xml
p22553
sg10
VSTD-van-Schayck-1991b
p22554
sg12
S'PMC463136'
p22555
sasa(dp22556
g3
VCD006860 v. 3.0 Personal assistance for adults (19-64) with both physical and intellectual impairments.rm5
p22557
sg5
(lp22558
(dp22559
g8
V6405641.xml
p22560
sg10
VSTD-Sherwood-1983
p22561
sg12
S'PMC1650873'
p22562
sa(dp22563
g8
V17244293.xml
p22564
sg10
VSTD-Carlson-2007
p22565
sg12
S'PMC1955332'
p22566
sasa(dp22567
g3
VCD004157 v. 4.0 Treatment for cramps in amyotrophic lateral sclerosismotor neuron disease.rm5
p22568
sg5
(lp22569
(dp22570
g8
V18608103.xml
p22571
sg10
VSTD-Rosenfeld-2008
p22572
sg12
S'PMC2631354'
p22573
sasa(dp22574
g3
VCD008570 v. 4.0 Ergonomic design and training for preventing work-related musculoskeletal disorders of the upper lim.rm5
p22575
sg5
(lp22576
(dp22577
g8
V15961625.xml
p22578
sg10
VSTD-Gerr-2005
p22579
sg12
S'PMC1741055'
p22580
sa(dp22581
g8
V16621849.xml
p22582
sg10
VSTD-Rempel-2006
p22583
sg12
S'PMC2092482'
p22584
sasa(dp22585
g3
VCD004009 v. 4.0 Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum m.rm5
p22586
sg5
(lp22587
(dp22588
g8
V16675812.xml
p22589
sg10
VSTD-Barennes-2006
p22590
sg12
S'PMC1458599'
p22591
sa(dp22592
g8
V15504872.xml
p22593
sg10
VSTD-Pussard-2004
p22594
sg12
S'PMC525409'
p22595
sa(dp22596
g8
V8735679.xml
p22597
sg10
VSTD-Barennes-1996a
p22598
sg12
S'PMC2042609'
p22599
sasa(dp22600
g3
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p22601
sg5
(lp22602
(dp22603
g8
V20164485.xml
p22604
sg10
VSTD-Carlo-2010
p22605
sg12
S'PMC3565382'
p22606
sa(dp22607
g8
V21292711.xml
p22608
sg10
VSTD-Gill-2011
p22609
sg12
S'PMC3032994'
p22610
sasa(dp22611
g3
VCD001954 v. 12.0 Azithromycin for acute lower respiratory tract infections.rm5
p22612
sg5
(lp22613
(dp22614
g8
V1324645.xml
p22615
sg10
VSTD-Mertens-1992
p22616
sg12
S'PMC191603'
p22617
sasa(dp22618
g3
VCD002928 v. 7.0 Enhancing partner support to improve smoking cessation.rm5
p22619
sg5
(lp22620
(dp22621
g8
V19357315.xml
p22622
sg10
VSTD-Patten-2009
p22623
sg12
S'PMC2670370'
p22624
sa(dp22625
g8
V6441794.xml
p22626
sg10
VSTD-Malott-1984
p22627
sg12
S'PMC1307970'
p22628
sasa(dp22629
g3
VCD003940 v. 6.0 Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV inf.rm5
p22630
sg5
(lp22631
(dp22632
g8
V11796357.xml
p22633
sg10
VSTD-Arathoon-2002
p22634
sg12
S'PMC127070'
p22635
sa(dp22636
g8
V18627504.xml
p22637
sg10
VSTD-Nittayananta-2008
p22638
sg12
S'PMC3253386'
p22639
sa(dp22640
g8
V1458072.xml
p22641
sg10
VSTD-Chavanet-1992
p22642
sg12
S'PMC1883525'
p22643
sasa(dp22644
g3
VCD003066 v. 5.0 G-CSF and GM-CSF for treating or preventing neonatal infections.rm5
p22645
sg5
(lp22646
(dp22647
g8
V11320043.xml
p22648
sg10
VSTD-Bedford_x002d_Russell-2001
p22649
sg12
S'PMC1721238'
p22650
sasa(dp22651
g3
VCD001093 v. 7.3 Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.rm5
p22652
sg5
(lp22653
(dp22654
g8
V417754.xml
p22655
sg10
VSTD-Greenwood-1978
p22656
sg12
S'PMC1604678'
p22657
sa(dp22658
g8
V4206451.xml
p22659
sg10
VSTD-Wahdan-1973
p22660
sg12
S'PMC2483073'
p22661
sa(dp22662
g8
V4211056.xml
p22663
sg10
VSTD-Erwa-1973
p22664
sg12
S'PMC2481142'
p22665
sa(dp22666
g8
V413639.xml
p22667
sg10
VSTD-Wahdan-1977
p22668
sg12
S'PMC2366720'
p22669
sasa(dp22670
g3
VCD003916 v. 7.1 Adjuvant radiotherapy for stage I endometrial cancer.rm5
p22671
sg5
(lp22672
(dp22673
g8
V19070891.xml
p22674
sg10
VSTD-ASTEC_x002f_EN.5
p22675
sg12
S'PMC2646125'
p22676
sasa(dp22677
g3
VCD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
p22678
sg5
(lp22679
(dp22680
g8
V10693368.xml
p22681
sg10
VSTD-Rindone-2000
p22682
sg12
S'PMC1070762'
p22683
sa(dp22684
g8
V17974032.xml
p22685
sg10
VSTD-Mehta-2007
p22686
sg12
S'PMC2131759'
p22687
sa(dp22688
g8
V22850875.xml
p22689
sg10
VSTD-Rovati-1997
p22690
sg12
S'PMC3400104'
p22691
sasa(dp22692
g3
VMR000026 v. 2.3 Checking reference lists to find additional studies for systematic reviews.rm5
p22693
sg5
(lp22694
(dp22695
g8
V9836655.xml
p22696
sg10
VSTD-McManus-1998
p22697
sg12
S'PMC28735'
p22698
sa(dp22699
g8
V15318916.xml
p22700
sg10
VSTD-McNally-2004
p22701
sg12
S'PMC2080777'
p22702
sa(dp22703
g8
V16100321.xml
p22704
sg10
VSTD-Ogilvie-2005
p22705
sg12
S'PMC1733146'
p22706
sa(dp22707
g8
V16230312.xml
p22708
sg10
VSTD-Greenhalgh-2005
p22709
sg12
S'PMC1283190'
p22710
sasa(dp22711
g3
VCD006982 v. 3.0 Cycled light in the intensive care unit for preterm and low birth weight infants.rm5
p22712
sg5
(lp22713
(dp22714
g8
V3096460.xml
p22715
sg10
VSTD-Mann-1986
p22716
sg12
S'PMC1342106'
p22717
sasa(dp22718
g3
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p22719
sg5
(lp22720
(dp22721
g8
V17324975.xml
p22722
sg10
VSTD-Howden_x002d_Chapman-2007
p22723
sg12
S'PMC1808149'
p22724
sa(dp22725
g8
V17035145.xml
p22726
sg10
VSTD-Kercsmar-2006
p22727
sg12
S'PMC1626393'
p22728
sasa(dp22729
g3
VCD002104 v. 10.0 Written information about individual medicines for consumers.rm5
p22730
sg5
(lp22731
(dp22732
g8
V1888619.xml
p22733
sg10
VSTD-Baker-1991
p22734
sg12
S'PMC1368470'
p22735
sa(dp22736
g8
V2569323.xml
p22737
sg10
VSTD-Gibbs-1989
p22738
sg12
S'PMC1379799'
p22739
sa(dp22740
g8
V12213142.xml
p22741
sg10
VSTD-Bergus-2002
p22742
sg12
S'PMC1495093'
p22743
sa(dp22744
g8
V9641933.xml
p22745
sg10
VSTD-Little-1998
p22746
sg12
S'PMC28594'
p22747
sa(dp22748
g8
V15175486.xml
p22749
sg10
VSTD-Knapp-2004
p22750
sg12
S'PMC1743828'
p22751
sa(dp22752
g8
V10473477.xml
p22753
sg10
VSTD-Peveler-1999
p22754
sg12
S'PMC28214'
p22755
sa(dp22756
g8
V5046455.xml
p22757
sg10
VSTD-Clark-1972
p22758
sg12
S'PMC1530384'
p22759
sasa(dp22760
g3
VCD002006 v. 10.0 Position in the second stage of labour for women without epidural anaesthesia.rm5
p22761
sg5
(lp22762
(dp22763
g8
V23492921.xml
p22764
sg10
VSTD-Bhardwaj-1994
p22765
sg12
S'PMC3590536'
p22766
sasa(dp22767
g3
VCD006093 v. 5.0 Interventions for promoting information and communication technologies adoption in healthcare profes.rm5
p22768
sg5
(lp22769
(dp22770
g8
V11999177.xml
p22771
sg10
VSTD-Bradley-2002
p22772
sg12
S'PMC100764'
p22773
sa(dp22774
g8
V1958910.xml
p22775
sg10
VSTD-Haynes-1991
p22776
sg12
S'PMC225582'
p22777
sa(dp22778
g8
V11903763.xml
p22779
sg10
VSTD-Cabell-2001
p22780
sg12
S'PMC1495306'
p22781
sa(dp22782
g8
V16929034.xml
p22783
sg10
VSTD-Haynes-2006
p22784
sg12
S'PMC1656957'
p22785
sa(dp22786
g8
V12950483.xml
p22787
sg10
VSTD-Katz-2003
p22788
sg12
S'PMC1494914'
p22789
sasa(dp22790
g3
VCD005044 v. 4.0 Quinine for muscle cramps.rm5
p22791
sg5
(lp22792
(dp22793
g8
V3555580.xml
p22794
sg10
VSTD-Warburton-1987
p22795
sg12
S'PMC1386096'
p22796
sa(dp22797
g8
V15808032.xml
p22798
sg10
VSTD-Woodfield-2005
p22799
sg12
S'PMC1463087'
p22800
sa(dp22801
g8
V8323792.xml
p22802
sg10
VSTD-Dunn-1993
p22803
sg12
S'PMC1372336'
p22804
sa(dp22805
g8
V2669346.xml
p22806
sg10
VSTD-Fung-1989
p22807
sg12
S'PMC1026949'
p22808
sasa(dp22809
g3
VCD003585 v. 5.0 Occupational therapy for patients with problems in activities of daily living after stroke.rm5
p22810
sg5
(lp22811
(dp22812
g8
V10698876.xml
p22813
sg10
VSTD-Glasgow-2000
p22814
sg12
S'PMC27300'
p22815
sasa(dp22816
g3
VCD001095 v. 14.0 Short-course antibiotics for acute otitis media.rm5
p22817
sg5
(lp22818
(dp22819
g8
V14506028.xml
p22820
sg10
VSTD-Arrieta-2003
p22821
sg12
S'PMC201139'
p22822
sa(dp22823
g8
V6802412.xml
p22824
sg10
VSTD-de-Saintongue-1982
p22825
sg12
S'PMC1497899'
p22826
sa(dp22827
g8
V10602721.xml
p22828
sg10
VSTD-Dagan-2000b
p22829
sg12
S'PMC89626'
p22830
sasa(dp22831
g3
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p22832
sg5
(lp22833
(dp22834
g8
V17991688.xml
p22835
sg10
VSTD-Arthur-2007
p22836
sg12
S'PMC2598642'
p22837
sa(dp22838
g8
V19623481.xml
p22839
sg10
VSTD-Cremin-2010
p22840
sg12
S'PMC2865634'
p22841
sasa(dp22842
g3
VMR000002 v. 7.0 Technical editing of research reports in biomedical journals.rm5
p22843
sg5
(lp22844
(dp22845
g8
V3931753.xml
p22846
sg10
VSTD-de-Lacey-1985-RA
p22847
sg12
S'PMC1416756'
p22848
sa(dp22849
g8
V8174031.xml
p22850
sg10
VSTD-Taddio-1994
p22851
sg12
S'PMC1336964'
p22852
sa(dp22853
g8
V15561784.xml
p22854
sg10
VSTD-Aronsky-2005-RA
p22855
sg12
S'PMC551554'
p22856
sa(dp22857
g8
V3079520.xml
p22858
sg10
VSTD-Eichorn-1987-RA
p22859
sg12
S'PMC1647239'
p22860
sa(dp22861
g8
V7599584.xml
p22862
sg10
VSTD-Harbourt-1995
p22863
sg12
S'PMC226026'
p22864
sa(dp22865
g8
V11719341.xml
p22866
sg10
VSTD-VargasOrigel-2001-RA
p22867
sg12
S'PMC1719006'
p22868
sasa(dp22869
g3
VCD009337 v. 2.0 Social marketing interventions to increase HIVSTI testing uptake among men who have sex with men an.rm5
p22870
sg5
(lp22871
(dp22872
g8
V18172146.xml
p22873
sg10
VSTD-Darrow-2008
p22874
sg12
S'PMC2376895'
p22875
sasa(dp22876
g3
VCD003720 v. 5.0 Timing of breast surgery in premenopausal breast cancer patients.rm5
p22877
sg5
(lp22878
(dp22879
g8
V19487378.xml
p22880
sg10
VSTD-Grant-2009
p22881
sg12
S'PMC2799061'
p22882
sasa(dp22883
g3
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p22884
sg5
(lp22885
(dp22886
g8
V20808854.xml
p22887
sg10
VSTD-Swoboda-2010
p22888
sg12
S'PMC2924376'
p22889
sasa(dp22890
g3
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p22891
sg5
(lp22892
(dp22893
g8
V18055472.xml
p22894
sg10
VSTD-Schiff-2008
p22895
sg12
S'PMC2564802'
p22896
sa(dp22897
g8
V16935912.xml
p22898
sg10
VSTD-Weinblatt-2007
p22899
sg12
S'PMC1798511'
p22900
sasa(dp22901
g3
VCD002767 v. 12.0 Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.rm5
p22902
sg5
(lp22903
(dp22904
g8
V1417051.xml
p22905
sg10
VSTD-Brett-1992
p22906
sg12
S'PMC1793633'
p22907
sa(dp22908
g8
V10770814.xml
p22909
sg10
VSTD-Elborn-2000
p22910
sg12
S'PMC1745744'
p22911
sasa(dp22912
g3
VCD000059 v. 12.0 Clozapine versus typical neuroleptic medication for schizophrenia.rm5
p22913
sg5
(lp22914
(dp22915
g8
V23984190.xml
p22916
sg10
VSTD-Xia-2002-_x0028_CPZ_x0029_
p22917
sg12
S'PMC3745831'
p22918
sasa(dp22919
g3
VCD001104 v. 7.0 Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.rm5
p22920
sg5
(lp22921
(dp22922
g8
V8882074.xml
p22923
sg10
VSTD-Grove-1996
p22924
sg12
S'PMC472490'
p22925
sa(dp22926
g8
V7570409.xml
p22927
sg10
VSTD-Ulrik-1995
p22928
sg12
S'PMC474647'
p22929
sasa(dp22930
g3
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p22931
sg5
(lp22932
(dp22933
g8
V18794178.xml
p22934
sg10
VSTD-Combe-2006
p22935
sg12
S'PMC2689524'
p22936
sasa(dp22937
g3
VCD000450 v. 6.0 Interventions for preventing and treating stress fractures and stress reactions of bone of the lower.rm5
p22938
sg5
(lp22939
(dp22940
g8
V3056045.xml
p22941
sg10
VSTD-Gardner-1988
p22942
sg12
S'PMC1349736'
p22943
sasa(dp22944
g3
VCD002261 v. 4.2 Pramipexole for levodopa-induced complications in Parkinson's disease.rm5
p22945
sg5
(lp22946
(dp22947
g8
V10201413.xml
p22948
sg10
VSTD-Pinter-1999
p22949
sg12
S'PMC1736320'
p22950
sasa(dp22951
g3
VCD006387 v. 3.0 Interventions for the treatment of oral cavity and oropharyngeal cancer radiotherapy.rm5
p22952
sg5
(lp22953
(dp22954
g8
V2125513.xml
p22955
sg10
VSTD-MacDougall-1990
p22956
sg12
S'PMC1664403'
p22957
sasa(dp22958
g3
VCD003134 v. 5.0 Non-steroid agents for idiopathic pulmonary fibrosis.rm5
p22959
sg5
(lp22960
(dp22961
g8
V2669218.xml
p22962
sg10
VSTD-Johnson-1989
p22963
sg12
S'PMC461792'
p22964
sasa(dp22965
g3
VCD002153 v. 4.0 Interventions for preventing reactions to snake antivenom.rm5
p22966
sg5
(lp22967
(dp22968
g8
V10205101.xml
p22969
sg10
VSTD-Premawardhena-1999
p22970
sg12
S'PMC27835'
p22971
sa(dp22972
g8
V10346769.xml
p22973
sg10
VSTD-Fan-1999
p22974
sg12
S'PMC27887'
p22975
sasa(dp22976
g3
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p22977
sg5
(lp22978
(dp22979
g8
V21515905.xml
p22980
sg10
VSTD-Ietswaart-2011
p22981
sg12
S'PMC3097892'
p22982
sa(dp22983
g8
V22506139.xml
p22984
sg10
VSTD-Yun-2010
p22985
sg12
S'PMC3309215'
p22986
sasa(dp22987
g3
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p22988
sg5
(lp22989
(dp22990
g8
V12946968.xml
p22991
sg10
VSTD-Viljanen-2003
p22992
sg12
S'PMC188429'
p22993
sa(dp22994
g8
V17907147.xml
p22995
sg10
VSTD-Hurley-2007
p22996
sg12
S'PMC2673355'
p22997
sa(dp22998
g8
V16734904.xml
p22999
sg10
VSTD-Nour-2006
p23000
sg12
S'PMC1525193'
p23001
sa(dp23002
g8
V15285783.xml
p23003
sg10
VSTD-Ersek-2004
p23004
sg12
S'PMC509247'
p23005
sa(dp23006
g8
V16426449.xml
p23007
sg10
VSTD-Smeets-2006
p23008
sg12
S'PMC1382224'
p23009
sasa(dp23010
g3
VCD002158 v. 6.0 Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agoni.rm5
p23011
sg5
(lp23012
(dp23013
g8
V7139504.xml
p23014
sg10
VSTD-Latimer-1982
p23015
sg12
S'PMC1862216'
p23016
sa(dp23017
g8
V7795451.xml
p23018
sg10
VSTD-Taggart-1995
p23019
sg12
S'PMC2550012'
p23020
sa(dp23021
g8
V2392793.xml
p23022
sg10
VSTD-Zainudin-1990
p23023
sg12
S'PMC462532'
p23024
sa(dp23025
g8
V7878558.xml
p23026
sg10
VSTD-Selroos-1994
p23027
sg12
S'PMC475329'
p23028
sasa(dp23029
g3
VCD006943 v. 4.49 Interventions for covert bacteriuria in children.rm5
p23030
sg5
(lp23031
(dp23032
g8
V7271298.xml
p23033
sg10
VSTD-NCBRG-1981
p23034
sg12
S'PMC1627274'
p23035
sasa(dp23036
g3
VCD006073 v. 3.0 Repetitive task training for improving functional ability after stroke.rm5
p23037
sg5
(lp23038
(dp23039
g8
V15774435.xml
p23040
sg10
VSTD-Van-Vliet-2005
p23041
sg12
S'PMC1739598'
p23042
sasa(dp23043
g3
VCD001208 v. 12.2 Human albumin solution for resuscitation and volume expansion in critically ill patients.rm5
p23044
sg5
(lp23045
(dp23046
g8
V4749684.xml
p23047
sg10
VSTD-Bland-1973
p23048
sg12
S'PMC1648558'
p23049
sa(dp23050
g8
V6342554.xml
p23051
sg10
VSTD-Goodwin-1983
p23052
sg12
S'PMC1353023'
p23053
sa(dp23054
g8
V9059186.xml
p23055
sg10
VSTD-So-1997
p23056
sg12
S'PMC1720603'
p23057
sasa(dp23058
g3
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p23059
sg5
(lp23060
(dp23061
g8
V7856157.xml
p23062
sg10
VSTD-Browner-1994
p23063
sg12
S'PMC1022738'
p23064
sa(dp23065
g8
V14604931.xml
p23066
sg10
VSTD-Moore-2003-b
p23067
sg12
S'PMC261745'
p23068
sa(dp23069
g8
V12879826.xml
p23070
sg10
VSTD-Moore-2003-a
p23071
sg12
S'PMC1314568'
p23072
sa(dp23073
g8
V9294786.xml
p23074
sg10
VSTD-Dolan1997
p23075
sg12
S'PMC1497157'
p23076
sa(dp23077
g8
V12694632.xml
p23078
sg10
VSTD-Forsetlund-2003
p23079
sg12
S'PMC153535'
p23080
sa(dp23081
g8
V15904552.xml
p23082
sg10
VSTD-Harmsen-2005
p23083
sg12
S'PMC1463156'
p23084
sa(dp23085
g8
V1571644.xml
p23086
sg10
VSTD-Dietrich-1992
p23087
sg12
S'PMC1881551'
p23088
sa(dp23089
g8
V21221270.xml
p23090
sg10
VSTD-Wilson-1992
p23091
sg12
S'PMC2145470'
p23092
sa(dp23093
g8
V10557684.xml
p23094
sg10
VSTD-Smeele-1999
p23095
sg12
S'PMC2483639'
p23096
sa(dp23097
g8
V15805455.xml
p23098
sg10
VSTD-Bekkering-2005
p23099
sg12
S'PMC1743983'
p23100
sa(dp23101
g8
V12183309.xml
p23102
sg10
VSTD-Flottorp-2002
p23103
sg12
S'PMC117890'
p23104
sa(dp23105
g8
V14521638.xml
p23106
sg10
VSTD-Schectman-2003
p23107
sg12
S'PMC1494929'
p23108
sa(dp23109
g8
V7554017.xml
p23110
sg10
VSTD-Westphal-1995
p23111
sg12
S'PMC2486792'
p23112
sa(dp23113
g8
V10420862.xml
p23114
sg10
VSTD-Worrall-1999
p23115
sg12
S'PMC1232647'
p23116
sa(dp23117
g8
V11375232.xml
p23118
sg10
VSTD-Morrison-2001
p23119
sg12
S'PMC31924'
p23120
sa(dp23121
g8
V15868015.xml
p23122
sg10
VSTD-Lewin-2005
p23123
sg12
S'PMC2626204'
p23124
sa(dp23125
g8
V15297305.xml
p23126
sg10
VSTD-Welschen-2004
p23127
sg12
S'PMC514206'
p23128
sa(dp23129
g8
V10480825.xml
p23130
sg10
VSTD-Kerse-1999
p23131
sg12
S'PMC28221'
p23132
sa(dp23133
g8
V11677701.xml
p23134
sg10
VSTD-Simons-2001
p23135
sg12
S'PMC1314123'
p23136
sa(dp23137
g8
V11964340.xml
p23138
sg10
VSTD-King-2002
p23139
sg12
S'PMC102328'
p23140
sa(dp23141
g8
V14758407.xml
p23142
sg10
VSTD-Garcia-2003
p23143
sg12
S'PMC2572366'
p23144
sa(dp23145
g8
V15576543.xml
p23146
sg10
VSTD-Verstappen-2004
p23147
sg12
S'PMC1466745'
p23148
sa(dp23149
g8
V12386042.xml
p23150
sg10
VSTD-Kiessling-2002
p23151
sg12
S'PMC129638'
p23152
sasa(dp23153
g3
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p23154
sg5
(lp23155
(dp23156
g8
V20428412.xml
p23157
sg10
VSTD-Chappell-2008
p23158
sg12
S'PMC2840539'
p23159
sasa(dp23160
g3
VCD006896 v. 4.0 Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes.rm5
p23161
sg5
(lp23162
(dp23163
g8
V5460838.xml
p23164
sg10
VSTD-Baumslag-1970
p23165
sg12
S'PMC1700896'
p23166
sa(dp23167
g8
V1263177.xml
p23168
sg10
VSTD-Trigg-1976
p23169
sg12
S'PMC2158056'
p23170
sa(dp23171
g8
V5648998.xml
p23172
sg10
VSTD-Chanarin-1968
p23173
sg12
S'PMC1986006'
p23174
sa(dp23175
g8
V5476865.xml
p23176
sg10
VSTD-Rae-1970
p23177
sg12
S'PMC476777'
p23178
sa(dp23179
g8
V14238675.xml
p23180
sg10
VSTD-Chanarin-1965
p23181
sg12
S'PMC2165857'
p23182
sasa(dp23183
g3
VCD001912 v. 12.0 Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.rm5
p23184
sg5
(lp23185
(dp23186
g8
V8129449.xml
p23187
sg10
VSTD-Weaver-1994
p23188
sg12
S'PMC1029705'
p23189
sa(dp23190
g8
V1996888.xml
p23191
sg10
VSTD-Chatfield-1991
p23192
sg12
S'PMC1590363'
p23193
sasa(dp23194
g3
VCD002795 v. 8.0 Pharmacotherapy for post traumatic stress disorder (PTSD).rm5
p23195
sg5
(lp23196
(dp23197
g8
V21407853.xml
p23198
sg10
VSTD-Pfizer588
p23199
sg12
S'PMC2955947'
p23200
sa(dp23201
g8
V21407853.xml
p23202
sg10
VSTD-Pfizer589
p23203
sg12
S'PMC2955947'
p23204
sasa(dp23205
g3
VCD007125 v. 3.0 Multidisciplinary rehabilitation for older people with hip fractures.rm5
p23206
sg5
(lp23207
(dp23208
g8
V3143450.xml
p23209
sg10
VSTD-Gilchrist-1988
p23210
sg12
S'PMC1834849'
p23211
sa(dp23212
g8
V3143436.xml
p23213
sg10
VSTD-Kennie-1988
p23214
sg12
S'PMC1834847'
p23215
sa(dp23216
g8
V12137074.xml
p23217
sg10
VSTD-Naglie-2002
p23218
sg12
S'PMC116636'
p23219
sasa(dp23220
g3
VCD005253 v. 3.0 Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in pr.rm5
p23221
sg5
(lp23222
(dp23223
g8
V10952698.xml
p23224
sg10
VSTD-Rogahn-2000
p23225
sg12
S'PMC1721136'
p23226
sasa(dp23227
g3
VCD003270 v. 9.2 Azathioprine as an oral corticosteroid sparing agent for asthma.rm5
p23228
sg5
(lp23229
(dp23230
g8
V4947381.xml
p23231
sg10
VSTD-Hodges-1971
p23232
sg12
S'PMC472390'
p23233
sa(dp23234
g8
V4947381.xml
p23235
sg10
VSTD-Hodges-1971a
p23236
sg12
S'PMC472390'
p23237
sasa(dp23238
g3
VCD006385 v. 3.0 Arthroscopy for temporomandibular disorders.rm5
p23239
sg5
(lp23240
(dp23241
g8
V17189464.xml
p23242
sg10
VSTD-Schiffman-2007
p23243
sg12
S'PMC2278036'
p23244
sasa(dp23245
g3
VCD005976 v. 9.2 Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in ch.rm5
p23246
sg5
(lp23247
(dp23248
g8
V15070633.xml
p23249
sg10
VSTD-Agarwal-2004
p23250
sg12
S'PMC383371'
p23251
sasa(dp23252
g3
VCD008194 v. 3.0 Outreach strategies for expanding health insurance coverage in children.rm5
p23253
sg5
(lp23254
(dp23255
g8
V15671460.xml
p23256
sg10
VSTD-Gordon-2005
p23257
sg12
S'PMC1449162'
p23258
sasa(dp23259
g3
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p23260
sg5
(lp23261
(dp23262
g8
V20832366.xml
p23263
sg10
VSTD-Smithuis-2010
p23264
sg12
S'PMC2947715'
p23265
sa(dp23266
g8
V22303437.xml
p23267
sg10
VSTD-Kolaczinski-2012
p23268
sg12
S'PMC3269419'
p23269
sa(dp23270
g8
V18074034.xml
p23271
sg10
VSTD-El_x002d_Sayed-2007
p23272
sg12
S'PMC2111052'
p23273
sa(dp23274
g8
V17105658.xml
p23275
sg10
VSTD-Ledermann-2006
p23276
sg12
S'PMC1665467'
p23277
sa(dp23278
g8
V15047537.xml
p23279
sg10
VSTD-Pukrittayakamee-2004
p23280
sg12
S'PMC375327'
p23281
sa(dp23282
g8
V17925871.xml
p23283
sg10
VSTD-Shekalaghe-2007
p23284
sg12
S'PMC1995753'
p23285
sasa(dp23286
g3
VCD006849 v. 3.0 Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.rm5
p23287
sg5
(lp23288
(dp23289
g8
V1851339.xml
p23290
sg10
VSTD-Smith-1991
p23291
sg12
S'PMC463022'
p23292
sasa(dp23293
g3
VCD008096 v. 4.0 Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing distu.rm5
p23294
sg5
(lp23295
(dp23296
g8
V8555849.xml
p23297
sg10
VSTD-Norton-1996
p23298
sg12
S'PMC2349687'
p23299
sa(dp23300
g8
V1628013.xml
p23301
sg10
VSTD-Park-1992
p23302
sg12
S'PMC1882203'
p23303
sasa(dp23304
g3
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p23305
sg5
(lp23306
(dp23307
g8
V20687915.xml
p23308
sg10
VSTD-Mistiaen-2009
p23309
sg12
S'PMC2924330'
p23310
sasa(dp23311
g3
VCD004851 v. 11.2 Newer generation antidepressants for depressive disorders in children and adolescents.rm5
p23312
sg5
(lp23313
(dp23314
g8
V22155653.xml
p23315
sg10
VSTD-Emslie-2007-Trial-1
p23316
sg12
S'PMC3268850'
p23317
sa(dp23318
g8
V22155653.xml
p23319
sg10
VSTD-Emslie-2007-Trial-2
p23320
sg12
S'PMC3268850'
p23321
sasa(dp23322
g3
VCD002128 v. 7.0 Dietary advice for reducing cardiovascular risk.rm5
p23323
sg5
(lp23324
(dp23325
g8
V9987465.xml
p23326
sg10
VSTD-Sorensen-work_x002b_family
p23327
sg12
S'PMC1508509'
p23328
sa(dp23329
g8
V20101007.xml
p23330
sg10
VSTD-ENCORE
p23331
sg12
S'PMC3633078'
p23332
sa(dp23333
g8
V9987465.xml
p23334
sg10
VSTD-Sorensen-worksite
p23335
sg12
S'PMC1508509'
p23336
sa(dp23337
g8
V15082472.xml
p23338
sg10
VSTD-Little--2004
p23339
sg12
S'PMC403849'
p23340
sa(dp23341
g8
V9702141.xml
p23342
sg10
VSTD-Havas-1998
p23343
sg12
S'PMC1508288'
p23344
sa(dp23345
g8
V7888933.xml
p23346
sg10
VSTD-Neil-dietitian1995
p23347
sg12
S'PMC2548942'
p23348
sa(dp23349
g8
V7888933.xml
p23350
sg10
VSTD-Neil-nurse-1995
p23351
sg12
S'PMC2548942'
p23352
sa(dp23353
g8
V9146440.xml
p23354
sg10
VSTD-Beresford-1997
p23355
sg12
S'PMC1380841'
p23356
sa(dp23357
g8
V2115348.xml
p23358
sg10
VSTD-Baron-men-1990
p23359
sg12
S'PMC1371239'
p23360
sa(dp23361
g8
V2115348.xml
p23362
sg10
VSTD-Baron-women-1990
p23363
sg12
S'PMC1371239'
p23364
sasa(dp23365
g3
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p23366
sg5
(lp23367
(dp23368
g8
V22695903.xml
p23369
sg10
VSTD-PITCH-2012
p23370
sg12
S'PMC3420230'
p23371
sasa(dp23372
g3
VCD003045 v. 8.0 Anabolic-androgenic steroids for alcoholic liver disease.rm5
p23373
sg5
(lp23374
(dp23375
g8
V695564.xml
p23376
sg10
VSTD-Fenster-1966
p23377
sg12
S'PMC1238286'
p23378
sasa(dp23379
g3
VCD004115 v. 4.2 Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p23380
sg5
(lp23381
(dp23382
g8
V1885075.xml
p23383
sg10
VSTD-Campieri-1991b
p23384
sg12
S'PMC1378964'
p23385
sa(dp23386
g8
V6113021.xml
p23387
sg10
VSTD-Palmer-1981
p23388
sg12
S'PMC1505556'
p23389
sa(dp23390
g8
V3081188.xml
p23391
sg10
VSTD-Powell_x002d_Tuck-1986
p23392
sg12
S'PMC1339576'
p23393
sa(dp23394
g8
V8801202.xml
p23395
sg10
VSTD-Lee-1996
p23396
sg12
S'PMC1383028'
p23397
sasa(dp23398
g3
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p23399
sg5
(lp23400
(dp23401
g8
V19477503.xml
p23402
sg10
VSTD-CLOTS-2009
p23403
sg12
S'PMC2692021'
p23404
sasa(dp23405
g3
VCD002837 v. 10.0 Enteral versus parenteral nutrition for acute pancreatitis.rm5
p23406
sg5
(lp23407
(dp23408
g8
V16149365.xml
p23409
sg10
VSTD-Louie-2005
p23410
sg12
S'PMC3211537'
p23411
sasa(dp23412
g3
VCD007506 v. 6.0 Lifestyle changes in women with polycystic ovary syndrome.rm5
p23413
sg5
(lp23414
(dp23415
g8
V19204602.xml
p23416
sg10
VSTD-Brown-2009
p23417
sg12
S'PMC2727938'
p23418
sa(dp23419
g8
V18728175.xml
p23420
sg10
VSTD-Hoeger-2008
p23421
sg12
S'PMC2582568'
p23422
sasa(dp23423
g3
VCD005449 v. 3.0 Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in typ.rm5
p23424
sg5
(lp23425
(dp23426
g8
V18753638.xml
p23427
sg10
VSTD-PRoFESS-2008
p23428
sg12
S'PMC2714259'
p23429
sasa(dp23430
g3
VCD006745 v. 4.2 Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcino.rm5
p23431
sg5
(lp23432
(dp23433
g8
V15973099.xml
p23434
sg10
VSTD-Huang-2005
p23435
sg12
S'PMC1357702'
p23436
sa(dp23437
g8
V16009687.xml
p23438
sg10
VSTD-Lin-2005
p23439
sg12
S'PMC1774888'
p23440
sasa(dp23441
g3
VCD003180 v. 8.0 Interventions for promoting physical activity.rm5
p23442
sg5
(lp23443
(dp23444
g8
V10496829.xml
p23445
sg10
VSTD-Harland-1999
p23446
sg12
S'PMC314213'
p23447
sa(dp23448
g8
V9773174.xml
p23449
sg10
VSTD-Stevens-1998
p23450
sg12
S'PMC1756094'
p23451
sa(dp23452
g8
V443500.xml
p23453
sg10
VSTD-Reid-1979
p23454
sg12
S'PMC1618997'
p23455
sa(dp23456
g8
V11487597.xml
p23457
sg10
VSTD-Stewart-2001
p23458
sg12
S'PMC1780022'
p23459
sa(dp23460
g8
V11896130.xml
p23461
sg10
VSTD-Lamb-2002
p23462
sg12
S'PMC1732126'
p23463
sa(dp23464
g8
V10953898.xml
p23465
sg10
VSTD-Smith-2000
p23466
sg12
S'PMC1724212'
p23467
sa(dp23468
g8
V12689976.xml
p23469
sg10
VSTD-Elley-2003
p23470
sg12
S'PMC153098'
p23471
sasa(dp23472
g3
VCD000950 v. 6.0 Carnitine supplementation of parenterally fed neonates.rm5
p23473
sg5
(lp23474
(dp23475
g8
V9713029.xml
p23476
sg10
VSTD-Shortland-1998
p23477
sg12
S'PMC1720799'
p23478
sasa(dp23479
g3
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p23480
sg5
(lp23481
(dp23482
g8
V19300631.xml
p23483
sg10
VSTD-Mok-2007
p23484
sg12
S'PMC2656338'
p23485
sasa(dp23486
g3
VCD003300 v. 7.0 Graduated driver licensing for reducing motor vehicle crashes among young drivers.rm5
p23487
sg5
(lp23488
(dp23489
g8
V12226120.xml
p23490
sg10
VSTD-Baker-2006
p23491
sg12
S'PMC1730866'
p23492
sasa(dp23493
g3
VCD004249 v. 9.0 Manipulation or Mobilisation for Neck Pain.rm5
p23494
sg5
(lp23495
(dp23496
g8
V19674713.xml
p23497
sg10
VSTD-Strunk-2008
p23498
sg12
S'PMC2647106'
p23499
sa(dp23500
g8
V6355460.xml
p23501
sg10
VSTD-Howe-1983
p23502
sg12
S'PMC1973006'
p23503
sa(dp23504
g8
V19119394.xml
p23505
sg10
VSTD-Krauss-2008
p23506
sg12
S'PMC2565124'
p23507
sa(dp23508
g8
V12356613.xml
p23509
sg10
VSTD-Hurwitz-2002
p23510
sg12
S'PMC1447299'
p23511
sasa(dp23512
g3
VCD004170 v. 9.12 Multi-disciplinary rehabilitation for acquired brain injury in adults of working age.rm5
p23513
sg5
(lp23514
(dp23515
g8
V9153604.xml
p23516
sg10
VSTD-Wade-1997
p23517
sg12
S'PMC486856'
p23518
sa(dp23519
g8
V6780105.xml
p23520
sg10
VSTD-Smith-1981
p23521
sg12
S'PMC1504295'
p23522
sa(dp23523
g8
V9703167.xml
p23524
sg10
VSTD-Wade-1998
p23525
sg12
S'PMC2170203'
p23526
sa(dp23527
g8
V11796769.xml
p23528
sg10
VSTD-Powell-2002
p23529
sg12
S'PMC1737759'
p23530
sasa(dp23531
g3
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p23532
sg5
(lp23533
(dp23534
g8
V22768793.xml
p23535
sg10
VSTD-Carlini-2012
p23536
sg12
S'PMC3438078'
p23537
sa(dp23538
g8
V19524389.xml
p23539
sg10
VSTD-McClure-2009
p23540
sg12
S'PMC2889910'
p23541
sa(dp23542
g8
V11818305.xml
p23543
sg10
VSTD-Hennrikus-2002
p23544
sg12
S'PMC1447056'
p23545
sa(dp23546
g8
V16954124.xml
p23547
sg10
VSTD-McClure-2006
p23548
sg12
S'PMC2018826'
p23549
sasa(dp23550
g3
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p23551
sg5
(lp23552
(dp23553
g8
V7856782.xml
p23554
sg10
VSTD-Lung-Health-Study
p23555
sg12
S'PMC1615316'
p23556
sa(dp23557
g8
V18072840.xml
p23558
sg10
VSTD-Cooney-2007
p23559
sg12
S'PMC2702144'
p23560
sa(dp23561
g8
V17475005.xml
p23562
sg10
VSTD-Binnie-2007
p23563
sg12
S'PMC1871574'
p23564
sa(dp23565
g8
V19959695.xml
p23566
sg10
VSTD-Wewers-2009
p23567
sg12
S'PMC2791896'
p23568
sa(dp23569
g8
V12709522.xml
p23570
sg10
VSTD-Rodriguez-2003
p23571
sg12
S'PMC1740534'
p23572
sa(dp23573
g8
V18048633.xml
p23574
sg10
VSTD-Hollis-2007
p23575
sg12
S'PMC2598511'
p23576
sa(dp23577
g8
V11387540.xml
p23578
sg10
VSTD-Schauffler-2001
p23579
sg12
S'PMC1747566'
p23580
sa(dp23581
g8
V22853197.xml
p23582
sg10
VSTD-Brandstein-2011
p23583
sg12
S'PMC3453521'
p23584
sa(dp23585
g8
V12775857.xml
p23586
sg10
VSTD-Molyneux-2003
p23587
sg12
S'PMC1746718'
p23588
sa(dp23589
g8
V17008577.xml
p23590
sg10
VSTD-Hall-2006
p23591
sg12
S'PMC1586139'
p23592
sasa(dp23593
g3
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p23594
sg5
(lp23595
(dp23596
g8
V22066891.xml
p23597
sg10
VSTD-_x00c5_gren-2011
p23598
sg12
S'PMC3233272'
p23599
sasa(dp23600
g3
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p23601
sg5
(lp23602
(dp23603
g8
V20163739.xml
p23604
sg10
VSTD-Bennell-2010
p23605
sg12
S'PMC2830179'
p23606
sasa(dp23607
g3
VCD007177 v. 3.0 Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee re.rm5
p23608
sg5
(lp23609
(dp23610
g8
V23930227.xml
p23611
sg10
VSTD-Stevens-2002
p23612
sg12
S'PMC3733520'
p23613
sasa(dp23614
g3
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p23615
sg5
(lp23616
(dp23617
g8
V21131037.xml
p23618
sg10
VSTD-Morgan-2010
p23619
sg12
S'PMC3639680'
p23620
sasa(dp23621
g3
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p23622
sg5
(lp23623
(dp23624
g8
V15175527.xml
p23625
sg10
VSTD-Ogilvie-2004
p23626
sg12
S'PMC1747869'
p23627
sa(dp23628
g8
V20825660.xml
p23629
sg10
VSTD-Jepson-2010
p23630
sg12
S'PMC2944371'
p23631
sa(dp23632
g8
V19692738.xml
p23633
sg10
VSTD-Bambra-2010
p23634
sg12
S'PMC2921286'
p23635
sa(dp23636
g8
V19426469.xml
p23637
sg10
VSTD-Darmstadt-2009
p23638
sg12
S'PMC2679412'
p23639
sa(dp23640
g8
V18505545.xml
p23641
sg10
VSTD-Main-2008
p23642
sg12
S'PMC2412872'
p23643
sa(dp23644
g8
V19426466.xml
p23645
sg10
VSTD-Yakoob-2009
p23646
sg12
S'PMC2679409'
p23647
sa(dp23648
g8
V19426467.xml
p23649
sg10
VSTD-Menezes-2009
p23650
sg12
S'PMC2679410'
p23651
sa(dp23652
g8
V19426468.xml
p23653
sg10
VSTD-Haws-2009
p23654
sg12
S'PMC2679411'
p23655
sa(dp23656
g8
V19828063.xml
p23657
sg10
VSTD-Shea-2009
p23658
sg12
S'PMC3226237'
p23659
sa(dp23660
g8
V19426470.xml
p23661
sg10
VSTD-Bhutta-2009
p23662
sg12
S'PMC2679413'
p23663
sa(dp23664
g8
V20233384.xml
p23665
sg10
VSTD-Barros-2010
p23666
sg12
S'PMC2841444'
p23667
sasa(dp23668
g3
VCD007569 v. 4.0 Interventions to enhance return-to-work for cancer patients.rm5
p23669
sg5
(lp23670
(dp23671
g8
V14570527.xml
p23672
sg10
VSTD-Lepore-_x0028_PE_x0029_-2003
p23673
sg12
S'PMC2593114'
p23674
sa(dp23675
g8
V14570527.xml
p23676
sg10
VSTD-Lepore-_x0028_PE_x002b_discus_x0029_-2003
p23677
sg12
S'PMC2593114'
p23678
sa(dp23679
g8
V19805678.xml
p23680
sg10
VSTD-Kornblith-2009
p23681
sg12
S'PMC2773220'
p23682
sasa(dp23683
g3
VCD006936 v. 5.0 Motivational interviewing for smoking cessation.rm5
p23684
sg5
(lp23685
(dp23686
g8
V18048633.xml
p23687
sg10
VSTD-Hollis-2007
p23688
sg12
S'PMC2598511'
p23689
sa(dp23690
g8
V17007707.xml
p23691
sg10
VSTD-Soria-2006
p23692
sg12
S'PMC1920717'
p23693
sa(dp23694
g8
V10800431.xml
p23695
sg10
VSTD-Glasgow-2000
p23696
sg12
S'PMC1446229'
p23697
sasa(dp23698
g3
VCD006332 v. 8.0 Mu-opioid antagonists for opioid-induced bowel dysfunction.rm5
p23699
sg5
(lp23700
(dp23701
g8
V519357.xml
p23702
sg10
VSTD-Nimmo-1979
p23703
sg12
S'PMC1597257'
p23704
sa(dp23705
g8
V15383800.xml
p23706
sg10
VSTD-Wolff-2004
p23707
sg12
S'PMC1356474'
p23708
sasa(dp23709
g3
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p23710
sg5
(lp23711
(dp23712
g8
V18952682.xml
p23713
sg10
VSTD-Collins-2008a
p23714
sg12
S'PMC2572211'
p23715
sasa(dp23716
g3
VCD003531 v. 6.0 Pressure modification for improving usage of continuous positive airway pressure machines in adults .rm5
p23717
sg5
(lp23718
(dp23719
g8
V18198804.xml
p23720
sg10
VSTD-Ballard-2007
p23721
sg12
S'PMC2556913'
p23722
sa(dp23723
g8
V16254055.xml
p23724
sg10
VSTD-West-2006
p23725
sg12
S'PMC2080742'
p23726
sasa(dp23727
g3
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p23728
sg5
(lp23729
(dp23730
g8
V18545692.xml
p23731
sg10
VSTD-Yeka-2007-UGA
p23732
sg12
S'PMC2405936'
p23733
sa(dp23734
g8
V18620577.xml
p23735
sg10
VSTD-Adjei-2006-GHA
p23736
sg12
S'PMC2478668'
p23737
sa(dp23738
g8
V17125496.xml
p23739
sg10
VSTD-Van-den-Broek-2004-ZAR
p23740
sg12
S'PMC1697822'
p23741
sa(dp23742
g8
V17366451.xml
p23743
sg10
VSTD-Hasugian-2005-IDN
p23744
sg12
S'PMC2532501'
p23745
sa(dp23746
g8
V16033307.xml
p23747
sg10
VSTD-Yeka-2004-UGA
p23748
sg12
S'PMC1181876'
p23749
sa(dp23750
g8
V17570848.xml
p23751
sg10
VSTD-Faye-2003-SEN
p23752
sg12
S'PMC1919387'
p23753
sa(dp23754
g8
V17971864.xml
p23755
sg10
VSTD-Grande-2005-PER
p23756
sg12
S'PMC2040506'
p23757
sa(dp23758
g8
V17631681.xml
p23759
sg10
VSTD-Mukhtar-2005-SDN
p23760
sg12
S'PMC1940006'
p23761
sa(dp23762
g8
V19099594.xml
p23763
sg10
VSTD-Kobbe-2007-GHA
p23764
sg12
S'PMC2625364'
p23765
sa(dp23766
g8
V17525792.xml
p23767
sg10
VSTD-Kamya-2006-UGA
p23768
sg12
S'PMC1876597'
p23769
sa(dp23770
g8
V19017387.xml
p23771
sg10
VSTD-Mens-2007-KEN
p23772
sg12
S'PMC2600646'
p23773
sa(dp23774
g8
V17336652.xml
p23775
sg10
VSTD-Ratcliff-2005-IDN
p23776
sg12
S'PMC2532500'
p23777
sa(dp23778
g8
V17477865.xml
p23779
sg10
VSTD-Bonnet-2004-GIN
p23780
sg12
S'PMC1868032'
p23781
sa(dp23782
g8
V16871329.xml
p23783
sg10
VSTD-Bukirwa-2005-UGA
p23784
sg12
S'PMC1488893'
p23785
sa(dp23786
g8
V16179089.xml
p23787
sg10
VSTD-Hutagalung-2002-THA
p23788
sg12
S'PMC1261533'
p23789
sa(dp23790
g8
V17519010.xml
p23791
sg10
VSTD-Menard-2006-MDG
p23792
sg12
S'PMC1887535'
p23793
sa(dp23794
g8
V18575626.xml
p23795
sg10
VSTD-Owusu_x002d_Agyei-2006-GHA
p23796
sg12
S'PMC2430614'
p23797
sa(dp23798
g8
V19128455.xml
p23799
sg10
VSTD-Kayentao-2006-MLI
p23800
sg12
S'PMC2631542'
p23801
sasa(dp23802
g3
VCD004921 v. 5.0 Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.rm5
p23803
sg5
(lp23804
(dp23805
g8
V22937790.xml
p23806
sg10
VSTD-Fang-1995
p23807
sg12
S'PMC3487803'
p23808
sasa(dp23809
g3
VCD005198 v. 8.7 Therapeutic interventions for Burkitt lymphoma in children.rm5
p23810
sg5
(lp23811
(dp23812
g8
V17132719.xml
p23813
sg10
VSTD-Patte-2007
p23814
sg12
S'PMC1852229'
p23815
sa(dp23816
g8
V766905.xml
p23817
sg10
VSTD-Magrath-1976
p23818
sg12
S'PMC1639074'
p23819
sa(dp23820
g8
V5109411.xml
p23821
sg10
VSTD-Ziegler-1971
p23822
sg12
S'PMC1800463'
p23823
sasa(dp23824
g3
VCD000067 v. 7.0 Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.rm5
p23825
sg5
(lp23826
(dp23827
g8
V8549944.xml
p23828
sg10
VSTD-Candy-1995
p23829
sg12
S'PMC1382873'
p23830
sasa(dp23831
g3
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p23832
sg5
(lp23833
(dp23834
g8
V11914160.xml
p23835
sg10
VSTD-Sangdee-2002-_x002a_
p23836
sg12
S'PMC102323'
p23837
sa(dp23838
g8
V15494348.xml
p23839
sg10
VSTD-Vas-2004
p23840
sg12
S'PMC529365'
p23841
sa(dp23842
g8
V17699546.xml
p23843
sg10
VSTD-Foster-2007
p23844
sg12
S'PMC1962890'
p23845
sa(dp23846
g8
V11914160.xml
p23847
sg10
VSTD-Sangdee-2002-_x002a__x002a_
p23848
sg12
S'PMC102323'
p23849
sasa(dp23850
g3
VCD004293 v. 6.0 Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.rm5
p23851
sg5
(lp23852
(dp23853
g8
V793706.xml
p23854
sg10
VSTD-Silverberg-1976
p23855
sg12
S'PMC1878979'
p23856
sasa(dp23857
g3
VCD001909 v. 12.0 Lamotrigine add-on for drug-resistant partial epilepsy.rm5
p23858
sg5
(lp23859
(dp23860
g8
V8505632.xml
p23861
sg10
VSTD-Schapel-1993
p23862
sg12
S'PMC1014998'
p23863
sasa(dp23864
g3
VCD005947 v. 5.0 Glutamine supplementation for young infants with severe gastrointestinal disease.rm5
p23865
sg5
(lp23866
(dp23867
g8
V15798461.xml
p23868
sg10
VSTD-Albers-2005
p23869
sg12
S'PMC1357063'
p23870
sasa(dp23871
g3
VCD006931 v. 3.0 Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration.rm5
p23872
sg5
(lp23873
(dp23874
g8
V15522362.xml
p23875
sg10
VSTD-SST-2004-Group-N
p23876
sg12
S'PMC1256024'
p23877
sa(dp23878
g8
V15522364.xml
p23879
sg10
VSTD-SST-2004-Group-B
p23880
sg12
S'PMC1256022'
p23881
sasa(dp23882
g3
VCD004192 v. 8.0 Dietary interventions for multiple sclerosis.rm5
p23883
sg5
(lp23884
(dp23885
g8
V363236.xml
p23886
sg10
VSTD-Bates-1978
p23887
sg12
S'PMC1608620'
p23888
sa(dp23889
g8
V334337.xml
p23890
sg10
VSTD-Bates-1977
p23891
sg12
S'PMC1631630'
p23892
sa(dp23893
g8
V2540285.xml
p23894
sg10
VSTD-Bates-1989
p23895
sg12
S'PMC1032650'
p23896
sa(dp23897
g8
V4571680.xml
p23898
sg10
VSTD-Millar-1973
p23899
sg12
S'PMC1588925'
p23900
sasa(dp23901
g3
VCD009594 v. 3.0 The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.rm5
p23902
sg5
(lp23903
(dp23904
g8
V15044693.xml
p23905
sg10
VSTD-Shen-2004
p23906
sg12
S'PMC397380'
p23907
sa(dp23908
g8
V20705755.xml
p23909
sg10
VSTD-Powell-2010
p23910
sg12
S'PMC2981533'
p23911
sasa(dp23912
g3
VCD004718 v. 7.0 Early intervention for psychosis.rm5
p23913
sg5
(lp23914
(dp23915
g8
V16141449.xml
p23916
sg10
VSTD-OPUS_x002d_Scandinavia
p23917
sg12
S'PMC1215551'
p23918
sasa(dp23919
g3
VCD006921 v. 4.0 Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.rm5
p23920
sg5
(lp23921
(dp23922
g8
V8229035.xml
p23923
sg10
VSTD-Alam-1993
p23924
sg12
S'PMC489825'
p23925
sasa(dp23926
g3
VCD007967 v. 3.0 Acetylcholinesterase inhibitors for schizophrenia.rm5
p23927
sg5
(lp23928
(dp23929
g8
V18325740.xml
p23930
sg10
VSTD-Dyer-2008
p23931
sg12
S'PMC2596972'
p23932
sasa(dp23933
g3
VCD000301 v. 7.0 Corticosteroids for maintenance of remission in Crohn's disease.rm5
p23934
sg5
(lp23935
(dp23936
g8
V355071.xml
p23937
sg10
VSTD-Smith-1978
p23938
sg12
S'PMC1412084'
p23939
sasa(dp23940
g3
VCD002271 v. 5.0 Continuous distending pressure for respiratory distress in preterm infants.rm5
p23941
sg5
(lp23942
(dp23943
g8
V782375.xml
p23944
sg10
VSTD-Durbin-1976
p23945
sg12
S'PMC1545933'
p23946
sasa(dp23947
g3
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p23948
sg5
(lp23949
(dp23950
g8
V14624703.xml
p23951
sg10
VSTD-Assadi-2003
p23952
sg12
S'PMC293465'
p23953
sasa(dp23954
g3
VCD008391 v. 2.0 Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progress.rm5
p23955
sg5
(lp23956
(dp23957
g8
V20124118.xml
p23958
sg10
VSTD-Jorge-2010
p23959
sg12
S'PMC3718472'
p23960
sasa(dp23961
g3
VCD004832 v. 7.2 Aspirin for in vitro fertilisation.rm5
p23962
sg5
(lp23963
(dp23964
g8
V9866064.xml
p23965
sg10
VSTD-Check-1998
p23966
sg12
S'PMC3454856'
p23967
sa(dp23968
g8
V11209540.xml
p23969
sg10
VSTD-Urman-2000
p23970
sg12
S'PMC3455451'
p23971
sa(dp23972
g8
V16518579.xml
p23973
sg10
VSTD-Duvan-2006
p23974
sg12
S'PMC3455434'
p23975
sasa(dp23976
g3
VCD002233 v. 5.2 Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patien.rm5
p23977
sg5
(lp23978
(dp23979
g8
V9391254.xml
p23980
sg10
VSTD-Jenkins-1997
p23981
sg12
S'PMC1891518'
p23982
sasa(dp23983
g3
VCD009228 v. 2.4 Helicopter emergency medical services for adults with major trauma.rm5
p23984
sg5
(lp23985
(dp23986
g8
V3389935.xml
p23987
sg10
VSTD-Moylan-1988
p23988
sg12
S'PMC1493556'
p23989
sa(dp23990
g8
V17550717.xml
p23991
sg10
VSTD-Mitchell-2007
p23992
sg12
S'PMC2384270'
p23993
sa(dp23994
g8
V19783323.xml
p23995
sg10
VSTD-Newgard-2010
p23996
sg12
S'PMC3008652'
p23997
sa(dp23998
g8
V7627033.xml
p23999
sg10
VSTD-Nicholl-1995
p24000
sg12
S'PMC2550277'
p24001
sasa(dp24002
g3
VCD004772 v. 5.0 Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.rm5
p24003
sg5
(lp24004
(dp24005
g8
V20942667.xml
p24006
sg10
VSTD-Palumbo-2010
p24007
sg12
S'PMC3021781'
p24008
sa(dp24009
g8
V19020325.xml
p24010
sg10
VSTD-Violari-2008
p24011
sg12
S'PMC2950021'
p24012
sasa(dp24013
g3
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p24014
sg5
(lp24015
(dp24016
g8
V14744822.xml
p24017
sg10
VSTD-Cluett-2004
p24018
sg12
S'PMC338094'
p24019
sa(dp24020
g8
V21054896.xml
p24021
sg10
VSTD-Nachum-2010
p24022
sg12
S'PMC2988803'
p24023
sasa(dp24024
g3
VCD004614 v. 6.0 Unit-dose packaged drugs for treating malaria.rm5
p24025
sg5
(lp24026
(dp24027
g8
V9763719.xml
p24028
sg10
VSTD-Li-1998a
p24029
sg12
S'PMC2305576'
p24030
sa(dp24031
g8
V11417034.xml
p24032
sg10
VSTD-Yeboah_x002d_Antwi-2001
p24033
sg12
S'PMC2566421'
p24034
sa(dp24035
g8
V9763719.xml
p24036
sg10
VSTD-Li-1998b
p24037
sg12
S'PMC2305576'
p24038
sasa(dp24039
g3
VCD001451 v. 8.2 Routine ultrasound in late pregnancy (after 24 weeks' gestation).rm5
p24040
sg5
(lp24041
(dp24042
g8
V6437476.xml
p24043
sg10
VSTD-Glasgow-1984
p24044
sg12
S'PMC1443311'
p24045
sa(dp24046
g8
V3113566.xml
p24047
sg10
VSTD-Peterborough-1987
p24048
sg12
S'PMC1246821'
p24049
sasa(dp24050
g3
VCD004607 v. 10.0 Speed cameras for the prevention of road traffic injuries and deaths.rm5
p24051
sg5
(lp24052
(dp24053
g8
V17666698.xml
p24054
sg10
VSTD-ES-Barcelona
p24055
sg12
S'PMC1963295'
p24056
sa(dp24057
g8
V14693888.xml
p24058
sg10
VSTD-GB-South-Wales
p24059
sg12
S'PMC1731028'
p24060
sasa(dp24061
g3
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p24062
sg5
(lp24063
(dp24064
g8
V19902034.xml
p24065
sg10
VSTD-Arun-2008
p24066
sg12
S'PMC2772000'
p24067
sa(dp24068
g8
V17892588.xml
p24069
sg10
VSTD-Zwarenstein-2007
p24070
sg12
S'PMC2200659'
p24071
sasa(dp24072
g3
VCD002010 v. 12.0 Bisphosphonates for osteoporosis in people with cystic fibrosis.rm5
p24073
sg5
(lp24074
(dp24075
g8
V11254825.xml
p24076
sg10
VSTD-Haworth-2001
p24077
sg12
S'PMC1746027'
p24078
sa(dp24079
g8
V15860755.xml
p24080
sg10
VSTD-Boyle-2005
p24081
sg12
S'PMC2718468'
p24082
sasa(dp24083
g3
VCD009391 v. 2.0 Brief co-incubation of sperm and oocytes for in vitro fertilization techniques.rm5
p24084
sg5
(lp24085
(dp24086
g8
V9866069.xml
p24087
sg10
VSTD-Coskun-1998
p24088
sg12
S'PMC3454860'
p24089
sa(dp24090
g8
V11042832.xml
p24091
sg10
VSTD-Lin-2000
p24092
sg12
S'PMC3455400'
p24093
sa(dp24094
g8
V11292990.xml
p24095
sg10
VSTD-Boone-2001
p24096
sg12
S'PMC3455812'
p24097
sasa(dp24098
g3
VCD008959 v. 3.5 Home fortification of foods with multiple micronutrient powders for health and nutrition in children.rm5
p24099
sg5
(lp24100
(dp24101
g8
V16556612.xml
p24102
sg10
VSTD-Sharieff-2006a
p24103
sg12
S'PMC2082848'
p24104
sasa(dp24105
g3
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p24106
sg5
(lp24107
(dp24108
g8
V5328359.xml
p24109
sg10
VSTD-Straker-1966
p24110
sg12
S'PMC1935503'
p24111
sa(dp24112
g8
V8904622.xml
p24113
sg10
VSTD-Edwards-1996
p24114
sg12
S'PMC2042690'
p24115
sa(dp24116
g8
V6337610.xml
p24117
sg10
VSTD-Feighner-1983
p24118
sg12
S'PMC1427892'
p24119
sa(dp24120
g8
V3263876.xml
p24121
sg10
VSTD-Upward-1988
p24122
sg12
S'PMC1386560'
p24123
sa(dp24124
g8
V334227.xml
p24125
sg10
VSTD-Grof-1977
p24126
sg12
S'PMC1429109'
p24127
sa(dp24128
g8
V22058460.xml
p24129
sg10
VSTD-Quadri-1980
p24130
sg12
S'PMC3013310'
p24131
sasa(dp24132
g3
VCD002292 v. 10.0 Interventions for bullous pemphigoid.rm5
p24133
sg5
(lp24134
(dp24135
g8
V363229.xml
p24136
sg10
VSTD-Burton-1978
p24137
sg12
S'PMC1608325'
p24138
sasa(dp24139
g3
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p24140
sg5
(lp24141
(dp24142
g8
V9218740.xml
p24143
sg10
VSTD-Avril-1997
p24144
sg12
S'PMC2223779'
p24145
sasa(dp24146
g3
VCD000307 v. 8.0 Depot fluphenazine decanoate and enanthate for schizophrenia.rm5
p24147
sg5
(lp24148
(dp24149
g8
V2282421.xml
p24150
sg10
VSTD-Jolley-1990
p24151
sg12
S'PMC1663999'
p24152
sasa(dp24153
g3
VCD006453 v. 4.0 Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.rm5
p24154
sg5
(lp24155
(dp24156
g8
V17382827.xml
p24157
sg10
VSTD-Marson-2007
p24158
sg12
S'PMC2080688'
p24159
sasa(dp24160
g3
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p24161
sg5
(lp24162
(dp24163
g8
V17176461.xml
p24164
sg10
VSTD-Nafisi-2006
p24165
sg12
S'PMC1764008'
p24166
sasa(dp24167
g3
VCD000974 v. 14.1 Vaccines for preventing cholera killed whole cell or other subunit vaccines (injected).rm5
p24168
sg5
(lp24169
(dp24170
g8
V5302328.xml
p24171
sg10
VSTD-Benenson-1968a
p24172
sg12
S'PMC2554479'
p24173
sa(dp24174
g8
V365388.xml
p24175
sg10
VSTD-Saroso-1978i
p24176
sg12
S'PMC2395651'
p24177
sa(dp24178
g8
V5303665.xml
p24179
sg10
VSTD-PCC-1968
p24180
sg12
S'PMC2554519'
p24181
sa(dp24182
g8
V4603994.xml
p24183
sg10
VSTD-PCC-1973b
p24184
sg12
S'PMC2480948'
p24185
sa(dp24186
g8
V4596491.xml
p24187
sg10
VSTD-PCC-1973a_x002d_i
p24188
sg12
S'PMC2481072'
p24189
sa(dp24190
g8
V5301381.xml
p24191
sg10
VSTD-das-Gupta-1965b_x002d_i
p24192
sg12
S'PMC2554277'
p24193
sa(dp24194
g8
V7028299.xml
p24195
sg10
VSTD-Pal-1980
p24196
sg12
S'PMC2395994'
p24197
sa(dp24198
g8
V5301381.xml
p24199
sg10
VSTD-das-Gupta-1965a
p24200
sg12
S'PMC2554277'
p24201
sa(dp24202
g8
V5302329.xml
p24203
sg10
VSTD-Benenson-1968b_x002d_i
p24204
sg12
S'PMC2554494'
p24205
sa(dp24206
g8
V798636.xml
p24207
sg10
VSTD-Burgasov-1976
p24208
sg12
S'PMC2366434'
p24209
sa(dp24210
g8
V5306540.xml
p24211
sg10
VSTD-McCormack-1969
p24212
sg12
S'PMC2554602'
p24213
sa(dp24214
g8
V5294176.xml
p24215
sg10
VSTD-Azurin-1965i
p24216
sg12
S'PMC2555245'
p24217
sasa(dp24218
g3
VCD006873 v. 3.0 Interventions for prevention of post-operative recurrence of Crohn's disease.rm5
p24219
sg5
(lp24220
(dp24221
g8
V16966711.xml
p24222
sg10
VSTD-Herfarth-2006
p24223
sg12
S'PMC1856424'
p24224
sa(dp24225
g8
V16377775.xml
p24226
sg10
VSTD-Marteau-2006
p24227
sg12
S'PMC1856210'
p24228
sa(dp24229
g8
V11413109.xml
p24230
sg10
VSTD-Colombel-2001
p24231
sg12
S'PMC1728363'
p24232
sa(dp24233
g8
V12171964.xml
p24234
sg10
VSTD-Prantera-2002
p24235
sg12
S'PMC1773351'
p24236
sasa(dp24237
g3
VCD001181 v. 5.0 Antimicrobial prophylaxis for colorectal surgery.rm5
p24238
sg5
(lp24239
(dp24240
g8
V2523210.xml
p24241
sg10
VSTD-Pollock-1989
p24242
sg12
S'PMC2498915'
p24243
sa(dp24244
g8
V2939239.xml
p24245
sg10
VSTD-Sauven-1986
p24246
sg12
S'PMC1290230'
p24247
sa(dp24248
g8
V6354113.xml
p24249
sg10
VSTD-Kaiser-1983
p24250
sg12
S'PMC1353198'
p24251
sa(dp24252
g8
V2100983.xml
p24253
sg10
VSTD-Schoetz-1990
p24254
sg12
S'PMC1358059'
p24255
sa(dp24256
g8
V1461853.xml
p24257
sg10
VSTD-Bates-1992
p24258
sg12
S'PMC2399526'
p24259
sa(dp24260
g8
V1847796.xml
p24261
sg10
VSTD-Becker-1991
p24262
sg12
S'PMC1358335'
p24263
sa(dp24264
g8
V12067168.xml
p24265
sg10
VSTD-Lewis-2002
p24266
sg12
S'PMC3686946'
p24267
sa(dp24268
g8
V3541803.xml
p24269
sg10
VSTD-Bergman-1987
p24270
sg12
S'PMC1492867'
p24271
sa(dp24272
g8
V7011223.xml
p24273
sg10
VSTD-Hoffmann-1981
p24274
sg12
S'PMC1345075'
p24275
sa(dp24276
g8
V2105115.xml
p24277
sg10
VSTD-Rowe_x002d_Jones-1990
p24278
sg12
S'PMC1661869'
p24279
sasa(dp24280
g3
VCD003424 v. 10.0 Drug therapies for reducing gastric acidity in people with cystic fibrosis.rm5
p24281
sg5
(lp24282
(dp24283
g8
V3140739.xml
p24284
sg10
VSTD-Robinson-1988
p24285
sg12
S'PMC1779094'
p24286
sa(dp24287
g8
V7429342.xml
p24288
sg10
VSTD-Durie-1980
p24289
sg12
S'PMC1419526'
p24290
sasa(dp24291
g3
VCD004641 v. 10.0 Potassium supplementation for the management of primary hypertension in adults.rm5
p24292
sg5
(lp24293
(dp24294
g8
V3300841.xml
p24295
sg10
VSTD-Siani-1987
p24296
sg12
S'PMC1246609'
p24297
sasa(dp24298
g3
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p24299
sg5
(lp24300
(dp24301
g8
V20181120.xml
p24302
sg10
VSTD-Zehnder-2010
p24303
sg12
S'PMC2841102'
p24304
sa(dp24305
g8
V18665688.xml
p24306
sg10
VSTD-Stice-c2008
p24307
sg12
S'PMC2553682'
p24308
sa(dp24309
g8
V19398279.xml
p24310
sg10
VSTD-Mason-2007
p24311
sg12
S'PMC2987740'
p24312
sa(dp24313
g8
V18665688.xml
p24314
sg10
VSTD-Stice-b2008
p24315
sg12
S'PMC2553682'
p24316
sa(dp24317
g8
V17007812.xml
p24318
sg10
VSTD-Stice-b2006
p24319
sg12
S'PMC2330269'
p24320
sa(dp24321
g8
V18665688.xml
p24322
sg10
VSTD-Stice-a2008
p24323
sg12
S'PMC2553682'
p24324
sa(dp24325
g8
V17548850.xml
p24326
sg10
VSTD-Barnet-2007
p24327
sg12
S'PMC1886481'
p24328
sa(dp24329
g8
V15547059.xml
p24330
sg10
VSTD-Bond-2004
p24331
sg12
S'PMC1732649'
p24332
sa(dp24333
g8
V19968378.xml
p24334
sg10
VSTD-Compas-2009
p24335
sg12
S'PMC2821830'
p24336
sa(dp24337
g8
V17007812.xml
p24338
sg10
VSTD-Stice-c2006
p24339
sg12
S'PMC2330269'
p24340
sa(dp24341
g8
V17007812.xml
p24342
sg10
VSTD-Stice-d2006
p24343
sg12
S'PMC2330269'
p24344
sa(dp24345
g8
V17007812.xml
p24346
sg10
VSTD-Stice-e2006
p24347
sg12
S'PMC2330269'
p24348
sa(dp24349
g8
V17007812.xml
p24350
sg10
VSTD-Stice-a2006
p24351
sg12
S'PMC2330269'
p24352
sa(dp24353
g8
V19491183.xml
p24354
sg10
VSTD-Garber-2009
p24355
sg12
S'PMC2737625'
p24356
sa(dp24357
g8
V19695776.xml
p24358
sg10
VSTD-Palermo-2009
p24359
sg12
S'PMC2760656'
p24360
sasa(dp24361
g3
VCD005146 v. 8.0 Haloperidol plus promethazine for psychosis-induced aggression.rm5
p24362
sg5
(lp24363
(dp24364
g8
V17954515.xml
p24365
sg10
VSTD-TREC_x002d_Rio_x002d_II
p24366
sg12
S'PMC2043463'
p24367
sa(dp24368
g8
V14512476.xml
p24369
sg10
VSTD-TREC_x002d_Rio_x002d_I
p24370
sg12
S'PMC200800'
p24371
sa(dp24372
g8
V17954514.xml
p24373
sg10
VSTD-TREC_x002d_Vellore_x002d_II
p24374
sg12
S'PMC2043469'
p24375
sasa(dp24376
g3
VCD006812 v. 4.2 Adjuvant radiotherapy andor chemotherapy after surgery for uterine carcinosarcoma.rm5
p24377
sg5
(lp24378
(dp24379
g8
V17822748.xml
p24380
sg10
VSTD-Wolfson-2007
p24381
sg12
S'PMC2752331'
p24382
sasa(dp24383
g3
VCD002959 v. 9.0 Vaccines for women to prevent neonatal tetanus.rm5
p24384
sg5
(lp24385
(dp24386
g8
V5338377.xml
p24387
sg10
VSTD-Newell-1966
p24388
sg12
S'PMC2476295'
p24389
sa(dp24390
g8
V6971190.xml
p24391
sg10
VSTD-Black-1980
p24392
sg12
S'PMC2396004'
p24393
sasa(dp24394
g3
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p24395
sg5
(lp24396
(dp24397
g8
V2510845.xml
p24398
sg10
VSTD-UK-1989
p24399
sg12
S'PMC1837690'
p24400
sa(dp24401
g8
V12637400.xml
p24402
sg10
VSTD-Nepal-2003
p24403
sg12
S'PMC151518'
p24404
sa(dp24405
g8
V15724045.xml
p24406
sg10
VSTD-Pakistan-2005
p24407
sg12
S'PMC1721853'
p24408
sa(dp24409
g8
V19902797.xml
p24410
sg10
VSTD-Ghana-2009
p24411
sg12
S'PMC2928084'
p24412
sasa(dp24413
g3
VCD000336 v. 7.0 Effect of outpatient pharmacists'non-dispensing roleson patient outcomes and prescribing patterns.rm5
p24414
sg5
(lp24415
(dp24416
g8
V9100140.xml
p24417
sg10
VSTD-Bogden-1997
p24418
sg12
S'PMC1497081'
p24419
sa(dp24420
g8
V10897509.xml
p24421
sg10
VSTD-Bond-2000
p24422
sg12
S'PMC1313673'
p24423
sa(dp24424
g8
V14514935.xml
p24425
sg10
VSTD-Barbanel-2003
p24426
sg12
S'PMC1746491'
p24427
sa(dp24428
g8
V10671912.xml
p24429
sg10
VSTD-Ilett-2000
p24430
sg12
S'PMC2014897'
p24431
sa(dp24432
g8
V16042672.xml
p24433
sg10
VSTD-Sadik-2005
p24434
sg12
S'PMC1884928'
p24435
sa(dp24436
g8
V11942445.xml
p24437
sg10
VSTD-Freemantle-2002
p24438
sg12
S'PMC1314269'
p24439
sasa(dp24440
g3
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p24441
sg5
(lp24442
(dp24443
g8
V16041208.xml
p24444
sg10
VSTD-Nathanson-2005
p24445
sg12
S'PMC1357723'
p24446
sa(dp24447
g8
V8725454.xml
p24448
sg10
VSTD-Kapoor-1996
p24449
sg12
S'PMC2443081'
p24450
sa(dp24451
g8
V3103731.xml
p24452
sg10
VSTD-Neoptolemos-1987
p24453
sg12
S'PMC1245519'
p24454
sa(dp24455
g8
V2039294.xml
p24456
sg10
VSTD-Stain-1991
p24457
sg12
S'PMC1358591'
p24458
sasa(dp24459
g3
VCD006107 v. 4.0 Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.rm5
p24460
sg5
(lp24461
(dp24462
g8
V15704516.xml
p24463
sg10
VSTD-Martins--2004
p24464
sg12
S'PMC3455614'
p24465
sa(dp24466
g8
V15807215.xml
p24467
sg10
VSTD-Li-2005
p24468
sg12
S'PMC3455385'
p24469
sasa(dp24470
g3
VCD007818 v. 4.3 Treatment for postpolio syndrome.rm5
p24471
sg5
(lp24472
(dp24473
g8
V14638885.xml
p24474
sg10
VSTD-Horemans-2003
p24475
sg12
S'PMC1757426'
p24476
sasa(dp24477
g3
VCD008652 v. 2.0 Pharmacotherapy for hyperuricemia in hypertensive patients.rm5
p24478
sg5
(lp24479
(dp24480
g8
V18728266.xml
p24481
sg10
VSTD-FEIG-2008
p24482
sg12
S'PMC2684336'
p24483
sasa(dp24484
g3
VCD006626 v. 4.0 Risperidone versus other atypical antipsychotics for schizophrenia.rm5
p24485
sg5
(lp24486
(dp24487
g8
V17662577.xml
p24488
sg10
VSTD-Wynn-2007
p24489
sg12
S'PMC2716219'
p24490
sasa(dp24491
g3
VCD007726 v. 3.0 Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symp.rm5
p24492
sg5
(lp24493
(dp24494
g8
V23075176.xml
p24495
sg10
VSTD-Devanand-ADAD--2012
p24496
sg12
S'PMC3490406'
p24497
sa(dp24498
g8
V21845596.xml
p24499
sg10
VSTD-Devanand-2011
p24500
sg12
S'PMC3685500'
p24501
sasa(dp24502
g3
VCD008081 v. 2.0 Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinop.rm5
p24503
sg5
(lp24504
(dp24505
g8
V18316700.xml
p24506
sg10
VSTD-Davis-2008
p24507
sg12
S'PMC2408888'
p24508
sa(dp24509
g8
V16647123.xml
p24510
sg10
VSTD-Sadda-2006
p24511
sg12
S'PMC1779509'
p24512
sa(dp24513
g8
V9479300.xml
p24514
sg10
VSTD-Hee-1998
p24515
sg12
S'PMC2923575'
p24516
sasa(dp24517
g3
VCD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
p24518
sg5
(lp24519
(dp24520
g8
V2143092.xml
p24521
sg10
VSTD-Meade-1990
p24522
sg12
S'PMC1663160'
p24523
sa(dp24524
g8
V16341712.xml
p24525
sg10
VSTD-Gudavalli-2006
p24526
sg12
S'PMC3233943'
p24527
sa(dp24528
g8
V20184717.xml
p24529
sg10
VSTD-Br_x00f8_nfort-1989
p24530
sg12
S'PMC2841070'
p24531
sasa(dp24532
g3
VCD004008 v. 4.0 Interventions for trachoma trichiasis.rm5
p24533
sg5
(lp24534
(dp24535
g8
V2178677.xml
p24536
sg10
VSTD-Reacher-1990
p24537
sg12
S'PMC1042003'
p24538
sa(dp24539
g8
V16170117.xml
p24540
sg10
VSTD-Burton-2005
p24541
sg12
S'PMC1772881'
p24542
sasa(dp24543
g3
VCD002985 v. 8.0 Gold as an oral corticosteroid sparing agent in stable asthma.rm5
p24544
sg5
(lp24545
(dp24546
g8
V1609377.xml
p24547
sg10
VSTD-Nierop-1992
p24548
sg12
S'PMC463749'
p24549
sasa(dp24550
g3
VCD004194 v. 7.0 Drugs and pacemakers for vasovagal carotid sinus and situational syncope.rm5
p24551
sg5
(lp24552
(dp24553
g8
V9505918.xml
p24554
sg10
VSTD-Ward-1998
p24555
sg12
S'PMC1728578'
p24556
sa(dp24557
g8
V9227301.xml
p24558
sg10
VSTD-McIntosh-1997
p24559
sg12
S'PMC484800'
p24560
sa(dp24561
g8
V9093048.xml
p24562
sg10
VSTD-Biffi-1997
p24563
sg12
S'PMC484696'
p24564
sasa(dp24565
g3
VCD007185 v. 3.3 Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.rm5
p24566
sg5
(lp24567
(dp24568
g8
V2183868.xml
p24569
sg10
VSTD-Maclean-1990
p24570
sg12
S'PMC1380116'
p24571
sasa(dp24572
g3
VCD000064 v. 8.0 Corticosteroids for acute ischaemic stroke.rm5
p24573
sg5
(lp24574
(dp24575
g8
V361156.xml
p24576
sg10
VSTD-Mulley-1978
p24577
sg12
S'PMC1607934'
p24578
sa(dp24579
g8
V3080050.xml
p24580
sg10
VSTD-Norris-1986
p24581
sg12
S'PMC1338973'
p24582
sasa(dp24583
g3
VCD003946 v. 10.0 Light therapy for managing cognitive sleep functional behavioural or psychiatric disturbances in.rm5
p24584
sg5
(lp24585
(dp24586
g8
V17596638.xml
p24587
sg10
VSTD-Dowling-2007
p24588
sg12
S'PMC2387134'
p24589
sa(dp24590
g8
V16035127.xml
p24591
sg10
VSTD-Dowling-2005b
p24592
sg12
S'PMC2387133'
p24593
sa(dp24594
g8
V18070004.xml
p24595
sg10
VSTD-Dowling-2008
p24596
sg12
S'PMC2642966'
p24597
sasa(dp24598
g3
VCD002859 v. 7.0 Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.rm5
p24599
sg5
(lp24600
(dp24601
g8
V9022487.xml
p24602
sg10
VSTD-Rai-1997
p24603
sg12
S'PMC2125731'
p24604
sasa(dp24605
g3
VCD002911 v. 6.0 Alarm interventions for nocturnal enuresis in children.rm5
p24606
sg5
(lp24607
(dp24608
g8
V6478342.xml
p24609
sg10
VSTD-Netley-1984
p24610
sg12
S'PMC1483635'
p24611
sa(dp24612
g8
V1192312.xml
p24613
sg10
VSTD-McKendry-1975
p24614
sg12
S'PMC1956570'
p24615
sa(dp24616
g8
V22974648.xml
p24617
sg10
VSTD-Caceres-1982
p24618
sg12
S'PMC3443867'
p24619
sa(dp24620
g8
V3513716.xml
p24621
sg10
VSTD-Wille-1986
p24622
sg12
S'PMC1777552'
p24623
sasa(dp24624
g3
VCD001802 v. 6.0 Tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronicrecurrent acute tonsi.rm5
p24625
sg5
(lp24626
(dp24627
g8
V17347187.xml
p24628
sg10
VSTD-Alho-2007
p24629
sg12
S'PMC1865439'
p24630
sa(dp24631
g8
V15361407.xml
p24632
sg10
VSTD-van-Staaij-2004
p24633
sg12
S'PMC517640'
p24634
sasa(dp24635
g3
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p24636
sg5
(lp24637
(dp24638
g8
V16517764.xml
p24639
sg10
VSTD-Shyu-2006
p24640
sg12
S'PMC1405861'
p24641
sa(dp24642
g8
V21269484.xml
p24643
sg10
VSTD-Yip-2011
p24644
sg12
S'PMC3221969'
p24645
sa(dp24646
g8
V22007348.xml
p24647
sg10
VSTD-Prasad-2011
p24648
sg12
S'PMC3191816'
p24649
sa(dp24650
g8
V12435860.xml
p24651
sg10
VSTD-Ehrenreich-2002
p24652
sg12
S'PMC2040012'
p24653
sasa(dp24654
g3
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p24655
sg5
(lp24656
(dp24657
g8
V11870500.xml
p24658
sg10
VSTD-Matsumoto-2002
p24659
sg12
S'PMC2375187'
p24660
sasa(dp24661
g3
VCD006763 v. 3.0 Altered dietary salt intake for preventing and treating diabetic kidney disease.rm5
p24662
sg5
(lp24663
(dp24664
g8
V2493869.xml
p24665
sg10
VSTD-Dodson_x005f_P-1989
p24666
sg12
S'PMC1835532'
p24667
sa(dp24668
g8
V2493869.xml
p24669
sg10
VSTD-Dodson_x005f_X-1989
p24670
sg12
S'PMC1835532'
p24671
sasa(dp24672
g3
VCD003139 v. 10.0 High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
p24673
sg5
(lp24674
(dp24675
g8
V11720455.xml
p24676
sg10
VSTD-MCG-2001
p24677
sg12
S'PMC2375253'
p24678
sasa(dp24679
g3
VCD002253 v. 7.0 Medical treatment for early fetal death (less than 24 weeks).rm5
p24680
sg5
(lp24681
(dp24682
g8
V14981379.xml
p24683
sg10
VSTD-Gilles-2004
p24684
sg12
S'PMC2866634'
p24685
sasa(dp24686
g3
VCD003057 v. 7.0 Hyperbaric oxygen therapy for multiple sclerosis.rm5
p24687
sg5
(lp24688
(dp24689
g8
V3891920.xml
p24690
sg10
VSTD-Neiman-1985
p24691
sg12
S'PMC1028364'
p24692
sa(dp24693
g8
V3080173.xml
p24694
sg10
VSTD-Wiles-1986
p24695
sg12
S'PMC1339347'
p24696
sa(dp24697
g8
V3320274.xml
p24698
sg10
VSTD-Barnes-1985
p24699
sg12
S'PMC1032548'
p24700
sa(dp24701
g8
V3320274.xml
p24702
sg10
VSTD-Barnes-1987
p24703
sg12
S'PMC1032548'
p24704
sasa(dp24705
g3
VCD001930 v. 8.4 Cognitive-behavioural interventions for children who have been sexually abused.rm5
p24706
sg5
(lp24707
(dp24708
g8
V20814304.xml
p24709
sg10
VSTD-Cohen-1998
p24710
sg12
S'PMC3013499'
p24711
sa(dp24712
g8
V15187799.xml
p24713
sg10
VSTD-Cohen-2004
p24714
sg12
S'PMC1201422'
p24715
sasa(dp24716
g3
VCD003120 v. 12.0 Ginkgo biloba for cognitive impairment and dementia.rm5
p24717
sg5
(lp24718
(dp24719
g8
V23478315.xml
p24720
sg10
VSTD-Augustin-1976
p24721
sg12
S'PMC3647991'
p24722
sasa(dp24723
g3
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p24724
sg5
(lp24725
(dp24726
g8
V18469091.xml
p24727
sg10
VSTD-LOTUS-Trial-2008
p24728
sg12
S'PMC2565581'
p24729
sasa(dp24730
g3
VCD004387 v. 6.0 Chlorproguanil-dapsone for treating uncomplicated malaria.rm5
p24731
sg5
(lp24732
(dp24733
g8
V2207399.xml
p24734
sg10
VSTD-Keuter-1990
p24735
sg12
S'PMC1663772'
p24736
sa(dp24737
g8
V9333058.xml
p24738
sg10
VSTD-Amukoye-1997
p24739
sg12
S'PMC164103'
p24740
sasa(dp24741
g3
VCD001255 v. 14.0 Hip protectors for preventing hip fractures in older people.rm5
p24742
sg5
(lp24743
(dp24744
g8
V12521969.xml
p24745
sg10
VSTD-Meyer-2003
p24746
sg12
S'PMC139934'
p24747
sa(dp24748
g8
V12810740.xml
p24749
sg10
VSTD-Cameron-2003
p24750
sg12
S'PMC1730958'
p24751
sasa(dp24752
g3
VCD005445 v. 6.4 Ribavirin plus interferon versus interferon for chronic hepatitis C.rm5
p24753
sg5
(lp24754
(dp24755
g8
V10438811.xml
p24756
sg10
VSTD-Gerotto-1999
p24757
sg12
S'PMC104248'
p24758
sa(dp24759
g8
V9862245.xml
p24760
sg10
VSTD-Khakoo-1998
p24761
sg12
S'PMC1873804'
p24762
sasa(dp24763
g3
VCD005633 v. 5.2 Vitamin D compounds for people with chronic kidney disease requiring dialysis.rm5
p24764
sg5
(lp24765
(dp24766
g8
V6786673.xml
p24767
sg10
VSTD-Memmos-1981
p24768
sg12
S'PMC1505819'
p24769
sasa(dp24770
g3
VCD008057 v. 3.0 Staples versus sutures for closing leg wounds after vein graft harvesting for coronary artery bypass.rm5
p24771
sg5
(lp24772
(dp24773
g8
V9389394.xml
p24774
sg10
VSTD-Johnson-1997
p24775
sg12
S'PMC1191122'
p24776
sa(dp24777
g8
V6096982.xml
p24778
sg10
VSTD-Angelini-1984
p24779
sg12
S'PMC459958'
p24780
sasa(dp24781
g3
VCD005191 v. 8.0 Brief interventions for heavy alcohol users admitted to general hospital wards.rm5
p24782
sg5
(lp24783
(dp24784
g8
V2858246.xml
p24785
sg10
VSTD-Chick-1985
p24786
sg12
S'PMC1418284'
p24787
sa(dp24788
g8
V10522717.xml
p24789
sg10
VSTD-Gentilello-1999
p24790
sg12
S'PMC1420896'
p24791
sasa(dp24792
g3
VCD008552 v. 2.0 Interventions for increasing fruit and vegetable consumption in children aged 5 years and under.rm5
p24793
sg5
(lp24794
(dp24795
g8
V21191095.xml
p24796
sg10
VSTD-Cooke-2011
p24797
sg12
S'PMC3272376'
p24798
sa(dp24799
g8
V18486203.xml
p24800
sg10
VSTD-Haire_x002d_Joshu-2008
p24801
sg12
S'PMC3607447'
p24802
sasa(dp24803
g3
VCD007730 v. 3.0 Multidimensional rehabilitation programmes for adult cancer survivors.rm5
p24804
sg5
(lp24805
(dp24806
g8
V16849763.xml
p24807
sg10
VSTD-Demark_x002d_Wahnefried-2006
p24808
sg12
S'PMC1532928'
p24809
sa(dp24810
g8
V14570527.xml
p24811
sg10
VSTD-Lepore-1999
p24812
sg12
S'PMC2593114'
p24813
sasa(dp24814
g3
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p24815
sg5
(lp24816
(dp24817
g8
V22035427.xml
p24818
sg10
VSTD-Begley-2009
p24819
sg12
S'PMC3226589'
p24820
sa(dp24821
g8
V21749629.xml
p24822
sg10
VSTD-Bernitz-2011
p24823
sg12
S'PMC3187863'
p24824
sa(dp24825
g8
V6388776.xml
p24826
sg10
VSTD-Klein-1984
p24827
sg12
S'PMC1440352'
p24828
sa(dp24829
g8
V7819846.xml
p24830
sg10
VSTD-Hundley-1994
p24831
sg12
S'PMC2541316'
p24832
sasa(dp24833
g3
VCD002055 v. 7.4 Early volume expansion for prevention of morbidity and mortality in very preterm infants.rm5
p24834
sg5
(lp24835
(dp24836
g8
V9059186.xml
p24837
sg10
VSTD-So-1997
p24838
sg12
S'PMC1720603'
p24839
sa(dp24840
g8
V3899020.xml
p24841
sg10
VSTD-Beverley-1985
p24842
sg12
S'PMC1777434'
p24843
sa(dp24844
g8
V1444555.xml
p24845
sg10
VSTD-Emery-1992
p24846
sg12
S'PMC1590455'
p24847
sasa(dp24848
g3
VCD003229 v. 5.0 Phlebotonics for venous insufficiency.rm5
p24849
sg5
(lp24850
(dp24851
g8
V23543784.xml
p24852
sg10
VSTD-Jaeger-2001
p24853
sg12
S'PMC3634691'
p24854
sasa(dp24855
g3
VCD002296 v. 13.0 Prevention of NSAID-induced gastroduodenal ulcers.rm5
p24856
sg5
(lp24857
(dp24858
g8
V3142593.xml
p24859
sg10
VSTD-Ehsanullah-1988
p24860
sg12
S'PMC1834765'
p24861
sa(dp24862
g8
V8311540.xml
p24863
sg10
VSTD-Melo-Gomes-1993
p24864
sg12
S'PMC1005220'
p24865
sasa(dp24866
g3
VCD006549 v. 3.0 Topical steroids for nasal polyps.rm5
p24867
sg5
(lp24868
(dp24869
g8
V3929943.xml
p24870
sg10
VSTD-Chalton-1985
p24871
sg12
S'PMC1417153'
p24872
sasa(dp24873
g3
VCD003466 v. 4.1 Speech and language therapy to improve the communication skills of children with cerebral palsy.rm5
p24874
sg5
(lp24875
(dp24876
g8
V7118759.xml
p24877
sg10
VSTD-Campbell-1982
p24878
sg12
S'PMC1308271'
p24879
sa(dp24880
g8
V6181049.xml
p24881
sg10
VSTD-Hurlbut-1982
p24882
sg12
S'PMC1308268'
p24883
sasa(dp24884
g3
VCD008131 v. 4.0 Home-based child development interventions for preschool children from socially disadvantaged famili.rm5
p24885
sg5
(lp24886
(dp24887
g8
V8518642.xml
p24888
sg10
VSTD-Johnson-1993
p24889
sg12
S'PMC1677859'
p24890
sasa(dp24891
g3
VCD004775 v. 4.0 Mass media interventions for promoting HIV testing.rm5
p24892
sg5
(lp24893
(dp24894
g8
V3117190.xml
p24895
sg10
VSTD-Turner-1987
p24896
sg12
S'PMC1247354'
p24897
sa(dp24898
g8
V9472506.xml
p24899
sg10
VSTD-Simpson-1998
p24900
sg12
S'PMC2665496'
p24901
sa(dp24902
g8
V3115372.xml
p24903
sg10
VSTD-Beck-1987
p24904
sg12
S'PMC1247040'
p24905
sa(dp24906
g8
V12196620.xml
p24907
sg10
VSTD-Amaro-2001
p24908
sg12
S'PMC1497375'
p24909
sasa(dp24910
g3
VCD006053 v. 7.0 Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whip.rm5
p24911
sg5
(lp24912
(dp24913
g8
V15492552.xml
p24914
sg10
VSTD-Tran-2004
p24915
sg12
S'PMC1356476'
p24916
sasa(dp24917
g3
VCD007281 v. 2.0 Interventions for cutaneous Bowen's disease.rm5
p24918
sg5
(lp24919
(dp24920
g8
V17223873.xml
p24921
sg10
VSTD-Perrett-2007
p24922
sg12
S'PMC2423222'
p24923
sasa(dp24924
g3
VCD002219 v. 13.0 Ivermectin for onchocercal eye disease (river blindness).rm5
p24925
sg5
(lp24926
(dp24927
g8
V3046657.xml
p24928
sg10
VSTD-Taylor-1988
p24929
sg12
S'PMC1041529'
p24930
sasa(dp24931
g3
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p24932
sg5
(lp24933
(dp24934
g8
V12839630.xml
p24935
sg10
VSTD-Scalambrino-1989
p24936
sg12
S'PMC1852268'
p24937
sa(dp24938
g8
V18476152.xml
p24939
sg10
VSTD-Chatwani-1997
p24940
sg12
S'PMC2364549'
p24941
sa(dp24942
g8
V18475417.xml
p24943
sg10
VSTD-Chatwani-1995
p24944
sg12
S'PMC2364413'
p24945
sa(dp24946
g8
V6360038.xml
p24947
sg10
VSTD-Blanco-1983
p24948
sg12
S'PMC185362'
p24949
sa(dp24950
g8
V12839630.xml
p24951
sg10
VSTD-Roy-2003
p24952
sg12
S'PMC1852268'
p24953
sa(dp24954
g8
V3415207.xml
p24955
sg10
VSTD-Knodel-1988
p24956
sg12
S'PMC172295'
p24957
sasa(dp24958
g3
VCD002206 v. 9.2 Media-based behavioural treatments for behavioural problems in children.rm5
p24959
sg5
(lp24960
(dp24961
g8
V14736626.xml
p24962
sg10
VSTD-Montgomery-2004
p24963
sg12
S'PMC1719807'
p24964
sasa(dp24965
g3
VCD003689 v. 5.2 Interventions for preventing depression after stroke.rm5
p24966
sg5
(lp24967
(dp24968
g8
V8664717.xml
p24969
sg10
VSTD-Forster-1996
p24970
sg12
S'PMC2351368'
p24971
sa(dp24972
g8
V10201422.xml
p24973
sg10
VSTD-Palomaki-1999
p24974
sg12
S'PMC1736281'
p24975
sasa(dp24976
g3
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p24977
sg5
(lp24978
(dp24979
g8
V15911537.xml
p24980
sg10
VSTD-Fairbank-2005
p24981
sg12
S'PMC558090'
p24982
sa(dp24983
g8
V18663487.xml
p24984
sg10
VSTD-van-der-Roer-2008
p24985
sg12
S'PMC2527421'
p24986
sa(dp24987
g8
V23537369.xml
p24988
sg10
VSTD-Strong-1998
p24989
sg12
S'PMC3617092'
p24990
sa(dp24991
g8
V16426449.xml
p24992
sg10
VSTD-Smeets-2006
p24993
sg12
S'PMC1382224'
p24994
sasa(dp24995
g3
VCD002217 v. 10.0 Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-c.rm5
p24996
sg5
(lp24997
(dp24998
g8
V7823066.xml
p24999
sg10
VSTD-Heller-1995
p25000
sg12
S'PMC1073267'
p25001
sasa(dp25002
g3
VCD003427 v. 12.0 Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.rm5
p25003
sg5
(lp25004
(dp25005
g8
V6426646.xml
p25006
sg10
VSTD-John-1984
p25007
sg12
S'PMC1441216'
p25008
sasa(dp25009
g3
VCD009154 v. 5.0 Luteal phase support for assisted reproduction cycles.rm5
p25010
sg5
(lp25011
(dp25012
g8
V12503886.xml
p25013
sg10
VSTD-Fujimoto-2002
p25014
sg12
S'PMC3455835'
p25015
sasa(dp25016
g3
VCD001746 v. 6.0 Family and carer smoking control programmes for reducing children's exposure to environmental tobacc.rm5
p25017
sg5
(lp25018
(dp25019
g8
V10926589.xml
p25020
sg10
VSTD-Hovell-2000
p25021
sg12
S'PMC27449'
p25022
sa(dp25023
g8
V14985605.xml
p25024
sg10
VSTD-Conway-2004
p25025
sg12
S'PMC1747828'
p25026
sa(dp25027
g8
V10346773.xml
p25028
sg10
VSTD-Irvine-1999
p25029
sg12
S'PMC27890'
p25030
sa(dp25031
g8
V15798126.xml
p25032
sg10
VSTD-Krieger-2005
p25033
sg12
S'PMC1449237'
p25034
sa(dp25035
g8
V15767382.xml
p25036
sg10
VSTD-Wiggins-2005
p25037
sg12
S'PMC1733057'
p25038
sasa(dp25039
g3
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p25040
sg5
(lp25041
(dp25042
g8
V22000272.xml
p25043
sg10
VSTD-Muir-2012
p25044
sg12
S'PMC3703932'
p25045
sa(dp25046
g8
V22094303.xml
p25047
sg10
VSTD-Gray-2011
p25048
sg12
S'PMC3299012'
p25049
sa(dp25050
g8
V22688429.xml
p25051
sg10
VSTD-I_x002d_SIGHT
p25052
sg12
S'PMC3593648'
p25053
sa(dp25054
g8
V22419858.xml
p25055
sg10
VSTD-Nakakura-2012
p25056
sg12
S'PMC3299559'
p25057
sasa(dp25058
g3
VCD004705 v. 7.2 Biomedical risk assessment as an aid for smoking cessation.rm5
p25059
sg5
(lp25060
(dp25061
g8
V10571715.xml
p25062
sg10
VSTD-Sippel-1999
p25063
sg12
S'PMC1496767'
p25064
sa(dp25065
g8
V6426618.xml
p25066
sg10
VSTD-Jamrozik-1984
p25067
sg12
S'PMC1441184'
p25068
sa(dp25069
g8
V18326503.xml
p25070
sg10
VSTD-Parkes-2008
p25071
sg12
S'PMC2267989'
p25072
sa(dp25073
g8
V19524389.xml
p25074
sg10
VSTD-McClure-2009
p25075
sg12
S'PMC2889910'
p25076
sa(dp25077
g8
V2556540.xml
p25078
sg10
VSTD-Sanders-1989
p25079
sg12
S'PMC1711904'
p25080
sasa(dp25081
g3
VCD001217 v. 8.2 Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.rm5
p25082
sg5
(lp25083
(dp25084
g8
V11224634.xml
p25085
sg10
VSTD-Mcleod-2001
p25086
sg12
S'PMC1421263'
p25087
sasa(dp25088
g3
VCD008271 v. 4.0 Botulinum toxin for shoulder pain.rm5
p25089
sg5
(lp25090
(dp25091
g8
V17088333.xml
p25092
sg10
VSTD-Yelnik-2007
p25093
sg12
S'PMC2117719'
p25094
sasa(dp25095
g3
VCD005122 v. 10.0 Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for ass.rm5
p25096
sg5
(lp25097
(dp25098
g8
V11408301.xml
p25099
sg10
VSTD-Mires-2001
p25100
sg12
S'PMC32308'
p25101
sa(dp25102
g8
V24019284.xml
p25103
sg10
VSTD-Mitchell-2008
p25104
sg12
S'PMC3767723'
p25105
sasa(dp25106
g3
VCD003885 v. 9.2 Pneumococcal vaccines for sickle cell disease.rm5
p25107
sg5
(lp25108
(dp25109
g8
V6426646.xml
p25110
sg10
VSTD-John-1984
p25111
sg12
S'PMC1441216'
p25112
sasa(dp25113
g3
VCD004898 v. 5.0 Monoamine oxidase B inhibitors for early Parkinson's disease.rm5
p25114
sg5
(lp25115
(dp25116
g8
V9583926.xml
p25117
sg10
VSTD-UK_x002d_PDRG-_x0028_RR_x0029_-1998
p25118
sg12
S'PMC28519'
p25119
sasa(dp25120
g3
VCD004951 v. 4.2 Body positioning for spontaneously breathing preterm infants with apnoea.rm5
p25121
sg5
(lp25122
(dp25123
g8
V1575555.xml
p25124
sg10
VSTD-Heimler-1992
p25125
sg12
S'PMC1793668'
p25126
sasa(dp25127
g3
VCD003960 v. 7.0 Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.rm5
p25128
sg5
(lp25129
(dp25130
g8
V16020489.xml
p25131
sg10
VSTD-Tack-2005
p25132
sg12
S'PMC1774790'
p25133
sa(dp25134
g8
V12692051.xml
p25135
sg10
VSTD-Kellow-2003
p25136
sg12
S'PMC1773630'
p25137
sasa(dp25138
g3
VCD008600 v. 2.2 Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrilla.rm5
p25139
sg5
(lp25140
(dp25141
g8
V17545350.xml
p25142
sg10
VSTD-Thomson-2007
p25143
sg12
S'PMC2464985'
p25144
sa(dp25145
g8
V16129870.xml
p25146
sg10
VSTD-McAlister-2005
p25147
sg12
S'PMC1188186'
p25148
sasa(dp25149
g3
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p25150
sg5
(lp25151
(dp25152
g8
V18330955.xml
p25153
sg10
VSTD-Wang-2008
p25154
sg12
S'PMC2693759'
p25155
sa(dp25156
g8
V19827166.xml
p25157
sg10
VSTD-Promrat-2010
p25158
sg12
S'PMC2799538'
p25159
sa(dp25160
g8
V20664019.xml
p25161
sg10
VSTD-Lazo-2010
p25162
sg12
S'PMC2945152'
p25163
sasa(dp25164
g3
VCD008872 v. 2.0 Safety of non-steroidal anti-inflammatory drugs including aspirin and paracetamol (acetaminophen) i.rm5
p25165
sg5
(lp25166
(dp25167
g8
V8215627.xml
p25168
sg10
VSTD-Seideman-1993
p25169
sg12
S'PMC1005122'
p25170
sasa(dp25171
g3
VCD004510 v. 4.2 Telephone follow-up initiated by a hospital-based health professional for postdischarge problems i.rm5
p25172
sg5
(lp25173
(dp25174
g8
V11220797.xml
p25175
sg10
VSTD-Fallis-2001
p25176
sg12
S'PMC3695182'
p25177
sa(dp25178
g8
V11889278.xml
p25179
sg10
VSTD-Phillips-2001
p25180
sg12
S'PMC1913671'
p25181
sasa(dp25182
g3
VCD001158 v. 6.0 Moderate-term low-dose corticosteroids for rheumatoid arthritis.rm5
p25183
sg5
(lp25184
(dp25185
g8
V13275875.xml
p25186
sg10
VSTD-Empire-1995
p25187
sg12
S'PMC1006832'
p25188
sasa(dp25189
g3
VCD008496 v. 2.0 Non-drug therapies for lower limb muscle cramps.rm5
p25190
sg5
(lp25191
(dp25192
g8
V15808033.xml
p25193
sg10
VSTD-Coppin-2005
p25194
sg12
S'PMC1463088'
p25195
sasa(dp25196
g3
VCD004763 v. 4.0 Laser photocoagulation for neovascular age-related macular degeneration.rm5
p25197
sg5
(lp25198
(dp25199
g8
V6184070.xml
p25200
sg10
VSTD-Moorfields-1982
p25201
sg12
S'PMC1039921'
p25202
sasa(dp25203
g3
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p25204
sg5
(lp25205
(dp25206
g8
V18478129.xml
p25207
sg10
VSTD-Harms-2008
p25208
sg12
S'PMC2373885'
p25209
sasa(dp25210
g3
VCD003934 v. 3.0 Maternal positions and mobility during first stage labour.rm5
p25211
sg5
(lp25212
(dp25213
g8
V698606.xml
p25214
sg10
VSTD-Flynn-1978
p25215
sg12
S'PMC1607519'
p25216
sasa(dp25217
g3
VCD000088 v. 14.0 Family intervention for schizophrenia.rm5
p25218
sg5
(lp25219
(dp25220
g8
V22700264.xml
p25221
sg10
VSTD-Schooler-1997
p25222
sg12
S'PMC3330401'
p25223
sasa(dp25224
g3
VCD001243 v. 7.0 Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in ve.rm5
p25225
sg5
(lp25226
(dp25227
g8
V15321956.xml
p25228
sg10
VSTD-Sandri-2004
p25229
sg12
S'PMC1721765'
p25230
sasa(dp25231
g3
VCD006856 v. 2.5 Personal assistance for adults (19-64) with physical impairments.rm5
p25232
sg5
(lp25233
(dp25234
g8
V17244293.xml
p25235
sg10
VSTD-Carlson-2007
p25236
sg12
S'PMC1955332'
p25237
sasa(dp25238
g3
VCD003114 v. 7.0 Occupational therapy for rheumatoid arthritis.rm5
p25239
sg5
(lp25240
(dp25241
g8
V7377854.xml
p25242
sg10
VSTD-Mowat-1980
p25243
sg12
S'PMC1000462'
p25244
sasa(dp25245
g3
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p25246
sg5
(lp25247
(dp25248
g8
V18628946.xml
p25249
sg10
VSTD-Begley-2008
p25250
sg12
S'PMC2443289'
p25251
sa(dp25252
g8
V20595141.xml
p25253
sg10
VSTD-McDaid-2010
p25254
sg12
S'PMC3010905'
p25255
sa(dp25256
g8
V17848992.xml
p25257
sg10
VSTD-Mor-2007-_x0028_HIV_x002d_pos_x0029_
p25258
sg12
S'PMC1955830'
p25259
sa(dp25260
g8
V19911990.xml
p25261
sg10
VSTD-Templeton-2009-_x0028_CS_x0029_
p25262
sg12
S'PMC2784211'
p25263
sa(dp25264
g8
V17848992.xml
p25265
sg10
VSTD-Mor-2007
p25266
sg12
S'PMC1955830'
p25267
sa(dp25268
g8
V17848992.xml
p25269
sg10
VSTD-Mor-2007-_x0028_HIV_x002d_neg_x0029_
p25270
sg12
S'PMC1955830'
p25271
sa(dp25272
g8
V19662523.xml
p25273
sg10
VSTD-Lane-2011
p25274
sg12
S'PMC2888758'
p25275
sa(dp25276
g8
V19911990.xml
p25277
sg10
VSTD-Templeton-2009-_x0028_P_x0029_
p25278
sg12
S'PMC2784211'
p25279
sasa(dp25280
g3
VCD009542 v. 2.5 Oral immunotherapy for milk allergy.rm5
p25281
sg5
(lp25282
(dp25283
g8
V18951617.xml
p25284
sg10
VSTD-Skripak-2008
p25285
sg12
S'PMC3764488'
p25286
sasa(dp25287
g3
VCD000319 v. 14.0 Medicinal and injection therapies for mechanical neck disorders.rm5
p25288
sg5
(lp25289
(dp25290
g8
V1532760.xml
p25291
sg10
VSTD-Koes-1992
p25292
sg12
S'PMC1881307'
p25293
sasa(dp25294
g3
VCD000216 v. 7.0 Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage.rm5
p25295
sg5
(lp25296
(dp25297
g8
V2407200.xml
p25298
sg10
VSTD-Ventriculomegaly--90
p25299
sg12
S'PMC1590164'
p25300
sasa(dp25301
g3
VCD000425 v. 8.0 Speech and language therapy for aphasia following stroke.rm5
p25302
sg5
(lp25303
(dp25304
g8
V6184453.xml
p25305
sg10
VSTD-David-1982
p25306
sg12
S'PMC491629'
p25307
sa(dp25308
g8
V466329.xml
p25309
sg10
VSTD-Meikle-1979
p25310
sg12
S'PMC1596055'
p25311
sasa(dp25312
g3
VCD009029 v. 2.2 Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.rm5
p25313
sg5
(lp25314
(dp25315
g8
V11292698.xml
p25316
sg10
VSTD-Hall-2001-_x0028_Study-2_x0029_
p25317
sg12
S'PMC98234'
p25318
sa(dp25319
g8
V11292698.xml
p25320
sg10
VSTD-Hall-2001-_x0028_Study-3_x0029_
p25321
sg12
S'PMC98234'
p25322
sa(dp25323
g8
V10899847.xml
p25324
sg10
VSTD-Cohen-2000-_x0028_Study-2_x0029_
p25325
sg12
S'PMC98356'
p25326
sa(dp25327
g8
V11238232.xml
p25328
sg10
VSTD-Jertborn-2001
p25329
sg12
S'PMC96073'
p25330
sa(dp25331
g8
V11292698.xml
p25332
sg10
VSTD-Hall-2001-_x0028_Study-1_x0029_
p25333
sg12
S'PMC98234'
p25334
sa(dp25335
g8
V10899847.xml
p25336
sg10
VSTD-Cohen-2000-_x0028_Study-1_x0029_
p25337
sg12
S'PMC98356'
p25338
sasa(dp25339
g3
VCD000299 v. 4.0 Anti-tuberculous therapy for maintenance of remission in Crohn's disease.rm5
p25340
sg5
(lp25341
(dp25342
g8
V8150348.xml
p25343
sg10
VSTD-Swift-1994
p25344
sg12
S'PMC1374591'
p25345
sa(dp25346
g8
V6363219.xml
p25347
sg10
VSTD-Shaffer-1984
p25348
sg12
S'PMC1432256'
p25349
sasa(dp25350
g3
VCD001691 v. 5.0 Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants.rm5
p25351
sg5
(lp25352
(dp25353
g8
V3513720.xml
p25354
sg10
VSTD-Anwar-1986
p25355
sg12
S'PMC1777581'
p25356
sasa(dp25357
g3
VCD005225 v. 6.2 Creatine for amyotrophic lateral sclerosismotor neuron disease.rm5
p25358
sg5
(lp25359
(dp25360
g8
V18608103.xml
p25361
sg10
VSTD-Rosenfeld-2008
p25362
sg12
S'PMC2631354'
p25363
sasa(dp25364
g3
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p25365
sg5
(lp25366
(dp25367
g8
V11474008.xml
p25368
sg10
VSTD-Forney-2001
p25369
sg12
S'PMC88255'
p25370
sa(dp25371
g8
V12791849.xml
p25372
sg10
VSTD-Forney-2003
p25373
sg12
S'PMC156472'
p25374
sa(dp25375
g8
V18834523.xml
p25376
sg10
VSTD-Abeku-2008a
p25377
sg12
S'PMC2571107'
p25378
sa(dp25379
g8
V18834523.xml
p25380
sg10
VSTD-Abeku-2008b
p25381
sg12
S'PMC2571107'
p25382
sa(dp25383
g8
V11693975.xml
p25384
sg10
VSTD-Bell-2001b
p25385
sg12
S'PMC2566678'
p25386
sa(dp25387
g8
V11693975.xml
p25388
sg10
VSTD-Bell-2001a
p25389
sg12
S'PMC2566678'
p25390
sa(dp25391
g8
V18959777.xml
p25392
sg10
VSTD-Kyabayinze-2008
p25393
sg12
S'PMC2584069'
p25394
sa(dp25395
g8
V19399156.xml
p25396
sg10
VSTD-Msellem-2009
p25397
sg12
S'PMC2667629'
p25398
sa(dp25399
g8
V10405377.xml
p25400
sg10
VSTD-Tjitra-1999
p25401
sg12
S'PMC85241'
p25402
sa(dp25403
g8
V18620560.xml
p25404
sg10
VSTD-Bharti-2008
p25405
sg12
S'PMC2478667'
p25406
sasa(dp25407
g3
VCD003862 v. 8.0 Red-light cameras for the prevention of road traffic crashes.rm5
p25408
sg5
(lp25409
(dp25410
g8
V12406815.xml
p25411
sg10
VSTD-Retting-Oxnard-2002
p25412
sg12
S'PMC1447335'
p25413
sasa(dp25414
g3
VCD006639 v. 6.0 Zinc supplements for preventing otitis media.rm5
p25415
sg5
(lp25416
(dp25417
g8
V11431296.xml
p25418
sg10
VSTD-Muller-2001
p25419
sg12
S'PMC33513'
p25420
sa(dp25421
g8
V12052800.xml
p25422
sg10
VSTD-Bhandari-2002
p25423
sg12
S'PMC115208'
p25424
sasa(dp25425
g3
VCD007028 v. 3.2 Mailuoning for acute ischaemic stroke.rm5
p25426
sg5
(lp25427
(dp25428
g8
V23272146.xml
p25429
sg10
VSTD-Zhang-2004
p25430
sg12
S'PMC3522714'
p25431
sasa(dp25432
g3
VCD004380 v. 4.0 School-based education programmes for the prevention of child sexual abuse.rm5
p25433
sg5
(lp25434
(dp25435
g8
V20495474.xml
p25436
sg10
VSTD-Kolko-1989
p25437
sg12
S'PMC3057358'
p25438
sa(dp25439
g8
V3198545.xml
p25440
sg10
VSTD-Poche-1988
p25441
sg12
S'PMC1286121'
p25442
sasa(dp25443
g3
VCD005346 v. 8.0 Insulin for glycaemic control in acute ischaemic stroke.rm5
p25444
sg5
(lp25445
(dp25446
g8
V19834016.xml
p25447
sg10
VSTD-GRASP-2009
p25448
sg12
S'PMC2790382'
p25449
sasa(dp25450
g3
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p25451
sg5
(lp25452
(dp25453
g8
V18796160.xml
p25454
sg10
VSTD-Arezzo-2008
p25455
sg12
S'PMC2565674'
p25456
sasa(dp25457
g3
VCD008685 v. 2.2 Optimal loading dose of warfarin for the initiation of oral anticoagulation.rm5
p25458
sg5
(lp25459
(dp25460
g8
V16160068.xml
p25461
sg10
VSTD-Hillman-2005
p25462
sg12
S'PMC1237155'
p25463
sasa(dp25464
g3
VCD002912 v. 13.3 Open retropubic colposuspension for urinary incontinence in women.rm5
p25465
sg5
(lp25466
(dp25467
g8
V12114234.xml
p25468
sg10
VSTD-Ward-2002
p25469
sg12
S'PMC117136'
p25470
sasa(dp25471
g3
VCD007760 v. 3.0 Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illne.rm5
p25472
sg5
(lp25473
(dp25474
g8
V19690306.xml
p25475
sg10
VSTD-Bakitas-2009
p25476
sg12
S'PMC3657724'
p25477
sa(dp25478
g8
V3966617.xml
p25479
sg10
VSTD-Zimmer-1985
p25480
sg12
S'PMC1645992'
p25481
sa(dp25482
g8
V7532501.xml
p25483
sg10
VSTD-McWhinney-1994
p25484
sg12
S'PMC2541867'
p25485
sa(dp25486
g8
V1737710.xml
p25487
sg10
VSTD-Hughes-1992
p25488
sg12
S'PMC1069857'
p25489
sa(dp25490
g8
V10582932.xml
p25491
sg10
VSTD-Grande-1999
p25492
sg12
S'PMC28293'
p25493
sasa(dp25494
g3
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p25495
sg5
(lp25496
(dp25497
g8
V15842558.xml
p25498
sg10
VSTD-Altan_x002d_Yaycioglu-2005
p25499
sg12
S'PMC1884849'
p25500
sa(dp25501
g8
V19143854.xml
p25502
sg10
VSTD-Choo-2008
p25503
sg12
S'PMC2680337'
p25504
sasa(dp25505
g3
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p25506
sg5
(lp25507
(dp25508
g8
V19317822.xml
p25509
sg10
VSTD-L-_x002d_-LEAD-1-Marre-2009
p25510
sg12
S'PMC2871176'
p25511
sa(dp25512
g8
V20722676.xml
p25513
sg10
VSTD-Lixi-_x002d_-Ratner-2010
p25514
sg12
S'PMC3068287'
p25515
sa(dp25516
g8
V19366970.xml
p25517
sg10
VSTD-T-_x002d_-Nauck-2009
p25518
sg12
S'PMC2699710'
p25519
sa(dp25520
g8
V19592625.xml
p25521
sg10
VSTD-A-_x002d_-Rosenstock-2009
p25522
sg12
S'PMC2752910'
p25523
sa(dp25524
g8
V18931095.xml
p25525
sg10
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p25526
sg12
S'PMC2606836'
p25527
sa(dp25528
g8
V19688338.xml
p25529
sg10
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p25530
sg12
S'PMC2744824'
p25531
sa(dp25532
g8
V19289857.xml
p25533
sg10
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p25534
sg12
S'PMC2699702'
p25535
sa(dp25536
g8
V20536952.xml
p25537
sg10
VSTD-T_x002d_-Ratner-2010
p25538
sg12
S'PMC2948428'
p25539
sasa(dp25540
g3
VCD006581 v. 4.0 Adjusting the pH of lidocaine for reducing pain on injection.rm5
p25541
sg5
(lp25542
(dp25543
g8
V8894861.xml
p25544
sg10
VSTD-Cornelius-1996
p25545
sg12
S'PMC1342770'
p25546
sa(dp25547
g8
V15140310.xml
p25548
sg10
VSTD-Younis-2004
p25549
sg12
S'PMC1964174'
p25550
sasa(dp25551
g3
VCD003900 v. 7.0 Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chron.rm5
p25552
sg5
(lp25553
(dp25554
g8
V7570433.xml
p25555
sg10
VSTD-Moayyedi-1995
p25556
sg12
S'PMC474895'
p25557
sasa(dp25558
g3
VCD004901 v. 5.0 Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for wome.rm5
p25559
sg5
(lp25560
(dp25561
g8
V12789117.xml
p25562
sg10
VSTD-Nakintu-2001
p25563
sg12
S'PMC2141556'
p25564
sasa(dp25565
g3
VCD002308 v. 8.18 Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.rm5
p25566
sg5
(lp25567
(dp25568
g8
V16433920.xml
p25569
sg10
VSTD-Bateman-2006
p25570
sg12
S'PMC1386666'
p25571
sasa(dp25572
g3
VCD002003 v. 12.0 Beta-blockers for hypertension.rm5
p25573
sg5
(lp25574
(dp25575
g8
V9732338.xml
p25576
sg10
VSTD-UKPDS_x002d_39_x002d_1998
p25577
sg12
S'PMC28660'
p25578
sa(dp25579
g8
V3109557.xml
p25580
sg10
VSTD-Coope-1986
p25581
sg12
S'PMC1245188'
p25582
sa(dp25583
g8
V2861880.xml
p25584
sg10
VSTD-MRC-1985
p25585
sg12
S'PMC1416260'
p25586
sasa(dp25587
g3
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p25588
sg5
(lp25589
(dp25590
g8
V10772522.xml
p25591
sg10
VSTD-Feste-2000
p25592
sg12
S'PMC3015351'
p25593
sa(dp25594
g8
V17761080.xml
p25595
sg10
VSTD-Venkatesh-2007
p25596
sg12
S'PMC3015718'
p25597
sasa(dp25598
g3
VCD003431 v. 9.2 Non surgical therapy for anal fissure.rm5
p25599
sg5
(lp25600
(dp25601
g8
V10205213.xml
p25602
sg10
VSTD-Carapeti-1999
p25603
sg12
S'PMC1727506'
p25604
sa(dp25605
g8
V3039130.xml
p25606
sg10
VSTD-Jensen-1987
p25607
sg12
S'PMC1290813'
p25608
sa(dp25609
g8
V3011180.xml
p25610
sg10
VSTD-Jensen-1986
p25611
sg12
S'PMC1340178'
p25612
sa(dp25613
g8
V12524411.xml
p25614
sg10
VSTD-Scholefield-2003
p25615
sg12
S'PMC1774963'
p25616
sa(dp25617
g8
V11668104.xml
p25618
sg10
VSTD-Kenny-2001
p25619
sg12
S'PMC1718983'
p25620
sasa(dp25621
g3
VCD003822 v. 7.0 Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.rm5
p25622
sg5
(lp25623
(dp25624
g8
V14651725.xml
p25625
sg10
VSTD-Patterson-2003
p25626
sg12
S'PMC1884398'
p25627
sasa(dp25628
g3
VCD002209 v. 11.0 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.rm5
p25629
sg5
(lp25630
(dp25631
g8
V17628351.xml
p25632
sg10
VSTD-Kinlock-2007
p25633
sg12
S'PMC2423344'
p25634
sa(dp25635
g8
V18243585.xml
p25636
sg10
VSTD-Gruber-2008
p25637
sg12
S'PMC2821580'
p25638
sa(dp25639
g8
V1659236.xml
p25640
sg10
VSTD-Yancovitz-1991
p25641
sg12
S'PMC1405649'
p25642
sasa(dp25643
g3
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p25644
sg5
(lp25645
(dp25646
g8
V9554895.xml
p25647
sg10
VSTD-Bonnema-1998
p25648
sg12
S'PMC28526'
p25649
sa(dp25650
g8
V1483075.xml
p25651
sg10
VSTD-Addington_x002d_Hall-1992
p25652
sg12
S'PMC1883850'
p25653
sa(dp25654
g8
V7532501.xml
p25655
sg10
VSTD-McWhinney-1994
p25656
sg12
S'PMC2541867'
p25657
sa(dp25658
g8
V12433764.xml
p25659
sg10
VSTD-Moore-2002
p25660
sg12
S'PMC133453'
p25661
sa(dp25662
g8
V10756611.xml
p25663
sg10
VSTD-Grunfeld-1996
p25664
sg12
S'PMC1313497'
p25665
sa(dp25666
g8
V15238983.xml
p25667
sg10
VSTD-Wells-2004
p25668
sg12
S'PMC2364768'
p25669
sa(dp25670
g8
V1737710.xml
p25671
sg10
VSTD-Hughes-1992
p25672
sg12
S'PMC1069857'
p25673
sa(dp25674
g8
V11533423.xml
p25675
sg10
VSTD-Williams-2001
p25676
sg12
S'PMC1743428'
p25677
sa(dp25678
g8
V19107130.xml
p25679
sg10
VSTD-King-2009
p25680
sg12
S'PMC2634705'
p25681
sa(dp25682
g8
V8608288.xml
p25683
sg10
VSTD-McArdle-1996
p25684
sg12
S'PMC2350687'
p25685
sa(dp25686
g8
V10750206.xml
p25687
sg10
VSTD-Drury-2000
p25688
sg12
S'PMC1313626'
p25689
sa(dp25690
g8
V16622437.xml
p25691
sg10
VSTD-Wattchow-2006
p25692
sg12
S'PMC2361245'
p25693
sa(dp25694
g8
V12232756.xml
p25695
sg10
VSTD-Hanks-2002
p25696
sg12
S'PMC2364271'
p25697
sasa(dp25698
g3
VCD002259 v. 4.3 Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
p25699
sg5
(lp25700
(dp25701
g8
V23810193.xml
p25702
sg10
VSTD-Guttman-1997
p25703
sg12
S'PMC3756563'
p25704
sasa(dp25705
g3
VCD008914 v. 3.0 Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy.rm5
p25706
sg5
(lp25707
(dp25708
g8
V17717446.xml
p25709
sg10
VSTD-Poon-2007
p25710
sg12
S'PMC1959348'
p25711
sasa(dp25712
g3
VCD006591 v. 3.0 Patient education and counselling for promoting adherence to treatment for tuberculosis.rm5
p25713
sg5
(lp25714
(dp25715
g8
V12196616.xml
p25716
sg10
VSTD-Morisky-2001
p25717
sg12
S'PMC1497389'
p25718
sasa(dp25719
g3
VCD005051 v. 3.0 Wholegrain cereals for coronary heart disease.rm5
p25720
sg5
(lp25721
(dp25722
g8
V1846723.xml
p25723
sg10
VSTD-Van-Horn-1991
p25724
sg12
S'PMC1404954'
p25725
sasa(dp25726
g3
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p25727
sg5
(lp25728
(dp25729
g8
V19493352.xml
p25730
sg10
VSTD-Hochreiter-2009
p25731
sg12
S'PMC2717450'
p25732
sasa(dp25733
g3
VCD002755 v. 6.0 Intravenous magnesium for acute myocardial infarction.rm5
p25734
sg5
(lp25735
(dp25736
g8
V23611177.xml
p25737
sg10
VSTD-Zhu-2002
p25738
sg12
S'PMC3756114'
p25739
sa(dp25740
g8
V8130021.xml
p25741
sg10
VSTD-Woods-1992
p25742
sg12
S'PMC483633'
p25743
sasa(dp25744
g3
VCD006116 v. 4.0 Psychosocial and psychological interventions for treating postpartum depression.rm5
p25745
sg5
(lp25746
(dp25747
g8
V9099116.xml
p25748
sg10
VSTD-Appleby-1997
p25749
sg12
S'PMC2126383'
p25750
sa(dp25751
g8
V2493868.xml
p25752
sg10
VSTD-Holden-1989
p25753
sg12
S'PMC1835559'
p25754
sasa(dp25755
g3
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p25756
sg5
(lp25757
(dp25758
g8
V11720460.xml
p25759
sg10
VSTD-Brown-2001
p25760
sg12
S'PMC2375236'
p25761
sa(dp25762
g8
V9346455.xml
p25763
sg10
VSTD-Hornberger-1997
p25764
sg12
S'PMC1497170'
p25765
sa(dp25766
g8
V10390003.xml
p25767
sg10
VSTD-Brown-1999
p25768
sg12
S'PMC2363012'
p25769
sa(dp25770
g8
V14966078.xml
p25771
sg10
VSTD-Little-2004
p25772
sg12
S'PMC344265'
p25773
sa(dp25774
g8
V2373656.xml
p25775
sg10
VSTD-Finney-1990
p25776
sg12
S'PMC1286226'
p25777
sa(dp25778
g8
V16707508.xml
p25779
sg10
VSTD-Middleton-2006
p25780
sg12
S'PMC1471934'
p25781
sasa(dp25782
g3
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p25783
sg5
(lp25784
(dp25785
g8
V6758706.xml
p25786
sg10
VSTD-Patra-1982
p25787
sg12
S'PMC1628063'
p25788
sa(dp25789
g8
V1582603.xml
p25790
sg10
VSTD-Alam-1992
p25791
sg12
S'PMC1374078'
p25792
sa(dp25793
g8
V9002327.xml
p25794
sg10
VSTD-El_x002d_Mougi-1996
p25795
sg12
S'PMC2486870'
p25796
sa(dp25797
g8
V8067787.xml
p25798
sg10
VSTD-Islam-1994
p25799
sg12
S'PMC1029905'
p25800
sa(dp25801
g8
V3300569.xml
p25802
sg10
VSTD-Alam-1987
p25803
sg12
S'PMC1778371'
p25804
sa(dp25805
g8
V18270575.xml
p25806
sg10
VSTD-Ramakrishna-2008
p25807
sg12
S'PMC2217593'
p25808
sa(dp25809
g8
V3910298.xml
p25810
sg10
VSTD-Molla-1985
p25811
sg12
S'PMC2536376'
p25812
sasa(dp25813
g3
VCD003741 v. 7.0 Soy formula for prevention of allergy and food intolerance in infants.rm5
p25814
sg5
(lp25815
(dp25816
g8
V3365008.xml
p25817
sg10
VSTD-Miskelly-1988
p25818
sg12
S'PMC1778829'
p25819
sasa(dp25820
g3
VCD003715 v. 7.0 Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.rm5
p25821
sg5
(lp25822
(dp25823
g8
V11559654.xml
p25824
sg10
VSTD-Mahmud-2001
p25825
sg12
S'PMC1728458'
p25826
sasa(dp25827
g3
VCD004107 v. 4.0 Options for self-management education for adults with asthma.rm5
p25828
sg5
(lp25829
(dp25830
g8
V7570436.xml
p25831
sg10
VSTD-Jones-1995
p25832
sg12
S'PMC474903'
p25833
sa(dp25834
g8
V2148702.xml
p25835
sg10
VSTD-Charlton-1990
p25836
sg12
S'PMC1664498'
p25837
sa(dp25838
g8
V8605463.xml
p25839
sg10
VSTD-Lahdensuo-1996
p25840
sg12
S'PMC2350456'
p25841
sa(dp25842
g8
V8148679.xml
p25843
sg10
VSTD-Grampian-1994
p25844
sg12
S'PMC2539575'
p25845
sasa(dp25846
g3
VCD009607 v. 2.2 Swimming training for asthma in children and adolescents aged 18 years and under.rm5
p25847
sg5
(lp25848
(dp25849
g8
V10325893.xml
p25850
sg10
VSTD-Matsumoto-1999
p25851
sg12
S'PMC1745437'
p25852
sasa(dp25853
g3
VCD005063 v. 8.3 Benzodiazepines for alcohol withdrawal.rm5
p25854
sg5
(lp25855
(dp25856
g8
V12047731.xml
p25857
sg10
VSTD-Malcolm-2002
p25858
sg12
S'PMC1495040'
p25859
sasa(dp25860
g3
VCD005397 v. 5.0 Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.rm5
p25861
sg5
(lp25862
(dp25863
g8
V9667087.xml
p25864
sg10
VSTD-Yardley-1998
p25865
sg12
S'PMC1410046'
p25866
sasa(dp25867
g3
VCD003328 v. 7.0 Interventions for paracetamol (acetaminophen) overdose.rm5
p25868
sg5
(lp25869
(dp25870
g8
V11874395.xml
p25871
sg10
VSTD-Christophersen-2002
p25872
sg12
S'PMC1874309'
p25873
sa(dp25874
g8
V1954453.xml
p25875
sg10
VSTD-Keays-1991
p25876
sg12
S'PMC1671790'
p25877
sa(dp25878
g8
V22454960.xml
p25879
sg10
VSTD-Gazzard-1974a
p25880
sg12
S'PMC1402556'
p25881
sa(dp25882
g8
V1983801.xml
p25883
sg10
VSTD-Underhill-1990
p25884
sg12
S'PMC1285692'
p25885
sa(dp25886
g8
V519312.xml
p25887
sg10
VSTD-Prescott-1979
p25888
sg12
S'PMC1597048'
p25889
sa(dp25890
g8
V1102398.xml
p25891
sg10
VSTD-Gazzard-1975
p25892
sg12
S'PMC1411015'
p25893
sa(dp25894
g8
V4820642.xml
p25895
sg10
VSTD-Gazzard-1974
p25896
sg12
S'PMC1412898'
p25897
sa(dp25898
g8
V623980.xml
p25899
sg10
VSTD-Smith-1978
p25900
sg12
S'PMC1602895'
p25901
sa(dp25902
g8
V1884059.xml
p25903
sg10
VSTD-O_x0027_Grady-1991
p25904
sg12
S'PMC1670505'
p25905
sa(dp25906
g8
V8020810.xml
p25907
sg10
VSTD-Mutimer-1994
p25908
sg12
S'PMC1374884'
p25909
sa(dp25910
g8
V338110.xml
p25911
sg10
VSTD-Hughes-1977
p25912
sg12
S'PMC1632345'
p25913
sa(dp25914
g8
V10606832.xml
p25915
sg10
VSTD-Yeates-2000
p25916
sg12
S'PMC2014891'
p25917
sasa(dp25918
g3
VCD004918 v. 4.0 Aqueous shunts for glaucoma.rm5
p25919
sg5
(lp25920
(dp25921
g8
V12881343.xml
p25922
sg10
VSTD-Susanna-2003
p25923
sg12
S'PMC1771784'
p25924
sasa(dp25925
g3
VCD000373 v. 7.2 Kinesthetic stimulation for preventing apnea in preterm infants.rm5
p25926
sg5
(lp25927
(dp25928
g8
V7030228.xml
p25929
sg10
VSTD-Jones-1981
p25930
sg12
S'PMC1627404'
p25931
sasa(dp25932
g3
VCD000201 v. 6.0 Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.rm5
p25933
sg5
(lp25934
(dp25935
g8
V8251842.xml
p25936
sg10
VSTD-McDonald-1993
p25937
sg12
S'PMC1679299'
p25938
sasa(dp25939
g3
VCD008203 v. 2.0 Statins for primary prevention of venous thromboembolism.rm5
p25940
sg5
(lp25941
(dp25942
g8
V19329822.xml
p25943
sg10
VSTD-JUPITER-trial
p25944
sg12
S'PMC2710995'
p25945
sasa(dp25946
g3
VCD009046 v. 2.5 Interventions for smoking cessation in Indigenous populations.rm5
p25947
sg5
(lp25948
(dp25949
g8
V15681499.xml
p25950
sg10
VSTD-Holt-2005
p25951
sg12
S'PMC1747282'
p25952
sasa(dp25953
g3
VCD009805 v. 2.0 Hormonal and intrauterine methods for contraception for women aged 25 years and younger.rm5
p25954
sg5
(lp25955
(dp25956
g8
V18082856.xml
p25957
sg10
VSTD-Stewart-2007
p25958
sg12
S'PMC3163239'
p25959
sasa(dp25960
g3
VCD009095 v. 3.0 Interventions to optimise prescribing for older people in care homes.rm5
p25961
sg5
(lp25962
(dp25963
g8
V11298072.xml
p25964
sg10
VSTD-Roberts-2001
p25965
sg12
S'PMC2015028'
p25966
sasa(dp25967
g3
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p25968
sg5
(lp25969
(dp25970
g8
V20696865.xml
p25971
sg10
VSTD-Juvenile-2009
p25972
sg12
S'PMC2945155'
p25973
sa(dp25974
g8
V19767384.xml
p25975
sg10
VSTD-Raccah-2009
p25976
sg12
S'PMC2782985'
p25977
sa(dp25978
g8
V21335621.xml
p25979
sg10
VSTD-Battelino-2011
p25980
sg12
S'PMC3064030'
p25981
sasa(dp25982
g3
VCD001801 v. 8.0 Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.rm5
p25983
sg5
(lp25984
(dp25985
g8
V2196954.xml
p25986
sg10
VSTD-Black-1990
p25987
sg12
S'PMC1663097'
p25988
sasa(dp25989
g3
VCD004785 v. 9.0 Antibiotics for preventing meningococcal infections.rm5
p25990
sg5
(lp25991
(dp25992
g8
V6440658.xml
p25993
sg10
VSTD-Edwards-1984
p25994
sg12
S'PMC1046385'
p25995
sa(dp25996
g8
V3252755.xml
p25997
sg10
VSTD-Dworzack-1988
p25998
sg12
S'PMC175963'
p25999
sa(dp26000
g8
V3113331.xml
p26001
sg10
VSTD-Renkonen-1987
p26002
sg12
S'PMC284224'
p26003
sa(dp26004
g8
V6732217.xml
p26005
sg10
VSTD-Pugsley-1984
p26006
sg12
S'PMC185560'
p26007
sasa(dp26008
g3
VCD001539 v. 6.0 Recordings or summaries of consultations for people with cancer.rm5
p26009
sg5
(lp26010
(dp26011
g8
V6784861.xml
p26012
sg10
VSTD-Reynolds-1981
p26013
sg12
S'PMC1505182'
p26014
sasa(dp26015
g3
VCD003770 v. 6.0 Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer .rm5
p26016
sg5
(lp26017
(dp26018
g8
V9860474.xml
p26019
sg10
VSTD-Lorenz-1998
p26020
sg12
S'PMC1191593'
p26021
sasa(dp26022
g3
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p26023
sg5
(lp26024
(dp26025
g8
V16542484.xml
p26026
sg10
VSTD-Luckner-2006
p26027
sg12
S'PMC1550871'
p26028
sa(dp26029
g8
V19017409.xml
p26030
sg10
VSTD-Morelli-2008b
p26031
sg12
S'PMC2646303'
p26032
sa(dp26033
g8
V16507156.xml
p26034
sg10
VSTD-Seguin-2006
p26035
sg12
S'PMC1550826'
p26036
sa(dp26037
g8
V19664253.xml
p26038
sg10
VSTD-Morelli-2009
p26039
sg12
S'PMC2750187'
p26040
sasa(dp26041
g3
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p26042
sg5
(lp26043
(dp26044
g8
V8431375.xml
p26045
sg10
VSTD-Fraser-1993
p26046
sg12
S'PMC1968186'
p26047
sa(dp26048
g8
V1260337.xml
p26049
sg10
VSTD-Brambilla-1976
p26050
sg12
S'PMC1639498'
p26051
sa(dp26052
g8
V10496359.xml
p26053
sg10
VSTD-Harper_x002d_Wynne-1999
p26054
sg12
S'PMC2362871'
p26055
sasa(dp26056
g3
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p26057
sg5
(lp26058
(dp26059
g8
V8239591.xml
p26060
sg10
VSTD-Akova-1993
p26061
sg12
S'PMC188077'
p26062
sa(dp26063
g8
V15214959.xml
p26064
sg10
VSTD-Karabay-2004
p26065
sg12
S'PMC459220'
p26066
sa(dp26067
g8
V4907514.xml
p26068
sg10
VSTD-McDevitt-1970
p26069
sg12
S'PMC1009044'
p26070
sa(dp26071
g8
V7695265.xml
p26072
sg10
VSTD-Colmenero-1994
p26073
sg12
S'PMC188288'
p26074
sasa(dp26075
g3
VCD008645 v. 2.0 Incentives for preventing smoking in children and adolescents.rm5
p26076
sg5
(lp26077
(dp26078
g8
V12933772.xml
p26079
sg10
VSTD-Crone-2003
p26080
sg12
S'PMC1732562'
p26081
sasa(dp26082
g3
VCD006922 v. 4.0 Regular treatment with salmeterol and inhaled steroids for chronic asthma serious adverse events.rm5
p26083
sg5
(lp26084
(dp26085
g8
V16449264.xml
p26086
sg10
VSTD-Koopmans-2006
p26087
sg12
S'PMC2104614'
p26088
sasa(dp26089
g3
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p26090
sg5
(lp26091
(dp26092
g8
V16483383.xml
p26093
sg10
VSTD-Lumley-2006
p26094
sg12
S'PMC1479326'
p26095
sa(dp26096
g8
V11053173.xml
p26097
sg10
VSTD-Small-2000
p26098
sg12
S'PMC27510'
p26099
sa(dp26100
g8
V18410212.xml
p26101
sg10
VSTD-Feinberg-2008
p26102
sg12
S'PMC3178882'
p26103
sa(dp26104
g8
V21318932.xml
p26105
sg10
VSTD-Ickovics-2011
p26106
sg12
S'PMC3311036'
p26107
sa(dp26108
g8
V10977833.xml
p26109
sg10
VSTD-Morrell-2000
p26110
sg12
S'PMC27472'
p26111
sa(dp26112
g8
V19147637.xml
p26113
sg10
VSTD-Dennis-2009
p26114
sg12
S'PMC2628301'
p26115
sasa(dp26116
g3
VCD006075 v. 3.0 Overground physical therapy gait training for chronic stroke patients with mobility deficits.rm5
p26117
sg5
(lp26118
(dp26119
g8
V16181164.xml
p26120
sg10
VSTD-Pang-2005
p26121
sg12
S'PMC3226792'
p26122
sa(dp26123
g8
V1559090.xml
p26124
sg10
VSTD-Wade-1992
p26125
sg12
S'PMC1881332'
p26126
sasa(dp26127
g3
VCD004405 v. 7.0 Corticosteroids for acute bacterial meningitis.rm5
p26128
sg5
(lp26129
(dp26130
g8
V22346503.xml
p26131
sg10
VSTD-King-1994
p26132
sg12
S'PMC3250832'
p26133
sa(dp26134
g8
V9014599.xml
p26135
sg10
VSTD-Qazi-1996
p26136
sg12
S'PMC1511808'
p26137
sasa(dp26138
g3
VCD010078 v. 1.0 Pharmacological interventions for promoting smoking cessation during pregnancy.rm5
p26139
sg5
(lp26140
(dp26141
g8
V18827129.xml
p26142
sg10
VSTD-Oncken-2008
p26143
sg12
S'PMC2630492'
p26144
sa(dp26145
g8
V17888856.xml
p26146
sg10
VSTD-Pollak-2007
p26147
sg12
S'PMC3602964'
p26148
sasa(dp26149
g3
VCD001877 v. 12.0 Screening for breast cancer with mammography.rm5
p26150
sg5
(lp26151
(dp26152
g8
V1423088.xml
p26153
sg10
VSTD-Canada-1980b
p26154
sg12
S'PMC1336544'
p26155
sa(dp26156
g8
V9012720.xml
p26157
sg10
VSTD-Canada-1980
p26158
sg12
S'PMC1226907'
p26159
sa(dp26160
g8
V20837718.xml
p26161
sg10
VSTD-UK-age-trial-1991
p26162
sg12
S'PMC2978129'
p26163
sa(dp26164
g8
V2592888.xml
p26165
sg10
VSTD-Edinburgh-1978
p26166
sg12
S'PMC1052787'
p26167
sasa(dp26168
g3
VCD003495 v. 5.2 Intravenous secretin for autism spectrum disorders (ASD).rm5
p26169
sg5
(lp26170
(dp26171
g8
V12876177.xml
p26172
sg10
VSTD-Levy-2003
p26173
sg12
S'PMC1719589'
p26174
sasa(dp26175
g3
VCD001331 v. 5.0 Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.rm5
p26176
sg5
(lp26177
(dp26178
g8
V3295122.xml
p26179
sg10
VSTD-Milligan-1987
p26180
sg12
S'PMC1031960'
p26181
sasa(dp26182
g3
VCD003774 v. 13.0 Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.rm5
p26183
sg5
(lp26184
(dp26185
g8
V7940710.xml
p26186
sg10
VSTD-Martin-1994-Liver
p26187
sg12
S'PMC2958671'
p26188
sasa(dp26189
g3
VCD008451 v. 2.4 The effect of financial incentives on the quality of health care provided by primary care physicians.rm5
p26190
sg5
(lp26191
(dp26192
g8
V17443360.xml
p26193
sg10
VSTD-Young-2007
p26194
sg12
S'PMC2219885'
p26195
sa(dp26196
g8
V17297068.xml
p26197
sg10
VSTD-Twardella-2007
p26198
sg12
S'PMC2598437'
p26199
sasa(dp26200
g3
VCD003645 v. 10.0 Positioning for acute respiratory distress in hospitalised infants and children.rm5
p26201
sg5
(lp26202
(dp26203
g8
V16014597.xml
p26204
sg10
VSTD-Curley-2005
p26205
sg12
S'PMC1237036'
p26206
sa(dp26207
g8
V2357093.xml
p26208
sg10
VSTD-Levene-1990
p26209
sg12
S'PMC1792134'
p26210
sasa(dp26211
g3
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p26212
sg5
(lp26213
(dp26214
g8
V18431475.xml
p26215
sg10
VSTD-Gilbert-2008
p26216
sg12
S'PMC2292251'
p26217
sa(dp26218
g8
V18645518.xml
p26219
sg10
VSTD-Cornman-2008
p26220
sg12
S'PMC2813056'
p26221
sasa(dp26222
g3
VCD005444 v. 6.4 Pre-operative biliary drainage for obstructive jaundice.rm5
p26223
sg5
(lp26224
(dp26225
g8
V2986562.xml
p26226
sg10
VSTD-Pitt-1985
p26227
sg12
S'PMC1250755'
p26228
sasa(dp26229
g3
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p26230
sg5
(lp26231
(dp26232
g8
V6418300.xml
p26233
sg10
VSTD-Brandon-1985
p26234
sg12
S'PMC1444141'
p26235
sa(dp26236
g8
V21206808.xml
p26237
sg10
VSTD-Girish-2003
p26238
sg12
S'PMC2951534'
p26239
sa(dp26240
g8
V21927109.xml
p26241
sg10
VSTD-Agarwal-1985
p26242
sg12
S'PMC3011123'
p26243
sa(dp26244
g8
V22058556.xml
p26245
sg10
VSTD-Bagadia-1981
p26246
sg12
S'PMC3012902'
p26247
sa(dp26248
g8
V22058544.xml
p26249
sg10
VSTD-Janakiramiah-1981
p26250
sg12
S'PMC3012948'
p26251
sasa(dp26252
g3
VCD007189 v. 4.9 Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.rm5
p26253
sg5
(lp26254
(dp26255
g8
V21091279.xml
p26256
sg10
VSTD-Grant-2010
p26257
sg12
S'PMC3079639'
p26258
sa(dp26259
g8
V17525796.xml
p26260
sg10
VSTD-Peterson-2007
p26261
sg12
S'PMC1876601'
p26262
sa(dp26263
g8
V22784040.xml
p26264
sg10
VSTD-Van-Damme-2012
p26265
sg12
S'PMC3687217'
p26266
sa(dp26267
g8
V22784037.xml
p26268
sg10
VSTD-Baeten-2012
p26269
sg12
S'PMC3770474'
p26270
sasa(dp26271
g3
VCD002252 v. 8.0 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
p26272
sg5
(lp26273
(dp26274
g8
V23560009.xml
p26275
sg10
VSTD-Brazil-2000a
p26276
sg12
S'PMC3611911'
p26277
sa(dp26278
g8
V3929874.xml
p26279
sg10
VSTD-Australia-1985
p26280
sg12
S'PMC1418204'
p26281
sa(dp26282
g8
V2242456.xml
p26283
sg10
VSTD-UK-1990
p26284
sg12
S'PMC1663720'
p26285
sa(dp26286
g8
V6407638.xml
p26287
sg10
VSTD-UK-1983a
p26288
sg12
S'PMC1548251'
p26289
sasa(dp26290
g3
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p26291
sg5
(lp26292
(dp26293
g8
V14644671.xml
p26294
sg10
VSTD-Jordan-2003
p26295
sg12
S'PMC1241771'
p26296
sa(dp26297
g8
V9842383.xml
p26298
sg10
VSTD-Farrell-1998
p26299
sg12
S'PMC1509060'
p26300
sa(dp26301
g8
V21563715.xml
p26302
sg10
VSTD-Campbell-2011
p26303
sg12
S'PMC3072906'
p26304
sasa(dp26305
g3
VCD000456 v. 7.0 Synchronized mechanical ventilation for respiratory support in newborn infants.rm5
p26306
sg5
(lp26307
(dp26308
g8
V1863121.xml
p26309
sg10
VSTD-OCTAVE-1991
p26310
sg12
S'PMC1590232'
p26311
sa(dp26312
g8
V7796236.xml
p26313
sg10
VSTD-Dimitriou-1995b
p26314
sg12
S'PMC2528429'
p26315
sa(dp26316
g8
V10634835.xml
p26317
sg10
VSTD-Beresford-2000
p26318
sg12
S'PMC1721039'
p26319
sa(dp26320
g8
V10634832.xml
p26321
sg10
VSTD-Baumer-2000
p26322
sg12
S'PMC1721044'
p26323
sa(dp26324
g8
V7796236.xml
p26325
sg10
VSTD-Dimitriou-1995a
p26326
sg12
S'PMC2528429'
p26327
sasa(dp26328
g3
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p26329
sg5
(lp26330
(dp26331
g8
V16835378.xml
p26332
sg10
VSTD-Blazar-2006
p26333
sg12
S'PMC1895527'
p26334
sa(dp26335
g8
V8688343.xml
p26336
sg10
VSTD-Symonds-1996
p26337
sg12
S'PMC2074575'
p26338
sa(dp26339
g8
V12671696.xml
p26340
sg10
VSTD-Stokman-2003
p26341
sg12
S'PMC2376383'
p26342
sa(dp26343
g8
V7917930.xml
p26344
sg10
VSTD-Jebb-1994
p26345
sg12
S'PMC2033386'
p26346
sa(dp26347
g8
V2669626.xml
p26348
sg10
VSTD-Bubley-1989
p26349
sg12
S'PMC284246'
p26350
sa(dp26351
g8
V3390377.xml
p26352
sg10
VSTD-Mills-1988
p26353
sg12
S'PMC2246575'
p26354
sa(dp26355
g8
V11161394.xml
p26356
sg10
VSTD-Hartmann-2001
p26357
sg12
S'PMC2363753'
p26358
sasa(dp26359
g3
VCD001057 v. 6.0 Topical umbilical cord care at birth.rm5
p26360
sg5
(lp26361
(dp26362
g8
V7030227.xml
p26363
sg10
VSTD-Arad-1981
p26364
sg12
S'PMC1627396'
p26365
sasa(dp26366
g3
VCD009058 v. 2.0 Cryotherapy for liver metastases.rm5
p26367
sg5
(lp26368
(dp26369
g8
V9065296.xml
p26370
sg10
VSTD-Korpan-1997
p26371
sg12
S'PMC1190648'
p26372
sasa(dp26373
g3
VCD003919 v. 3.0 Laser trabeculoplasty for open angle glaucoma.rm5
p26374
sg5
(lp26375
(dp26376
g8
V3828273.xml
p26377
sg10
VSTD-Sherwood-1987
p26378
sg12
S'PMC1041116'
p26379
sa(dp26380
g8
V10340983.xml
p26381
sg10
VSTD-Damji-1999
p26382
sg12
S'PMC1723059'
p26383
sasa(dp26384
g3
VCD008274 v. 2.2 Long-term effects of weight-reducing diets in hypertensive patients.rm5
p26385
sg5
(lp26386
(dp26387
g8
V3440987.xml
p26388
sg10
VSTD-Croft-1986
p26389
sg12
S'PMC1960639'
p26390
sasa(dp26391
g3
VCD001395 v. 6.0 Phytoestrogens for vasomotor menopausal symptoms.rm5
p26392
sg5
(lp26393
(dp26394
g8
V18257146.xml
p26395
sg10
VSTD-Khaodhiar-2007
p26396
sg12
S'PMC3207039'
p26397
sasa(dp26398
g3
VCD007182 v. 5.0 Antimicrobial agents for treating uncomplicated urinary tract infection in women.rm5
p26399
sg5
(lp26400
(dp26401
g8
V12604518.xml
p26402
sg10
VSTD-Kavatha-2003
p26403
sg12
S'PMC149311'
p26404
sa(dp26405
g8
V2802557.xml
p26406
sg10
VSTD-Hooton-1989
p26407
sg12
S'PMC172645'
p26408
sa(dp26409
g8
V2188590.xml
p26410
sg10
VSTD-Boyko-1990
p26411
sg12
S'PMC171664'
p26412
sa(dp26413
g8
V3158277.xml
p26414
sg10
VSTD-Goldstein-1985
p26415
sg12
S'PMC176290'
p26416
sasa(dp26417
g3
VCD001079 v. 5.0 Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm inf.rm5
p26418
sg5
(lp26419
(dp26420
g8
V2201266.xml
p26421
sg10
VSTD-Ten-Centre-1987
p26422
sg12
S'PMC1590200'
p26423
sasa(dp26424
g3
VCD003793 v. 7.0 Pulmonary rehabilitation for chronic obstructive pulmonary disease.rm5
p26425
sg5
(lp26426
(dp26427
g8
V882944.xml
p26428
sg10
VSTD-McGavin-1977
p26429
sg12
S'PMC470605'
p26430
sa(dp26431
g8
V1549826.xml
p26432
sg10
VSTD-Simpson-1992
p26433
sg12
S'PMC463573'
p26434
sa(dp26435
g8
V7025334.xml
p26436
sg10
VSTD-Cockcroft-1981
p26437
sg12
S'PMC471476'
p26438
sasa(dp26439
g3
VCD008324 v. 3.0 Psychological therapies versus antidepressant medication alone and in combination for depression in.rm5
p26440
sg5
(lp26441
(dp26442
g8
V19321268.xml
p26443
sg10
VSTD-Cornelius-2009
p26444
sg12
S'PMC2720419'
p26445
sa(dp26446
g8
V19730274.xml
p26447
sg10
VSTD-TASA-2009
p26448
sg12
S'PMC2891930'
p26449
sa(dp26450
g8
V17556431.xml
p26451
sg10
VSTD-ADAPT-2007
p26452
sg12
S'PMC1925185'
p26453
sasa(dp26454
g3
VCD003839 v. 7.8 Self-monitoring and self-management of oral anticoagulation.rm5
p26455
sg5
(lp26456
(dp26457
g8
V12401823.xml
p26458
sg10
VSTD-Fitzmaurice-2002
p26459
sg12
S'PMC1769803'
p26460
sa(dp26461
g8
V16216821.xml
p26462
sg10
VSTD-Fitzmaurice-2005
p26463
sg12
S'PMC1283185'
p26464
sasa(dp26465
g3
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p26466
sg5
(lp26467
(dp26468
g8
V18356109.xml
p26469
sg10
VSTD-START-A-2008
p26470
sg12
S'PMC2323709'
p26471
sasa(dp26472
g3
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p26473
sg5
(lp26474
(dp26475
g8
V365289.xml
p26476
sg10
VSTD-Newton-1978
p26477
sg12
S'PMC1608821'
p26478
sa(dp26479
g8
V16137351.xml
p26480
sg10
VSTD-Vargas-2005
p26481
sg12
S'PMC1269449'
p26482
sasa(dp26483
g3
VCD001272 v. 7.0 Antiplatelet agents for intermittent claudication.rm5
p26484
sg5
(lp26485
(dp26486
g8
V7047575.xml
p26487
sg10
VSTD-Aukland-1982
p26488
sg12
S'PMC497768'
p26489
sasa(dp26490
g3
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p26491
sg5
(lp26492
(dp26493
g8
V12454299.xml
p26494
sg10
VSTD-Bourjeily_x002d_Habr-2002
p26495
sg12
S'PMC1758803'
p26496
sa(dp26497
g8
V11923552.xml
p26498
sg10
VSTD-Neder-2002
p26499
sg12
S'PMC1746295'
p26500
sa(dp26501
g8
V21552662.xml
p26502
sg10
VSTD-N_x00e1_polis-2011
p26503
sg12
S'PMC3071998'
p26504
sasa(dp26505
g3
VCD001825 v. 6.0 Closed suction surgical wound drainage after orthopaedic surgery.rm5
p26506
sg5
(lp26507
(dp26508
g8
V8371245.xml
p26509
sg10
VSTD-Murphy-1993
p26510
sg12
S'PMC1293006'
p26511
sasa(dp26512
g3
VCD006413 v. 3.0 Managerial supervision to improve primary health care in low- and middle-income countries.rm5
p26513
sg5
(lp26514
(dp26515
g8
V19299681.xml
p26516
sg10
VSTD-Rowe-2009
p26517
sg12
S'PMC2667861'
p26518
sasa(dp26519
g3
VCD003005 v. 6.0 Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys.rm5
p26520
sg5
(lp26521
(dp26522
g8
V6407642.xml
p26523
sg10
VSTD-White-1983
p26524
sg12
S'PMC1548305'
p26525
sasa(dp26526
g3
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p26527
sg5
(lp26528
(dp26529
g8
V19781053.xml
p26530
sg10
VSTD-Nilsson-2009
p26531
sg12
S'PMC2760502'
p26532
sa(dp26533
g8
V17206496.xml
p26534
sg10
VSTD-Franke-2008
p26535
sg12
S'PMC2269030'
p26536
sa(dp26537
g8
V9728313.xml
p26538
sg10
VSTD-Hedstrom-1994
p26539
sg12
S'PMC3619593'
p26540
sasa(dp26541
g3
VCD004191 v. 9.0 Self-help and guided self-help for eating disorders.rm5
p26542
sg5
(lp26543
(dp26544
g8
V22449893.xml
p26545
sg10
VSTD-Grilo-2005b
p26546
sg12
S'PMC3327763'
p26547
sa(dp26548
g8
V12830564.xml
p26549
sg10
VSTD-Durand-2003
p26550
sg12
S'PMC1314596'
p26551
sasa(dp26552
g3
VCD002247 v. 13.0 Primary repair for penetrating colon injuries.rm5
p26553
sg5
(lp26554
(dp26555
g8
V384941.xml
p26556
sg10
VSTD-Stone-1979
p26557
sg12
S'PMC1344502'
p26558
sa(dp26559
g8
V2025069.xml
p26560
sg10
VSTD-Chappius-1991
p26561
sg12
S'PMC1358480'
p26562
sasa(dp26563
g3
VCD002829 v. 8.0 Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease.rm5
p26564
sg5
(lp26565
(dp26566
g8
V19743457.xml
p26567
sg10
VSTD-QALS-Study-Group-2009
p26568
sg12
S'PMC2854625'
p26569
sasa(dp26570
g3
VCD001169 v. 14.0 Amantadine and rimantadine for influenza A in adults.rm5
p26571
sg5
(lp26572
(dp26573
g8
V7044294.xml
p26574
sg10
VSTD-Millet-1982
p26575
sg12
S'PMC181819'
p26576
sa(dp26577
g8
V4947223.xml
p26578
sg10
VSTD-Schapira-1971
p26579
sg12
S'PMC2156417'
p26580
sa(dp26581
g8
V7347558.xml
p26582
sg10
VSTD-Hayden-1981
p26583
sg12
S'PMC181399'
p26584
sa(dp26585
g8
V5310209.xml
p26586
sg10
VSTD-Nafta-1970
p26587
sg12
S'PMC2427540'
p26588
sa(dp26589
g8
V3521480.xml
p26590
sg10
VSTD-Hayden-1986
p26591
sg12
S'PMC176405'
p26592
sa(dp26593
g8
V2285274.xml
p26594
sg10
VSTD-Brady-1990
p26595
sg12
S'PMC171896'
p26596
sa(dp26597
g8
V5312248.xml
p26598
sg10
VSTD-Smorodintsev-1970
p26599
sg12
S'PMC2427564'
p26600
sa(dp26601
g8
V4919024.xml
p26602
sg10
VSTD-Oker_x002d_Blom-1970
p26603
sg12
S'PMC1701794'
p26604
sa(dp26605
g8
V6859836.xml
p26606
sg10
VSTD-Younkin-1983
p26607
sg12
S'PMC184704'
p26608
sa(dp26609
g8
V4908341.xml
p26610
sg10
VSTD-Hornick-1969d
p26611
sg12
S'PMC2427751'
p26612
sa(dp26613
g8
V4908341.xml
p26614
sg10
VSTD-Hornick-1969c
p26615
sg12
S'PMC2427751'
p26616
sa(dp26617
g8
V4908341.xml
p26618
sg10
VSTD-Hornick-1969b
p26619
sg12
S'PMC2427751'
p26620
sa(dp26621
g8
V4908341.xml
p26622
sg10
VSTD-Hornick-1969a
p26623
sg12
S'PMC2427751'
p26624
sasa(dp26625
g3
VCD006911 v. 6.0 Music interventions for improving psychological and physical outcomes in cancer patients.rm5
p26626
sg5
(lp26627
(dp26628
g8
V23741635.xml
p26629
sg10
VSTD-Ferrer-2005
p26630
sg12
S'PMC3666262'
p26631
sasa(dp26632
g3
VCD007986 v. 4.0 Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children a.rm5
p26633
sg5
(lp26634
(dp26635
g8
V19436468.xml
p26636
sg10
VSTD-Belanger-2009
p26637
sg12
S'PMC2661342'
p26638
sasa(dp26639
g3
VCD002916 v. 9.0 Pleurodesis for malignant pleural effusions.rm5
p26640
sg5
(lp26641
(dp26642
g8
V7692617.xml
p26643
sg10
VSTD-Koldsland-1993
p26644
sg12
S'PMC464703'
p26645
sasa(dp26646
g3
VCD005440 v. 9.0 Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.rm5
p26647
sg5
(lp26648
(dp26649
g8
V9563529.xml
p26650
sg10
VSTD-Lo-1998
p26651
sg12
S'PMC1191296'
p26652
sasa(dp26653
g3
VCD006461 v. 5.0 Interventions for strabismic amblyopia.rm5
p26654
sg5
(lp26655
(dp26656
g8
V16751033.xml
p26657
sg10
VSTD-PEDIG-2006
p26658
sg12
S'PMC1609192'
p26659
sa(dp26660
g8
V18789533.xml
p26661
sg10
VSTD-PEDIG-2008
p26662
sg12
S'PMC2615691'
p26663
sasa(dp26664
g3
VCD007950 v. 2.0 Effects and safety of periconceptional folate supplementation for preventing birth defects.rm5
p26665
sg5
(lp26666
(dp26667
g8
V6786536.xml
p26668
sg10
VSTD-Laurence-1981
p26669
sg12
S'PMC1505459'
p26670
sa(dp26671
g8
V1489222.xml
p26672
sg10
VSTD-Kirke-1992
p26673
sg12
S'PMC1793975'
p26674
sasa(dp26675
g3
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p26676
sg5
(lp26677
(dp26678
g8
V18831749.xml
p26679
sg10
VSTD-Wahl-2008
p26680
sg12
S'PMC2573879'
p26681
sasa(dp26682
g3
VCD006061 v. 3.0 Whole grain foods for the prevention of type 2 diabetes mellitus.rm5
p26683
sg5
(lp26684
(dp26685
g8
V10983198.xml
p26686
sg10
VSTD-Liu-2000
p26687
sg12
S'PMC1447620'
p26688
sasa(dp26689
g3
VCD007632 v. 1.2 Methods of vascular occlusion for elective liver resections.rm5
p26690
sg5
(lp26691
(dp26692
g8
V17122617.xml
p26693
sg10
VSTD-Petrowsky-2006
p26694
sg12
S'PMC1856627'
p26695
sa(dp26696
g8
V15798459.xml
p26697
sg10
VSTD-Figueras-2005
p26698
sg12
S'PMC1357061'
p26699
sa(dp26700
g8
V8757378.xml
p26701
sg10
VSTD-Belghiti-1996
p26702
sg12
S'PMC1235336'
p26703
sa(dp26704
g8
V10077049.xml
p26705
sg10
VSTD-Belghiti-1999
p26706
sg12
S'PMC1191702'
p26707
sasa(dp26708
g3
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p26709
sg5
(lp26710
(dp26711
g8
V21995590.xml
p26712
sg10
VSTD-Mansour-2011
p26713
sg12
S'PMC3233274'
p26714
sasa(dp26715
g3
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p26716
sg5
(lp26717
(dp26718
g8
V19637345.xml
p26719
sg10
VSTD-Griffith-2009
p26720
sg12
S'PMC2761503'
p26721
sa(dp26722
g8
V18581595.xml
p26723
sg10
VSTD-Hwang-2008
p26724
sg12
S'PMC2615347'
p26725
sa(dp26726
g8
V19831159.xml
p26727
sg10
VSTD-Mustian-2009
p26728
sg12
S'PMC3034389'
p26729
sa(dp26730
g8
V21116175.xml
p26731
sg10
VSTD-Hacker-2011
p26732
sg12
S'PMC3085978'
p26733
sa(dp26734
g8
V20842268.xml
p26735
sg10
VSTD-Vadiraja-2009b
p26736
sg12
S'PMC2933732'
p26737
sa(dp26738
g8
V17307761.xml
p26739
sg10
VSTD-Mutrie-2007
p26740
sg12
S'PMC1819494'
p26741
sa(dp26742
g8
V19826172.xml
p26743
sg10
VSTD-Adamsen-2009
p26744
sg12
S'PMC2762035'
p26745
sa(dp26746
g8
V19880433.xml
p26747
sg10
VSTD-Oh-2010
p26748
sg12
S'PMC2826100'
p26749
sasa(dp26750
g3
VCD006580 v. 4.0 Culture-specific programs for children and adults from minority groups who have asthma.rm5
p26751
sg5
(lp26752
(dp26753
g8
V10679534.xml
p26754
sg10
VSTD-Moudgil-2000
p26755
sg12
S'PMC1745690'
p26756
sa(dp26757
g8
V18061648.xml
p26758
sg10
VSTD-Canino-2008
p26759
sg12
S'PMC3136215'
p26760
sasa(dp26761
g3
VCD006265 v. 6.0 Case management for persons with substance use disorders.rm5
p26762
sg5
(lp26763
(dp26764
g8
V16616167.xml
p26765
sg10
VSTD-Rapp-2006
p26766
sg12
S'PMC1986793'
p26767
sa(dp26768
g8
V17018819.xml
p26769
sg10
VSTD-Morgenstern-2006
p26770
sg12
S'PMC1751803'
p26771
sasa(dp26772
g3
VCD003854 v. 7.0 Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples.rm5
p26773
sg5
(lp26774
(dp26775
g8
V16496208.xml
p26776
sg10
VSTD-Liu-2006
p26777
sg12
S'PMC3454905'
p26778
sasa(dp26779
g3
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p26780
sg5
(lp26781
(dp26782
g8
V17260162.xml
p26783
sg10
VSTD-Voerman-2007
p26784
sg12
S'PMC1915628'
p26785
sasa(dp26786
g3
VCD004110 v. 6.0 Speech and language therapy interventions for children with primary speech and language delay or dis.rm5
p26787
sg5
(lp26788
(dp26789
g8
V1739321.xml
p26790
sg10
VSTD-Barratt-1992
p26791
sg12
S'PMC1793542'
p26792
sa(dp26793
g8
V11030677.xml
p26794
sg10
VSTD-Glogowska_x002c_-2000
p26795
sg12
S'PMC27499'
p26796
sasa(dp26797
g3
VCD004916 v. 5.4 Interventions to slow progression of myopia in children.rm5
p26798
sg5
(lp26799
(dp26800
g8
V2667638.xml
p26801
sg10
VSTD-P_x00e4_rssinen-1989
p26802
sg12
S'PMC1041798'
p26803
sa(dp26804
g8
V22986450.xml
p26805
sg10
VSTD-Schwartz-1981
p26806
sg12
S'PMC3703778'
p26807
sasa(dp26808
g3
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p26809
sg5
(lp26810
(dp26811
g8
V18581595.xml
p26812
sg10
VSTD-Hwang-2008
p26813
sg12
S'PMC2615347'
p26814
sasa(dp26815
g3
VCD003711 v. 7.5 Herbal medicines for viral myocarditis.rm5
p26816
sg5
(lp26817
(dp26818
g8
V18723572.xml
p26819
sg10
VSTD-Pan-XS-2010
p26820
sg12
S'PMC2553588'
p26821
sasa(dp26822
g3
VCD001423 v. 12.0 Serenoa repens for benign prostatic hyperplasia.rm5
p26823
sg5
(lp26824
(dp26825
g8
V6207850.xml
p26826
sg10
VSTD-Champault-1984
p26827
sg12
S'PMC1463641'
p26828
sa(dp26829
g8
V21954478.xml
p26830
sg10
VSTD-Barry-2011
p26831
sg12
S'PMC3326341'
p26832
sasa(dp26833
g3
VCD003391 v. 7.0 Antidepressants versus placebo for people with bulimia nervosa.rm5
p26834
sg5
(lp26835
(dp26836
g8
V6337607.xml
p26837
sg10
VSTD-Sabine-1983
p26838
sg12
S'PMC1427898'
p26839
sasa(dp26840
g3
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p26841
sg5
(lp26842
(dp26843
g8
V15667657.xml
p26844
sg10
VSTD-Carey-2005
p26845
sg12
S'PMC547907'
p26846
sasa(dp26847
g3
VCD005556 v. 3.3 Interventions for chronic blepharitis.rm5
p26848
sg5
(lp26849
(dp26850
g8
V19277245.xml
p26851
sg10
VSTD-Macsai-2008
p26852
sg12
S'PMC2646454'
p26853
sa(dp26854
g8
V7880791.xml
p26855
sg10
VSTD-Seal-1995
p26856
sg12
S'PMC505018'
p26857
sa(dp26858
g8
V2344168.xml
p26859
sg10
VSTD-Hyndiuk-1990
p26860
sg12
S'PMC171652'
p26861
sa(dp26862
g8
V4872706.xml
p26863
sg10
VSTD-More-1968
p26864
sg12
S'PMC506604'
p26865
sasa(dp26866
g3
VCD003651 v. 7.0 Vaginal disinfection for preventing mother-to-child transmission of HIV infection.rm5
p26867
sg5
(lp26868
(dp26869
g8
V12181464.xml
p26870
sg10
VSTD-Mandelbrot-2002
p26871
sg12
S'PMC1744488'
p26872
sasa(dp26873
g3
VCD007982 v. 3.0 Email for the provision of information on disease prevention and health promotion.rm5
p26874
sg5
(lp26875
(dp26876
g8
V6224550.xml
p26877
sg10
VSTD-Pearson-2004
p26878
sg12
S'PMC1875562'
p26879
sasa(dp26880
g3
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p26881
sg5
(lp26882
(dp26883
g8
V17491173.xml
p26884
sg10
VSTD-Mermelstein-2006
p26885
sg12
S'PMC2373262'
p26886
sa(dp26887
g8
V12509354.xml
p26888
sg10
VSTD-Munoz-2006-Study-3
p26889
sg12
S'PMC150356'
p26890
sa(dp26891
g8
V18407003.xml
p26892
sg10
VSTD-Strecher-2008
p26893
sg12
S'PMC2697448'
p26894
sa(dp26895
g8
V19033146.xml
p26896
sg10
VSTD-Rabius-2008
p26897
sg12
S'PMC2630842'
p26898
sa(dp26899
g8
V16436397.xml
p26900
sg10
VSTD-Swartz-2006
p26901
sg12
S'PMC2563640'
p26902
sa(dp26903
g8
V19097974.xml
p26904
sg10
VSTD-Stoddard-2008
p26905
sg12
S'PMC2630832'
p26906
sa(dp26907
g8
V15829474.xml
p26908
sg10
VSTD-Etter-2005
p26909
sg12
S'PMC1550632'
p26910
sa(dp26911
g8
V19640833.xml
p26912
sg10
VSTD-Munoz-2009
p26913
sg12
S'PMC2725004'
p26914
sa(dp26915
g8
V19017582.xml
p26916
sg10
VSTD-McKay-2008
p26917
sg12
S'PMC2630830'
p26918
sa(dp26919
g8
V19087949.xml
p26920
sg10
VSTD-Brendryen-2008a
p26921
sg12
S'PMC2630841'
p26922
sasa(dp26923
g3
VCD008305 v. 3.3 Chinese herbal medicines for hypercholesterolemia.rm5
p26924
sg5
(lp26925
(dp26926
g8
V23555827.xml
p26927
sg10
VSTD-Ding-1999
p26928
sg12
S'PMC3608539'
p26929
sasa(dp26930
g3
VCD004863 v. 6.0 Early erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight in.rm5
p26931
sg5
(lp26932
(dp26933
g8
V12496225.xml
p26934
sg10
VSTD-Meyer-2003
p26935
sg12
S'PMC1756013'
p26936
sa(dp26937
g8
V9797624.xml
p26938
sg10
VSTD-Carnielli-1998
p26939
sg12
S'PMC1720813'
p26940
sasa(dp26941
g3
VCD000958 v. 7.0 Sulfasalazine for treating rheumatoid arthritis.rm5
p26942
sg5
(lp26943
(dp26944
g8
V6138117.xml
p26945
sg10
VSTD-Pullar-1983
p26946
sg12
S'PMC1549364'
p26947
sa(dp26948
g8
V1358037.xml
p26949
sg10
VSTD-Danis-1992
p26950
sg12
S'PMC1004800'
p26951
sasa(dp26952
g3
VCD001285 v. 6.0 Inhaled short acting beta2-agonist use in chronic asthma regular versus as needed treatment.rm5
p26953
sg5
(lp26954
(dp26955
g8
V8977598.xml
p26956
sg10
VSTD-Wilding-1996
p26957
sg12
S'PMC472646'
p26958
sa(dp26959
g8
V10319056.xml
p26960
sg10
VSTD-Taylor-1998
p26961
sg12
S'PMC1745306'
p26962
sa(dp26963
g8
V10335000.xml
p26964
sg10
VSTD-Hancox--1999a
p26965
sg12
S'PMC1745487'
p26966
sa(dp26967
g8
V10799426.xml
p26968
sg10
VSTD-Chavasse-2000
p26969
sg12
S'PMC1718341'
p26970
sa(dp26971
g8
V10335000.xml
p26972
sg10
VSTD-Hancox-1999b
p26973
sg12
S'PMC1745487'
p26974
sasa(dp26975
g3
VCD002150 v. 6.0 Antibiotics for treating scrub typhus.rm5
p26976
sg5
(lp26977
(dp26978
g8
V17638700.xml
p26979
sg10
VSTD-Phimda-2007
p26980
sg12
S'PMC2043199'
p26981
sa(dp26982
g8
V17404000.xml
p26983
sg10
VSTD-Kim-2007
p26984
sg12
S'PMC1891405'
p26985
sasa(dp26986
g3
VCD006015 v. 7.0 Finasteride for benign prostatic hyperplasia.rm5
p26987
sg5
(lp26988
(dp26989
g8
V8911291.xml
p26990
sg10
VSTD-Nickel-1996
p26991
sg12
S'PMC1335066'
p26992
sasa(dp26993
g3
VCD001855 v. 11.0 Helmets for preventing head and facial injuries in bicyclists.rm5
p26994
sg5
(lp26995
(dp26996
g8
V2240332.xml
p26997
sg10
VSTD-Thompson-1990
p26998
sg12
S'PMC1405121'
p26999
sa(dp27000
g8
V8312768.xml
p27001
sg10
VSTD-Thomas-1994
p27002
sg12
S'PMC2542522'
p27003
sa(dp27004
g8
V8019309.xml
p27005
sg10
VSTD-Maimaris-1994
p27006
sg12
S'PMC2540472'
p27007
sasa(dp27008
g3
VCD000085 v. 5.0 Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.rm5
p27009
sg5
(lp27010
(dp27011
g8
V18476211.xml
p27012
sg10
VSTD-Magann-_x0028_M_x0029_-1993b
p27013
sg12
S'PMC2364670'
p27014
sa(dp27015
g8
V18476211.xml
p27016
sg10
VSTD-Magann-_x0028_S_x0029_-1993b
p27017
sg12
S'PMC2364670'
p27018
sasa(dp27019
g3
VCD007834 v. 2.0 Iron for restless legs syndrome.rm5
p27020
sg5
(lp27021
(dp27022
g8
V18280205.xml
p27023
sg10
VSTD-Earley-2009
p27024
sg12
S'PMC2703581'
p27025
sasa(dp27026
g3
VCD006429 v. 3.0 Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.rm5
p27027
sg5
(lp27028
(dp27029
g8
V12885981.xml
p27030
sg10
VSTD-Nandi-2003
p27031
sg12
S'PMC1746761'
p27032
sa(dp27033
g8
V1481177.xml
p27034
sg10
VSTD-Leach-1992
p27035
sg12
S'PMC464043'
p27036
sa(dp27037
g8
V10325901.xml
p27038
sg10
VSTD-Garrod-1999
p27039
sg12
S'PMC1745430'
p27040
sa(dp27041
g8
V3238640.xml
p27042
sg10
VSTD-Davidson-1988
p27043
sg12
S'PMC461601'
p27044
sa(dp27045
g8
V3353874.xml
p27046
sg10
VSTD-McKeon-1988a
p27047
sg12
S'PMC461095'
p27048
sa(dp27049
g8
V10856311.xml
p27050
sg10
VSTD-Killen-2000
p27051
sg12
S'PMC1745798'
p27052
sasa(dp27053
g3
VCD005420 v. 5.0 Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor set.rm5
p27054
sg5
(lp27055
(dp27056
g8
V9624473.xml
p27057
sg10
VSTD-Torre-et-al-1998
p27058
sg12
S'PMC105601'
p27059
sasa(dp27060
g3
VCD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
p27061
sg5
(lp27062
(dp27063
g8
V3094811.xml
p27064
sg10
VSTD-HEP-1986
p27065
sg12
S'PMC1341855'
p27066
sa(dp27067
g8
V1445513.xml
p27068
sg10
VSTD-MRCOA-1992
p27069
sg12
S'PMC1995577'
p27070
sa(dp27071
g8
V6794796.xml
p27072
sg10
VSTD-Sprackling-1981
p27073
sg12
S'PMC1507336'
p27074
sa(dp27075
g8
V22530180.xml
p27076
sg10
VSTD-Carter-1970
p27077
sg12
S'PMC3327043'
p27078
sasa(dp27079
g3
VCD002742 v. 7.4 Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma.rm5
p27080
sg5
(lp27081
(dp27082
g8
V8202885.xml
p27083
sg10
VSTD-Zainudin-1994
p27084
sg12
S'PMC1021158'
p27085
sasa(dp27086
g3
VCD003101 v. 6.0 Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.rm5
p27087
sg5
(lp27088
(dp27089
g8
V3094775.xml
p27090
sg10
VSTD-Cardozo-1986
p27091
sg12
S'PMC1341914'
p27092
sasa(dp27093
g3
VCD000081 v. 8.2 Episiotomy for vaginal birth.rm5
p27094
sg5
(lp27095
(dp27096
g8
V6428627.xml
p27097
sg10
VSTD-Harrison-1984
p27098
sg12
S'PMC1442189'
p27099
sasa(dp27100
g3
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p27101
sg5
(lp27102
(dp27103
g8
V20467301.xml
p27104
sg10
VSTD-Dodd-2010a
p27105
sg12
S'PMC2891044'
p27106
sa(dp27107
g8
V18581595.xml
p27108
sg10
VSTD-Hwang-2008
p27109
sg12
S'PMC2615347'
p27110
sa(dp27111
g8
V19831159.xml
p27112
sg10
VSTD-Mustian-2009
p27113
sg12
S'PMC3034389'
p27114
sa(dp27115
g8
V20467301.xml
p27116
sg10
VSTD-Dodd-2010b
p27117
sg12
S'PMC2891044'
p27118
sa(dp27119
g8
V17307761.xml
p27120
sg10
VSTD-Mutrie-2007
p27121
sg12
S'PMC1819494'
p27122
sa(dp27123
g8
V19826172.xml
p27124
sg10
VSTD-Adamsen-2009
p27125
sg12
S'PMC2762035'
p27126
sa(dp27127
g8
V19880433.xml
p27128
sg10
VSTD-Oh-2010
p27129
sg12
S'PMC2826100'
p27130
sasa(dp27131
g3
VCD003320 v. 10.0 Anaesthesia for treating distal radial fracture in adults.rm5
p27132
sg5
(lp27133
(dp27134
g8
V3893460.xml
p27135
sg10
VSTD-Wardrope-1985
p27136
sg12
S'PMC1285259'
p27137
sa(dp27138
g8
V3935242.xml
p27139
sg10
VSTD-Cobb-1985
p27140
sg12
S'PMC1418745'
p27141
sa(dp27142
g8
V3408537.xml
p27143
sg10
VSTD-McGlone-1988
p27144
sg12
S'PMC1285492'
p27145
sa(dp27146
g8
V9413772.xml
p27147
sg10
VSTD-Kendall-1997
p27148
sg12
S'PMC1342971'
p27149
sa(dp27150
g8
V8894860.xml
p27151
sg10
VSTD-London-1996
p27152
sg12
S'PMC1342769'
p27153
sasa(dp27154
g3
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p27155
sg5
(lp27156
(dp27157
g8
V10917122.xml
p27158
sg10
VSTD-Lepere-2000
p27159
sg12
S'PMC3015374'
p27160
sasa(dp27161
g3
VCD004163 v. 5.0 Identification of children in the first four years of life for early treatment for otitis media with.rm5
p27162
sg5
(lp27163
(dp27164
g8
V16093466.xml
p27165
sg10
VSTD-Paradise-2005
p27166
sg12
S'PMC1201478'
p27167
sasa(dp27168
g3
VCD000953 v. 7.0 Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.rm5
p27169
sg5
(lp27170
(dp27171
g8
V2449871.xml
p27172
sg10
VSTD-McHugh-1988
p27173
sg12
S'PMC1003442'
p27174
sa(dp27175
g8
V7538285.xml
p27176
sg10
VSTD-Belch-1995
p27177
sg12
S'PMC1005556'
p27178
sasa(dp27179
g3
VCD001991 v. 10.0 Screening for lung cancer.rm5
p27180
sg5
(lp27181
(dp27182
g8
V5345935.xml
p27183
sg10
VSTD-North-London-Study
p27184
sg12
S'PMC1629689'
p27185
sasa(dp27186
g3
VCD002873 v. 6.0 Short acting beta2-agonists for recurrent wheeze in children under two years of age.rm5
p27187
sg5
(lp27188
(dp27189
g8
V8024294.xml
p27190
sg10
VSTD-Clarke-1993
p27191
sg12
S'PMC1029426'
p27192
sa(dp27193
g8
V2829374.xml
p27194
sg10
VSTD-Prendiville-1987a
p27195
sg12
S'PMC460631'
p27196
sa(dp27197
g8
V10799426.xml
p27198
sg10
VSTD-Chavasse-1999a
p27199
sg12
S'PMC1718341'
p27200
sasa(dp27201
g3
VCD008495 v. 1.2 Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying.rm5
p27202
sg5
(lp27203
(dp27204
g8
V10364900.xml
p27205
sg10
VSTD-Dougados-1999
p27206
sg12
S'PMC1752864'
p27207
sa(dp27208
g8
V16926184.xml
p27209
sg10
VSTD-Capell-2007
p27210
sg12
S'PMC1798490'
p27211
sasa(dp27212
g3
VCD004945 v. 7.0 Induction of labour for improving birth outcomes for women at or beyond term.rm5
p27213
sg5
(lp27214
(dp27215
g8
V3109575.xml
p27216
sg10
VSTD-Augensen-1987
p27217
sg12
S'PMC1246355'
p27218
sasa(dp27219
g3
VCD001186 v. 6.0 Injection allergen immunotherapy for asthma.rm5
p27220
sg5
(lp27221
(dp27222
g8
V2318962.xml
p27223
sg10
VSTD-Machiels-1990a
p27224
sg12
S'PMC296531'
p27225
sa(dp27226
g8
V1998791.xml
p27227
sg10
VSTD-Varney-1991
p27228
sg12
S'PMC1668945'
p27229
sa(dp27230
g8
V990806.xml
p27231
sg10
VSTD-Gaddie-1976
p27232
sg12
S'PMC1689452'
p27233
sa(dp27234
g8
V6800440.xml
p27235
sg10
VSTD-Hill-1982
p27236
sg12
S'PMC1495893'
p27237
sasa(dp27238
g3
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p27239
sg5
(lp27240
(dp27241
g8
V3092934.xml
p27242
sg10
VSTD-Klaus-1986
p27243
sg12
S'PMC1341377'
p27244
sa(dp27245
g8
V17612408.xml
p27246
sg10
VSTD-Bruggemann-2007
p27247
sg12
S'PMC1936417'
p27248
sasa(dp27249
g3
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p27250
sg5
(lp27251
(dp27252
g8
V7819058.xml
p27253
sg10
VSTD-Cascinu-1995
p27254
sg12
S'PMC2033463'
p27255
sa(dp27256
g8
V7683942.xml
p27257
sg10
VSTD-Scheithauer-1993
p27258
sg12
S'PMC1677246'
p27259
sasa(dp27260
g3
VCD008282 v. 2.0 Adenoidectomy for recurrent or chronic nasal symptoms in children.rm5
p27261
sg5
(lp27262
(dp27263
g8
V14769785.xml
p27264
sg10
VSTD-Koivunen-2004
p27265
sg12
S'PMC351838'
p27266
sasa(dp27267
g3
VCD004016 v. 6.0 Corticosteroid injections for shoulder pain.rm5
p27268
sg5
(lp27269
(dp27270
g8
V6416401.xml
p27271
sg10
VSTD-Hollingworth-1983
p27272
sg12
S'PMC1549498'
p27273
sa(dp27274
g8
V9804720.xml
p27275
sg10
VSTD-van-der-Windt-1998
p27276
sg12
S'PMC28713'
p27277
sa(dp27278
g8
V1855018.xml
p27279
sg10
VSTD-Jacobs-1991
p27280
sg12
S'PMC1670184'
p27281
sa(dp27282
g8
V2712613.xml
p27283
sg10
VSTD-Dacre-1989
p27284
sg12
S'PMC1003749'
p27285
sa(dp27286
g8
V9158469.xml
p27287
sg10
VSTD-Winters-1997
p27288
sg12
S'PMC2126546'
p27289
sa(dp27290
g8
V10774861.xml
p27291
sg10
VSTD-Plafki-2000
p27292
sg12
S'PMC3619854'
p27293
sa(dp27294
g8
V53845.xml
p27295
sg10
VSTD-Richardson-1975
p27296
sg12
S'PMC1864199'
p27297
sa(dp27298
g8
V6742895.xml
p27299
sg10
VSTD-Bulgen-1984
p27300
sg12
S'PMC1001344'
p27301
sasa(dp27302
g3
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p27303
sg5
(lp27304
(dp27305
g8
V16804523.xml
p27306
sg10
VSTD-Kikuchi-2006
p27307
sg12
S'PMC2360636'
p27308
sa(dp27309
g8
V12177800.xml
p27310
sg10
VSTD-Hoshiyama-2002
p27311
sg12
S'PMC2364221'
p27312
sa(dp27313
g8
V15054454.xml
p27314
sg10
VSTD-Suzuki-2004
p27315
sg12
S'PMC2409667'
p27316
sa(dp27317
g8
V18669903.xml
p27318
sg10
VSTD-Inoue-2008
p27319
sg12
S'PMC2574755'
p27320
sa(dp27321
g8
V10584890.xml
p27322
sg10
VSTD-Key-1999
p27323
sg12
S'PMC2374337'
p27324
sa(dp27325
g8
V18766189.xml
p27326
sg10
VSTD-Li-2008
p27327
sg12
S'PMC2567088'
p27328
sasa(dp27329
g3
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p27330
sg5
(lp27331
(dp27332
g8
V18317253.xml
p27333
sg10
VSTD-Chao-2008
p27334
sg12
S'PMC2483341'
p27335
sa(dp27336
g8
V18261131.xml
p27337
sg10
VSTD-Wright-2008
p27338
sg12
S'PMC2440307'
p27339
sasa(dp27340
g3
VCD005536 v. 5.0 Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in childr.rm5
p27341
sg5
(lp27342
(dp27343
g8
V16905564.xml
p27344
sg10
VSTD-Zar-2007
p27345
sg12
S'PMC2083341'
p27346
sasa(dp27347
g3
VCD001244 v. 4.0 Excitatory amino acid antagonists for acute stroke.rm5
p27348
sg5
(lp27349
(dp27350
g8
V23709702.xml
p27351
sg10
VSTD-Lub_x002d_Int-9
p27352
sg12
S'PMC3704336'
p27353
sa(dp27354
g8
V8799514.xml
p27355
sg10
VSTD-Sipatrigine-137_x002d_101
p27356
sg12
S'PMC2042617'
p27357
sasa(dp27358
g3
VCD008366 v. 3.0 Community wide interventions for increasing physical activity.rm5
p27359
sg5
(lp27360
(dp27361
g8
V10553400.xml
p27362
sg10
VSTD-Eaton-1999
p27363
sg12
S'PMC1508977'
p27364
sa(dp27365
g8
V19197403.xml
p27366
sg10
VSTD-Sarrafzadegan-2009
p27367
sg12
S'PMC2649597'
p27368
sa(dp27369
g8
V10589309.xml
p27370
sg10
VSTD-O_x0027_Loughlin-1999
p27371
sg12
S'PMC1509008'
p27372
sasa(dp27373
g3
VCD002885 v. 5.4 Oral xanthines as maintenance treatment for asthma in children.rm5
p27374
sg5
(lp27375
(dp27376
g8
V6788244.xml
p27377
sg10
VSTD-Evans-1981
p27378
sg12
S'PMC1505984'
p27379
sa(dp27380
g8
V6791596.xml
p27381
sg10
VSTD-Glass-1981
p27382
sg12
S'PMC1627266'
p27383
sa(dp27384
g8
V3535686.xml
p27385
sg10
VSTD-Conway-1986
p27386
sg12
S'PMC1777982'
p27387
sa(dp27388
g8
V6775752.xml
p27389
sg10
VSTD-Edmunds-1980
p27390
sg12
S'PMC1714307'
p27391
sa(dp27392
g8
V7785004.xml
p27393
sg10
VSTD-Wilson-1982
p27394
sg12
S'PMC474269'
p27395
sasa(dp27396
g3
VCD004390 v. 5.0 Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.rm5
p27397
sg5
(lp27398
(dp27399
g8
V8219860.xml
p27400
sg10
VSTD-Issenman-1993
p27401
sg12
S'PMC2379847'
p27402
sa(dp27403
g8
V1789830.xml
p27404
sg10
VSTD-Mackenzie-1991
p27405
sg12
S'PMC1670684'
p27406
sa(dp27407
g8
V3901934.xml
p27408
sg10
VSTD-Sharifi-1985
p27409
sg12
S'PMC1777458'
p27410
sasa(dp27411
g3
VCD007639 v. 5.0 Nebuliser systems for drug delivery in cystic fibrosis.rm5
p27412
sg5
(lp27413
(dp27414
g8
V12876172.xml
p27415
sg10
VSTD-Byrne-2003
p27416
sg12
S'PMC1719590'
p27417
sa(dp27418
g8
V1750018.xml
p27419
sg10
VSTD-Thomas-1991
p27420
sg12
S'PMC463390'
p27421
sa(dp27422
g8
V3406919.xml
p27423
sg10
VSTD-Newman-1988
p27424
sg12
S'PMC461220'
p27425
sasa(dp27426
g3
VCD002977 v. 6.0 Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP).rm5
p27427
sg5
(lp27428
(dp27429
g8
V11517199.xml
p27430
sg10
VSTD-Mazzella-2001
p27431
sg12
S'PMC1721298'
p27432
sasa(dp27433
g3
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p27434
sg5
(lp27435
(dp27436
g8
V22615593.xml
p27437
sg10
VSTD-Baharvand-2010
p27438
sg12
S'PMC3232086'
p27439
sasa(dp27440
g3
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p27441
sg5
(lp27442
(dp27443
g8
V19703826.xml
p27444
sg10
VSTD-Osman-2010
p27445
sg12
S'PMC2922723'
p27446
sasa(dp27447
g3
VCD005497 v. 7.0 Advance provision of emergency contraception for pregnancy prevention.rm5
p27448
sg5
(lp27449
(dp27450
g8
V18398664.xml
p27451
sg10
VSTD-Schwartz-2008
p27452
sg12
S'PMC2517895'
p27453
sasa(dp27454
g3
VCD005481 v. 4.4 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
p27455
sg5
(lp27456
(dp27457
g8
V19358725.xml
p27458
sg10
VSTD-Kumar-2009
p27459
sg12
S'PMC2672933'
p27460
sa(dp27461
g8
V20554983.xml
p27462
sg10
VSTD-Shapiro-2010
p27463
sg12
S'PMC2999916'
p27464
sasa.